<SEC-DOCUMENT>0001093557-23-000220.txt : 20231026
<SEC-HEADER>0001093557-23-000220.hdr.sgml : 20231026
<ACCEPTANCE-DATETIME>20231026171439
ACCESSION NUMBER:		0001093557-23-000220
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231026
DATE AS OF CHANGE:		20231026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		231351019

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dxcm-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163,d:9fa53d16cdda40f09337e7f3f72540fe--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dxcm="http://www.dexcom.com/20230930" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dxcm-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-28">0001093557</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-29">12/31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-162" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-847">0.0243476</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-182" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-848">0.0061571</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-176" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-849">0.006662</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-202" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-850">0.5</ix:nonFraction><ix:nonNumeric contextRef="c-250" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-964">367</ix:nonNumeric><ix:nonNumeric contextRef="c-248" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-965">366</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dxcm-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-10</xbrli:startDate><xbrli:endDate>2022-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="purchaser"><xbrli:measure>dxcm:purchaser</xbrli:measure></xbrli:unit><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:FederalReserveBankOfNewYorkRateNYFRBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dxcm:claim</xbrli:measure></xbrli:unit><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>dxcm:patent</xbrli:measure></xbrli:unit><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dxcm:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023TerminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023TerminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023AdoptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023AdoptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:NicholasAugustinosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:NicholasAugustinosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.306%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.&#160;20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:522.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:490.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September&#160;30, 2023</ix:nonNumeric></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160; &#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-51222</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><img src="dxcm-20230930_g1.jpg" alt="dexcom-logo-green-rgb (1).jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:215px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">DEXCOM, INC.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.590%"><tr><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">33-0857544</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.590%"><tr><td style="width:1.0%"></td><td style="width:45.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">6340 Sequence Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">San Diego</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">CA</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">92121</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">200-0200</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.945%"><tr><td style="width:1.0%"></td><td style="width:30.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">DXCM</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;                                                     &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;                                                                                                                   &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.338%"><tr><td style="width:1.0%"></td><td style="width:28.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       &#160;&#9744;&#160;&#160;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">October&#160;19, 2023, there were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">386,373,935</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.081%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;border-top:1pt solid #58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt solid #58a618;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_16">PART I. FINANCIAL INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_13">ITEM&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_16">Consolidated Balance Sheets (unaudited) as of </a>September&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_16"> and </a>December&#160;31, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_19">Consolidated Statements of Operations (unaudited) for the </a>three and nine m<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_19">onths ended </a>September&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_19"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_22">Consolidated Statements of Comprehensive Income (unaudited) for the </a>three and nine<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_22"> months ended </a>September&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_22"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_25">Consolidated Statements of Stockholders&#8217; Equity (unaudited) for the </a>three and nine<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_25"> months ended </a>September&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_25"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_31">Consolidated Statements of Cash Flows (unaudited) for the </a>nine months ended<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_31"> </a>September&#160;30, 2023<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_31"> and </a>2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_34">Notes to Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_145">ITEM&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_145">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_145">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_181">ITEM&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_181">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_181">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_193">ITEM&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_193">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_193">41</a></span></div></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_196">PART II. OTHER INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_199">ITEM&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_199">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_199">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_202">ITEM&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_202">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_202">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_253">ITEM&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_253">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_253">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_259">ITEM&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_259">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_259">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_262">ITEM&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_262">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_262">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_265">ITEM&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_265">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_265">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_268">ITEM&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_268">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_268">88</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i9fa53d16cdda40f09337e7f3f72540fe_271">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_271">90</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for historical financial information contained herein, the matters discussed in this Quarterly Report on Form 10-Q may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and subject to the safe harbor created by the Securities Litigation Reform Act of 1995. Such statements include declarations regarding our intent, belief, or current expectations and those of our management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which are beyond our control; actual results could differ materially from those indicated by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i) that the information is of a preliminary nature and may be subject to further adjustment; (ii) those risks and uncertainties identified under &#8220;Risk Factors&#8221;; and (iii) the other risks detailed from time-to-time in our reports and registration statements filed with the Securities and Exchange Commission, or the SEC. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVAILABLE INFORMATION</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is located at dexcom.com and our investor relations website is located at investors.dexcom.com. We file electronically with the SEC our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. We make available on our website, free of charge, copies of these reports and other information as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We announce material information to the public about us, our products, and other matters through a variety of means, including filings with the SEC, press releases, public conference calls, presentations, webcasts, and our investor relations website in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. Except as expressly set forth in this Quarterly Report on Form 10-Q, the contents of our website is not incorporated by reference into, or otherwise to be regarded as part of, this Quarterly Report on Form 10-Q or in any other report or document we file with the SEC, and any references to our website is intended to be inactive textual references only.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information disclosed by the foregoing channels could be deemed to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and review the information disclosed through such channels.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #32ad10;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1. FINANCIAL STATEMENTS</span></div></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_16"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Balance Sheets</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except par value data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-30">643.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-31">642.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-32">2,596.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-33">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-34">785.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-35">713.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-36">498.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-37">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-38">173.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-39">192.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-40">4,698.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-41">3,668.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-42">1,078.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-43">1,055.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-44">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-45">80.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-46">25.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-47">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-48">144.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-49">173.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-50">501.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-51">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-52">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-53">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-54">6,596.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-55">5,391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-56">1,373.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-57">901.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-58">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-59">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" scale="6" id="f-60">124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" scale="6" id="f-61">772.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-62">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-63">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-64">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-65">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-66">1,678.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-67">1,839.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-68">2,432.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-69">1,197.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-70">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-71">94.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-72">133.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-73">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-74">4,328.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-75">3,259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-76"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-77"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-78"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-79">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-80"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-81">5.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-83"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-85">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-88"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-89">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-91">800.0</ix:nonFraction></ix:nonFraction> million shares authorized;</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-92">405.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-93">386.4</ix:nonFraction> million shares issued and outstanding, respectively, at September&#160;30, 2023; and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-94">393.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-95">386.3</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-96">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-97">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-98">3,618.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-99">2,258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-100">35.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-101">11.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-102">765.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-103">479.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-104">19.1</ix:nonFraction> million shares at September&#160;30, 2023 and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-105">6.9</ix:nonFraction> million shares at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-106">2,080.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-107">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-108">2,267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-109">2,131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-110">6,596.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-111">5,391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-112">975.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-113">769.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-114">2,587.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-115">2,094.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-116">351.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-117">275.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-118">955.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-119">752.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-120">623.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-121">494.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-122">1,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-123">1,341.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-124">131.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-125">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-126">369.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-127">367.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-128">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-129">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-130">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-131">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-132">284.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-133">234.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-134">876.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-135">702.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-136">417.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-137">346.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-138">1,251.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-139">1,076.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-140">205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-141">147.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-142">380.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-143">265.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="f-144">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" format="ixt:fixed-zero" scale="6" id="f-145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="f-146">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="f-147">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-148">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-149">1.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-150">82.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-151">8.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-152">240.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-153">146.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-154">464.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-155">257.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-156">119.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-157">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-158">179.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-159">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-160">120.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-161">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-162">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-163">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-164">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-165">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-166">0.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-167">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-168">386.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-169">389.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-170">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-171">390.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-172">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-173">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-174">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-175">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted net income per share</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-176">426.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-177">425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-178">428.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-179">428.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-180">120.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-181">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-182">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-183">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments and other</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-184">7.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-185">19.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-186">25.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-187">34.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-188">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-189">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-190">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-191">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-192">6.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-193">18.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-194">24.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-195">41.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-196">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-197">83.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-198">261.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-199">207.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-200">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-201">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-202">2,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-203">29.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-204">644.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-205">784.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-206">2,100.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-207">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-208">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-209">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-210">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock, including excise tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" scale="6" id="f-211">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" scale="6" id="f-212">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-213">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-214">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-215">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" scale="6" id="f-216">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:num-dot-decimal" scale="6" id="f-217">1,296.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" sign="-" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:num-dot-decimal" scale="6" id="f-218">1,296.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:fixed-zero" scale="6" id="f-219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-220">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-221">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-222">120.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-223">120.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-224">6.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-225">6.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-226">386.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-227">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-228">3,618.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-229">35.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-230">765.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-231">2,080.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-232">2,267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at June 30, 2022 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-233">392.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-234">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-235">2,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-236">23.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-237">286.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-238">37.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-239">2,255.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-240">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-241">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-242">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-243">6.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-244">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-245">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-246">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-247">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-248">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-249">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-250">18.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-251">18.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at September 30, 2022 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-252">386.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-253">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-254">2,072.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-255">41.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-256">388.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-257">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-258">1,824.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-259">386.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-260">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-261">2,258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-262">11.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-263">479.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-264">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-265">2,131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-266">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-267">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-268">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-269">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock, including excise tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-270">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" sign="-" name="dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" scale="6" id="f-271">188.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" scale="6" id="f-272">188.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-273">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-274">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-275">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" scale="6" id="f-276">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:num-dot-decimal" scale="6" id="f-277">1,296.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" sign="-" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:num-dot-decimal" scale="6" id="f-278">1,296.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:fixed-zero" scale="6" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call transactions, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-280">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-281">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-282">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-283">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-284">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-285">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-286">24.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-287">24.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at September 30, 2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-288">386.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-289">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-290">3,618.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-291">35.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-292">765.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-293">2,080.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-294">2,267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-295">388.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-296">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-297">2,108.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-298">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-299">138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-300">206.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-301">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-302">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-303">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-304">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-305">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-306">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-307">189.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-308">189.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone" scale="6" id="f-309">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-310">6.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-311">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-312">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-313">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-314">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-315">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-316">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" scale="6" id="f-317">0.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" scale="6" id="f-318">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" sign="-" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" scale="6" id="f-319">33.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedgeValue" format="ixt:fixed-zero" scale="6" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-321">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-322">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-323">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-324">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-325">41.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-326">41.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at September 30, 2022 </span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-327">386.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-328">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-329">2,072.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-330">41.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-331">388.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-332">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-333">1,824.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consolidated Statements of Cash Flows</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-334">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-335">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to cash provided by operating activities:</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-336">133.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-337">119.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-338">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-339">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-340">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-341">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized (gain) loss on equity investment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-342">1.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-343">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-344">136.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-345">53.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash income and expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-346">47.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-347">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-348">72.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-349">51.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-350">193.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-351">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-352">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-353">81.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-354">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-355">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-356">496.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-357">171.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-358">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-359">14.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue and other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-360">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-361">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-362">614.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-363">537.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-364">2,947.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-365">1,397.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-366">2,228.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-367">1,387.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-368">184.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-369">301.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-371">3.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-372">18.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-373">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-374">922.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-375">327.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-376">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-377">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-378">188.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-379">557.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of senior convertible notes, net of issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-380">1,230.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of capped call transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" scale="6" id="f-382">101.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:fixed-zero" scale="6" id="f-383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for conversions of senior convertible notes</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="f-384">650.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-386">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-387">16.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-388">313.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-389">551.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-390">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-391">12.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-392">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-393">354.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-394">643.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-395">1,053.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-396">644.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-397">699.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-398">643.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-399">698.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-400">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-401">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-402">644.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-403">699.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued for conversions of 2023 Notes</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="6" id="f-404">1,316.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="f-405">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares received under note hedge upon conversion of 2023 Notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" format="ixt:num-dot-decimal" scale="6" id="f-406">1,296.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" scale="6" id="f-407">33.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of property and equipment included in accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-408">47.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-409">60.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" scale="6" id="f-410">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" scale="6" id="f-411">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for finance lease liabilities</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-412">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-413">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-top:9pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notes to Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_37"></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-414" continuedAt="f-414-1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table></ix:nonNumeric></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_40"></div><ix:continuation id="f-414-1" continuedAt="f-414-2"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_43"></div><ix:continuation id="f-414-2" continuedAt="f-414-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-415" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-416" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a <ix:nonFraction unitRef="number" contextRef="c-62" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" format="ixt-sec:numwordsen" scale="0" id="f-417">four</ix:nonFraction>-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $<ix:nonFraction unitRef="usdPerShare" contextRef="c-63" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-418">0.001</ix:nonFraction> per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_46"></div><ix:continuation id="f-414-3" continuedAt="f-414-4"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Seasonality</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_49"></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="f-414-4" continuedAt="f-414-5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Significant Accounting Policies</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-414-5" continuedAt="f-414-6">There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the nine months ended September&#160;30, 2023</ix:continuation>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-414-6" continuedAt="f-414-7"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-419" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_55"></div><ix:continuation id="f-414-7" continuedAt="f-414-8"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-420" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_61"></div><ix:continuation id="f-414-8" continuedAt="f-414-9"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-421" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from <ix:nonNumeric contextRef="c-64" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-422">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-65" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-423">90</ix:nonNumeric> days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of September&#160;30, 2023 included unbilled accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-424">8.8</ix:nonFraction> million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-425">21.3</ix:nonFraction> million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of September&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-426">19.0</ix:nonFraction> million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_64"></div><ix:continuation id="f-414-9" continuedAt="f-414-10"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-427" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-414-10" continuedAt="f-414-11"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-428" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-429">120.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-430">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-431">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-432">249.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-433">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-434">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-435">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-436">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-437">123.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-438">104.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-439">294.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-440">257.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-441">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-442">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-443">0.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-444">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-445">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-446">0.24</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-447">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-448">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-449">386.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-450">389.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-451">386.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-452">390.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-453">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-454">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-455">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-456">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-457">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-458">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-72" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-459">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-460">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-461">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-462">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-463">28.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-464">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-465">426.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-466">425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-467">428.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-468">428.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-469" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-78" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-471">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-81" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-473">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_70"></div><ix:continuation id="f-414-11"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-474" continuedAt="f-474-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-474-1">We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements</ix:continuation>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-475" continuedAt="f-475-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-82" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-476">29.57</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the fourth quarter of 2018, we made an initial payment for an upfront fee of $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="dxcm:CollaborativeArrangementUpfrontFee" scale="6" id="f-477">250.0</ix:nonFraction> million through the issuance of <ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-478">7,363,772</ix:nonFraction> shares of our common stock. We recorded a $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="f-479">217.7</ix:nonFraction> million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-82" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-480">29.57</ix:nonFraction> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" format="ixt:num-dot-decimal" scale="6" id="f-481">3.2</ix:nonFraction> million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" format="ixt:num-dot-decimal" scale="6" id="f-482">87.1</ix:nonFraction> million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-483">2,945,508</ix:nonFraction> shares of our common stock in connection with our achievement of the related milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-484">152.4</ix:nonFraction> million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) <ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-485">5,154,640</ix:nonFraction> shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-82" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-486">29.57</ix:nonFraction> per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-475-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">life of <ix:nonNumeric contextRef="c-91" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:durmonth" id="f-487">64</ix:nonNumeric> months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_82"></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="f-488" continuedAt="f-488-1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table></ix:nonNumeric></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_2244"></div><ix:continuation id="f-488-1" continuedAt="f-488-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-489" continuedAt="f-489-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of September&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-490">360.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-491">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-493">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-495">1,819.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-497">1,819.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-499">387.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-501">387.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-503">390.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-505">390.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-506">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-507">2,596.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-509">2,596.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-510">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-513">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-514">374.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-515">2,626.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-517">3,001.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-488-2" continuedAt="f-488-3"><ix:continuation id="f-489-1"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-518">375.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-519">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-521">420.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-523">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-525">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-527">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-528">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-529">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-531">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-533">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-535">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-537">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-538">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-541">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-542">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-543">1,858.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-544">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-545">2,244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-546"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-547"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-548"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-549">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transfers into or out of Level 3 securities during the three and nine months ended September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2274"></div><ix:continuation id="f-488-3" continuedAt="f-488-4"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="f-550" continuedAt="f-550-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="f-551">281.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-552">2,136.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-553">1,140.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-554">1,314.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-555">1,109.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:fixed-zero" scale="6" id="f-556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-557">2,531.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-558">3,451.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 5 &#8220;Debt&#8221; to the consolidated financial statements.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2219"></div><ix:continuation id="f-488-4" continuedAt="f-488-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-559">89.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-560">62.0</ix:nonFraction> million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_2194"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-488-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-561">38.5</ix:nonFraction>&#160;million as of September&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-562">19.0</ix:nonFraction> million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-563"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-564"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-565"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-566">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> significant impairment losses during the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_88"></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="f-567" continuedAt="f-567-1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4. Balance Sheet Details and Other Financial Information</span></div></td></tr></table></ix:nonNumeric></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_91"></div><ix:continuation id="f-567-1" continuedAt="f-567-2"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-568" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-569">1,820.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-570">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-571">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-572">1,819.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-573">387.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-575">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-576">387.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-577">391.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-579">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-580">390.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-581">2,599.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-582">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-583">3.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-584">2,596.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-585">1,535.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-586">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-587">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-588">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-589">119.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-591">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-592">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-593">164.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-595">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-596">163.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-597">1,819.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-598">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-599">5.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-600">1,813.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-601">2.60</ix:nonFraction>&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-602">1.81</ix:nonFraction>&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-567-2" continuedAt="f-567-3">reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at September&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</ix:continuation></span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_94"></div><ix:continuation id="f-567-3" continuedAt="f-567-4"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-603" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-604">277.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-605">159.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-606">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-607">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-608">193.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-609">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-610">498.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-611">306.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_97"></div><ix:continuation id="f-567-4" continuedAt="f-567-5"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Prepaid and Other Current Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock" id="f-612" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-613">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-614">48.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-615">61.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-616">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-617">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-618">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-619">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-620">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-621">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-622">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-623">173.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-624">192.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_100"></div><ix:continuation id="f-567-5" continuedAt="f-567-6"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-625" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-626">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-627">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-628">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-629">54.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-630">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-631">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-632">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-633">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-634">632.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-635">449.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-636">276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-637">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-638">343.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-639">542.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-640">1,545.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-641">1,418.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-642">466.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-643">363.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-644">1,078.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-645">1,055.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_106"></div><ix:continuation id="f-567-6" continuedAt="f-567-7"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="f-646" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-647">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-648">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-649">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-650">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-651">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-652">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-653">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-654">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-567-7" continuedAt="f-567-8"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-655" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-656">242.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-657">237.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="f-658">218.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFees" scale="6" id="f-659">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="f-660">837.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:PharmacyRebates" scale="6" id="f-661">556.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-662">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-663">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-664">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-665">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-666">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-667">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-668">1,373.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-669">901.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_112"></div><ix:continuation id="f-567-8" continuedAt="f-567-9"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accrued Payroll and Related Expenses</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" id="f-670" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-671">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-672">96.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-673">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-674">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-675">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-676">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_115"></div><ix:continuation id="f-567-9" continuedAt="f-567-10"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="f-677" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-678">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-679">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-680">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-681">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-682">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-683">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-684">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-685">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-686">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-687">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-688">133.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-689">128.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2537"></div><ix:continuation id="f-567-10"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Income (Expense), Net</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-690" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividend income</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-691">41.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-692">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-693">101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-694">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-695">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-696">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-697">15.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="f-698">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-699">2.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-700">2.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-701">3.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-702">4.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-703">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-704">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-705">82.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-706">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-707" continuedAt="f-707-1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table></ix:nonNumeric></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_2166"></div><ix:continuation id="f-707-1" continuedAt="f-707-2"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><ix:continuation id="f-550-1"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-708">124.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-709">774.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-710">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-711">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-712">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:fixed-zero" scale="6" id="f-713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-714">2,581.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-715">1,982.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-716">25.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-717">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-718">2,556.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-719">1,970.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConvertibleDebtTableTextBlock" id="f-720" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-721">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-722">1,361.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-724">33.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-727">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:num-dot-decimal" scale="6" id="f-728">1,395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="f-729" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-730">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-731">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-732">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-733">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-734">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-735">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-736">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-737">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-738">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-739">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-740">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-741">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-156" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-742">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-157" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-743">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-156" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-744">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-157" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-745">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-746">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-159" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-747">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-748">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-159" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-749">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-160" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-750">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-160" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-751">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Not applicable as no notes were outstanding at this date.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2140"></div><ix:continuation id="f-707-2" continuedAt="f-707-3"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-161" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-752">0.75</ix:nonFraction>% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-753">850.0</ix:nonFraction> million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;<ix:nonFraction unitRef="number" contextRef="c-161" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-754">0.75</ix:nonFraction>%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#8220;2023 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-755">836.6</ix:nonFraction> million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-756">41.07</ix:nonFraction>&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#8220;2023 Note Hedge&#8221;) and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-707-3" continuedAt="f-707-4"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants (the &#8220;2023 Warrants&#8221;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, holders of $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" format="ixt:num-dot-decimal" scale="6" id="f-757">17.5</ix:nonFraction>&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-758">425,552</ix:nonFraction> shares to settle the converted 2023 Notes. We received <ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" format="ixt:num-dot-decimal" scale="0" id="f-759">287,492</ix:nonFraction> shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2023, we settled $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" format="ixt:num-dot-decimal" scale="6" id="f-760"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" format="ixt:num-dot-decimal" scale="6" id="f-761">650.5</ix:nonFraction></ix:nonFraction>&#160;million in aggregate principal amount of the 2023 Notes through a combination of $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" format="ixt:num-dot-decimal" scale="6" id="f-762"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" format="ixt:num-dot-decimal" scale="6" id="f-763">650.5</ix:nonFraction></ix:nonFraction>&#160;million in cash for the principal amount and <ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-764"><ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-765">10,599,907</ix:nonFraction></ix:nonFraction> shares of common stock for the amount in excess of the principal amount. We received <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="INF" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" format="ixt:num-dot-decimal" scale="0" id="f-766"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" format="ixt:num-dot-decimal" scale="0" id="f-767">10,585,850</ix:nonFraction></ix:nonFraction> shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining outstanding principal of $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" format="ixt:num-dot-decimal" scale="6" id="f-768">124.3</ix:nonFraction>&#160;million as of September&#160;30, 2023 and any amount in excess of the principal amount will settle on or before the maturity date of December&#160;1, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at <ix:nonFraction unitRef="number" contextRef="c-122" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-769">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes had the ability to convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-168" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-770">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-169" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-771">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-168" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-772">130</ix:nonFraction>% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-170" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-773">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-171" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-774">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-171" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-775">five</ix:nonFraction>-day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-171" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-776">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022, March&#160;31, 2023, and June&#160;30, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through August 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. See above for a description of conversion activity related to the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom was permitted to redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-777">130</ix:nonFraction>% of the conversion price then in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-707-4" continuedAt="f-707-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect for at least <ix:nonFraction unitRef="d" contextRef="c-168" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-778">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-169" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-779">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price was equal to <ix:nonFraction unitRef="number" contextRef="c-148" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-780">100</ix:nonFraction>% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with <ix:nonFraction unitRef="purchaser" contextRef="c-172" decimals="INF" name="dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" format="ixt-sec:numwordsen" scale="0" id="f-781">two</ix:nonFraction> of the initial purchasers of the 2023 Notes (the &#8220;2023 Counterparties&#8221;) entitling us to purchase up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-173" decimals="-5" name="dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="f-782">20.7</ix:nonFraction> million&#160;shares of our common stock at an initial price of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-783">41.07</ix:nonFraction>&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-784">218.9</ix:nonFraction> million and we accounted for it as an equity instrument by recognizing $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-785">218.9</ix:nonFraction> million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-162" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="6" id="f-786">20.7</ix:nonFraction> million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the <ix:nonFraction unitRef="d" contextRef="c-162" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-787">60</ix:nonFraction> scheduled trading days starting on March&#160;1, 2024. We received&#160;$<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-788">183.8</ix:nonFraction> million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $<ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-789">49.60</ix:nonFraction> per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2114"></div><ix:continuation id="f-707-5" continuedAt="f-707-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-790">0.25</ix:nonFraction>% Senior Convertible Notes due 2025</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-791">1.21</ix:nonFraction> billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-792">0.25</ix:nonFraction>% and a maturity date of November&#160;15, 2025 (the &#8220;2025 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="9" id="f-793">1.19</ix:nonFraction> billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-794">150.11</ix:nonFraction> per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-795">100</ix:nonFraction>% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-178" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-796">20</ix:nonFraction> trading days (whether or </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-707-6" continuedAt="f-707-7"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-179" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-797">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-178" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-798">130</ix:nonFraction>% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-180" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-799">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-181" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-800">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-181" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-801">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-181" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-802">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom was not permitted to redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-150" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-803">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="c-178" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-804">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-179" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-805">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-152" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-806">100</ix:nonFraction>% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2088"></div><ix:continuation id="f-707-7" continuedAt="f-707-8"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-807">0.375</ix:nonFraction>% Senior Convertible Notes due 2028</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-808">1.25</ix:nonFraction>&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of <ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-809">0.375</ix:nonFraction>% and a maturity date of May&#160;15, 2028 (the &#8220;2028 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="9" id="f-810">1.23</ix:nonFraction>&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-177" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-811">162.41</ix:nonFraction> per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to <ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-812">100</ix:nonFraction>% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-183" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-813">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-184" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-814">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-183" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-815">130</ix:nonFraction>% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the <ix:nonFraction unitRef="d" contextRef="c-185" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-816">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="d" contextRef="c-186" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-817">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that <ix:nonFraction unitRef="d" contextRef="c-186" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-818">five</ix:nonFraction> day consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-186" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-819">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-707-8" continuedAt="f-707-9"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-152" decimals="2" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-820">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="d" contextRef="c-183" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-821">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="c-184" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-822">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-152" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-823">100</ix:nonFraction>% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Capped Call Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#8220;2028 Capped Calls&#8221;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-187" decimals="INF" name="dxcm:DebtInstrumentCapCallTransactionCapPricePerShare" scale="0" id="f-824">212.62</ix:nonFraction> per share, subject to adjustments, which represents a premium of <ix:nonFraction unitRef="number" contextRef="c-187" decimals="INF" name="dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" scale="-2" id="f-825">80</ix:nonFraction>% over the closing price of our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-188" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-826">118.12</ix:nonFraction> per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:num-dot-decimal" scale="6" id="f-827">101.3</ix:nonFraction> million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#8217; equity.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2062"></div><ix:continuation id="f-707-9" continuedAt="f-707-10"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a <ix:nonNumeric contextRef="c-189" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-828">five-year</ix:nonNumeric> revolving credit facility, that provides for an available principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-829">200.0</ix:nonFraction> million which can be increased up to $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="INF" name="dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" format="ixt:num-dot-decimal" scale="6" id="f-830">500.0</ix:nonFraction> million at our option subject to customary conditions and approval of our lenders (the &#8220;Credit Facility&#8221;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="f-831" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-832">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-833">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="f-834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="f-835">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="f-836">192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#8220;ABR&#8221;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-193" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-837">0.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-194" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-838">1.000</ix:nonFraction>%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) for a one month interest period plus <ix:nonFraction unitRef="number" contextRef="c-195" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-839">1</ix:nonFraction>%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-707-10"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-196" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-840">1.375</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-197" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-841">2.000</ix:nonFraction>%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#8220;RFR&#8221;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between <ix:nonFraction unitRef="number" contextRef="c-198" decimals="6" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-842">0.0326</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-199" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-843">0.100</ix:nonFraction>% depending on the loan denomination. We will also pay a commitment fee of between <ix:nonFraction unitRef="number" contextRef="c-200" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-844">0.175</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-201" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-845">0.250</ix:nonFraction>%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="6" id="f-846">5.3</ix:nonFraction>&#160;million term deposit that is included in non-current &#8220;Other assets&#8221; on our consolidated balance sheets.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_130"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-851" continuedAt="f-851-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6. Contingencies</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:23.15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between June 2021 through the nine months ended September 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have served complaints against each other in multiple jurisdictions, including in the United States (United States District Court ("U.S.D.C.&#8221;), District of Delaware), the United Kingdom (Business and Property Courts of England and Wales), France (United Patent Court (&#8220;UPC&#8221;) in Paris), Spain (Commercial Courts of Barcelona) and Germany (National Courts (&#8220;N.C.&#8221;) of Munich, Mannheim, Dusseldorf and Hamburg and the UPC in Munich), primarily involving claims of patent infringement, invalidity and other patent related actions. In June and July of 2021, we initiated patent infringement litigation against Abbott in the United States (U.S.D.C., Western District of Texas) and Germany (N.C. in Mannheim) and filed additional patent infringement actions in May 2023 in Germany (N.C. in Munich) over certain of Abbott's continuous glucose monitoring products. In July and August 2023, we initiated patent infringement litigation in France and Germany in the UPC and in Spain (Commercial Courts of Barcelona).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between July 2021 through the nine months ended September 30, 2023, Abbott initiated patent infringement litigation against Dexcom in multiple jurisdictions, including the United States (U.S.D.C., Delaware), the United Kingdom (Business and Property Courts of England and Wales), and in Germany (N.C. in Mannheim, Dusseldorf and Hamburg) over certain of Dexcom's continuous glucose monitoring products. In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in that jurisdiction. <ix:nonFraction unitRef="claim" contextRef="c-203" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-852">Three</ix:nonFraction> trials on liability have already been conducted in the United Kingdom. On October 18, judgment was handed down in favor of Dexcom in one of these trials. The parties are awaiting rulings on the remaining <ix:nonFraction unitRef="claim" contextRef="c-204" decimals="0" name="dxcm:LossContingencyPendingClaimsRemainingNumber" format="ixt-sec:numwordsen" scale="0" id="f-853">two</ix:nonFraction>. Dexcom and Abbott seek injunctive relief and monetary damages as a result of their respective claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract lawsuit against Dexcom in the U.S.D.C., District of Delaware alleging that Dexcom breached the parties' Settlement and License Agreement dated July 2, 2014 (&#8220;SLA&#8221;). The U.S.D.C., District of Delaware consolidated Abbott&#8217;s breach of contract lawsuit with Dexcom&#8217;s patent infringement lawsuit which had been transferred from the U.S.D.C., Western District of Texas. Dexcom asserted counterclaims that Abbott also breached the SLA. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury verdict determined that Abbott was not licensed to <ix:nonFraction unitRef="claim" contextRef="c-205" decimals="0" name="dxcm:LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" format="ixt-sec:numwordsen" scale="0" id="f-854">thirteen</ix:nonFraction> claims of certain Dexcom patents and that Abbott was licensed to <ix:nonFraction unitRef="claim" contextRef="c-205" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-855">five</ix:nonFraction> claims. Dexcom&#8217;s patent infringement claims in Delaware are stayed until November 10, 2023, at which point the U.S. Patent and Trademark Office will have issued </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-851-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its final written decisions on certain patents involved in the lawsuit. We will continue to enforce the remaining claims of the patents asserted in Delaware.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s patent infringement action against Dexcom is currently scheduled for trial in the U.S.D.C., District of Delaware on March 11, 2024. In the lead up to trial, the U.S.D.C., District of Delaware invalidated <ix:nonFraction unitRef="patent" contextRef="c-206" decimals="0" name="us-gaap:LossContingencyPatentsFoundNotInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="f-856">one</ix:nonFraction> of Abbott&#8217;s patents and Abbott dropped <ix:nonFraction unitRef="patent" contextRef="c-206" decimals="0" name="dxcm:LossContingencyAdditionalPatentsFoundNotInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="f-857">four</ix:nonFraction> other patents from the litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in December 2023, Abbott has several patent infringement hearings against Dexcom in the National Court in Hamburg and Munich wherein Abbott is seeking damages and injunctive relief.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March and April of 2024, Dexcom has several patent infringement hearings in Munich against Abbott, wherein Dexcom is seeking damages and injunctive relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding patent litigation procedures initiated by Dexcom and Abbott throughout multiple jurisdictions, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_133"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-858" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our annual effective tax rate to be <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent" scale="-2" id="f-859">24.7</ix:nonFraction>% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, increases to unrecognized tax benefits, and impact of foreign operations, partially offset by federal tax credits generated. Our actual effective tax rate of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-860">38.6</ix:nonFraction>% for the nine months ended September&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, increased by discrete foreign taxes related to an intra-entity transfer of certain intellectual property, and decrease in the state tax rate applied to beginning of year deferred tax assets, partially offset by tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, we completed an intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries to align our structure with the expansion of international business operations. We recorded a $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="6" id="f-861">186.6</ix:nonFraction>&#160;million deferred tax asset, which represents the difference between the basis of the intellectual property for financial statement and tax purposes, applying the appropriate enacted statutory tax rate. Based on available evidence, management believes it is not more-likely-than-not that the additional foreign deferred tax asset will be realizable, and is therefore, fully offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer resulted in $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="6" id="f-862">65.2</ix:nonFraction>&#160;million of net tax expense, which increased our actual effective tax rate for the nine months ended September&#160;30, 2023.</span></div></ix:nonNumeric><div id="i9fa53d16cdda40f09337e7f3f72540fe_136"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-863" continuedAt="f-863-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8. Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-864" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-865">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-866">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-867">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-868">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-869">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-870">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-871">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-872">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-873">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-874">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-875">68.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-876">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-877">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-878">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-879">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-880">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-881">238.4</ix:nonFraction> million and are expected to be recognized through 2027.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-863-1" continuedAt="f-863-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest date fair value of RSUs and PSUs that vested during the nine months ended September&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-882">138.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-883">9.9</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2301"></div><ix:continuation id="f-863-2" continuedAt="f-863-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-884">700.0</ix:nonFraction>&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#8220;2022 Share Repurchase Program&#8221;). Shares of common stock repurchased under the 2022 Share Repurchase Program became treasury shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased approximately $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-885">557.7</ix:nonFraction> million of our outstanding common stock throughout the duration of the 2022 Share Repurchase Program. The 2022 Share Repurchase Program and the remaining authorization of approximately $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="f-886">142.3</ix:nonFraction>&#160;million expired on June 30, 2023. There were <ix:nonFraction unitRef="usd" contextRef="c-225" decimals="0" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="0" id="f-887">no</ix:nonFraction> share repurchases under the 2022 Share Repurchase Program in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase <ix:nonFraction unitRef="shares" contextRef="c-226" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="f-888">1.6</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-889">188.7</ix:nonFraction> million, excluding excise tax due under the Inflation Reduction Act of 2022, for an average per share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-226" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-890">118.12</ix:nonFraction>, via privately negotiated transactions, independent of the 2022 Share Repurchase Program.</span></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_2325"></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-863-3">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</ix:continuation></span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_139"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-891" continuedAt="f-891-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-892">one</ix:nonFraction> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><ix:continuation id="f-891-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-893" continuedAt="f-893-1" escape="true">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="f-893-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-894">713.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-895">73</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-896">573.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-897">75</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-898">261.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-229" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-899">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-900">196.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-230" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-901">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-902">975.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-903">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-904">769.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-905">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-906">1,856.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-231" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-907">72</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-908">1,535.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-232" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-909">73</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-910">731.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-233" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-911">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-912">559.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-234" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-913">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-914">2,587.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-915">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-916">2,094.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-917">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by customer sales channel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-918" continuedAt="f-918-1" escape="true">The following table sets forth revenue by major sales channel for the periods shown:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="f-918-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-919">839.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-920">86</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-921">656.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-922">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-923">135.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-237" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-924">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-925">113.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-926">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-927">975.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-928">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-929">769.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-930">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-931">2,197.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-932">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-933">1,768.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-934">84</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-935">390.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-936">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-937">326.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-938">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-939">2,587.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-940">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-941">2,094.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-942">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div id="i9fa53d16cdda40f09337e7f3f72540fe_142"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-943" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10. Subsequent Events</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2023, our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-944">500.0</ix:nonFraction>&#160;million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#8220;2023 Share Repurchase Program&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases of our common stock under the 2023 Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, and other applicable federal and state laws and regulations. The timing of any repurchases will depend on market conditions and will be made at our discretion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Share Repurchase Program does not obligate us to repurchase any dollar amount or number of shares, and the program may be extended, modified, suspended, or discontinued at any time.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 2 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_148"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Overview</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Who We Are</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation systems, the Dexcom G6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> integrated Continuous Glucose Monitoring System, or G6, in 2018 and more recently received marketing clearance from the FDA on the Dexcom G7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or G7,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in December 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Global Presence</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in North America and certain international markets to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to sell our products.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Future Developments</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Development:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partnerships:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Opportunities:</span><span style="color:#e98300;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_154"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Critical Accounting Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which we have prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the estimates, assumptions and judgments involved in the accounting policies described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 have the greatest potential impact on our financial statements, so we consider them to be our critical accounting policies and estimates. There were no material changes to our critical accounting estimates during the nine months ended September&#160;30, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.473%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview of Financial Results</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most important financial indicators that we use to assess our business are revenue, gross profit, operating income, net income, and operating cash flow.</span></div></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Key Highlights for the Three Months Ended September&#160;30, 2023 include the following:</span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="39" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Gross Profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating <br/>Cash Flow</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$975.0 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$623.3 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$205.5 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$120.7 million</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">$269.2 million</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 27% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 26% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 39% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">up 19% from the same period 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">down 8% from the same period 2022</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We ended the third quarter of 2023 with cash, cash equivalents and short-term marketable securities totaling $3.24 billion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Business Trends</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking ahead we expect our business could be affected by the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Increase in the worldwide incidence of people diagnosed with diabetes and costs related to the management and treatment of diabetes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Changes in medical reimbursement policies and programs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Growing demand for digital health technologies by both healthcare providers and consumers to reduce costs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">An expected interest in empowering consumers to make better-informed decisions about their own health and new potential options for facilitating prevention, early diagnosis of life-threatening diseases, and management of chronic conditions outside of traditional health care settings.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Growing research and interest in the use of CGM technology outside of the ambulatory care setting, including use by hospital systems.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Continued product innovation and competition from other CGM device makers.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our ability to scale efficiently with our Malaysia manufacturing facility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Results of Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="dxcm-20230930_g2.jpg" alt="6" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Financial Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Three Months Ended September&#160;30, 2023 Compared to Three Months Ended September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 - 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The sum of the individual percentages may not equal the total due to rounding.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not meaningful</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. All of our manufacturing costs are included in cost of sales. In addition, amortization of certain licensing related intangibles are also included in cost of sales.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses are primarily related to employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials including budgeted clinical site compensation and reimbursement, study monitoring and oversight expenses, clinical trial product and associated travel expenses. Our research and development expenses also include fees for design services, contractors and development materials.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amortization expense primarily relates to acquired technology and intellectual property and other acquired intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses primarily consist of salary, fringe benefits and share-based compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income from equity investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity investments is comprised of realized gains from the sale of an equity investment.</span></div><div style="margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense), net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists primarily of interest and dividend income on our cash, cash equivalents and short-term marketable securities portfolio, foreign currency transaction gains and losses due to the effects of foreign currency fluctuations, and interest expense related to our senior convertible notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:9pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September&#160;30, 2023 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September&#160;30, 2022 </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 13pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue increase was primarily driven by increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base and the shift to G7, partially offset by mix shift and price associated with the evolution of our channel and product strategy.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disposable sensor and other revenue comprised approximately 90% of total revenue and Reusable Hardware revenue comprised approximately 10% of total revenue for the three months ended September&#160;30, 2023. Disposable sensor and other revenue comprised approximately 87% of total revenue and Reusable Hardware revenue comprised approximately 13% of total revenue for the three months ended September&#160;30, 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cost of sales &amp; Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales and gross profit increased primarily due to an increase in sales volume.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit margin percentage in the third quarter of 2023 compared to the third quarter of 2022 was primarily driven by the amortization of an intangible asset and price, product, and channel mix changes.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and development expense</span></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased primarily due to $13.6 million in compensation-related costs most notably due to higher headcount.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to $32.2 million in compensation-related costs most notably due to higher headcount</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.6 million in legal expense primarily related to a patent infringement lawsuit.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt 0 7pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, increased primarily due to $35.8&#160;million in interest and dividend income on our cash, cash equivalents, and marketable securities portfolio. The increase in interest income was related to a significant increase in market interest rates, as well as an increase in the average invested balances compared to the same period in 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt 0 7pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimated annual effective tax rate from normal, recurring operations decreased from 28.5% to 24.7% during the three months ended September&#160;30, 2023 primarily due to decrease in state and foreign taxes, increase in federal tax credits generated, partially offset by an increase to unrecognized tax benefits and an increase in disallowed executive compensation. There are discrete taxes related to the intra-entity transfer of certain intellectual property and decrease in the state tax rate applied to beginning of year deferred tax assets. </span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the three months ended September&#160;30, 2022 was primarily attributable to income tax expense from normal, recurring operations.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><img src="dxcm-20230930_g3.jpg" alt="4" style="height:320px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Nine Months Ended September&#160;30, 2023 Compared to Nine Months Ended September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 - 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The sum of the individual percentages may not equal the total due to rounding.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not meaningful</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September&#160;30, 2023 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September&#160;30, 2022</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue increase was primarily driven by</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base and the shift to G7, partially offset by mix shift and price associated with the evolution of our channel and product strategy.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disposable sensor and other revenue comprised approximately 89% of total revenue and Reusable Hardware revenue comprised approximately 11% of total revenue for the nine months ended September&#160;30, 2023. Disposable sensor and other revenue comprised approximately 86% of total revenue and Reusable Hardware revenue comprised approximately 14% of total revenue for the nine months ended September&#160;30, 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cost of sales &amp; Gross profit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales and gross profit increased primarily due to an increase in sales volume.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit margin percentage in 2023 compared to 2022 was primarily driven by the amortization of an intangible asset and price, product, and channel mix changes.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Research and development expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased primarily due to $26.8 million in compensation-related costs most notably due to higher headcount</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and various increases to individually insignificant items, partially offset by $16.4&#160;million of lower third party and consulting fees primarily related to software development for new products and significant enhancements and $11.5 million in lower costs related to set-up and validation costs for new CGM equipment.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 13pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to $73.9&#160;million in compensation-related costs most notably due to higher headcount, $43.0 million in legal expense primarily related to a patent infringement lawsuit, and $30.7 million in advertising and marketing costs associated with global product launches.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, increased primarily due to $90.8 million in interest and dividend income on our cash, cash equivalents, and marketable securities portfolio. The increase in interest income was related to a significant increase in market interest rates, as well as an increase in the average invested balances compared to the same period in 2022.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the nine months ended September&#160;30, 2023 is primarily attributable to state and foreign income taxes, nondeductible executive compensation, increases to unrecognized tax benefits, and impact of foreign operations, partially offset by federal tax credits generated. There are discrete taxes related to the intra-entity asset transfer of certain intellectual property, and decrease in the state tax rate applied to beginning of year deferred tax assets, partially offset by excess tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the nine months ended September&#160;30, 2022 is primarily attributable to income tax expense from normal, recurring operations, partially offset by excess tax benefits recognized for share-based compensation for employees (net of disallowed executive compensation) and the Verily milestone payment, and generation of research and development tax credits.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Overview, Capital Resources, and Capital Requirements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our senior convertible notes issuances, and access to our Credit Facility. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government agencies, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including but not limited to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.399%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The evolution of the international expansion of our business and the revenue generated by sales of our approved products and other future products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our ability to efficiently scale our operations to meet demand for our current and any future products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The success of our research and development efforts;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The expenses we incur in manufacturing, developing, selling and marketing our products;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The costs, timing and risks of delays of additional regulatory approvals;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The quality levels of our products and services;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The emergence of competing or complementary technological developments;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The terms and timing of any collaborative, licensing and other arrangements that we may establish; and</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The third-party reimbursement of our products for our customers;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rate of progress and cost of our clinical trials and other development activities;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that existing cash and short-term investments and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. We will be exposed to additional foreign currency exchange risk related to our international operations as we expand our manufacturing internationally and as our business continues to increase in international markets. See &#8220;Foreign Currency Exchange Risk&#8221; in Part II, Item 7A of our Annual Report for more information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Main Sources of Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and short-term marketable securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and short-term marketable securities totaled $3.24 billion as of September&#160;30, 2023. None of those funds were restricted and $3.07 billion (approximately 95%) of those funds were located in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flow from Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2023, we had positive cash flows of $614.9 million from operating activities. We anticipate that we will continue to generate positive cash flows from operations for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received net proceeds of $836.6 million in November 2018 from the 2023 Notes offering, net proceeds of $1.19 billion in May 2020 from the 2025 Notes offering, and net proceeds of $1.23&#160;billion from the 2028 Notes offering. We used $100.0&#160;million of the net proceeds from the offering of the 2023 Notes to repurchase a portion of our common stock in 2018. We used $282.6 million of the net proceeds from the offering of the 2025 Notes to repurchase a portion of our senior convertible notes due in 2022. We used $289.9 million of the net proceeds from the offering of the 2028 Notes to purchase capped call transactions and repurchase shares of our common stock in May 2023. We intend to use the remainder of the net proceeds from the 2023 Notes, 2025 Notes, and 2028 Notes offerings for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2023 Notes and 2028 Notes offerings, we purchased the 2023 Note Hedge and 2028 Capped Calls, respectively. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge as well as for more information about our senior convertible notes, the 2023 Note Hedge, the 2023 Warrants, and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we had no outstanding borrowings, $7.3 million in outstanding letters of credit, and a total available balance of $192.7 million under the Amended Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the Credit Facility. We currently believe that the Credit Facility will be available to us should we choose to borrow under it. Revolving loans will be available for general corporate purposes, including working capital and capital expenditures. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for more details on the Revolving Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term liquidity requirements primarily consist of regular operating costs, interest payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and short-term material cash requirements as described below. As of September&#160;30, 2023, we had a working capital ratio of 2.80 and a quick ratio of 2.40, which indicates that our current assets are more than enough to cover our short-term liabilities. We expect to have significant capital expenditures for the next year to drive our strategic initiative of building out our manufacturing facilities and/or equipment in Malaysia and Ireland and the capacity scale-up in Mesa, Arizona.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and borrowings under our Credit Facility will be sufficient to meet our anticipated seasonal working capital needs, all capital expenditure requirements, material cash requirements as described below, and other liquidity requirements associated with our operations for at least the next 12 months. We may use cash for strategic initiatives that strengthen our foundation for long-term growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outstanding principal related to our 2023 Notes of $124.3&#160;million as of September&#160;30, 2023 and any amount in excess of the principal amount will primarily settle through a combination of cash and stock on or before the maturity date of December&#160;1, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term liquidity requirements primarily consist of interest and principal payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and long-term material cash requirements as described below. As of September&#160;30, 2023, we had a debt-to-assets ratio of 0.39, which indicates that our total assets are more than enough to cover our short-term and long-term debts. As demand grows for our products, we will continue to expand global operations to meet demand through investments in manufacturing and operations. We expect to meet our long-term liquidity requirements from our main sources of liquidity as described above to support our future operations, capital expenditures, acquisitions, and other liquidity requirements associated with our operations beyond the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we have outstanding senior convertible notes that will mature in November 2025 and May 2028. However, the outstanding principal of our senior convertible notes could be converted into cash and/or shares of our common stock prior to maturity once certain conditions are met. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for information on conversion rights prior to maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of business, we enter into a variety of purchase arrangements including but not limited to, purchase arrangements related to capital expenditures, components used in manufacturing for the United States and Malaysia, and research and development activities. See &#8220;Contractual Obligations&#8221; below in Part I, Item 2 of this Quarterly Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued senior convertible notes in November 2018, May 2020, and May 2023. These obligations include both principal and interest for these notes. Although these notes mature in December 2023, November 2025, and May 2028, respectively, they may be converted into cash and/or shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayment of the principal amounts sooner than the scheduled repayment. As of September&#160;30, 2023, we had outstanding letters of credit of $7.3 million for which we cannot forecast with certainty the amount and timing of repayments. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for further discussion of the terms of our senior convertible notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various leasing arrangements, primarily for office, manufacturing and warehouse space that expire at various times through December 2030, excluding any renewal options. We also have land leases in Penang, Malaysia for the build-out of our international manufacturing facility lease that expire through 2082. We anticipate incurring significant expenditures related to the build-out of the Malaysia manufacturing facility and equipment over the next year and the build-out of the Ireland manufacturing facility and equipment over the next five years. See Note 6 &#8220;Leases and Other Commitments&#8221; to the consolidated financial statements in Part II, Item 8 of our Annual Report for more information about our leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for more information about the terms of the Credit Agreement, our senior convertible notes, the 2023 Note Hedge, the 2023 Warrants, and the 2028 Capped Calls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Cash Flows</span></div></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of our cash flows for the periods indicated. See the consolidated financial statements in Part I, Item 1 of this Quarterly Report for complete consolidated statements of cash flows for these periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="dxcm-20230930_g4.jpg" alt="9887" style="height:600px;margin-bottom:5pt;vertical-align:text-bottom;width:700px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we had $3.24 billion in cash, cash equivalents and short-term marketable securities, which is an increase of $784.1 million compared to $2.46 billion as of December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary cash flows during the nine months ended September&#160;30, 2023 and September&#160;30, 2022 are described below. See the consolidated financial statements in Part I, Item 1 of this Quarterly Report for complete consolidated statements of cash flows for these periods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.75pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:50pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cash Flows</span></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$285.2 million of net income, $68.4 million of net non-cash adjustments, and a net increase of $261.3 million in changes of working capital balances</span></div></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$249.4 million of net income and $194.9 million of net non-cash adjustments, and a net increase of $92.7 million in changes of working capital balances</span></div></td></tr><tr style="height:38pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Cash Flows</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$719.5 million in net purchases of marketable securities</span></div></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$301.3 million in capital expenditures</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$184.1 million in capital expenditures</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.5 million in purchases of equity investments</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.5 million in purchases of equity investments</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9.9 million in net purchases of marketable securities</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.9&#160;million in acquisitions, net of cash acquired</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 13pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt 0 7pt"></td><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"></td></tr><tr style="height:38pt"><td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Cash Flows</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.23 billion in proceeds from issuance of senior convertible notes, net of issuance costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$22.5 million in proceeds from issuance of common stock under our employee stock plans</span></div></td></tr><tr style="height:38pt"><td colspan="3" rowspan="5" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$26.6 million in proceeds from issuance of common stock under our employee stock plans</span></div></td><td colspan="3" rowspan="5" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$557.7 million in purchases of treasury stock</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$650.5&#160;million in payments for conversions of senior convertible notes</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14.6&#160;million in payments for financing leases</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$188.7 million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in purchases of treasury stock</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101.3 million in purchases of capped call transactions</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_175"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We presented our contractual obligations as of December&#160;31, 2022 in Note 6 &#8220;Leases and Other Commitments&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022. There were no significant changes to our lease obligations during the nine months ended September&#160;30, 2023. As of September&#160;30, 2023, we had approximately $420.3&#160;million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year. See Note 5 &#8220;Debt&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report for conversion activity related to our senior convertible notes.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_178"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recently issued accounting pronouncements and the potential impact on our consolidated financial statements, if any, see&#160;Note 1&#160;&#8220;Organization and Significant Accounting Policies&#8221; to the consolidated financial statements in Part I, Item 1 of this Quarterly Report.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_181"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes to our quantitative and qualitative disclosures about market risk during the nine months ended September&#160;30, 2023. See Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 for a detailed discussion of our market risks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 4 - CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations under the Exchange Act require public companies to maintain &#8220;disclosure controls and procedures,&#8221; which are defined to mean a company&#8217;s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act, is accumulated and timely communicated to management, including our Chief Executive Officer and Chief Financial Officer, recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures. Based on their evaluation as of September&#160;30, 2023, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date for this purpose.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Effectiveness of Controls</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, we cannot guarantee that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_199"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #58a618;border-top:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1 - LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:23.15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between June 2021 through the nine months ended September 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have served complaints against each other in multiple jurisdictions, including in the United States (United States District Court ("U.S.D.C.&#8221;), District of Delaware), the United Kingdom (Business and Property Courts of England and Wales), France (United Patent Court (&#8220;UPC&#8221;) in Paris), Spain (Commercial Courts of Barcelona) and Germany (National Courts (&#8220;N.C.&#8221;) of Munich, Mannheim, Dusseldorf and Hamburg and the UPC in Munich), primarily involving claims of patent infringement, invalidity and other patent related actions. In June and July of 2021, we initiated patent infringement litigation against Abbott in the United States (U.S.D.C., Western District of Texas) and Germany (N.C. in Mannheim) and filed additional patent infringement actions in May 2023 in Germany (N.C. in Munich) over certain of Abbott's continuous glucose monitoring products. In July and August 2023, we initiated patent infringement litigation in France and Germany in the UPC and in Spain (Commercial Courts of Barcelona).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between July 2021 through the nine months ended September 30, 2023, Abbott initiated patent infringement litigation against Dexcom in multiple jurisdictions, including the United States (U.S.D.C., Delaware), the United Kingdom (Business and Property Courts of England and Wales), and in Germany (N.C. in Mannheim, Dusseldorf and Hamburg) over certain of Dexcom's continuous glucose monitoring products. In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in that jurisdiction. Three trials on liability have already been conducted in the United Kingdom. On October 18, judgment was handed down in favor of Dexcom in one of these trials. The parties are awaiting rulings on the remaining two. Dexcom and Abbott seek injunctive relief and monetary damages as a result of their respective claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract lawsuit against Dexcom in the U.S.D.C., District of Delaware alleging that Dexcom breached the parties' Settlement and License Agreement dated July 2, 2014 (&#8220;SLA&#8221;). The U.S.D.C., District of Delaware consolidated Abbott&#8217;s breach of contract lawsuit with Dexcom&#8217;s patent infringement lawsuit which had been transferred from the U.S.D.C., Western District of Texas. Dexcom asserted counterclaims that Abbott also breached the SLA. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury verdict determined that Abbott was not licensed to thirteen claims of certain Dexcom patents and that Abbott was licensed to five claims. Dexcom&#8217;s patent infringement claims in Delaware are stayed until November 10, 2023, at which point the U.S. Patent and Trademark Office will have issued its final written decisions on certain patents involved in the lawsuit. We will continue to enforce the remaining claims of the patents asserted in Delaware.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s patent infringement action against Dexcom is currently scheduled for trial in the U.S.D.C., District of Delaware on March 11, 2024. In the lead up to trial, the U.S.D.C., District of Delaware invalidated one of Abbott&#8217;s patents and Abbott dropped four other patents from the litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in December 2023, Abbott has several patent infringement hearings against Dexcom in the National Court in Hamburg and Munich wherein Abbott is seeking damages and injunctive relief.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March and April of 2024, Dexcom has several patent infringement hearings in Munich against Abbott, wherein Dexcom is seeking damages and injunctive relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding patent litigation procedures initiated by Dexcom and Abbott throughout multiple jurisdictions, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 1A - RISK FACTORS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described below, in addition to the other information contained in or incorporated by reference into this Quarterly Report on Form 10-Q, as well as the other information we file with the SEC. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2 of this Quarterly Report.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_205"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities. As a result, the below summary risks do not contain all of the information that may be important to you, and you should read the summary risks together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Quarterly Report on Form 10-Q.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional risks, beyond those summarized below or discussed elsewhere in this Quarterly Report on Form 10-Q, may apply to our activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. Consistent with the foregoing, we are exposed to a variety of risks, including risks associated with the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to cost-containment efforts by third-party payors that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to complex and evolving U.S. and foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo, or 510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Environmental, social and governance, or ESG, regulations, policies and provisions could expose us to numerous risks.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_208"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Business and Operations</span></td></tr></table></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_211"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Pricing and Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors, increased market power of our payors, and increased competition among suppliers, including manufacturing services providers, as the medical device industry consolidates. If the prices for our products and services decrease and we are unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products, our business, results of operations, financial condition and cash flows will be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to cost-containment efforts by third-party payors that could result in reduced product pricing and/or sales of our products and cause a reduction in future revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, government and private sector access to health care products continues to be a subject of focus, and efforts to reduce health care costs are being made by third-party payors. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products. We expect that the continuing cost reduction and containment measures may reduce the cost or utilization of health care products and could lead to patients being unable to obtain approval for coverage or payment from these third-party payors or to costs being shifted to patients for our products. Additionally, as a result of the economic slowdown, some customers have lost access and others may lose access to their private health insurance plan if they lose their job, and an impact to job status may extend for a prolonged period of time, beyond possible coverage periods through COBRA, or where the cost to maintain coverage may not be affordable to our customer. As most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of our products, our customers may lose coverage or reimbursement for our products, which may harm our business and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, downward pressure on product pricing. To the extent these cost containment efforts are not offset by greater patient access to our products, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, reimbursement from government and/or commercial third-party healthcare payors, including Medicare and Medicaid, is an important element of our success. The Centers for Medicare &amp; Medicaid Services, or CMS, provides coverage for &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment eligible for coverage under Medicare Part B. Coverage criteria for therapeutic CGMs is determined by CMS under national coverage determinations as well as by local Medicare Administrative Contractors under local coverage determinations. Therefore, Medicare reimbursement for our CGM devices is subject to various coverage conditions and often requires a patient-specific coverage analysis. Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment, or DME, benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. To the extent that a receiver is not used by a Medicare beneficiary or CMS otherwise determines that the items and supplies ordered are not medically necessary, Medicare may not cover that CGM system or any associated supplies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of regulatory and commercial hurdles remain relating to wide-scale sales where a government or commercial third-party payor provides reimbursement, including sales to Medicare beneficiaries. If we are unable to successfully address these hurdles, reimbursement of our products may be limited to a smaller subset of people with diabetes covered by Medicare or to those people with diabetes covered by other third-party payors that have adopted policies for CGM devices allowing for coverage of these devices if certain conditions are met. Adverse coverage or reimbursement decisions relating to our products, or rescission or limitation of favorable determinations, by CMS, its Medicare Administrative Contractors, other state, federal or international payors, and/or third-party commercial payors could significantly reduce reimbursement, which could have an impact on the acceptance of, and demand for, our products and the prices that our customers are willing to pay for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the eight largest private third-party payors, in terms of the number of covered lives, have issued coverage policies for the category of CGM devices. In addition, we have negotiated contracted rates with all of those third-party payors for the purchase of our current CGM systems by their members. Nevertheless, coverage and reimbursement-related barriers remain. Among other things, people with diabetes without insurance that covers our products bear the entire financial cost of using our products. In addition, in the United States, people with diabetes using existing single-point finger stick devices are generally reimbursed all or part of the product cost by Medicare or other third-party payors, which may be perceived as more advantageous for consumers. Further, while many third-party payors have adopted some form of coverage policy on CGM devices, in a sizeable percentage of cases, under durable medical equipment benefits, those coverage policies frequently are restrictive and require significant medical documentation and other requirements in order for policy holders to obtain reimbursement, and as a result, we have difficulty improving the efficiency of our customer service group. Moreover, it is not uncommon for governmental, including federal and/or state, agencies and their contractors to conduct periodic routine billing and compliance reviews that may entail extensive documentation requests, cooperation with which may require significant time and resources, and may result in identification of overpayments that may need to be refunded. The commercial success of our products in both domestic and international markets will substantially </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">depend on whether timely and comprehensive third-party reimbursement is widely available for individuals that use them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has adopted coverage guidelines for CGMs, which could have a favorable impact on us.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, Medicare coverage for CGM was only available to Medicare patients who take at least three doses of insulin a day, limiting CGM reimbursement for Medicare beneficiaries with intensive Type 1 and 2 diabetes. The Local Coverage Determination, or LCD, that CMS released in April 2023 extends Medicare CGM coverage to patients who use insulin at least once per day. Further, the LCD also allows coverage for patients not taking insulin if the patient has a history of problematic hypoglycemia.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevertheless, third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of new and existing medical devices, and, as a result, they may be restrictive, or they may not cover or provide adequate payment for our products. In order to obtain additional reimbursement arrangements, including under pharmacy benefits, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as leveraging increased competition, increasing eligibility requirements such as second opinions and other documentation, purchasing in a bundle, or redesigning benefits. In December 2021, CMS published a final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs (i.e., CGMs that do not replace standard blood glucose monitors for treatment decisions) and related supplies. This final rule expands coverage of CGMs to include a large competitor&#8217;s competing device, which may negatively impact our sales. We are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of our current CGM systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party payors provide adequate coverage and reimbursement for our current CGM systems, people without coverage who have diabetes may not use our products. Furthermore, payors are increasingly basing reimbursement rates on factors such as prior approvals and the effectiveness of the product, clinical outcomes associated with the product, and any factors that negatively impact the effectiveness or clinical outcomes (or cause a perception of any such negative impact), such as the results of a clinical trial, a product defect, or a product recall, which could negatively impact the reimbursement rate. Also, the trends toward managed healthcare in the United States and legislative efforts intended to reduce the cost of government insurance programs could significantly influence the purchase of healthcare services and products and may result in lower prices for our products or the exclusion of our products from reimbursement programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some foreign markets, pricing and profitability of medical devices are subject to government control. We are susceptible to changes in government-mandated coverage requirements and other controls which could impact access to and affordability of our products. In the United States, we expect that there will continue to be federal and state proposals for similar controls.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_214"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risks Related to Product Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to address the anticipated needs of our customers, pursue new markets for our existing products, and remain competitive, we focus our research and development efforts and strategic third-party collaboration activities on the enhancement of our current CGM products, the development of next-generation products and the development of novel technologies and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of new products, or novel technologies and services and the enhancement of our current CGM products (including seeking and potentially obtaining new indications for use), requires significant investment in research and development, intellectual property protection, clinical trials, regulatory approvals and third party reimbursement. The results of our product development and commercialization efforts may be affected by a range of factors, including our ability to anticipate customer needs, innovate and develop new products (whether independently or with our partners), determine a feasible or timely regulatory pathway or approach, and launch those products cost effectively into multiple markets and geographies. If we are unable to successfully anticipate customer needs, innovate, develop new products and successfully launch them, we may not be able to generate significant future revenues or profits from these efforts. Failing to timely launch our products may cause them to become obsolete and materially and adversely affect our business and financial position.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercial launch timelines for our products depend a great deal on our ability to achieve clinical endpoints and satisfy regulatory requirements and to overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional review boards, or inquiries from regulators about our independent and collaborative product development activities, product performance and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical and regulatory personnel. Even if our development and clinical trial efforts appear successful to us and our regulatory submission appears satisfactory to us, the FDA may disagree and may decide not to grant marketing authorization for the products or may require additional product testing or clinical trials or other data to be developed and submitted before approving the products, which would result in product launch delays and additional expense. Even if a product receives marketing authorization from the FDA, it may not be accepted in the marketplace by physicians and people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business we enter into collaborative arrangements with third parties to expand into new markets, including with insulin device manufacturers such as Eli Lilly, Insulet, Novo Nordisk, Tandem Diabetes and The Ypsomed Group to integrate our CGM technology into their insulin delivery systems. We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems. As a result of these relationships, our operating results depend, to some extent, on the ability of our partners to successfully commercialize their insulin delivery systems or monitoring products. Any factors that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures, technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to insulin pump products, or changes in reimbursement rates or policies of third-party payors relating to insulin pumps or similar products, could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies that we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event of such a termination, we may be required to devote additional resources to product development and commercialization, we may need to cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of our collaborations will result in the successful development of a commercially viable product or result in significant additional future revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that sales of our current CGM systems will account for substantially all of our product revenue for the foreseeable future. If and when we receive FDA or other regulators&#8217; marketing authorization for, and begin commercialization of, our next-generation CGM systems, we expect most patients will migrate onto those systems. In the periods leading up to the launch of new or upgraded versions of our CGM systems, however, our customers&#8217; anticipation of the release of those products may cause them to cancel, change or delay current period purchases of our current products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our prior experience in marketing and selling our products, we might be unable to successfully expand the commercialization of our existing products or begin commercialization of our next-generation CGM systems on a wide-scale for a number of reasons, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our G6 and G7 systems prompt the user to replace the sensor no later than the tenth day, which might make it expensive for users;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">widespread market acceptance of our products by physicians and people with diabetes will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the limited size of our sales force;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not have sufficient financial or other resources to adequately expand the commercialization efforts for our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expanded coverage opportunities for our competitors&#8217; CGM devices and supplies, including coverage for adjunctive CGMs, increasing competition in the marketplace;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our FDA and other regulatory authority marketing application submissions and reviews may be delayed, or cleared or approved with limited product indications and labeling;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not be able to manufacture our products in commercial quantities commensurate with demand or at an acceptable cost;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">for people with Type 2 diabetes, current reimbursement from third-party payors is generally limited to people on intensive insulin therapy;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the uncertainties associated with establishing and qualifying new manufacturing facilities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">people with diabetes may need to incur the costs of single-point finger stick devices, in addition to our systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the relative immaturity of the CGM market internationally, and limited international reimbursement of CGM systems by third-party payors and government healthcare providers outside the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of competing products and technologies, which may have a lower cost or price, allow for a convenience improvement and/or allow for improved accuracy and reliability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of new drug therapies for the treatment and management of diabetes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name or brand recognition and more established medical product distribution channels by some of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to obtain sufficient quantities of supplies timely and at appropriate quality levels from our single- or sole-source and other key suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture products that perform in accordance with expectations of consumers; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">rapid technological change may make our technology and our products obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the risks outlined above, our G6 and G7 systems are more invasive than many other self-monitored glucose testing systems, including single-point finger stick devices, and people with diabetes may be unwilling to insert a sensor in their body, especially if their current diabetes management involves no more than two finger sticks per day. Moreover, people with diabetes may not perceive the benefits of CGM and may be unwilling to change their current treatment regimens. Physicians may not recommend or prescribe our products unless and until (i)&#160;there is more long-term clinical evidence to convince them to alter their existing treatment methods, (ii)&#160;there are additional recommendations from prominent physicians that our products are effective in monitoring glucose levels, and (iii)&#160;reimbursement or insurance coverage is more widely available. In addition, market acceptance of our products by physicians and people with diabetes in Europe or other countries will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use. If we are unable to do so, we may not be able to generate product revenue from our sales efforts in Europe or other countries. We cannot predict when, if ever, healthcare professionals, including physicians, and people with diabetes may adopt more widespread use of CGM systems, including our systems. If our CGM systems do not achieve and maintain an adequate level of acceptance by people with diabetes, healthcare professionals, including physicians, and third party payors, our future revenue may be reduced and our business may be harmed.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_217"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Manufacturing, Commercial Operations and Commercialization</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing manufacturing facilities are designed to manufacture current and next-generation CGM systems, but may not be scaled quickly enough to permit us to manufacture one or more of our CGM systems in quantities sufficient to meet market demand. In the past, we have had difficulty scaling our manufacturing operations to provide a sufficient supply of product to support market demand and our commercialization efforts. From time to time, we have also experienced brief periods of backorder and, at times, have had to limit the efforts of our sales force to introduce our products to new customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput. We have made progress in manufacturing to enable us to supply adequate amounts of product to support our commercialization efforts; however, we cannot guarantee that supply will not be constrained in the future. We may not adequately predict the market demand for our products, in order to produce our products in the quantities we anticipate will be necessary to meet market demand. We will need to adequately predict the market demand for our products and increase our manufacturing capacity by a significant factor over the current level to meet or exceed the anticipated market demand by product. In addition, we may have </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to modify our manufacturing design, reliability and process for next-generation products that may hereafter be approved, cleared or otherwise authorized by the applicable regulatory body and commercialized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are technical challenges to increasing manufacturing capacity, including equipment design, automation, validation and installation, contractor issues and delays, licensing and permitting delays or rejections, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. Delays in the launch of next-generation products may result in unanticipated continuing increases in demand for current-generation products (to substitute for the unavailability of the next-generation products) which, if not adequately prepared for, may result in deficits in our ability to produce adequate amounts of the prior-generation products to meet demand at appropriate prices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scaling of manufacturing capacity is subject to numerous risks and uncertainties, and may lead to variability in product quality or reliability, increased construction timelines, as well as resources required to design, install and maintain manufacturing equipment, among others, all of which can lead to unexpected delays in manufacturing output. In addition, any changes to our manufacturing processes may trigger the need for submissions or notifications to, and in some cases advance approval from, the FDA or other regulatory authorities because of the potential impact of changes on our previously cleared, approved and/or authorized devices. Our facilities are subject to inspections by the FDA and corresponding state agencies on an ongoing basis, and we must comply with Good Manufacturing Practices and the FDA Quality System Regulation, as well as certain state requirements. We may be unable to adequately maintain, develop and expand our manufacturing process and operations or maintain compliance with FDA and state agency requirements, and manufacturing issues could impact our cleared and approved products. If we are unable to manufacture a sufficient supply of our current products or any future products for which we may receive approval or clearance, maintain control over expenses or otherwise adapt to anticipated growth, or if we underestimate growth, we may not have the capability to satisfy market demand, contractual obligations, and our business will suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are manufactured at certain facilities, with limited alternate facilities. If an event occurs at one of our facilities that results in damage to, restrictions on the use of, or closure of, one or more of such facilities, or if our distributions from those facilities are limited or restricted in any way, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve and lease a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production capacity in the event manufacturing capacity is lost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the majority of our operations are conducted at facilities located in San Diego, California, Mesa, Arizona and, beginning in 2023, Penang Malaysia. We take precautions to safeguard our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However, a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event, such as a public health emergency, could cause substantial delays in our operations, damage, destroy or limit our manufacturing equipment, inventory, or records and cause us to incur additional expenses. Earthquakes are of particular significance since our manufacturing facilities in California are located in an earthquake-prone area. Wildfires are also increasingly more common in southern California and present risk to our manufacturing operations. Our Arizona facility may confront water supply issues resulting from the ongoing drought in the Western United States and our Malaysia facility may confront issues related to its construction on a reclaimed wetland and the political stability of the Malaysia government. In the event our existing manufacturing facilities or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in any particular case.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture the majority of our products and procure important third-party services, such as sterilization services, at numerous facilities worldwide. We purchase many of the components, materials and services needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used in manufacturing, such as for the application-specific integrated </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">circuit that is incorporated into the transmitter and certain polymers used to synthesize the polymeric biointerface membranes for our products. In some cases, our agreements with these and other suppliers can be terminated by either party upon short notice. Our contract manufacturers may also rely on single- or sole- source suppliers to manufacture some of the components used in our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work with our suppliers to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials and services has in some cases been, and may continue to be impacted, interrupted or insufficient. Our manufacturers and suppliers may also encounter problems during manufacturing for a variety of reasons. They may fail to follow specific protocols and procedures, fail to comply with applicable regulations, or be the subject of FDA or other regulatory authority audits or inspections that result in allegations of non-compliance (for example, resulting in Form 483 Observations, Warning Letters, or other FDA enforcement actions). Our manufacturers and suppliers may also experience or be impacted by equipment malfunction, environmental factors, and public health emergencies, any of which could delay or impede their ability to meet our demand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if our sole- or single-source suppliers shift their manufacturing and assembly sites to other locations, depending on the circumstances and nature of the item supplied, in addition to quality system activities such as verification and validation, there could be a need for FDA notifications or submissions, and the new locations could be subject to regulatory inspections. If there are regulatory delays or impediments impacting our suppliers or us for any reason, we may not be able to quickly establish additional or replacement suppliers, particularly for our single-source components, in part because of the custom nature of various parts we design. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these outside manufacturers and suppliers also subjects us to other risks that could harm our business, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply in a timely manner or on commercially reasonable terms from additional or replacement sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our products are technologically complex and it is difficult to develop alternative supply sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; needs higher priority than ours;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness or safety of our products or cause delays in shipment of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">switching components may require product redesign and submission to the FDA of new applications (such as new 510(k) submissions or PMA supplements) which could significantly delay production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner or at the current pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may discontinue the production of components that are critical to our products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders and meet our requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also outsource certain services to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially result in repercussions such as missed deadlines or other timeliness issues, erroneous data, supply disruptions, non-compliance (including with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on our results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also require the suppliers, service providers and business partners of components or services for our products and related services to comply with law and certain of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible for such violations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must continue to develop and grow our sales and marketing organization and enter into partnerships or other arrangements to market and sell our products and/or collaborate with third parties, including distributors and others, to market and sell our products to maintain the commercial success of our current systems and to achieve commercial success for any of our future products. If we are unable to establish and maintain adequate sales, marketing and distribution capabilities, independently or with others, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing and managing a direct sales organization is a difficult, expensive and time-consuming process.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To continue to develop our sales and marketing organization to successfully achieve market awareness and sell our products, we must:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recruit and retain adequate numbers of effective and experienced sales and marketing personnel;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel in the benefits and risks of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establish and maintain successful sales, marketing, training and education programs that educate health care professionals, including endocrinologists, physicians and diabetes educators, so they can appropriately inform their patients about our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">manage geographically dispersed sales and marketing operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel on the applicable advertising and promotion, and fraud and abuse laws that govern interactions with healthcare professionals and institutions as well as current and prospective patients and maintain active oversight and auditing measures to ensure continued compliance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently employ sales and marketing personnel for the direct sale and marketing of our products in North America, Asia Pacific, Europe and the Middle East. Our direct sales and marketing team calls on healthcare providers and people with diabetes throughout the applicable country, to the extent permissible, to raise awareness and initiate sales of our products. Our sales and marketing organization competes with the experienced, larger and well-funded marketing and sales operations of our competitors. We may not be able to successfully manage our dispersed sales force or increase our product sales at acceptable rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into distribution arrangements to leverage existing distributors (including wholesalers) already engaged in the distribution of drugs, devices and/or products in the diabetes marketplace. Some of our U.S distributors are focused on accessing underrepresented regions and or third-party payors that contract exclusively with distributors in the United States, while some of our international distributors call directly on healthcare providers and patients to market and sell our products. Because of the competition for their services, we may&#160;be unable to partner with or retain additional qualified distributors. Further, we may&#160;not be able to enter into agreements with distributors on commercially reasonable terms, if at all. Our distributors might not have the resources to continue to support our recent rapid growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span id="ifc0336e40e5f4b699803d5f8737c9f6d_24142"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our distribution agreements with AmerisourceBergen, Byram and affiliates, Cardinal Health and affiliates (including Edgepark Medical Supplies), and McKesson, our most significant wholesalers and distributors, each generated 10% or more of our total revenue during the nine months ended September&#160;30, 2023. We cannot guarantee that these relationships will continue or that we will be able to maintain this volume of sales from these relationships in the future. A substantial decrease or loss of these sales could have a material adverse effect on our financial results and operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into arrangements with pharmacy organizations in various countries to dispense our products directly to patients. Because of the competition for their services, we may be unable to enter into new partnerships or otherwise expand our pharmacy network on commercially reasonable terms, if at all. In addition, we cannot guarantee that our existing pharmacy relationships will continue, or that we will be able to maintain or increase sales volume from these relationships in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we enter into additional arrangements with third parties to perform sales, marketing, distribution and billing services, our product margins could be lower than if we directly marketed and sold our products. To the extent that we enter into co-promotion or other marketing and sales arrangements with other companies, any revenue received will depend on the skills and efforts of others, and we cannot predict whether these efforts will be successful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adequately predict market demand or otherwise optimize and operate our distribution channel successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, immediate shortages in product or component supply, or harm our business in other ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants, including enhanced software capabilities, and related data and IT platforms. Our products are based on our proprietary technology, but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. FDA or other regulatory approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market acceptance of our systems. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore, our products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors manufacturing adjunctive CGMs have also recognized expanded Medicare coverage of their CGM devices and supplies following CMS&#8217; December 2021 final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs. These devices now directly compete with our CGM products in the Medicare market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott for several years and their Libre family of CGM products. Medtronic markets and sells one or more standalone glucose monitoring products both internationally and in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for general health and wellness, or population health.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the companies developing or marketing competing devices are large and well-known publicly traded companies, and these companies may possess competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name recognition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established relations with healthcare professionals, customers and third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional lines of products, and the ability to bundle products to offer higher discounts or incentives to gain a competitive advantage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and marketing approved products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">duration of sensor life;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the ability to integrate multiple products to provide additional features beyond CGM systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater financial and human resources for product development, manufacturing, sales and marketing, and patent litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may not be able to compete effectively against these companies or their products, which may adversely impact our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risks associated with public health issues, such as the recent COVID-19 pandemic, and other events beyond our control. Public health issues and crises may adversely impact our operations, supply chain and logistics network if the locations where we operate, manufacture or distribute our products; where our raw materials or products are sourced, manufactured or distributed; or where our third-party distributors, suppliers and other service providers operate, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. In addition, public health issues and crises may adversely impact our customers and/or their businesses due to lockdowns, labor shortages, lost access to private health insurance plans or modified spending priorities, all of which could cause a decline in demand for our products. These disruptions could also cause economic slowdowns or increased economic uncertainty.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we largely navigated disruptions to our business as a result of the COVID-19 pandemic, a future public health issue, pandemic or outbreak of COVID-19 could lead to delays in the manufacturing and supply of products, which could have a material adverse effect on our business, financial condition and results of operations. Moreover, any future public health issue, such as a resurgence in COVID-19 infections, including due to new variants of the virus for which current vaccines may not be effective, could result in the imposition of new governmental restrictions, quarantine requirements or other measures to slow the spread of the virus, which could result in closures or other restrictions that significantly disrupt our operations or those of our third-party distributors, suppliers or other service providers, or otherwise adversely affect our customers or their businesses or operations, or result in economic weakness or slowdowns in one or more of our key geographies, any of which could adversely affect our business, financial condition and results of operations.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_220"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to our International Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in countries outside the United States, which accounted for approximately 28% of our revenue for the nine months ended September&#160;30, 2023, are accompanied by certain financial and other risks. In addition to our offices with manufacturing and administrative and operations in countries throughout the world, we intend to continue to pursue growth opportunities in sales outside the United States, especially in Asia and Europe. Additionally, we may increase our use of administrative and support functions from locations outside the United States. These business activities could expose us to greater risks associated with our sales and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we pursue opportunities outside the United States, we may become more exposed to these risks and our ability to scale our operations effectively may be affected. For example, we are building out a manufacturing facility in Malaysia.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international expansion efforts, including our new and proposed manufacturing facilities in Malaysia and Ireland, respectively, may not be successful and we may experience difficulties in scaling these functions from locations outside the United States and may not experience the expected cost efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">local product preferences and product requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">longer-term receivables than are typical in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in foreign currency exchange rates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">less intellectual property protection in some countries outside the United States than exists in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">trade protection measures and import and export licensing requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">workforce instability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in trade policy and tariff regulations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">political and economic instability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the tax laws in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. We have a significant presence in the European Union, as well as significant sales in the European Union, such that any changes in tax laws in the European Union will impact our business. The overall impact of such legislation in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Union member states is uncertain, and our business and financial condition could be adversely affected by any laws impacting our tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in foreign currency exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a 2016 referendum of voters in the United Kingdom, or the U.K, to exit from the European Union, or the E.U., the U.K. left the E.U. on January 31, 2020, which began a transition period that ended on December 31, 2020. In December 2020, the U.K. and E.U. agreed on a trade and cooperation agreement that was ratified by the parties in May 2021. The agreement sets out certain procedures for approval and recognition of medical products in each jurisdiction. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of the trade and cooperation agreement or otherwise, could prevent us from marketing our CGM systems in the U.K. and/or the E.U. and restrict our ability to generate revenue and achieve and sustain profitability. Under the trade and cooperation agreement, U.K. service suppliers no longer benefit from automatic access to the entire E.U. single market, U.K. goods no longer benefit from the free movement of goods and there is no longer the free movement of people between the U.K. and the E.U. Depending on the application of the terms of the trade and cooperation agreement, we could face new regulatory costs and challenges which could have a material adverse effect on our business, results of operations, or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing the export of our products could adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established procedures designed to assist with our compliance with such laws and regulations. However, we have only limited experience dealing with these laws and regulations and we cannot guarantee that our procedures will effectively prevent us from violating these regulations in every transaction in which we may engage. Any such violation could adversely affect our reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions could materially adversely affect our business and result in civil and/or criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to non-U.S. government officials and, in some instances, other persons for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental entities and are therefore potentially subject to such anti-bribery laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by U.S. and foreign governmental agencies, and assessment of significant fines and penalties against companies and individuals. Our international operations create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents, or distributors, because these parties are not always subject to our direct oversight and control. It is our policy to implement safeguards to educate our employees and agents on these legal requirements and discourage improper practices. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible. In addition, the government agencies may seek to hold us liable for successor liability for anti-corruption law violations committed by any companies in which we invest or that we acquire. Any alleged or actual violations of these regulations may subject us to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government scrutiny, severe criminal or civil sanctions and other liabilities, including exclusion from government contracting, and could disrupt our business, and result in a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, including the current conflict in Ukraine, concerns over continued sovereign debt, monetary and financial uncertainties in Europe and other foreign countries, and global health pandemics. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. In addition, a recession, depression or other sustained adverse market event could materially and adversely affect our access to capital on favorable terms or at all, our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to obtain any required regulatory authorization in foreign jurisdictions will prevent us from marketing our products abroad.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct limited commercial and marketing efforts in certain international markets in the Asia-Pacific, North America and Europe, Middle East and Africa regions, with respect to our CGM systems and may seek to market our products in other regions in the future. Outside the United States, we can market a product only if we receive a marketing authorization and, in some cases, pricing approval, from the appropriate regulatory authorities. The marketing authorization procedures vary among countries and can involve additional testing, and the time required to obtain any required authorization or approval may differ from that required to obtain FDA marketing authorization(s). Foreign regulatory authorization or approval processes may include all of the risks associated with obtaining FDA marketing authorization(s) in addition to other risks. We may not obtain foreign regulatory authorizations or approvals on a timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities in other countries will follow, and authorization or approval by one foreign regulatory authority does not ensure authorization or approval by regulatory authorities in other foreign countries or by the FDA. In addition, in order to obtain the authorization to market our products in certain foreign jurisdictions, in some cases we may need to obtain a Certificate to Foreign Government from the FDA. The FDA may refuse to issue a Certificate to Foreign Government if significant compliance-related concerns are identified. As a result, there are a range of factors that could preclude or impede our ability to file for regulatory approvals or marketing authorizations or to receive necessary approvals or authorizations to commercialize our products in any market outside the United States on a timely basis, or at all.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_223"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Privacy and Security</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to complex and evolving U.S. and foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a number of foreign, federal and state laws and regulations protecting the use, disclosure, and confidentiality of certain patient health and personal information, including patient records, and restricting the use and disclosure of that protected information, including state breach notification laws, the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, the European Union&#8217;s General Data Protection Regulation, or GDPR, the UK Data </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protection Act and the UK GDPR, and the California Consumer Privacy Act, or CCPA, among others. As our customer base grows to include U.S. federal government agencies, Dexcom may also need comply with Federal Risk and Authorization Management Program and Cybersecurity Maturity Model Certification requirements. These frameworks, in addition to similar laws being enacted by other states and counties, impose stringent cybersecurity standards and potentially significant non-compliance penalties, involve the expenditure of significant resources, the investment of significant resources and the investment of significant time and effort to comply. As these laws and regulations continue develop in the United States and internationally, we may be required to expend significant time and resources in order to update existing processes or implement additional mechanisms as necessary to ensure compliance with such cybersecurity laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. For example, data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, vendors and others, which data may include full names, social security numbers, addresses, and birth dates, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, disrupt our operations and the services we provide to our clients or damage our reputation, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow and expand our administrative, customer support or IT support services, we may also utilize the services of personnel and contractors located outside of the United States to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state, or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry standard security measures for offshore access to protected health information and other personal information, unauthorized access or disclosure of such information by offshore personnel could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and regulatory penalties, disrupt our operations and the services we provide to our clients, damage to our reputation or result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other disruptions that compromise our information and expose us to liability could cause our business and reputation to suffer and could subject us to substantial liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996, as amended and implemented, or HIPAA, extensively regulates the use and disclosure of certain personal information (&#8220;protected health information&#8221;) and requires covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. Certain provisions of the security and privacy regulations apply to business associates (entities that handle protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these provisions. In addition, a covered entity may be subject to penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity. Dexcom is a covered entity under HIPAA and may also function in a business associate capacity to other covered entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for Civil Rights, or OCR and, in certain situations involving large breaches, to the media. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA privacy and security regulations may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, state attorneys general are authorized to bring civil actions seeking either injunction or damages in response to violations that threaten the privacy of state residents. We follow and maintain a HIPAA compliance plan, which we believe complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA privacy regulations and security regulations have and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. For example, from time-to-time, the OCR issues bulletins that outline its interpretations of HIPAA as applied to specific use cases. On December 1, 2022, OCR issued a bulletin on the requirements under HIPAA for online tracking technologies (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, cookies, pixels) to protect the privacy and security of health information. This bulletin outlined OCR&#8217;s position on the use of online tracking technology vendors, when certain information received by such vendors constitutes protected health information under HIPAA, and accordingly, when business associate agreements must be executed between covered entities, like Dexcom, and such vendors. Dexcom has assessed its responsibilities under the bulletin and undertaken a number of initiatives to support its compliance with HIPAA and other requirements relating to online tracking technologies, including updates to its cookie banners and preference center. These steps are in addition to measures Dexcom had taken previously and the company continues to evaluate its compliance with applicable laws and adjust its practices to address developments in the field over time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also remain subject to federal or state privacy-related laws outside of the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy and data security violations. California enacted the CCPA, which came into effect January 1, 2020, was amended and expanded by the CPRA, passed on November 3, 2020, which took effect January 1, 2023. The CCPA and CPRA, among other things, create data privacy obligations for covered companies and provide privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. In addition, other states have, or may, enact similar legislation. It remains unclear what, if any, additional modifications will be made to this legislation or how it will be interpreted. The effects of the CCPA and CPRA are significant and will likely require us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California. There are also a number of other legislative proposals worldwide, including in the United States at both the federal and state level, that could impose additional and potentially conflicting obligations in areas affecting our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to laws and regulations in foreign countries covering data privacy and other protection of health and employee information that may be more onerous than corresponding U.S. laws, including in particular the laws of Europe.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The GDPR applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4% of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. Data transfer risk remains a potential issue as certain Data Protection Authorities continue to raise concerns about the transfer of data to the United States. Though a new framework to permit cross-border transfers - the EU-US Data Privacy Framework - came into effect in 2023, it may be challenged as well. We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU agencies, could negatively impact our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation in the future. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous and evolving risks to our cybersecurity and privacy from cyber threat actors. These cyber threat actors, whether internal of external to the Company, are becoming more frequent, sophisticated and coordinated in their attempts to access data, including third parties with whom the Company conducts business through, without limitation, malicious software; data privacy breaches by employees, insiders or others with authorized access; cyber of phishing-attacks; ransomware; attempts to gain unauthorized access to our data and systems; and other electronic security breaches. In the ordinary course of business, we collect and store sensitive information on our network, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure maintenance of this information and technology is critical to our business operations. We have implemented and deploy multiple layers of security measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such data. We utilize current security technologies, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in response to the onset of the COVID-19 pandemic, we modified our business practices and initially implemented telework policies for certain categories of &#8220;non-essential&#8221; employees to the extent possible. We have since adopted a hybrid workplace model for our employees. Our hybrid workplace allows us to work together globally to bring our life-changing products to as many people as possible. This means we have some employees who work primarily onsite, some who work primarily offsite, and others who flex in and out of the office based on the needs of the business and the individual. We recognized the need for flexibility in our physical workplace during the COVID-19 pandemic, but also noted the potential benefits of a hybrid workplace to expand and retain our talent pool and reduce our real estate needs. The hybrid workplace does, however, introduce additional operational risk, including increased cybersecurity risk. These cyber risks include, among other risks, increased phishing, malware, and other cybersecurity attacks, vulnerability to, or disruptions of, our information technology infrastructure and systems to support remote operations, increased risk of unauthorized access, use or dissemination of confidential information, limited ability to restore the systems in the event of a systems failure or interruption, greater risk of a security breach resulting in destruction, alteration or misuse of valuable information, including proprietary business information and personally identifiable information of individuals, all of which could expose us to risks of data or financial loss, litigation and liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These threats can come from a variety of sources, including criminal hackers, state-sponsored intrusions, industrial espionage and employee malfeasance. Cyber threats may be generic, or they may be custom-crafted against our information systems. Over the past several years, cyberattacks have become more prevalent and much harder to detect and defend against. These threat actors may be able to penetrate our security measures, breach our information technology systems, misappropriate or compromise confidential and proprietary information of our company and our customers, cause system disruptions and shutdowns, or introduce ransomware, malware, or vulnerabilities into our products, systems, and networks or those of our customers and partners. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security or other problems that unexpectedly could interfere with the operation of our products. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving our employees, contractors and temporary staff.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we maintain cybersecurity insurance coverage there is no guarantee that it will be sufficient to cover the financial, legal, business, or reputational losses that may result from an interruption or breach of our systems. Our cybersecurity insurance includes coverage for a breach event covering expenses for notification, credit monitoring, investigation, crisis management, public relations and legal advice. Our cybersecurity insurance also provides coverage in relation to regulatory action defense including oversight, investigations and disclosure obligations as well as fines and penalties, potential payment card industry fines and penalties and costs related to cyber extortion; however, damages and claims arising from such incidents may not be covered and/or may exceed the amount of any coverage and do not cover the time and effort we incur investigating and responding to any incidents, which may be significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and may continue to be subject to cybersecurity incidents that bypass our security measures. Such incidents may impact the integrity, availability or privacy of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">harm to customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruptions and delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the loss, misappropriation, corruption or unauthorized access of data, confidential information or intellectual property;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reputational damage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">significant remediation costs, including liability for stolen customer or employee information, repairing system damage, or providing benefit to affected customers or employees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increase to insurance premiums; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">foreign, federal and state governmental inquiries, violations or sanctions, any of which could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our information technology infrastructure against cyberattacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures or outages, including any potential disruptions due to significantly increased global demand on certain cloud-based systems, or failures to adequately scale our data platforms and architectures support patient care could compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial reporting. Such failures could materially adversely affect our operating results and financial condition. Our information technology systems, some of which are managed by third parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, denial-of-service attacks, phishing attacks, ransomware or other malware, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Although we have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security. In addition, certain countries have implemented or may implement legislative and technological actions that either do or can effectively regulate access to the internet, including the ability of internet service providers to limit access to specific websites or content. Other countries have attempted or are attempting to change or limit the legal protections available to businesses that depend on the internet for the delivery of their services. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may significantly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">suffer and we may be subject to litigation, government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional government oversight of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of existing customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in attracting new customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">problems in determining product cost estimates and establishing appropriate pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in preventing, detecting, and controlling fraud;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disputes with customers, physicians, and other health care professionals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increases in operating expenses, incurrence of expenses, including notification and remediation costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory fines or penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">individual actions or class actions for damages;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of revenues (including through loss of coverage or reimbursement);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product development delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disruption of key business operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">diversion of attention of management and key information technology resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyberattacks aimed at accessing our devices, products, and services, or related devices, products, and services, and modifying or using them in a way inconsistent with our FDA clearances and approvals could create risks to users.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. For example, we are pursuing collaborations to enable the connectivity and interoperability of our current and next-generation sensors and transmitters with third-party patient monitoring products, which may in turn be connected with the internet, hospital networks and in some cases, other medical devices. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties. As such, a cyberattack which intrudes, disrupts, or corrupts our devices, products, and services, or related devices, products, and services could impact the quality-of-care patients receive or the confidentiality of patient information. Additionally, modifying or using any such devices, products, or services in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_226"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Non-Compliance with Laws, Regulations and Contractual Requirements and Healthcare Industry Shifts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry generally, and our business specifically, is subject to extensive foreign, federal, state and local laws and regulations, including those relating to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">authorizations necessary for the clinical investigation and commercial marketing of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the pricing of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the distribution of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the dispensing of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">billing for or causing the submission of claims for our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">financial relationships with physicians and other referral sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inducements and courtesies given to physicians and other health care providers and patients;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling, advertising and promoting products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the characteristics and quality of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">communications with payors and physicians and other healthcare stakeholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">confidentiality, maintenance and security issues associated with medical records and individually identifiable health and other personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device adverse event reporting;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">prohibitions on kickbacks, including the Anti-Kickback Statute and related laws and/or regulations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any scheme to defraud any healthcare benefit program;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">physician and other healthcare professional payment disclosure requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">use and disclosure of personal health information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">privacy of health information and personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">data protection and data localization;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">mobile communications;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient access and non-discrimination;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">false claims; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">licensure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are extremely complex and, in many cases, still evolving. If our operations are found to violate any of the foreign, federal, state or local laws and regulations which govern our activities, we may be subject to litigation, government enforcement actions, and applicable penalties associated with the violation, potentially including civil and criminal penalties, damages, fines, exclusion from participation in certain payor programs or curtailment of our operations. Compliance obligations under these various laws are oftentimes detailed and onerous, further contributing to the risk that we could be found to be out of compliance with particular requirements. The risk of being found in violation of these laws and regulations is further increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, particularly with respect to new and emerging technologies and remote delivery of services, and their provisions are open to a variety of interpretations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, CMS, OIG, OCR, FTC, Department of Justice, states&#8217; attorneys general and other governmental authorities actively enforce the laws and regulations discussed above. In the United States, medical device manufacturers have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of medical devices, payments intended to influence the referral of federal or state healthcare business, and submission of false claims for government reimbursement. While we make every effort to comply with applicable laws, we cannot rule out the possibility that the government or other third parties could interpret these laws differently and challenge our practices under one or more of these laws. This likelihood of allegations of non-compliance is increased by the fact that under certain federal and state laws applicable to our business, individuals may bring an action on behalf of the government alleging violations of such laws, and potentially be awarded a share of any damages or penalties ultimately awarded to the applicable government body.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and the FTC share oversight of medical device promotion. The FDA has broad authority over device marketing (including assessment and oversight of safety and effectiveness) and over FDA-approved &#8220;promotional labeling,&#8221; while the FTC has authority over &#8220;advertising&#8221; for most medical devices (i.e., non-&#8220;restricted&#8221; devices, such as ours).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any action against us alleging a violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s time and attention from the operation of our business, and have a material effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws and regulations impacting or affecting our business may change significantly in the future, which may adversely affect our business. A review of our business by courts or regulatory authorities may result in a determination that could adversely affect our operations. Also, the regulatory environment applicable to our business may change in a way that restricts or adversely impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers or distributors fail to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product for which we obtain marketing approval, clearance or authorization (and the activities related to its production, distribution, and promotion, sale, and marketing)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be subject to continual review and periodic inspections by the FDA and other regulatory bodies, which may include inspection of our manufacturing processes, complaint handling and adverse event reporting, post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations require that we report to the FDA any incident in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which our product may have caused or contributed to a death or serious injury, or in which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation, financial condition, and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our suppliers are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling, packaging, storage, complaint handling, shipping and servicing of our products. The FDA may enforce the QSR through announced (through prior notification) or unannounced inspections.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with ongoing regulatory requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes and regulations administered by the FDA, competent authorities and other regulatory bodies, or failure to take adequate response to any observations, could result in, among other things, any of the following actions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving, or refusal to approve, our CGM systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil or criminal penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">administrative detention;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production, partial suspension, or complete shutdown of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of the supply of components from our key component suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">court consent decrees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA orders to repair, replace, or refund the cost of devices;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect of these events can in some cases be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the number or types of MDRs filed by us. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR, MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls (through corrections or removals), fines, suspension of regulatory approvals, product seizures, injunctions, the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their marketing efforts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is very important to us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Since the first commercial launch of our products in 2006, we have had periodic field failures related to our products and associated services, including reports of sensor errors, sensor failures, broken sensors, receiver malfunctions, audible alarms and alert failures, as well as server and transmitter failures. To comply with the FDA&#8217;s medical device reporting requirements, for example, we have filed reports of applicable field failures. Although we believe we have taken and are taking appropriate action aimed at reducing and/or eliminating field failures, we may have other product failures in the future. Product or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to, or death of, a patient. These problems could lead to recalls, corrections or removals of, or issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not able to maintain stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts could be delayed, which would harm our business and our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, our reputation could be harmed and our revenue and results of operations could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential long-term complications from our current or future products or other CGM systems under development may not be revealed by our clinical experience to date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience, complications from use of our products may include sensor errors, sensor failures, broken sensors, lodged sensors or skin irritation under the adhesive dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products or other glucose monitoring systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. With respect to our G6 systems, our clinical trials have been limited to ten days of continuous use. It is possible that the data from our clinical studies and trials may not be indicative of long-term patient outcomes. We cannot assure you that repeated, long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may never receive approval, marketing authorization or clearance from the U.S. FDA and other governmental agencies to market additional CGM systems, expanded indications for use of current and future generation CGM systems, future software platforms, or any other products under development.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, via the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process, the FDA classified the G6 and substantially equivalent devices of this generic type (i.e., &#8220;integrated continuous glucose monitoring systems&#8221; or &#8220;iCGMs&#8221;) into Class II, meaning that going forward products of this generic type may utilize the 510(k) pathway. Since then we have received 510(k) clearances for modifications to the G6 and approval for G7.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any subsequent modifications of our cleared products that could significantly affect their safety or effectiveness (for example, a significant change in design or manufacture), or that would constitute a major change in its intended use, will require us to obtain a new 510(k) clearance or could require a new </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> submission or a PMA. The FDA requires each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require the manufacturer to cease marketing and/or recall the modified device until appropriate clearance or approval is obtained. Under these circumstances, the FDA may also subject a manufacturer to significant regulatory fines or other penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If future product candidates are not deemed by the FDA to meet the criteria for submission under the 510(k) pathway, or for down-classification under the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process or otherwise, we would need to pursue a PMA. The PMA process requires us to prove the safety and effectiveness of our systems to the FDA&#8217;s satisfaction. This process can be expensive, prolonged and uncertain, requires detailed and comprehensive scientific and human clinical data, and may never result in the FDA granting a PMA. The FDA&#8217;s </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification of our G6 system under the generic name </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">integrated continuous glucose monitoring system,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> makes it a predicate device for future </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">510(k) submissions. Complying with this classification requires ongoing compliance with the general controls required by the federal Food Drug and Cosmetic Act and the special controls specified by the FDA&#8217;s G6 order as a Class II device. Any future system or expanded indications for use of current generation systems will require approval of the applicable regulatory authorities. In addition, we intend to seek either 510(k) clearances or PMA approvals for certain changes and modifications to our existing software platform, but cannot predict when, if ever, those changes and modifications will be approved.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can refuse to grant a 510(k) clearance or a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> request for marketing authorization, or delay, limit or deny approval of a PMA application or supplement for many reasons, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not be deemed by the FDA to be substantially equivalent to appropriate predicate devices under the 510(k) pathway;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not satisfy the FDA&#8217;s safety or effectiveness requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the data from pre-clinical studies and clinical trials may be insufficient to support clearance or approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the manufacturing process or facilities used may not meet applicable requirements; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in FDA approval policies or adoption of new regulations may require additional data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if approved or cleared by the FDA or foreign regulatory agencies, future generations of our CGM systems, expanded indications for use of current and future generation CGM systems, our software platforms or any other CGM system under development, may not be cleared or approved for the indications that are necessary or desirable for successful commercialization. We may not obtain the necessary regulatory approvals or clearances to market these CGM systems in the United States or outside of the United States. Any delay in, or failure to receive or maintain, clearance or approval for our products could prevent us from generating revenue from these products. The uncertain timing of regulatory approvals for future generations of our products could subject our current inventory to excess or obsolescence charges, which could have an adverse effect on our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations and contractual requirements regulating the provision of, and reimbursement for, health care goods and services in our capacity as a medical device manufacturer. The laws and regulations of health care goods and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. We have in place a compliance program, through which we seek to reduce common industry risks of noncompliance with U.S. federal and state and applicable foreign laws in areas such as sales contracts, marketing materials, referral source relationships, programmatic offerings, and billing practices (among others), monitor for compliance, and address non-compliance if identified. If a governmental authority were to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors and employees could be subject to criminal and civil penalties, as well as administrative sanctions such as exclusion from participation in federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by individual patients, who may be eligible for insurance coverage of their devices from various third-party payors, such as governmental programs (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Medicare, Medicaid, TRICARE, other federal and state health benefit plans, and comparable non-U.S. programs), private insurance plans, and managed care plans. The ability of our customers to obtain appropriate reimbursement for products and services from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. As a result, our products are subject to regulation regarding quality and cost by the U.S. Department of Health &amp; Human Services, including CMS, as well as comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care goods and services. The principal U.S. federal laws relating to reimbursement include those that prohibit (i) the filing of false or improper claims for federal payment, known as the federal civil False Claims Act, (ii) unlawful inducements for the referral of items and services reimbursed by Federal health care programs, known as the federal Anti-Kickback Statute, and (iii) the Civil Monetary Penalties Law, including its prohibitions on Beneficiary Inducement. Many states have similar laws that apply to reimbursement by state Medicaid and other government-funded programs, as well as, in some cases, to all payors, including self-pay patients. Insurance companies can also bring a private cause of action claiming treble damages against a manufacturer for causing a false claim to be filed under the federal Racketeer Influenced and Corrupt Organizations Act, or RICO. Additionally, as a manufacturer of FDA&#8209;approved or -cleared devices reimbursable by federal healthcare programs, we are subject to the federal Physician Payments Sunshine Act, which requires us to annually </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">report certain payments and other transfers of value we make to certain U.S.-licensed health care professionals and U.S. teaching hospitals, and under an expansion of the law to physician assistants, nurse practitioners, and other mid-level practitioners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the federal Anti-Kickback Statute, Congress and the OIG have established a large number of statutory exceptions and regulatory safe harbors that protect financial relationships with our customers and referral sources. An arrangement that fits squarely into an exception or safe harbor will not be deemed to violate the Anti-Kickback Statute.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We train and educate employees and marketing representatives on the Anti-Kickback Statute and their obligations thereunder, and we endeavor to comply with the applicable safe harbors. However, some of our arrangements, like many other common and non-abusive arrangements, may implicate the Anti-Kickback Statute and are not covered by a safe harbor, but nevertheless we do not believe them to present a significant risk to beneficiaries or federal healthcare programs and, as such, appear unlikely to invite government scrutiny or prosecution, warrant the imposition of sanctions, or be found to violate the statute. However, we cannot offer assurance that the government or a whistleblower would agree with our position that certain arrangements fall within a safe harbor, or that arrangements that do not squarely meet an exception or safe harbor will not be found to violate the Anti-Kickback Statute. Allegations of violations of the Anti-Kickback Statute can also trigger liability under the federal Civil Monetary Penalty Law and federal civil False Claims Act, thereby increasing the penalty structure for these violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period in which we directly billed Medicare, our financial relationships with referring physicians and their immediate family members were required to comply with the federal Physician Self-Referral law, commonly referred to as the Stark Law, by meeting an applicable exception. Unlike the Anti-Kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is unintentional. Violations of the Stark Law create overpayment liability under the federal civil False Claims Act and can also trigger separate penalties under the Civil Monetary Penalties Law. Knowing violations of the Stark Law carry increased civil monetary penalties and would likely be classified as the knowing submission of a false claim or knowingly making a false statement to the government, triggering liability under the federal civil False Claims Act. Certain Stark Law violations can also trigger exclusion from participation in federal healthcare programs. Historical violations of the Stark Law, if any, could continue to give rise to liability during the six year statute of limitations period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private third-party payors and other managed care organizations, such as pharmacy benefit managers, continue to take action to manage utilization and control costs. Consolidation among managed care organizations has increased the negotiating power of managed care organizations and other private third-party payors. Private third-party payors, as well as governments, increasingly employ formularies to control costs by taking into account discounts in connection with decisions about formulary inclusion or favorable formulary placement. Failure to obtain or maintain timely adequate pricing or favorable formulary placement for our products, or failure to obtain such formulary placement at favorable pricing, could adversely impact revenue. Private third-party payors, including self-insured employers, often implement formularies with co-payment tiers to encourage utilization of certain products and have also been raising co-payments required from beneficiaries, particularly for higher-cost products. Private third-party payors also use additional measures such as value-based pricing/contracting to improve their cost-containment efforts. Private third-party payors also are increasingly imposing utilization management tools, such as requiring prior authorization or requiring the patient to first fail on a lower-cost product before permitting access to a higher-cost product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many health care industry companies, including health care systems, distributors, manufacturers, providers, and insurers, are also consolidating or vertically integrating, or have formed strategic alliances. As the health care industry consolidates, competition to provide goods and services to industry participants may become more intense. This consolidation will continue to create larger enterprises with greater negotiating power, which they can try to use to negotiate price concessions or reductions for medical devices and components produced by us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the U.S. payor market consolidates further and we face greater pricing pressure from private third-party payors, who will continue to drive more of their patients to use lower cost alternatives, we may lose customers, our revenues may decrease and our business, financial condition, results of operations and cash flows may suffer.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo,&#160;or&#160;510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support current and any future additional PMA, 510(k), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applications or supplements, we together with our partners, must successfully complete pre-clinical studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development, including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays and failure at any stage. Furthermore, the data obtained from the studies and trials may be inadequate to support approval of an application and the FDA may request additional clinical data in support of those applications, which may result in significant additional clinical expenses and may delay product approvals. While we have in the past obtained, and may in the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, FDA approval of an IDE application permitting us to conduct testing does not mean that the FDA will consider the data gathered in the trial to be sufficient to support approval of a PMA, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 510(k) application or supplement, even if the trial&#8217;s intended safety and effectiveness endpoints are achieved.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to the regulatory landscape may impact our ability to obtain marketing authorization for future product developments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development or changes to the FDA or foreign regulatory approval standards and processes, including both legal and policy changes, could also delay or prevent the approval of our products submitted for review. For example, medical device cybersecurity continues to be an area of focus for and evolving guidance from FDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at the end of 2022, Congress passed the Food and Drug Omnibus Reform Act of 2022, or FDORA which (among other things), and similarly to the 2022 FDA Guidance, requires device sponsors to submit clinical trial diversity action plans outlining the goals for increasing representation of participants from racial and ethnic minority populations that have been underrepresented in clinical trials.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support clearance or approval of our products or additional or expanded indications. Medical device company stock prices have declined significantly in certain circumstances where companies have failed to meet expectations in regards to the timing of regulatory approval. If the FDA&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock price (and the market price of our senior convertible notes) could decline substantially. It is uncertain how these potential changes may impact our ability to gain clearance or approval from FDA for our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of FDA marketing applications or supplements, for numerous reasons, including, but not limited to, the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not enroll in clinical trials at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients or study site personnel who do not comply with clinical trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient follow-up does not occur at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients experience adverse side effects;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients die during a clinical trial, even though their death may not be related to our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">institutional review boards and third-party clinical investigators may delay or reject our clinical trial protocol;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the investigator agreements, clinical trial protocol, good clinical practices or other FDA or institutional review board requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we or third-party organizations do not perform data collection, monitoring or analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators have significant financial interests related to us or the study that the FDA deems to make the study results unreliable, or we or clinical investigators fail to disclose such interests;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory inspections of our clinical trials or manufacturing facilities may results in allegations or findings of noncompliance and, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in governmental regulations, policies or administrative actions applicable to our trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or efficacy; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, health epidemics could limit or restrict our ability to initiate, conduct or continue our clinical trials. Delays and disruption in our clinical trials could results in delays for expanded FDA clearance or approval of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of pre-clinical studies or other forms of early product testing do not necessarily predict future clinical trial results, and prior clinical trial results might not be repeated in subsequent clinical trials. Additionally, the FDA may disagree with our interpretation of the data from our pre-clinical studies, product testing, and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or effectiveness, and may require us to pursue the development of additional data, which could further delay the approval of our products. If we are unable to demonstrate the safety and effectiveness of our products in our clinical trials to the FDA&#8217;s satisfaction, where clinical data are required, we will be unable to obtain regulatory approval to market our products in the United States. In addition, the data we collect from our current clinical trials, our pre-clinical studies and other clinical trials may not be sufficient to support FDA approval, even if our endpoints are met.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also conduct clinical studies to demonstrate the relative or comparative effectiveness of CGM systems for the treatment of diabetes. These types of studies, which often require substantial investment and effort, may not show adequate, or any, clinical benefit or value for the use of CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our CGM systems currently have regulatory marketing authorization limited to individual patient home-use, and have otherwise not received clearance or approval from the FDA or other regulators for use in hospital or other in-patient facility settings, although the FDA has advised us that it will not object to the use of our CGM systems in such settings during the COVID-19 pandemic. Our potential supply of our CGM systems for use in this environment during the COVID-19 pandemic may present risks to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received, and may continue to receive, numerous inquiries from hospitals around the country about the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following direct communication with the FDA regarding the potential use of our CGM devices in a hospital or other in-patient setting, the FDA notified us on April 1, 2020 that in an exercise of its enforcement discretion it will not object, in the context of the COVID-19 pandemic, to Dexcom providing CGM devices and support to users to enable real-time remote patient monitoring in hospitals and other healthcare facilities, to support COVID-19 healthcare-related efforts, so long as we provide certain FDA-specified information with respect to the unique challenges that CGM technologies can raise in the hospital environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of its exercise of enforcement discretion, the FDA has advised that we communicate the following information related to implementing the use of CGM systems for remote monitoring of hospitalized patients:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Hospitals should consider whether they have the resources and expertise necessary to adequately implement CGM use and provide appropriate training to healthcare providers.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM glucose results are less accurate than blood glucose results obtained using traditional testing methods (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, lab glucose, blood glucose meters). Users should consider all CGM glucose information (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, trend) along with individual glucose values, and interpret CGM results in the context of the full clinical picture.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">CGM systems are subject to interferences that may generate falsely high and falsely low glucose readings. Levels of interference depend on drug concentration; substances that may not significantly interfere in non-hospitalized patients may interfere when used in the hospital setting because of higher dose levels. Most drugs used in hospital or critical care settings have not been evaluated and their interference with CGM systems is unknown. Known interferences vary by CGM brand, and can include Acetaminophen, Ascorbic acid, Hydroxyurea, or other reducing drugs/ compounds.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Poor peripheral blood perfusion may cause inaccurate sensor readings.&#160;CGM results should be interpreted considering accompanying patient conditions and medications. Other clinical conditions may also cause inaccurate readings.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision of our CGM systems to hospitals and other healthcare facilities for use during have and will continue to have the above notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we received Breakthrough Device designation for our G6 CGM system in the hospital setting. The FDA&#8217;s Breakthrough Device designation is designed to expedite the development and regulatory review of medical devices that hold the potential for more effective treatment or diagnosis of life-threatening or irreversibly debilitating disease or condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our CGM devices (and related support) for inpatient use, but if we supply them to such facilities as currently permitted by the FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that our CGM devices have not yet been fully evaluated or tested by either us or the FDA to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can also decide, at any time, to change its position regarding its Breakthrough Device Designation and/or enforcement discretion for our devices, and require that we seek marketing authorization for this additional intended use by submitting a 510(k) premarket notification, or that we seek and obtain Emergency Use Authorization. The COVID-19 public health emergency declared by the Department of Health and Human Services expired on May 11, 2023. While the end of the public health emergency does not by itself impact the FDA's ability to authorize devices for emergency use, and the FDA has published guidance for transition plans for medical devices that fall within enforcement policies issued during the COVID-19 pandemic. We will continue to closely monitor regulatory developments that impact our products, business, or financial results, including those relating to FDA enforcement discretion and Breakthrough Device Designation for the provision of our CGM systems in the hospital setting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays that are outside of our control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on clinical investigators and clinical sites to enroll patients in our clinical trials, and other third parties to manage the trial and to perform related data collection and analysis. However, we may not be able to control the amount and timing of resources that clinical sites may devote to our clinical trials. If these clinical investigators and clinical sites fail to enroll a sufficient number of patients in our clinical trials or fail to ensure compliance by patients with clinical protocols or fail to comply with regulatory requirements, we will be unable to complete these trials, which could prevent us from obtaining regulatory approvals for our products. Our agreements with clinical investigators and clinical sites for clinical testing place substantial responsibilities on these parties and, if these parties fail to perform as expected, our trials could be delayed or terminated. If these clinical investigators, clinical sites or other third parties do not carry out their contractual duties or obligations or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, or the clinical data may be rejected by the FDA, and we may be unable to obtain regulatory approval for, or successfully commercialize, our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the OIG published a Special Fraud Alert addressing manufacturer Speaker Programs, signaling both a more narrow government view of AKS compliance with respect to such programs as well as the potential for increased enforcement in this space by government oversight agencies such as the OIG and DOJ. In March, 2022, the Advanced Medical Technology Association, or AdvaMed, announced revisions to its Code of Ethics on Interactions with Health Care Professionals, or Code. The revised Code, effective June, 2022, addressed concerns noted in the OIG&#8217;s Special Fraud Alert, addressing things like virtual meetings, speaker programs and alcohol at events. The revised Code also addresses value-based care arrangements. We continue to assess industry responses to the Special Fraud Alert and have and may continue to make modifications to certain aspects of our speaker programs, which may have a detrimental impact on our ability to educate healthcare providers about </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our products and to promote use of our products, and which may in turn lead to decreased product sales and negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive healthcare legislation, signed into law in the United States in March 2010, titled the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively, the ACA, imposes certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, and enhanced penalties for non-compliance. Despite the ACA going into effect over a decade ago, there have been numerous legal and Congressional challenges to the law&#8217;s provisions and the effect of certain provisions have made compliance costly.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what additional new legislation, agency priorities, and rulemaking may be on the horizon as the United States continue to reassess how it pays for healthcare. As a result, we cannot quantify or predict what impact any changes might have on our business and results of operations. However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legal, regulatory and commercial policy influences are subjecting our industry to significant changes, and we cannot predict whether new regulations or policies will emerge from U.S. federal or state governments, foreign governments, or third-party payors. Government and commercial payors may, in the future, consider healthcare policies and proposals intended to curb rising healthcare costs, including those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for our current and future products. These include changes that may reduce reimbursement rates for our products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_229"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Intellectual Property Protection and Use</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties have asserted, and may assert, infringement or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods for continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third parties or others. Our competitors may assert that our CGM systems or the methods we employ in the use of our systems are covered by U.S. or foreign patents held by them. We have in the past settled some such allegations and may need to do so again in the future. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications relating to self-monitored glucose testing systems in the medical technology field. Because patent applications may take years to issue, there may be applications now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market for CGM systems grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our business operations may be harmed. We have been involved in various patent infringement actions in the past. For example, in July 2014, we entered into a Settlement and License Agreement with Abbott to settle all pending patent infringement legal proceedings brought by Abbott against us, which expired on March 31, 2021. Since the expiration of that agreement, we and certain Abbott entities have served complaints for patent infringement, validity, and other patent-related actions against each other in multiple jurisdictions, inside and outside the United States. We intend to vigorously pursue our claims and defenses in these cases to protect our intellectual property and to defend against Abbott&#8217;s infringement allegations. See &#8220;Legal Proceedings&#8221; in Part II, Item 1 above for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prohibited from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all, and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even if we are able to redesign our products to avoid an infringement claim, we may not receive FDA approval for such changes in a timely manner or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse determination in litigation or interference proceedings to which we are or may become a party relating to patents or other intellectual property rights could subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe third-party copyrights or trademarks or misappropriate third-party trade secrets, based on the intellectual property at issue, a court could order us to pay statutory damages, actual damages, or profits, such as reasonable royalty or lost profits of the owners, unjust enrichment, disgorgement of profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we may not be able to redesign our products to avoid infringement and any redesign may not receive FDA approval or other requisite marketing authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary intellectual property licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive approach and/or include multiple allegations in a single litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we are subject to various claims, complaints and legal actions arising out of the ordinary course of business, including commercial insurance, product liability or employment-related matters. Also, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment-related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and our ability to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent, copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous recent changes to the patent laws and proposed changes to the rules of the U.S. Patent and Trademark Office, which may have a significant impact on our ability to protect our technology and enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our proprietary rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual property rights are not infringed, or are invalid or unenforceable, and could award attorney fees.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to safeguard our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able to design around our patents. Furthermore, the laws of foreign countries may not protect our proprietary rights to the same extent as the laws of the United States.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_232"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Litigation Risks</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our products. This liability may vary based on the FDA classification associated with our devices. Notably, the classification of our G6 and G7 systems as Class II medical devices is likely to weaken our ability to rely on federal preemption of state law claims that assert liability against us for harms arising from use of those systems. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, healthcare providers or others selling our products. The risk of product liability claims may increase given that G6 and G7 do not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable. The risk of claims may also increase if our products are subject to a product recall or seizure. An example of the difficulty of complying with the regulatory requirements associated with the manufacture of our products, we issued notifications to our customers regarding the audible alarms and alerts associated with our receivers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claims with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling and that differs from the manner in which it was used in clinical studies and approved by the FDA. For example, our current systems are designed to be used by an individual continuously for up to 10 days for our G6 and G7 systems, but the individual might be able to circumvent the safeguards designed into the systems and use the products for longer than 10 days. Off-label use of products by customers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. In addition, other regulatory agencies may in the future approve similar diabetes treatment indications. We expect that such diabetes treatment indications could expose us to additional liability. These liabilities could prevent or interfere with our product commercialization efforts. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or inability to recruit, clinical trial volunteers or result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the recent COVID-19 pandemic, we have received and continue to receive, numerous requests from hospitals and healthcare facilities around the country regarding the use of our CGM devices to remotely monitor COVID-19 patients admitted into the hospital. As noted above, in 2020, the FDA informed us that they intend to exercise enforcement discretion and will not object to our provision of G6 CGM systems to such facilities for use in the inpatient setting during the pandemic. However, our CGM devices are currently approved only for in-home use by patients for the purpose of personal diabetes management and have not otherwise been cleared or approved by the FDA for hospital use. Given that the G6 CGM has not yet been fully evaluated or tested (by us or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment. To the extent that inpatient use of our CGM systems causes or contributes to an adverse event, we may be subjected to additional product liability lawsuits. Defending a suit, regardless of merit, could be costly, could divert management </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attention and might result in adverse publicity, which could result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies are subject to numerous investigations and inquiries by various governmental agencies. Further, under the False Claims Act, private parties have the right to bring&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or &#8220;whistleblower,&#8221; suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Depending upon whether the underlying conduct alleged in such inquiries or investigations could be considered systemic, any resolution of any such investigations could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and their agents, such as CMS Medicare Administrative Contractors and other CMS contractors, as well as the OIG, state Medicaid programs, and other state and federal agencies may conduct audits of our operations, relating to covered items and services including those furnished to beneficiaries, health care providers and distributors. Commercial and government-funded managed care payors may conduct similar post-payment audits. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have a material adverse effect on our financial position and results of operations. Our compliance program includes internal audit and monitoring functions designed to identify potential issues and facilitate remediation as appropriate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future investigations of our executives, our managers or us could result in significant liabilities or penalties to us, as well as adverse publicity. Even if we are found to have complied with applicable law, the investigation or litigation may pose a considerable expense and would divert management&#8217;s attention, and have a potentially negative impact on the public&#8217;s perception of us, all of which could negatively impact our financial position and results of operations. Further, should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to fines, penalties and injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses or determined to have made claims that are untruthful or misleading or not adequately substantiated.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing, promotional and educational materials and practices are subject to FDCA, Federal Trade Commission Act, and other applicable laws and regulations, as may be amended from time to time. If the FDA, FTC or other regulatory body with competent jurisdiction over us, our activities or products takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved or improper use, or that they contain untruthful, misleading, or inadequately substantiated statements or claims, such regulatory body could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance, depending on the regulatory body and the nature of the alleged violation, of a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider promotional, marketing or other materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the FDA&#8217;s enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks in this area in part due to the potential False Claims Act exposure and the FDA&#8217;s continued focus on ensuring devices are marketed in a manner consistent with their FDA-required labeling.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting nor do we plan to actively promote our G6 or G7 systems for inpatient use, but if we supply them to such facilities as currently permitted by FDA, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that the G6 and G7 systems have not yet been fully evaluated or tested (by us or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In some instances in our advertising and promotion, we may make claims regarding our product as compared to competing products, which may subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA applies a heightened level of scrutiny to comparative claims when applying its statutory standards for advertising and promotion, including with regard to its requirement that promotional labeling be truthful and not </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">misleading. There is potential for differing interpretations of whether certain communications are consistent with a product&#8217;s FDA-required labeling, and FDA will evaluate communications on a fact-specific basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, making comparative claims may draw concerns from our competitors.&#160;Where a company makes a claim in advertising or promotion that its product is superior to the product of a competitor (or that the competitor&#8217;s product is inferior), this creates a risk of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade practices law, and possibly also state libel law.&#160;Such a suit may seek injunctive relief against further advertising, a court order directing corrective advertising, and compensatory and punitive damages where permitted by law.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct-to-consumer marketing and social media efforts may expose us to additional regulatory scrutiny.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to promote our products via direct-to-consumer marketing and social media initiatives may subject us to additional scrutiny of our practices of effective communication of risk information, benefits or claims, under the oversight of the FDA, FTC, HHS-OCR, or others.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_235"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Risks Related to Our Business and Financial Condition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses in the past. We have financed our operations primarily through private and public offerings of equity securities and debt and the sales of our products. We have devoted substantial resources to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">research and development relating to our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">sales and marketing and manufacturing expenses associated with the commercialization of our CGM systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expansion of our workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to increase in connection with our clinical trials and other development activities related to our products, including our next-generation sensors, transmitters and receivers, as well as other collaborations. We also expect that our general and administrative expenses will continue to increase due, among other things, to the additional operational and regulatory burdens applicable to public healthcare and medical device companies. As a result, it is possible that we could incur operating losses in the future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend on our ability to attract and retain our personnel and manage our human capital, while controlling labor costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend to a significant degree on our senior management, especially Kevin Sayer, our President and Chief Executive Officer. Our success will depend on our ability to retain our senior management and to attract and retain qualified personnel in the future, including salespersons, scientists, clinicians, engineers and other highly skilled personnel. Competition for senior management personnel, as well as salespersons, scientists, clinicians and engineers, is intense and we may not be able to retain our personnel. The loss of the services of members of our senior management, scientists, clinicians or engineers could prevent the implementation and completion of our objectives, including the commercialization of our current products and the development and introduction of additional products. The loss of a member of our senior management or our professional staff would require the remaining executive officers to divert immediate and substantial attention to seeking a replacement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our officers may terminate their employment at any time without notice and without cause or good reason. Additionally, volatility or a lack of positive performance in our stock price may adversely affect our ability to retain key employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to expand our operations and grow our research and development, manufacturing, sales and marketing, product development and administrative operations. We expect this expansion to place a significant strain on our management and it will require hiring a significant number of qualified personnel. Accordingly, recruiting and retaining such personnel will be critical to our success. There is intense competition from other companies and research and academic institutions for qualified personnel in the areas of our activities. If we fail to identify, attract, retain and motivate these skilled personnel, we may be unable to continue our development and commercialization activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may undertake reorganizations of our workforce, which may result in a temporary reduction in the number of employees in certain locations. We would undertake a reorganization to reduce operating expenses or achieve other business objectives, though we cannot guarantee any specific amount of long-term cost savings. Further, the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">turnover in our employee base could result in operational and administrative inefficiencies, which could adversely impact the results of our operations, stock price and customer relationships, and could make recruiting for future management and other positions more difficult.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may conduct additional financings to continue the development or commercialization of our current or future generation CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products, including growth of our manufacturing capacity, on research and development, and conducting clinical trials for our next-generation ambulatory CGM sensors and systems. Although we raised substantial net proceeds through the private sale of our convertible notes, we could need funds to continue the commercialization of our current products and to develop and commercialize our next-generation sensors and systems or pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all. Any additional financing may be dilutive to stockholders or may require us to grant a lender a security interest in our assets. The amount of funding we may need will depend on many factors, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the revenue generated by sales of our products and other future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs, timing and risks of delay of additional regulatory approvals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to scale our manufacturing operations to meet demand for our current and any future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs to produce our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the rate of progress and cost of our clinical trials and other development activities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the success of our research and development efforts;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the emergence of competing or complementary technologies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future products including those integrated with other companies&#8217; products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the acquisition of business, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available, we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm our business and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncollectible uninsured and patient due accounts could adversely affect our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary collection risks for our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (exclusions, deductibles and copayments) remain outstanding. In addition, as a result of the economic slowdown, some customers have, and others may, lose access to their private health insurance plan if they lose their job. As most of our customers rely on third-party payors, including private health insurance plans, to cover the cost of our products, there has been, and may continue to be, a shift in financial responsibility to our customers for the amounts previously covered by their primary insurance carrier.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are unsuccessful in collecting payments owed by patients, and/or experience increases in the amount, or deterioration in the collectability, of uninsured and patient due accounts receivable, this could adversely affect our cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts, as a result of increases in the adoption of plan structures, due to evolving health care policy and insurance landscapes that shift greater responsibility for care to individuals through greater exclusions, prior authorizations, and copayment and deductible amounts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our business strategy or restructuring of our businesses may increase our costs or otherwise affect the profitability of our businesses or the value of our assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As changes in our business environment occur we have adjusted, and may further, adjust our business strategies to meet these changes and we may otherwise decide to further restructure our operations or particular businesses or assets. Our new organization and strategies may not produce the anticipated benefits, such as supporting our growth strategies and enhancing shareholder value. Our new organization and strategies could be less successful than our previous organizational structure and strategies. In addition, external events including changing technology, changing consumer patterns, acceptance of our products and changes in macroeconomic conditions may impair the value of our assets. When these changes or events occur, we may incur costs to change our business strategy and may need to write-down the value of assets. For example, current economic conditions, including rising interest rates, inflation and a potential recession, as well as our business decisions, may reduce the value of some of our assets. We also make investments in existing or new businesses, including investments in the international expansion of our sales efforts and the build-out of our manufacturing facility in Malaysia as well as our proposed facility in Ireland. Additionally, we also invest in early to late-stage companies for strategic reasons and to support key business initiatives, and we may not realize a return on our equity investments. Many such companies generate net losses and the market for their products, services, or technologies may be slow to develop or never materialize. We are subject to risks associated with our equity investments including partial or complete loss of invested capital, and significant changes in the fair value of this portfolio could adversely impact our financial results. Some of these investments may have returns that are negative or low, the ultimate business prospects of the businesses related to these investments may be uncertain, and these risks may be exacerbated by current macroeconomic conditions. In any of these events, our costs may increase or returns on new investments may be lower than prior to the change in strategy or restructuring.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_238"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Relating to Our Public Company Status, Tax Laws and Growth Through Acquisition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face risks associated with acquisitions of companies, products and technologies and our business could be harmed if we are unable to address these risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are presented with appropriate opportunities, we could acquire or make other investments in complementary companies, products or technologies. We may not realize the anticipated benefit of our acquisitions, or the realization of the anticipated benefits may require greater expenditures than anticipated by us. We will likely face risks, uncertainties and disruptions associated with the integration process, including difficulties in the integration of the operations and services of any acquired company, integration of acquired technology with our products, diversion of our management&#8217;s attention from other business concerns, the potential loss of key employees or customers of the acquired businesses and impairment charges if future acquisitions are not as successful as we originally anticipated. If we fail to successfully integrate other companies, products or technologies that we acquire, our business could be harmed. Furthermore, we may have to incur debt or issue equity or equity-linked securities to pay for any future acquisitions or investments, the issuance of which could be dilutive to our existing stockholders. In addition, our operating results may suffer because of acquisition-related costs, amortization expenses or charges relating to acquired intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with regulations relating to public company corporate governance matters and reporting may strain our resources and divert management&#8217;s attention.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many laws and regulations, notably those adopted in connection with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and The Nasdaq Stock Market listing rules, impose obligations on public companies, such as ours, which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Compliance with these laws and regulations, including enhanced new disclosures, has required and will continue to require substantial management time and oversight and the incurrence of significant accounting and legal costs. The effects of new laws and regulations remain unclear and will likely require substantial management time and oversight and require us to incur significant additional accounting and legal costs. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may require us to incur greater accounting fees. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to continue to invest resources to comply with evolving laws, regulations, and standards, and this investment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to changes in our tax rates, new U.S. or international tax legislation or additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the United States and numerous foreign jurisdictions, where a number of our subsidiaries are organized. The tax laws in the United States and in other countries in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. Further, due to economic and political conditions, tax rates in various jurisdictions may be subject to change. Our effective tax rates could be affected by numerous factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in tax laws or their interpretation, both in and outside the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is growing pressure in many jurisdictions, including the United States, and from multinational organizations such as the OECD and the European Union to amend existing international tax rules in order to render them more responsive to current global business practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax returns and other tax matters also are subject to examination by the U.S. Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. We cannot guarantee the outcome of these examinations. If our effective tax rates were to increase, particularly in the United States, or in other countries implementing legislation to reform existing tax legislation, including the European Union and Germany, or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, operating results and cash flows could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to use our net operating losses, or NOLs, to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability. We may be limited in the portion of NOL carryforwards that we can use in the future to offset taxable income for U.S. federal and state income tax purposes, and federal tax credits to offset federal tax liabilities. Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state law provisions, limit the use of NOLs and tax credits after a cumulative change in corporate ownership of more than 50% occurs within a three-year period. The statutes place a formula limit on how much NOLs and tax credits a corporation can use in a tax year after a change in ownership. Avoiding an ownership change is generally beyond our control. Although the ownership changes we experienced in the past have not prevented us from using all NOLs and tax credits accumulated before such ownership changes, we could experience another ownership change that might limit our use of NOLs and tax credits in the future. In addition, realization of deferred tax assets, including net operating loss carryforwards, depends upon our future earnings in applicable tax jurisdictions. If we have insufficient future taxable income in the applicable tax jurisdiction for any reason, including any future corporate reorganization or restructuring activities, we may be limited in our ability to utilize some or all of our net operating losses to offset such income and reduce our tax liability in that jurisdiction. We utilized that the majority of our remaining NOLs by the end of 2021, with the exception of the NOLs limited by Section 382 of the Internal Revenue Code of 1986. See Note 8 &#8220;Income Taxes&#8221; to the consolidated financial statements for the fiscal year ended December 31, 2022 in Part II, Item 8 of our Annual Report on Form 10-K that we filed with the SEC on February 9, 2023 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that due to regulatory changes or changes to federal or state law, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable either in whole or in part to offset future income tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of share-based payments, which we are required to perform for purposes of recording compensation expense under authoritative guidance for share-based payment, involves assumptions that are subject to change and difficult to predict.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense in the consolidated statements of operations for share-based payments, such as restricted stock units and employee stock purchase plan shares, using the fair value method. The requirements of the authoritative guidance for share-based payment have and will continue to have a material effect </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our future financial results reported under U.S. generally accepted accounting principles, or GAAP, and make it difficult for us to accurately predict the impact on our future financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, estimating the fair value of share-based payments is highly dependent on assumptions regarding the future exercise behavior of our employees and changes in our stock price. If there are errors in our input assumptions for our valuations models, we may inaccurately calculate actual or estimated compensation expense for share-based payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for share-based payment could also adversely impact our ability to provide accurate guidance on our future financial results as assumptions that are used to estimate the fair value of share-based payments are based on estimates and judgments that may differ from period to period. We may also be unable to accurately predict the amount and timing of the recognition of tax benefits associated with share-based payments as they are highly dependent on the exercise behavior of our employees and the price of our stock relative to the exercise price of each outstanding stock option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those reasons, among others, the authoritative guidance for share-based payment may create variability and uncertainty in the share-based compensation expense we will record in future periods, which could adversely impact our stock price and increase our expected stock price volatility as compared to prior periods.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_241"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Common Stock</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the market price of our common stock, like the securities of many other medical products companies, fluctuates and could continue to be volatile in the future, especially as our business continues to grow and our business plan continues to evolve. From January&#160;1, 2023 through September&#160;30, 2023, the closing price of our common stock on the Nasdaq Global Select Market was as high as $137.93 per share and as low as $86.06 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock is influenced by many factors that are beyond our control, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">securities analyst coverage or lack of coverage of our common stock or changes in their estimates of our financial performance;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">variations in quarterly operating results;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">future sales of our common stock by our stockholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">investor perception of us and our industry;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">announcements by us or our competitors of significant agreements, acquisitions, or capital commitments or product launches or discontinuations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in market valuation or earnings of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">negative business or financial announcements regarding our partners;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">general economic conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory actions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">legislation and political conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global health pandemics, such as the recent COVID-19 pandemic; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">other events or factors, including the, ongoing conflicts in Ukraine and Israel, recessions, rising interest rates, inflation, local and national elections, international currency fluctuations, corruption, political instability and acts of war or terrorism</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please also refer to the factors described elsewhere in this &#8220;Risk Factors&#8221; section. In addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated and disproportionate to the operating performance of companies in our industry. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation has often been brought against public companies that experience periods of volatility in the market prices of their securities. Securities class action litigation could result in substantial costs and a diversion of our management&#8217;s attention and resources.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares by us in the future or sales of shares by our stockholders may cause the market price of our common stock to drop significantly, even if our business is performing well.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This issuance of shares by us in the future, including by conversion of our senior convertible notes in certain circumstances, the issuance of shares of our common stock to partners, including up to 5,154,640 shares of our common stock that we may issue to Verily pursuant to the Restated Collaboration Agreement, or sales of shares by our stockholders may cause the market price of our common stock to decline, perhaps significantly, even if our business is performing well. The market price of our common stock could also decline if there is a perception that sales of our shares are likely to occur in the future. This might also make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. Also, we may issue securities in connection with future financings and acquisitions, and those shares could dilute the holdings of other stockholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future and the terms of our credit agreement restrict our ability to declare or pay any dividends. As a result, stockholders (including holders of our senior convertible notes who receive shares of our common stock, if any, upon conversion of their notes) may only receive a return on their investment in our common stock if the market price of our common stock increases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover effects of our charter documents and Delaware law could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are provisions in our certificate of incorporation and bylaws, as well as provisions in the Delaware General Corporation Law, that may discourage, delay or prevent a change of control that might otherwise be beneficial to stockholders. For example:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders do not have cumulative voting rights and, therefore, each of our directors can only be elected by holders of a majority of our outstanding common stock;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a special meeting of stockholders may only be called by a majority of our Board of Directors, the Chairman of our Board of Directors, our Chief Executive Officer, our President or our Lead Independent Director;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders may not take action by written consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors is divided into three classes, only one of which is elected each year (however, over a three year period beginning with the 2022 annual meeting of stockholders the Board will be declassified and by the conclusion of this process all directors will be elected annually); and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we require advance notice for nominations for election to the Board of Directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all claims brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. In September 2020, we amended and restated our restated bylaws to provide that the federal district courts of the United States will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or a Federal Forum Provision. Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Neither the exclusive forum provision nor the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to our exclusive forum provisions, including the Federal Forum Provision. The exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provisions contained in our restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results, and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay, or prevent a change of control of our company. Section 203 imposes certain restrictions on mergers, business combinations, and other transactions between us and holders of 15% or more of our common stock.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_244"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Our Debt</span></td></tr></table></div><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing our financial leverage could affect our operations and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to our Second Amended and Restated Credit Agreement, or the Amended Credit Agreement, with JPMorgan Chase and other syndicate lenders, which amended and restated the credit agreement, or the Credit Agreement, we had previously entered into in December 2018 and amended in May 2020 and October 2021, respectively. The Amended Credit Agreement is a five-year $200.0 million revolving credit facility, or the Credit Facility. As of September&#160;30, 2023, we had no outstanding borrowings, $7.3 million in outstanding letters of credit, and a total available balance of $192.7 million under the Amended Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage ratio may affect the availability to us of additional capital resources as well as our operations in several ways, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms on which credit may be available to us could be less attractive, both in the economic terms of the credit and the legal covenants;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible lack of availability of additional credit;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the potential for higher levels of interest expense to service or maintain our outstanding debt;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possibility of additional borrowings in the future to repay our indebtedness when it comes due; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible diversion of capital resources from other uses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe we will have the ability to service our debt and obtain additional resources in the future if and when needed, that will depend upon our results of operations and financial position at the time, the then-current state of the credit and financial markets, and other factors that may be beyond our control. Therefore, we cannot give assurances that sufficient credit will be available on terms that we consider attractive, or at all, if and when necessary or beneficial to us.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with covenants in the Amended Credit Agreement could result in our inability to borrow additional funds and adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement imposes numerous financial and other restrictive covenants on our operations, including covenants relating to our general profitability and our liquidity. As of September&#160;30, 2023, we were in compliance with the covenants imposed by the Amended Credit Agreement. If we violate these or any other covenants, any outstanding amounts under the Amended Credit Agreement could become due and payable prior to their stated maturity dates, each lender could proceed against any collateral in our operating accounts and our ability to borrow funds in the future may be restricted or eliminated. These restrictions may also limit our ability to borrow additional funds and pursue other business opportunities or strategies that we would otherwise consider to be in our best interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of $850.0 million aggregate principal amount of 0.75% senior convertible notes due 2023, or 2023 Notes, which offering we refer to as the 2018 Notes Offering. In May 2020, we completed an offering of approximately $1.21 billion aggregate principal amount of 0.25% senior convertible notes due 2025, or 2025 Notes, which offering we refer to as the 2020 Notes Offering. In May 2023, we completed an offering of approximately $1.25&#160;billion aggregate principal amount of 0.375% senior convertible notes due 2028, or 2028 Notes, which offering we refer to as the 2023 Notes Offering. We refer to the 2018 Notes Offering, the 2020 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes Offering, and the 2023 Notes Offering, collectively, as the Notes Offerings, and we refer to the 2023 Notes, the 2025 Notes, and the 2028 Notes, collectively, as the Notes. As a result of the Notes Offerings, we incurred $3.31 billion principal amount of indebtedness, the principal amount of which we may be required to pay at maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture for each of the Notes) at a purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our level of increased debt after the completion of the Notes Offerings:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our vulnerability to adverse general economic conditions and competitive pressures will be heightened;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we will be required to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our flexibility in planning for, or reacting to, changes in our business and industry may be more limited; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that our leverage resulting from the level of increased debt after the completion of the Notes Offerings will not materially and adversely affect our ability to finance our operations or capital needs or to engage in other business activities. In addition, we cannot be sure that additional financing will be available when required or, if available, will be on terms satisfactory to us. Further, even if we are able to obtain additional financing, we may be required to use such proceeds to repay a portion of our debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to repurchase the Notes upon a fundamental change when required by the holders or repay prior to maturity any accelerated amounts due under the notes upon an event of default or redeem the Notes unless specified conditions are met under our Credit Facility, and our future debt may contain additional limitations on our ability to pay cash upon conversion, repurchase or repayment of the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change purchase date. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than cash in lieu of any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase Notes surrendered upon a fundamental change or repay prior to maturity any accelerated amounts or pay cash for Notes being converted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes upon an event of default or pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our indebtedness outstanding at the time, including our Credit Facility. Under our Credit Facility, we are only permitted to use cash to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes if we meet certain conditions that are defined under the Credit Agreement. We may not meet these conditions in the future. Our failure to repurchase Notes at a time when the repurchase is required by the respective indenture (whether upon a fundamental change or otherwise under each indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under each indenture. A default under each indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness, including our Credit Facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may incur substantial additional debt in the future, subject to the restrictions contained in our debt instruments, some of which may be secured debt. We are not restricted under the terms of the indentures governing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the convertible senior notes that could have the effect of diminishing our ability to make payments on the Notes when due.</span></div><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The capped call transactions we entered into in connection with the pricing of the 2028 Notes may affect the value of our 2028 Notes and common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing of the 2028 Notes, we entered into capped call transactions, or the 2028 Capped Calls, relating to such 2028 Notes with the option counterparties. The 2028 Capped Calls relating to the 2028 Notes cover, subject to customary adjustments, the number of shares of our common stock that initially underlie the 2028 Notes. The 2028 Capped Calls are generally expected to reduce the potential dilution to stockholders upon any conversion of the 2028 Notes, and/or offset any cash payments that we are required to make in excess of the principal amount upon any conversion of the 2028 Notes, with such reduction and/or offset subject to a cap.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions following the pricing of the 2028 Notes, as applicable, and prior to the maturity of the 2028 Notes (and are likely to do so during any observation period related to a conversion of such Notes or following any repurchase of such notes by us on any fundamental change repurchase date or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our 2028 Notes or common stock, which could affect a holder&#8217;s ability to convert its 2028 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2028 Notes, it could affect the amount and value of the consideration that a holder will receive upon conversion of such 2028 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of the 2028 Notes or our common stock will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of 2028 Notes or our common stock (and as a result, the amount and value of the consideration that a holder would receive upon the conversion of any 2028 Notes) and, under certain circumstances, a holder&#8217;s ability to convert its notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2028 Notes or our common stock. In addition, we do not make any representation that the option counterparties or their respective affiliates will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The convertible note hedge and warrant transactions may affect the value of the 2023 Notes and our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the 2023 Notes, we entered into convertible note hedge, or the 2023 Note Hedge, transactions with certain financial institutions, or option counterparties. We also entered into warrant transactions with the option counterparties pursuant to which we sold warrants for the purchase of our common stock, or the 2023 Warrants. The 2023 Note Hedge transactions are expected generally to reduce the potential dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes. The 2023 Warrant transactions could separately have a dilutive effect to the extent that the market price per share of our common stock exceeds the exercise price of the 2023 Warrants, which is $49.60.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions prior to the maturity of 2023 Notes (and are likely to do so during any observation period related to a conversion of 2023 Notes, or following any repurchase of Notes by us on any fundamental change repurchase date (as defined in the indenture for the 2023 Notes) or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the 2023 Notes, which could affect note holders&#8217; ability to convert the 2023 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2023 Notes, it could affect the amount and value of the consideration that note holders will receive upon conversion of the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of our common stock or the 2023 Notes will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock and the value of the 2023 Notes (and as a result, the value of the consideration, the amount of cash and/or the number of shares, if any, that note holders would receive upon the conversion of the 2023 Notes) and, under certain circumstances, the ability of the note holders to convert the 2023 Notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the 2023 Notes or our common stock. In addition, we do not make any representation that the option counterparties will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to counterparty risk with respect to the 2023 Note Hedge transactions and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties to the 2023 Note Hedge transactions and 2028 Capped Calls are financial institutions, and we will be subject to the risk that any or all of them may default under the 2023 Note Hedge transactions and 2028 Capped Calls, respectively. Our exposure to the credit risk of these counterparties is not secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with that option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the counterparties with respect to the 2023 Note Hedge transactions and 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Notes, depends on our future financial condition and operating performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to satisfy our obligations under the Notes, our existing indebtedness and any future indebtedness we may incur and to make necessary capital expenditures. We may not maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on (as well as any cash due upon conversion of) our debt, including the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. These alternative measures may not be successful and may not permit us to meet our scheduled debt servicing obligations. Further, we may need to refinance all or a portion of our debt on or before maturity, and our ability to refinance the Notes, existing indebtedness or future indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities on commercially reasonable terms or at all, which could result in a default on the Notes or our current and future indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Credit Facility imposes restrictions on us that may adversely affect our ability to operate our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Credit Facility contains restrictive covenants relating to our capital raising activities and other financial and operational matters which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, our Credit Facility and the agreements governing the notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other borrowings. For example, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million, in the case of the 2023 Notes, $50.0 million, in the case of the 2025 Notes, and $50.0 million, in the case of the 2028 Notes, that causes such indebtedness to become due prior to its scheduled maturity date would cause a cross-default under the indenture governing the Notes. In addition, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a default under our Credit Facility. The occurrence of a default under any of these borrowing arrangements would permit the holders of the Notes or the lenders under our Credit Facility to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable. If the Note holders or the trustee under the indenture governing the Notes or the lenders under our Credit Facility accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay those borrowings.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the Notes will, to the extent we deliver shares upon conversion of such Notes, dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares upon conversion of any of the Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than cash in lieu of any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of the Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible debt securities that may be settled in cash, such as the Notes, may have a material effect on our reported financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than by paying cash in lieu of delivering any fractional share), we may settle all or a portion of our conversion obligation in cash, which could adversely affect our liquidity. In addition, the consideration received upon the unwind or termination of the capped call transactions may not completely offset, and may be substantially less than, any cash payments in excess of the principal amount of the Notes we are required to make upon conversion of the Notes. Even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take over Dexcom.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of Dexcom would trigger an option of the holders of the Notes to require us to repurchase the Notes. In addition, if a make-whole fundamental change occurs prior to the maturity date of the Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change. Furthermore, each indenture for the Notes prohibits us from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes our obligations under the notes. These and other provisions of each indenture may have the effect of delaying or preventing a takeover of Dexcom.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_247"></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Risks Related to Environmental, Social and Governance Matters</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance, or ESG, regulations, policies and provisions could expose us to numerous risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasingly, regulators, customers, investors, employees and other stakeholders are focusing on ESG matters and related disclosures. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. For example, collecting, measuring and reporting ESG-related data and information is subject to evolving reporting standards, including the SEC&#8217;s proposed climate-related reporting requirements, and similar proposals by other international regulatory bodies. In addition, a number of our customers who are payors or distributors have adopted, or may adopt, procurement policies that include ESG provisions that their suppliers or manufacturers must comply with, or they may seek to include such provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary ESG groups or organizations, such as the Responsible Business Alliance. These </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESG provisions and initiatives are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and the outsourced manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our suppliers to comply, with such policies or provisions, a customer may stop purchasing products from us, and may take legal action against us, which could harm our reputation, revenue and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by evolving expectations and challenges relating to implementing ESG initiatives, setting ESG-related goals, collecting ESG-related data, and disclosing ESG-related information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may communicate certain initiatives and goals regarding ESG-related matters in our SEC filings or in other public disclosures. These ESG-related initiatives and goals could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for the accuracy, adequacy or completeness of the disclosure. Further, statements about our ESG-related initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our ESG-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to our ESG-related goals on a timely basis, or at all, our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Climate change may have a long-term impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we seek to partner with organizations that mitigate their business risks associated with climate change, we recognize that there are inherent risks related to climate change wherever business is conducted. Access to clean water and reliable energy in the communities where we conduct our business, whether for our offices or for our vendors, is a priority. Our manufacturing sites in California, Arizona and Malaysia and our operations in the Philippines are vulnerable to climate change effects. For example, in California and Arizona, increasing intensity of droughts throughout the states and annual periods of wildfire danger increase the probability of planned and unplanned power outages in the communities where we work and live. While this danger has a low-assessed risk of disrupting normal business operations, it has the potential impact on employees&#8217; abilities to commute to work or to work from home and stay connected effectively. Climate-related events, including the increasing frequency of extreme weather events and their impact on the U.S., the Philippines, Malaysia and other major regions&#8217; critical infrastructure, have the potential to disrupt our business, our third-party suppliers, and/or the business of our customers, and may cause us to experience higher attrition, losses, and additional costs to maintain or resume operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be liable for contamination or other harm caused by materials that we handle, and changes in environmental regulations could cause us to incur additional expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to international and domestic (including federal, state and local) laws, rules and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%">General Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in domestic and global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies (including the conflict between Ukraine and Russia), monetary and financial uncertainties in Europe and other foreign countries, global health pandemics, rising interest rates, and domestic and global inflationary trends. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. A recession, depression or other sustained adverse market event could materially and adversely affect our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by the effects of inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation has the potential to adversely affect our liquidity, business, financial condition and results of operations by increasing our overall cost structure. The existence of inflation in the economy has resulted in, and may continue to result in, higher interest rates and capital costs, supply shortages, increased costs of labor, components, manufacturing and shipping, as well as weakening exchange rates and other similar effects. As a result of inflation, we have experienced and may continue to experience cost increases. Although we may take measures to mitigate the effects of inflation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Even if such measures are effective, there could be a difference between the timing of when these beneficial actions impact our results of operations and when the cost of inflation is incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully maintain effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal control over financial reporting, there could be inaccuracies or omissions in the consolidated financial information we are required to file with the SEC. Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other securities exchange on which it is then listed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in financial accounting standards or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in accounting standards or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our products may have an impact on the manner in which we recognize revenue. In addition, changes to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require us to incur greater accounting fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our operating results include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">possible delays in our research and development programs or in the completion of any clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a lack of acceptance of our products in the marketplace by physicians and people with diabetes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the inability of customers to receive reimbursements from third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the purchasing patterns of our customers, including as a result of seasonality;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our failure to continue the commercialization of any of our CGM systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">competition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inadequate financial and other resources; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global political and economic conditions, political instability and military hostilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_253"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_259"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 3 - DEFAULTS UPON SENIOR SECURITIES</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_262"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 4 - MINE SAFETY DISCLOSURES</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_265"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 5 - OTHER INFORMATION</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-945" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Plans</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2023, none of our directors or officers informed us of the adoption or termination of a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;<ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-946"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-947">non-Rule 10b5-1</ix:nonNumeric></ix:nonNumeric> trading arrangement,&#8221; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Character of Trading Arrangement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 10b5-1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Rule 10b5-1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Shares to be Sold</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="ecd:TrdArrIndName" id="f-948">Michael Brown</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="ecd:TrdArrIndTitle" id="f-949">Executive Vice President, Chief Legal Officer</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-true" id="f-950">Termination</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="ecd:TrdArrAdoptionDate" id="f-951">8/29/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-245" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-952">3,612</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="ecd:TrdArrTerminationDate" id="f-953">12/15/2023</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-246" name="ecd:TrdArrIndName" id="f-954">Michael Brown</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-246" name="ecd:TrdArrIndTitle" id="f-955">Executive Vice President, Chief Legal Officer</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-246" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-956">Adoption</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-246" name="ecd:TrdArrAdoptionDate" id="f-957">8/29/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to <ix:nonFraction unitRef="shares" contextRef="c-247" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-958">14,463</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-248" name="ecd:TrdArrIndName" id="f-959">Nicholas Augustinos</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-248" name="ecd:TrdArrIndTitle" id="f-960">Director</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-248" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-961">Adoption</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-248" name="ecd:TrdArrAdoptionDate" id="f-962">9/15/2023</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to <ix:nonFraction unitRef="shares" contextRef="c-249" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-963">7,648</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/15/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on 12/15/2022 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), as then in effect, under the Exchange Act.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The number of shares of common stock sold under the Rule 10b5-1 trading arrangement will be net of shares withheld for applicable tax obligations upon the vesting of covered securities and is not yet determinable.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each new Rule 10b5-1 Plan that was adopted in the above table includes a representation from Messrs. Brown and Augustinos, respectively, to the broker administering the plan that he was not in possession of any material nonpublic information regarding Dexcom or the securities subject to the Rule 10b5-1 Plan at the time the Rule 10b5-1 Plan was entered into. A similar representation was made to Dexcom in connection with the adoption of the Rule 10b5-1 Plan under Dexcom&#8217;s insider trading policy. Those representations were made as of the Adoption Date set forth above, and speak only as of that date. In making those representations, there is no assurance with respect to any material nonpublic information of which the directors and officers was unaware, or with respect to any material nonpublic information acquired by the above directors and officers or Dexcom after the date of the representation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once executed, transactions under a Rule 10b5-1 Plan adopted during the period described above will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, Dexcom does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Messrs. Brown and Augustinos, respectively, or other officers or directors of Dexcom.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_268"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITEM 6 - EXHIBITS</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;of<br/>First<br/>Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023ex1001-byramhea.htm">10.01*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023ex1001-byramhea.htm">Amendment Number Sixteen to Amended and Restated Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and Byram Healthcare Centers, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023ex1002-edgepark.htm">10.02*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023ex1002-edgepark.htm">Amendment Number Thirteen to Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023exhibit3101.htm">31.01</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023exhibit3101.htm">Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023exhibit3102.htm">31.02</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023exhibit3102.htm">Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023exhibit3201.htm">32.01**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023exhibit3201.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dxcm9302023exhibit3202.htm">32.02**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm9302023exhibit3202.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="-sec-extract:exhibit;color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;of<br/>First<br/>Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provided<br/>Herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File - the cover page from the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2023 is formatted in Inline XBRL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.866%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">This certification is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Dexcom specifically incorporates it by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i9fa53d16cdda40f09337e7f3f72540fe_271"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">Table </a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7">of</a><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i9fa53d16cdda40f09337e7f3f72540fe_7"> Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SIGNATURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.504%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEXCOM, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ KEVIN R. SAYER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kevin R. Sayer,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Chairman of the Board of Directors,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">President and Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JEREME M. SYLVAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jereme M. Sylvain,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.01
<SEQUENCE>2
<FILENAME>dxcm9302023ex1001-byramhea.htm
<DESCRIPTION>EX-10.01
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1fa518c7e3794aed9a127984e0273bf6_1"></div><div style="min-height:64.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.01</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER SIXTEEN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER SIXTEEN TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of September 1, 2023 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Byram Healthcare Centers, Inc. (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Amended and Restated Non-Exclusive Distribution Agreement entered into by the Parties as of February 1, 2016 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Section 17, General Provisions. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt">The below subsection of Section 17, General Provisions, is hereby deleted and replaced in its entirety with the following&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:67.5pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.51pt">17.1 Notice. Any notice or other communication required or permitted to be given under this Agreement shall be properly served only if it is in writing addressed as set out below or through electronic means including by e-mail to the e-mail address(es) listed below. Notice in writing may be sent by any of the following methods&#58; (i) personal delivery&#59; (ii) nationally recognized overnight courier service&#59; (iii) U.S. Postal Service certified or registered mail, return receipt requested, postage prepaid&#59; or (iv) via e-mail. Service shall be deemed to have been duly given on the date of delivery or on the date which is &#91;******&#93; days from the date of deposit in the U.S. Postal Service in the manner described above. Either party may change the names, address(es), and e-mail address(es) for receipt of notice by complying with this Section 17.1. </font></div><div style="padding-left:67.5pt;text-align:justify"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to DexCom&#58; &#160;&#160;&#160;&#160;DexCom, Inc. </font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6340 Sequence Drive</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;San Diego, CA 92121</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Strategic Accounts Contracting</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;DexCom, Inc. </font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6340 Sequence Drive</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;San Diego, CA 92121</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Legal Department</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice E-mail&#58;&#160;&#160;&#160;&#160;&#91;******&#93; and &#91;******&#93;</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to Distributor&#58;&#160;&#160;&#160;&#160;Byram Healthcare</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;120 Bloomingdale Road, Suite 301</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;White Plains, NJ 10605</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;Byram Healthcare</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Legal Department</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5302 Rancho Road</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Huntington Beach, CA 92847</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice E-mail&#58;&#160;&#160;&#160;&#160;&#91;******&#93; &#38; &#91;******&#93;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1, The Products and The Prices</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1</font><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement is hereby deleted and replaced in its entirety.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 7, &#91;******&#93; Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7 (A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Exhibit 7 (B),</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is hereby appended to the Agreement and made a part hereof. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Distributor</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Neel Vadhan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Purchasing</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9&#47;25&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9&#47;22&#47;2023</font></td></tr></table></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i1fa518c7e3794aed9a127984e0273bf6_96"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#292929;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">The Products and The Prices</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i1fa518c7e3794aed9a127984e0273bf6_108"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 7 (A)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">&#91;******&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline"> Rebate</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><div id="i1fa518c7e3794aed9a127984e0273bf6_122"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 7 (B)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Eligible Plans</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.02
<SEQUENCE>3
<FILENAME>dxcm9302023ex1002-edgepark.htm
<DESCRIPTION>EX-10.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i94ba9b9c5e2f492faa7070db74102045_1"></div><div style="min-height:64.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 10.02</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;******&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDMENT NUMBER THIRTEEN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This AMENDMENT NUMBER THIRTEEN TO THE NON-EXCLUSIVE DISTRIBUTION AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made effective as of September 1, 2023 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and RGH Enterprises LLC. dba Edgepark Medical Supplies (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;Distributor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor previously entered into that certain Non-Exclusive Distribution Agreement entered into by the Parties as of April 30, 2008 (as the same has been and may be amended from time to time, the &#8220;Agreement&#8221;)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, DexCom and Distributor agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Section 16, General Provisions. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt">The below subsection of Section 16, General Provisions, is hereby deleted and replaced in its entirety with the following&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:67.5pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.51pt">16.1 Notice. Any notice or other communication required or permitted to be given under this Agreement shall be properly served only if it is in writing addressed as set out below or through electronic means including by e-mail to the e-mail address(es) listed below. Notice in writing may be sent by any of the following methods&#58; (i) personal delivery&#59; (ii) nationally recognized overnight courier service&#59; (iii) U.S. Postal Service certified or registered mail, return receipt requested, postage prepaid&#59; or (iv) via e-mail. Service shall be deemed to have been duly given on the date of delivery or on the date which is &#91;******&#93; days from the date of deposit in the U.S. Postal Service in the manner described above. Either party may change the names, address(es), and e-mail address(es) for receipt of notice by complying with this Section 16.1. </font></div><div style="padding-left:67.5pt;text-align:justify"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to DexCom&#58; &#160;&#160;&#160;&#160;DexCom, Inc. </font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6340 Sequence Drive</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;San Diego, CA 92121</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Strategic Accounts Contracting</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;DexCom, Inc. </font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6340 Sequence Drive</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;San Diego, CA 92121</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Legal Department</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice E-mail&#58;&#160;&#160;&#160;&#160;&#91;******&#93; and &#91;******&#93;</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font><br></font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to Distributor&#58;&#160;&#160;&#160;&#160;RGH Enterprises, Inc.</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1810 Summit Commerce Park</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:126pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Twinsburg, OH 44087</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58;  Gordon Harris</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;RGH Enterprises, LLC</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7000 Cardinal Place</font></div><div style="padding-left:126pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dublin, OH 43017</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; VP, Asst. General Counsel, CHAH</font></div><div style="padding-left:162pt;text-align:justify;text-indent:-94.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice E-mail&#58;&#160;&#160;&#160;&#160;&#91;******&#93;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1, The Products and The Prices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement is hereby deleted and replaced in its entirety.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 7, &#91;******&#93; Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Exhibit 7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7 (A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Exhibit 7 (B),</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto is hereby appended to the Agreement and made a part hereof. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">Section A. Rebates of Amendment dated April 30, 2016</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt">Paragraph 2. Rebate of Section A. Rebates of the Amendment dated April 30, 2016 is hereby amended and restated in its entirety as of the Amendment Effective Date to read as follows&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  DexCom shall pay Distributor, &#91;******&#93;, a monthly rebate equal to &#91;******&#93;  (the &#34;Rebate&#34;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The aggregate Rebate invoiced by Distributor shall be paid in full by DexCom to Distributor within &#91;******&#93; days following receipt by DexCom of the invoice and reports from Distributor for such month. DexCom shall remit payments either electronically, via wire transfer or ACH, to Distributor's bank account or by check to Distributor's lock box according to instructions provided by Distributor. Should Distributor not receive payment within this time period, Distributor may deduct the amount of the Rebate from any subsequent payment owed by Distributor to DexCom.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt;text-decoration:underline">No Further Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank&#59; <br>Signature Page Follows</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties have executed this Amendment effective as of the Amendment Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DexCom, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">RGH Enterprises, LLC</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Gordon Harris</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christophe Cantenot</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gordon Harris</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VP, Finance and Corporate Controller</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Senior Director, Strategic Sourcing</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9&#47;13&#47;2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9&#47;12&#47;2023</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i94ba9b9c5e2f492faa7070db74102045_51"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">The Products and The Prices</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i94ba9b9c5e2f492faa7070db74102045_62"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 7 (A)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">&#91;******&#93; Rebate</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i94ba9b9c5e2f492faa7070db74102045_73"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">EXHIBIT 7 (B)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Eligible Plans</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;******&#93;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.01
<SEQUENCE>4
<FILENAME>dxcm9302023exhibit3101.htm
<DESCRIPTION>EX-31.01
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i517eda4577494a979df3ae789b39aa3b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin R. Sayer, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.02
<SEQUENCE>5
<FILENAME>dxcm9302023exhibit3102.htm
<DESCRIPTION>EX-31.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4176ce09bdf94b488771c5acc414d34c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jereme M. Sylvain, certify that&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.01
<SEQUENCE>6
<FILENAME>dxcm9302023exhibit3201.htm
<DESCRIPTION>EX-32.01
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5b92650e8b56434ab14edd210cf457fe_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.01</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Kevin R. Sayer, President and Chief Executive Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the quarterly Report on Form 10-Q for the period ended September&#160;30, 2023 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; October&#160;26, 2023</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.02
<SEQUENCE>7
<FILENAME>dxcm9302023exhibit3202.htm
<DESCRIPTION>EX-32.02
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icb4ef67e2d1d43a5aaac16086ef97b2d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.02</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Jereme M. Sylvain, Executive Vice President and Chief Financial Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the quarterly Report on Form 10-Q for the period ended September&#160;30, 2023 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; October&#160;26, 2023</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dxcm-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dxcm="http://www.dexcom.com/20230930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.dexcom.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>0000002 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited">
        <link:definition>0000004 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreements" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements">
        <link:definition>0000009 - Disclosure - Development and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dexcom.com/role/FairValueMeasurements">
        <link:definition>0000010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformation" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation">
        <link:definition>0000011 - Disclosure - Balance Sheet Details and Other Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.dexcom.com/role/Debt">
        <link:definition>0000012 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.dexcom.com/role/Contingencies">
        <link:definition>0000013 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dexcom.com/role/IncomeTaxes">
        <link:definition>0000014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.dexcom.com/role/StockholdersEquity">
        <link:definition>0000015 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformation" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation">
        <link:definition>0000016 - Disclosure - Business Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.dexcom.com/role/SubsequentEvents">
        <link:definition>0000017 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables">
        <link:definition>9954473 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationTables" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables">
        <link:definition>9954474 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.dexcom.com/role/DebtTables">
        <link:definition>9954475 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.dexcom.com/role/StockholdersEquityTables">
        <link:definition>9954476 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationTables" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables">
        <link:definition>9954477 - Disclosure - Business Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954478 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails">
        <link:definition>9954479 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails">
        <link:definition>9954480 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreementsDetails" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails">
        <link:definition>9954481 - Disclosure - Development and Other Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails">
        <link:definition>9954482 - Disclosure - Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9954483 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails">
        <link:definition>9954484 - Disclosure - Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails">
        <link:definition>9954485 - Disclosure - Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails">
        <link:definition>9954486 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationInventoryDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails">
        <link:definition>9954487 - Disclosure - Balance Sheet Details and Other Financial Information - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9954488 - Disclosure - Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails">
        <link:definition>9954489 - Disclosure - Balance Sheet Details and Other Financial Information - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails">
        <link:definition>9954490 - Disclosure - Balance Sheet Details and Other Financial Information - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>9954491 - Disclosure - Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails">
        <link:definition>9954492 - Disclosure - Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails">
        <link:definition>9954493 - Disclosure - Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails">
        <link:definition>9954494 - Disclosure - Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails">
        <link:definition>9954495 - Disclosure - Debt - Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionValueofConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails">
        <link:definition>9954496 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
        <link:definition>9954497 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.dexcom.com/role/DebtNarrativeDetails">
        <link:definition>9954498 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
        <link:definition>9954499 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNarrativeDetails" roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails">
        <link:definition>9954500 - Disclosure - Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesDetails">
        <link:definition>9954501 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareBasedCompensationExpenseDetails" roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails">
        <link:definition>9954502 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>9954503 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails">
        <link:definition>9954504 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationScheduleofRevenueDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails">
        <link:definition>9954505 - Disclosure - Business Segment and Geographic Information - Schedule of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.dexcom.com/role/SubsequentEventsDetails">
        <link:definition>9954506 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" abstract="false" name="TreasuryStockValueBenefitReceivedFromNoteHedge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AccruedTaxAuditAndLegalFees" abstract="false" name="AccruedTaxAuditAndLegalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementInitialPaymentMember" abstract="true" name="CollaborativeArrangementInitialPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" abstract="false" name="SharesReceivedFromBenefitOfNoteHedgeValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ContractPaymentTermsNumberofDays" abstract="false" name="ContractPaymentTermsNumberofDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_SellingGeneralAndAdministrativeMember" abstract="true" name="SellingGeneralAndAdministrativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermAxis" abstract="true" name="DebtInstrumentConversionTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_OtherTaxLiabilitiesNoncurrent" abstract="false" name="OtherTaxLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" abstract="false" name="DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_NonCashInterestExpenseAbstract" abstract="true" name="NonCashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DeferredCompensationPlanAssetsCurrent" abstract="false" name="DeferredCompensationPlanAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" abstract="false" name="StockIssuedDuringPeriodSharesAchievementOfMilestone" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_RestrictedAndPerformanceStockUnitsMember" abstract="true" name="RestrictedAndPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AccruedWagesBonusesAndTaxesCurrent" abstract="false" name="AccruedWagesBonusesAndTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PrepaidInventoryCurrent" abstract="false" name="PrepaidInventoryCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" abstract="false" name="PotentialFutureCommonStockIssuableSharesNewIssues" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" abstract="false" name="DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementApprovalMilestoneMember" abstract="true" name="CollaborativeArrangementApprovalMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" abstract="false" name="IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" abstract="false" name="LossContingencyAdditionalPatentsFoundNotInfringedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" abstract="false" name="PrepaidAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_FairValueAssetsLevel3TransfersAmount" abstract="false" name="FairValueAssetsLevel3TransfersAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2028Member" abstract="true" name="ConvertibleNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermTwoMember" abstract="true" name="DebtInstrumentConversionTermTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsAxis" abstract="true" name="PaymentsUnderCollaborationAgreementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_RevenuePercentage" abstract="false" name="RevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" abstract="false" name="LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_CashInterestExpenseAbstract" abstract="true" name="CashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" abstract="true" name="FairValueDisclosuresSeniorConvertibleNotesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermOneMember" abstract="true" name="DebtInstrumentConversionTermOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" abstract="false" name="StockIssuedDuringPeriodValueAchievementOfMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AbbottMember" abstract="true" name="AbbottMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsDomain" abstract="true" name="PaymentsUnderCollaborationAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_PaymentsForPurchasesOfCappedCallTransactions" abstract="false" name="PaymentsForPurchasesOfCappedCallTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PharmacyRebates" abstract="false" name="PharmacyRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_VerilyLifeSciencesMember" abstract="true" name="VerilyLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SharesReceivedFromBenefitOfNoteHedge" abstract="false" name="SharesReceivedFromBenefitOfNoteHedge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_MichaelBrownMember" abstract="true" name="MichaelBrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2025Member" abstract="true" name="ConvertibleNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" abstract="true" name="FederalReserveBankOfNewYorkRateNYFRBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" abstract="false" name="EstimatedAnnualEffectiveIncomeTaxRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" abstract="false" name="ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementUpfrontFee" abstract="false" name="CollaborativeArrangementUpfrontFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LossContingencyPendingClaimsRemainingNumber" abstract="false" name="LossContingencyPendingClaimsRemainingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SimpleRiskFreeRateRFRMember" abstract="true" name="SimpleRiskFreeRateRFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" abstract="false" name="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DebtInstrumentCovenantRepurchasePricePercentage" abstract="false" name="DebtInstrumentCovenantRepurchasePricePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2023Member" abstract="true" name="ConvertibleNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermDomain" abstract="true" name="DebtInstrumentConversionTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_OtherLongTermAssets" abstract="false" name="OtherLongTermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeResearchAndDevelopmentFee" abstract="false" name="CollaborativeResearchAndDevelopmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" abstract="false" name="TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LongTermDeposits" abstract="false" name="LongTermDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" abstract="false" name="NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_NicholasAugustinosMember" abstract="true" name="NicholasAugustinosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" abstract="false" name="DebtInstrumentCapCallTransactionCapPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" abstract="false" name="DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_FairValueDisclosuresLineItems" abstract="true" name="FairValueDisclosuresLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementMilestonePaymentsMember" abstract="true" name="CollaborativeArrangementMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_MichaelBrownAugust2023TerminationMember" abstract="true" name="MichaelBrownAugust2023TerminationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_MichaelBrownAugust2023AdoptionMember" abstract="true" name="MichaelBrownAugust2023AdoptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dxcm-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_460a77c9-0acb-4b70-a225-7c5269e4320b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_460a77c9-0acb-4b70-a225-7c5269e4320b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ddb79f7b-561d-4994-a504-c5a6f80747a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ddb79f7b-561d-4994-a504-c5a6f80747a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_c266ec9d-c863-4e19-bf07-d91b99b1dca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_c266ec9d-c863-4e19-bf07-d91b99b1dca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bc34dbce-5b81-46c2-87a9-3b63f6a97b87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bc34dbce-5b81-46c2-87a9-3b63f6a97b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_349594ed-de0d-4f33-a3db-928c0443698c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ac6974aa-8b2a-4887-9994-0ef469167fb6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_349594ed-de0d-4f33-a3db-928c0443698c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_3b0a7760-3399-4bab-b4c2-8cf6604bbef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_3b0a7760-3399-4bab-b4c2-8cf6604bbef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_c63efd62-8b9f-4596-980e-34cdcfbc6cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_TreasuryStockCommonValue_c63efd62-8b9f-4596-980e-34cdcfbc6cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_082fd330-285d-432a-a6f7-e36f2e082f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_082fd330-285d-432a-a6f7-e36f2e082f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_6332183b-d032-4e15-9652-b4152d74f231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_CommonStockValueOutstanding_6332183b-d032-4e15-9652-b4152d74f231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eba3fdd2-e3fe-4126-a682-8c03d241d75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eba3fdd2-e3fe-4126-a682-8c03d241d75a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6924d694-c55f-40fd-ae38-9f52f150c487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_363bed05-0956-46e1-b378-a3c8fd9d462c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6924d694-c55f-40fd-ae38-9f52f150c487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ecb94dde-98cd-4123-af36-f3d43f3ffca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_93388877-90e8-4709-926a-0deadb778033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecb94dde-98cd-4123-af36-f3d43f3ffca1" xlink:to="loc_us-gaap_LiabilitiesCurrent_93388877-90e8-4709-926a-0deadb778033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_7db69a5b-4219-4006-97a3-c1bdd7e5a380" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecb94dde-98cd-4123-af36-f3d43f3ffca1" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_7db69a5b-4219-4006-97a3-c1bdd7e5a380" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_56924763-e4d0-48d2-b9fe-51352391ccbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecb94dde-98cd-4123-af36-f3d43f3ffca1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_56924763-e4d0-48d2-b9fe-51352391ccbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_139ef392-3c71-4b0c-b81e-0aecc30fcb80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecb94dde-98cd-4123-af36-f3d43f3ffca1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_139ef392-3c71-4b0c-b81e-0aecc30fcb80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ad725316-0941-46db-b92d-26f96aa66739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_AssetsCurrent_ad725316-0941-46db-b92d-26f96aa66739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ab3b21f3-bf44-4f79-a3f9-f3082843a871" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ab3b21f3-bf44-4f79-a3f9-f3082843a871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_35d79d75-6cc6-4973-88b3-1db78d5a6473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_35d79d75-6cc6-4973-88b3-1db78d5a6473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c1335750-6b68-41ff-8e4e-10645df9cf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c1335750-6b68-41ff-8e4e-10645df9cf2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ca0788fc-cd85-4c8d-a658-fec5a984c51e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_Goodwill_ca0788fc-cd85-4c8d-a658-fec5a984c51e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b8d388cf-1e92-4413-8cdb-e00fc71492a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b8d388cf-1e92-4413-8cdb-e00fc71492a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_86ed5928-f9e1-4fa4-8e06-d38964afbed9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc835d58-7fb5-4c7a-8cc1-c43f84178d5f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_86ed5928-f9e1-4fa4-8e06-d38964afbed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3767d138-a824-42e5-906f-530f9c0c3c04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8e09ab1b-4077-49df-8252-87dd0a4b52ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3767d138-a824-42e5-906f-530f9c0c3c04" xlink:to="loc_us-gaap_Liabilities_8e09ab1b-4077-49df-8252-87dd0a4b52ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00b1ebda-94de-4ad7-b5fa-808d036d5119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3767d138-a824-42e5-906f-530f9c0c3c04" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00b1ebda-94de-4ad7-b5fa-808d036d5119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c915f89d-ea76-4b7d-9be2-401d4bbadba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3767d138-a824-42e5-906f-530f9c0c3c04" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c915f89d-ea76-4b7d-9be2-401d4bbadba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc3c2b80-91a9-46b8-9f7c-7bee613d5ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc3c2b80-91a9-46b8-9f7c-7bee613d5ac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_dec3e3db-45d3-4acb-adc6-16433ea9bfde" xlink:href="dxcm-20230930.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_dec3e3db-45d3-4acb-adc6-16433ea9bfde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fb8df31e-a495-44da-abd1-90160482d584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fb8df31e-a495-44da-abd1-90160482d584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_826701ea-1801-4069-bde8-e6ab33218781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:to="loc_us-gaap_InventoryNet_826701ea-1801-4069-bde8-e6ab33218781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_42ee35fa-05a0-4bfb-a667-9dbbf11c350d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bd1d24b-d53c-4590-9f47-cd596b23d360" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_42ee35fa-05a0-4bfb-a667-9dbbf11c350d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83e7f3ab-cb37-43db-85ad-fc1eb899146a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_67166e69-aec4-4f77-8676-e1fae6786ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83e7f3ab-cb37-43db-85ad-fc1eb899146a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_67166e69-aec4-4f77-8676-e1fae6786ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aea71119-04fc-4d62-89d9-2c7ddffd7a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83e7f3ab-cb37-43db-85ad-fc1eb899146a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aea71119-04fc-4d62-89d9-2c7ddffd7a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_836bf63b-a71b-49b7-96a0-2e2f941ac38b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cc60844c-f195-4fbe-8a0b-755263e0967f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_836bf63b-a71b-49b7-96a0-2e2f941ac38b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cc60844c-f195-4fbe-8a0b-755263e0967f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_896a8702-83d6-47c8-9ba7-73ec6426adb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_836bf63b-a71b-49b7-96a0-2e2f941ac38b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_896a8702-83d6-47c8-9ba7-73ec6426adb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7f0dea74-0bb6-470b-98bd-a1c33295eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4689e9a4-cd41-45cd-86ea-562ac5f77a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7f0dea74-0bb6-470b-98bd-a1c33295eb82" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4689e9a4-cd41-45cd-86ea-562ac5f77a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8ad925f3-5f6b-42de-8425-92e21d7d3561" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7f0dea74-0bb6-470b-98bd-a1c33295eb82" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8ad925f3-5f6b-42de-8425-92e21d7d3561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_86c72418-52ef-4030-bd7d-9a805bf517a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7f0dea74-0bb6-470b-98bd-a1c33295eb82" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_86c72418-52ef-4030-bd7d-9a805bf517a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00b76ab1-d5b5-4b77-a96d-c12daf695738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ea703e82-4922-4594-aff8-a097764a9f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00b76ab1-d5b5-4b77-a96d-c12daf695738" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ea703e82-4922-4594-aff8-a097764a9f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3399f4be-cf80-4a66-b5d6-8e5cd901fb99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00b76ab1-d5b5-4b77-a96d-c12daf695738" xlink:to="loc_us-gaap_OperatingIncomeLoss_3399f4be-cf80-4a66-b5d6-8e5cd901fb99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_53890319-f086-45ed-b8aa-55d52adae516" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00b76ab1-d5b5-4b77-a96d-c12daf695738" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_53890319-f086-45ed-b8aa-55d52adae516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71073b5a-7549-4837-9c2d-0c9dcdb8dc09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3c6aa6da-a871-4fbb-889c-fd5e39057ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71073b5a-7549-4837-9c2d-0c9dcdb8dc09" xlink:to="loc_us-gaap_GrossProfit_3c6aa6da-a871-4fbb-889c-fd5e39057ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_64a7ddde-e5c7-4565-aa37-4f4721d594bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_71073b5a-7549-4837-9c2d-0c9dcdb8dc09" xlink:to="loc_us-gaap_OperatingExpenses_64a7ddde-e5c7-4565-aa37-4f4721d594bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_adbd27e5-b88a-44f1-a09d-229edc4ee85c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0b896445-b660-4679-85e3-e9f4d8f7d22f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_adbd27e5-b88a-44f1-a09d-229edc4ee85c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0b896445-b660-4679-85e3-e9f4d8f7d22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e53cb549-74c4-41ea-9e8c-fedb15b94ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_adbd27e5-b88a-44f1-a09d-229edc4ee85c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e53cb549-74c4-41ea-9e8c-fedb15b94ac3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8078941b-b879-4e85-9447-26fef1cefd30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42a3b89f-3ebd-489c-9bb4-61783d9da21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8078941b-b879-4e85-9447-26fef1cefd30" xlink:to="loc_us-gaap_NetIncomeLoss_42a3b89f-3ebd-489c-9bb4-61783d9da21e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8b578451-ab54-4d33-90c1-dae467d1ea9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8078941b-b879-4e85-9447-26fef1cefd30" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8b578451-ab54-4d33-90c1-dae467d1ea9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_09533b95-fbb1-4f8b-9469-53de22c4a308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_09533b95-fbb1-4f8b-9469-53de22c4a308" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6cc1dab5-7c3b-4271-9444-ed31bd6640d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6cc1dab5-7c3b-4271-9444-ed31bd6640d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_f6f81e5d-6013-4ea5-8211-1ddedf6ff3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_PaidInKindInterest_f6f81e5d-6013-4ea5-8211-1ddedf6ff3c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_75ad2cb8-bf91-45e3-8a05-c82a60a5d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_75ad2cb8-bf91-45e3-8a05-c82a60a5d72f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f30656a8-c2aa-4b3b-8c7e-87d1b6ffc1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_ShareBasedCompensation_f30656a8-c2aa-4b3b-8c7e-87d1b6ffc1ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_5ed4cfc2-f2de-4a47-a60b-482543a6f53d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_5ed4cfc2-f2de-4a47-a60b-482543a6f53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_178c0cf0-3937-44d8-8042-cbe563f52e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_178c0cf0-3937-44d8-8042-cbe563f52e38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a4608ca-1cfa-411c-876e-8aca81125846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_NetIncomeLoss_3a4608ca-1cfa-411c-876e-8aca81125846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b9e343dc-699a-4e83-bc04-0dfd4a71f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b9e343dc-699a-4e83-bc04-0dfd4a71f7b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_00d8cd84-502a-45dc-a96e-7ccd3e5ddb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_00d8cd84-502a-45dc-a96e-7ccd3e5ddb8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_f23d7ecf-256c-4ef9-a932-594d90ada3d8" xlink:href="dxcm-20230930.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_f23d7ecf-256c-4ef9-a932-594d90ada3d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68293a5e-1ee9-4c08-a12d-5489d8369f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68293a5e-1ee9-4c08-a12d-5489d8369f8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_18e1de29-3fa1-4aef-b347-0e5da93b8e76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_18e1de29-3fa1-4aef-b347-0e5da93b8e76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_94eb8b93-5fa6-44cf-9cdb-fd9806247424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_59fd94df-80c7-4f5d-acab-992456ea7cad" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_94eb8b93-5fa6-44cf-9cdb-fd9806247424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b84eb61-2cc1-4733-8cd7-555abc399823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c738172-d8b0-4669-ab2c-2eb0864f6243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b84eb61-2cc1-4733-8cd7-555abc399823" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c738172-d8b0-4669-ab2c-2eb0864f6243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9e552d0f-c8c5-49cd-a112-79c96be23a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b84eb61-2cc1-4733-8cd7-555abc399823" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9e552d0f-c8c5-49cd-a112-79c96be23a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5805c485-dfb3-44fb-ad2f-74df5b9d5ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b84eb61-2cc1-4733-8cd7-555abc399823" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5805c485-dfb3-44fb-ad2f-74df5b9d5ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cbc6a6e-301f-495b-af19-f59e7c53ed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b84eb61-2cc1-4733-8cd7-555abc399823" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cbc6a6e-301f-495b-af19-f59e7c53ed5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3ba16f84-7461-4418-a1e4-4418fb976805" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3ba16f84-7461-4418-a1e4-4418fb976805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_936a0b04-dbf9-4088-8f68-3422cc5dc2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_936a0b04-dbf9-4088-8f68-3422cc5dc2e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_0ed16550-54bc-4a20-9c8f-18a2ac750443" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_0ed16550-54bc-4a20-9c8f-18a2ac750443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bce65968-13af-43ff-b4dd-aa91e9b691c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bce65968-13af-43ff-b4dd-aa91e9b691c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ee1c05ea-446d-430b-9d00-8a5139a67392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ee1c05ea-446d-430b-9d00-8a5139a67392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_bb3399e4-8f93-4923-bf7e-8b2d3f463df0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be09fedf-6285-4084-967e-1dd6de659d02" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_bb3399e4-8f93-4923-bf7e-8b2d3f463df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28db4bf5-f997-44e0-96c6-01eba26ddc97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c18e854f-5ede-4964-a8a0-24fe6e35aeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28db4bf5-f997-44e0-96c6-01eba26ddc97" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c18e854f-5ede-4964-a8a0-24fe6e35aeeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_d29bfb60-c1c1-4392-97bf-27a0b47369fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28db4bf5-f997-44e0-96c6-01eba26ddc97" xlink:to="loc_us-gaap_RestrictedCash_d29bfb60-c1c1-4392-97bf-27a0b47369fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_55520693-ef81-4c7a-9728-3f41caf36589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_55520693-ef81-4c7a-9728-3f41caf36589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_f557d398-2db1-479e-b76d-177de9f5a9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_f557d398-2db1-479e-b76d-177de9f5a9c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a8f92206-3a03-4171-aa66-e6d5d151c6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a8f92206-3a03-4171-aa66-e6d5d151c6fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa1b297e-9b97-48a1-98f7-b8570a381ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa1b297e-9b97-48a1-98f7-b8570a381ada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8f6a598f-e5ff-4252-b6fc-3d0dd8f09633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_216bacdb-930a-40fd-b063-d5a49faf9eac" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_8f6a598f-e5ff-4252-b6fc-3d0dd8f09633" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_5be784f0-1a88-43d1-b8a1-174038121d89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3f618db7-1265-43af-80b1-2c2426882cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_5be784f0-1a88-43d1-b8a1-174038121d89" xlink:to="loc_us-gaap_NetIncomeLoss_3f618db7-1265-43af-80b1-2c2426882cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5a0e3474-8020-4c61-94ba-6d59a2de134b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_5be784f0-1a88-43d1-b8a1-174038121d89" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5a0e3474-8020-4c61-94ba-6d59a2de134b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dee68eec-9aa8-41af-9497-7722369d43d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faad9f0f-0b7e-4e6d-abbb-b678228cce98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dee68eec-9aa8-41af-9497-7722369d43d0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faad9f0f-0b7e-4e6d-abbb-b678228cce98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_98bfe62c-6621-42d5-aa46-374d03ebbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dee68eec-9aa8-41af-9497-7722369d43d0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_98bfe62c-6621-42d5-aa46-374d03ebbec9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bca59d78-952e-4bcd-b094-89fe3a393859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f67e2c06-707a-41f4-b675-a56f0d1acbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bca59d78-952e-4bcd-b094-89fe3a393859" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f67e2c06-707a-41f4-b675-a56f0d1acbdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4e74ff17-fa09-4e1d-8117-71c764dab616" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bca59d78-952e-4bcd-b094-89fe3a393859" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4e74ff17-fa09-4e1d-8117-71c764dab616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_820b4932-15b9-4d47-8b44-276a6a542132" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bca59d78-952e-4bcd-b094-89fe3a393859" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_820b4932-15b9-4d47-8b44-276a6a542132" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_831c5348-b6bf-436d-bf6f-1860b28efa78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ce103347-b339-45fe-9250-85223524654d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_831c5348-b6bf-436d-bf6f-1860b28efa78" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ce103347-b339-45fe-9250-85223524654d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb78e351-fad9-4fa5-b49e-fe2ea0e7e1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_831c5348-b6bf-436d-bf6f-1860b28efa78" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb78e351-fad9-4fa5-b49e-fe2ea0e7e1f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3b036645-3170-4812-a2c8-bdc8f403edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_831c5348-b6bf-436d-bf6f-1860b28efa78" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3b036645-3170-4812-a2c8-bdc8f403edbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8565dc09-071e-4bbc-88f3-e9e6b2c614b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_62ed3318-a049-48e7-acda-062b4d7e7c78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8565dc09-071e-4bbc-88f3-e9e6b2c614b4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_62ed3318-a049-48e7-acda-062b4d7e7c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3846dea5-39b0-48bb-af03-26db3688ddc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8565dc09-071e-4bbc-88f3-e9e6b2c614b4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3846dea5-39b0-48bb-af03-26db3688ddc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3e027486-635f-476a-9e87-c85a66cd0a38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8565dc09-071e-4bbc-88f3-e9e6b2c614b4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3e027486-635f-476a-9e87-c85a66cd0a38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_dde68adb-9fc1-418e-a991-6ff1894aed15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_dde68adb-9fc1-418e-a991-6ff1894aed15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_bf3f646e-583d-4f6d-b4ab-6b480f45636b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_bf3f646e-583d-4f6d-b4ab-6b480f45636b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_17594421-5b23-41db-9e48-c61ca479311f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:to="loc_us-gaap_OtherAssetsCurrent_17594421-5b23-41db-9e48-c61ca479311f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_339f2e4d-8620-4cf2-a063-e06027b6a8c9" xlink:href="dxcm-20230930.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:to="loc_dxcm_PrepaidInventoryCurrent_339f2e4d-8620-4cf2-a063-e06027b6a8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_efda7561-0383-4f13-ad52-e90de72b8204" xlink:href="dxcm-20230930.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9655e090-b384-41f4-bda3-7540f3d885b3" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_efda7561-0383-4f13-ad52-e90de72b8204" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_10646370-7489-46e3-9008-f57d2eef993b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a754d6f5-e1f4-4a27-9d0b-451b399a9fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_10646370-7489-46e3-9008-f57d2eef993b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a754d6f5-e1f4-4a27-9d0b-451b399a9fd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c801ef61-d768-4349-983b-4cb1d0bfdff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_10646370-7489-46e3-9008-f57d2eef993b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c801ef61-d768-4349-983b-4cb1d0bfdff9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_896d011c-dfde-4c37-b17f-efd7752d0cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_d59788a4-c4a0-4a78-ba4c-28d4080b7d00" xlink:href="dxcm-20230930.xsd#dxcm_OtherLongTermAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_896d011c-dfde-4c37-b17f-efd7752d0cc9" xlink:to="loc_dxcm_OtherLongTermAssets_d59788a4-c4a0-4a78-ba4c-28d4080b7d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_3bba809d-93a4-4622-babe-d66eb12215ce" xlink:href="dxcm-20230930.xsd#dxcm_LongTermDeposits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_896d011c-dfde-4c37-b17f-efd7752d0cc9" xlink:to="loc_dxcm_LongTermDeposits_3bba809d-93a4-4622-babe-d66eb12215ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_65b2373d-335f-4e04-9a65-d456cf000eee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_896d011c-dfde-4c37-b17f-efd7752d0cc9" xlink:to="loc_us-gaap_LongTermInvestments_65b2373d-335f-4e04-9a65-d456cf000eee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_3d0b4dd9-cbde-4029-acc9-f2cb0cb93d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_3d0b4dd9-cbde-4029-acc9-f2cb0cb93d14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_5d9cf3e1-ffab-47a2-822b-ecc5da4ce7a4" xlink:href="dxcm-20230930.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_5d9cf3e1-ffab-47a2-822b-ecc5da4ce7a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_1a47498d-fa8d-4500-b91c-aa7fd2a3b301" xlink:href="dxcm-20230930.xsd#dxcm_PharmacyRebates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_dxcm_PharmacyRebates_1a47498d-fa8d-4500-b91c-aa7fd2a3b301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_18e2fe3f-d135-4af8-ab92-3646251b8bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_18e2fe3f-d135-4af8-ab92-3646251b8bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8467ba09-259d-4778-8ab7-2c3fc6ee44c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8467ba09-259d-4778-8ab7-2c3fc6ee44c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_5d7cd907-d40f-4dd7-b6d1-8c5b6b2546fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f65048d5-f5c4-4332-af76-f50ef39196e7" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_5d7cd907-d40f-4dd7-b6d1-8c5b6b2546fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d86589ff-f2c2-409d-b9bd-9cda331be79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_88272f44-a7a8-456b-af12-26bd84d43aa9" xlink:href="dxcm-20230930.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d86589ff-f2c2-409d-b9bd-9cda331be79e" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_88272f44-a7a8-456b-af12-26bd84d43aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_2858ab4e-d8b3-486d-9a00-046d6bc538ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d86589ff-f2c2-409d-b9bd-9cda331be79e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_2858ab4e-d8b3-486d-9a00-046d6bc538ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_137f093a-88d3-499e-bb2c-3cabc62b2099" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_137f093a-88d3-499e-bb2c-3cabc62b2099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_41695be4-2151-4029-954f-9e31688adc09" xlink:href="dxcm-20230930.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_41695be4-2151-4029-954f-9e31688adc09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e0964e1e-3e4d-40e1-88fe-ca737bbe6b04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e0964e1e-3e4d-40e1-88fe-ca737bbe6b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a335400d-7c20-43cd-a158-292cb8a90830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a335400d-7c20-43cd-a158-292cb8a90830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e0941d88-cfe3-4eba-9e0d-ac62f3f09c76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4def474a-4b47-4621-9b76-045094a2c2d4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e0941d88-cfe3-4eba-9e0d-ac62f3f09c76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d460fe11-dc30-4807-b2f2-586cf7bc38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_2f3e74a1-7fda-425d-aa72-80601e734021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_d460fe11-dc30-4807-b2f2-586cf7bc38b4" xlink:to="loc_us-gaap_OtherNonoperatingExpense_2f3e74a1-7fda-425d-aa72-80601e734021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_24565047-e5fc-4e28-bd10-cdfcced370f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_d460fe11-dc30-4807-b2f2-586cf7bc38b4" xlink:to="loc_us-gaap_InterestExpense_24565047-e5fc-4e28-bd10-cdfcced370f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_8e1e9fab-7d2a-492b-a02d-02bc7d824e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_d460fe11-dc30-4807-b2f2-586cf7bc38b4" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_8e1e9fab-7d2a-492b-a02d-02bc7d824e8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b15eeed8-e20a-4f7e-a8d5-84e7a47509b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9c375e11-700b-46ce-a2db-b02a820cf86b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_b15eeed8-e20a-4f7e-a8d5-84e7a47509b3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9c375e11-700b-46ce-a2db-b02a820cf86b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_5b17d077-9667-43f9-86b2-867e0f2f0a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_b15eeed8-e20a-4f7e-a8d5-84e7a47509b3" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_5b17d077-9667-43f9-86b2-867e0f2f0a55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_076a3e27-5560-43cc-962e-96b36038be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1670aa7f-e0f2-4f48-b11e-8d6cb670c63c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_076a3e27-5560-43cc-962e-96b36038be7a" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_1670aa7f-e0f2-4f48-b11e-8d6cb670c63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a385b51d-c28b-46e4-bef6-61d1d7905aec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_076a3e27-5560-43cc-962e-96b36038be7a" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a385b51d-c28b-46e4-bef6-61d1d7905aec" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dxcm-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_124a8484-a396-4c2a-a0a1-e9ace9207217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_124a8484-a396-4c2a-a0a1-e9ace9207217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_36bc4bbe-deb2-46b5-a2c6-26979786923d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockholdersEquity_36bc4bbe-deb2-46b5-a2c6-26979786923d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_04d0c657-39cc-4b71-97c4-4a8f5db54b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_04d0c657-39cc-4b71-97c4-4a8f5db54b80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_55dc8127-ebbc-4ce8-891d-1392f1c738f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_55dc8127-ebbc-4ce8-891d-1392f1c738f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_64ed16d4-adfd-478d-9d7e-ab6197fe54f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_64ed16d4-adfd-478d-9d7e-ab6197fe54f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_cde472d7-e739-495b-a8d2-cb1b63f06cb7" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_cde472d7-e739-495b-a8d2-cb1b63f06cb7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_4670a2b0-850f-4fe2-908d-9cbdcdf6dd92" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_4670a2b0-850f-4fe2-908d-9cbdcdf6dd92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9a280d79-f096-4942-b6dc-b8fd450b5526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9a280d79-f096-4942-b6dc-b8fd450b5526" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_df45e524-424d-40bc-ae40-b0fc278ceab4" xlink:href="dxcm-20230930.xsd#dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_df45e524-424d-40bc-ae40-b0fc278ceab4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_91d36395-7424-400c-8fe1-11099fc8e967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_91d36395-7424-400c-8fe1-11099fc8e967" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_45c40c80-8ec5-49f3-8690-4c31f04cff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_45c40c80-8ec5-49f3-8690-4c31f04cff3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6b730ab5-79d4-418a-aac2-2a3236ed6699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6b730ab5-79d4-418a-aac2-2a3236ed6699" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_0c4129b4-266c-4d6d-869b-c0200adb4b63" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_0c4129b4-266c-4d6d-869b-c0200adb4b63" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_0efc82e7-e011-4902-a8a1-d844ff1e22be" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_0efc82e7-e011-4902-a8a1-d844ff1e22be" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_8159d9d7-b691-4e9d-9a58-12780d163dfa" xlink:href="dxcm-20230930.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_8159d9d7-b691-4e9d-9a58-12780d163dfa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fa58699-5af3-4570-a0c7-48055bf925fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fa58699-5af3-4570-a0c7-48055bf925fa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a77a6395-5f12-40bb-b810-75ca48054d56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_NetIncomeLoss_a77a6395-5f12-40bb-b810-75ca48054d56" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_186a109c-7604-4fe8-bc3e-dc93f981103d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_186a109c-7604-4fe8-bc3e-dc93f981103d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6ddeff3d-1b5f-43b3-a49f-f93230509a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c9e64cc9-f178-43dc-84b6-9e34b5fe45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:to="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_89db7a5f-0c60-43e1-8709-c30474717f33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:to="loc_us-gaap_EquityComponentDomain_89db7a5f-0c60-43e1-8709-c30474717f33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:to="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1ffdd0c1-a2cd-47c9-b207-ec6ab4a72789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_CommonStockMember_1ffdd0c1-a2cd-47c9-b207-ec6ab4a72789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_440ca1f1-ed1b-4a61-8f1c-602973aa7927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_440ca1f1-ed1b-4a61-8f1c-602973aa7927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2f8e267f-9ed5-4c06-892d-0309dc9c3f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2f8e267f-9ed5-4c06-892d-0309dc9c3f8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8c9f60df-3ca7-4ffd-8194-6cf10ccb6fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_RetainedEarningsMember_8c9f60df-3ca7-4ffd-8194-6cf10ccb6fb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_73f7facd-5bda-4829-adc4-2e6b8bc2b728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_TreasuryStockCommonMember_73f7facd-5bda-4829-adc4-2e6b8bc2b728" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7f672656-f352-4cbb-b64f-fb63df7e6841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7f672656-f352-4cbb-b64f-fb63df7e6841" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50bd8a06-8465-460a-be85-451a79bfcfa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50bd8a06-8465-460a-be85-451a79bfcfa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_2559824f-dadb-40e7-9ee9-76ffa85c68b4" xlink:href="dxcm-20230930.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_2559824f-dadb-40e7-9ee9-76ffa85c68b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_65ac61a6-035a-4078-852e-f3b80e8286b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_UnbilledContractsReceivable_65ac61a6-035a-4078-852e-f3b80e8286b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f592368b-cf6a-4b07-a69d-aece174dfe63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f592368b-cf6a-4b07-a69d-aece174dfe63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:to="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:to="loc_srt_RangeMember_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:to="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4e5d0f7-203b-4100-9198-70a826e82655" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:to="loc_srt_MinimumMember_e4e5d0f7-203b-4100-9198-70a826e82655" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15766a5f-7390-4f08-bbe7-606a4f9d1900" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:to="loc_srt_MaximumMember_15766a5f-7390-4f08-bbe7-606a4f9d1900" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_400c483d-77cf-4466-a664-a08bc2844aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_NetIncomeLoss_400c483d-77cf-4466-a664-a08bc2844aa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_80dcf941-1dab-419d-aa24-7748ce37e393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_80dcf941-1dab-419d-aa24-7748ce37e393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_3cb9dfb0-3904-477e-b1ca-c7a843bf83b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_3cb9dfb0-3904-477e-b1ca-c7a843bf83b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_18378c58-1fce-43fc-9c82-d527b859d50b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:to="loc_us-gaap_EarningsPerShareBasic_18378c58-1fce-43fc-9c82-d527b859d50b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5283ebed-e905-4b7a-ba03-a08035c79e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5283ebed-e905-4b7a-ba03-a08035c79e3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4c26977-883e-49f9-8388-3103dbddfef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4c26977-883e-49f9-8388-3103dbddfef0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_51f6bfc2-d56b-4244-991d-e92bfcea902d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_51f6bfc2-d56b-4244-991d-e92bfcea902d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9394b065-9f34-4c20-accf-8692c6a453dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9394b065-9f34-4c20-accf-8692c6a453dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da976eee-bd84-4264-a836-af3f27b14f6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da976eee-bd84-4264-a836-af3f27b14f6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4db4b137-d434-4351-b941-732c6f8969d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4db4b137-d434-4351-b941-732c6f8969d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_77c10201-0607-4b3a-8e63-48fe81b231a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_WarrantMember_77c10201-0607-4b3a-8e63-48fe81b231a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_277a300a-eda3-4c24-9ad9-6cca7ef2c313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_277a300a-eda3-4c24-9ad9-6cca7ef2c313" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_761a84bd-19f9-4e1f-8509-3ed53401980c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_761a84bd-19f9-4e1f-8509-3ed53401980c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_79c47301-7929-458f-88cf-715eb8244f00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_79c47301-7929-458f-88cf-715eb8244f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_9b203888-420e-4678-9082-fd54c9e1dff5" xlink:href="dxcm-20230930.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_9b203888-420e-4678-9082-fd54c9e1dff5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_a766dd6a-212d-4c4e-a558-ef6ec2f68338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_SharePrice_a766dd6a-212d-4c4e-a558-ef6ec2f68338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_17d95be5-0a21-4c07-b338-301faed1a4c2" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_17d95be5-0a21-4c07-b338-301faed1a4c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa57d884-255c-49cc-9b87-22062be7d8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa57d884-255c-49cc-9b87-22062be7d8ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_f1923aed-b255-468b-93bc-0a01afeba80b" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_f1923aed-b255-468b-93bc-0a01afeba80b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_70adb9c2-a061-4d38-ad88-c1cae49f6acb" xlink:href="dxcm-20230930.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_70adb9c2-a061-4d38-ad88-c1cae49f6acb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8d7e2f96-24c3-4f26-a3a9-86483a1b40ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8d7e2f96-24c3-4f26-a3a9-86483a1b40ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7e2e5fbf-449b-4dee-aea5-ee8c956582ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7e2e5fbf-449b-4dee-aea5-ee8c956582ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_26b64aea-08dc-4dba-9179-33a68492846c_default" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_26b64aea-08dc-4dba-9179-33a68492846c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_97233516-8dad-43c5-ad9b-42444a481ca3" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_97233516-8dad-43c5-ad9b-42444a481ca3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_b9e21e6c-7e4e-4afb-a552-f7378cb30c2d" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_b9e21e6c-7e4e-4afb-a552-f7378cb30c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_d72cc805-e77b-4bea-978b-c153c7080a02" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_d72cc805-e77b-4bea-978b-c153c7080a02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba6d9f88-1872-4b8e-aece-60515365671d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ba6d9f88-1872-4b8e-aece-60515365671d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_333b7733-69bd-4855-817e-952d35260380" xlink:href="dxcm-20230930.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:to="loc_dxcm_VerilyLifeSciencesMember_333b7733-69bd-4855-817e-952d35260380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_82746c4a-d4e1-45c5-ac1d-e440211c8574_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_82746c4a-d4e1-45c5-ac1d-e440211c8574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_7ca29682-5e10-463a-8c9e-182c024a850a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:to="loc_us-gaap_CollaborativeArrangementMember_7ca29682-5e10-463a-8c9e-182c024a850a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f0555bac-7ab3-42b1-a601-4622a30081d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f0555bac-7ab3-42b1-a601-4622a30081d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17722c1d-fec9-4ed5-aa55-3da30017b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17722c1d-fec9-4ed5-aa55-3da30017b7f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_13004cf7-69d4-412f-bb6c-56dc2eccdb49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_13004cf7-69d4-412f-bb6c-56dc2eccdb49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a8fad7ea-a8f3-48dc-b7d1-1f5deef40b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a8fad7ea-a8f3-48dc-b7d1-1f5deef40b76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0887271-6601-4bb6-85f9-5536de8adefe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0887271-6601-4bb6-85f9-5536de8adefe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ec7f856c-30cc-4969-8e58-9ad98b225a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ec7f856c-30cc-4969-8e58-9ad98b225a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99b33642-e0c1-44a6-b5c5-d0ad48714aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99b33642-e0c1-44a6-b5c5-d0ad48714aae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_44579822-d264-4c7b-a171-893f21c79f12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_44579822-d264-4c7b-a171-893f21c79f12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_735274aa-a221-4ff1-921d-c60f206ad213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_735274aa-a221-4ff1-921d-c60f206ad213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_58810358-3576-4135-aa62-951f6d1a68ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_CommercialPaperMember_58810358-3576-4135-aa62-951f6d1a68ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_86a56ce1-77f3-441c-a0bc-1da8da3a81de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_86a56ce1-77f3-441c-a0bc-1da8da3a81de" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_ca0524fe-720a-467e-bd3f-8a62e89ac841" xlink:href="dxcm-20230930.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_ca0524fe-720a-467e-bd3f-8a62e89ac841" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a59b231f-5ef1-4d4d-ab04-825baa11792b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a59b231f-5ef1-4d4d-ab04-825baa11792b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_ee274529-1148-4339-9cb8-c4abeeaa3a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_LongTermInvestments_ee274529-1148-4339-9cb8-c4abeeaa3a55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5f22b2ac-758b-4034-a922-ea4278b09f98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5f22b2ac-758b-4034-a922-ea4278b09f98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5482f4f8-b238-4f9e-aafe-cc81eaea1005_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5482f4f8-b238-4f9e-aafe-cc81eaea1005_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ecb5aad4-576b-462a-aeed-8aacb4801506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ecb5aad4-576b-462a-aeed-8aacb4801506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:to="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_27cbf642-9669-42b5-8516-3ef73d55fb42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_27cbf642-9669-42b5-8516-3ef73d55fb42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_271e4c2e-4e70-49fe-8812-026f5d3c0e24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_271e4c2e-4e70-49fe-8812-026f5d3c0e24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_698d17d1-d5c6-4266-8076-f17c82159786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_698d17d1-d5c6-4266-8076-f17c82159786" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_a6729bb0-7948-4631-ad7e-f8fbc536387b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_a6729bb0-7948-4631-ad7e-f8fbc536387b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:to="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5098767c-bb81-4338-a751-a69a446b9737_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5098767c-bb81-4338-a751-a69a446b9737_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0e90346c-1b94-4ab8-b49d-df85912fa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:to="loc_us-gaap_SeniorNotesMember_0e90346c-1b94-4ab8-b49d-df85912fa2ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:to="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_16573127-c76b-40f7-8b0a-2dc950db243e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_16573127-c76b-40f7-8b0a-2dc950db243e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6d8c5d48-a569-459a-b614-4c9e936c02b5" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6d8c5d48-a569-459a-b614-4c9e936c02b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_259ef42b-4d55-4506-a54d-669ef4375f80" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_259ef42b-4d55-4506-a54d-669ef4375f80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_3aa8f82d-d6bf-446e-b899-ef34049e40db" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_3aa8f82d-d6bf-446e-b899-ef34049e40db" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0d923c0-a930-4eee-8bc5-1cb3ae2139e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0d923c0-a930-4eee-8bc5-1cb3ae2139e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69a54687-5569-4e9c-9999-33942883b553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69a54687-5569-4e9c-9999-33942883b553" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_639f0514-6080-4968-94c2-7f211b9d4fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_639f0514-6080-4968-94c2-7f211b9d4fcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_413cfc80-4529-47fb-9964-8d59d6064a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_413cfc80-4529-47fb-9964-8d59d6064a4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae50acf3-f65c-49ea-b642-a82079dd1414_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae50acf3-f65c-49ea-b642-a82079dd1414_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_60c118ae-3e48-4ab4-becb-7500af2a48bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_60c118ae-3e48-4ab4-becb-7500af2a48bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_26e13965-5b5b-43a4-bf4a-65f9bb7ebbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_CommercialPaperMember_26e13965-5b5b-43a4-bf4a-65f9bb7ebbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_85f31011-00dd-44ca-88fd-46904050ae64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_85f31011-00dd-44ca-88fd-46904050ae64" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6119f336-fef6-40c3-aea1-40dc887baf21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6119f336-fef6-40c3-aea1-40dc887baf21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_953693c2-bd67-4c95-be4c-b6eb2b1604c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_953693c2-bd67-4c95-be4c-b6eb2b1604c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d48ce8a1-f940-4354-947f-122e932bb864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d48ce8a1-f940-4354-947f-122e932bb864" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_be89d76f-c695-46e3-961f-3a356d03fbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_be89d76f-c695-46e3-961f-3a356d03fbb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0923893c-ad0c-462f-8025-c4dfda9b1484_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0923893c-ad0c-462f-8025-c4dfda9b1484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_6de096ee-ac31-4ed2-966c-24d72b63b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_6de096ee-ac31-4ed2-966c-24d72b63b7f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_89224f00-b0b0-4a80-9ff3-7a295993ac58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_BuildingMember_89224f00-b0b0-4a80-9ff3-7a295993ac58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_634bdef1-3db6-4c62-b0cd-88395b34071f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_634bdef1-3db6-4c62-b0cd-88395b34071f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_20fe6433-fd99-48e8-8aa3-2290044fa78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_ComputerEquipmentMember_20fe6433-fd99-48e8-8aa3-2290044fa78e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_ab3a4215-1597-490c-b6a1-927640be968a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_EquipmentMember_ab3a4215-1597-490c-b6a1-927640be968a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3bff422a-11b3-4745-8f1e-e04bef645d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3bff422a-11b3-4745-8f1e-e04bef645d0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_93d2abc1-42f4-48fe-aa89-28699a4d60c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_ConstructionInProgressMember_93d2abc1-42f4-48fe-aa89-28699a4d60c4" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a9a8e616-8dbc-404e-8cbd-4a4471de1e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a9a8e616-8dbc-404e-8cbd-4a4471de1e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_1828272c-4d93-4842-8440-0b8ad6ef84f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_1828272c-4d93-4842-8440-0b8ad6ef84f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_771afbf5-0e44-4c3d-9c02-28e955f60663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_ConvertibleNotesPayable_771afbf5-0e44-4c3d-9c02-28e955f60663" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:to="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6f8dbeaf-b623-4ec6-9f8c-b014828d464c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:to="loc_us-gaap_SeniorNotesMember_6f8dbeaf-b623-4ec6-9f8c-b014828d464c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0b3be1d6-4314-43f6-84b6-b2730ba8f295_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0b3be1d6-4314-43f6-84b6-b2730ba8f295_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_78376c1c-ee8e-4140-8316-f4955454f5be" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_78376c1c-ee8e-4140-8316-f4955454f5be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_901d3dc1-9d9a-46a0-b7a7-96961bc7e703" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_901d3dc1-9d9a-46a0-b7a7-96961bc7e703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a7e77303-98b3-4590-aa60-17cfe41b8525" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a7e77303-98b3-4590-aa60-17cfe41b8525" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_5455fd6e-e2c0-46d6-b522-3a73f76950e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_5455fd6e-e2c0-46d6-b522-3a73f76950e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:to="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_056c65ca-cfb3-43d7-94c8-4ddd1861cc54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_056c65ca-cfb3-43d7-94c8-4ddd1861cc54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fb274af7-5be8-4c40-aa14-69c80ae6c019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:to="loc_us-gaap_SeniorNotesMember_fb274af7-5be8-4c40-aa14-69c80ae6c019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:to="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d75c8af8-8e8f-44c8-8d37-d4847566115e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d75c8af8-8e8f-44c8-8d37-d4847566115e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_d3564353-3d6a-42a8-8c8e-65af6da32f1e" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_d3564353-3d6a-42a8-8c8e-65af6da32f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_057e093d-1d8f-445e-adaf-dd8214dc3d82" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_057e093d-1d8f-445e-adaf-dd8214dc3d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_c5b60c11-02fd-4021-b73c-eb3b8289215b" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_c5b60c11-02fd-4021-b73c-eb3b8289215b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:href="dxcm-20230930.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_12e1934e-5f9d-4e74-9bfe-4a4e76766079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_12e1934e-5f9d-4e74-9bfe-4a4e76766079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:href="dxcm-20230930.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_50fc5a07-4136-45c2-888d-90bee43bed85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_50fc5a07-4136-45c2-888d-90bee43bed85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4cfb098a-e8df-415f-aaae-70d7fb0b67e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:to="loc_us-gaap_InterestExpenseDebt_4cfb098a-e8df-415f-aaae-70d7fb0b67e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e342aafa-9ca0-4a54-994a-705dbce8dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e342aafa-9ca0-4a54-994a-705dbce8dcd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:to="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4acfef13-01eb-4492-930a-ba7652341a44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4acfef13-01eb-4492-930a-ba7652341a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_fd1fe1ef-8180-4b48-a1dc-ab0261bb57c0" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_fd1fe1ef-8180-4b48-a1dc-ab0261bb57c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_ab5e087c-b10e-477d-befc-e0e56907cb68" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_ab5e087c-b10e-477d-befc-e0e56907cb68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_bee08340-c088-4632-9787-9f1f43cf5a7c" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_bee08340-c088-4632-9787-9f1f43cf5a7c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9649056c-b744-4c01-a18a-18680b4e18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9649056c-b744-4c01-a18a-18680b4e18a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_14de7e7d-9042-4b61-b191-fa653fb976fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_14de7e7d-9042-4b61-b191-fa653fb976fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_b86bc2ea-d77d-4703-98d9-882cd88c16df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_b86bc2ea-d77d-4703-98d9-882cd88c16df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3300cec1-71d4-4b4c-8bb6-5f9b691815c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3300cec1-71d4-4b4c-8bb6-5f9b691815c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_105ca8a0-ad20-4d18-9b31-3a284d230702" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_105ca8a0-ad20-4d18-9b31-3a284d230702" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_3faff0f6-8ff0-4b2d-b3b0-245a37d0aba1" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_3faff0f6-8ff0-4b2d-b3b0-245a37d0aba1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_6cec563f-88ac-4108-a680-c515b9dbb282" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_6cec563f-88ac-4108-a680-c515b9dbb282" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3d1f509c-5960-4ab9-a816-94cbfaa650e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3d1f509c-5960-4ab9-a816-94cbfaa650e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_c9634bcf-6f7b-4b07-84c0-b008380ac4b5" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_c9634bcf-6f7b-4b07-84c0-b008380ac4b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_832b8c74-e53c-45a6-abb3-5575922ded62" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_832b8c74-e53c-45a6-abb3-5575922ded62" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_b77a94e7-bf88-4d87-9649-782180f28070" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_b77a94e7-bf88-4d87-9649-782180f28070" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_134e7483-1bcf-4a8b-980f-f525f72e3fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_134e7483-1bcf-4a8b-980f-f525f72e3fc3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5fa852fb-7110-495d-9531-93c8f5009813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5fa852fb-7110-495d-9531-93c8f5009813" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_77f34139-53c4-4d58-806e-27b609f97813" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_77f34139-53c4-4d58-806e-27b609f97813" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b27e3852-5a54-40f4-93af-e6058ac40c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b27e3852-5a54-40f4-93af-e6058ac40c56" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_c4abacc1-047d-49c7-b12e-4ecf42980ab8" xlink:href="dxcm-20230930.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_c4abacc1-047d-49c7-b12e-4ecf42980ab8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_2f294726-2ead-4550-9998-0a2cf3f35289" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_2f294726-2ead-4550-9998-0a2cf3f35289" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_7aa86cbc-3495-4fc5-b483-2f766506ffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_7aa86cbc-3495-4fc5-b483-2f766506ffa6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_82d68282-56d0-45e1-8209-205f5fa867a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_82d68282-56d0-45e1-8209-205f5fa867a5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_2304d0dd-f6b0-4eee-8197-b81593418981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_2304d0dd-f6b0-4eee-8197-b81593418981" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_94c1c4b5-7de1-4e6d-afba-bc4d4d242031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_94c1c4b5-7de1-4e6d-afba-bc4d4d242031" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_66e5fc81-27b4-4adf-bb16-a6087ed437d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_66e5fc81-27b4-4adf-bb16-a6087ed437d0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_912fae33-a086-4768-b128-e5cde67164eb" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_912fae33-a086-4768-b128-e5cde67164eb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_be4f6a9a-4907-4d5f-9eac-2fa9a105a670" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_be4f6a9a-4907-4d5f-9eac-2fa9a105a670" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_177afbbe-a6da-4eba-ad47-1c2f3fcf31fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_SharePrice_177afbbe-a6da-4eba-ad47-1c2f3fcf31fd" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_7e94bb2d-dd65-4c7f-af3e-2745fd8ece33" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_7e94bb2d-dd65-4c7f-af3e-2745fd8ece33" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ad7ef383-4215-4e09-8805-79e66cadb018" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentTerm_ad7ef383-4215-4e09-8805-79e66cadb018" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5f9ba1f2-2dc2-4219-9203-d9f8c36c8bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5f9ba1f2-2dc2-4219-9203-d9f8c36c8bf2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_717a0600-af3c-4eef-a580-60420e2e0512" xlink:href="dxcm-20230930.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_717a0600-af3c-4eef-a580-60420e2e0512" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff9a3939-6837-4706-a384-4fa1036a07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff9a3939-6837-4706-a384-4fa1036a07e2" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_793ca81c-efcb-4411-9c96-31d5079aa7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_793ca81c-efcb-4411-9c96-31d5079aa7f1" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_df7b006a-cdb5-425e-93f0-9e4867335eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DepositAssets_df7b006a-cdb5-425e-93f0-9e4867335eac" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a27c8475-ee61-43ad-9c0a-14301e9cae6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a27c8475-ee61-43ad-9c0a-14301e9cae6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_168fa448-8e4e-4568-80ae-a34d45f68781" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_168fa448-8e4e-4568-80ae-a34d45f68781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_7e4cd1f0-4224-44ed-954e-b4615d1b4ce6" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_7e4cd1f0-4224-44ed-954e-b4615d1b4ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_8693ec99-2dbf-496b-8a11-ee0951b8f8a6" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_8693ec99-2dbf-496b-8a11-ee0951b8f8a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5632e6a8-aef4-4521-9787-7ac639595171_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5632e6a8-aef4-4521-9787-7ac639595171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_56bccde3-934f-4d98-93be-db5a87850b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:to="loc_us-gaap_SeniorNotesMember_56bccde3-934f-4d98-93be-db5a87850b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7898767b-8138-4d2e-ae84-9b37b09b2614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:to="loc_us-gaap_LineOfCreditMember_7898767b-8138-4d2e-ae84-9b37b09b2614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:to="loc_us-gaap_EquityComponentDomain_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:to="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_279450be-9726-4b78-ba09-6b7cb87e20b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:to="loc_us-gaap_CommonStockMember_279450be-9726-4b78-ba09-6b7cb87e20b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_0263df1e-3be7-41a6-a62b-d9c1b11d3e70_default" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_0263df1e-3be7-41a6-a62b-d9c1b11d3e70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_6dabfb9c-5ebc-45ec-b6dd-90d782d0480e" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_6dabfb9c-5ebc-45ec-b6dd-90d782d0480e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_511eaa9f-bd94-4ca1-80d0-8e9cf7b15686" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_511eaa9f-bd94-4ca1-80d0-8e9cf7b15686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_379ef918-5adc-4a87-9d0c-a1a76a257b42_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:to="loc_srt_RangeMember_379ef918-5adc-4a87-9d0c-a1a76a257b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:to="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6860464d-52b0-4039-ad44-1de32906bc11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:to="loc_srt_MinimumMember_6860464d-52b0-4039-ad44-1de32906bc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_841ec562-e375-4c1a-bcfa-13f92bfb63ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:to="loc_srt_MaximumMember_841ec562-e375-4c1a-bcfa-13f92bfb63ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_40056d87-564b-47a4-befe-b003f8b46500_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:to="loc_us-gaap_HedgingDesignationDomain_40056d87-564b-47a4-befe-b003f8b46500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:to="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_df610da7-ff63-438e-b74d-0de0c791a300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_df610da7-ff63-438e-b74d-0de0c791a300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cf03a758-5b66-420c-b7b4-b38af0bade95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:to="loc_us-gaap_VariableRateDomain_cf03a758-5b66-420c-b7b4-b38af0bade95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:to="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_787c5ab1-6c79-4d76-8fdb-273c534132b2" xlink:href="dxcm-20230930.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_787c5ab1-6c79-4d76-8fdb-273c534132b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0f19b1e1-f43b-4dbc-9a03-c285ba94ae72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0f19b1e1-f43b-4dbc-9a03-c285ba94ae72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember_a36907f2-c228-416e-bf89-bf0501bbde3f" xlink:href="dxcm-20230930.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_dxcm_SimpleRiskFreeRateRFRMember_a36907f2-c228-416e-bf89-bf0501bbde3f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8487ec33-599b-4f0c-9113-b5fa90d899cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8487ec33-599b-4f0c-9113-b5fa90d899cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_1d5f4780-a6b7-4b6c-b869-404264487e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCredit_1d5f4780-a6b7-4b6c-b869-404264487e0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c7bdc43b-ef3f-4b90-88c2-d5106e12ec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c7bdc43b-ef3f-4b90-88c2-d5106e12ec4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9b8987d4-8bbe-4e3a-93d4-f9cf0ee6ed18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9b8987d4-8bbe-4e3a-93d4-f9cf0ee6ed18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_60d2d618-751d-4753-9737-15f62a6a9d11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_60d2d618-751d-4753-9737-15f62a6a9d11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_240e1052-aa4e-4f2a-9750-3ebe2339b12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:to="loc_us-gaap_LineOfCreditMember_240e1052-aa4e-4f2a-9750-3ebe2339b12e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:to="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_16ba02b5-4c19-4470-b767-9c3e9049d9de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:to="loc_us-gaap_CreditFacilityDomain_16ba02b5-4c19-4470-b767-9c3e9049d9de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:to="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_870636af-0c3d-467c-acd7-b514e4d3306d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:to="loc_us-gaap_LetterOfCreditMember_870636af-0c3d-467c-acd7-b514e4d3306d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_b8e5cf09-e3f8-4262-ac4b-3a9bf8260a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_b8e5cf09-e3f8-4262-ac4b-3a9bf8260a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsRemainingNumber_5414721d-5b04-41e7-89c4-126efc60c089" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsRemainingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyPendingClaimsRemainingNumber_5414721d-5b04-41e7-89c4-126efc60c089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_caf799a9-fca6-458f-8eff-77b79065f8f9" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_caf799a9-fca6-458f-8eff-77b79065f8f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_38ee542c-e2b9-41bc-ab19-7cabff69cc82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_38ee542c-e2b9-41bc-ab19-7cabff69cc82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_b78aecc7-b2dd-4542-b8cd-cca24749df8b" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_b78aecc7-b2dd-4542-b8cd-cca24749df8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:to="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d34fa814-8998-48f0-965e-dd3f89182cf1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d34fa814-8998-48f0-965e-dd3f89182cf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AbbottMember_93773e2d-abae-4a13-a2d7-4599658fa201" xlink:href="dxcm-20230930.xsd#dxcm_AbbottMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:to="loc_dxcm_AbbottMember_93773e2d-abae-4a13-a2d7-4599658fa201" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c8f7903f-3cd6-42a5-a534-938941ab18ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c8f7903f-3cd6-42a5-a534-938941ab18ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a08c8eed-75c6-4736-b691-26ad56118903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:to="loc_us-gaap_SubsequentEventMember_a08c8eed-75c6-4736-b691-26ad56118903" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_89f5a2fa-5eca-45c6-bacb-d69c6fb69e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_89f5a2fa-5eca-45c6-bacb-d69c6fb69e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f3edf303-51cd-4f24-ae23-f5d5c03721dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f3edf303-51cd-4f24-ae23-f5d5c03721dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_83f4632f-4fd4-4cbf-b480-1ba670c8ff02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_us-gaap_CostOfSalesMember_83f4632f-4fd4-4cbf-b480-1ba670c8ff02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11beaf47-c67f-40b9-b8c1-09181a661a76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11beaf47-c67f-40b9-b8c1-09181a661a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_0887a064-a69a-47ec-9022-b45e86d14011" xlink:href="dxcm-20230930.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_0887a064-a69a-47ec-9022-b45e86d14011" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6c0c6f-521f-4416-9580-fefc03183def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6c0c6f-521f-4416-9580-fefc03183def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b3dcf097-90ee-4b86-9fa8-a93cb25ff577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b3dcf097-90ee-4b86-9fa8-a93cb25ff577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff3be12b-71ec-4e81-b62f-12acdbf1f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff3be12b-71ec-4e81-b62f-12acdbf1f1ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c709b6df-9a11-42f2-8735-f463ab51ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c709b6df-9a11-42f2-8735-f463ab51ed47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b78e3eee-bf90-43b6-8361-18dc639893bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b78e3eee-bf90-43b6-8361-18dc639893bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8aeaada1-20fd-41d9-ba7b-284bba3abd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8aeaada1-20fd-41d9-ba7b-284bba3abd4f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2095d3b4-d8f5-4b9c-95d2-cc71ecc00dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2095d3b4-d8f5-4b9c-95d2-cc71ecc00dca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:to="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fe16f21-2521-45a2-b030-e5276793b1ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fe16f21-2521-45a2-b030-e5276793b1ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c452cf78-d11c-4ca2-929a-70233a512050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c452cf78-d11c-4ca2-929a-70233a512050" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c08748e9-440b-4131-88cd-327703361383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:to="loc_us-gaap_PerformanceSharesMember_c08748e9-440b-4131-88cd-327703361383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8b6b8b72-5394-4e39-830e-15899bcab817_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8b6b8b72-5394-4e39-830e-15899bcab817_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_ccdd0749-6b68-403a-b213-50528dd62398" xlink:href="dxcm-20230930.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_ccdd0749-6b68-403a-b213-50528dd62398" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BusinessSegmentandGeographicInformationScheduleofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e400b4bd-b8b0-438b-86bf-3c1fbf742b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e400b4bd-b8b0-438b-86bf-3c1fbf742b60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_d5974182-c9c0-4f7e-93a1-5630533ba3c3" xlink:href="dxcm-20230930.xsd#dxcm_RevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:to="loc_dxcm_RevenuePercentage_d5974182-c9c0-4f7e-93a1-5630533ba3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:to="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_33ebfd42-5798-4831-b24c-8c16432e8413_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:to="loc_srt_SegmentGeographicalDomain_33ebfd42-5798-4831-b24c-8c16432e8413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:to="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01937daa-4e44-451a-91eb-1900327247a6" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:to="loc_country_US_01937daa-4e44-451a-91eb-1900327247a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_5395093c-90d3-4832-98cc-1d158cf48ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:to="loc_us-gaap_NonUsMember_5395093c-90d3-4832-98cc-1d158cf48ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_67c64c04-0eaa-413f-a9d3-d1efa97c23bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_67c64c04-0eaa-413f-a9d3-d1efa97c23bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_14b93bb5-5333-4f8d-8e27-80e1d45fbee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_14b93bb5-5333-4f8d-8e27-80e1d45fbee3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_253fdf89-6b61-4b3c-adda-3f6a209cae06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_253fdf89-6b61-4b3c-adda-3f6a209cae06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_05700190-7678-421f-b234-a0bc68a9ff8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_05700190-7678-421f-b234-a0bc68a9ff8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:to="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1f593e1a-e576-4e5d-9695-95308a956aad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1f593e1a-e576-4e5d-9695-95308a956aad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8168d0e2-e30e-4768-b800-8620c4105dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:to="loc_us-gaap_SubsequentEventMember_8168d0e2-e30e-4768-b800-8620c4105dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f61625f-7ced-453b-b829-a2d29127938e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:to="loc_us-gaap_EquityComponentDomain_0f61625f-7ced-453b-b829-a2d29127938e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:to="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a842a6c5-745d-446e-b76f-c66d0a00189a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:to="loc_us-gaap_CommonStockMember_a842a6c5-745d-446e-b76f-c66d0a00189a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#TradingArrangmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023TerminationMember_13fb2606-53c6-406f-af35-b8b165c721c0" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023TerminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="loc_dxcm_MichaelBrownAugust2023TerminationMember_13fb2606-53c6-406f-af35-b8b165c721c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023AdoptionMember_9ce98890-589b-41c8-a3ce-be17a6b49a62" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023AdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="loc_dxcm_MichaelBrownAugust2023AdoptionMember_9ce98890-589b-41c8-a3ce-be17a6b49a62" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownMember_5da183ff-1705-416e-9f4f-7534af564178" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_MichaelBrownMember_5da183ff-1705-416e-9f4f-7534af564178" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NicholasAugustinosMember_11aca1e0-ddcd-4b34-8c08-8a83f525b2f3" xlink:href="dxcm-20230930.xsd#dxcm_NicholasAugustinosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_NicholasAugustinosMember_11aca1e0-ddcd-4b34-8c08-8a83f525b2f3" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dxcm-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_5bfff33e-2a49-4f6d-8022-054e758d0db9_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_9be6a32a-a47a-43e5-b26d-3e84c6e7dad4_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_label_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_documentation_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:to="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ebb1b872-7e5e-4c3c-92db-8667ee169659_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1a7fc556-4a86-4972-aeff-fc5f5021197f_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dc48b91a-52e8-49f3-9d86-667abc7ffc42_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24641028-78bb-447f-801e-81b47d7e4b6c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available principal amount and letters of credit sub-facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c9b6c370-3524-4af3-b143-7644008b9c87_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_eac08138-d64e-4fec-b8c3-714fc28007e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_03004d57-1d99-4924-aa20-33d44651b809_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_521098f9-55ab-4ed8-a664-5e3e885dded2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0b9eaf61-32f5-4cfd-81df-6f496691fcc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_de42d7b6-5010-4409-b97e-25b9e176aa47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_847e2123-8107-4367-ba55-144516d43872_terseLabel_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual effective tax rate (as percent)</link:label>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_label_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Annual Effective Income Tax Rate, Percent</link:label>
    <link:label id="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_documentation_en-US" xlink:label="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Annual Effective Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:href="dxcm-20230930.xsd#dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:to="lab_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_050a1476-ca72-4be5-a4ba-be0327f737aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_517779ce-7cd1-4e43-a9c9-980f1f93ff43_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_06ef770c-6a62-4271-8b76-f3c340c58b99_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_09179e20-523b-4c40-a310-f17c994b48a4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_6d3675d6-4880-4084-9117-7f5cbbb1ff3e_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software and hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_57936cc8-a7bf-413d-8546-dc0797eb1d17_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:to="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_04cf9fa8-621f-4527-9872-78e6b1fdc833_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_9735d266-a5a1-4397-b53e-c416c3e9e3c8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims or trials</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b8b96e25-0e5e-4de6-a273-f387341ce86a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_121cfd4e-8d95-4690-9a9b-c52f0ef8d549_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_87e0b101-e350-486e-b79e-599ba9176cc5_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible principal amount settled through cash</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Settled Through Cash</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Settled Through Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_0ace566f-93a0-4e1e-a4c3-2e7089d05cf9_terseLabel_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_label_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresLineItems_documentation_en-US" xlink:label="lab_dxcm_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Fair Value Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueDisclosuresLineItems" xlink:to="lab_dxcm_FairValueDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_75262fbd-05d6-41f6-a0fb-9b511448de81_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_015b006e-62be-41e9-bba2-aeb5cb912ab0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_49d639ed-2a1c-404c-90e5-63820f534462_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_ca06b1a0-2081-445e-9340-00e69b5d6460_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_163994b1-3296-4ac1-a5af-fa7b0d486a51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_0da16e78-4ddf-4f9e-a947-3b299ac5aee2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_ad2ad1a3-74b4-4fd7-b135-60643475116b_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued upon conversion of senior notes (in shares)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:to="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8f58965b-a4e1-4de2-8c7e-caff7e32089d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f05efc48-28d2-47ba-86fc-897b966eccb1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_bb7bb7fd-c823-4cc1-b936-5b39a6d6b02b_terseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge, Value</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:to="lab_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1a4c01c1-dc1d-4150-894c-64e006cf27b5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4f1e26ac-dbaf-4865-b5c7-30d2b32a7c34_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6aae5f33-f7fe-4109-81b2-21badc0c0551_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_38408c11-a439-4346-b04d-99afe82144af_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b5c4936c-a57d-450e-ba30-7eaa414865e5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_5ea1ef0c-9e53-410c-bbab-ad04809b75f6_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, principal amount settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Expected To Settle Through Cash</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Expected To Settle Through Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b895945f-418f-401d-8bbf-91064345b8e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e0347722-0578-4021-9880-aef8cb7d15f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_08d15d6b-ea43-4e3d-ab9c-58c7afcea10c_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_46e80dbc-735a-4f8c-ab7a-0eb1900676b3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ac304b10-a475-47d8-a66d-ea05a2d19f3a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c3b32232-be18-407c-9b9d-f59ec5c1e46b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_4a2b4113-13b5-4046-b10a-9cb6962253f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_7ff91e56-288e-4796-a588-031439dcf176_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term two</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_71345c69-3e4b-4f38-b1c3-9a6d45792c74_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_db3a07eb-4ea6-4234-a4c3-3271553d5d0a_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_a51a7080-fce6-4af6-b10a-e3e1bf2ba107_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and dividend income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_527916d7-c606-4d25-ab7a-1b96fa8b3b59_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4ff9eb29-7f73-4220-a0c4-8509c8518e53_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_13625ca9-29c4-424e-aa8c-b0198e02c4b3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d3966fbd-55d4-43e9-ae56-b8e1b7e6a05e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_fe6d23c7-b044-4045-80cc-cc60ebb0dde1_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e4cdf505-4b4d-4133-ae2b-d8c3c671ac1c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_c14c25f3-794c-4183-8445-39483b4f3b32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_99d10693-0f6d-4e97-a456-915c635164fb_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible principal amount settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised And Settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised And Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_1428efb0-7428-495c-b6d2-14ca5d137e75_terseLabel_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages, bonus and taxes</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_label_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_documentation_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:href="dxcm-20230930.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:to="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e45ded60-6504-49a6-8a5d-c39a5180b606_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9605c931-434b-473e-a07d-8ff8b8a927fc_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_859c7b56-73a5-47f8-af39-bc1df81159c7_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:to="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dceb2f62-3a17-4649-8ee0-449bf82beab1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_MichaelBrownMember_label_en-US" xlink:label="lab_dxcm_MichaelBrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown [Member]</link:label>
    <link:label id="lab_dxcm_MichaelBrownMember_documentation_en-US" xlink:label="lab_dxcm_MichaelBrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MichaelBrownMember" xlink:to="lab_dxcm_MichaelBrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_99ed4201-6400-4a2f-9f39-1db42449ee70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for conversions of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0a320864-aef4-4413-8e62-f028c7c019f1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c78d5023-6ebf-4c64-91e1-6efef7f86c2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_ec2d3ea2-6101-449b-b026-ce7f187d82e6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a439f8a-6d56-4063-924f-94e5d3828e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_fa01799d-13aa-4861-890e-1d91660f9cf3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_d99a6f47-5ff2-4b7e-8be4-d56dafc9eeae_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_080fba36-0edc-4f1e-93ec-3e054c93d435_negatedLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:href="dxcm-20230930.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:to="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_bf6f9af5-b4db-4f4b-b54a-e601d36cfaf6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9f6a3c47-d3f6-454c-8db8-11ab054d94b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_a41e0148-0fa2-4f3d-9231-932c720bf572_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_f95a677c-09d7-46e4-94d8-12c60f9c4d84_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_78b82a38-57ea-442a-a74d-489f47a9ecd6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_62698ae3-a410-4956-9961-cd8d7bc45fe0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5adbb979-f936-4ccb-a434-9d9fa5b22771_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants or rights (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8cea43fb-c024-4745-81f6-f89d52e9b87e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8de18676-6617-4924-ac9b-109f25863756_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8406e237-dd06-4be8-99c5-891f6223da55_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_97c9a5d6-9d26-43cb-9c8e-f82f3f194117_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_1cb3d5b0-36e5-4b99-aa97-aae3be11065a_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_349f3075-4c74-42f0-9abe-3fa372fa6255_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:href="dxcm-20230930.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:to="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_beb574d8-d32a-44dc-a491-cb85cf7a2618_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_c2bb63f3-ce4e-47ac-a027-49da045c9dc6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_43b6dd52-08ae-463d-8328-3720acd04cfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0f8dc361-c785-4abf-93ed-965e7988907a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_a96587b6-1187-4d57-9eb5-87a9d2e188ef_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_09a7810f-f201-4510-9cad-0f6e06e331df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_edace663-9bf1-4a1d-a412-ebd201b87af2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d9d6c104-b93e-41cf-9417-294d1e9dd6d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9dd2b668-9f62-42b0-ad92-47b134b5777e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsRemainingNumber_bb72dceb-4343-442b-9de1-c535ff4c462e_terseLabel_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims remaining</link:label>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsRemainingNumber_label_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims Remaining, Number</link:label>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsRemainingNumber_documentation_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims Remaining, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsRemainingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:to="lab_dxcm_LossContingencyPendingClaimsRemainingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_b9e9bd5d-62ca-4bdd-92f3-11700b15fa8b_terseLabel_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_label_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_dxcm_SellingGeneralAndAdministrativeMember_documentation_en-US" xlink:label="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The allocation of expenses to selling, general and administrative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:href="dxcm-20230930.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SellingGeneralAndAdministrativeMember" xlink:to="lab_dxcm_SellingGeneralAndAdministrativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_cdb5cff8-f6b4-4720-84e4-96128ceb77c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0101067d-7c14-4247-aaad-4b2978fb6d70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_2d3ed06a-00ca-4cd6-a8fb-81e1e6c7dadd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5476623-fa35-4344-b7e1-b1ab32c9ce59_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_847f17c3-d9d4-4653-b11d-c80477bb8949_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b09434b8-d4c5-4eef-b769-71983566fcc9_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_f17ffb35-d0e3-466c-884e-3fd872ed2a0b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_332b4f92-563c-4365-ba35-5d1aef5af190_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of conversion price (as percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_label_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:to="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_0d1d832a-272f-46a0-93b4-600289ef1877_terseLabel_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_label_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</link:label>
    <link:label id="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_documentation_en-US" xlink:label="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:href="dxcm-20230930.xsd#dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:to="lab_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_88c6efcd-6821-4242-b5e7-0d2105be84ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_de3709ad-9420-40aa-97fe-c33a8b0ca584_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_bdb5e304-5d97-43f2-998b-d5abb6560a81_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense recognized on senior notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0bd5384c-fe58-449c-8d33-622ca5537b06_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_4c590342-362f-4aea-9113-66b411d86f5e_terseLabel_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR)</link:label>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_label_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR) [Member]</link:label>
    <link:label id="lab_dxcm_SimpleRiskFreeRateRFRMember_documentation_en-US" xlink:label="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Risk Free Rate (RFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember" xlink:href="dxcm-20230930.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SimpleRiskFreeRateRFRMember" xlink:to="lab_dxcm_SimpleRiskFreeRateRFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_1a7f9503-a377-4ad3-8244-5d765a63e0a0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0a2199f1-2b47-415d-a87d-b02101d5d8d4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_788dfe08-0505-4bca-8faa-0eba0ca9d1c5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d54b0f4a-d527-4d00-b0d5-6b19a90cc66b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_59f462ad-0522-4afc-98dc-fdbabc986e59_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9ce70bca-6b0c-47d9-9a6c-f37e78a9881f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_20fd20e2-0dca-4a1d-aee7-8081a6ae8fdf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivables</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f18f0dfb-7bc6-4b62-923d-3537097e3874_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0a177f67-0052-4fc8-b3a4-8acab488fb52_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized estimated compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AbbottMember_7bda5266-1bca-4c0c-8dc0-b656a4685a08_terseLabel_en-US" xlink:label="lab_dxcm_AbbottMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abbott</link:label>
    <link:label id="lab_dxcm_AbbottMember_label_en-US" xlink:label="lab_dxcm_AbbottMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abbott [Member]</link:label>
    <link:label id="lab_dxcm_AbbottMember_documentation_en-US" xlink:label="lab_dxcm_AbbottMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abbott</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AbbottMember" xlink:href="dxcm-20230930.xsd#dxcm_AbbottMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AbbottMember" xlink:to="lab_dxcm_AbbottMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_e7fe9c37-9d56-4261-9b35-82bfec339c11_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5675e85b-88c5-4450-a4ac-394be04e0a91_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_daac5370-2e25-4ba5-af38-d5da5d1b1c36_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approval Milestone</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Approval Milestone [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Approval Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:to="lab_dxcm_CollaborativeArrangementApprovalMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_c73f1392-a7f0-4d6b-a722-638fe2cbdca7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details and Other Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_d336b4fb-dc47-4cd4-807b-1540100980ee_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e11bc0a8-82af-4e71-8086-177c5f82415a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_f81fe6da-d439-4f80-8fe8-2bb71a89fa2b_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2c507812-c0e2-4b3d-b06b-373c10bcbbbb_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_c075e654-915e-4d30-b4ab-1098adbec0a0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3287cf64-2932-4851-975a-17f156f1bde2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_618342b6-3cb7-4d0d-9d09-8f5279be9e4e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_a078e103-c7ba-44d0-a57f-2ef5efb5f508_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of 2025 Notes issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_232031d6-66ab-4732-99d8-30f2cb425053_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_101c69fa-abcf-45ab-addf-41d92599eceb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_53ff513e-805b-4e34-a0f1-ce6d18be20a5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3e830f5e-303d-49c0-9e01-8c82b1bf9d44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bf3bba14-754b-4651-9c92-672e048fbbe2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherLongTermAssets_46f56537-1032-4f50-af98-e1840732c19e_terseLabel_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_label_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_documentation_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets" xlink:href="dxcm-20230930.xsd#dxcm_OtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherLongTermAssets" xlink:to="lab_dxcm_OtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_b537733d-efad-4875-b7b4-bdb7fdbbf5c8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3c0cf573-730c-4639-b948-d24e4631098b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_27783cd2-574c-44d2-b8c6-bc175065da35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_785e6a7f-5e66-44be-bc23-9ba79bda7ac7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_ec933cf1-92df-4b8f-97ca-3c1970f4f52e_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument convertible principal amount exercised</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_a5fc18a0-3fb8-4ce4-b6ae-29bb0c434c7b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b0176a23-cc3d-444d-8ee8-6c79940a8ee3_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_84abf047-822a-456c-8038-a66f22e5be18_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f48427cc-0b75-42dd-931c-ee9f3ad2219c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_a3e3a6a3-7f94-494e-b43c-40b3aba5765f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_03c10c32-3fc0-47b3-9e1e-30220b119161_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_ee5f52e2-1dc4-451e-ab9d-0d7a8236671d_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9c8d8ce7-bb12-4994-8bde-4247742f61ba_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0b938133-8811-4834-aa54-0ec1a2b32ce5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_26929dc7-6923-4bfd-aa84-589acf9ee206_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab54f389-0afc-4a26-ad95-cf386d6de574_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6b796f92-1f92-4650-a9e1-17770e2e8313_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10a93ae8-37a3-4d53-a073-8dca70ab20a6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fa658d71-99bf-4e76-a0b0-f244af62ce50_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_63597ce2-439c-4045-98a3-4243d1cee19c_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c73dff0d-ec5b-4886-8242-fcdb639e4497_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_f2c8502f-7254-42ed-bbfd-1f334c4aaec1_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 19.1 million shares at September&#160;30, 2023 and 6.9 million shares at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_608f1354-45fb-4c6b-b309-628614a99a1e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b92c05a9-f751-48eb-82fd-f9028f7b3a4e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_41612a7a-14d1-4069-8495-69ce3538ebae_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7d60b97-0362-4a22-84e4-67b14c968892_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PharmacyRebates_e6b0bef4-e10a-494e-be72-f50ac80c6f84_terseLabel_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_label_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebates_documentation_en-US" xlink:label="lab_dxcm_PharmacyRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates" xlink:href="dxcm-20230930.xsd#dxcm_PharmacyRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PharmacyRebates" xlink:to="lab_dxcm_PharmacyRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_eb65e158-eab1-4cfa-a701-a373ca6fc539_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and Other Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_f63772d7-5ce8-4280-99f5-fec1e1a0193b_terseLabel_en-US" xlink:label="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, including excise tax</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_label_en-US" xlink:label="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Including Excise Tax Adjustment</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_documentation_en-US" xlink:label="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Including Excise Tax Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:href="dxcm-20230930.xsd#dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:to="lab_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_71b6eda4-1b4c-41e6-b387-59327942097e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_85951b89-f9a9-477b-b30e-a1452e562ae0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1f3df5ec-337e-45d0-b8f6-da55383831fa_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_340eab32-a921-4364-9968-e460b99a943d_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d248aa63-1b76-49bb-b9ff-b036d77e619c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_abe33438-6e04-4f74-8007-583551b20e53_terseLabel_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Initial purchasers</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_label_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_documentation_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:href="dxcm-20230930.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:to="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_03518fc1-8ae2-4a18-a2a6-2da2d4a91feb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c0b8ac11-bb46-4d99-b38e-218911c2d998_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_b6c04847-a973-4bdc-b327-2decb31fb19c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9e526341-0d7e-4b2f-b5f3-49b9860e3312_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_151f69d0-abef-48a1-8c06-7568cfb23fb9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_e0c817ad-77ac-47cf-bd8d-f19c5649ec3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4043abcc-7e33-411e-9b1a-ca52741a06c1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4ad2cd91-6003-4aa7-85fb-616ec594c7ce_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_7defdf38-35ed-401a-b2ec-5104b6c3a8b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash income and expenses</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d674921a-98ac-4fcd-ba18-5bcd2a79ec42_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7cda5e30-a10a-41ba-b8c4-7f0dc5312bf4_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_70789f2d-bdc6-43a7-804f-25f4bfb9b886_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_b46ab5a3-4667-4210-b87a-3567ad22387c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Availability and Outstanding Borrowings on Credit Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_6458e7d1-4bda-4c21-9167-845c87bc4657_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a26ce435-b16e-4bed-86f2-d4d8fe9c1e24_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f3c85dd8-5667-45cc-b6be-2e41fc766130_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_ca621c6a-ec43-4297-9538-92f285662483_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6681a94a-4f44-44c8-9399-ee4d552c891d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a2ed46d6-1934-40f6-a07f-3597b3a91635_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_MichaelBrownAugust2023AdoptionMember_label_en-US" xlink:label="lab_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown August 2023 Adoption [Member]</link:label>
    <link:label id="lab_dxcm_MichaelBrownAugust2023AdoptionMember_documentation_en-US" xlink:label="lab_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown August 2023 Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023AdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:to="lab_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_MichaelBrownAugust2023TerminationMember_label_en-US" xlink:label="lab_dxcm_MichaelBrownAugust2023TerminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown August 2023 Termination [Member]</link:label>
    <link:label id="lab_dxcm_MichaelBrownAugust2023TerminationMember_documentation_en-US" xlink:label="lab_dxcm_MichaelBrownAugust2023TerminationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michael Brown August 2023 Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023TerminationMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023TerminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MichaelBrownAugust2023TerminationMember" xlink:to="lab_dxcm_MichaelBrownAugust2023TerminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_fd21af42-560f-40ab-b08a-fc8db03d196e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_f65d3607-fddd-4ede-88d0-6dc39009fec6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_79cb15fc-1513-46ed-ae83-89521417f8e3_terseLabel_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential future common stock issuable (in shares)</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_label_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_documentation_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:href="dxcm-20230930.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:to="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_8ae878ff-2f79-4864-9f8a-edee98f130ee_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_ff0372db-925d-4089-b10e-48c9eb165719_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for conversions of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_dcf9e0c5-f968-413c-8e5a-765317754817_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative research and development fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_label_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Research and Development Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:to="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25a30694-cf8b-448d-bfee-a54487c1d67f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_58eb077b-af8a-43b0-95d6-f8be8a9e89a9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2459a6dc-9f77-454f-8ab5-067b5c58627f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_a6584bad-1a49-4949-bb2f-0807eeee24e9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_f10590c2-4b80-420c-be61-4dd121bf29f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock counterparties to acquire with warrants purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ebcfb9f3-eb15-4a64-9530-3e2850bf8c29_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_379b6729-79a9-4907-a7de-bb6e9cc877f0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual coupon interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_7812a916-90be-4759-876e-51bff137f232_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_09b6d5c1-449d-412e-ac1b-6eedb3836a10_terseLabel_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest expense:</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract" xlink:href="dxcm-20230930.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CashInterestExpenseAbstract" xlink:to="lab_dxcm_CashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1e403a0e-7f56-4da3-9b62-c12b51fb19a2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_c65b5e06-964e-44b5-a887-54ec85fdee36_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_d0c2ddee-ba69-4572-ba9f-ca3a8872c9db_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_8eb97d88-ef81-4f97-aca7-d9e0fa9e267c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_12bd600d-e226-4ab8-90ca-a4186a37953d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_09062d62-ffcf-4214-939f-bc61654b31f0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_44120e3b-ce8a-4299-8e95-5136499dfc22_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e4577c6-1f10-4fd6-ad54-b13a8b698afd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_7881cdf9-93cc-4e3c-94b5-03eef00002da_terseLabel_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_label_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted And Performance Stock Units [Member]</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted And Performance Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:href="dxcm-20230930.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:to="lab_dxcm_RestrictedAndPerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b522377a-5832-449f-8b65-26bcfec13ac4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0bc971bc-00b0-4a3f-b0d6-aa612f8eee58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b1da1a72-e0df-4336-91e0-cbb25a9ca031_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_434ac4bd-af5b-4dbc-b37e-cf2d94d07d31_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a1d0cb53-4303-4ee7-ac54-378e7b927436_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3d99c31e-5696-4a63-b9d7-475975a18b04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c245e187-6701-434a-b9ff-d233acf4b813_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4ce597c1-0db0-4fd1-9102-63540ef42d2c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_dc0983b4-0c7d-4fbc-91a4-e9e020c64e55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_337141ec-3a0a-4276-93ec-807678354ea5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b83fb43e-b5a6-4265-8010-ab9ae750a438_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_deafdb57-bce3-41e2-b509-eabfb971e3bd_terseLabel_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract payment term (in days)</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_label_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_documentation_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:href="dxcm-20230930.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:to="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1794e033-0e69-498c-a1fa-4fe83f882fbe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_5b2351ef-b5ba-4a2c-b608-cd9af4de5885_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_be6eda4e-b2cb-40e1-8099-589495e4a528_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_8c3a5072-f335-4bd5-a333-8485bfb9a9d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6f0c7ab1-63b9-4e9c-bb6f-1106fbd2a763_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_81656187-63f8-4caf-8cb8-61f0ed369700_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_809ad873-19b5-4bed-9a7d-452dff782678_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes (in shares)</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_08c82d68-6530-46db-a48f-16f2d03d23b8_verboseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received from Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received From Benefit Of Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:to="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b9d97d64-499a-490c-9ae4-de88d76839cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6a2a263a-7804-4c23-9d5f-fde495606748_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9cf187d7-027b-4bd3-abdc-1f35f791ca63_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_874f177f-07d4-41ba-b19c-d691dc5a3441_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price of convertible notes (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_f9bebf34-10e3-47e1-a76d-61b97c04476a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f8a3fa93-6091-433e-951d-7bd572482d9a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_1defd4ed-471e-4c72-907d-72e32a775b86_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_bae9bb9e-1576-4461-9132-b82262f33105_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of applicable conversion price (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_eb46d1f3-ac64-4014-8e19-3bf513929d66_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1540f266-5ada-4838-b8c6-281eeed016fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_683f959b-41f9-4b34-a712-ebd4ceaf584d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7dec5c32-37cc-4b5e-9e9d-b6b11e5694d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_843f9847-ea50-4e2c-af0f-7bc8ecc9725c_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Payment</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:to="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_f969992b-4456-4126-83fd-460996d6ea35_terseLabel_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan assets</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_label_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_documentation_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:href="dxcm-20230930.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:to="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_50f44b62-84ee-4a9c-836a-79c90cf4fea8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_537d52af-0745-4ab4-b725-256b909e2afd_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0abf50e6-1126-4523-9e88-c75f354ee9b1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (as percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f846c56c-0823-4bb4-b800-05bdfd797a17_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_86cc47dc-6d59-4642-a85f-0c76e8d5df55_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9db987a8-2d8b-4237-bd2d-babdf3a0537c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7cd093f8-48aa-423b-9957-d4b6e8f7d878_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8204f486-46b0-4f70-b87b-bf42a3783063_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d3ade75b-303f-4ee0-b02f-113ee33936c1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_10e365da-33e3-4ee5-92f5-526647a8e19c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_b86bd542-8e80-47c3-afa9-bc28658b8034_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_4f878442-036b-4739-99d5-30ed3b9995de_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, long-term</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_ce606cbe-977c-4726-aa11-563aee8da07e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, long-term</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_5a2018e4-9a37-4893-a9fb-6164a7de5f03_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments, effective tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_38b7e16e-73a5-4338-892f-e0d66a3ee290_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7952d278-4eb9-4d18-a9b1-7ddd4fa2759e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_275ec0e6-5c22-44ac-90c5-a04413f104e5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_37316202-aee8-4a9a-b08f-085901f9dbc5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_3ac10fad-d665-4e6f-b128-66bf99fa5f06_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_188e0cd9-bdca-4de8-bcc4-381c6d477313_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f670ed50-6c8f-4f8c-85fd-4236f0049dd3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_cc1d66d2-6110-43f3-a2a3-ecef4429080d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_9053de89-9a1c-4886-89e1-73ad76918150_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_e1aa459d-37d7-468a-a4e7-83854159534e_negatedTerseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call transactions, net of tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:href="dxcm-20230930.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_a088097b-cc45-47a5-b6d2-b24a97a68e30_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term one</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_e8f980f3-7e7e-41e2-87c7-d57dc450cd82_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_194ffebd-595e-430f-98bf-e9c7d220228f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_83d5c3ff-f65b-48e7-9a3b-5bc6099892f6_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holder's repurchase price percentage in event of fundamental change (as percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:to="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_99891ee3-240c-4f7b-a8b3-d59db02b6011_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_e2797bdf-5cd0-49cd-bbc1-dd0a9addcad6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_00816078-eae1-43e3-8003-b8750be48086_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Equity Securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale and Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:href="dxcm-20230930.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5c2db385-5fbe-4b21-b2b3-567b9117b6cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_48acba85-5888-4a59-b7cc-f4fca14ea5e4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_38cbc5cc-78d3-4e74-a57e-8f6414cc59bd_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8c290eb9-b632-4975-8de6-16f609493e3c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c61fa01c-f5db-4217-8519-73fc6a275c39_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_662c7605-6f27-45af-824a-a1099be357bf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_96c9f718-039e-43fb-a4bb-56676b0ba822_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_5e685e69-f94c-467f-b484-2781f994cd55_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_10f54f7a-1185-4cc8-8aed-6bcf2d5be5a1_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock premium (as percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:to="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7822ee3b-31d1-4dfb-9892-1b100228a3ab_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_5e20cb37-776f-4a8f-b1b9-b70edd88ff9a_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_3780e2c8-e3e7-425b-a8dd-54c62c936bc7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_023dfd19-8fc0-4847-ac6d-5721cac182fa_terseLabel_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other tax liabilities</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:href="dxcm-20230930.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:to="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4ab86ba-1e87-4123-b1c4-f1fddedfcf6a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_b45febe6-1ba7-4855-99f5-37a1e451d822_terseLabel_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense:</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract" xlink:href="dxcm-20230930.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract" xlink:to="lab_dxcm_NonCashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_41aabcf6-02a8-4478-b302-0a6ada8527a0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities current</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_bc21ce63-277a-4ec7-bdfc-48f7edf5a27d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_1b9e644f-eed9-43a0-af16-47240f6bb271_terseLabel_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB)</link:label>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_label_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB) [Member]</link:label>
    <link:label id="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_documentation_en-US" xlink:label="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of New York Rate (NYFRB)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:href="dxcm-20230930.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:to="lab_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_d938cd2f-376c-4a60-b7e9-16d74c3d3005_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_aada3e3f-e3cd-49fb-8355-99d183adf72f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_9b0a8b56-60bd-4985-858d-e5db0fb219e8_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2025</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2025Member" xlink:to="lab_dxcm_ConvertibleNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_c9a6fa58-32a5-47c3-b512-daf925357747_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a20e080-f2b6-459a-917c-13fb4a9e8bf5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on convertible notes (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_12125141-6e6e-417b-b925-b4eac2b8ca6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_dc58f34f-339e-4daa-9240-cb1eb1d94971_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_9806ac41-88e5-4a4b-a2fe-c620c18108d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6d76c16f-3e9e-43b4-bf49-72c95c7d044d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_8f6e75f6-9c45-4273-9d13-c3fce9146843_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_606dd54a-7146-48b8-808d-1fa66e8e7374_terseLabel_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into or out of Level 3 securities</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_label_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_documentation_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:href="dxcm-20230930.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:to="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4952255d-8ca5-4ae0-b15c-390174927c85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_db7d93d0-f3d6-4e2e-8258-d7896f43645d_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:to="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e72637fe-52f0-44be-b90d-73eae2fa0f88_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_c5c0a974-2b25-4592-bcdd-916541fdfd73_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d515391c-23d7-4cf4-83e0-f5d15c06066d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b0d19376-35e8-49e3-99cd-af1988e5312b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_24e3439f-c9e5-4d16-8fbb-ad1936d95479_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e1dc0473-367b-4d86-8c0c-fca83e4733f5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversions of 2023 Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a694e60f-3516-41aa-96f0-bb1d6bfba9f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and conversions of notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_69fe612f-820f-4a72-872b-2631c6997feb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_dc2adf48-a436-4901-8dad-f269fd7a0509_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d87497b7-0ae1-4dd5-9000-09a77c46eb8b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5341de7c-649d-44bd-a59b-a53002c82f58_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0b3172fc-df4d-441a-8989-27301cb1695d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_5f9ee1ab-9de9-481f-a73e-5d08ae4b40c3_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid inventory</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_label_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_documentation_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent" xlink:href="dxcm-20230930.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidInventoryCurrent" xlink:to="lab_dxcm_PrepaidInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6ede8af8-ba3f-4637-b747-1a650a617d07_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1d9b1534-f7bc-481f-8da3-6478f599b2bd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_39ee294e-1959-4abf-aeb1-e842922dcc21_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total available balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f31066b-a8d1-4bfc-a5f6-519b897343ed_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1bfbbc12-7e3b-4908-a3c7-b1bf845acb8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_fdeca4dd-395f-490d-aa4e-367b75419ce7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_328d5175-9d82-4c04-b55d-2f0a69d4bc5e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_76fb8fa4-0d4b-4749-b0e7-369a8695f852_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_fa5e1e2d-5d14-467d-b749-26cfe7a16af2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0b107bf5-763b-4666-8392-f69facd95cda_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_99b298bd-1f02-4584-978b-b3843bf3acf2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_06cdcf3c-4fa4-44ea-a1c6-b75e88aff012_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_90cb84f0-9a44-47b5-b63c-4cb3d68ffc80_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_1319b659-19e5-423e-acd7-3e8675413876_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e42cdf0-07d1-4271-a879-187cc926c2e7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cf479bc2-f89d-415a-952e-e5225dcfef1b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_20740de3-1df8-48a9-97b2-98afef156e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_c3c53670-cc20-4114-963d-61b1d6498c50_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a1fb6394-ff4a-4a74-9217-ff01a8a9d087_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f72bc8cc-f394-4515-a5b8-4ae8c76632da_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NicholasAugustinosMember_label_en-US" xlink:label="lab_dxcm_NicholasAugustinosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nicholas Augustinos [Member]</link:label>
    <link:label id="lab_dxcm_NicholasAugustinosMember_documentation_en-US" xlink:label="lab_dxcm_NicholasAugustinosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nicholas Augustinos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NicholasAugustinosMember" xlink:href="dxcm-20230930.xsd#dxcm_NicholasAugustinosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NicholasAugustinosMember" xlink:to="lab_dxcm_NicholasAugustinosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f390798a-ddcc-4bae-b86a-9faf5915e369_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5aae5f04-e107-4f6f-a3ed-31d507bc3694_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_7294786b-694e-4776-b9a2-08ec644624a9_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_32acedf5-2c2d-40a9-89b5-d6ef47ae95ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_54c05fdd-1aa8-49e1-8882-af2d96187aae_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4f299d50-8311-4d78-8c0f-1f636843346a_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_5ad28504-2750-4f42-a343-a6dce8885150_terseLabel_en-US" xlink:label="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional patent infringements dropped</link:label>
    <link:label id="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_label_en-US" xlink:label="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Additional Patents Found Not Infringed, Number</link:label>
    <link:label id="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_documentation_en-US" xlink:label="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Additional Patents Found Not Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:to="lab_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f38f90fa-cb9d-44d0-ab97-fd813356dd70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f69df149-7944-49a0-bf69-c996f4546f7e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5e11a9ec-a37a-4b87-9ec4-955519125a3c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_8cc0bf29-af97-48d7-afbb-4fe618943886_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4914b743-1bd6-4de0-a31d-65be1a824c94_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_80489738-13b6-4652-8852-b1ff4082770c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period (in months)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5f717a90-5ff1-4ee4-b371-fe8e9ecaba0c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2c40c9a3-43f6-48c1-acbd-6e6f28bf2ff3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_12c65148-b5ea-4cfb-aafe-50439bc1a833_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_26d2adc5-e22c-4d60-8ff2-7a7ae8b74a3e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_1771f4c2-1a16-4c5e-b592-5d0208d57a59_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of invalidated patents</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Found Not Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_31e5996e-e1fe-4643-a9a5-97d7f96e8c15_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Converted Value of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_20fa24b3-47fb-4ac9-a0ff-0349f0696698_terseLabel_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued tax, audit, and legal fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_label_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Tax Audit And Legal Fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFees_documentation_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:href="dxcm-20230930.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedTaxAuditAndLegalFees" xlink:to="lab_dxcm_AccruedTaxAuditAndLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_cd7f6ae3-2eb5-4357-a4ef-cbe14f23f364_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_7ff770a9-cf8a-4bf1-8037-3a82277c4394_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3f2cb6e6-da05-4b39-95de-41c410177949_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_255f6ce4-5f1e-4853-a47c-9eea5bb24bc4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributor</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_89bfe634-f3c2-45c9-84cc-9cf7bcec0316_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_d2227920-8fab-4773-8347-a2e74be76f8f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of outstanding senior convertible notes:</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_75430397-3d5b-48fa-bdc9-acf8c4160327_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_163f96d6-ba81-4a35-b01d-e313976d6200_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f95a23c2-2e95-4bfe-8b7c-316381a62b17_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12e99002-0f3c-4107-8682-d32c4e92dc29_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e1dda91-e3eb-4b17-a598-642814b80822_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_6cd8c223-e81b-4c71-8abd-7dbef0df55bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized (gain) loss on equity investment</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_6b1af682-2d4d-48ba-a4fb-404473677539_terseLabel_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_label_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures, Senior Convertible Notes [Table]</link:label>
    <link:label id="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_documentation_en-US" xlink:label="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures, Senior Convertible Notes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:to="lab_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_2df06640-7007-4af3-8633-9fcafe125d20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_cfad42cd-292c-4085-be2d-7077e36ce097_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_a0852cd8-19c2-4564-b93b-0c8b55eb4ac9_terseLabel_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember" xlink:href="dxcm-20230930.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareRepurchaseProgramMember" xlink:to="lab_dxcm_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc7d944b-d655-4da3-9416-4e0d24276be1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_4c59e233-3bb4-41db-b0e9-63b586f3c81f_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2023</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2023Member" xlink:to="lab_dxcm_ConvertibleNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_1d241361-997a-4215-99a4-c63a3f2697e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LongTermDeposits_aac12baa-a638-46c5-a0a5-d373e990c379_terseLabel_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_label_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_documentation_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits" xlink:href="dxcm-20230930.xsd#dxcm_LongTermDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LongTermDeposits" xlink:to="lab_dxcm_LongTermDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_95dcb4f9-eac6-4ff1-9d3a-af5dd7c0aa3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, 800.0 million shares authorized; 405.5 million and 386.4 million shares issued and outstanding, respectively, at September&#160;30, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1e34f4a7-e4f2-4148-9245-9417af7e6846_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c04407b9-bc36-4b88-bac3-50603554c756_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total vest date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_d2158f83-e4eb-4fc9-8b7a-d591fa67801e_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_cbb7e3b0-c6d4-411b-a183-481b9240b62c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5e23a83e-348b-4337-9acf-0e919b1b2a09_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c52e572-62cc-433a-bb76-32febeccb5fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5f491378-d91f-424b-8a30-9a81bfc527ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16e0e145-cda0-4f1b-9de5-b5a6914b0c29_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ad2da9bf-e5b3-43f0-9fcc-dd5d921d87a6_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_9171e0b5-d1e7-4356-9461-b12f8d9a0931_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing stock price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4aa61d41-84cb-40d8-96e0-ef04e225dace_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_950cd475-3084-472b-bb98-68b1c2a7eaf2_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_a66a7256-db8a-4faa-9619-6ed8d9c946a2_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial payment on collaborative agreement</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:to="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_7596bfc3-0e65-4311-9b8f-dc0b511b5e4e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_379b2ee1-965d-4e71-962e-c74f684b8331_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_65bee90a-269a-488a-a7a6-465369d6459e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2fbe6e79-62b2-4aec-bd5c-8e1083289828_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_e2ca7330-40f1-41fb-8d54-bcd181da3897_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a0bba713-c234-4523-a92f-5c7d577ae0bc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_f914c2b6-d54c-4386-a46c-21ce0151b0bf_terseLabel_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase revolving line of credit</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_label_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_documentation_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:href="dxcm-20230930.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:to="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_7b744fc9-0b20-4bda-9d53-1b95535de103_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4b0d3175-8bd6-4140-8e02-dc8f6dbef16b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestones</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0c3abad3-ca9f-420d-a3c7-34f3038ddee0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_2399ac39-1584-42ea-8834-62cd045693fe_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_4290aaf8-8b34-4929-9a6c-a6f8b73fdf05_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_5a57620e-2baf-482f-8752-ac4bf27c176b_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RevenuePercentage_07e4ed27-7aa4-46dd-ba89-2b1a5a755b65_terseLabel_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of revenue (as percent)</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_label_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_documentation_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage" xlink:href="dxcm-20230930.xsd#dxcm_RevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenuePercentage" xlink:to="lab_dxcm_RevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_f54a9604-f2d2-4a08-aa4b-3eda7c1fc16c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_87523b74-98f7-433d-af0e-d206d4bd567b_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ba8166aa-9b6e-4a3c-b7af-c7ea8aa67784_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_57cb2730-e86d-4769-9719-13d4e1096d67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_89744080-b43c-4339-87f1-7675cb49c59b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_362a1bb7-316b-45ae-b717-2e39acb444a1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_64d54222-e38c-4294-967f-e6a1971f959d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_73c99a29-5051-4b9b-98b8-e0c692f391ee_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_22a272bd-985a-4291-99d4-ae11d565a3bb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_5d1d4624-9df0-4fca-91ae-213a8f21a5d9_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestone</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:to="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_9a7b89f4-4340-45b8-8e4f-efe5e6635bd1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total by which the notes&#8217; if-converted value exceeds their principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c102aa2-5c3c-401d-9343-1b5ff94061fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4fe52714-7e17-4559-a7dd-bf9ea4b5f947_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d9ef935a-2d81-4e0c-83b3-213e6b52a7b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_f910739c-aaf9-44c2-b610-0ea1dbd77eea_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_a4869ad6-0ddc-4b5b-b208-1e2fc0eb858f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, including excise tax (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_06674a09-33bb-49c6-a1e5-96ac90bdfbd9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_1dc05a7d-08fe-439c-bc4f-7cc398f6a452_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid And Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid And Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:href="dxcm-20230930.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1f0eb8cf-ef5b-4a17-bab2-b37a8d03a3a1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_55221ded-3cb9-46df-9898-c0811704b778_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a31db78a-a467-4b80-8813-47afed38601e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cbfe3db9-6e7c-4a84-bbea-d1507953c342_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_30614fa0-7222-4390-a7e1-e2ca4f98b79f_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_a4f0333a-1834-4a1b-ad43-a427dfddbd91_terseLabel_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims not licensed to</link:label>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_label_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims Counterparty Not Licensed To, Number</link:label>
    <link:label id="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_documentation_en-US" xlink:label="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims Counterparty Not Licensed To, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:to="lab_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_3e717295-27bc-40ca-9f8e-e909dcd69abf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24012470-0c5b-4745-a3ab-d1e885231020_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_999978bb-308c-43da-a7fa-227cbb1f7bf8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_26184aa2-49d5-4a02-90b2-435597f2a2f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_fd3c78ab-c485-4add-a224-a462f3244b94_terseLabel_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_label_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_documentation_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember" xlink:href="dxcm-20230930.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyLifeSciencesMember" xlink:to="lab_dxcm_VerilyLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7401934e-674a-45e8-a062-6e18a9aa51d9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_976c7db0-4bf5-4827-b910-043895b10e51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_92e10da7-3848-42d0-a360-ca2aee451de3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_00a20c43-3e22-4b58-8141-b5ae288110c9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_dfcbb3a7-ef73-423a-a877-8fd568363300_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_4e86a6b9-03c4-4380-b258-8a7b0cea8320_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_a88835a4-3e04-49ae-adbf-3acff2b81f6b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_ccdefb39-5b78-4635-838f-f85470194dc4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior convertible notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_9601efb9-219e-4c82-bc12-83db094ab675_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_15064b53-b84a-45b8-8d7b-92a26b0099ec_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_6b9ab868-c2a2-48d3-be87-44bd7ceec48c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5c201126-7ac9-4687-8ac1-9aff912d7a93_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74d341cf-b887-43f4-a29a-f1a56bfc4064_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_2370b4b6-646a-422b-a459-28f5e1990c2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_db517ae4-7360-4f0e-b82e-4580287e20ca_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_182ba704-28fc-4e1d-9750-f3533d7064a5_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3dd474ce-f2b8-41c0-a308-e08e0d8e3d85_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_96e04d42-1069-49e0-8fab-e1313e5e6ace_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a0f7881-172f-40dd-8914-1343d79d5a37_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_105d2e76-1b9d-4d06-80e5-c6b9e9f93ccf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6f2ab066-f342-4b4c-a4bf-da8235975222_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_e237af7d-d7b6-4791-b21e-f833c0fe58e7_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:to="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_4559a6df-f6ee-4d18-8c5c-04b2321a83a4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_af33ed02-66d4-4fe1-8b34-e40221621991_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8bb275fb-5e3c-45ff-92df-16d89147a01a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute basic net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f8281066-8f41-404a-8659-4242686f6a9f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_817e1ca3-3b3e-4fa6-8bd4-a6761030eacd_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_b7d0b1ed-a6b2-44d7-8540-49e712f1c020_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bc3c0b2d-81fb-4fe2-8e61-d9a02f930bfd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_c3389414-881b-4b40-8227-5477843d3255_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call, cap price (in USD per share)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:to="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ecf49e74-78d4-4aa1-b269-b3f7c91da700_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_417ce267-bf0e-4a44-9a8d-a8d83b857cf4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_fcd0c81e-0dac-4a38-8e70-ed084a065db2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversions of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_571adbc1-2aab-4c65-ad6a-5c8a80c37fe9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_ce9b1da4-a03c-4a42-b9a9-2b34da43675a_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2028</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2028 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2028Member" xlink:to="lab_dxcm_ConvertibleNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_b5242bb4-a063-4a89-b688-c0fcc26d7e2d_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_fb6c584a-f788-437d-b5f5-45212b7467f7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_1ceafa8a-83f6-4088-8fd8-fc5931b37066_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1d9f04c2-027b-49f8-82b6-bd04ecadf9cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_2f7b3e6b-2a42-401c-8469-dac9e72c7762_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_4b79c139-c080-4154-92cd-d4d0c1338a5c_terseLabel_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received under note hedge upon conversion of 2023 Notes</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_label_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_documentation_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:href="dxcm-20230930.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:to="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dxcm-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:78f2f0f2-9626-4e08-b84b-64296ff62679,g:1dec24e5-6bd9-4b0a-a941-1a79d6d5d163-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/Cover" xlink:type="simple" xlink:href="dxcm-20230930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_123ae0f3-a889-45ff-bca8-da0049a876c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentType_123ae0f3-a889-45ff-bca8-da0049a876c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3978ee59-50cb-446f-b6a7-ba3c13865675" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentQuarterlyReport_3978ee59-50cb-446f-b6a7-ba3c13865675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0d1fdea3-19f7-4a7f-8ed7-a27e44212bfc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentPeriodEndDate_0d1fdea3-19f7-4a7f-8ed7-a27e44212bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2b0eba8c-8add-4a8b-9f82-18b4e033682a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentTransitionReport_2b0eba8c-8add-4a8b-9f82-18b4e033682a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_976fd4d7-9af2-432e-96c5-d5426b39fcc0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityFileNumber_976fd4d7-9af2-432e-96c5-d5426b39fcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_367cd95f-e24c-4b43-98b8-d9ebabaefc2b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityRegistrantName_367cd95f-e24c-4b43-98b8-d9ebabaefc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3a76098e-f4b2-4afc-bd53-155c306e7e36" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3a76098e-f4b2-4afc-bd53-155c306e7e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d4dd02c4-5364-4494-81f1-2874af997fa7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityTaxIdentificationNumber_d4dd02c4-5364-4494-81f1-2874af997fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3730678a-47a9-4460-92b3-407dbe8fab6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityAddressAddressLine1_3730678a-47a9-4460-92b3-407dbe8fab6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_48d632cc-26a5-4f32-8d8a-c6d5484d3c1e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityAddressCityOrTown_48d632cc-26a5-4f32-8d8a-c6d5484d3c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_52c59206-546e-491e-aafd-bf135ebb6d29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityAddressStateOrProvince_52c59206-546e-491e-aafd-bf135ebb6d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4ea7f8b2-008b-4ee4-b784-a4cfa0149807" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityAddressPostalZipCode_4ea7f8b2-008b-4ee4-b784-a4cfa0149807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d3a60191-0d0a-4029-a451-6baf59df2a54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_CityAreaCode_d3a60191-0d0a-4029-a451-6baf59df2a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_78c6994c-e4c3-4ff4-a105-425354cb526c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_LocalPhoneNumber_78c6994c-e4c3-4ff4-a105-425354cb526c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_208859b3-316b-4de9-a155-4d7a44fe8690" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_Security12bTitle_208859b3-316b-4de9-a155-4d7a44fe8690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_03061a7c-7703-429e-8182-507d7b43152e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_TradingSymbol_03061a7c-7703-429e-8182-507d7b43152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9ce4071c-e812-4c84-a391-f1029ff81334" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_SecurityExchangeName_9ce4071c-e812-4c84-a391-f1029ff81334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_07a653ae-6726-4722-9be6-d2913db308d5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityCurrentReportingStatus_07a653ae-6726-4722-9be6-d2913db308d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_21887bc7-8552-4626-a0ce-d91d0285e1c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityInteractiveDataCurrent_21887bc7-8552-4626-a0ce-d91d0285e1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b0a26a54-9bdf-4904-954f-f649a7e9fa10" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityFilerCategory_b0a26a54-9bdf-4904-954f-f649a7e9fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9b4256d5-fbf3-4b00-b260-cedaed1770a6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntitySmallBusiness_9b4256d5-fbf3-4b00-b260-cedaed1770a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6306a5e8-93b5-4ca3-8652-056ead799d25" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityEmergingGrowthCompany_6306a5e8-93b5-4ca3-8652-056ead799d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_14bc62b2-6ee1-4168-9fe2-d193d7aaf6fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityShellCompany_14bc62b2-6ee1-4168-9fe2-d193d7aaf6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7cd0bf40-6aaa-4faf-9f95-4103bd203801" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7cd0bf40-6aaa-4faf-9f95-4103bd203801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_24ee7e57-dd7d-47f4-9d23-5d91863d4233" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_AmendmentFlag_24ee7e57-dd7d-47f4-9d23-5d91863d4233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_c40dddbb-7a10-4a05-93a3-bd3e0409ffb1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentFiscalYearFocus_c40dddbb-7a10-4a05-93a3-bd3e0409ffb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_16c176df-d5d8-4f46-8b74-7b0fc6d02336" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_16c176df-d5d8-4f46-8b74-7b0fc6d02336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_02290180-271f-4037-957f-c3506f78f9e5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_EntityCentralIndexKey_02290180-271f-4037-957f-c3506f78f9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e96dd9e5-89d7-41dd-acb1-916848892834" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c80e7b7-6043-472e-aeb8-03da47477b6d" xlink:to="loc_dei_CurrentFiscalYearEndDate_e96dd9e5-89d7-41dd-acb1-916848892834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e177f335-bb7e-4d6c-9f66-56d6e15a0091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e177f335-bb7e-4d6c-9f66-56d6e15a0091" xlink:to="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8058613-0011-4b0b-97c9-e7c311a0fef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8058613-0011-4b0b-97c9-e7c311a0fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_e60f44f9-134c-4c81-b219-012e97550854" xlink:href="dxcm-20230930.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_e60f44f9-134c-4c81-b219-012e97550854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c1d87097-bd78-4d0b-8b31-0181c557a5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c1d87097-bd78-4d0b-8b31-0181c557a5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9e4bc801-9c72-48e2-9fb8-c56e5cf2e394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_us-gaap_InventoryNet_9e4bc801-9c72-48e2-9fb8-c56e5cf2e394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0d37a132-63cf-452e-b499-dc87ddf295b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0d37a132-63cf-452e-b499-dc87ddf295b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e083564e-255a-4519-9c12-73964d3b592f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c0e30917-71cf-48cf-85ea-f09062f5955e" xlink:to="loc_us-gaap_AssetsCurrent_e083564e-255a-4519-9c12-73964d3b592f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_03245ea0-a607-417b-80f2-4adc8fd09cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_03245ea0-a607-417b-80f2-4adc8fd09cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_67c118d0-e1fe-4af7-bfb1-6511dbade0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_67c118d0-e1fe-4af7-bfb1-6511dbade0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52cb3b61-1870-4579-a3c6-8c48276f6984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_Goodwill_52cb3b61-1870-4579-a3c6-8c48276f6984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4861d4c-c568-4a3b-81db-44d2fbc5e6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4861d4c-c568-4a3b-81db-44d2fbc5e6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_42a426e2-1633-4cf9-b61a-b1d26b2d4106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_42a426e2-1633-4cf9-b61a-b1d26b2d4106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8871b159-3637-4343-a2d1-bc422c89aa42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8871b159-3637-4343-a2d1-bc422c89aa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5b3ad9ed-8c36-41af-a4c8-70b2bbb4d62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1fbf8d81-6763-44ff-b2e3-7246867e9b32" xlink:to="loc_us-gaap_Assets_5b3ad9ed-8c36-41af-a4c8-70b2bbb4d62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e177f335-bb7e-4d6c-9f66-56d6e15a0091" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1032e887-6c0a-44d8-a13d-f56fecdb413e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1032e887-6c0a-44d8-a13d-f56fecdb413e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d67da52-03a9-414e-9a5c-507ebadbe200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d67da52-03a9-414e-9a5c-507ebadbe200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_2e1f9058-fdd7-45e7-b83f-accc5b18c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_2e1f9058-fdd7-45e7-b83f-accc5b18c63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_709a732e-6642-4390-9c70-3c7471f92d89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_709a732e-6642-4390-9c70-3c7471f92d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9846c711-61b3-4ccc-a927-6c5a50130d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9846c711-61b3-4ccc-a927-6c5a50130d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b8c48663-9a2f-45cc-aafb-060b48bc45cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2d3cf755-6b6a-47f2-8ff9-344c9d20a83d" xlink:to="loc_us-gaap_LiabilitiesCurrent_b8c48663-9a2f-45cc-aafb-060b48bc45cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_5f15e584-1444-4060-887a-f14617d71a91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_5f15e584-1444-4060-887a-f14617d71a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_70d30fd8-7eb6-456f-8ec9-36d0a51fc837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_70d30fd8-7eb6-456f-8ec9-36d0a51fc837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c2f5788c-2592-4746-aaa4-9fca8f06aaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c2f5788c-2592-4746-aaa4-9fca8f06aaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_aa3b648f-31d0-4fa3-95d4-d5db9ac98061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_Liabilities_aa3b648f-31d0-4fa3-95d4-d5db9ac98061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a0292183-74cd-4e30-9c2e-bc7910f98a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a0292183-74cd-4e30-9c2e-bc7910f98a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_7852d67c-38f9-444e-8adc-a0cce8a60cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_7852d67c-38f9-444e-8adc-a0cce8a60cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_afd2f86a-b842-4349-a9d2-f7adb9409a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_CommonStockValueOutstanding_afd2f86a-b842-4349-a9d2-f7adb9409a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62bd1778-1fa5-4c99-b55c-6e2fbe073417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62bd1778-1fa5-4c99-b55c-6e2fbe073417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_431c168d-5171-4210-895e-48746ab1876d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_431c168d-5171-4210-895e-48746ab1876d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_df3a7dc1-b108-48ee-95b7-2ef26ebbcd36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_df3a7dc1-b108-48ee-95b7-2ef26ebbcd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_6d1277e4-af60-41c6-8892-47098c3c95c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_TreasuryStockCommonValue_6d1277e4-af60-41c6-8892-47098c3c95c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fe82798-aeb3-474c-8ca8-20f8bc136277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e84a28-a3b2-4465-86f2-9f617e51382a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fe82798-aeb3-474c-8ca8-20f8bc136277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d885643f-f1e6-47c6-8e3b-6a8e421530a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_04faedd0-f6d6-4e0d-b91e-659a78e6e9ae" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d885643f-f1e6-47c6-8e3b-6a8e421530a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_71ab1a7c-201c-493f-887a-28a3155e33bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_71ab1a7c-201c-493f-887a-28a3155e33bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_58a599ee-4e2c-43a3-a346-b48182b3ab2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_58a599ee-4e2c-43a3-a346-b48182b3ab2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_73c63b5f-46d8-4a94-8744-7cafb85d7da3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_PreferredStockSharesIssued_73c63b5f-46d8-4a94-8744-7cafb85d7da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f9074939-3255-4d5d-9393-ad89c60e8e43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f9074939-3255-4d5d-9393-ad89c60e8e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_98ad0ad5-61ed-4fc2-ac2d-52bf2c724188" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_98ad0ad5-61ed-4fc2-ac2d-52bf2c724188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4d048ac4-b875-47eb-b2a6-ff2de6b77497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4d048ac4-b875-47eb-b2a6-ff2de6b77497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_39aed6fe-a6c3-41e2-b365-6484e573c065" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_CommonStockSharesIssued_39aed6fe-a6c3-41e2-b365-6484e573c065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a86db4c4-e31e-4558-ba15-b3e6ac5649d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a86db4c4-e31e-4558-ba15-b3e6ac5649d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_092eab29-3552-42ec-b54e-50070a10650a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c229330d-24a2-407c-a95a-6cf94a8831cd" xlink:to="loc_us-gaap_TreasuryStockCommonShares_092eab29-3552-42ec-b54e-50070a10650a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97dd8a0c-dc75-49a6-8668-d00adae755d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97dd8a0c-dc75-49a6-8668-d00adae755d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_114d16d9-882a-4005-af01-ee994d7bc8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_114d16d9-882a-4005-af01-ee994d7bc8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8934678d-f8fd-436c-a2cc-b163e215e74f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_GrossProfit_8934678d-f8fd-436c-a2cc-b163e215e74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fcfd5fc0-7d84-47a6-a682-9c102da78d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fcfd5fc0-7d84-47a6-a682-9c102da78d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e6c3c1c3-6ae9-4a1f-b7d8-a0cbe11793e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e6c3c1c3-6ae9-4a1f-b7d8-a0cbe11793e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_747d908e-8f78-4423-96f9-db5e5b45f118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_747d908e-8f78-4423-96f9-db5e5b45f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_87ed2367-3f30-470c-b9ee-ba15dafdec70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_adfa00e2-f4a8-4528-92fe-e9e9e979c477" xlink:to="loc_us-gaap_OperatingExpenses_87ed2367-3f30-470c-b9ee-ba15dafdec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2f3e344e-0814-4089-a589-189652d9f6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_OperatingIncomeLoss_2f3e344e-0814-4089-a589-189652d9f6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_493eef2c-e881-4c7c-a2d8-7d50063f149d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_493eef2c-e881-4c7c-a2d8-7d50063f149d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eb7613f9-66dd-4310-93bd-7c5ddbb20364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eb7613f9-66dd-4310-93bd-7c5ddbb20364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1534694b-56f0-4b84-a777-aad2daa6fd38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1534694b-56f0-4b84-a777-aad2daa6fd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_704798d3-3012-446b-9d40-3e0ca1a18487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_704798d3-3012-446b-9d40-3e0ca1a18487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ce409822-fadc-418b-a118-503ff0330718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_NetIncomeLoss_ce409822-fadc-418b-a118-503ff0330718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_50a93bf3-1de1-4b91-9bae-8b263f97112d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_EarningsPerShareBasic_50a93bf3-1de1-4b91-9bae-8b263f97112d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04c9115f-77b9-4a6c-972f-4faa840897c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04c9115f-77b9-4a6c-972f-4faa840897c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e5845b55-10f8-4713-9a3a-a78fd3eac96b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e5845b55-10f8-4713-9a3a-a78fd3eac96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_868d6a36-c1a8-44d3-b207-5faa88ae85fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fca265ed-8802-4680-9d1c-7bfc15c6f5ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_868d6a36-c1a8-44d3-b207-5faa88ae85fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d20d9f5c-3d47-4ff8-8705-168ac4824eae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_442e4c3b-1cff-4f32-816e-6df25ea488db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d20d9f5c-3d47-4ff8-8705-168ac4824eae" xlink:to="loc_us-gaap_NetIncomeLoss_442e4c3b-1cff-4f32-816e-6df25ea488db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_792d3133-62ce-4d96-91af-370c56be063c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d20d9f5c-3d47-4ff8-8705-168ac4824eae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_792d3133-62ce-4d96-91af-370c56be063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6c1f37aa-99ca-4cab-9803-1cf75ff94030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_792d3133-62ce-4d96-91af-370c56be063c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6c1f37aa-99ca-4cab-9803-1cf75ff94030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9cc0204c-c1ee-416d-89e9-364e0542ae45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_792d3133-62ce-4d96-91af-370c56be063c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9cc0204c-c1ee-416d-89e9-364e0542ae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9baa30e2-0d01-4a22-a1ab-d635ca1038ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_792d3133-62ce-4d96-91af-370c56be063c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9baa30e2-0d01-4a22-a1ab-d635ca1038ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_82db456e-8711-453a-89a6-10b9aca3d1af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d20d9f5c-3d47-4ff8-8705-168ac4824eae" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_82db456e-8711-453a-89a6-10b9aca3d1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d61e47a9-155e-4550-b330-9209dbc92eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d61e47a9-155e-4550-b330-9209dbc92eac" xlink:to="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_89db7a5f-0c60-43e1-8709-c30474717f33" xlink:to="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1ffdd0c1-a2cd-47c9-b207-ec6ab4a72789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_CommonStockMember_1ffdd0c1-a2cd-47c9-b207-ec6ab4a72789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_440ca1f1-ed1b-4a61-8f1c-602973aa7927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_440ca1f1-ed1b-4a61-8f1c-602973aa7927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2f8e267f-9ed5-4c06-892d-0309dc9c3f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2f8e267f-9ed5-4c06-892d-0309dc9c3f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8c9f60df-3ca7-4ffd-8194-6cf10ccb6fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_RetainedEarningsMember_8c9f60df-3ca7-4ffd-8194-6cf10ccb6fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_73f7facd-5bda-4829-adc4-2e6b8bc2b728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5290f5bd-764d-4aea-9e0c-ccec67a56602" xlink:to="loc_us-gaap_TreasuryStockCommonMember_73f7facd-5bda-4829-adc4-2e6b8bc2b728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6ccf1d1b-7294-4b0d-af10-a7695cfcb9f2" xlink:to="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0384dede-d7fd-4e73-bdee-e0220f830a36" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_124a8484-a396-4c2a-a0a1-e9ace9207217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_124a8484-a396-4c2a-a0a1-e9ace9207217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_36bc4bbe-deb2-46b5-a2c6-26979786923d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockholdersEquity_36bc4bbe-deb2-46b5-a2c6-26979786923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_04d0c657-39cc-4b71-97c4-4a8f5db54b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_04d0c657-39cc-4b71-97c4-4a8f5db54b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_55dc8127-ebbc-4ce8-891d-1392f1c738f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_55dc8127-ebbc-4ce8-891d-1392f1c738f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_64ed16d4-adfd-478d-9d7e-ab6197fe54f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_64ed16d4-adfd-478d-9d7e-ab6197fe54f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_cde472d7-e739-495b-a8d2-cb1b63f06cb7" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_cde472d7-e739-495b-a8d2-cb1b63f06cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_4670a2b0-850f-4fe2-908d-9cbdcdf6dd92" xlink:href="dxcm-20230930.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone_4670a2b0-850f-4fe2-908d-9cbdcdf6dd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9a280d79-f096-4942-b6dc-b8fd450b5526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9a280d79-f096-4942-b6dc-b8fd450b5526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_df45e524-424d-40bc-ae40-b0fc278ceab4" xlink:href="dxcm-20230930.xsd#dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment_df45e524-424d-40bc-ae40-b0fc278ceab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_91d36395-7424-400c-8fe1-11099fc8e967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_91d36395-7424-400c-8fe1-11099fc8e967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_45c40c80-8ec5-49f3-8690-4c31f04cff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_45c40c80-8ec5-49f3-8690-4c31f04cff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6b730ab5-79d4-418a-aac2-2a3236ed6699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6b730ab5-79d4-418a-aac2-2a3236ed6699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_0c4129b4-266c-4d6d-869b-c0200adb4b63" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_0c4129b4-266c-4d6d-869b-c0200adb4b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_0efc82e7-e011-4902-a8a1-d844ff1e22be" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedgeValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue_0efc82e7-e011-4902-a8a1-d844ff1e22be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_8159d9d7-b691-4e9d-9a58-12780d163dfa" xlink:href="dxcm-20230930.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_8159d9d7-b691-4e9d-9a58-12780d163dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fa58699-5af3-4570-a0c7-48055bf925fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fa58699-5af3-4570-a0c7-48055bf925fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a77a6395-5f12-40bb-b810-75ca48054d56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_NetIncomeLoss_a77a6395-5f12-40bb-b810-75ca48054d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_186a109c-7604-4fe8-bc3e-dc93f981103d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_186a109c-7604-4fe8-bc3e-dc93f981103d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6ddeff3d-1b5f-43b3-a49f-f93230509a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6ddeff3d-1b5f-43b3-a49f-f93230509a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c9e64cc9-f178-43dc-84b6-9e34b5fe45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_924f628c-302a-43dd-a76e-a26dfb85f018" xlink:to="loc_us-gaap_StockholdersEquity_c9e64cc9-f178-43dc-84b6-9e34b5fe45b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_31e5d489-6f0b-4852-8b5d-383d8cdd8585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:to="loc_us-gaap_NetIncomeLoss_31e5d489-6f0b-4852-8b5d-383d8cdd8585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8e055dff-dc19-480a-99c8-f2dd5f47379d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8e055dff-dc19-480a-99c8-f2dd5f47379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e0f20bfd-1a57-4930-ac55-d56544906051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_ShareBasedCompensation_e0f20bfd-1a57-4930-ac55-d56544906051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_30265448-10da-4ba5-b569-7d4c4b839288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_PaidInKindInterest_30265448-10da-4ba5-b569-7d4c4b839288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_f02c13cb-eab2-446f-8634-217101f22269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_f02c13cb-eab2-446f-8634-217101f22269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed4764b7-687d-4182-9d48-b944ca8f1140" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed4764b7-687d-4182-9d48-b944ca8f1140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f9a19685-ad67-4191-9adb-9ced075f87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d280a20a-316f-4afb-94cf-03a52b979e1a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f9a19685-ad67-4191-9adb-9ced075f87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6f8c7423-992a-49b3-bee1-0a9c2fe803c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6f8c7423-992a-49b3-bee1-0a9c2fe803c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_dfb558fb-2d11-4d68-b0eb-ee9aaa86c256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_dfb558fb-2d11-4d68-b0eb-ee9aaa86c256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9755675a-32ab-45a3-a35e-7fb8c92ccdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9755675a-32ab-45a3-a35e-7fb8c92ccdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_6bca1478-1136-4322-aec4-006ba08478a6" xlink:href="dxcm-20230930.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_6bca1478-1136-4322-aec4-006ba08478a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9673a87e-f5e0-464f-b437-b33d4e51c482" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9673a87e-f5e0-464f-b437-b33d4e51c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f38fecd6-e3a5-4ccc-82f1-9339f3f04bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f38fecd6-e3a5-4ccc-82f1-9339f3f04bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_b4a39e05-c40d-4261-93e3-9b93f5166468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b0ee3dd8-0c5d-4a43-8547-4d618f7b3df8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_b4a39e05-c40d-4261-93e3-9b93f5166468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aae294ac-8c98-4892-8695-cd8b2bc611a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b217b4f0-be14-420b-9a79-0bd186cf4709" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aae294ac-8c98-4892-8695-cd8b2bc611a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d5415d75-a006-4bff-aa71-3566f4fb2780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d5415d75-a006-4bff-aa71-3566f4fb2780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2b3eb525-bb54-4e2d-8176-5f0130008ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2b3eb525-bb54-4e2d-8176-5f0130008ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a05e774-4cb4-48f1-9dbe-d4119beebeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a05e774-4cb4-48f1-9dbe-d4119beebeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_750e0671-27ad-4133-ba76-3113397d090e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_750e0671-27ad-4133-ba76-3113397d090e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e464ea95-439e-4a2f-a91f-14c7dfc48b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e464ea95-439e-4a2f-a91f-14c7dfc48b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c82deaa-b042-4c63-920b-94e5b8fb0610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f594065-d634-42bd-8399-404439bb0ab4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c82deaa-b042-4c63-920b-94e5b8fb0610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_eb328f88-6497-42b1-9e17-d0ac7254bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_eb328f88-6497-42b1-9e17-d0ac7254bfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_eb81cca0-b68c-4f0f-9b98-89be27626cce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_eb81cca0-b68c-4f0f-9b98-89be27626cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f07348bf-5527-4137-b414-90d94bbc0eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f07348bf-5527-4137-b414-90d94bbc0eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_9012873e-9d39-4867-8206-2fce9e810703" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_9012873e-9d39-4867-8206-2fce9e810703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_b00aff6e-d725-4086-b188-dc235dcd7186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_b00aff6e-d725-4086-b188-dc235dcd7186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f63ed0e4-1833-441b-a829-adb3838749b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f63ed0e4-1833-441b-a829-adb3838749b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bfe0fec4-c284-4d4b-8c53-11324a49b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61b786d9-4681-4927-aa51-76e63379377d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bfe0fec4-c284-4d4b-8c53-11324a49b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_08274585-530f-40b9-8fb0-9487797d014c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_08274585-530f-40b9-8fb0-9487797d014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b0467ce-a8d8-44e7-a175-e7c45ad49ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b0467ce-a8d8-44e7-a175-e7c45ad49ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb0af68e-6dad-45d6-99f6-2820a0a4ab92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb0af68e-6dad-45d6-99f6-2820a0a4ab92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17684c8f-0e3c-4392-a9f1-a48c6a90d72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17684c8f-0e3c-4392-a9f1-a48c6a90d72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f65ac9ef-e660-4b66-a7ed-022d3a0af106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f65ac9ef-e660-4b66-a7ed-022d3a0af106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_249f04d1-5f87-476f-a9d1-ed3a88cfba9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f65ac9ef-e660-4b66-a7ed-022d3a0af106" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_249f04d1-5f87-476f-a9d1-ed3a88cfba9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_e85b9166-7e70-46c2-85bb-1bbc8c08b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f65ac9ef-e660-4b66-a7ed-022d3a0af106" xlink:to="loc_us-gaap_RestrictedCash_e85b9166-7e70-46c2-85bb-1bbc8c08b12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f2c7b7e-6f5e-4c6d-99e5-6d03154ec6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f65ac9ef-e660-4b66-a7ed-022d3a0af106" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f2c7b7e-6f5e-4c6d-99e5-6d03154ec6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_79d567fc-7020-48d8-b658-87f69b253d99" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_91d80644-e52f-426a-b903-02d36f074759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_91d80644-e52f-426a-b903-02d36f074759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_18231de0-7cf8-4769-b0d7-9b238a810eff" xlink:href="dxcm-20230930.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:to="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_18231de0-7cf8-4769-b0d7-9b238a810eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e6886865-0dfa-419a-a9a2-752c889efaab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e6886865-0dfa-419a-a9a2-752c889efaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_3b939700-91d8-4251-ad75-9f682e69ff03" xlink:href="dxcm-20230930.xsd#dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:to="loc_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet_3b939700-91d8-4251-ad75-9f682e69ff03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6df8237d-27a9-4af2-8a8d-72039df62b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b51b2a85-1e57-4d2d-96d4-f435ea3eb040" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6df8237d-27a9-4af2-8a8d-72039df62b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_730fd933-84a2-44a5-ba3e-c4103d75af53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_66382dd4-9dd2-4d74-a985-05f9c6f05f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_730fd933-84a2-44a5-ba3e-c4103d75af53" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_66382dd4-9dd2-4d74-a985-05f9c6f05f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DevelopmentandOtherAgreements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_832cc7dc-6b81-4619-8744-2eba71d057b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_38140372-0691-4057-8d9a-43007cbb23b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_832cc7dc-6b81-4619-8744-2eba71d057b9" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_38140372-0691-4057-8d9a-43007cbb23b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_237d6f8a-010b-4c08-8b52-3702793a88cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_e496d84f-ab67-4d2d-9628-988d137096d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_237d6f8a-010b-4c08-8b52-3702793a88cc" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_e496d84f-ab67-4d2d-9628-988d137096d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd9521d9-1ade-4772-8da7-5956ab88e74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_8a0d3356-2ee0-49db-ad80-74ff9cfac189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd9521d9-1ade-4772-8da7-5956ab88e74c" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_8a0d3356-2ee0-49db-ad80-74ff9cfac189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20230930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4606d1b5-4a0f-4611-9935-37fa4503c57b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_302265b3-a474-4e66-9077-9002b791586e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4606d1b5-4a0f-4611-9935-37fa4503c57b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_302265b3-a474-4e66-9077-9002b791586e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20230930.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_378cbf9a-80b8-4b2b-8199-8a20f3d59ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_ffaa6583-5840-4b62-b91f-3c6ead38a2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_378cbf9a-80b8-4b2b-8199-8a20f3d59ca6" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_ffaa6583-5840-4b62-b91f-3c6ead38a2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20230930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c739a29-0f1f-4591-9925-759ece42d877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0f404ab6-e9dd-4fff-b873-eb9d7f037443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c739a29-0f1f-4591-9925-759ece42d877" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0f404ab6-e9dd-4fff-b873-eb9d7f037443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquity" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_631df113-c6c2-468f-8cfe-141441469cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d3128927-7ae8-43c0-88b7-923364578518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_631df113-c6c2-468f-8cfe-141441469cc6" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d3128927-7ae8-43c0-88b7-923364578518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BusinessSegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_972ae734-1edc-44d1-a802-2353800f85d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_36723ab1-9bf6-44aa-83fc-1b73f4198451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_972ae734-1edc-44d1-a802-2353800f85d2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_36723ab1-9bf6-44aa-83fc-1b73f4198451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SubsequentEvents" xlink:type="simple" xlink:href="dxcm-20230930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_8cddd503-a74c-43e3-a7c7-14855530de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_0a4a5ab5-7206-4ae9-96f9-83cfd93396e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_8cddd503-a74c-43e3-a7c7-14855530de6e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_0a4a5ab5-7206-4ae9-96f9-83cfd93396e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92bee84a-6ba0-4de4-9ed9-fcb8ac3a9575" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92bee84a-6ba0-4de4-9ed9-fcb8ac3a9575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_1ea97826-f620-46e9-8144-4816cfc15165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_1ea97826-f620-46e9-8144-4816cfc15165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a2ea3bfe-b58a-4e25-9b70-882e5314c87d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_UseOfEstimates_a2ea3bfe-b58a-4e25-9b70-882e5314c87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_c6e874d4-e66f-4491-b93d-2398176f8247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_c6e874d4-e66f-4491-b93d-2398176f8247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d6a49780-118d-4f7f-a0c9-d7c858a080c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d6a49780-118d-4f7f-a0c9-d7c858a080c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_ff2235e6-48c2-482c-8fdd-dc7d88217c11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_ff2235e6-48c2-482c-8fdd-dc7d88217c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f43c76f1-a70a-4cf9-a0a7-bcddebcb9765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd30d4d3-553f-44f6-810c-a1290a3987d6" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f43c76f1-a70a-4cf9-a0a7-bcddebcb9765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6252641f-8b46-4b05-83a3-434d6b2b898b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d13bb7de-3dce-4a31-b5da-32ccab7aaeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6252641f-8b46-4b05-83a3-434d6b2b898b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d13bb7de-3dce-4a31-b5da-32ccab7aaeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c9d0a642-beb6-4ef0-a109-f11cce1da7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6252641f-8b46-4b05-83a3-434d6b2b898b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c9d0a642-beb6-4ef0-a109-f11cce1da7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46b9b061-ff0a-41e7-878e-b73b73613bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_aa74c8ca-3dbe-4c2d-84cb-5a788ce91d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46b9b061-ff0a-41e7-878e-b73b73613bbb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_aa74c8ca-3dbe-4c2d-84cb-5a788ce91d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_8b0c8266-606a-4316-ab4a-b79249561e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46b9b061-ff0a-41e7-878e-b73b73613bbb" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_8b0c8266-606a-4316-ab4a-b79249561e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_72ce0a96-66e4-494c-a2b1-4e86f643a7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_72ce0a96-66e4-494c-a2b1-4e86f643a7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_8c32c9bf-35d1-4280-8637-0efedfd1434a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_8c32c9bf-35d1-4280-8637-0efedfd1434a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_29e0acbb-75dc-441e-8ce7-59a388d6ccce" xlink:href="dxcm-20230930.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_29e0acbb-75dc-441e-8ce7-59a388d6ccce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9f8315f0-4d72-4a8c-a66a-992aae5856d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9f8315f0-4d72-4a8c-a66a-992aae5856d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_436c3852-532f-4064-95b4-f9ee9adfeec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_436c3852-532f-4064-95b4-f9ee9adfeec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5a92e187-42e6-4261-bc51-3734c9dd3cee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5a92e187-42e6-4261-bc51-3734c9dd3cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_c739900b-b0fb-442d-ac16-3ebd7c7f75d1" xlink:href="dxcm-20230930.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_c739900b-b0fb-442d-ac16-3ebd7c7f75d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_d9a388dc-b45c-4a22-a5c3-a92659b080d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_d9a388dc-b45c-4a22-a5c3-a92659b080d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_9db64b0f-192d-4dd9-ba59-e8d07987c204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6688bcf0-8e43-4ecd-9832-210ae289025b" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_9db64b0f-192d-4dd9-ba59-e8d07987c204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_de57416d-114f-4b2b-b4bb-941dda804354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9160db4e-790c-4196-97e7-96491cb38708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de57416d-114f-4b2b-b4bb-941dda804354" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9160db4e-790c-4196-97e7-96491cb38708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_e1213926-ec44-4366-93f2-1c487a06fb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de57416d-114f-4b2b-b4bb-941dda804354" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_e1213926-ec44-4366-93f2-1c487a06fb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_8474cf5f-97e6-4ca4-8c7e-2c0d23f3ccdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de57416d-114f-4b2b-b4bb-941dda804354" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_8474cf5f-97e6-4ca4-8c7e-2c0d23f3ccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_8e909068-a355-498a-a02a-eff8ae485d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de57416d-114f-4b2b-b4bb-941dda804354" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_8e909068-a355-498a-a02a-eff8ae485d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba80ee7d-992c-42a2-8135-ea3b19809dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_17504cef-989d-4378-bd7e-1d110679179b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba80ee7d-992c-42a2-8135-ea3b19809dac" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_17504cef-989d-4378-bd7e-1d110679179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_db4272e7-ed14-4641-b11f-34124ee0d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a109308f-c59f-4e6f-bafe-7b28a080cc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_db4272e7-ed14-4641-b11f-34124ee0d8b6" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a109308f-c59f-4e6f-bafe-7b28a080cc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_aa4ccad9-410b-43b4-9d5e-19999bcd4e50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_db4272e7-ed14-4641-b11f-34124ee0d8b6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_aa4ccad9-410b-43b4-9d5e-19999bcd4e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8f521c5-b04f-4080-8739-b5fd1992882b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8f521c5-b04f-4080-8739-b5fd1992882b" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:to="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd2e5b76-eb18-43b2-a684-e2b4fcd60eba" xlink:to="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4e5d0f7-203b-4100-9198-70a826e82655" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:to="loc_srt_MinimumMember_e4e5d0f7-203b-4100-9198-70a826e82655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15766a5f-7390-4f08-bbe7-606a4f9d1900" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4c85e2a-c5b7-47a1-8ecb-fd25ce8efb1a" xlink:to="loc_srt_MaximumMember_15766a5f-7390-4f08-bbe7-606a4f9d1900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:href="dxcm-20230930.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_11f47859-49d5-4830-b2aa-11216a4954cc" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7f672656-f352-4cbb-b64f-fb63df7e6841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_7f672656-f352-4cbb-b64f-fb63df7e6841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50bd8a06-8465-460a-be85-451a79bfcfa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50bd8a06-8465-460a-be85-451a79bfcfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_2559824f-dadb-40e7-9ee9-76ffa85c68b4" xlink:href="dxcm-20230930.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_2559824f-dadb-40e7-9ee9-76ffa85c68b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_65ac61a6-035a-4078-852e-f3b80e8286b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_UnbilledContractsReceivable_65ac61a6-035a-4078-852e-f3b80e8286b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f592368b-cf6a-4b07-a69d-aece174dfe63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7821dd15-91d0-44b9-9f79-0a73e2f72b5f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f592368b-cf6a-4b07-a69d-aece174dfe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a93701e6-9032-4a5d-9e96-5cb1f99b46d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a93701e6-9032-4a5d-9e96-5cb1f99b46d9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da976eee-bd84-4264-a836-af3f27b14f6c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4db4b137-d434-4351-b941-732c6f8969d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4db4b137-d434-4351-b941-732c6f8969d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_77c10201-0607-4b3a-8e63-48fe81b231a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_WarrantMember_77c10201-0607-4b3a-8e63-48fe81b231a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_277a300a-eda3-4c24-9ad9-6cca7ef2c313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_304d3c5c-3c02-4727-9924-1b81c677ea74" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_277a300a-eda3-4c24-9ad9-6cca7ef2c313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5c7647b2-05eb-4648-af98-61e9405fa361" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_400c483d-77cf-4466-a664-a08bc2844aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_NetIncomeLoss_400c483d-77cf-4466-a664-a08bc2844aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_80dcf941-1dab-419d-aa24-7748ce37e393" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_80dcf941-1dab-419d-aa24-7748ce37e393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_3cb9dfb0-3904-477e-b1ca-c7a843bf83b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_3cb9dfb0-3904-477e-b1ca-c7a843bf83b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_18378c58-1fce-43fc-9c82-d527b859d50b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:to="loc_us-gaap_EarningsPerShareBasic_18378c58-1fce-43fc-9c82-d527b859d50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5283ebed-e905-4b7a-ba03-a08035c79e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df2b53c5-a9c9-480c-aed7-1023aa3e2139" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5283ebed-e905-4b7a-ba03-a08035c79e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4c26977-883e-49f9-8388-3103dbddfef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4c26977-883e-49f9-8388-3103dbddfef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_51f6bfc2-d56b-4244-991d-e92bfcea902d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_51f6bfc2-d56b-4244-991d-e92bfcea902d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9394b065-9f34-4c20-accf-8692c6a453dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f63cb989-4245-450e-80f7-96272c9d5bbe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9394b065-9f34-4c20-accf-8692c6a453dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0d8f0d8-e413-4781-9312-166ecbcab0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0d8f0d8-e413-4781-9312-166ecbcab0c4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_79c47301-7929-458f-88cf-715eb8244f00" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_9b203888-420e-4678-9082-fd54c9e1dff5" xlink:href="dxcm-20230930.xsd#dxcm_RestrictedAndPerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_08814f34-71c8-4627-a22f-e1aa1169a12e" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMember_9b203888-420e-4678-9082-fd54c9e1dff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_36634513-c2ba-422b-834f-ad4ac534cbf9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_761a84bd-19f9-4e1f-8509-3ed53401980c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22f575c8-e644-4be6-beb0-06cfa1c144f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_761a84bd-19f9-4e1f-8509-3ed53401980c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b252d968-952e-4bdc-bf56-7560ea879b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b252d968-952e-4bdc-bf56-7560ea879b81" xlink:to="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_26b64aea-08dc-4dba-9179-33a68492846c" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_97233516-8dad-43c5-ad9b-42444a481ca3" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_97233516-8dad-43c5-ad9b-42444a481ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_b9e21e6c-7e4e-4afb-a552-f7378cb30c2d" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_b9e21e6c-7e4e-4afb-a552-f7378cb30c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_d72cc805-e77b-4bea-978b-c153c7080a02" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementApprovalMilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_3674ed63-be88-4878-8753-bbac5770b968" xlink:to="loc_dxcm_CollaborativeArrangementApprovalMilestoneMember_d72cc805-e77b-4bea-978b-c153c7080a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ba6d9f88-1872-4b8e-aece-60515365671d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_333b7733-69bd-4855-817e-952d35260380" xlink:href="dxcm-20230930.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_722c44e7-f850-4c18-8e79-72cd7bded5ce" xlink:to="loc_dxcm_VerilyLifeSciencesMember_333b7733-69bd-4855-817e-952d35260380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_82746c4a-d4e1-45c5-ac1d-e440211c8574" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_7ca29682-5e10-463a-8c9e-182c024a850a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b3a378d9-5379-4a45-a390-b1c421b8dccb" xlink:to="loc_us-gaap_CollaborativeArrangementMember_7ca29682-5e10-463a-8c9e-182c024a850a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_27561594-563e-437c-a0f3-bda8a1ba0b1f" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_a766dd6a-212d-4c4e-a558-ef6ec2f68338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_SharePrice_a766dd6a-212d-4c4e-a558-ef6ec2f68338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_17d95be5-0a21-4c07-b338-301faed1a4c2" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_17d95be5-0a21-4c07-b338-301faed1a4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa57d884-255c-49cc-9b87-22062be7d8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa57d884-255c-49cc-9b87-22062be7d8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_f1923aed-b255-468b-93bc-0a01afeba80b" xlink:href="dxcm-20230930.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_f1923aed-b255-468b-93bc-0a01afeba80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_70adb9c2-a061-4d38-ad88-c1cae49f6acb" xlink:href="dxcm-20230930.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_70adb9c2-a061-4d38-ad88-c1cae49f6acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8d7e2f96-24c3-4f26-a3a9-86483a1b40ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8d7e2f96-24c3-4f26-a3a9-86483a1b40ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7e2e5fbf-449b-4dee-aea5-ee8c956582ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f8c6da41-ff28-46e7-bfe2-be649b790884" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7e2e5fbf-449b-4dee-aea5-ee8c956582ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0ed61400-1ad8-4ea7-be28-2eacfcb147d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0ed61400-1ad8-4ea7-be28-2eacfcb147d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa2c78fd-30e1-4ffc-a6f3-827cb9b0f3d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d0887271-6601-4bb6-85f9-5536de8adefe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d0887271-6601-4bb6-85f9-5536de8adefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ec7f856c-30cc-4969-8e58-9ad98b225a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ec7f856c-30cc-4969-8e58-9ad98b225a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99b33642-e0c1-44a6-b5c5-d0ad48714aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce99f66d-6cc4-4deb-a1d8-54c87e302207" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99b33642-e0c1-44a6-b5c5-d0ad48714aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44579822-d264-4c7b-a171-893f21c79f12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_735274aa-a221-4ff1-921d-c60f206ad213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_735274aa-a221-4ff1-921d-c60f206ad213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_58810358-3576-4135-aa62-951f6d1a68ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_CommercialPaperMember_58810358-3576-4135-aa62-951f6d1a68ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_86a56ce1-77f3-441c-a0bc-1da8da3a81de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6da81cb1-cd92-4bf1-947a-e05ab8177303" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_86a56ce1-77f3-441c-a0bc-1da8da3a81de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_91fed32a-0ebe-4ebb-8bde-c1aa6015d2ad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ea56b9-7151-4e1d-acbb-72af6cfdf87b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f0555bac-7ab3-42b1-a601-4622a30081d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f0555bac-7ab3-42b1-a601-4622a30081d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17722c1d-fec9-4ed5-aa55-3da30017b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17722c1d-fec9-4ed5-aa55-3da30017b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_13004cf7-69d4-412f-bb6c-56dc2eccdb49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_13004cf7-69d4-412f-bb6c-56dc2eccdb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a8fad7ea-a8f3-48dc-b7d1-1f5deef40b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_3385fe73-b8d2-4092-8259-059df376a555" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a8fad7ea-a8f3-48dc-b7d1-1f5deef40b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b8e30921-d772-4b87-af64-53e99b6e8a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b8e30921-d772-4b87-af64-53e99b6e8a12" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5482f4f8-b238-4f9e-aafe-cc81eaea1005" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ecb5aad4-576b-462a-aeed-8aacb4801506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_26ead8d1-e044-49c1-ac54-3e3093b7cfa4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ecb5aad4-576b-462a-aeed-8aacb4801506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d08fd4f7-a8d0-4e0e-b8d5-476888691d4e" xlink:to="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_27cbf642-9669-42b5-8516-3ef73d55fb42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e15c047e-a7c0-4296-9f86-4a73c2769641" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_27cbf642-9669-42b5-8516-3ef73d55fb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_271e4c2e-4e70-49fe-8812-026f5d3c0e24" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_698d17d1-d5c6-4266-8076-f17c82159786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4b1a3c6f-9c5b-41d1-a86b-63807d4afc75" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_698d17d1-d5c6-4266-8076-f17c82159786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d9f73ebd-8609-4648-b4ab-7b16ab820809" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_ca0524fe-720a-467e-bd3f-8a62e89ac841" xlink:href="dxcm-20230930.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_ca0524fe-720a-467e-bd3f-8a62e89ac841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a59b231f-5ef1-4d4d-ab04-825baa11792b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a59b231f-5ef1-4d4d-ab04-825baa11792b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_ee274529-1148-4339-9cb8-c4abeeaa3a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_LongTermInvestments_ee274529-1148-4339-9cb8-c4abeeaa3a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5f22b2ac-758b-4034-a922-ea4278b09f98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ebf74c3d-cbb2-48f5-a41d-681a4862067e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_5f22b2ac-758b-4034-a922-ea4278b09f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c406461a-2fc9-4c63-b3ac-6c4da4357034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresSeniorConvertibleNotesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c406461a-2fc9-4c63-b3ac-6c4da4357034" xlink:to="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5098767c-bb81-4338-a751-a69a446b9737" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0e90346c-1b94-4ab8-b49d-df85912fa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_628cd0e2-f35b-45e6-9f56-7e5e607370a3" xlink:to="loc_us-gaap_SeniorNotesMember_0e90346c-1b94-4ab8-b49d-df85912fa2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:to="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_16573127-c76b-40f7-8b0a-2dc950db243e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6d8c5d48-a569-459a-b614-4c9e936c02b5" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6d8c5d48-a569-459a-b614-4c9e936c02b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_259ef42b-4d55-4506-a54d-669ef4375f80" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_259ef42b-4d55-4506-a54d-669ef4375f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_3aa8f82d-d6bf-446e-b899-ef34049e40db" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b34baa0-6829-4bfc-b009-79262a951e56" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_3aa8f82d-d6bf-446e-b899-ef34049e40db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:href="dxcm-20230930.xsd#dxcm_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresSeniorConvertibleNotesTable_57aa76bf-98ae-4fd6-a2e2-54d730ab1e8d" xlink:to="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_a6729bb0-7948-4631-ad7e-f8fbc536387b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_FairValueDisclosuresLineItems_90810171-0246-48ea-a63c-49c2d48b4772" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_a6729bb0-7948-4631-ad7e-f8fbc536387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db0b3b74-183a-46d1-b552-d8efb72536a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db0b3b74-183a-46d1-b552-d8efb72536a7" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae50acf3-f65c-49ea-b642-a82079dd1414" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_60c118ae-3e48-4ab4-becb-7500af2a48bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_60c118ae-3e48-4ab4-becb-7500af2a48bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_26e13965-5b5b-43a4-bf4a-65f9bb7ebbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_CommercialPaperMember_26e13965-5b5b-43a4-bf4a-65f9bb7ebbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_85f31011-00dd-44ca-88fd-46904050ae64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef23d44b-8793-4002-899a-6108763e17fe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_85f31011-00dd-44ca-88fd-46904050ae64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_aa479ab1-7a08-45d2-bb06-83019fa376cc" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6ad375a4-5e46-41e6-bcb3-c33cceea8e66" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0d923c0-a930-4eee-8bc5-1cb3ae2139e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0d923c0-a930-4eee-8bc5-1cb3ae2139e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69a54687-5569-4e9c-9999-33942883b553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69a54687-5569-4e9c-9999-33942883b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_639f0514-6080-4968-94c2-7f211b9d4fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_639f0514-6080-4968-94c2-7f211b9d4fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_413cfc80-4529-47fb-9964-8d59d6064a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_641363b1-7dd4-4a7a-bfd9-5e80b9af90b0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_413cfc80-4529-47fb-9964-8d59d6064a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e2d7960-617d-41b3-87c7-033e043b0012" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_69944403-7e86-4328-ac18-b57fa5c70d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e2d7960-617d-41b3-87c7-033e043b0012" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_69944403-7e86-4328-ac18-b57fa5c70d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c6b3e29-d9c6-4e88-a78e-641b6a604080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a4d77a24-b9ee-4761-87ff-658f12842b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c6b3e29-d9c6-4e88-a78e-641b6a604080" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_a4d77a24-b9ee-4761-87ff-658f12842b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_90a03649-0465-45b9-b7a1-9ab0418fdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c6b3e29-d9c6-4e88-a78e-641b6a604080" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_90a03649-0465-45b9-b7a1-9ab0418fdcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_51c66da5-ca9f-415d-8048-00f4fc87a1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c6b3e29-d9c6-4e88-a78e-641b6a604080" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_51c66da5-ca9f-415d-8048-00f4fc87a1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3c9ef9ed-4b4b-4f4a-9630-86ed0f8f456e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c6b3e29-d9c6-4e88-a78e-641b6a604080" xlink:to="loc_us-gaap_InventoryNet_3c9ef9ed-4b4b-4f4a-9630-86ed0f8f456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2bca1569-f5da-4854-8385-39870782d562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2bca1569-f5da-4854-8385-39870782d562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_825c72c9-e94c-42e2-ab91-0e33c0c64260" xlink:href="dxcm-20230930.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_dxcm_PrepaidInventoryCurrent_825c72c9-e94c-42e2-ab91-0e33c0c64260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_4c9caf91-4b5e-4268-9861-36526028d409" xlink:href="dxcm-20230930.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_4c9caf91-4b5e-4268-9861-36526028d409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_782173ee-2512-4f0c-8235-37b669750f64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_us-gaap_IncomeTaxesReceivable_782173ee-2512-4f0c-8235-37b669750f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_14f04a61-1775-45dd-83a9-734744566f08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_us-gaap_OtherAssetsCurrent_14f04a61-1775-45dd-83a9-734744566f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33c3c69d-0c4a-4f5d-9204-c211c878c308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75e69910-455e-4d7b-bd58-1c552dbb28c2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33c3c69d-0c4a-4f5d-9204-c211c878c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a827a437-d5ec-46e0-bda1-b13d1593f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a827a437-d5ec-46e0-bda1-b13d1593f9d5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0923893c-ad0c-462f-8025-c4dfda9b1484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_6de096ee-ac31-4ed2-966c-24d72b63b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_6de096ee-ac31-4ed2-966c-24d72b63b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_89224f00-b0b0-4a80-9ff3-7a295993ac58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_BuildingMember_89224f00-b0b0-4a80-9ff3-7a295993ac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_634bdef1-3db6-4c62-b0cd-88395b34071f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_634bdef1-3db6-4c62-b0cd-88395b34071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_20fe6433-fd99-48e8-8aa3-2290044fa78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_ComputerEquipmentMember_20fe6433-fd99-48e8-8aa3-2290044fa78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_ab3a4215-1597-490c-b6a1-927640be968a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_EquipmentMember_ab3a4215-1597-490c-b6a1-927640be968a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3bff422a-11b3-4745-8f1e-e04bef645d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3bff422a-11b3-4745-8f1e-e04bef645d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_93d2abc1-42f4-48fe-aa89-28699a4d60c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f8c8aea-0648-4b98-a907-d0750c0756d2" xlink:to="loc_us-gaap_ConstructionInProgressMember_93d2abc1-42f4-48fe-aa89-28699a4d60c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27d7410f-d467-41a2-94ce-b901fb3b4e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6119f336-fef6-40c3-aea1-40dc887baf21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6119f336-fef6-40c3-aea1-40dc887baf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_953693c2-bd67-4c95-be4c-b6eb2b1604c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_953693c2-bd67-4c95-be4c-b6eb2b1604c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d48ce8a1-f940-4354-947f-122e932bb864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d48ce8a1-f940-4354-947f-122e932bb864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_be89d76f-c695-46e3-961f-3a356d03fbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5cf74ed8-6a06-4f5a-8072-8ec7ed0d956c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_be89d76f-c695-46e3-961f-3a356d03fbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ff391f2-e1b1-4892-93d9-2c097243c902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_30574965-fc90-4be2-b6bc-08b16437d933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ff391f2-e1b1-4892-93d9-2c097243c902" xlink:to="loc_us-gaap_LongTermInvestments_30574965-fc90-4be2-b6bc-08b16437d933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_1908110d-3de6-40d4-b93c-04756f464f8f" xlink:href="dxcm-20230930.xsd#dxcm_LongTermDeposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ff391f2-e1b1-4892-93d9-2c097243c902" xlink:to="loc_dxcm_LongTermDeposits_1908110d-3de6-40d4-b93c-04756f464f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_5c8d48f0-a285-4b68-9f6d-979fda4722b3" xlink:href="dxcm-20230930.xsd#dxcm_OtherLongTermAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ff391f2-e1b1-4892-93d9-2c097243c902" xlink:to="loc_dxcm_OtherLongTermAssets_5c8d48f0-a285-4b68-9f6d-979fda4722b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fe9bff99-8061-44fe-8058-33cb91a5d244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ff391f2-e1b1-4892-93d9-2c097243c902" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fe9bff99-8061-44fe-8058-33cb91a5d244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59e8d2a6-411a-43ac-81e3-f6a70f8284cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59e8d2a6-411a-43ac-81e3-f6a70f8284cf" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_90b20866-53c1-4b4c-9b71-b40e8a36a8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_90b20866-53c1-4b4c-9b71-b40e8a36a8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFees_dba60e34-f8b4-4b47-b492-99595cc6db51" xlink:href="dxcm-20230930.xsd#dxcm_AccruedTaxAuditAndLegalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFees_dba60e34-f8b4-4b47-b492-99595cc6db51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebates_5995bb78-1717-43f4-a8e3-7ffecd61952b" xlink:href="dxcm-20230930.xsd#dxcm_PharmacyRebates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_dxcm_PharmacyRebates_5995bb78-1717-43f4-a8e3-7ffecd61952b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_5d33dabb-a45a-4be7-9bd8-d5a3482250c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_5d33dabb-a45a-4be7-9bd8-d5a3482250c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_ce83b9b6-9075-47c3-b78a-a07a0b99bc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_ce83b9b6-9075-47c3-b78a-a07a0b99bc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_93236131-7217-44ae-bac2-c423527e9e97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_93236131-7217-44ae-bac2-c423527e9e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_723e728a-45ff-4bb2-aff3-dea276fc841c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_979e3b03-669f-4555-bbe9-707d396e2ff3" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_723e728a-45ff-4bb2-aff3-dea276fc841c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d45787f8-03d6-4af6-a4c7-eed8025aaa90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_0c088009-8ad6-4c3f-a092-d4a9a8ca490e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d45787f8-03d6-4af6-a4c7-eed8025aaa90" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_0c088009-8ad6-4c3f-a092-d4a9a8ca490e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_4ebeb4ee-1a28-4ea6-be7d-ae587d36a071" xlink:href="dxcm-20230930.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_0c088009-8ad6-4c3f-a092-d4a9a8ca490e" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_4ebeb4ee-1a28-4ea6-be7d-ae587d36a071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_6e0b33af-d0f7-49a1-8300-4ddf1116055a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_0c088009-8ad6-4c3f-a092-d4a9a8ca490e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_6e0b33af-d0f7-49a1-8300-4ddf1116055a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8e26bb5-6fdc-4e41-9ac5-71afbe1944fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_0c088009-8ad6-4c3f-a092-d4a9a8ca490e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b8e26bb5-6fdc-4e41-9ac5-71afbe1944fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_650118f5-41ec-4c50-8de0-63f3852a8d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_650118f5-41ec-4c50-8de0-63f3852a8d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bee1c8cb-d9d5-4ddb-88cf-6eaff5cdcb30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bee1c8cb-d9d5-4ddb-88cf-6eaff5cdcb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b7ece53-a0fc-44b8-b8e2-623bfa247470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b7ece53-a0fc-44b8-b8e2-623bfa247470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_7557052a-c577-4b33-aa48-5580f03e316a" xlink:href="dxcm-20230930.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_7557052a-c577-4b33-aa48-5580f03e316a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_709969c7-7a3c-4b7d-bee3-11c12e7c34b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_709969c7-7a3c-4b7d-bee3-11c12e7c34b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9a2baccc-406d-47ce-a9eb-3cf828f1890c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0919874e-a4be-4f69-81af-da3c96949a8f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9a2baccc-406d-47ce-a9eb-3cf828f1890c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b76e624-2a08-48b3-b60d-09fd04e16848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_9db9e93e-4798-40da-be6a-530cbe7776a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b76e624-2a08-48b3-b60d-09fd04e16848" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_9db9e93e-4798-40da-be6a-530cbe7776a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6401512e-aba9-4cbd-8cb6-2cd90213c044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b76e624-2a08-48b3-b60d-09fd04e16848" xlink:to="loc_us-gaap_InterestExpense_6401512e-aba9-4cbd-8cb6-2cd90213c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_f08361a7-1d3d-4090-a49f-94acca3ec232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b76e624-2a08-48b3-b60d-09fd04e16848" xlink:to="loc_us-gaap_OtherNonoperatingExpense_f08361a7-1d3d-4090-a49f-94acca3ec232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6c552ba0-a4e0-48a5-8874-5d360ba96ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b76e624-2a08-48b3-b60d-09fd04e16848" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6c552ba0-a4e0-48a5-8874-5d360ba96ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5901c674-0d5f-4142-86c9-47920d77a8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5901c674-0d5f-4142-86c9-47920d77a8ba" xlink:to="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d6dc7a8c-5c84-488e-8d36-5f4d9eec62f9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6f8dbeaf-b623-4ec6-9f8c-b014828d464c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a4ed6022-ce17-406b-9e6b-739228edffae" xlink:to="loc_us-gaap_SeniorNotesMember_6f8dbeaf-b623-4ec6-9f8c-b014828d464c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b3be1d6-4314-43f6-84b6-b2730ba8f295" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_78376c1c-ee8e-4140-8316-f4955454f5be" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_78376c1c-ee8e-4140-8316-f4955454f5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_901d3dc1-9d9a-46a0-b7a7-96961bc7e703" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_901d3dc1-9d9a-46a0-b7a7-96961bc7e703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a7e77303-98b3-4590-aa60-17cfe41b8525" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9663762f-191c-4a3d-aae8-0aad30b1721f" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a7e77303-98b3-4590-aa60-17cfe41b8525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_11396444-821d-400d-bf5d-08d7a1ac5297" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6cb76734-56b3-4c1a-a509-d90dd61b2a15" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a9a8e616-8dbc-404e-8cbd-4a4471de1e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a9a8e616-8dbc-404e-8cbd-4a4471de1e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_1828272c-4d93-4842-8440-0b8ad6ef84f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_1828272c-4d93-4842-8440-0b8ad6ef84f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_771afbf5-0e44-4c3d-9c02-28e955f60663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_b8e12cfd-021a-43fa-8f59-31cc8c71c692" xlink:to="loc_us-gaap_ConvertibleNotesPayable_771afbf5-0e44-4c3d-9c02-28e955f60663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtConversionValueofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ae3a03c5-3127-439b-92ac-0272426f5a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ae3a03c5-3127-439b-92ac-0272426f5a09" xlink:to="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_056c65ca-cfb3-43d7-94c8-4ddd1861cc54" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_fb274af7-5be8-4c40-aa14-69c80ae6c019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_233b9dc7-53db-4938-8b5b-b23b748bc56d" xlink:to="loc_us-gaap_SeniorNotesMember_fb274af7-5be8-4c40-aa14-69c80ae6c019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:to="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d75c8af8-8e8f-44c8-8d37-d4847566115e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_d3564353-3d6a-42a8-8c8e-65af6da32f1e" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_d3564353-3d6a-42a8-8c8e-65af6da32f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_057e093d-1d8f-445e-adaf-dd8214dc3d82" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_057e093d-1d8f-445e-adaf-dd8214dc3d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_c5b60c11-02fd-4021-b73c-eb3b8289215b" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9566c9cd-c3f9-484a-9f4e-ef056308cd16" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_c5b60c11-02fd-4021-b73c-eb3b8289215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2c8b8c1-b996-48ff-82ae-a9f871f62fa2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_5455fd6e-e2c0-46d6-b522-3a73f76950e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80209382-f6e2-44c8-a5cc-de03518c7151" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_5455fd6e-e2c0-46d6-b522-3a73f76950e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e3de4df5-c783-4d0d-8161-45db76031847" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3de4df5-c783-4d0d-8161-45db76031847" xlink:to="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:to="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4acfef13-01eb-4492-930a-ba7652341a44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_fd1fe1ef-8180-4b48-a1dc-ab0261bb57c0" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_fd1fe1ef-8180-4b48-a1dc-ab0261bb57c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_ab5e087c-b10e-477d-befc-e0e56907cb68" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_ab5e087c-b10e-477d-befc-e0e56907cb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_bee08340-c088-4632-9787-9f1f43cf5a7c" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2864cf50-c913-45b9-9588-7e2c63045515" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_bee08340-c088-4632-9787-9f1f43cf5a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c324fd53-f210-4932-a187-e08456f5f713" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:href="dxcm-20230930.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_12e1934e-5f9d-4e74-9bfe-4a4e76766079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_CashInterestExpenseAbstract_5733908f-63d9-4d92-afeb-0551993345ec" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_12e1934e-5f9d-4e74-9bfe-4a4e76766079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:href="dxcm-20230930.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_50fc5a07-4136-45c2-888d-90bee43bed85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_50fc5a07-4136-45c2-888d-90bee43bed85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4cfb098a-e8df-415f-aaae-70d7fb0b67e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_6085fce1-d72f-4c06-bf01-0638510d2e5e" xlink:to="loc_us-gaap_InterestExpenseDebt_4cfb098a-e8df-415f-aaae-70d7fb0b67e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e342aafa-9ca0-4a54-994a-705dbce8dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b9dd7421-05c4-46a1-a2a3-a8e854c18052" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e342aafa-9ca0-4a54-994a-705dbce8dcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_30fabd11-131c-48db-b810-747683588069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_30fabd11-131c-48db-b810-747683588069" xlink:to="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a27c8475-ee61-43ad-9c0a-14301e9cae6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_168fa448-8e4e-4568-80ae-a34d45f68781" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_168fa448-8e4e-4568-80ae-a34d45f68781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_7e4cd1f0-4224-44ed-954e-b4615d1b4ce6" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_7e4cd1f0-4224-44ed-954e-b4615d1b4ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_8693ec99-2dbf-496b-8a11-ee0951b8f8a6" xlink:href="dxcm-20230930.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_43d034be-b11f-4c32-9b5f-fc5c8e8a1fbc" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_8693ec99-2dbf-496b-8a11-ee0951b8f8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5632e6a8-aef4-4521-9787-7ac639595171" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_56bccde3-934f-4d98-93be-db5a87850b51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:to="loc_us-gaap_SeniorNotesMember_56bccde3-934f-4d98-93be-db5a87850b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7898767b-8138-4d2e-ae84-9b37b09b2614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_207521b3-a4d6-45bb-8fd2-394ce713c55d" xlink:to="loc_us-gaap_LineOfCreditMember_7898767b-8138-4d2e-ae84-9b37b09b2614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8dc9ab9-22b5-49a7-a569-0fba63bf23b8" xlink:to="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_279450be-9726-4b78-ba09-6b7cb87e20b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e21044f-2395-4ef6-8844-c5a8de50dea1" xlink:to="loc_us-gaap_CommonStockMember_279450be-9726-4b78-ba09-6b7cb87e20b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_0263df1e-3be7-41a6-a62b-d9c1b11d3e70" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_6dabfb9c-5ebc-45ec-b6dd-90d782d0480e" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_6dabfb9c-5ebc-45ec-b6dd-90d782d0480e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_511eaa9f-bd94-4ca1-80d0-8e9cf7b15686" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_b8dea0f6-dea2-421f-ae42-0af3ad3db36f" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_511eaa9f-bd94-4ca1-80d0-8e9cf7b15686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_379ef918-5adc-4a87-9d0c-a1a76a257b42" xlink:to="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6860464d-52b0-4039-ad44-1de32906bc11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:to="loc_srt_MinimumMember_6860464d-52b0-4039-ad44-1de32906bc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_841ec562-e375-4c1a-bcfa-13f92bfb63ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7fc6b99-dc6c-465d-a1ff-818b8acf6896" xlink:to="loc_srt_MaximumMember_841ec562-e375-4c1a-bcfa-13f92bfb63ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_40056d87-564b-47a4-befe-b003f8b46500" xlink:to="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_df610da7-ff63-438e-b74d-0de0c791a300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_55334d74-b0f3-4da6-8537-032530df3da1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_df610da7-ff63-438e-b74d-0de0c791a300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_cf03a758-5b66-420c-b7b4-b38af0bade95" xlink:to="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_787c5ab1-6c79-4d76-8fdb-273c534132b2" xlink:href="dxcm-20230930.xsd#dxcm_FederalReserveBankOfNewYorkRateNYFRBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_dxcm_FederalReserveBankOfNewYorkRateNYFRBMember_787c5ab1-6c79-4d76-8fdb-273c534132b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0f19b1e1-f43b-4dbc-9a03-c285ba94ae72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0f19b1e1-f43b-4dbc-9a03-c285ba94ae72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SimpleRiskFreeRateRFRMember_a36907f2-c228-416e-bf89-bf0501bbde3f" xlink:href="dxcm-20230930.xsd#dxcm_SimpleRiskFreeRateRFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_daac1ecb-0046-4ca7-9d25-27cc6a586870" xlink:to="loc_dxcm_SimpleRiskFreeRateRFRMember_a36907f2-c228-416e-bf89-bf0501bbde3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baac0471-bfbc-4121-8728-ba7401e3b3e9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9649056c-b744-4c01-a18a-18680b4e18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9649056c-b744-4c01-a18a-18680b4e18a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_14de7e7d-9042-4b61-b191-fa653fb976fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_14de7e7d-9042-4b61-b191-fa653fb976fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_b86bc2ea-d77d-4703-98d9-882cd88c16df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_b86bc2ea-d77d-4703-98d9-882cd88c16df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3300cec1-71d4-4b4c-8bb6-5f9b691815c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3300cec1-71d4-4b4c-8bb6-5f9b691815c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_105ca8a0-ad20-4d18-9b31-3a284d230702" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_105ca8a0-ad20-4d18-9b31-3a284d230702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_3faff0f6-8ff0-4b2d-b3b0-245a37d0aba1" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash_3faff0f6-8ff0-4b2d-b3b0-245a37d0aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_6cec563f-88ac-4108-a680-c515b9dbb282" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled_6cec563f-88ac-4108-a680-c515b9dbb282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3d1f509c-5960-4ab9-a816-94cbfaa650e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3d1f509c-5960-4ab9-a816-94cbfaa650e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_c9634bcf-6f7b-4b07-84c0-b008380ac4b5" xlink:href="dxcm-20230930.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_c9634bcf-6f7b-4b07-84c0-b008380ac4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_832b8c74-e53c-45a6-abb3-5575922ded62" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash_832b8c74-e53c-45a6-abb3-5575922ded62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_b77a94e7-bf88-4d87-9649-782180f28070" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_b77a94e7-bf88-4d87-9649-782180f28070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_134e7483-1bcf-4a8b-980f-f525f72e3fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_134e7483-1bcf-4a8b-980f-f525f72e3fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5fa852fb-7110-495d-9531-93c8f5009813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5fa852fb-7110-495d-9531-93c8f5009813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_77f34139-53c4-4d58-806e-27b609f97813" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_77f34139-53c4-4d58-806e-27b609f97813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b27e3852-5a54-40f4-93af-e6058ac40c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b27e3852-5a54-40f4-93af-e6058ac40c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_c4abacc1-047d-49c7-b12e-4ecf42980ab8" xlink:href="dxcm-20230930.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_c4abacc1-047d-49c7-b12e-4ecf42980ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_2f294726-2ead-4550-9998-0a2cf3f35289" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_2f294726-2ead-4550-9998-0a2cf3f35289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_7aa86cbc-3495-4fc5-b483-2f766506ffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_7aa86cbc-3495-4fc5-b483-2f766506ffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_82d68282-56d0-45e1-8209-205f5fa867a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_82d68282-56d0-45e1-8209-205f5fa867a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_2304d0dd-f6b0-4eee-8197-b81593418981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_2304d0dd-f6b0-4eee-8197-b81593418981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_94c1c4b5-7de1-4e6d-afba-bc4d4d242031" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_94c1c4b5-7de1-4e6d-afba-bc4d4d242031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_66e5fc81-27b4-4adf-bb16-a6087ed437d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_66e5fc81-27b4-4adf-bb16-a6087ed437d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_912fae33-a086-4768-b128-e5cde67164eb" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_912fae33-a086-4768-b128-e5cde67164eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_be4f6a9a-4907-4d5f-9eac-2fa9a105a670" xlink:href="dxcm-20230930.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_be4f6a9a-4907-4d5f-9eac-2fa9a105a670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_177afbbe-a6da-4eba-ad47-1c2f3fcf31fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_SharePrice_177afbbe-a6da-4eba-ad47-1c2f3fcf31fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_7e94bb2d-dd65-4c7f-af3e-2745fd8ece33" xlink:href="dxcm-20230930.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_7e94bb2d-dd65-4c7f-af3e-2745fd8ece33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ad7ef383-4215-4e09-8805-79e66cadb018" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentTerm_ad7ef383-4215-4e09-8805-79e66cadb018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5f9ba1f2-2dc2-4219-9203-d9f8c36c8bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5f9ba1f2-2dc2-4219-9203-d9f8c36c8bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_717a0600-af3c-4eef-a580-60420e2e0512" xlink:href="dxcm-20230930.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_717a0600-af3c-4eef-a580-60420e2e0512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff9a3939-6837-4706-a384-4fa1036a07e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff9a3939-6837-4706-a384-4fa1036a07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_793ca81c-efcb-4411-9c96-31d5079aa7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_793ca81c-efcb-4411-9c96-31d5079aa7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_df7b006a-cdb5-425e-93f0-9e4867335eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_649b1e00-38cb-4320-a772-8464cfdee78a" xlink:to="loc_us-gaap_DepositAssets_df7b006a-cdb5-425e-93f0-9e4867335eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_24a51bb9-a8e0-4dea-a1a2-1d021be265fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24a51bb9-a8e0-4dea-a1a2-1d021be265fd" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_60d2d618-751d-4753-9737-15f62a6a9d11" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_240e1052-aa4e-4f2a-9750-3ebe2339b12e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3467f631-943d-440a-af23-59d04eab9355" xlink:to="loc_us-gaap_LineOfCreditMember_240e1052-aa4e-4f2a-9750-3ebe2339b12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:to="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_16ba02b5-4c19-4470-b767-9c3e9049d9de" xlink:to="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_870636af-0c3d-467c-acd7-b514e4d3306d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a831e632-b9dd-4267-b577-f0619f6d4109" xlink:to="loc_us-gaap_LetterOfCreditMember_870636af-0c3d-467c-acd7-b514e4d3306d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97cc9613-1c63-4567-a8e2-0c171bf6e127" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8487ec33-599b-4f0c-9113-b5fa90d899cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8487ec33-599b-4f0c-9113-b5fa90d899cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_1d5f4780-a6b7-4b6c-b869-404264487e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCredit_1d5f4780-a6b7-4b6c-b869-404264487e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c7bdc43b-ef3f-4b90-88c2-d5106e12ec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c7bdc43b-ef3f-4b90-88c2-d5106e12ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9b8987d4-8bbe-4e3a-93d4-f9cf0ee6ed18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_31afa267-36d7-41c8-b8c5-7aabbcbe7f80" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9b8987d4-8bbe-4e3a-93d4-f9cf0ee6ed18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#ContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9bc647cb-e664-47e3-9d24-d3dde816f0de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9bc647cb-e664-47e3-9d24-d3dde816f0de" xlink:to="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:to="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d34fa814-8998-48f0-965e-dd3f89182cf1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AbbottMember_93773e2d-abae-4a13-a2d7-4599658fa201" xlink:href="dxcm-20230930.xsd#dxcm_AbbottMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_03b9daa6-cd7a-4b6f-8925-fe4f1d96e326" xlink:to="loc_dxcm_AbbottMember_93773e2d-abae-4a13-a2d7-4599658fa201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c8f7903f-3cd6-42a5-a534-938941ab18ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a08c8eed-75c6-4736-b691-26ad56118903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_911b5c10-8bed-43c7-97d3-7e2552ebc338" xlink:to="loc_us-gaap_SubsequentEventMember_a08c8eed-75c6-4736-b691-26ad56118903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e00d503a-f62e-40ba-8ad2-faa821615101" xlink:to="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_b8e5cf09-e3f8-4262-ac4b-3a9bf8260a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_b8e5cf09-e3f8-4262-ac4b-3a9bf8260a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsRemainingNumber_5414721d-5b04-41e7-89c4-126efc60c089" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsRemainingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyPendingClaimsRemainingNumber_5414721d-5b04-41e7-89c4-126efc60c089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_caf799a9-fca6-458f-8eff-77b79065f8f9" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber_caf799a9-fca6-458f-8eff-77b79065f8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_38ee542c-e2b9-41bc-ab19-7cabff69cc82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_38ee542c-e2b9-41bc-ab19-7cabff69cc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_b78aecc7-b2dd-4542-b8cd-cca24749df8b" xlink:href="dxcm-20230930.xsd#dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e2324d0-c4ec-4295-af6e-27afa5a2507d" xlink:to="loc_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber_b78aecc7-b2dd-4542-b8cd-cca24749df8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b552cdd7-d25b-4a75-b25f-f81993119278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_be7c9d03-e18c-44f4-88e7-27505b6fd7be" xlink:href="dxcm-20230930.xsd#dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b552cdd7-d25b-4a75-b25f-f81993119278" xlink:to="loc_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent_be7c9d03-e18c-44f4-88e7-27505b6fd7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_193d41c7-e55c-400a-9d23-7bb78580a70e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b552cdd7-d25b-4a75-b25f-f81993119278" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_193d41c7-e55c-400a-9d23-7bb78580a70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_5980872f-57c0-4056-8e8f-5e653be76149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b552cdd7-d25b-4a75-b25f-f81993119278" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_5980872f-57c0-4056-8e8f-5e653be76149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_20d90d29-548e-4695-a6c1-08d9b6160d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b552cdd7-d25b-4a75-b25f-f81993119278" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_20d90d29-548e-4695-a6c1-08d9b6160d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquityShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a3d277b-209b-415d-becb-1643879c3330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a3d277b-209b-415d-becb-1643879c3330" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3edf303-51cd-4f24-ae23-f5d5c03721dc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_83f4632f-4fd4-4cbf-b480-1ba670c8ff02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_us-gaap_CostOfSalesMember_83f4632f-4fd4-4cbf-b480-1ba670c8ff02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11beaf47-c67f-40b9-b8c1-09181a661a76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_11beaf47-c67f-40b9-b8c1-09181a661a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SellingGeneralAndAdministrativeMember_0887a064-a69a-47ec-9022-b45e86d14011" xlink:href="dxcm-20230930.xsd#dxcm_SellingGeneralAndAdministrativeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ddcf13b2-45b9-45e3-a8e0-dbe892051bec" xlink:to="loc_dxcm_SellingGeneralAndAdministrativeMember_0887a064-a69a-47ec-9022-b45e86d14011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d86e2829-ec5b-4d71-b1d5-a00e549d7c14" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_89f5a2fa-5eca-45c6-bacb-d69c6fb69e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_58595233-6aa0-44eb-bfba-5f08a5d73bdc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_89f5a2fa-5eca-45c6-bacb-d69c6fb69e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b71bdec-298a-4161-9e33-20427fdd7934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b71bdec-298a-4161-9e33-20427fdd7934" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:to="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9fe16f21-2521-45a2-b030-e5276793b1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c452cf78-d11c-4ca2-929a-70233a512050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c452cf78-d11c-4ca2-929a-70233a512050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c08748e9-440b-4131-88cd-327703361383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4553ab37-bd89-452c-af97-eb7d29f42be0" xlink:to="loc_us-gaap_PerformanceSharesMember_c08748e9-440b-4131-88cd-327703361383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8b6b8b72-5394-4e39-830e-15899bcab817" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_ccdd0749-6b68-403a-b213-50528dd62398" xlink:href="dxcm-20230930.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_30bdf397-a98d-4058-89b2-4c5b059765cc" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_ccdd0749-6b68-403a-b213-50528dd62398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b1191ac2-4343-4c65-aaa9-fb94f10c164d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6c0c6f-521f-4416-9580-fefc03183def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6c0c6f-521f-4416-9580-fefc03183def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b3dcf097-90ee-4b86-9fa8-a93cb25ff577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b3dcf097-90ee-4b86-9fa8-a93cb25ff577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff3be12b-71ec-4e81-b62f-12acdbf1f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff3be12b-71ec-4e81-b62f-12acdbf1f1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c709b6df-9a11-42f2-8735-f463ab51ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c709b6df-9a11-42f2-8735-f463ab51ed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b78e3eee-bf90-43b6-8361-18dc639893bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b78e3eee-bf90-43b6-8361-18dc639893bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8aeaada1-20fd-41d9-ba7b-284bba3abd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8aeaada1-20fd-41d9-ba7b-284bba3abd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2095d3b4-d8f5-4b9c-95d2-cc71ecc00dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2e0dd61-1749-4539-914d-8c5abcf2cc70" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2095d3b4-d8f5-4b9c-95d2-cc71ecc00dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cbf0c18d-c6ea-41e7-a100-1cbe129e46ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ddfc80fd-a1af-41ea-baf3-53e28920a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cbf0c18d-c6ea-41e7-a100-1cbe129e46ad" xlink:to="loc_us-gaap_NumberOfReportableSegments_ddfc80fd-a1af-41ea-baf3-53e28920a0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#BusinessSegmentandGeographicInformationScheduleofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5eb1fc35-3bb8-47a9-9cf9-1f716191ed94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5eb1fc35-3bb8-47a9-9cf9-1f716191ed94" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:to="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_33ebfd42-5798-4831-b24c-8c16432e8413" xlink:to="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01937daa-4e44-451a-91eb-1900327247a6" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:to="loc_country_US_01937daa-4e44-451a-91eb-1900327247a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_5395093c-90d3-4832-98cc-1d158cf48ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_edad3d94-7180-4ac7-9ac6-5a8a8db5025b" xlink:to="loc_us-gaap_NonUsMember_5395093c-90d3-4832-98cc-1d158cf48ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_67c64c04-0eaa-413f-a9d3-d1efa97c23bf" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_14b93bb5-5333-4f8d-8e27-80e1d45fbee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_14b93bb5-5333-4f8d-8e27-80e1d45fbee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_253fdf89-6b61-4b3c-adda-3f6a209cae06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_905d2806-19a1-43c2-8bf3-09c754a73473" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_253fdf89-6b61-4b3c-adda-3f6a209cae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fd590a8d-7cab-439f-ba83-927261b1ee10" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e400b4bd-b8b0-438b-86bf-3c1fbf742b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e400b4bd-b8b0-438b-86bf-3c1fbf742b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_d5974182-c9c0-4f7e-93a1-5630533ba3c3" xlink:href="dxcm-20230930.xsd#dxcm_RevenuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_512bc1f9-15d4-4e83-9891-5cd7372abaad" xlink:to="loc_dxcm_RevenuePercentage_d5974182-c9c0-4f7e-93a1-5630533ba3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="dxcm-20230930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a07fe59b-4ebf-4e83-95d2-46d1818b70fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a07fe59b-4ebf-4e83-95d2-46d1818b70fd" xlink:to="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1f593e1a-e576-4e5d-9695-95308a956aad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8168d0e2-e30e-4768-b800-8620c4105dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2c185043-daf1-401b-a4dd-e3f2cf9d5465" xlink:to="loc_us-gaap_SubsequentEventMember_8168d0e2-e30e-4768-b800-8620c4105dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f61625f-7ced-453b-b829-a2d29127938e" xlink:to="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a842a6c5-745d-446e-b76f-c66d0a00189a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8427252e-a37f-4ca1-aa66-3d551c63da05" xlink:to="loc_us-gaap_CommonStockMember_a842a6c5-745d-446e-b76f-c66d0a00189a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1e928340-3a06-4e69-a3ca-a5908160678b" xlink:to="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_05700190-7678-421f-b234-a0bc68a9ff8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d4ed4d9d-a53c-413d-9eff-d9fbb450f557" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_05700190-7678-421f-b234-a0bc68a9ff8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023TerminationMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023TerminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="loc_dxcm_MichaelBrownAugust2023TerminationMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownAugust2023AdoptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="loc_dxcm_MichaelBrownAugust2023AdoptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MichaelBrownMember" xlink:href="dxcm-20230930.xsd#dxcm_MichaelBrownMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_MichaelBrownMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NicholasAugustinosMember" xlink:href="dxcm-20230930.xsd#dxcm_NicholasAugustinosMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_dxcm_NicholasAugustinosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>dxcm-20230930_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230930_g1.jpg
M_]C_X  02D9)1@ ! @$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M_?R@",T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M[R<E]TKK\#KO^&GO%W_00_\ )>V_^-5O_:57^;\(_P"1V_ZP8G^?_P DA_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?YOPC_D'^L&)_G_ /)(?_(A_P -/>+O^@A_Y+VW_P :H_M*K_-^$?\ (/\
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M()[Z>+IU-I+7I>S^YZGMT<SHUK<LXZNR3:3O>VSL_334]&KK/3"@ H * "@
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M ,DA_P#(A_PT]XN_Z"'_ )+VW_QJC^TJO\WX1_R#_6#$_P __DD/_D30TO\
M:K\5:?,LDEU'<(N<Q201!&R".3$L;\9R-K#D#.1D&HYI53O>_DTOT29I3XCQ
M,'=R4O)QC;_R51?XG7?\-G^(/^?:P_[]S?\ Q^NC^V*G:/W/_P"2.S_6JO\
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ME0RDCC<.HX7G7:/_ )-_P$>-+BUVTIZVTO.ZOZ<JO]Z]3B?^&S_$'_/M8?\
M?N;_ ./US_VQ4[1^Y_\ R1P?ZU5_Y8?=+_Y,X'_AI[Q=_P!!#_R7MO\ XU7+
M_:57^;\(_P"1Y_\ K!B?Y_\ R2'_ ,B'_#3WB[_H(?\ DO;?_&J/[2J_S?A'
M_(/]8,3_ #_^20_^1#_AI[Q=_P!!#_R7MO\ XU1_:57^;\(_Y!_K!B?Y_P#R
M2'_R(?\ #3WB[_H(?^2]M_\ &J/[2J_S?A'_ "#_ %@Q/\__ ))#_P"1#_AI
M[Q=_T$/_ "7MO_C5']I5?YOPC_D'^L&)_G_\DA_\B;^A_M;^)])W^=);W>[&
M/.A"[,9SM\@Q=<\[MW08QSG6&:U([V?JO\K'11XEQ%.]W&5_YHVM_P" \OXW
M.VT7]M75()";ZQM9H]IPL+20L&R,$L[3 C&1MV@Y(.X8P>B&<R7Q)/TNOSN=
M]+BNHG[\(M6^S>+OZMR_+YGINB_MJZ7/&3?6-U#)N.%A:.92N!@EG:$@YR-N
MTC !W'.!V0SF+^)->EG^=CU:7%=-KWX23O\ 9M)6]6X_E\SWSPQ\;_#GC"3R
M;/4(3)N1523="SLY(54$RH7)(QA-Q!(!QN&?3IXVG4T4E\]-_6USZ'#YO0Q#
MM&:O=*SO%MO:W,E?Y'JM=IZX4 % !0 4 % !0 4 % !0 4 4-4U6WT2%KBZE
MC@A3&Z21U1%R0!EF( R2 ,GDD#J:F4E!7;LN[T,ZE2--<TFDEU;27;=GB7BC
M]ICPQX8\Q?M?VF6/;^[MD,F[=C[DG$)P#EOWG&"OWQMKSJN94Z?6[71:_CM^
M)X6(S_#T;^]S-6TBK[VV>D>O?\=#PO7_ -MJ-&E33].9EV_NI9Y@IW%>KQ(K
M<!OX1+EE'WE)X\VIG/\ +'T;?Z+_ #/GZW%BU4(=-'*5M;=4D^O][7NCR/6O
MVO?$NJ1A(3:VK!@3)#"2Q&"-I$S2K@YSPH;('S8R#PSS:I+:R]%_FV>-5XFQ
M$U9<L==XQU]/><E^!S'_  T]XN_Z"'_DO;?_ !JL?[2J_P WX1_R.7_6#$_S
M_P#DD/\ Y$X'_A:WB#_H*W__ (%S?_%US?6JG\TO_ G_ )GG?VC7_P"?D_\
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M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * /,O''QBT/X>K)]NNX_.CX-O&0\Y8H75?+4Y7<,89]B?,N7 8&N.
MMBX4?B>O9:O:^W^>AY6+S2CA+\\E=?96LMKK1;7[NRVU/C[QW^V;=7;-%HEL
ML,95AYUP-\N64898U;8A4[L;C,K?*2HY4^%7SAO2"MYO?[MOS/B\9Q5*6E&-
ME9ZRU>V]D[*VN_-?3T/F3Q=\7-=\=*4U"^FEC*JK1 B.)@K;ANBC"HQ!YW%2
MW"\_*,>/5Q<ZOQ-ORV7W*R/E<3F=;$Z3FVK;;+1WVC9/UL><UR'F!0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 >NZ'\>O$_A[?Y.I7#;\9\XBXQMSC;YXDV]>
M=N-W&<X&.Z&.J0VD_GK^=SV:.<XBE>TY:_S>_P#^E7M\CZ;\%_MI_>76[/U*
MR6G_  '"F.5_]XEQ)_=7R^K5[%'./YU\X_Y-_K\CZK"<5_\ /V/HX?+2TGZZ
MW^74^R?!_CW3/'T)GTRYCN$7[P4D.F2P&^-@'3.UMNY1N R,CFO?I5XUE>+O
M_7;<^VPN,IXI7IR4OS6^Z=FMM+K4ZZMSM"@ H * "@ H * "@ H * "@ H *
M "@"AJFJV^B0M<74L<$*8W22.J(N2 ,LQ &20!D\D@=34RDH*[=EW>AG4J1I
MKFDTDNK:2[;L\JUK]H/PMH,@BFU*%F*A@80\ZX)(Y>%74'C[I.X#!Q@@GBGC
MZ4-')?*[_*YY%7.\/2=G-;?9O)??%-?(Q_\ AI[PC_T$/_)>Y_\ C59_VE2_
MF_"7^1C_ *P8;^?_ ,DG_P#(A_PT]X1_Z"'_ )+W/_QJC^TJ7\WX2_R#_6##
M?S_^23_^1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K!AOY_P#R2?\ \B'_
M  T]X1_Z"'_DO<__ !JC^TJ7\WX2_P @_P!8,-_/_P"23_\ D0_X:>\(_P#0
M0_\ )>Y_^-4?VE2_F_"7^0?ZP8;^?_R2?_R(?\-/>$?^@A_Y+W/_ ,:H_M*E
M_-^$O\@_U@PW\_\ Y)/_ .1#_AI[PC_T$/\ R7N?_C5']I4OYOPE_D'^L&&_
MG_\ ))__ "(?\-/>$?\ H(?^2]S_ /&J/[2I?S?A+_(/]8,-_/\ ^23_ /D0
M_P"&GO"/_00_\E[G_P"-4?VE2_F_"7^0?ZP8;^?_ ,DG_P#(FAI?[1GA75YE
M@CU&-7;.#(DL2< GF25$1>G&YADX R2 :CF%*3MS?>FOQ:2-*>>8:H[*:U[J
M45]\DE^)[):7<=_&DT+K)'(H9'4AE96&0RD<$$<@C@CFO03OJCVXR4E=:IJZ
M:U5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#R+7/CUX8
M\/;/.U*W;?G'DDW&-N,[O($FWKQNQNYQG!QPSQU.&\E\M?RN>-6SG#TK7G'7
M^7W_ /TF]OF8'_#3WA'_ *"'_DO<_P#QJLO[2I?S?A+_ ".?_6##?S_^23_^
M1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K!AOY_P#R2?\ \B'_  T]X1_Z
M"'_DO<__ !JC^TJ7\WX2_P @_P!8,-_/_P"23_\ D0_X:>\(_P#00_\ )>Y_
M^-4?VE2_F_"7^0?ZP8;^?_R2?_R(?\-/>$?^@A_Y+W/_ ,:H_M*E_-^$O\@_
MU@PW\_\ Y)/_ .1#_AI[PC_T$/\ R7N?_C5']I4OYOPE_D'^L&&_G_\ ))__
M "(?\-/>$?\ H(?^2]S_ /&J/[2I?S?A+_(/]8,-_/\ ^23_ /D0_P"&GO"/
M_00_\E[G_P"-4?VE2_F_"7^0?ZP8;^?_ ,DG_P#(A_PT]X1_Z"'_ )+W/_QJ
MC^TJ7\WX2_R#_6##?S_^23_^1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K
M!AOY_P#R2?\ \B>NZ'XKT_Q/O^P75O<^7C?Y,J2;=V=N[83C.#C/7!]*[H58
MU/A:=NS3_(]FCB85K\DHRMORR3W]&^QOUJ= 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0!0U35;?1(6N+J6."%,;I)'5$7) &68@#)( R>20.IJ924%=NR[
MO0SJ5(TUS2:275M)=MV?)OB[]LG1](8IIMO-?,&7YR?(B*E<DJ65I,@X7:T:
M@_,0V -WAU<WA'X4Y?@O\_P/C\3Q32IZ4TYZ[_"K6\TWY:I>O?Y=\2_M4>)_
M$.Y4GCM(VC*,EO&%SG.6#R>9(KX. 4==N 1ALD^-4S.I/K;3HO\ .[_$^3K\
M18BKLU%-6M%6^=W=I^C7EJ>!ZIJMQK<S7%U+)/,^-TDCL[M@ #+,23@  9/
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@
M#DD\ <TF[:LF4E%7>B2NV]%8^9?'?[66A>%U9+$MJ%P&9=L>4B!5@#F9EP01
MN*-$LJMMZJ&#5X]?-(4_A]Y^6B^__*Y\KC.)*-#2'ON[VT6C[M?<TG?\3Y-\
M8_M8>(?$VZ.V>.QA;S%Q"N9"C\ -*^XAU'1XA$<DM@';M\2MFE2>WNK7;?[W
M^:L?'XKB2O6TC:"U^%:V?F[ZKNK=^UOG35-5N-;F:XNI9)YGQNDD=G=L  99
MB2<  #)X  Z"O*E)S=V[ON]3YFI4E4?-)MM]6VWVW9GU!F% !0 4 % !0 4
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MLX)4-M8=4<!@2C ,N>0#7MTZL:BO%W1]A0Q$,1'F@U)=T_*]GV>NSU1OUJ=
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M3"C\3M^+^Y7?0\[%YA2PG\225^FK?76R3=M-[6/D;QI^VG]U=$L_0M)=_P#
MLJ(XG_W2',G]Y?+Z-7AULX_D7SE_DG^OR/C<7Q7_ ,^H^KG\]+1?IK?Y=3Y<
M\3_&_P 1^,(_)O-0F,>UU9(]L*NK@!E<0J@<$#&'W  D#&XY\:IC:E31R?RT
MW]+7/D\1F]?$*TINUFK*T4T][\J5_F>55Q'D!0 4 % !0 4 % !0 4 % !0
M4 % 'HWA'XN:[X%4)I]]-%&%95B)$D2AFW';%(&123SN"AN6Y^8YZZ6+G2^%
MM>6Z^YW1Z>&S.MAM(3:5MMUJ[[2NEZV/I/P=^V??66V/5[2.X0>6IEA/E28'
M$CLAW([GA@J^2N01P"-OK4<XDOC5]M5H_/R?X'U&%XJG'2K%2VUC[K\W;5-^
M2Y5^GV#X$^->A?$5EBL;I?M!53]GD!CER5+%0K8$A4*V_P HNJXSNP03[U#&
M0K:1>O9Z/_@_*Y]I@\VHXO2$M;+W7H]KVUWM;6U['JM=IZX4 % !0 4 % 'A
M?C[]HOP_\/9/(FF:YN VUX;8+(R8+ [V+*BE2NUD+>8"0=F#FO-KYA3HZ-W?
M9:_\#Y;G@8W/*.$=F^9WU4;-K??5);:J]_(^-O%W[8.NZTQ73TAL(]RE2%$T
MN N"K/(-A!/S<1JPPHW'!+>!5S:<OAM'\7^.GX'Q&)XGK5/@2@K]N9[;7EI_
MY*O\_F76O$%YXDD$U]<37,@4*'FD:1@H)(4%R3C))QTR2>]>1.HYZR;?J[_F
M?*U:\JSO-N3M:\FV[?,QZS,0H * "@ H * "@ H * "@ H * -C1?$%YX;D,
MUC<36TA4J7AD:-BI()4E"#C(!QTR >U:0J.&L6UZ.WY&U*O*B[P;B[6O%M.W
MR/>_#'[5WB7PY'Y4DD-XH5%0W,9+*%!'WXVC9RW&YI"[$@'.2Q/IT\TJ0TT?
MJO\ *WXGT6'XCQ%%6;4M%;F6NGG%Q;\V[GTWX1_;)T?5V":E;S6+%F^<'SX@
MH7(+%563).5VK&P'RDM@G;Z]+-X2^)./XK_/\#ZK#<4TJFE1.&N_Q*UO))^6
MB?KV^LM+U6WUN%;BUECGA?.V2-U=&P2#AE)!P00<'@@CJ*]R,E-73NNZU/L*
M=2-1<T6FGU337;=%^J- H * "@!RT .H * //OBM_P B_JO_ %X7?_HEZY<5
M_#E_AE^3/.S'^!4_Z]S_ /26?B;7YZ?A04 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % '3Z+XVU3PW&8;&]NK:,L6*0SR1J6( +$(P
M&< #/7  [5M"M*&D6UZ-K\CKI8NI15H2E%7O:,FE?Y,]LT7]K'Q3I<A>:>&Z
M4J0(YH$"@Y!W PB)LC&.6*X)^7."/1AFE6.[3]4OTL>[2XDQ$'=M2TVE%6]?
M=Y7^)Z[H'[;4B+$FH:<K-N_>RP3%1M+=4B=6Y"_PF7#,/O*#QW4\Y_FCZM/]
M'_F>S1XL>BG#KJXRMI?HFGT_O:]T>^>$?VGO#7BQA&;AK.0LP"72B,$!=VXR
M M$H/(&YU8L,;>5W>G2S*G4ZV_Q:?CJOQ/H<-Q!AZ^G-RN^TU;I>]TW%?-_H
M>]VEW'?QI-"ZR1R*&1U(965AD,I'!!'((X(YKTT[ZH^BC)25UJFKIK56+%,H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H \3^*GQYTGX5J8Y6^T7AR%M8F4NIV;E,IS^Z0Y7D@L0VY4<!L>=BL=##[Z
MOLO3KV_K0\+,<YIX'1^]+^5-7VOKV6WGK=)GP!X^_:7\0>-I/W,[6%N&RD5L
MS(W!;&^4$.QPV& *QL5#>6I%?,5\QJ5=GRKLM/QW_3R/SK&Y_6Q+T?(KZ*+:
M?7=[O?79=;'SW7EGS84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MB]0>AX/!!&0RD%64E2""16E.HZ;NM&C:C6E0DIP=FGHU_7WKKLS]UZ_2#^@
MH * "@ H * "@ H * "@ H * "@ H X'X@_$S3/AC;BXU*79OW"*-06DE95R
M511^ +,512RAG7<,\M?$QH*\GZ+J_P"ON/.QN/IX*/-4=KWLMV[*^B_5V6JN
MU<^%_''[8^IZHTD>D0QVD)X260"6?AR=V#^Z7<N 4*R;<MB0G:5^<K9O*6D%
M9=WJ]_N_/U/@<7Q14G=4DHKHW[TM]^RNNEG;74^3M:\07GB2037UQ-<R!0H>
M:1I&"@DA07).,DG'3))[UXDZCGK)M^KO^9\=5KRK.\VY.UKR;;M\S'K,Q"@
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M^V?_ ,B_;?\ 7_'_ .B9Z\/./X:_Q+\I'QO%7\"/_7Q?^DS/S)KX\_*PH *
M"@ H * "@ H * /5?A!\4KKX5:DES$S?99&1;N$#<)(@><*2H\Q028VR,-P3
ML9U;MPF)>'E=;=5Y?Y]CU\LS&6!J*2^%M<RWNOO6JZ/]&S]B]*U2'6[>*ZMV
MWPSQI)&V"-R.H93@@$9!!P0".X!K[V,E-)K9JZ^9^UTZBJ14HZJ233\FKK<O
MU1H><^/OBOH_PTCW:C<*LA7<D"_/,_#8VH.0&*E0[;8PW!<5R5\5"A\3^77[
MOEOL>9C<RI8->_+6VD5K)[]/E:[LK]3\\?B)^U3KGC/,5F?[.MCCY86)F/W3
M\T^%88921Y8C^5BC;QS7RV(S.=71>ZO+?IU_RL?FV.XBK8C2/N1_NOWNGVM'
MNNEM'9W/FR[NY+^1YIG:221BSNQ+,S,<EF)Y))Y)/)/->0W?5GR\I.3N]6W=
MMZNY7I$A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?4?PQ_:GUCP?)
M'#J3M?V6X;_,^:X126)*2$@L<L#ME+ A0BM&#N'LX;,YT])>\O/?[_\ /TT/
MK,OXBJX=I5'SQOK?626NSZ[];[631^CW@?QQ8_$2QCO["3?$_#*>'C<8W1R+
MD[7&1D<@@AE+(RL?K*-:-:/-';^M#]-PF+ABX*<'=/[T^S\_^'6AUU;G:% '
M@?Q)_:-T/X=;X?,^UWB[A]G@(;:PW#$LGW(\,NUU^:5<@^417F8C,(4=-WV7
MSW?3;U\CY['Y[1PEU?FDOLQUUUW>RU5GNUV/@CXD_M&ZY\1=\/F?9+-MP^SP
M$KN4[AB63[\F5;:Z_+$V ?*!KYG$9A.MILNR^>[Z[^GD?GF/SVMB[J_+%_9C
MIIKN]WH[/9/L>!UYA\Z% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Z
M-X!^*^L?#23=IUPRQEMSP-\\+\KG<AX!8*%+KMD"\!Q770Q4Z'POY=/N^6^Y
MZ>"S*K@W[DM+ZQ>L7MT^5KJSMU/U%^$OQNTWXN1L+?=#=Q*K2V\A&X @99"/
MOQACMW85@<;D3>F[[+"XV.(VT:W3_K5'ZQEN;4\>O=TDDKQ>_JNZOI?[TKH]
MDKO/;"@ H <M #J "@#S[XK?\B_JO_7A=_\ HEZY<5_#E_AE^3/.S'^!4_Z]
MS_\ 26?B;7YZ?A04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0!Z-X!^*^L?#23=IUPRQEMSP-\\+\KG<AX!8*%+KMD"\
M!Q770Q4Z'POY=/N^6^YZ>"S*K@W[DM+ZQ>L7MT^5KJSMU/O#X;?M<:9XEV6^
MK+]@N3M7S,EK=V.T9W?>BRQ8X<%$1<M,37TN'S6,])^Z^_3I]WST7<_0<!Q+
M3K6C5]R7?>+V6^ZUOOHEO(^N:]P^R"@ H * "@ H * "@ H * "@ H * "@
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MYI-MOJVV^V[,^H,PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_3YVN[NW4\YKD/,"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MN]3\IJ5)5'S2;;?5MM]MV9]09A0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+%8Y&0%B !G YP ,]A7YS6AR2<5T;7W.Q^"8NDJ-24%M&<DK[V3:.8K$Y H
M* "@ H * "@ H * +%I=R6$B30NT<D;!D=25964Y#*1R"#R".0>::=M45&3B
M[K1IW36CN%W=R7\CS3.TDDC%G=B69F8Y+,3R23R2>2>:&[ZL)2<G=ZMN[;U=
MRO2)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#8T#7[KPO
M=17ME*T-Q"VZ.1>H/0\'@@C(92"K*2I!!(K2G4=-W6C1M1K2H24X.S3T:_K[
MUUV9^R/PM^)5K\5=-74+96C.XQS1-R8Y5 ++NP PPP*L.JD9"MN1?O<-B%B(
M\R]&O,_;<NQ\<=3YXZ:V:?1Z:>>^C_)Z'HU=9Z8Y: '4 % 'GWQ6_P"1?U7_
M *\+O_T2]<N*_AR_PR_)GG9C_ J?]>Y_^DL_$VOST_"@H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^NOA
M)^U;?>$MMKK/F7MH-Y\W.^Z4GD#<[@2)G(PY# -P^U%C/NX3-)4])^\M==Y?
MB]?ZUZ'V66<1SH>[5O..NN\_O;U7KKKO9)'Z/:!K]KXHM8KVRE6:WF7='(O0
MCH>#R"#D,I 96!4@$$5]73J*HKK5,_3J-:->*G!W36C7]?>NFS->M#8* "@
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MK?@[;/M=(^BZ]4^F"@ H * "@ H * "@ H * /@C]L?X;?ZGQ!;)Z07>U?\
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M]Y^/XW'U,;+FJ.]KV6R5W?1?J[O17;L<#7*><% !0 4 % !0 4 % !0 4 %
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M_$#Q*=.EI&]G+K)>G1?BU:]M4?'M>"?%A0 4 % !0 4 % !0 4 % !0 4 %
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MJWX77FGSX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5C.6,:*W;YGJUHKI+SN]=].7;8_/"OE3\V"@ H * "@ H * "@ H * "@ H
M^F_V5OAW_P )GK@O)1FVT[;,W/68D^0O#*PPRF3(#+^[V,,.*]C+,/[6=WM'
M7Y].OS^1]5P[@?K%;F?PT[2_[>^SU3W5^JTL]S]5*^T/UP* "@ H * "@ H
M* "@ H \Y^*7Q*M?A5IK:A<JTAW".&)>#)*P)5=V"%&%)9CT4' 9MJ-R8G$+
M#QYGZ)>9YF8X^.!I\\M=;)+J]=/+;5_F]#\A?''CB^^(E])?W\F^5^%4<)&@
MSMCC7)VH,G Y))+,6=F8_"UJTJTN:6_]:'XSB\7/%S<YN[?W)=EY?\.]3D*P
M.(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6
MK9M1HRKR4(*[;T2_K[WTW9^W'A30_P#A&-/M;#?YGV:WBAWXV[O+0)NVY.,X
MSC)QTR:_0Z4/9Q4>R2^Y6/WC#4?8PC"]^6,8WVV27GV-^M3H"@ H * "@ H
M* "@ H KW=W'81O-,ZQQQJ6=V(5551DLQ/  '))X YI-VU9,I**N]$E=MZ*Q
M^7?[07[04GQ)D;3]/9H]+C;D\JURRGAW'41@\QQGG.)'&_:L7QN/Q_M_=C\/
MY_\  [+YOR_)\ZSIXQ\D-*:?HY/N_+LOF];)?+E>,?)A0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'UU^S'\
M<?\ A"[@:3J<^W39<^2S\K!,S \MD;(GRV_@JKD/\@,KGW<MQOLGR2?NO;R?
MZ+]>VI]EP_F_U>7LZC]Q[7Z2OWZ)]>B>NFK/TUKZ\_5 H * "@ H * "@ H
M* "@ H * "@ H _.']M719(-4L;XE?+FM6A49.X-#(SL2,8P1,NW!)R&R!@9
M^3SF%I*7=6^YW_4_,N*Z352$^CA;SO%MO_TI?B?%U?/GPP4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M7W5.HJBNM4S]GHUHUXJ<'=-:-?U]ZZ;,UZT-@H * "@ H * "@ H * "@ H
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MA6,Q3Q5251_:>W9;);+9)*_4Y"L#B"@ H * "@ H * "@ H * "@ H _7O\
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MM_+_ )7WVTLD_O"OI3]!"@ H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 =O:?#37+^-)H=-OI(Y%#(ZVTK*RL,AE(7!!'((X(Y
MKH6&F]5&7_@+_P COC@*TE=0FTU=-0DU;[CT7_AF'Q=_T#__ "8MO_CM=?\
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MA18XXU"HB@*JJHP%4#@ #@ < <5](E;1'W\8J*LM$E9):*Q8IE!0 4 % !0
M4 % 'RK\>?V<K?Q["U]I4<<&IIN9E4*B7.268/T E))*RG[Q.V0[2KQ^+CLO
M59<T=)?=?_@^?W^7R.<Y%'%+GII*:N^B4NNOGV?79]U^85W:26$CPS(T<D;%
M71@5964X*L#R"#P0>0>*^.:MHS\IE%Q=GHT[-/1W*](D* "@ H * "@ H *
M"@ H _2[]D'XAMX@TV72KF9I+BS8&$.5S]F8 *J<[V$; @Y&$5XD#8VJOUV4
MXCGBXMZQV]/^!^&A^I<,8[VM-TY.[@]+V^#1675V?W72\C[!KWC[0* "@ H
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M[M:^2_X/Y>J9\3Q%FOL8^Q@US23YNMHM;=KM/U2Z:IGYLU\D?EX4 % !0 4
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M * "@ H * "@ H * /T7_9R_9R_L#R]:UJ/_ $KA[:V<?ZGN)) ?^6O=$/\
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M7P]0Q%[+DD^L=%M;X=K=7:S?<^3?%W['VNZ*Q;3WAOX]RA0&$,N"N2S)(=@
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M=QW\:30NLD<BAD=2&5E89#*1P01R".".:_0$[ZH_<8R4E=:IJZ:U5BQ3*"@
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M5?\ KPN__1+URXK^'+_#+\F>=F/\"I_U[G_Z2S\3:_/3\*"@ H * "@ H *
M"@ H * "@ H * /KK]C#_D8+G_KPD_\ 1T%>[D_\1_X7^<3[+A7^/+_KV_\
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MT7AW*8N*KSU=WRKHK-J[\[K3MOO:WWA7TI^@A0 4 % !0 4 % !0 4 % !0
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M<&OL<JK^TARO[/Y/;\ONL?JW#.-=>DX/>FTK_P!UWMU>UFNB2L?65>V?8!0
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MR6_^7S/D^),9["CR+>H[:-K16;_1-=;^I^65?&'Y*% !0 4 % !0 4 % !0
M4 % !0 4 ?L'\!OA6OPKTE8I!F\N-LMTQ"95RHQ$&7.4CY ^9@6+N,!]H^[P
M.%^KPMU>KV^[Y?YG[3DV7?4:=G\4K.6V]MM.B]7K=K<]LKT3W0H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#PO]H+XI
M-\+M':6W91?7#>5; A6P>KR;"1D(O0X91(T892K$5YN/Q/L(76[T7^?]=;'@
M9UF/U*E>/Q2=H[/U=F^B]=6KJS/R$KX4_& H * "@ H * "@ H * "@ H *
M/KK]D?X;?\)+J;:M<)FVL,>7N7*O<,/EQE2I\M<N<%71S"PX->[E6'YY<[VC
MMZ_=TW\G8^RX:P'MJGM9+W8;><GMNK:+7>Z?*S]-:^O/U0* "@ H * "@ H
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M,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]5_Z\+O\ ]$O7+BOX<O\
M#+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_
M8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O_P!*@?IK7UY^J!0 4 %
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M5+?RI+[];_C^!^2\38AU*_+TA%+?2[7,W;INE\D?+E>,?)A0 4 % !0 4 %
M!0 4 % !0 4 ?3?[*WP[_P"$SUP7DHS;:=MF;GK,2?(7AE8893)D!E_=[&&'
M%>QEF']K.[VCK\^G7Y_(^JX=P/UBMS/X:=I?]O?9ZI[J_5:6>Y^JE?:'ZX%
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MHKYON_Z_ _<\!@HX*FJ<=;;NR5V]WI]RWT25W8[ZNH]$* "@ H * "@ H *
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
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MXZ?+'1+XI=$O\^RZ^EVOUS\#^!['X=V,=A81[(DY9CR\CG&Z21L#<YP,G@
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MW_EW_P!Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\
M7A:?^B4K]"PO\./^&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0
M4 % 'X(5^9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E
M?H6%_AQ_PQ_)'[KEW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\
M1+URXK^'+_#+\F>=F/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@
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MQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0
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MDK:(_>XQ459:)*R2T5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /DW]L77VTSP_':I*JM=72*\?R[GBC5I#@'G
M"N(BS+C!*J3AL'Q,WJ<M.W=K3R6OYV/C^**W)144_BFKK2[23?X-+5>7<_,*
MOCC\I"@ H * "@ H * "@ H * "@ H ^V?V)]#^T:AJ%_OQY-O'#LQ][SWW[
MMV>-ODXQ@YW9R-O/T.30O*4NR2^]W_0^[X3HWG.=]HJ-O\3O_P"V?B?HM7U9
M^EA0 4 % !0 4 % !0 4 % !0 4 % !0!Y5\<=%CU[PUJ<,I8*MK),"I .Z
M><@Y!X+( W<KD @X(XL;#GIR3[-_=K^AY&;TE5P]1/\ D;T[Q]Y?BM3\9:^
M/Q * "@ H * "@ H * "@ H * "@"Q:7<EA(DT+M')&P9'4E65E.0RD<@@\@
MCD'FFG;5%1DXNZT:=TUH[G[D>%-<_P"$GT^UO]GE_:;>*;9G=M\Q ^W=@9QG
M&<#/7 K]&I3]I%2[I/[U<_?,-6]M",[6YHQE;?=)^7<WZU.@* "@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
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M%G=B69F8Y+,3R23R2>2>:_-F[ZL_G^4G)W>K;NV]7<KTB0H * "@ H * "@
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M?:T:,:,>6.W]:GZ]A,)#"04(*R7WM]WY_P##+0ZZMSM"@ H * "@ H * "@
MH * "@ H _/C]MCQ+YEQI^F*T@V1R7$BY_=MYC>7&<9Y=?+EY(^4/P3N8#Y?
M.:FL8^3?EKHOR9^<<65[RA3UT3D^VKLOFK/[_-GPO7S9\ % !0 4 % !0 4
M% !0 4 % !0!])_LG:+)JGBF"9"H6UAGFD!)R5*&$!< Y.Z53S@;0QSG /KY
M7#FJI]DW^%OU/J.&Z3GB$U]F,F_2W+^<D?JY7VI^O!0 4 % !0 4 % !0 4
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M\,?R1^ZY=_ I_P#7N'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
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M9)?>[_H?=\)T;SG.^T5&W^)W_P#;/Q/T6KZL_2PH * "@ H * "@ H * "@
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MP:K_ -?]W_Z.>OSW%?Q)?XI?FS\*S'^/4_Z^3_\ 2F<#7*><% !0 4 % !0
M4 % !0 4 % !0!^@_P"Q'JDTMOJ=JS9ACDMY$7 X>59%<YQDY$2#!) V\ $G
M/U&32;4ET33^^_\ DC]'X2J-QJ1Z)Q:7FU)/_P!)1]T5](??A0 4 % !0 4
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MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X?^DH] 6NH]$=0 4
M>??%;_D7]5_Z\+O_ -$O7+BOX<O\,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H
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MT+"_PX_X8_DC]UR[^!3_ .O</_24=]74>B% !0 4 % !0 4 % !0 4 % !0
M4 % !0!D:_H%KXHM9;*]B6:WF7;)&W0CJ.1R"#@JP(96 8$$ UG4IJHK/5,Q
MK48UXN$U=-:I_P!?<^FZ/R;^-WP1NOA'=;EW3:=,Q$$Y'(/7RI<<"0#.#PLB
M@LH!#HGQ.-P3P[[Q>S_1^?Y_E^/YME,L!+O!OW9?H_/\]UU2\+KS3Y\* "@
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MH?"/_+S_ +A_^WGWO7TQ^AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!^%_BO7/^$GU"ZO\ 9Y?VFXEFV9W;?,<O
MMW8&<9QG SUP*_.*L_:2<N[;^]W/P+$UO;3E.UN:4I6WW;?EW,"LCF"@ H *
M "@ H * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^
M!3_Z]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 % !0 4 % 'XG?%;_D8-5_
MZ_[O_P!'/7Y[BOXDO\4OS9^%9C_'J?\ 7R?_ *4S@:Y3S@H * "@ H * "@
MH * "@ H * /JK]CS5(=/\2-'(VU[BSECB&"=SAHY2. 0/DC=LG XQG) /M9
M3)*IKUBTOO3_ "1]=PO44*]G]J$DO6\9?E%GZBU]D?K 4 % !0 4 % !0 4
M% 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9/SP*
M "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/
MW7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%
M?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4
M% !0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_
M )%_2O\ KPM/_1*5^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\
M5O\ D7]5_P"O"[_]$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H
M* "@ H * "@ H * "@ H ^NOV,/^1@N?^O"3_P!'05[N3_Q'_A?YQ/LN%?X\
MO^O;_P#2H'Z:U]>?J@4 % !0 4 % !0 4 % !0 4 % 'YL_MIZ7-%K%G=,N(
M9+/RT;(Y>*5V<8SD8$J') !W<$D''R6<1:FGT<;?<W_FC\PXKIM58RZ.%D_-
M2;?_ *4CXVKP#X@* "@ H * "@ H * "@ H * "@#U7X':U)H/B73)H@I9KJ
M.$A@2-LY\ESP1R%<E>P;!((R#VX*?)4BUW2^_3]3U\HJNEB*;7\Z6O:7NO\
M!Z'[-5]^?MX4 % !0 4 % !0 4 ?!'[<'_,)_P"WS_VA7S.=?9_[>_\ ;3\\
MXM_Y=_\ <3_VP^!Z^9/SP* "@ H * "@ H * "@ H * "@ H _>^OTP_H8*
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MQD\K&I#,"2B/Z6"P3Q#[16[_ $7G^7Y_093E,L?+M!/WI?HO/\MWT3_630-
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M/Q/.S&I[.C.5[6A*SO;6S2U[WM;S/Q.K\]/PH* "@ H * "@ H * "@ H *
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MN'_I*.^KJ/1"@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
MH * "@ H * /WOK],/Z&"@ H * "@ H * "@#S+Q+\9O#WA+<+O4+=760QM&
MC>;(KC.0T<0=UQ@@E@ #\I() /'4QE.GO);V[O[E=GE5\UH4/BG'1V:3YG?S
M4;M;=CYL\3_MJV<4>-+L9I)"K_-<LL:HV!L.V-I#(,Y++NC.  &YRODU,Y7V
M4_GI^5[_ ('R^(XKBE^[@V[/XK))]-$Y7\]5ZGSYXE_:H\3^(=RI/':1M&49
M+>,+G.<L'D\R17P< HZ[< C#9)\JIF=2?6VG1?YW?XGSE?B+$5=FHIJUHJWS
MN[M/T:\M3P/5-5N-;F:XNI9)YGQNDD=G=L  99B2<  #)X  Z"O-E)S=V[ON
M]3YVI4E4?-)MM]6VWVW9GU!F% !0 4 % !0 4 % !0 4 % !0 4 % '[H>%-
M#_X1C3[6PW^9]FMXH=^-N[RT";MN3C.,XR<=,FOT>E#V<5'LDON5C]^PU'V,
M(PO?EC&-]MDEY]C?K4Z H * "@ H * "@ H * "@ H * "@ H * "@ H R-?
MT"U\46LME>Q+-;S+MDC;H1U'(Y!!P58$,K ,"" :SJ4U45GJF8UJ,:\7":NF
MM4_Z^Y]-T?DW\;O@C=?".ZW+NFTZ9B()R.0>OE2XX$@&<'A9%!90"'1/B<;@
MGAWWB]G^C\_S_+\?S;*98"7>#?NR_1^?Y[KJEX77FGSX4 % !0 4 % !0 4
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M;_Q/\HGZIPK_  )?]?'_ .DP/KFO</L@H * "@ H * "@ H * "@ H * "@
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M 4 % !0!^]]?IA_0P4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * "@#]%
M_"W[9>F0V,":E!>->+&JS/&D+([KP7'[R/&[&XJ% 4DJ,@!C]72S>*BN9.]M
M;)?YH_2\/Q334$JBGS)*[2BTWWWCOO:VFQO_ /#9_A__ )]K_P#[]P__ !^M
M?[8I]I?<O_DCI_UJH?RS^Z/_ ,F'_#9_A_\ Y]K_ /[]P_\ Q^C^V*?:7W+_
M .2#_6JA_+/[H_\ R8?\-G^'_P#GVO\ _OW#_P#'Z/[8I]I?<O\ Y(/]:J'\
ML_NC_P#)A_PV?X?_ .?:_P#^_</_ ,?H_MBGVE]R_P#D@_UJH?RS^Z/_ ,F8
M^M?MJZ7!&#8V-U-)N&5F:.%0N#DAD:8DYP-NT#!)W#&#G/.8KX4WZV7Y7,:O
M%=-+W(2;O]JT5;U3E^7S/&_%'[8^N:KYB6$-O9QMMV-@S3)C!;YGQ&V2".8N
M%./O#?7!5S><OA27XO\ '3\#P\1Q16G=048K2WVI+;J]/_)=O/4^?/%WQ(UC
MQVQ.I7DTZEE;RRV(@RKM#+$N(U.,C*J"<L3RQ)\JKB)U?B;?ET^[8^<Q./JX
MK^))O6]KZ72MLK)?)'$5SG % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 :&
MEZ5<:W,MO:Q23S/G;'&C.[8!)PJ@DX ).!P 3T%7&+F[)7?9:FE.G*H^6*;;
MZ)-OOLC]#OV??V:6\*2+JNN1J;Q&S;V^5=82#Q*Y4E6D[Q@$K&,/DR8\KZG
M9=[/WI[]%O;S]>W;UV_2LER'V#]I67O)^['1I>;M=-]NV^^WVC7T!]P% !0
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MJJC 50.  . !P!Q7V25M$?K$8J*LM$E9):*Q8IE!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % !0!^FW[&'
M_(OW/_7_ "?^B8*^PR?^&_\ $_RB?JG"O\"7_7Q_^DP/KFO</L@H * "@ H
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M]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H * "@ H *
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M_P#2F?LO#_\ NT/^W_\ TN1[Y7IGT(4 % !0 4 % !0 4 % !0 4 % !0 4
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M?_<3_P!L/@>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H *
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M_7_'_P"B9Z\/./X:_P 2_*1\;Q5_ C_U\7_I,S\R:^//RL* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?F5^V?_ ,C!;?\
M7A'_ .CIZ^0SC^(O\*_.1^5\5?QX_P#7M?\ I4SY%KPCXT* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0!\$?MP?\PG_M\_\ :%?,YU]G_M[_ -M/
MSSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E
M?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'?5U'HA0 4 % !0 4 % !
M0 4 % 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9
M/SP* "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_A
MC^2/W7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A
M0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN
M7?P*?_7N'_I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_)GG9
MC_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H ^NOV,/^1@N
M?^O"3_T=!7NY/_$?^%_G$^RX5_CR_P"O;_\ 2H'Z:U]>?J@4 % !0 4 % !0
M 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@
M>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H * "@ H * "@#
MX(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N'_I*.^KJ/1"@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
M'E_U[?\ Z5 _36OKS]4"@ H * "@ H * "@ H * "@ H ^"/VX/^83_V^?\
MM"OF<Z^S_P!O?^VGYYQ;_P N_P#N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4
M % !0 4 ?O?7Z8?T,% !0 4 % !0 4 % 'P1^W!_S"?^WS_VA7S.=?9_[>_]
MM/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % !0 4 % !0 4 % !0!R/CCQQ8_#NQDO[^39$G"J.7D<YVQQKD;G.#@<
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M,OX4OE_Z4CY[B#_=I_\ ;G_I<3\C*^&/QH* "@ H * "@ H * "@ H * "@
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M -H5\SG7V?\ M[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H *
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M'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M[<;N,YP,>A# TX;17SU_.Y[=')L/2O:$=?YO?_\ 2KV^1Z[7<>R% !0 4 %
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
M"@ H * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_
M "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1?TK_
M *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H *
M/@C]N#_F$_\ ;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0
M 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N
M'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_P#;Y_[0KYG.OL_]O?\
MMI^><6_\N_\ N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1
M?TK_ *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@
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MZT-@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC7(W.<' X
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M/#I+[,I)^M^;\I(^DZ]<^H"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[8_"G_D7]*_Z\+3_P!$I7Z%A?X<?\,?R1^ZY=_ I_\ 7N'_ *2COJZC
MT0H * "@ H * "@ H * "@ H _!"OS,_GD* "@ H * "@ H * "@ H * "@#
M]L?A3_R+^E?]>%I_Z)2OT+"_PX_X8_DC]UR[^!3_ .O</_24>@+74>B.H *
M//OBM_R+^J_]>%W_ .B7KEQ7\.7^&7Y,\[,?X%3_ *]S_P#26?B;7YZ?A04
M% !0 4 % !0 4 % !0 4 % !0!]=?L8?\C!<_P#7A)_Z.@KW<G_B/_"_SB?9
M<*_QY?\ 7M_^E0/TUKZ\_5 H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 =O\-+2._P!<TV&9%DCDOK971@&5E:5058'@@C@@\$<5T897G%/^:/YH
M[\!%2K03U3J033U5N9'[<5^B'[N% !0 4 % !0 4 % 'P1^W!_S"?^WS_P!H
M5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H * "@ H * "@
M H * /VB^#GA:'PAH-C;QP?9Y&MXI)T*E7,[HIE,F[YM^[@AON@!  JA1^@8
M2DJ<$K6T3?JUJ?N.5X=8>C"*7*W&+DK6?,TKWOK>_P!VVR/3:[#U0H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC
M7(W.<' X  +,516885JT:,>:6W]:'%B\7#"0<YNR7WM]EY_\.]#\C/BI\5+[
MXL7QNKH[(DRMO;J<I$A[#IN<X!=R 6('"HJ(OPV*Q4L1*[VZ+M_75GXWF.8S
MQT^:6B7PQZ)?Y]WU]+)>8UQGE!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?HO^SE^T;_;_EZ+K4G^E<);7+G_ %W81R$_\M>R.?\ 6_=/[W!E^KR_
M,.?W)[]'W\GY_GZ[_I>19[[6U*J_>VC)]?)^?9]?7?[8KZ$^["@ H * "@ H
M * "@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H *
M "@#]%_V)]<^T:?J%ALQY-Q'-OS][STV;=N.-ODYSDYW8P-O/U>33O&4>S3^
M]6_0_2^$ZUX3A;:2E?\ Q*W_ +9^)]L5]"?=A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ' _%;_D7]5_Z\+O\ ]$O7
M+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$ZOST_"@H * "@ H * "@ H * "@ H
M* "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/W7+OX%/_ *]P_P#24=]7
M4>B% !0 4 % !0 4 % !0 4 % !0 4 % !0!^87[9-W'<>(H51U9H[&)9 ""
M48R2N%8#H=K*V#SM93T(KX[-W>HO**_-L_*>*9)UU;I3BGY/FD_R:9\FUXA\
M>% !0 4 % !0 4 % !0 4 % !0!ZK\#M%DU[Q+ID,14,MU',2Q(&V ^<XX!Y
M*H0O8M@$@9([<%#GJ12[I_=K^AZ^44G5Q%-+^=/7M'WG^"T/V:K[\_;PH *
M"@ H * "@ H * /@C]N#_F$_]OG_ +0KYG.OL_\ ;W_MI^><6_\ +O\ [B?^
MV'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%
M_AQ_PQ_)'[KEW\"G_P!>X?\ I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_
M )A/_;Y_[0KYG.OL_P#;W_MI^><6_P#+O_N)_P"V'P/7S)^>!0 4 % !0 4
M% !0 4 % !0 4 ?MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X
M?^DH[ZNH]$* "@ H * "@ H * "@ H * /P0K\S/YY"@ H * "@ H * "@ H
M * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1Z
MM=1Z(Z@ H \^^*W_ "+^J_\ 7A=_^B7KEQ7\.7^&7Y,\[,?X%3_KW/\ ])9^
M)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'UU^QA_R,%S_UX2?^CH*]W)_X
MC_PO\XGV7"O\>7_7M_\ I4#]-:^O/U0* "@ H * "@ H * "@ H * "@#X(_
M;@_YA/\ V^?^T*^9SK[/_;W_ +:?GG%O_+O_ +B?^V'P/7S)^>!0 4 % !0
M4 % !0 4 % !0 4 ?3?[)&A_VMXGCFW[?LEO--C&=^X"#;G(V_ZW=GG[N,<Y
M'L95#FJ7[)O]/U/JN&J/M,0G?X(REZ_9_P#;K_(_52OM#]<"@ H * "@ H *
M "@#XG_;8T/[1I^GW^_'DW$D.S'WO/3?NW9XV^3C&#G=G(V\_/9S"\8R[-K[
MU?\ 0^$XLHWA"=]I.-O\2O\ ^V?B?G17RA^:!0 4 % !0 4 % !0 4 % !0
M4 % '[WU^F']#!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M3_ _1ZOK#]-"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#-)3Q%W]F$FO72/Y29^IE?9GZT% !0 4 % !0 4 % !0!\$?MP?\PG_M\_\
M:%?,YU]G_M[_ -M/SSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@
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MR2268L[,Q^&K5I5I<TM_ZT/QO%XN>+FYS=V_N2[+R_X=ZG(5@<04 % !0 4
M% !0 4 % !0![I\-?V>=:^*%JU[:^3#;AMJ27#.@E(R&\L*CDA2,%B N[*@D
MJX7TL/@)UU=62\[Z_<F?08#)*N-CSQLE?1R;5^]K)[=_ET=N)^(/PSU/X8W
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M\K'[GEDE*A3MK^[@M.ZBD_N:LST:NL],* "@ H * "@ H * "@ H * "@ H
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MA'[J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % 'YI?MD^$5TC6+?4D"A;Z$A_F8L98-JEB#P!L:)5VGDJQ*@\M\CF
M]+EFI?S+\5_P+'Y;Q3AO9U547VXZ[WO&RO\ <TM.S^?Q[7@GQ84 % !0 4 %
M !0 4 % !0 4 % 'Z+_L3ZY]HT_4+#9CR;B.;?G[WGILV[<<;?)SG)SNQ@;>
M?J\FG>,H]FG]ZM^A^E\)UKPG"VTE*_\ B5O_ &S\3[8KZ$^["@ H * "@ H
M* "@ H * "@ H * "@ H _"CQ!K4GB2\N+Z8*)+F:29PH(4-(Q<A023C)XR2
M<=S7YO4GSMR?5M_?J?S_ %ZKK2<WO*3;MM=NYCUF8A0 4 % !0 4 % !0 4
M% !0 4 ?JY^R=HL>E^%H)D+%KJ:>:0$C 8.80%P!@;8E/.3N+'., ?:Y7#EI
M)]VW^-OT/U[ANDH8=-?:E)OUOR_E%'TG7KGU 4 % !0 4 % !0 4 % 'P1^W
M!_S"?^WS_P!H5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H
M * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+_#C_ (8_DC]UR[^!3_Z]
MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * "@#ZZ_8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O
M_P!*@?IK7UY^J!0 4 % !0 4 % !0 4 % !0!@>*]<_X1C3[J_V>9]FMY9MF
M=N[RT+[=V#C.,9P<=<&LJL_9Q<NR;^Y7.?$UO8PE.U^6,I6VV3?GV/POK\X/
MP$* "@ H * "@ H * "@ H * "@ H _=#PIH?_",:?:V&_S/LUO%#OQMW>6@
M3=MR<9QG&3CIDU^CTH>SBH]DE]RL?OV&H^QA&%[\L8QOMLDO/L;]:G0% !0
M4 % !0 4 % !0!^*WQ=T!O#/B#4;4Q+"JW4K1QKM"K%(WF1;0O &QE(48VCY
M2 00/S[%T_9U)+;5Z>3U7X'X9F='V-:<;6]]V2M:S=UMY-:=#SFN0\P* "@
MH * "@ H * "@ H * "@#]5/V2-<_M;PQ'#LV_9+B:'.<[]Q$^[&!M_UNW'/
MW<YYP/M,JGS4[=FU^OZGZYPU6]IATK?!*4?7[7_MUOD?3=>P?5!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5Z1(4 % !0 4 % !0 4 % !0!]L_LY?M&_V!Y>BZU)_HO"6URY_U/81R$_\
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M%&$[W;BKNUO>6CZ+JGY=M#OJZCT0H * "@ H * "@ H * "@ H * "@ H *
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M_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0 4 %
M!0 4 % !0!\$?MP?\PG_ +?/_:%?,YU]G_M[_P!M/SSBW_EW_P!Q/_;#X'KY
MD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\ 7A:?^B4K]"PO\./^
M&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A0
M4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_PQ_)'[KE
MW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\ 1+URXK^'+_#+\F>=
MF/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_8P_P"1
M@N?^O"3_ -'05[N3_P 1_P"%_G$^RX5_CR_Z]O\ ]*@?IK7UY^J!0 4 % !0
M 4 % !0 4 % !0!^=/[9_C'[;?6FD1ME+>,S2A9,CS)>$5XQP'1%W*6R=LW
M .6^4SBM>2AV5WKU?EZ?F?FG%6*YIQI+[*YGKU>UUW25UY2^_P")J^>/A H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MP2-V<8&!7Y]B:WMIN7=_@M%WZ(_#,PQ?UNK*IMS/3T2275ZV2OYG URGG!0
M4 % !0 4 % !0 4 % !0!8M+22_D2&%&DDD8*B*"S,S' 50.22> !R3Q32OH
MBHQ<G9:MNR2U=S]H?A1X!C^&FCV^G+M,BKNG=<?/,_+MG:I8 _*A8;A&J*>E
M?H&%H>P@H_?Z]>WR\C]QRW!+!THPZI7D^\GOT5^ROK9(]&KK/3"@ H * "@
MH * "@ H * *]W:1W\;PS(LD<BE71@&5E88*L#P01P0>".*35]&3**DK/5-6
M:>JL?B?\2/"+>!-8O--(8+!,PCW,K,8C\T3,5XRR%6. ,$X*J<@?GF(I>RFX
M]G^'3\#\*Q^&^JU94_Y9.U[-VW3T[IIG$5SG % !0 4 % !0 4 % !0 4 %
M!0!^JG[)_C'_ (2;P\EM(VZ:QD:$[I-[F,_/$Q!Y1 &,2#D8B.#@;5^TRNMS
MT[=8NV]]-U_DO0_7.&\5[:ARO>#<=[NVZ]%K9>FG9?3=>P?5!0 4 % !0 4
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MKS3L]C/J#,* "@ H * "@ H * "@ H * /JK]G+X\S> KB/2KYM^F3R!59F
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MA7S.=?9_[>_]M/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H
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M!!%?=4ZBJ*ZU3/V>C6C7BIP=TUHU_7WKILS7K0V"@ H * "@ H * "@ H *
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MN9^B7D?B&8X^6.J<\M-+)+HM=//?5_DM#SFN0\P* "@ H * "@ H * "@ H
M* /5?@S\-6^*FL1V!9D@"M+<2+MW+$F =H8]68J@(#;2V\JRJ17;@\/]8GR]
M-WZ?UH>OE6 ^O55#96;DU:]EZ]VTNMKWL['[)6EI'81I#"BQQQJ%1% 5551@
M*H'  '  X XK[Y*VB/VV,5%66B2LDM%8L4R@H * "@ H * "@ H ^+OVLOA
MNMVIU^R11<6R_P"EA48O-%\H5_ER,Q#)8D#]UDEP(E4_/YIA.9>T6ZW\U_P/
MRZZ'P_$F6>TC[:"UBO>LG=K17T[=?+=Z)'YPU\F?F(4 % !0 4 % !0 4 %
M!0 4 % 'WQ^RM\<>F@:K/_=6P=_Q!@+D_P"[Y (_O1AO]5'7TV68W_EW)_X?
M\O\ +[NR/T/AW-_^7-1]E!O_ -)O_P"D_=?X4?>]?3'Z&% !0 4 % !0 4 %
M !0 4 % 'YL_MC^!VTO4X=7CCQ#=QB.5QO/[^(8&[(VKNCV! "-WER';D%F^
M2S>CRR4UM)6>^Z_X'Y,_,.*,)R5%52TFK-Z_$OP5U:W>ST/C:O /B H * "@
M H * "@ H * "@ H * /1OA;\2KKX5:DNH6RK(-ICFB;@21,067=@E3E058=
M& R&7<C=>&Q#P\N9>C7D>GEV/E@:G/'72S3ZK33RVT?YK0_7OP/XXL?B)8QW
M]A)OB?AE/#QN,;HY%R=KC(R.000RED96/W5&M&M'FCM_6A^S83%PQ<%.#NG]
MZ?9^?_#K0ZZMSM"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * /Q]_:%\#KX"\0W,$,?EVTVVX@7Y,;)/O!50 *BR"1$4
M@$*HZC#'X3'T?8U&EL]5MU]/.Z/Q;.\)]5KR25HOWH[;/TV2=TEV1XE7G'A!
M0 4 % !0 4 % !0 4 % !0!O^%O$MQX.OH-0M6VS6\BNO+ ''56VE24895P"
M-RDKT-:TJCIR4ENF=.'KRP\U..\6GU^[2VCV?='[4^#?%UKX[L(-2LRQ@G4E
M=R[6!!*LK#U5@5."5)&59EP3^@T:JJQ4ELS]SPN)CBH*I#:2ZZ/>S7R:M^1T
M];'4% !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@ #DD\ <
MTF[:LF4E%7>B2NV]%8_'WXY_$Z3XGZQ+.LC-90LT=HF3M$8P"X!52#*1O;<-
MX!5"2$7'PF-Q/MYM]%HO3OTWW_#H?BV;Y@\;5;O[J=HKI;OLM[7UUV71'C5>
M>>(% !0 4 % !0 4 % !0 4 % %BTM)+^1(84:221@J(H+,S,<!5 Y))X ')
M/%-*^B*C%R=EJV[)+5W/V*^!WP[_ .%9Z'!9N,7+_OKGG_EM(!E>&=?D4+'E
M#M;9OP"QK[W!8?V$$NN[]7\WZ'[7E&!^IT5%_$_>E_B?S:T5EIH[7ZGKM=Q[
M(4 % !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%?,YU]G_M[_VT_/.+?^7?
M_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H _;'X4_\B_I7_7A:?^B4
MK]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 % 'P1^
MW!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@
MH * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z
M]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 %
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MO)>?Y>NWPF>Y[[*]*D_>VE)=/)>?=]/7;\Z*^4/S0* "@ H * "@ H * "@
MH * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6K9M
M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [DMXPI;D;W)+2/@LQ&YRS;<D+
MG:. *_0:%)48J*Z+_A_Q/W/!X586G&FOLK?N]V]WNVW;H==6YVA0 4 % !0
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MGH^OW[=#]2P.;T<9I%VE_++277Y/17T;LM['KM=Q[(4 % !0 4 % !0 4 %
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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M# '#*K9 ^!K4G2DXO='XGBL-+"S=.6\7TU6UT_FG?\SF*Q.0* "@ H * "@
MH * "@ H * /=/V??BDOPNUA9;AF%C<+Y5R &; ZI)L!&2C=3AF$;2!5+,!7
MI8#$^PG=[/1_Y_UTN?09+F/U*K>7PR5I;OT=D^C]=&[*[/U[K[H_9@H * "@
M H * "@ H * "@ H _.G]KCX3?V3<+KMC#B";(O-B_*DQ;Y96^;CS=VTD*J[
MURS&27GY3-<+ROGBM'OZ]_G^?FS\TXERWV<O;06C^.RVE?=Z];VVM=:ZR/B:
MOGCX0* "@ H * "@ H * "@ H * "@ H W_#7BF^\'W"W6GSR6\RX^9&QD!@
MVUAT="5!*,"K8Y!%:TZLJ;O%V9TT,1/#RYH-Q?=/SO9]UIL]&?HO\-OVN-,\
M2[+?5E^P7)VKYF2UN[':,[OO198L<."B(N6F)KZO#YK&>D_=??IT^[YZ+N?I
M> XEIUK1J^Y+OO%[+?=:WWT2WD?6-I=QW\:30NLD<BAD=2&5E89#*1P01R".
M".:]M.^J/L(R4E=:IJZ:U5BQ3*"@ H * "@ H * .8\3^---\&1^;J-U#;*5
M=E$C@,X0 ML3[SD9'RH&8D@ 9(!QJ5HTM9-+U?;\SEQ&+IX=7G)1T>[U=M[+
M=^B/F7Q=^V3H^D,4TVWFOF#+\Y/D1%2N25+*TF0<+M:-0?F(; &[QZN;PC\*
M<OP7^?X'RN)XII4]*:<]=_A5K>:;\M4O7O\ +OB7]JCQ/XAW*D\=I&T91DMX
MPN<YRP>3S)%?!P"CKMP",-DGQJF9U)];:=%_G=_B?)U^(L15V:BFK6BK?.[N
MT_1KRU/ ]4U6XUN9KBZEDGF?&Z21V=VP !EF))P  ,G@ #H*\V4G-W;N^[U/
MG:E251\TFVWU;;?;=F?4&84 % %BTNY+"1)H7:.2-@R.I*LK*<AE(Y!!Y!'(
M/--.VJ*C)Q=UHT[IK1W/U%_9]_:"C^),:Z?J#+'JD:\'A5N54<N@Z"0#F2,<
M8S(@V;EB^RP&/]O[LOB_/_@]U\UY?K&2YTL8N2>E1+T4EW7GW7S6ETOJ*O9/
MK H * "@ H * "@ H * "@#\^/VH?@--%--XATU=\3_/>0JH!C('S3*% W(<
M;I<Y96+2DLC,8_E\RP+NZD=NJ_7_ #^_T_..(<F:;KT]4]9I+;^\K=.LNJ=W
MM>WPO7S9\ % !0 4 % !0 4 % !0 4 % !0!ZK\-?C-K'PK9A82*8';=);RK
MOB9MI4-@$,IZ$E&4MM4-N50*[</C)X?X=NSV_KT/7P&:U<#\#T;NXM75[6\F
MODU>RO>Q^CWPV_:-T/XB[(?,^R7C;1]GG(7<QVC$4GW),LVU%^65L$^4!7UF
M'S"%;39]G\MGUW]?(_3L!GM'%V5^63^S+3739[/5V6S?8]\KTSZ$* "@ H *
M "@#D?&'CW3/ ,(GU.YCMT;[H8DN^"H.R-07?&Y=VU3M!R<#FL*M>-%7D[?U
MVW.+%8RGA5>I)1_-[;)7;WULM#XF^+O[7']J0RV&@+)&'RK7K':^W+!O)3JN
MX;2LC%74%AY:.%=?GL7FO,G&GI_>_P O\]_*Y\+F?$O.G"C=7TYWH^NRZ7TL
MWJNR>I\/W=W)?R/-,[222,6=V)9F9CDLQ/))/))Y)YKYQN^K/@I2<G=ZMN[;
MU=RO2)"@ H * "@ H * "@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@
M#)9B0JJ"Q( )K2G3=1V6K9M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [D
MMXPI;D;W)+2/@LQ&YRS;<D+G:. *_0:%)48J*Z+_ (?\3]SP>%6%IQIK[*W[
MO=O=[MMVZ'75N=H4 % !0 4 % !0 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\S
MG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M_;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1WU=1Z(4 %
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MO_\ P+F_^+H^M5/YI?\ @3_S#^T:_P#S\G_X'+_,/^%K>(/^@K?_ /@7-_\
M%T?6JG\TO_ G_F']HU_^?D__  .7^8?\+6\0?]!6_P#_  +F_P#BZ/K53^:7
M_@3_ ,P_M&O_ ,_)_P#@<O\ ,X&N4\X* "@ H * "@ H * "@ H * "@ H *
M "@#ZC_9]_9]D^),BZAJ"M'I<;<#E6N64X*(>HC!XDD'.<QH=^YHO9P& ]O[
MTOA_/_@=W\EY?69+DKQCYYZ4T_1R?9>7=_):W:_4ROLS]:"@ H * "@ H *
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M/B#+/K4.>"O."V25VKZKOINOFDKL_+*OC#\E"@ H * "@ H * "@ H * "@
MH _3W]E#XI-XPTUM+NF7[58*BQ\*I>V "IP#EC&1L=@H 4Q9+.S$_8Y7B?:1
MY7O&UO3_ ('^1^K<.9C]8I^SE\5-*VRO#9==;;-V[;MGUE7MGV 4 % !0 4
M% !0 4 % !0!0U72X=;MY;6X7?#/&\<BY(W(ZE6&001D$C((([$&IE%333V:
ML_F9U*:J1<9:J2::\FK/8_)/XW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R
M*"R@$.B?#XW!/#OO%[/]'Y_G^7X[FV4RP$N\&_=E^C\_SW75+PNO-/GPH *
M"@ H * "@ H * "@ H * "@ H W]#\5ZAX8W_8+JXMO,QO\ )E>/=MSMW;",
MXR<9Z9/K6L*LJ?PMJ_9M?D=-'$SHWY)2C??EDUMZ-=SU6T_:5\664:1+J+%4
M4*"T,#M@# W.\99CZLQ+$\DD\UVK,:JTYOP3_-'KQS[$Q5N?9=8P;^]Q;?JR
MQ_PT]XN_Z"'_ )+VW_QJG_:57^;\(_Y%?ZP8G^?_ ,DA_P#(A_PT]XN_Z"'_
M )+VW_QJC^TJO\WX1_R#_6#$_P __DD/_D0_X:>\7?\ 00_\E[;_ .-4?VE5
M_F_"/^0?ZP8G^?\ \DA_\B'_  T]XN_Z"'_DO;?_ !JC^TJO\WX1_P @_P!8
M,3_/_P"20_\ D0_X:>\7?]!#_P E[;_XU1_:57^;\(_Y!_K!B?Y__)(?_(G(
MZI\:/$FKS-/)JEXKMC(CF:). !Q'$41>G.U1DY)R22<)8RI)WYG\FU^"LCBJ
M9K7J.[J3U[2<5]T;+\#S&N,\H* "@ H * "@ H * +%I=R6$B30NT<D;!D=2
M5964Y#*1R"#R".0>::=M45&3B[K1IW36CN?J9^SO\=_^%I0FQO1MU.WCWNRK
MA)HP0OF# PC@LH=. 20R?*62/[/+\=]87++XDOO7?_/\/+]:R/./KJY)_'%7
M>FC6BOY/75?-=E]-U[!]4% !0 4 % !0 4 % !0 4 ?EU^T;\!IO 5Q)JMBN
M_3)Y"S*J@?9G=ON%5  B).(F  7B-L-L:3XW,,"Z+YH_"W]U_P!.WW>OY/GN
M3/"R=2&L)/HOA;>VG3L^FSZ7^5:\4^1"@ H * "@ H * "@ H * "@ H * .
M^\+_ !2USP9Y8L+ZXBCBW;(MY:$;L[OW+[HSDL3RI^8[OO<UU4L3.E\,FK=+
MZ?<]#T</F-;#VY)R25[*]XZWZ.ZZ]M]=SOO^&GO%W_00_P#)>V_^-5T_VE5_
MF_"/^1Z/^L&)_G_\DA_\B'_#3WB[_H(?^2]M_P#&J/[2J_S?A'_(/]8,3_/_
M .20_P#D0_X:>\7?]!#_ ,E[;_XU1_:57^;\(_Y!_K!B?Y__ "2'_P B'_#3
MWB[_ *"'_DO;?_&J/[2J_P WX1_R#_6#$_S_ /DD/_D3 USX]>)_$.SSM2N%
MV9QY)%OG=C.[R!'NZ<;L[><8R<Y3QU2>\G\M/RL<U;.<15M><M/Y?<_])M?Y
MGD5<)XP4 % !0 4 % !0 4 % !0 4 % !0 4 ?IM^S'\#O\ A"[<:MJ<&W4I
M<^2K\M!"R@<K@;)7RV_DLJ$)\A,J'[#+<%[)<\E[SV\E^C_3MJ?JG#^4?5X^
MTJ+WWM?I&W;HWUZI:::H^N:]P^R"@ H * "@ H * "@ H * "@ H * /@C]N
M#_F$_P#;Y_[0KYG.OL_]O?\ MI^><6_\N_\ N)_[8? ]?,GYX% !0 4 % !0
M 4 % !0 4 % !0!^V/PI_P"1?TK_ *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]
M>X?^DH[ZNH]$* "@ H * "@ H * "@ H ^"/VX/^83_V^?\ M"OF<Z^S_P!O
M?^VGYYQ;_P N_P#N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^V/PI_
MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
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MHB@*JJHP%4#@ #@ < <5]<E;1'ZE&*BK+1)626BL6*904 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!R/CCP/8_$2QDL+^/?$_*L.'C<9VR1M@[7&3@\@@E6
M#(S*<*U&-:/++;^M3BQ>$ABX.$U=/[T^Z\_^&>A^-OCCP/??#N^DL+^/9*G*
ML.4D0YVR1M@;D.#@\$$%6"NK*/@:U&5&7++?^M3\3Q>$GA)N$U9K[FNZ\O\
MAGJ<A6!Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'Y#GF5?4IWBGR2V\GK[M_P 5?==[-GSG7E'S(4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^B_[.7[.7]@>7
MK6M1_P"E</;6SC_4]Q)(#_RU[HA_U7WC^]P(OJ\OR_D]^>_1=O-^?Y>NWZ7D
M61>RM5JKWMXQ?3S?GV73UV^V*^A/NPH * "@ H * "@ H * "@ H * "@ H
M^"/VX/\ F$_]OG_M"OF<Z^S_ -O?^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0
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M ->%W_Z)>N7%?PY?X9?DSSLQ_@5/^O<__26?B;7YZ?A04 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 6+2T
MDOY$AA1I))&"HB@LS,QP%4#DDG@ <D\4TKZ(J,7)V6K;LDM7<^__ (#?LO0Q
M0KJ7B&'?*^UH;-\@1@$,&F7C<YQCRFRJJ2)%9V*Q_3X'+5;FJ+7I'_/_ "^_
MR_1<FX>27M*ZNW9J#Z=;OS_NO1+=7T7W17TA]^% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 >-_&[X2Q_%S3?LX98KN%C);RLH(#8P48X+"-^-VW
MD,J/A]FQN#&X7ZQ&VS6J?Z>AXF;9:L?3Y=I)WB[=>SZV?6WD];6/R;\7>#;_
M ,"71L]2@:"<*K;2005;HRLI*L.HRI(#!E/S*0/B*M&5)VDK,_'\3A9X67)4
M5G:_39^:NG\O0YBL3D"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMT??^NJ/Q3,<NG@9\LM4_AET:_S[KIZ6;\QKC/*"@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#VWX'_!N;XOWS1E_
M*L[?8US("-^&SM2,'/SOM;#$%4 +')VH_HX+"/$R[);L]W*,K>/G:]HQMS/K
MK>R7F[/79;]D_P!>K2TCL(TAA18XXU"HB@*JJHP%4#@ #@ < <5]TE;1'[/&
M*BK+1)626BL6*904 % !0 4 % !0 4 % !0!D:_H%KXHM9;*]B6:WF7;)&W0
MCJ.1R"#@JP(96 8$$ UG4IJHK/5,QK48UXN$U=-:I_U]SZ;H_)OXW?!&Z^$=
MUN7=-ITS$03D<@]?*EQP) ,X/"R*"R@$.B?$XW!/#OO%[/\ 1^?Y_E^/YME,
ML!+O!OW9?H_/\]UU2\+KS3Y\* "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H L6EI)?R)#"C222,%1%!9F9C@*H'))/  Y
M)XII7T148N3LM6W9):NY^GOP&_9RM_ 4*WVJQQSZF^UE5@KI;8(90G4&4$ M
M*/ND;8SM#/)]C@<O5%<TM9??;_@^?W>?ZMDV11PJYZB3F[/HU'KIY]WTV7=_
M55>T?7!0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?!'[<'_,)_P"WS_VA7S.=
M?9_[>_\ ;3\\XM_Y=_\ <3_VP^!Z^9/SP* "@ H * "@ H * "@ H * "@#]
ML?A3_P B_I7_ %X6G_HE*_0L+_#C_AC^2/W7+OX%/_KW#_TE'?5U'HA0 4 %
M !0 4 % !0 4 % 'P1^W!_S"?^WS_P!H5\SG7V?^WO\ VT_/.+?^7?\ W$_]
ML/@>OF3\\"@ H * "@ H * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+
M_#C_ (8_DC]UR[^!3_Z]P_\ 24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^
M9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/\ T2E?H6%_AQ_P
MQ_)'[KEW\"G_ ->X?^DH] 6NH]$=0 4 >??%;_D7]5_Z\+O_ -$O7+BOX<O\
M,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H * "@ H * "@ H * "@ H * "@ H
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M0PPP&&4@J>#C<J,O)B,-'$*TODUN>9C\NIXZ/+/H]&M&O31[]5^J1^8?Q4^
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M^AAHT%:*]7U?]?<?J>"P%/!1Y::M>UWNW96U?Z*RU=DKG?5U'HA0 4 % !0
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MO%27S79_U^!^XX#&QQM-5(Z7W5T[-;K3[UMHT[*YWU=1Z(4 % !0 4 % !0
M4 % !0 4 <CXX\#V/Q$L9+"_CWQ/RK#AXW&=LD;8.UQDX/(()5@R,RG"M1C6
MCRRV_K4XL7A(8N#A-73^]/NO/_AGH?E'\6O@CJ7PCD4W&V:TE9EBN(P=I()P
MK@_<D*C=MRRD9VN^Q]OQ6*P4L/OJGLU_6C/R',LIJ8!^]K%MVDMO1]G;6WW-
MV9XU7GGB!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MP/URLHOX5[TO\*^:>KLM-5>_0_8JTM(["-(846..-0J(H"JJJ,!5 X  X '
M'%?>I6T1^UQBHJRT25DEHK%BF4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M 4-5TN'6[>6UN%WPSQO'(N2-R.I5AD$$9!(R"".Q!J914TT]FK/YF=2FJD7&
M6JDFFO)JSV/Q&\:>&)/!FI76G2[BUM,\89D*%U!^1]I)P'7#KR058$$C!/YW
M6I^RDXOHVNWS/PC%X=X>I*#^S)K56NNCMYK5',5B<@4 % !0 4 % !0 4 %
M!0 4 ?9/[''CAM+U.;2)),0W<9DB0[S^_B&3MP=J[H]Y<D#=Y<8W9 5O?RBM
MRR<'M)76^Z_X'Y(^WX7Q?)4=)O2:NEK\2_!75[][+4_2:OK3]/"@ H * "@
MH * "@ H * "@ H KW=I'?QO#,BR1R*5=& 965A@JP/!!'!!X(XI-7T9,HJ2
ML]4U9IZJQ\(?%O\ 9$^]=^&_]@&Q=OP9HYI'_P!UBDA_OD2?<CKYK%Y3UI^7
MN_\ !;_/[^A^?9GPS]JAY>XW][4I/\'YZ[(^%]4TJXT29K>ZBD@F3&Z.1&1U
MR 1E6 (R"",CD$'H:^<E%P=FK/L]#X"I3E3?+)--=&FGWV9GU!F% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '3^$?!M_X[NA9Z; T\
MY5FV@@ *O5F9B%4=!EB 6*J/F8 [4J,JKM%79UX;"SQ4N2FKNU^FR\W9+Y^A
M^A_PD_92L?"6VZUGR[V[&\>5C?:J#P#M= 9'QDY<!06X3<BR'ZK"97&GK/WG
MKIO'\5K_ %IU/TG+.'(4/>JVG+73>'W-:OUTUVNDSZYKW#[(* "@ H * "@
MH * "@ H * "@ H * "@"O=VD=_&\,R+)'(I5T8!E96&"K \$$<$'@CBDU?1
MDRBI*SU35FGJK'Q/\7_V28]49[[P^5BE9G>2T<A8C\N0("%^0EAPCGR_GX:)
M$"GY[%Y5S>]3T?;I\NWY>A\)F?#2G>=#1W;<'HMOLZ::]'IKNDK'P!JFE7&B
M3-;W44D$R8W1R(R.N0",JP!&001D<@@]#7S$HN#LU9]GH?G52G*F^62::Z--
M/OLS/J#,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /
M?/AM^SEKGQ%V3>7]DLVVG[1."NY3M.8H_OR95MR-\L38(\T&O3P^7SK:[+N_
MELNN_IYGT6 R*MB[.W+%_:EIIILMWH[K9/N?I;\-?A;IOPJM6MM/5LR-NEFD
M(:60C.W<P"C"@X50 HY.-S.S?78?#1PZM'YM[GZC@,NIX&/+#J]6]6_71;=%
M^K9Z-76>F% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'P1^W!_P PG_M\
M_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9/SP* "@ H * "@ H * "
M@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/W7+OX%/_ *]P_P#2
M4=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%?,YU]G_M[_VT_/.+
M?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H _;'X4_\B_I7_7A:
M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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MVOV5EOH>FUV'JA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?\  _(_,N*<'R355?;5I:.UTE;7S733X6^Y\75\^?#!0 4 % !0 4 % !0
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MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * -_0_"FH>)]_P!@M;BY\O&_R8GDV[L[=VP'&<'&>N#Z5K"E
M*I\*;MV3?Y'31PTZU^2,I6WY8M[^B?8W_P#A5/B#_H%7_P#X"3?_ !%:_5:G
M\LO_  %_Y'1_9U?_ )]S_P# )?Y!_P *I\0?] J__P# 2;_XBCZK4_EE_P"
MO_(/[.K_ //N?_@$O\@_X53X@_Z!5_\ ^ DW_P 11]5J?RR_\!?^0?V=7_Y]
MS_\  )?Y!_PJGQ!_T"K_ /\  2;_ .(H^JU/Y9?^ O\ R#^SJ_\ S[G_ . 2
M_P @_P"%4^(/^@5?_P#@)-_\11]5J?RR_P# 7_D']G5_^?<__ )?Y!_PJGQ!
M_P! J_\ _ 2;_P"(H^JU/Y9?^ O_ "#^SJ__ #[G_P" 2_R#_A5/B#_H%7__
M ("3?_$4?5:G\LO_  %_Y!_9U?\ Y]S_ / )?Y'7Z7^SGXJU>%9X].D5&S@2
M/%$_!(YCE='7IQN49&",@@G>.7U9*_+][2_!M,[*>1XFHKJ#U[N,7]TFG^!?
M_P"&8?%W_0/_ /)BV_\ CM5_9M7^7\8_YFO^K^)_D_\ )X?_ "0?\,P^+O\
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MG;'&BHBY))PJ@ 9)).!R23U->G&*@K)679:'T5.G&FN6*22Z))+OLB_5&@4
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M(8UC4L0 6(0 9P ,]< #M7K0IJ&D4EZ*WY'U%*A&BK02BKWM%)*_R->M#8*
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M_P#_  $F_P#B*/JM3^67_@+_ ,@_LZO_ ,^Y_P#@$O\ (/\ A5/B#_H%7_\
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M7_\ X"3?_$4?5:G\LO\ P%_Y!_9U?_GW/_P"7^0?\*I\0?\ 0*O_ /P$F_\
MB*/JM3^67_@+_P @_LZO_P ^Y_\ @$O\@_X53X@_Z!5__P" DW_Q%'U6I_++
M_P !?^0?V=7_ .?<_P#P"7^0?\*I\0?] J__ / 2;_XBCZK4_EE_X"_\@_LZ
MO_S[G_X!+_(/^%4^(/\ H%7_ /X"3?\ Q%'U6I_++_P%_P"0?V=7_P"?<_\
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MZMSM"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!_PQAX?_ .?F_P#^_D/_ ,8H_L>GWE]Z_P#D0_U5H?S3^^/_ ,@'_#&'A_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'_\ GYO_ /OY#_\ &*/['I]Y?>O_ )$/]5:'\T_OC_\ (!_PQAX?_P"?F_\
M^_D/_P 8H_L>GWE]Z_\ D0_U5H?S3^^/_P @'_#&'A__ )^;_P#[^0__ !BC
M^QZ?>7WK_P"1#_56A_-/[X__ "!Z;I?[.?A72)EGCTZ-G7.!(\LJ<@CF.5W1
MNO&Y3@X(P0".N.7THN_+][;_  ;:/5IY'AJ;NH+3NY27W2;7X'JNB^'[/PW&
M8;&WAMHRQ8I#&L:EB "Q" #. !GK@ =J[84U#2*2]%;\CUZ5"-%6@E%7O:*2
M5_D:]:&P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M 'D7Q4^"^G_%[[/]ODN(_LWF;/)9%SYFS=NWH^?N#&,=^O;AQ6#CB;<U]+[6
MZV[I]CQLQRJ&/Y>=R7+>W*TM[=T^QY'_ ,,8>'_^?F__ ._D/_QBN'^QZ?>7
MWK_Y$\;_ %5H?S3^^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_
M %5H?S3^^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^
M^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_
M  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_  QAX?\
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M=]74>B% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .6
M@!U !0 F* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
M #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #%
M !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B
M@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q
M0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8
MH ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,
M4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &
M* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #
M% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !
MB@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@
MQ0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0
M8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M&* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
*#% !C% "T ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>dxcm-20230930_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230930_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMMJ$MLQFBU"38=\3*W&X\9P:_?FOQ*_X)/\ _*>_XG_]AGQI_P"E[T"/7O\
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M;G[.G[&GC/XQ>"K?4/!WB#1---QH%S=>*9ITOKL$!+0Q7#L'\PG8-F&!8-G
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M"_!6P;_@J5_P7QUOXL7B_;_ OPJO3<63'YH7M],D\BR53T(FO2;G:>JF3CT
ML?HI^VS_ ,%)O@'^P+\+]'\;?'F/4%US7X-VD^#-)$<]_/(%4R#)98UCC+!6
ME+!<GY=Q(%?-WP-_X.0/V7OB!\0M.\#_ !D^$7BGX=6NL,BZ?X@U26.YLE#G
M"R3%0CQQD\>8JNHZL0H+#Y"_X+$Z[\0_%G_!;C0?#MA\.8/&MQHK>&[;POX.
MU.8);:L"$N1:,7(79+/+(C9(!R0:](_X*(^#O^"M/_!1/X6:/\./'?\ P2\T
M_0+G0=86^TO7M,\16DES GE/');KOGXC?<A9>F8D/\(H'9'Z,?M\_MU> _V
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M]L=M;Q(7DD8]@JJ2?I7YO>,/^#FGX!6VOZC!\+?V8O''B;1=-8^;K;SPVBE
M2/-\O$A1#C(WE3CJ%.0/NC]L7XA_ ?X4_LR>,OB!^TWHMMJ?@73M)+:_I=U9
M)<K?(SJD=N(GPKO)*T:*&(&YER1U'YU?LI?M>?ME_%[X:ZIX8_X)+_\ !+GP
M9X+^'=_J]P)]=\5ZL'M9IV"I+*5:2 2,%"J43SE3&W! Q0"/M[_@G]_P4B^
M?_!17P/JGB;X00ZGINIZ!-#%X@\.ZW"BW-F90QBD#1LR21OY<@5@<_(=RJ<
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MJ;XS_9\^*MRFGZMJ&CZKX8M3=L$,FI6U]#)Y63W=+>;;_>(4#)(H$C[G\?\
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M:OX4\,Z;-<>,+.[N_%=Z;9'?4;C[5/$T<Q(^=8U01!#P G3).?A+]BO1]+^
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M_:3T!7BOO"7Q(U[2Y[JWX>..[N'FCD)'0)+9@ ]C-[U[-^P_\2+_ /X*:_\
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MSR/[6SB;.['[WROLWE]?DSM[XK[E_P""BW[1/Q>L_P!@/X&_L'^");B?XO\
MQT\*:%I&JV[R$3V]L;6W2]>4]4\V9O*8L,>7]H/\!KZ3U+_@E#_P3&\&^/KK
M]H[5_P!F+PU87^F22:K=W=Q>W2Z=;&/,CS&S,WV157!;'E;1C.*^,?V</C--
M\7/BO\?/^"[OQ3\,SWWAOX>Z5=:'\&=%N\H&6-/+5AD9CRLJ*S#< ]]<XY3%
M ]S]*OV6?V>?!O[*7[/GA3]GSP'&/[/\,:3':FXV;6NYSEY[A@.C2RM)(?=S
MVKOZ_'>7_@J9_P %4O@G\#_AQ_P42^,OBKP3K_PO^(7BJ?3SX L-"2WGLX4D
MG'R3!!(K,MM<&-FEDQM0N&W$#]?]&U>PU_1[37M*F\RUO;:.XMI,8W1NH93^
M((H!HLT444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR?]M/]CGX2_MS_  'U
M'X#_ !=MYDM;B1;G2]4M /M&EWJ!A'<Q$\9 9E*GAD=E/7->L44 ?C W_!'?
M_@L7^S)H>M_!;]G#XV^&_%/P^UN1_M&D7-] ;2X5N"\MAJ43PQ2, ,^67Z#Y
MCCCQ3QQ_P0=_X*&_L\>#=/\ CY<?#+PKXY?2-3CN]1\#:/=RZA<-#&ROB6!4
MC^T1,05>.!V?:>!U*_T%44#NSRS]BKXO_%/X]_LQ>$_BY\9?A%'X&UW6]/\
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M,=!U'4$8VMW!+M,EK<&,%U4LB,L@5BA#?*0YKZ_HH"[/R+\<_L"?\%\OVHO
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M\-O^"3/[>_[7'[8?AK]K3_@I[\1_#2VWA-[4V/ASPZ8WEN8[:9IX;7$*+%%
M979G<N\C!F7C(9?U)HH"Y^??_!3;_@E'^T1\</VB]$_;9_8H^-46@>/-&>VF
MET?6[Z1+9KBW4)%<VS;9$1R@5'B=/+D R3RP;QSXR_\ !.__ (+6?\%&9?#W
MPU_;9^)G@7PYX,T34UO99-.6WDD:78T9G2*U0F64([@*\D:?.>E?K/10%SF?
M@S\*/"GP)^$GAKX,>!HI4T?PKH=MI>F^>^Z1HH(UC5G( W.=N6.!DDFO*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
M"#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\
M_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO
M_@6U;%% &/\ \(/I'_/S>_\ @6U:&FZ=!I5J+2W>1E#$YE<L>?<U8HH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDF3F/$^*P>'CBJ.$=2C)1<9*<5?GM9*+]Z^MK)'ZMT5\7_\ !2/7?%O[,/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AXI\2Z+X
M+\,ZCXQ\2730:=I-C->7\Z0/*8X8D+NP2,,SD*I.U02>@!-?FK\;OV<_V3/V
MEOBKX#\<_L:^.;C07\>>*=4L-2N[:&5+>QO+>U^TB1+=PDD)8D$@,%VL"JC&
M*_3:XM[>[MWM+N!)8I4*2Q2*&5U(P00>"".U?!/QE_X([Z%#\:_#M]\#?$'B
M+2_"^MZI=?\ "3QVMY#_ ,2.$P-M,!=E=U<L8MI#D*QR2*^"XZR[,,QP]*-+
M#1KTU*/,M54B^>.L9=$U>,NJ3YKV3M\7QE@,;CJ%*-/#QK04E=:J:?-'6,NB
M:NI=4G>]D2_L:^.Q^U%^P_\ $GX0_MA?$J.30O#^IKIW_"::EJ"CRD)1H7-Q
M+Q(8YT1E9R2P=%.1@5YS\6O@+^T=X%_84U:"^_;*\->(/@UI<'F>'X=$MM\^
MJO\ :@D-N7,8*QB<[BHED"[" ,*,?=/P[_8[^!/PT_9]O/V:-"\+M-X:U.VE
MCU<7<VZ>^>50KS22*!^\PJX90-NQ=H 48^?=&_X(K_"^UU.'2O$'Q[\8ZGX/
MM;XW5OX3>1(X]W?<ZG;DC@LD:,03@CK7A9APMGLLNP]%TO:U?8RIRFJLH-7=
MTI_\_*<4]K7;79GCXWAS.98"C2=/VM3V3IRFJDH-7=TI?STU?:UVUV9WG_!)
M;0KWPS^PIX9N]84P+?76H7L?F\;83=2*K'/0$)N!]"#7E?\ P3263]IK]J[X
MK?MK>)HS,$OAI?A?SAG[/"^>%S]UDMXX$R.OFOZU]H3> M!M_AU)\,?#ENND
MZ8-&;3+*.Q0*+2'RC$H0=!M7&/I7!_L?_LF>$/V.?AK>_#7P=XCO]5@O]:DU
M*:[U%$63>\446SY !M A!'NQKZ6'#^+I5\KP[]ZCA8MR=]YJ"C!VWT;DUVT/
M?CDF)IULNH/WJ6'BW)]YJ*C!V\O>:['%_M_^#OV./B)#X1\)_M:_$N]T!3J$
MLN@06ET\7VN0F)) Q$3C W("3MVAR<C.:^8/^"J'[-7P/_9+T;X?_$_]G/1?
M^$2\11ZXT< TZ^E9I5B02+./,=COC<(-PZ^;\V>*^V_VJOV2_A5^UYX!C\#_
M !,@N87LYS/I.K:>ZK<V4I&"5+ AE88#(00<#H0I'C7PE_X)*_#?P?\ $'2O
M'_Q:^,'B7X@'P^4.A:9K;8MK?8<HK*6<NJD A 53(Y!'%>7Q1P_F6:XJO2HX
M.D_:\G+7NE.GRVNY7O)M6]WDMIHSSN(LDQ^98BM3I86F_:<G+6O:<.6U^:^K
M:MIR6TW/IWP[XD6XT'29/$MQ;V>IWUA!)-922A'$KH-RA2<\,2/PKX2T=!X1
M_P""[%^-:<1)K-B3I\DAP)-VC)@ G_:C=!ZD8KZ;^-O[%'@SXW_M$^"_VC=:
M\8ZI9:CX)>U:RT^UCC,-QY%RUPN\L"PRS8.#TJC^UY^P)\,OVM-4TOQK>^(]
M3\,^*]&01V'B/1B/,\L,75'4XW!6+,I!5E+'G'%>GG^ SK,J5.5.DN;#5J=2
M%YK][&*UZ6@W=VOV/1SK!9MF%.$H4US4*L)PO)?O%%:]/=;N]^Q\YZW%_P )
MA_P76T]=%82IHE@K:A)&<B+9H[DY(_VI$3ZMBOT#KPC]D']@7X:_LE:IJOC2
MS\2ZGXG\5:TACO\ Q%K)'F>46#LB*,[0S!68LS,Q4<X&*]WKNX5RS&Y?AL15
MQ<5&I7JSJN*=^7FLE&ZT;26K1U\.9?B\#0KU,2E&=:I.HXIWY>:UE?9M):M'
MY+>'?AC_ ,+5_P"&N])@M_,NM+O9M7M"!DJUIJEQ,^/<Q+(O_ JM?LE>+M>_
M:\_:3\':EXDMY'M?A5\(IH'$AR'-K!+#%*3_ 'C)<1-GJ?+]J^[_ (%_L+?#
M[X'_ !#^(7C^R\3ZEJQ^(TDYU?3[^.,11++-+(Z)M )'[UEYSP*R?V3_ /@G
M1\,?V2T\5/X5\8ZMJT_BG34L9;C4HX@UK"/,R$V*,[BZDY_YYK7P6%X&SF.*
MPDII*"E-U5=:J-252EZW<OEU/B\/P?FL<3A92244Y.HKK:-252GZW;^74\G_
M ."%?_)N_B[_ +'0_P#I);U]O5Y#^QU^Q_X1_8U\#:IX$\'^*]1U>#5-6-_+
M/J21JZ/Y21[1L &,(#^->O5^B<)Y=BLIX=P^$Q*M.$;-7OU;W1]UPU@<1EN1
M4,-75IQ5GK?J^H4445]">X%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445P/[4'QP_
MX9N^!'B'XV?\(Q_;/]@P0R?V9]M^S>?OGCBQYFQ]N/,S]T],=\UAB<11P>&G
M7K.T()R;U=DE=NRUV[:F.(KTL+0G6JNT8IMOLDKMZ:[=COJ*_.W_ (?X_P#5
MJ/\ Y?7_ -PT?\/\?^K4?_+Z_P#N&OC/^(E<$_\ 05_Y)4_^0/E/]?\ A+_H
M)_\ )*G_ ,@?HE17YV_\/\?^K4?_ "^O_N&C_A_C_P!6H_\ E]?_ '#1_P 1
M*X)_Z"O_ "2I_P#(!_K_ ,)?]!/_ ))4_P#D#]$J*_.W_A_C_P!6H_\ E]?_
M '#1_P /\?\ JU'_ ,OK_P"X:/\ B)7!/_05_P"25/\ Y /]?^$O^@G_ ,DJ
M?_('Z)45^=O_  _Q_P"K4?\ R^O_ +AH_P"'^/\ U:C_ .7U_P#<-'_$2N"?
M^@K_ ,DJ?_(!_K_PE_T$_P#DE3_Y _1*BOSM_P"'^/\ U:C_ .7U_P#<-'_#
M_'_JU'_R^O\ [AH_XB5P3_T%?^25/_D _P!?^$O^@G_R2I_\@?HE17YV_P##
M_'_JU'_R^O\ [AH_X?X_]6H_^7U_]PT?\1*X)_Z"O_)*G_R ?Z_\)?\ 03_Y
M)4_^0/T2HK\[?^'^/_5J/_E]?_<-'_#_ !_ZM1_\OK_[AH_XB5P3_P!!7_DE
M3_Y /]?^$O\ H)_\DJ?_ "!^B5%?G;_P_P ?^K4?_+Z_^X:/^'^/_5J/_E]?
M_<-'_$2N"?\ H*_\DJ?_ " ?Z_\ "7_03_Y)4_\ D#]$J*_.W_A_C_U:C_Y?
M7_W#1_P_Q_ZM1_\ +Z_^X:/^(E<$_P#05_Y)4_\ D _U_P"$O^@G_P DJ?\
MR!^B5%?G;_P_Q_ZM1_\ +Z_^X:/^'^/_ %:C_P"7U_\ <-'_ !$K@G_H*_\
M)*G_ ,@'^O\ PE_T$_\ DE3_ .0/T2HK\[?^'^/_ %:C_P"7U_\ <-'_  _Q
M_P"K4?\ R^O_ +AH_P"(E<$_]!7_ ))4_P#D _U_X2_Z"?\ R2I_\@?HE17Y
MV_\ #_'_ *M1_P#+Z_\ N&C_ (?X_P#5J/\ Y?7_ -PT?\1*X)_Z"O\ R2I_
M\@'^O_"7_03_ .25/_D#]$J*_.W_ (?X_P#5J/\ Y?7_ -PT?\/\?^K4?_+Z
M_P#N&C_B)7!/_05_Y)4_^0#_ %_X2_Z"?_)*G_R!^B5%?G;_ ,/\?^K4?_+Z
M_P#N&C_A_C_U:C_Y?7_W#1_Q$K@G_H*_\DJ?_(!_K_PE_P!!/_DE3_Y _1*B
MH-,O/[1TVWU#R]GGP))LSG;N .,]^M3U]RFFKH^P335T%%%%,84444 %%%%
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M-I_Z76]>]UX)_P %0/\ DQ#X@_\ 7C:?^EUO7B\2?\D[C/\ KU4_](9Y.?\
M_(BQ7_7N?_I+/Q6HHHK^,3^40HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH _H7\,_\BYI_P#UXQ?^@"KM4O#/
M_(N:?_UXQ?\ H J[7]RT_P"&O0_L&G\"] HHHJRPHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMR3J*]Z<H-SO/7K+3E22M+F\S*_X*Z?%KQ/_ ,(=X2_9.^'-R5USXFZU':W
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M^%]:A^QWTH6)-2:-1)$9, *CNC2Q$\+N"L<9-,\.?L6_\%%_V3+CQ/\ "_\
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M9D.<4L90J8BFW[*M""=MJ5-3][_"W):^1]2T445^Y'[ %%%% !1110 4444
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M#/\ T'4?_!L/_D@_UBX?_P"@RE_X,A_F?1-%?.W_  ]?_8"_Z+W_ .6MJO\
M\BT?\/7_ -@+_HO?_EK:K_\ (M'^M'#/_0=1_P#!L/\ Y(/]8N'_ /H,I?\
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M?BM1117\8G\HA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU3P@_P"2HJ?]>I?^E0/T?PO_ .2AG_U[E_Z5 ^J**Q_^$EU?_H4+W_OI:/\
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M* /Z%_#/_(N:?_UXQ?\ H J[5+PS_P BYI__ %XQ?^@"KM?W+3_AKT/[!I_
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MFK]4\(/^2HJ?]>I?^E0/T?PO_P"2AG_U[E_Z5 ^EJ***_I0_?0HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?ST>)O\ D8]0_P"OZ7_T,U_0O7\]'B;_
M )&/4/\ K^E_]#-?AWC1_#P/K4_]L/Q_Q8^#!^M3_P!L*5%%%?A!^-A1110
M4444 %%%% !17V3_ ,$K/V=/A5XGT7QS^U-\;?#,.M:-X L7DL=*NHA)#+-'
M \\TCHWRN4C5 JME<R9(RH-=;\9OVM/AS\6?V?/$/A[]L']B_5_!=Y=Q-_PK
MK6-)\*/&$<H[1$37'E?=8+NV';(K'Y1BOK\+PI&IE$,;B<3&DZBE*$7&334=
M/>DM(<STC>]SZC#\-QGED<77KJFYJ3@G%M-1T]Z2TC=Z1ON?!-%>J_L<?LO>
M)/VL_C;I_P -=*:2VTR+_2O$6J*O%E9*1O;)XWMD(@[LPSP"1]B?\%>O#GPM
MT']D;X91_"#3-/BT%=9C31Y]/C&V6U%E)Y;!\9<$8.XD[LYYSFN?+^&,5CLA
MQ&:RERTZ2T36LW=)VU6D;J[UU=N]L,#P]B<9DU?,G+EA3VTUD[I.VNRNKO75
MV/SFHHK[RF_;=_9(_8[^#'@_PA^R3X!\->.-:NK<_P#"8ZQJ^DSP2^8J1[][
M2Q)(YD=WV $HBIC!R*XLHRS!X]59XK$QHPII-MKFD[NR48)IR\[;+5G)E>7X
M7&^TGB,1&E""3;>LG=V2C%-.7G;9:L^#:*_0?]OW]GCX%:UX_P#@1\6K+P/:
M^$_^%D:Y86WBO1;9%@4P3-;.[LJ!0LB+*Z.X W94GD<^K?$::3XC^,?V@OV9
M/B#X(TJW^'/@;P!:WGA&*/18H8]*E-AYWG12*HP=X9AS@>3@?Q _3K@&O'%5
MJ%2NDXM1BU%M2<J<JJYM4X+EC9NTFF[6MJ?0K@NM'$U:,ZRO%I1:BVI.5.51
M7U3BN6.KL]>EM3\HJ*^M?V?Q_P ,=?L3>)/VI+P?9_&?Q)\SPY\/\\2VUGG_
M $J\7N.5.#V:*+L]?)5?(YAEO]GT*#G+WZD>=QM\,6_<N[ZN2]ZUE9-;WT^8
MQN ^I4:+G+WYQYG&WPI_#=WWDO>M9636]]"BBBO,//"BBB@ HHHH **** "O
MV._X)%_\F(>%/^O[4_\ TNFK\<:_8[_@D7_R8AX4_P"O[4__ $NFK]4\(/\
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M7)\QHU9TYPUC'G>L6N72TE).S3NDK-W>BU/)****\D\P**** "BBB@ HHHH
M**** /Z%_#/_ "+FG_\ 7C%_Z *NU2\,_P#(N:?_ ->,7_H J[7]RT_X:]#^
MP:?P+T"BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB#5=*OT+6U]#G(5PI!# \JX(*DGJ"P/L7QU_X*P?$SXH_#35?A=\.OA7X?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1110 4444 %%%% !1110 45PGQE^,MA\.K Z9IC)/K$Z?NHCRL"G^-_Z#O\
M2CX-?&6P^(M@-,U-D@UB!/WL0X6=1_&G]1V^E?0_ZK9Y_8?]K>R?L;[];?S6
MWY;Z7_34]S_5S./['_M/V3]E??K;^:W\O2_Z'=T445\\>&%%%% !1110 444
M4 %%%% !1110 5^QW_!(O_DQ#PI_U_:G_P"ETU?CC7['?\$B_P#DQ#PI_P!?
MVI_^ETU?JGA!_P E14_Z]2_]*@?H_A?_ ,E#/_KW+_TJ!]+4445_2A^^A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** /Z%_#/_(N:?\ ]>,7_H J[5+PS_R+FG_]>,7_ * *NU_<M/\
MAKT/[!I_ O0****LL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?ST>)O^1CU#_K^E_P#0S7]"]?ST
M>)O^1CU#_K^E_P#0S7X=XT?P\#ZU/_;#\?\ %CX,'ZU/_;"E1117X0?C8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5^QW_!(O_DQ#PI_U_:G_P"ETU?CC7['?\$B_P#DQ#PI_P!?VI_^ETU?JGA!
M_P E14_Z]2_]*@?H_A?_ ,E#/_KW+_TJ!]+4445_2A^^A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X)_P5
M _Y,0^(/_7C:?^EUO7O=>"?\%0/^3$/B#_UXVG_I=;UXO$G_ "3N,_Z]5/\
MTAGDY_\ \B+%?]>Y_P#I+/Q6HHHK^,3^40HHHH **** "BBB@ HHHH ****
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
M?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_
MZ#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5?S]>)
M"&\17[ \&]EQ_P!]FOZ$?[.T_P#Y\8?^_0K^>[Q+QXCU#'_/[+_Z&:_#O&C^
M'@?6I_[8?C_BQ\&#]:G_ +84J***_"#\;"BBB@ HHHH **** "BBB@ HHHH
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M4O\ TJ!^C^%__)0S_P"O<O\ TJ!]+4445_2A^^A1110 4444 %%%% !1110
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M_P!+IJ_'&OV._P""1?\ R8AX4_Z_M3_]+IJ_5/"#_DJ*G_7J7_I4#]'\+_\
MDH9_]>Y?^E0/I:BBBOZ4/WT**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O!/^"H'_)B'Q!_Z\;3_ -+K>O>Z
M\$_X*@?\F(?$'_KQM/\ TNMZ\7B3_DG<9_UZJ?\ I#/)S_\ Y$6*_P"O<_\
MTEGXK4445_&)_*(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?T+^&?\ D7-/_P"O&+_T 5=JEX9_Y%S3_P#K
MQB_] %7:_N6G_#7H?V#3^!>@4445984444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7\]'B;_ )&/4/\ K^E_]#-?T+U_/1XF_P"1CU#_ *_I?_0S7X=XT?P\#ZU/
M_;#\?\6/@P?K4_\ ;"E1117X0?C84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5^QW_!(O_DQ#PI_U_:G_ .ETU?CC
M7['?\$B_^3$/"G_7]J?_ *735^J>$'_)45/^O4O_ $J!^C^%_P#R4,_^O<O_
M $J!]+4445_2A^^A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5X)_P %0/\ DQ#X@_\ 7C:?^EUO7O=>"?\
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M8/UJ?^V%*BBBOP@_&PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K]CO\ @D7_ ,F(>%/^O[4__2Z:OQQK]CO^"1?_
M "8AX4_Z_M3_ /2Z:OU3P@_Y*BI_UZE_Z5 _1_"__DH9_P#7N7_I4#Z6HHHK
M^E#]]"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KP3_@J!_R8A\0?^O&T_\ 2ZWKWNO!/^"H'_)B'Q!_Z\;3
M_P!+K>O%XD_Y)W&?]>JG_I#/)S__ )$6*_Z]S_\ 26?BM1117\8G\HA1110
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MG_H%_P#)ZG_R8?Z@<)?] W_D]3_Y,_.W_AP=_P!77?\ EB__ '=1_P .#O\
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M=_Y8O_W=1_PX._ZNN_\ +%_^[J_1*BOC/^(:\$_] O\ Y/4_^3/E/]0.$O\
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M_P"3U/\ Y,/]0.$O^@;_ ,GJ?_)GYV_\.#O^KKO_ "Q?_NZC_AP=_P!77?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZRV]S"LL$J]'1@"I'U!!K\K_ !/_ ,$W/^"K'_!1SXG^#;+_ (*5>,?"N@^
MO!=P99[+PW/";C4]Q02LB6^5$LJH%,CLHC!)2/)*G]4K6UMK&UCLK.!8H88P
MD4:+A44#  '8 4 R2BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M5QG[1_BSQ!X"_9Y\>>.?"=_]DU71?!FJ7^F77E))Y-Q#:2R1OM<%6PR@X8$'
M&""*RQ%:.'H3JRVBFW;R5S*M5C0HRJ2VBF_NU.SHK\9/^'K_ .W[_P!%[_\
M+6TK_P"1:/\ AZ_^W[_T7O\ \M;2O_D6ORW_ (C#PS_SYK?^ P_^6'YU_P 1
M2X?_ .?57_P&'_R9^S=%?C)_P]?_ &_?^B]_^6MI7_R+7ZT?LX>+/$'CW]GG
MP'XY\67_ -KU76O!FEW^IW7E)'YUQ-:122/M0!5RS$X4 #.  *^FX9XWRKBJ
MO4I82$XN"3?.HK=VTM*1]#P_Q=EO$E:=+#0FG!7?,HK=VTM)G9T45XY\6?\
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M%>[Z%KVA^*=&M?$?AG6;34=/OH%FLK^QN%FAN(V&5='0E64CD$$@T 6Z***
M"BJ'BCQ1X=\$^'+_ ,8>+];MM-TK3+22ZU'4+V81Q6\**6>1V/"J "2:\5\"
M_P#!3G]A;XDV=UJ/@[X_6=S;V>LV6DSSS:/?0(+R[\[[-"IE@4.9/(FP5R/W
M9R1Q0![S15*_\2^'=*U>PT#5->L[:_U5Y$TRRGN426[:-#(XB0G+E4!8[0<
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ME&5%\U ZLHD3<C%3M8X- '3T444 %%%% !1110 4444 %%%% !1110 4444
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MT<3R6HG,0<@$@$XSC-?$7P1TG4-;_8[_ &Z-*TFT>>>3XD>-?*@B7+/BW+8
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M^@7_ ,GJ?_)GR/\ J!PE_P! W_D]3_Y,_.W_ (<'?]77?^6+_P#=U?>'P@\
M_P#"J?A+X7^%W]K?;_\ A&O#MEI7V[R/*^T_9X$A\S9N;9NV9V[CC.,GK714
M5[.3<*Y#P_5G4R^CR.2L_>G*ZW^U)GJY5PYDN25)5,%2Y')6?O2>G_;S85S>
MD?!_X8:!\2]6^,>C>!]/MO%.NVL5MK&NQ0 7%W#&J+&CMW"A$ '^R*Z2BOH3
MW"KKFAZ/XFT6\\-^(M,@O=/U"UDMKZRNH@\4\+J5>-U/#*RD@@]0:YGP=^S_
M /!/P!\-)_@UX1^%^BV?A.Y\T7'AP62O92"7F16B?*E6/)&,$DG')KL** /&
M/AY_P3O_ &)/A3XXA^)'@']FSPS8:U;3>=:7OV5I?LT@.0\22,R1,#T9 ".V
M*]?UC2-+\0:3=:#KFGQ7=E?6SV]Y:SH&CFB=2KHP/!4J2".X-6** ,'X9_"[
MX=_!KP;:_#SX5>#;#0-$LFD:UTS3+<1Q1EW9W( [EF8D^]<C\<_V-OV7?VEK
MZWU;XY?!'0_$-[:QB.#4+JW*7*Q@DB/SHRLA0$DA2V 2>.:],HH Y?X2?!7X
M2_ ;PFG@7X-?#S2O#>DK(9#9:3:+$LDA !D<CF1R !N8DX &>*G^%WPF^&WP
M4\(0^ /A/X+L- T6WEDD@TW38!'$CNQ9V"CN22370T4 <[X$^$?PS^&#:T_P
M^\$:?I!\1:O-JFN?8H OVZ\E_P!9/)_>=L<GO7G_ (:_X)^?L5>#_B,/BSX9
M_9I\*6>O+.9H;R'3AL@ESGS(XB?*B<'D,B@@]"*]BHH YWP/\)/AE\-?AW#\
M)/ O@73-,\,6\,T46A6]JOV41S.[RIY9R"KM(Y(/!W'UKS/P_P#\$W?V$_"W
MC>/XB:#^R[X3@U6&<302?8"T,,@.0Z0,3$A!Y!5!@@8Q@5[=10 4444 %%%%
M !1110 5\5?\%</^"1_@K]OSP4_Q&^',%GHWQ6T:S*Z7JC@1Q:S$HR+.Z(_*
M.4\H3@Y4D#[5HH ^*O\ @D?_ ,$C_!7[ ?@I/B-\1H+/6?BMK-GMU35$ DBT
M:)ADV=J3^4DHY<C PH /VK110 4444 >3?&?]A3]D']H37&\3_&#]GWP[K&J
M/CSM4-H8+J;'3?-"4>3'0;B<5O\ P6_9D_9]_9TLI;'X'_![0/#(N%"W,^F:
M>J3S@'($DQS)(!V#,<5W5% '/6/PF^&VF_$N]^,EAX+L(O%.HZ:FGWVNI !<
MSVJLK+"S=U!53CV%0_%OX*_";X\^$W\"_&3X>:5XDTEY!(++5K195CD ($B$
M\QN 2 RD, 3SS73T4 >;? O]C[]F/]F>XN;[X%_!70_#MU>)Y=S?VEN7N9$S
MGRS-(6DV9 .W=MR!QQ3/CI^QM^R[^TO?V^K_ !S^"6A^(;ZTB\JWU"Z@*7*Q
MY)$?G1E7* DD*3@$GCDUZ910!RGPA^!GP>^ 7A3_ (0CX,?#?2/#6EF0R26F
ME6:QB:0C&^1OO2/@ ;F). !GBO.=5_X)I_L%ZUXR?Q[J?[+'A*349)S-+BP*
MP.Y.26MU(A;)Y.4YR?4U[C10!%8V-EIEE#INFV<5O;V\2Q6]O!&$2)%&%55'
M"@   #@ 5@>/O@_\,/BE?Z'JGQ$\#Z?K%QX:U6/4] FOH [6%XA!2>/^ZX(!
M!]JZ2B@ K"^)7PR\ ?&+P7>?#GXH^$K+7="U'R_MVEZC#YD,WER+*FY>^'1&
M'NHK=HH BLK.UTZSBT^Q@6*"")8X8D& B*, #V %>,:[_P $X/V%?$WCIOB1
MKG[+GA*?5I)S--(=/VPRR$Y+O I$+DGDED.223G)KVRB@#"\:?#'X>_$7P'<
M_"[QOX.T_4O#MW;I!<Z+<VX-N\2%61-@XV@JN .!M%4O&'P0^$?C_P +:/X)
M\:?#[3-3TGP_>6UWHNGW=N&BLI[=2D$D8_A9%) /8&NJHH X3XW_ +,?P _:
M3LK&P^.OPGT?Q.FF2,^G-J=MN>V+8WA'!#*&VKN .&VC(.!7;6-C::98PZ;8
M0"*"WB6*&->B(HP /H!4M% '.:)\(_AGX<^(NM?%S0O!.GVOB;Q%#!#KFMPP
M 7%['"BI$LC?Q!510/0**C\-_!7X3>#_ (AZW\6?"_P]TJP\2^(T1-=UNVM%
M6XOE0 *)'')QM'Y"NGHH YSPW\(OAEX0\=:[\3?#'@C3['Q!XG\G_A(-7MX
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M-GS1:032M%:;\D'RE3@D=#BO8** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>dxcm-20230930_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230930_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@Q;B9PD0U"^:S0L>@WW"H@_.OH.WN(+N!+JUG26*5 \<D;!E=2,@@C@@CO0
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ML'PK\0^,/%_B>.Q%O#H4T"I;S7=PT,$,AD8$.<!S@<*ZGO7PCX=2T_X),_\
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M'\.O^"</A+PUXN^(GP]UKQ!%XFU&>SMHM%EA5H6BC5RS>:P&"&QQ7SK\:?\
M@Y&_9=^'FK1V/PU^#WBOQM9PI"-6UNQDBMK&WG= Q@CE;=YS*25)PJDKE68<
MUXW_ ,'$#^/)/V)?V=)/BI9RVWB=ESXCMYI%=XK_ /LVW^T*S*2"1+O!()!Q
MP37UMI/P9^''A[_@A;-\/M.\(V$>G3?LY2:C<P+;+MEOGT8W3W3#',IN#YN_
MJ' (Z"@-#VC]C;]MCX+_ +<OP+3X\?!:YO?L,=S+::IIFI0K'=Z==QHKO!*J
MLRYVNC!E8J5<'.<@>8_\$Y?^"K_PL_X*0^(/%/A_X=_"_P 0>'I/"MG:W%U)
MK4T#"83O(JA/*8\CRSG/J*^5O^#8":9OV=OB_;&0E%\2VC*F> 3:."?QVC\J
M\\_X-8Y$'Q/^,,18;FT'22!Z@3W.?YB@+'W3^T+_ ,%9OA5^SO\ MP^$OV&?
M$'PN\07^M^+K_1[6TUJSF@%K VHW(MXRX9@Y",<M@=.E=Q^W=_P42_9W_P""
M>_@.S\7?&O4KRYU#5G>/0?#6C1+)>Z@R ;V56952-=R[I'8 ;@!N8A3^:?\
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M>?:?["\G^U_/\V3S/.\O][N^T?9]F_\ V=O&*^[_ /@L?\1_'7[27Q%^%_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'3GD\.^'DN[=YM9U&.,K:F\N+:W!:)6PS/*TCDC[FX^8OUW_ ,$=?V,?B_\
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MVN-/OY)+1(Y=,:UM$DD:-6 $LDS,0IP). <5^@%% 7T/@+_@F/\ \$J?BO\
ML\_L8_%W]E7]IO5M'1?B7)<VZ77AB_>X\BWFL/LS29DC3#JQ+ 8(X&?2O"/V
M6O\ @F]_P6]_85U/Q'\&OV8_BK\/K7PEXBU 32^([^>.:&%POEB[2&6%Y8Y?
M+"AE".N44?-M#5^NE% [L_,G]@'_ ()!?M<_L6_\%%W_ &B/$WQ%\/>,O"M_
M8WT&MZ_/?RQ:I>2W4 EDG-NR,-QNQ@YE)*$MDGBNF^&7_!+C]I;PC_P6EO\
M]OW5;[PP? MSK&J74<46J2&_V7&ES6L>8C$%SYCKGY^!D\]*_1"B@+GB?_!1
M#P?^S9\0?V1/%G@7]K+QK;^&_!FKPPVUSX@N&V_V==-,GV6=6P0&6<1D9^4_
M=/#&OS1_8W_X)H_\%$E\.:IX"_8X_P""G?@J7X-ZKJTL.J:]X(\2SW+(2J>;
MLMDB/V:[,;1ED6=."N9",&OUK^/GP*^&W[3'P>U[X%_%[0SJ'A[Q'9?9]0MU
MD*.,,KI(C#[LB2*CJW9D!P>E?G(W_!M5J?A2\O\ 3O@M_P %$?&'A?0-1?\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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MU<E:[/W#HHHK]:/TP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ^-^];N;9AD>;9AB72J58?5W4C4^&U1<MGRJVCU7Q/WK=SX-^'7B;X.>&?\
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MVXXQ7GW_  7)_P"32_#_ /V42T_](;^OLFVMK>SMX[.SMTBBB0)%%&@544#
M4 <  <8KG_B=\(OAE\:- B\+?%;P1I^OZ=!>+=0V>I0"2-)E5T$@!_B"NXSZ
M,:]C&\/U:W"3R>G4O+V:@I2\DE=[]CU<7DE2KPR\KA.\N10YGY)*[W['Y>_\
M%%-.\3?!3Q[X'^+'@Z<VT?CSX.0:7J3@<3_Z&+6X0XZ_N)+?\0*N_M!?##_A
M4?PW_9&\)S6_EW,IFU&]4C#":ZO+&Y8-[KYH7_@..U?I)\0?V=?@;\5M'TK0
M/B1\+='UJRT.(QZ/;W]H'6T0JJE4S]T$(@_X"/2I_'7P'^#?Q-O=&U'Q_P##
M?2M6G\/-NT.2\M0QLCE#^[_N\QI_WR*^4Q/AYB*M?&5(58_O>3E3O[K4X3J7
MT^TX:6^9\U7X'KU*V*G"HOWG)RIW]VTH2G?_ !.&EOF=;1117ZH?HX4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !117D7[>'Q/\<_!G]DSQC\3/AKKG]FZYI5K;O87O
MV:*;RF:ZAC8[)59&RKL.5/7UKEQV+IX#!5<543<:<92=M[13;MMKIIJCGQ>)
MIX+"5,1--QA%R=M[)7=MM=#UVBOQD_X>O_M^_P#1>_\ RUM*_P#D6C_AZ_\
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MVE?_ "+1_P /7_V_?^B]_P#EK:5_\BT?\1AX9_Y\UO\ P&'_ ,L#_B*7#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O!/^"H'_)B'Q!_Z\;3_ -+K>O>Z\$_X*@?\
MF(?$'_KQM/\ TNMZ\7B3_DG<9_UZJ?\ I#/)S_\ Y$6*_P"O<_\ TEGXK444
M5_&)_*(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7OA[X=> +.T\&ZI="#7?#%E:_P!EO;W,9BEV2"T9,-\L3;D8AE &2,BO'/\
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M>)/^2=QG_7JI_P"D,\G/_P#D18K_ *]S_P#26?BM1117\8G\HA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
M0OX9_P"1<T__ *\8O_0!5VJ7AG_D7-/_ .O&+_T 5=K^Y:?\->A_8-/X%Z!1
M115EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9OC&P\0ZK
MX1U72_".NC2]6N=.GBTS4S"L@M+AHV$<VQU96VN5;:P(.,$&OS"\0?M8_M5>
M ?BUX&\,?M;_  ?USQ#XD\$^*-4N;,I8+&=:BN+-H%@C$<7ER('^82(&!1R,
M97G]3ZYWQ;\*O WCGQ;X<\<>)M':XU/PG=S7.@W N9$%O++$8G8JK!7RA(PP
M('4<U\MQ+D.-SA4YX3$NE*#5UO"24HRUB].:/+>+^3T>GSF?Y-B\T5.6&KNG
M*+6F\6N:,M8O2\;7B_D]'I\8?LI^%?C=^PY^P]X_^-6J_#*[C\6^*=46Y\.^
M#K?3Y))+3?B*%I(5!9 ID>1HS@A(U!()P/G3]EWXM_$OX'?%;5OCS\5OV,_&
M/Q&\:ZA=&:UUS4Y+FW^QLWWW6,V<N9#T#Y&U1M4+SG]?**\:OP)-_5(X7%RI
MQPR]U.$9KF;;<VI:<SOII[O2QY5;@V;^K1P^*<(T%[J<(R]YMMS:EI=WTTTZ
M6/FKQ%^W;\1]+_8R3]J:/]FO4+;5/[5:VN/"%W>3&2"%9'5IV?[.K!=J[\F,
M  ]>]>?_ /!0#X4_$#]N']A[P+\;/A]X-DDUZVL[;7F\/V;F:1K:ZM@TT<7
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M7PG_ !&G_J _\J__ ',^-_XBS_U!_P#E3_[F?T245_.W11_Q&G_J _\ *O\
M]S#_ (BS_P!0?_E3_P"YG]$E%?SMT4?\1I_Z@/\ RK_]S#_B+/\ U!_^5/\
M[F?T245_.W11_P 1I_Z@/_*O_P!S#_B+/_4'_P"5/_N9_1)17\[=%'_$:?\
MJ _\J_\ W,/^(L_]0?\ Y4_^YG]$E%?SMT4?\1I_Z@/_ "K_ /<P_P"(L_\
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M;9Q5K<D>^]^A]'POQS_K)F,L+]7]G:+E?GYMFE:W*N_<^EJ***_2C[\****
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M*J2E?W;NN0#[BI:* ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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M_P"E0/I:BBBOZ4/WT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O!/\ @J!_R8A\0?\ KQM/_2ZWKWNO!/\
M@J!_R8A\0?\ KQM/_2ZWKQ>)/^2=QG_7JI_Z0SR<_P#^1%BO^O<__26?BM11
M17\8G\HA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!_0OX9_Y%S3_ /KQB_\ 0!5VJ7AG_D7-/_Z\8O\ T 5=
MK^Y:?\->A_8-/X%Z!1115EA1110 4444 %%%% !1110 4444 %%%% !1110
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M:V]WOKIIU,>BO0OCG^RI^T%^S6]D/C9\,[O1(]1R+*Y:XAN(96 R5$L#N@8
MYVD[L=JRK+X%_%2_^#EY\?X/"V/"-CJBZ=/J\U]!&&NFVD11QNXDE.&!)16
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M_P"O&+_T 5=K^Y:?\->A_8-/X%Z!1115EA1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "O!/\ @J!_R8A\0?\ KQM/_2ZWKWNO!/\ @J!_R8A\0?\
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M9Y.?_P#(BQ7_ %[G_P"DL_%:BBBOXQ/Y1"BBB@ HHHH **** "BBB@ HHHH
M@U'3K#5["73-3M$GMYT*2Q2+E64]C7SO\5/@1KOA'78_^$9LY[[3[Z<):;%W
M/$YZ1M_1NA[U]'T5]5PMQ=F?"N)E/#^]"7Q0>S[/R:[KIH?2<.<3YAPWB'.A
M[T);Q>S[/R:[]M#A/@U\&K#X=6 U/4U2?6)T_>RCE8%/\"?U/?Z5W=%%>+FF
M:8[.<=/%XN?-.7X=DET2Z(\G,LRQF;8R6*Q4N:<OP\EV2Z(****\\X0HHHH
M**** "BBB@ HHHH **** /Z%_#/_ "+FG_\ 7C%_Z *NU2\,_P#(N:?_ ->,
M7_H J[7]RT_X:]#^P:?P+T"BBBK+"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M_GH\3?\ (QZA_P!?TO\ Z&:_H7K^>CQ-_P C'J'_ %_2_P#H9K\.\:/X>!]:
MG_MA^/\ BQ\&#]:G_MA2HHHK\(/QL**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *_8[_@D7_R8AX4_Z_M3_P#2Z:OQ
MQK]CO^"1?_)B'A3_ *_M3_\ 2Z:OU3P@_P"2HJ?]>I?^E0/T?PO_ .2AG_U[
ME_Z5 ^EJ***_I0_?0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *\$_X*@?\ )B'Q!_Z\;3_TNMZ][KP3_@J!
M_P F(?$'_KQM/_2ZWKQ>)/\ DG<9_P!>JG_I#/)S_P#Y$6*_Z]S_ /26?BM1
M117\8G\HA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!_0OX9_Y%S3_P#KQB_] %7:I>&?^1<T_P#Z\8O_ $ 5
M=K^Y:?\ #7H?V#3^!>@4445984444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5%>3R6UJ\\-LTS*N5B3JWL*EHH Q_\ A)=7_P"A0O?^^EH_
MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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M%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
MOI:V** ,?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z
M6C_A)=7_ .A0O?\ OI:V** ,?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'
M_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:V** ,?_A)=7_Z%"]_[Z6O"?\
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M?CC7['?\$B_^3$/"G_7]J?\ Z735^J>$'_)45/\ KU+_ -*@?H_A?_R4,_\
MKW+_ -*@?2U%%%?TH?OH4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>"?\%0/^3$/B#_ ->-I_Z76]>]UX)_
MP5 _Y,0^(/\ UXVG_I=;UXO$G_).XS_KU4_](9Y.?_\ (BQ7_7N?_I+/Q6HH
MHK^,3^40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH _H7\,_\BYI__7C%_P"@"KM4O#/_ "+FG_\ 7C%_Z *N
MU_<M/^&O0_L&G\"] HHHJRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYZ/$W
M_(QZA_U_2_\ H9K^A>OYZ/$W_(QZA_U_2_\ H9K\.\:/X>!]:G_MA^/^+'P8
M/UJ?^V%*BBBOP@_&PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K]CO^"1?_)B'A3_ *_M3_\ 2Z:OQQK]CO\ @D7_
M ,F(>%/^O[4__2Z:OU3P@_Y*BI_UZE_Z5 _1_"__ )*&?_7N7_I4#Z6HHHK^
ME#]]"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KP3_@J!_R8A\0?^O&T_P#2ZWKWNO!/^"H'_)B'Q!_Z\;3_
M -+K>O%XD_Y)W&?]>JG_ *0SR<__ .1%BO\ KW/_ -)9^*U%%%?QB?RB%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7\]'B;_D8]0_Z_I?\ T,U_0O7\]'B;_D8]0_Z_
MI?\ T,U^'>-'\/ ^M3_VP_'_ !8^#!^M3_VPI4445^$'XV%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?L=_P2+_Y
M,0\*?]?VI_\ I=-7XXU^QW_!(O\ Y,0\*?\ 7]J?_I=-7ZIX0?\ )45/^O4O
M_2H'Z/X7_P#)0S_Z]R_]*@?2U%%%?TH?OH4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"?\%0/^3$/B#_UX
MVG_I=;U[W7@G_!4#_DQ#X@_]>-I_Z76]>+Q)_P D[C/^O53_ -(9Y.?_ /(B
MQ7_7N?\ Z2S\5J***_C$_E$**** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!>Y?\ I4#Z6HHHK^E#]]"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KP3_ (*@?\F(?$'_ *\;3_TNMZ][
MKP3_ (*@?\F(?$'_ *\;3_TNMZ\7B3_DG<9_UZJ?^D,\G/\ _D18K_KW/_TE
MGXK4445_&)_*(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?T+^&?^1<T_P#Z\8O_ $ 5=JEX9_Y%S3_^O&+_
M - %7:_N6G_#7H?V#3^!>@4445984444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5%>3R6UJ\\-LTS*N5B3JWL*EHH Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V**
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MO_R?7Z544?\ $->"?^@7_P GJ?\ R8?Z@<)?] W_ )/4_P#DS\U?^'&>K_\
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M44?\0UX)_P"@7_R>I_\ )A_J!PE_T#?^3U/_ ),_-7_AQGJ__1?[W_PAU_\
MD^OL;]D7X.:O^RM\"-*^">;W7O[,GN9/[3^PK:^;YT[RX\OS)-N-^/O'.,\=
M*]DHKU<GX0X=R'%/$8"AR3:<;\TWHVG:TI-;I=+GI97POD62XAU\'1Y)M6OS
M2>C:=K2DUT1C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q17TI[YC_\
M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PD
MNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\
M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK
M_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\
M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PD
MNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\
M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK
M_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\
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M_1?[W_PAU_\ D^OTJHH_XAKP3_T"_P#D]3_Y,/\ 4#A+_H&_\GJ?_)GYJ_\
M#C/5_P#HO][_ .$.O_R?1_PXSU?_ *+_ 'O_ (0Z_P#R?7Z544?\0UX)_P"@
M7_R>I_\ )A_J!PE_T#?^3U/_ ),_-7_AQGJ__1?[W_PAU_\ D^C_ (<9ZO\
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MOS\_X*\?MG_MU?\ !/CXJ>"_CE\.M0T[6_@]JU_;VOB'0Y]$A,UK<H=TEO\
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M;5M_P4D_:S_9"_X*F)^R-^W%XITO4?AUXJD\KP9XHBT2&R*17$F+*YD>, ,
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M%\.Z#=>+6L9+G1/$GAN%461TM/MFV01XC>-[<,ZNJHRLNUE);Y/T/H$%%%%
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MZ^]*!L_)/2O^5JS4_P#KQ7_U#(J^J_\ @O9_RBG^)_\ UUT/_P!/=C7%V/\
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M%/V7?AG9_![X"?&?X=>'/#MC)))!I]M9Z1(6D=MSR22RZ:TDKD_Q.S-@ 9P
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M]LKQUX4TGX3_  VN(4BU/2;Z*:[OK>&,0(5"+OEF6#,2/*(PH=F8,W#>T_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4&E3ZQ\!?BWI/B2.TP;R"SE9+BW!^Z9() LL8/."R@'!QTH ]!HHHH ****
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MH^$/%]O>L?M-]"/,>U*D;2OD@.&#<^;&,<U\M_M7_ ;]F/X<_L]W'C+XQ?\
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MB.;1FQ<VUB-5U:!YXS@X='GC()! )R>!7L_QK^"G[-?AC]F?5/C1XX_X*O\
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MTK6(M-_MR%H@8KB./S";F-8UB!93$V&CW9&* /:O@7^V9XYUKP!\2=6_:?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"1_@K]@/P4GQ&^(T%GK/Q6UFSVZIJB 21:-$PR;.U)_*24<N1@84 '[5HHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>dxcm-20230930_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20230930_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\4/ /QH\ Z9\4OA=XF@UGP_K-OY^EZG;*PCN(]Q7<H8 XRI'('2M^@ HHHH
M**** "BBB@ HHJ#4M2T[1M.N-8UC4(+2TM86FNKJYE$<<,:@LSNS$!5 !))X
M % $]%?+'BO_ (+8?\$NO!GB&3PQK'[6VDRW,4AC:32M%U&_M\YQQ/;6TD3#
MW#D>]>Z_ _\ :'^!_P"TKX/'C[X#?%+1O%6DB3RY;K2+Q9#!)C/ERI]^)\8.
MQPK8(..: .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO%?C
M=_P47_8=_9R\5OX%^,W[3'AC1M:B(%SI)NVN+FW)Q@2QP*[1$@@X<+P<].:
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M77/#T%TS-'',MA<W%U A_A4F&!B@XW3,W5R3Y;_P13_8*^#O_!2K6OBY\?\
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M73_B4?\ @HQ^W7<7M[X^UF22_P##FB:R2]U:R3J=U_>!ONSE&(CA_P"62G)
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ML-KU\]NMQ9.4DAVLD;Y,<@EXP/\ 7'TK[_HH"^I\+^+?^"5'B75_^"-&G_\
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M;0K+PQX<TR"RT[3K2.UL+*VC"1V\,:A$C11PJJH  [ 5;HHH$%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM,_$7]IC]DE+GXS7XO/&G@?Q/?\ A'Q9J  'VR[LV0B8X ^9HI8=Q[ON.!G
MY+_@O?KFM>'?^"9/C/5?#^KW5C=1ZKHX2YL[AHI%!U" $!E((R.* ZGV517Q
M9_P1.^(7C&R^"_C7]D3XJ:]<:AXH^#/C:YTM[J\E9Y;K2[IFN;*Y+,2Q#[I]
MN>B(@]A\I_\ !PU\8OB5X[^)DO@#X9>+]0TW0O@YX>L;_P 5S:;=R1>;JNL7
M*1VUK)L(Y%K"9E)[.X[T#L?K_1110(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#QK]K+QQ^Q_JU_X4_9,_:NL=
M/U,_%B]FLO#6@:KI,TT-_/;A&8B94*6\BF2/:Q='W.-G.<?FIXS^!/B7_@G;
M\,_C3^V/^Q?\<O$GA"V^$_QT_L5OAQ=ZO)=:)K>F.FE((9(926>8->MF1F9O
M+3Y2C*'K]+_VS_V*/A1^V[\.['P7\1;_ %72-1T+5(]4\*^*O#UT(-1T6^3[
MLT$F#CH,J1@X!&&567Y5^ G_  1]^('C+QWXFN?VW?V@_&/C#PKIOQ6FUW1_
M"5VMI;V/BJ5;2T2+5KX0,QD+;&B\EMI_<$GB1@P,^J_VIOVG(?@)^Q-XK_:E
M:R^S3Z7X*;4M.M+H9VWLT2K:PO\ 6>6)#]37GW_!'S]GB7X _L,>%;_Q&'F\
M5>/HSXO\7ZA<'=-=7E^!,OF$\[DA,*$?WE8]6->D_ML?LG>'/VVOV<]9_9N\
M6^,=2T+3-;N+22[O=)2-IL6]Q'.J 2 K@O&N>.U>G:%HUCX=T2S\/Z9'LMK&
MUCM[=/[J(H51^0% CY??]E[_ ()K_M%?MY^-O'?BC1M,\<?%7PYI-C;>)O#7
MB2)KNTTJ%HE$$BVL\?DEF15.X;\;\_*7!/B_C?X1?#[]CS_@M=\%K#]E+PY9
M^&+3XJ>%]9@^(7A#P_"+>QFM[:"62&[-NF$B.],Y4*,VYP,N^[W[]IG_ ()P
MZ)\9?CA;_M4?!/XZ>)_A-\3H]+&FWWB?PND4T6JV@ VQ7EK*-D^W:@!)'"*"
M&V)MO?LJ_P#!/3PI^SY\4]8_:,^(_P 6_$GQ0^)^N6(L;GQKXM:,/:68(/V:
MT@C 2VC) ) R>" 0"009Y'_P0Y4>&/ GQX^$VK,(]9\-_M$^(%U&V;[X1TME
MCD(]&,,@![[*/@0O_"5_\%Y_C;XGT8B:S\,_![2-%U2:/E8[NXDM+E$)'&[9
M&_'^R1V->@_'#_@FM-XK^/&K?M,?LR?M.>+/@YXP\3VD5OXPE\.VL%W8ZV(A
MMCFEM9QM$ZKP) ?4XW,[-WW[&G[%7PW_ &,/!^KZ3X5U_6/$?B#Q3JS:IXR\
M9^);H3ZCK=ZV?WDK@#"KN;:@X&YB269F(!%_P4;\+ZKXR_8'^,?AS0X&ENY_
MAQJ[6\,8RTC):R/L [D[< >IK-_X)>>*-(\5?\$ZO@QJ^D74<D$/PZTVSD=&
M&!+;0+;R@^XDB<'W!KI?V9?V8)/V=+#Q?IVI?&3Q3XVC\6>)[C5R/%M[]H_L
MY)0 ;2 '.V!<<+[FO +W_@CQ>^&;37OAK^SY^V_\2/AW\+_$]Y-/JWPYT86\
MT,"SD^=#9W,@\RTC<$@J V03NW4"*/\ P0CC.L? SXN?$RT&=,\7?M >(M3T
M65?N3VK+;(LBGN"RNO\ P"K_ /P<$?\ *+KQM_V%]&_].,%?4WP)^!_PV_9M
M^$>A? _X1: --\/>';(6VGVN\LQ&2SR.QY>1W9G9CU9B>]<G^VW^R1X4_;@_
M9VU?]G/QKXIU'1M.U>YM)I=0TM(VFC,$Z3* ) 5P2@!R.AH'U/F3QEK>D_L7
M_P#!4KP'\<=<OH]-\&?';X6/HGB>]F.(8-8TJW2>"XD(Z%K=8X%!ZY?\/EK]
MK'0-7\8?\$=/B/\ MF^,K"2#7/CK\9K7Q*L=P/WMMI"736VFVQ/=4@C++U^6
M85^D'[<G[ /PQ_;M^ >E_ CX@^)=3TF+1=4MK_3-:TI8_M,$L43PD#>"-KQR
M.&'T/84?M2_\$_OA;^T[^R'IW[&EQX@U'PWX:TB/3(M.GTE(VFAAL5588P'4
MKC:H!XH"Y[S1110(**** ,[4O#.GZK=&[N)[E6*@8BN"HX]A4'_"#Z1_S\WO
M_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _
M-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;
M5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!
M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
M@6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q1
M0!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4
M?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/
M_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z
M1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#
MZ1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/
MS>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_
M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M*PSJ1]HU=1NN:W>U[V^1;Q>%6(5!U(\[UY;KFMWMN=G17)?&/X[?"/\ 9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(C"\1TL7Q#4RR$-(QYN>^C=HNR5NBDM;GTQ1117U9]*%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '\^WQ,_Y*1X@_[#EW_Z.>L2MOXF
M?\E(\0?]AR[_ /1SUB5_#F(_CS]7^9_(%?\ CR]7^84445D9!1110 4444 %
M%%% !1110 4444 %%%% !7WO_P $'?\ DI'Q"_[ =E_Z.DKX(K[W_P""#O\
MR4CXA?\ 8#LO_1TE?:>'G_)983UE_P"D2/K.!O\ DJ\-ZR_])D?I;1117]:'
M],!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T
M;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;L
MO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_
M\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&_
M_0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]
M!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q1
M6/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\
MC1]B\;_]!NR_\!C_ (T ?$/_  7B_P"2;_#W_L.7O_HF.OS1K](/^"YD&O0_
M#KP =8OX)E.M7FP0Q;<'R8^M?F_7\K>)_P#R6=?TA_Z1$_G'Q#_Y*NMZ0_\
M24%%%%? 'Q(4444 %%%% !1110 4444 %%%% !1110 4444 ?T$_#/\ Y)OX
M?_[ =I_Z)2MNN,^&UGXT/PZT QZU9A?[%M=H-L>!Y*^];?V+QO\ ]!NR_P#
M8_XU_<6'_P!WAZ+\C^OZ'\"/HOR-BBL?[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7
M_@,?\:V-38HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=
ME_X#'_&@#8HK'^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8HK'^Q>-_\
MH-V7_@,?\:T--CU&*U":I<1RR[CEXDVC';B@"Q1110 4444 %%%% !1110 4
M444 %%%% 'CW[9_[%'PH_;=^'=CX+^(M_JND:CH6J1ZIX5\5>'KH0:CHM\GW
M9H),''094C!P",,JLORK\!/^"/OQ \9>._$US^V[^T'XQ\8>%=-^*TVNZ/X2
MNUM+>Q\52K:6B1:M?"!F,A;8T7DMM/[@D\2,&_0NB@#P?]L;]@3X??M;ZQX9
M^(]OX[\0>!?B!X)E=_"?CSPE<+%>6:O]^%U8%9H6YRAQU8 @.X;EO@M_P31B
M\.?'32?VE_VH?VD_%?QE\9>&H'B\)3^)+:"TT_1"XP\T%G -@F(_Y:$]@<;E
M5E^H:* /GK]J_P#X)^:#^T-\4=#_ &BOAI\9/$?PO^)WA[3WT^S\9^%A'(;J
MQ9BWV6ZMY1LN(PS,P!(P6YW  ";]D7]@7PW^S-X\\1_'/QK\6/$/Q)^)GBVW
MCMM<\<^*3&LPM$(*VMO#&-MO#E4)0$Y*+R J@>_T4 ?+WQP_X)K3>*_CQJW[
M3'[,G[3GBSX.>,/$]I%;^,)?#MK!=V.MB(;8YI;6<;1.J\"0'U.-S.S=]^QI
M^Q5\-_V,/!^KZ3X5U_6/$?B#Q3JS:IXR\9^);H3ZCK=ZV?WDK@#"KN;:@X&Y
MB269F/L=% 'E7[,O[,$G[.EAXOT[4OC)XI\;1^+/$]QJY'BV]^T?V<DH -I
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M_2(G\X^(?_)5UO2'_I*"BBBO@#XD**** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P3_ ,%XO^2;
M_#W_ +#E[_Z)CK\T:_2[_@O%_P DW^'O_8<O?_1,=?FC7\K>)_\ R6=?TA_Z
M1$_G'Q#_ .2KK>D/_24%%%%? 'Q(4444 %%%% !1110 4444 %%%% !1110
M4444 ?T$_#/_ ))OX?\ ^P':?^B4K;K$^&?_ "3?P_\ ]@.T_P#1*5MU_<6'
M_P!WAZ+\C^OZ'\"/HOR"BBBMC4**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#^?;XF?\E(\0?]AR[_\ 1SUB5M_$S_DI'B#_ +#EW_Z.>L2OX<Q'\>?J
M_P S^0*_\>7J_P PHHHK(R"BBB@ HHHH **** "BBB@ HHHH **** "OO?\
MX(._\E(^(7_8#LO_ $=)7P17WO\ \$'?^2D?$+_L!V7_ *.DK[3P\_Y++">L
MO_2)'UG W_)5X;UE_P"DR/TMHHHK^M#^F HHHH **** "BBB@ HHHH ****
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M^XL/_N\/1?D?U_0_@1]%^04445L:A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?S[?$S_DI'B#_ +#EW_Z.>L2MOXF?\E(\0?\ 8<N__1SUB5_#F(_C
MS]7^9_(%?^/+U?YA11161D%%%% !1110 4444 %%%% !1110 4444 %?>_\
MP0=_Y*1\0O\ L!V7_HZ2O@BOO?\ X(._\E(^(7_8#LO_ $=)7VGAY_R66$]9
M?^D2/K.!O^2KPWK+_P!)D?I;1117]:'],!1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7[<'A"W\,0> ]2\]6^)6HQ6-AJTL7F(LUO(LPZQ2++&&8,ZS JNY> .IF?\
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MI5\3?\&]W_*,#PC_ -AS6?\ TNEK[9H)>X4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^"[O3;C3[KPWI]DL-K-;SHR3(RIC=YBLVYC\S;B223FH/ /[-/P#^&'PCE^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%]&_].,% ^I]7_"/XO?#7X\?#S3?BQ\(/&%IKWAS5TD;3=6LBWESA)&B?&X
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M_L.7O_HF.OS1K^5O$_\ Y+.OZ0_](B?SCXA_\E76](?^DH****^ /B0HHHH
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M!!IG_!P1_P HNO&W_87T;_TXP5]FV%A8:580:7I=E#;6MM"L5M;6\82.*-0
MJ*HX50   . !6#\6?@]\+_COX'N?AK\8O VG>(] O)(WNM)U2 20RM&X="5/
M4JR@CW% ^I\._MX^.K#]@_\ :H^"/_!1B\LYO^$;U+P?=^!/B$+5#F6-K5KS
M3^G5C/&Y)(Z0J/3'A'[7OPJ\2> /^"!C>/\ XAQ?\5?\4OB!9^._%TS+AI+O
M4[HSID'D%;?R%*GH5/3I7ZH_%CX$_!SXZ^ Q\,/C#\.-)\1^'UEBE72-5M1+
M"KQ_ZM@IZ%><'W-'Q3^!7P>^-W@$?"SXL_#C2M?\."2%UT74;4/;AHO]60G0
M;>WI0%SK****!!1110!G:EX9T_5;HW=Q/<JQ4#$5P5''L*@_X0?2/^?F]_\
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
M@6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q1
M0!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;5
M^6O_  =!Z!9:/\(/A/):RSL7\2:D#YTQ;_EWBZ9K]8J_*O\ X.F/^2._"3_L
M9M2_])XJ!K<_%^BBB@L**** "BBB@ HHHH **** "BBB@ HHHH **** "OZM
M_@SX*TF3X/\ A21KF\RWAJQ)Q=-_S[I7\I%?UG?!7_DCGA+_ +%FP_\ 2>.@
MF1>_X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@DQ_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
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M+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8H
MH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "
MVK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'T
MC_GYO?\ P+:M#3=.@TJU%I;O(RAB<RN6//N:L44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH _H)^&?_)-_#__ & [3_T2E;=8GPS_ .2;^'_^P':?^B4K;K^XL/\
M[O#T7Y']?T/X$?1?D%%%%;&H4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBBO@#XD**** "BBB@ HHHH **** "BBB@ HHHH **** /Z"?AG_ ,DW\/\
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MF.OS1K^5O$__ )+.OZ0_](B?SCXA_P#)5UO2'_I*"BBBO@#XD**** "BBB@
MHHHH **** "BBB@ HHHH **** /Z"?AG_P DW\/_ /8#M/\ T2E;=8GPS_Y)
MOX?_ .P':?\ HE*VZ_N+#_[O#T7Y']?T/X$?1?D%%%%;&H4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?S[?$S_DI'B#_L.7?_HYZQ*V_B9_R4CQ!_V'+O\ ]'/6)7\.8C^/
M/U?YG\@5_P"/+U?YA11161D%%%% !1110 4444 %%%% !1110 4444 %?>__
M  0=_P"2D?$+_L!V7_HZ2O@BOO?_ ((._P#)2/B%_P!@.R_]'25]IX>?\EEA
M/67_ *1(^LX&_P"2KPWK+_TF1^EM%%%?UH?TP%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^5?_!TQ_P D=^$G_8S:E_Z3
MQ5^JE?E7_P '3'_)'?A)_P!C-J7_ *3Q4#6Y^+]%%%!84444 %%%% !1110
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MBBB@ HHHH **** "BBB@#X)_X+Q?\DW^'O\ V'+W_P!$QU^:-?I=_P %XO\
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MD"B-6/RATR<8&X>M 'H]%%% !1110 4444 %%%% !1110!_/M\3/^2D>(/\
ML.7?_HYZQ*V_B9_R4CQ!_P!AR[_]'/6)7\.8C^//U?YG\@5_X\O5_F%%%%9&
M04444 %%%% !1110 4444 %%%% !1110 5][_P#!!W_DI'Q"_P"P'9?^CI*^
M"*^]_P#@@[_R4CXA?]@.R_\ 1TE?:>'G_)983UE_Z1(^LX&_Y*O#>LO_ $F1
M^EM%%%?UH?TP%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6_8(_P"B*3?^%1J7_P D4?\ #I;]@C_HBDW_ (5&I?\ R11_Q![B;_G]1_\
M I__ "L/^(6\0?\ /VE_X%/_ .0/QJHK]E?^'2W[!'_1%)O_  J-2_\ DBC_
M (=+?L$?]$4F_P#"HU+_ .2*/^(/<3?\_J/_ (%/_P"5A_Q"WB#_ )^TO_ I
M_P#R!^-5%?LK_P .EOV"/^B*3?\ A4:E_P#)%'_#I;]@C_HBDW_A4:E_\D4?
M\0>XF_Y_4?\ P*?_ ,K#_B%O$'_/VE_X%/\ ^0/QJK[W_P""#O\ R4CXA?\
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M1;B2?3(GU^]M?(DD4*[9MI8RV0H&&)'% '\N%%?T8_\ #A'_ ()4?]&RS?\
MA;ZU_P#)E'_#A'_@E1_T;+-_X6^M?_)E!?,C^<ZBOZ,?^'"/_!*C_HV6;_PM
M]:_^3*/^'"/_  2H_P"C99O_  M]:_\ DR@.9'\YU%?T8_\ #A'_ ()4?]&R
MS?\ A;ZU_P#)E'_#A'_@E1_T;+-_X6^M?_)E <R/YSJ*_HQ_X<(_\$J/^C99
MO_"WUK_Y,H_X<(_\$J/^C99O_"WUK_Y,H#F1_.=17]&/_#A'_@E1_P!&RS?^
M%OK7_P F4?\ #A'_ ()4?]&RS?\ A;ZU_P#)E <R/YSJ*_HQ_P"'"/\ P2H_
MZ-EF_P#"WUK_ .3*/^'"/_!*C_HV6;_PM]:_^3* YD?SG45_1C_PX1_X)4?]
M&RS?^%OK7_R91_PX1_X)4?\ 1LLW_A;ZU_\ )E <R/YSJ*_HQ_X<(_\ !*C_
M *-EF_\ "WUK_P"3*/\ APC_ ,$J/^C99O\ PM]:_P#DR@.9'\YU?UG?!7_D
MCGA+_L6;#_TGCKYB_P"'"/\ P2H_Z-EF_P#"WUK_ .3*^HM'^&/AC0-)M="T
MDWD-I96R06T7VUVV1HH55R22<  9)S02W<Z&BL?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:@1L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U 'Q#_ ,%XO^2;
M_#W_ +#E[_Z)CK\T:_=;XT?L?? /]H;3['2_C%X4NM:@TV9Y;*-]8N8?*=@
MQS#(A.0!US7GW_#I;]@C_HBDW_A4:E_\D5^+<8^'&><0\05<=AJE-0DHV4G)
M/2*3V@UT[GY-Q5P)F^>9W4QE"=-1DHV4G)/2*72+73N?C517[*_\.EOV"/\
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M'N)O^?U'_P "G_\ *P_XA;Q!_P _:7_@4_\ Y _&JBOV5_X=+?L$?]$4F_\
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M'_Y(_I!HK^;[_A]?_P %._\ HZ"?_P )32/_ )$H_P"'U_\ P4[_ .CH)_\
MPE-(_P#D2C^TJ'9_A_F'^OF3_P#/NI]T?_DC^D&BOYOO^'U__!3O_HZ"?_PE
M-(_^1*/^'U__  4[_P"CH)__  E-(_\ D2C^TJ'9_A_F'^OF3_\ /NI]T?\
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MWI7644 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?-7_  6&_P"49_Q>_P"Q:7_TIAKZ5KYJ
M_P""PW_*,_XO?]BTO_I3#6=;^%+T9P9I_P BRO\ X)?^DL_FLHHHKY<_GX**
M** "BBB@ HHHH **** "BBB@ HHHH **** "OZ"?^#>C_E&?X?\ ^QEU?_TI
M-?S[5_03_P &]'_*,_P__P!C+J__ *4FN_+?]X?I_D?9<"_\CF7^!_G$^WZ*
M**]T_7@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:/\ DL7BS_L9K_\ ]*'KFJZ7XT?\EB\6?]C-?_\ I0]<U0:+8**** "BBB@
MHHHH **** "BBB@ HHHH **** "OU4_X-9_^2Q_%K_L6=-_]*):_*NOU4_X-
M9_\ DL?Q:_[%G3?_ $HEH$]C]H****" HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KYJ_X+#?\HS_ (O?]BTO_I3#7TK7S5_P6&_Y1G_%[_L6E_\
M2F&LZW\*7HS@S3_D65_\$O\ TEG\UE%%%?+G\_!1110 4444 %%%% !1110
M4444 %%%% !1110 5_03_P &]'_*,_P__P!C+J__ *4FOY]J_H)_X-Z/^49_
MA_\ [&75_P#TI-=^6_[P_3_(^RX%_P"1S+_ _P XGV_1117NGZ\%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-?\ _I0]<U72_&C_ )+%XL_[&:__ /2AZYJ@T6P4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#^?;_ (.%_P#E)AX@_P"Q:TC_ -)A7Q!7V_\ \'"__*3#Q!_V+6D?^DPK
MX@KYK$_[Q+U/P3/?^1SB/\<OS"BBBL#R@HHHH **** "BBB@ HHHH **** "
MBBB@ KZ5_P""//\ RDP^$/\ V,K?^DTU?-5?2O\ P1Y_Y28?"'_L96_])IJT
MH_QH^J.[*_\ D9T/\<?_ $I']*=%%%?4']!!1110!_)A\:/^2Q>+/^QFO_\
MTH>N:KI?C1_R6+Q9_P!C-?\ _I0]<U0:+8**** "BBB@ HHHH **** "BBB@
M HHHH **** "OU4_X-9_^2Q_%K_L6=-_]*):_*NOU4_X-9_^2Q_%K_L6=-_]
M*):!/8_:"BBB@@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^:O\
M@L-_RC/^+W_8M+_Z4PU]*U\U?\%AO^49_P 7O^Q:7_TIAK.M_"EZ,X,T_P"1
M97_P2_\ 26?S64445\N?S\%%%% !1110 4444 %%%% !1110 4444 %%%% !
M7]!/_!O1_P HS_#_ /V,NK_^E)K^?:OZ"?\ @WH_Y1G^'_\ L9=7_P#2DUWY
M;_O#]/\ (^RX%_Y',O\  _SB?;]%%%>Z?KP4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOS"BBBL#R@HHHH **** "BBB@ HHHH **** "BBB@ KZ5_X(\_\ *3#X0_\
M8RM_Z335\U5]*_\ !'G_ )28?"'_ +&5O_2::M*/\:/JCNRO_D9T/\<?_2D?
MTIT445]0?T$%%%% '\F'QH_Y+%XL_P"QFO\ _P!*'KFJZ7XT?\EB\6?]C-?_
M /I0]<U0:+8**** "BBB@ HHHH **** "BBB@ HHHH **** "OU4_P"#6?\
MY+'\6O\ L6=-_P#2B6ORKK]5/^#6?_DL?Q:_[%G3?_2B6@3V/V@HHHH("BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OFK_@L-_P HS_B]_P!BTO\
MZ4PU]*U\U?\ !8;_ )1G_%[_ +%I?_2F&LZW\*7HS@S3_D65_P#!+_TEG\UE
M%%%?+G\_!1110 4444 %%%% !1110 4444 %%%% !1110 5_03_P;T?\HS_#
M_P#V,NK_ /I2:_GVK^@G_@WH_P"49_A__L9=7_\ 2DUWY;_O#]/\C[+@7_D<
MR_P/\XGV_1117NGZ\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"+W_8M+_Z4PUG6_A2]&<&:?\BRO_@E_P"DL_FLHHHKY<_GX**** "BBB@
MHHHH **** "BBB@ HHHH **** "OZ"?^#>C_ )1G^'_^QEU?_P!*37\^U?T$
M_P#!O1_RC/\ #_\ V,NK_P#I2:[\M_WA^G^1]EP+_P CF7^!_G$^WZ***]T_
M7@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVL_@_P#M;7?_  4%_9%\#Z3XZBU;X<2>%O'_ ($U'55L;F2U5_-6ZM)I/D#
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M\)CX8_Z#4'_?5>Z?KQI45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
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M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
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MQ'W47I7Z@44#N%%%% @HHHH CEL[29M\UK&[>K(":;_9VG_\^,/_ 'Z%344
M0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_
M 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9
MVG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#
M_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_
MV=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_W
MZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG
M_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_
M]^A7S7_P6#LK*/\ X)I?%UX[2)6'AI<%8P"/])AKZ:KYJ_X+#?\ *,_XO?\
M8M+_ .E,-9UOX4O1G!FG_(LK_P""7_I+/YK****^7/Y^"BBB@ HHHH ****
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M?&'_ +]"I(XHH5V0QJB^BK@4ZB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM GL?M!11100%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-7_!8;
M_E&?\7O^Q:7_ -*8:^E:^:O^"PW_ "C/^+W_ &+2_P#I3#6=;^%+T9P9I_R+
M*_\ @E_Z2S^:RBBBOES^?@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M_H)_X-Z/^49_A_\ [&75_P#TI-?S[5_03_P;T?\ *,_P_P#]C+J__I2:[\M_
MWA^G^1]EP+_R.9?X'^<3[?HHHKW3]>"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GV_P"#A?\
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M^QFO_P#TH>N:H-%L%%%% !1110 4444 %%%% !1110 4444 %%%% !7ZJ?\
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MP+_R.9?X'^<3[?HHHKW3]>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC]OC]K3XFZ%\1I+6P\'V&A_VGX5\.Q:=$DEA$]U&D0>8*'F;RF&23@DD@ 8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYJ_X+#?\HS_ (O?]BTO_I3#
M7TK7S5_P6&_Y1G_%[_L6E_\ 2F&LZW\*7HS@S3_D65_\$O\ TEG\UE%%%?+G
M\_!1110 4444 %%%% !1110 4444 %%%% !1110 5_03_P &]'_*,_P__P!C
M+J__ *4FOY]J_H)_X-Z/^49_A_\ [&75_P#TI-=^6_[P_3_(^RX%_P"1S+_
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M  6]_;6\!W_[8G@S]C3X\KX@M?A'X:>T\0>/[;PW"DMYX@F96D@M0K2Q@0J
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M5O9[77\2W+_Z3UV/K;P!_P B)HG_ &"+;_T4M:U5=$TN/1-%L]%BE,BV=K'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^3#XT?\EB\6?]C-?_\
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MM_"EZ,X,T_Y%E?\ P2_])9_-91117RY_/P4444 %%%% !1110 4444 %%%%
M!1110 4444 %?T$_\&]'_*,_P_\ ]C+J_P#Z4FOY]J_H)_X-Z/\ E&?X?_[&
M75__ $I-=^6_[P_3_(^RX%_Y',O\#_.)]OT445[I^O!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M_)A\:/\ DL7BS_L9K_\ ]*'KFJZ7XT?\EB\6?]C-?_\ I0]<U0:+8**** "B
MBB@ HHHH **** "BBB@ HHHH **** "OU4_X-9_^2Q_%K_L6=-_]*):_*NOU
M4_X-9_\ DL?Q:_[%G3?_ $HEH$]C]H****" HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ^'_ -MO]GC]K/X/_M;7?_!07]D7P/I/CJ+5OAQ)X6\?^!-1
MU5;&YDM5?S5NK2:3Y P"1Y4Y/[L@*_F?)@?\$G?VZOV=/B1X*^$7[+'Q&^$^
MK^$_B=X>^&UC%X/O/%_AY(UURS2S0/<:9='+,DD<9DV_+N53C?M;'2?M?_M/
M?M+_ +'?[6^K^*_B[I'B3Q)^SUXP\"M9Z9<^&_#J70\):PJ!6:Y\F/SC')M9
MMSEO]< G^K*U\[_LAW7B+]N[QU^QYI/PA^&.OVGAK]GGPG!=>.?B#JNE/:VD
MUY]BMH_[.M)' ^T9DMP&V\$.6'RKE@9]%?L^ZK+\?_\ @M-\:_'6KMY]E\&?
M ND>%/#D3_=MY+\&ZN)E':0O%/'NZE,#IP.?_:M^&/[??BK_ (*Q:#\7?V8_
M@OH-SIWA?X4/I6C^+/'US-%HEE>7%Q(UQ,1;YFFD\J18A$@!)^8G:IK9_9/L
MY?@O_P %G?VC_ACK(,2_$KPIH'C#P^TAQ]I@ME:VGV^I6>XE7CLA-=!^T1^V
M)^T7^Q?^V7<Z[\<O!NMZ_P#L]>)/#T*Z+K7A/PO]LE\,:J@02K>>2IE:.3:[
M G(_>J$!V.  4O@C^W#^US\)?VN= _8K_P""B/P_\&V^H^.;&>?X>^//A]+<
M#3=3E@4M):RQW)WI)@=?EPQC781('K)_X(W8\3_$?]JGXJZH-^JZM^T-JUA<
M3-RPMK4_Z/%GKM03NH'85S]CXB\1?\%1_P#@H-\)?C;\,_ACXET;X1? X:CJ
M1\8^)]&ET\^(-4NDB5+>TBE =XT,$+,Y P!(&"DQ[H/!7Q0;_@D]^V!\:+#X
M[?#SQ3)\+/BWXJ/C'PEXV\.Z!/J%M:7\X8WEE<K K-$Y=@$&/NQ@XPV5 -#4
M=>O?A3_P7*^)%_X74*->_9C_ +9U*%1\LMY:7,<<,K#NRQPA!GLQKK_^"!.B
M6EC_ ,$P?!/B5/GO?$6KZYJ.JW#'+SW']J7,&]SU+;((QD^@K*_85\'^-OVJ
MOVU_BC_P48\=_"[6?#'A'7?"=OX+^'.D^)[(V][?Z6K)+<WDD+<QI))&I3U$
MC $[<MYY^QO^U%:?\$EOA[KO[#O[6OPQ\=(GA7Q'J$_PX\1:!X5GU"T\3Z9<
M3-/$L,D0*K/O=]R,5"EPK%2"* /0?^"83-X=_;X_;-^&FE_N])L_B'I&L6]L
MG")=7\5Y)<,!T!8QIG_=]JZ;_@NWXGU7PO\ \$MOB9-H\[Q2WHTNRDD0X(BE
MU.U60?1D+(?9C5?_ ():?"GXK^$_#_Q?_;/^.GP]O_#GB+XR^,9O$%OX2NHS
M]MT_28%D^Q02J<%9MLDGRD X*9"DE1I?%M+G_@K3_P $R?&OA[PO\,O$7@S4
M?%%E-#HVB>-K,6ETM]97*3V_F#)"1R30(-V>%8F@.I[58?#+PHG[(D/P<&G0
M_P!ACX<+HWV38/+^R_8/(V8Z8V<8]*^?O^"&.I2?$?\ X)1^ ]%\9PK?VR1Z
MQI4L5T-RS6HU"Z01L#U41L(\?W5 KS:+_@JSKUO^R0O[.<G[-/Q.'[0J^%/^
M$;7P3_PAMSM;4Q!]F^W"XV^7]EW?OL[L[>.GSU]2?\$\/V;KS]C7]B7P'\!O
M%5U;KJ.@:,\^O2I*#%'>7$TEU<@/T94DF=0W0J@/% =#QS_@B#XJUC3OV??'
MG[,>O:A+<R?!CXM:YX3T^29]SFQBF\R(%CR<.\RCT55 X& W_@X(_P"477C;
M_L+Z-_Z<8*K?\$/-+O/%/PI^+G[3TUO)':?%KXWZ_KVB%Q_K;'SMBR#_ +:^
M>O\ P"MG_@N_X1\5^./^":?C+PYX*\,:CK&HS:KI#16&EV4EQ,X74(&8A(P6
M( !)P. * ZG+_P#!/!?^&7OV^/C'^QO<?Z/HGCC3+'XG^!H#\J8N42#4E0=.
M)]JJHZ+ 3]/D7_@J\O\ PT?X;_:+_;!N?W^D>#_&.A?"[P-,>5"6=Q]HU1U[
M$-=NFUQU (R<5]6_\%5O#_QD^"4'P6_;\_9W\ ZAKGB[X>?:-#U72-.L9)I;
MK3M0L'C!DC16+)%,H(&.&FSVR/-_VYOV2/'7P;_X(0>&O@/H?A'5=9\5KJ6D
MZGXEMK"QDNKJ74KFX:ZO&8("S[)963<1]U%Z4 ?J!1110(**** *5]XBT339
M_LM_J4<4@ .QCSBHO^$Q\,?]!J#_ +ZJ]+9VDS;YK6-V]60$TW^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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M.=;9"VLRR16NL:'=#R[_ $^9XHY&5C&3)$^Q@DB]!O+#W:BB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN_M,;L;L9P,XZ"LS_B%2_P"K\?\ S%__ -\Z_7JB@=V?D+_Q"I?]7X_^8O\
M_OG1_P 0J7_5^/\ YB__ .^=?KU10%V?D+_Q"I?]7X_^8O\ _OG1_P 0J7_5
M^/\ YB__ .^=?KU10%V?D+_Q"I?]7X_^8O\ _OG1_P 0J7_5^/\ YB__ .^=
M?KU10%V?D+_Q"I?]7X_^8O\ _OG1_P 0J7_5^/\ YB__ .^=?KU10%V?D+_Q
M"I?]7X_^8O\ _OG1_P 0J7_5^/\ YB__ .^=?KU10%V?D+_Q"I?]7X_^8O\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S5_P %AO\ E&?\7O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]\>:98^+_'5A''.-&U.+3(8H70HC0RNUHB2E 8Y&'F$<@I7T5^T_K'_"\O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %?-7_  6&_P"49_Q>_P"Q:7_TIAKZ
M5KYJ_P""PW_*,_XO?]BTO_I3#6=;^%+T9P9I_P BRO\ X)?^DL_FLHHHKY<_
MGX**** "BBB@ HHHH **** "BBB@ HHHH **** "OZ"?^#>C_E&?X?\ ^QEU
M?_TI-?S[5_03_P &]'_*,_P__P!C+J__ *4FN_+?]X?I_D?9<"_\CF7^!_G$
M^WZ***]T_7@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\!_X*5?L@^,OVUOV7[_ .$OPU^)ESX3
M\36U_%J6@ZI%>S00R3QJZ&"X,/SF%TD<' ;:VQ]K;,'WZB@#\6_A!^PG_P %
M&/VYOB5\0_V<OVE?%_AG1?#6G?$K2-1^+FMVS>9?ZG>VVEPPPK:[ 4??;E7+
M811(Y8YVB.OHG]N+PK'^S3_P6B_9H_:E-J+;PSXHL)/!%W*/]5!=LEQ;0AV_
MARM_"1GJ+=CV-?HW7G7[4/[+'P>_; ^&'_"IOC3H]S<Z='J=OJ-E<6%XUO=6
M5W"V8YX95YC< LN1_"[#O0.Y\Y_M]_LR?\%$?^&DO"W[7_[!'QD^VSZ-8_9=
M9^%?BKQ!<)H]Z0LB><D!D6$ETDVN"8V#1HZONSCG?V(O^"?O[5FO_MIZ[_P4
M;_X*"ZEX>L_&=UI+:;X9\)^$KAF@TJ)H?L[2&0,VW;#O15620DS.[.#@5]X6
ML)MK:.W:=Y3&@4RRD%GP,9. !D_2GT"N?F:G[,'_  7,_9@OO'GP9_9_^*6@
M_$_P;XTNIGTGQE\0O$LUQJVA)(GE;PUQ,&641A00!/&60.J@LRGZF_X)>?L&
MVG_!/3]EZV^#5WXA@U?7]1U.75_%.IVJL()+V1(X]D.X!O*2.*- 6 +$,^%W
M;1]&44#N?%/A#]AGX]Z-_P %K_%/[<][I^F#P#JWA&/3[.X74E-T9QI]G 08
M<9 WPOSGI@]Z]3^+VD?\%!;C]NKP'JGPB\4:/!\"XM%0>/--N8[0W<U[OO-S
M1EXC,!M-G]QU'RMQ][/T'10(^!/CG^SI_P %;?V??VP?%'[1/[$OQ&TSXC^$
M_&D3"7P)\2/$EP\.A2L0S"".2>-$C5]QC\J1=J.8S&0JL>K_ ."8O[!OCS]B
MRV^)?[5?[77CS2]0^(WQ$O)M7\6W6G.39Z5;*\MS*H?:H9F>1W<@;%"(JY"E
MF^T*YCXS_"?PU\=OA3K_ ,'/&=WJ$.C^)=,DT_56TN[,$[V\@VR(L@!*AERA
M]58CO0.Y\-?\&^/@;6=<^''Q>_;$UO39+3_A;WQ*N;S3DE7!EM;>6=O,'J//
MN[F/ZQ-7N?\ P5Q_9;^+'[8W[$^M_ OX*V=C/K]_J^GW%O'J-Z+>(I#<+(^7
M((!V@X]:]W^$GPJ\"_ WX9:%\(/AEH::;H'AS38K'2[-"3Y<2+@%B>68G+,Q
MY9B2<DFNBH#J?E7_ ,%(/^",W[2?[3WP\_9^_P"%3V&@CQ'X)^&%CX4\<&_U
M98DB^S0P>48VP?-42/=],<;<=>/:_B;_ ,$Z?B\W_!4KX"_M&_#+2=,7X;?"
MWX<6OAR\>;452YB\A-3C14AQE@$N8.1[^E?=-% 784444""BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KYJ_X+#?\HS_ (O?]BTO_I3#7TK7
MS5_P6&_Y1G_%[_L6E_\ 2F&LZW\*7HS@S3_D65_\$O\ TEG\UE%%%?+G\_!1
M110 4444 %%%% !1110 4444 %%%% !1110 5_03_P &]'_*,_P__P!C+J__
M *4FOY]J_H)_X-Z/^49_A_\ [&75_P#TI-=^6_[P_3_(^RX%_P"1S+_ _P X
MGV_1117NGZ\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\U?\ !8;_ )1G_%[_ +%I?_2F&OI6OFK_ (+#?\HS_B]_V+2_^E,-9UOX
M4O1G!FG_ "+*_P#@E_Z2S^:RBBBOES^?@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *_H)_X-Z/^49_A_P#[&75__2DU_/M7]!/_  ;T?\HS_#__ &,N
MK_\ I2:[\M_WA^G^1]EP+_R.9?X'^<3[?HHHKW3]>"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^:O^"PW_*,_XO?]BTO_ *4PU]*U
M\U?\%AO^49_Q>_[%I?\ TIAK.M_"EZ,X,T_Y%E?_  2_])9_-91117RY_/P4
M444 %%%% !1110 4444 %%%% !1110 4444 %?T$_P#!O1_RC/\ #_\ V,NK
M_P#I2:_GVK^@G_@WH_Y1G^'_ /L9=7_]*37?EO\ O#]/\C[+@7_D<R_P/\XG
MV_1117NGZ\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?$
MG[8WQ_\ VJ/C'^V9<?L$?LL_%2S^'-GX>^&TOB[QYXUDT>*^OI86D$4=G:12
M_(I.^,F3AAO)!'E[9.7_ ."87C+_ (*&^!+GX0^%OBMKEY\4?A+\1OA=:ZO9
M>+)-(2&Z\&W?V195L[F=3FYC;B-9)"TCEU.5",#ZO^W?^P'_ ,+N^($/[4?P
M)^/NI_#'XK^'/"MQ8_VSIMK'=P:KIGSN;6[M7($B;BP#Y(&>5?8@7P'_ ()O
M_MH?M1?L]:?^SW^S-^U?X'\,W/@/XJ>";.+X2^-?#,DBSVYCLXGBL;^-^#)L
M>)-RJHW."#(-Q0&?3_[4_P"T-\2)?VF/AI^Q1^SWXD&E>)_$\K>(O&FO)9PW
M#Z)X8M'_ 'I6.9'02W4H%M&[*P3+G .UAF_M&>$?^"N6J_&#5+[]EKXK_!;3
M/ [I;_V/9>+]-OY-0C(@C$WFM%$R',PD*X)^4KGG->>?L37<GQ*_X*_?M8?$
M/6FW7/A33_#/AK1T?K!:/!(\BKGD*TMJ)#VR]?0O[=O[2]I^Q_\ LD>.?VA9
MEB>ZT#1F.D03'Y9K^5EAM4([J9I(]V/X0Q[4 ?)_[,'[3_\ P5*\;_\ !0J?
M]E+Q_P"//A3XH\/^"K6.\^*&M>#=%NE@TSS%?RK$33!,W3-M.Q5( #Y.8W"]
M;\>?VD/^"A/Q4_X* >*OV2/V&_$_PYT?3_ O@G3=2\17OCK3;B4&[NF+K&KP
M!B"8I(B%*@81CGD"O1O^"3?[+][^S5^Q_HMWXU:6Y\<^/G/BOQ[J=X,W-QJ-
MZ!+LD8\DQHR(1G&\2,/OFO-KW_@D=\1_'_[57Q=^/'Q!_;+\:^&M$^(^J6D\
M.C?"[4SI5W)#:Q-#;QW=TZ.S)'&<"- %8G<3\JB@-#VG]D?PY_P4;T/Q)J\W
M[;?Q#^%^LZ2]B@T2+P%97<4T=QO^=I3/&H*;.F,G->#_  T_:#_X*+_\%$-1
M\6_%[]CCXJ^!_AO\,O#_ (ANM'\&R>(/#1U.Z\526_$ES,Q.+>W9B-IC&X<@
MABI)R?@!X[_:0_97_;"^(?\ P3:^)'QMU[XE:#?_  IN?%OPT\3>)Y_M&L68
M&^$VD\W64;EEP3T,*%0@D*KZ#_P0-%@/^"5?PV-GM\PW.M_:MO7S/[9O<9]]
MFS\,4 >A?\$[?VPO%?[6'PU\0Z7\7O"-IX>^(_P[\57/AGX@:)I\A:W2]@.!
M/!N)/DR#.W)/*. 6 #'TO]I7X\^$OV7_ (">*_V@/',<DFF>%=&EOIK>%@'N
M748C@0G@-)(4C!/&7&:^5/\ @FF&_P"'CO[:9L?^/#_A,O#NS;]W[1Y%_P"=
MCWW8S^%;W_!?#^T?^'5OQ(^P;MGVC1?M6W_GG_:]GU]MVV@.IP<?Q1_X+.3_
M +.0_;PA\7_#4V#Z'_PDJ_!,^&9-_P#8_E^?Y?V[?YOVK[/\VSINXZ_)7O'B
M[X__ !0_:4_X)]V?[57[%6O'3?$-WH$/B/1=+N[*&Z2^:W.^ZT>8.AYD\N:V
M+QE'5PK*Z@'/JMD-!7]G:$#R_P"S!X+7TV>1]D_EMKYH_P"" HU ?\$LOA]]
MMW>6;[6OLF[_ )Y_VK==/;?OH ^COV7_ -H3P5^U9\ /"O[0GP_8C3/%&E)=
M) [AGM902DUNY'!>*59(V(XRAQQ7D_\ P5M_:7^*_P"R+^PWXF^.GP4U2UL_
M$.F:AIL5I<7EDEQ&JS7D43Y1Q@Y1V'M7FG_!$NZD\+Z-^T!\ [1LZ5X!_:$\
M06&AJ/NPVID $2XX"AHV;'K(:N_\'!'_ "BZ\;?]A?1O_3C!0'4[O_@E/^UK
M\1/VM?V9;C5OCA]GC^(7A#Q5J/ASQO!;VZP*MY!+N0B->%'E21KQP61\>@\!
M_P""VO\ P4Z_:(_8Z\9^&OAC^RO?V$&I0:!)KWC:[O=+BNUMK.6ZCM+-0),A
M2TOFY[XVGIFNK_9_4?LJ?\%9];^&[?Z/X:_:'^&]EXET=.D8U[38O+NHE!_B
M>#S;AR.I9/P^1OV[%_X7Q^Q%^T'^W]?#S;?XA?&/2M"\$3L,J?#VCSM:PRQ_
MW1-,)G8#@M'GF@%N?M)1110(**** "BL[4M9U"QNC!;^'KFY7:#YL3#'TYJ#
M_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL
M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_
M .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_
M *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[
MZ6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_
M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
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MX8>!OB1\,=?\076K^#8?$'B-M,NO"LER=SVTJD8N+=& *B,[FP3E2Q4?>-%
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M[XZ_X)6^&_V$OV>%TE]5\/1Z-&)=1NS;P7#6QW7,Q;:<-)(7DQCDN>E?:]%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYJ_X+#?\
MHS_B]_V+2_\ I3#7TK7S5_P6&_Y1G_%[_L6E_P#2F&LZW\*7HS@S3_D65_\
M!+_TEG\UE%%%?+G\_!1110 4444 %%%% !1110 4444 %%%% !1110 5_03_
M ,&]'_*,_P /_P#8RZO_ .E)K^?:OZ"?^#>C_E&?X?\ ^QEU?_TI-=^6_P"\
M/T_R/LN!?^1S+_ _SB?;]%%%>Z?KP4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7S5_P6&_Y1G_ !>_[%I?_2F&OI6OFK_@L-_RC/\
MB]_V+2_^E,-9UOX4O1G!FG_(LK_X)?\ I+/YK****^7/Y^"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K^@G_@WH_P"49_A__L9=7_\ 2DU_/M7]!/\
MP;T?\HS_  __ -C+J_\ Z4FN_+?]X?I_D?9<"_\ (YE_@?YQ/M^BBBO=/UX*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYJ_X+#?\
M*,_XO?\ 8M+_ .E,-?2M?-7_  6&_P"49_Q>_P"Q:7_TIAK.M_"EZ,X,T_Y%
ME?\ P2_])9_-91117RY_/P4444 %%%% !1110 4444 %%%% !1110 4444 %
M?T$_\&]'_*,_P_\ ]C+J_P#Z4FOY]J_H)_X-Z/\ E&?X?_[&75__ $I-=^6_
M[P_3_(^RX%_Y',O\#_.)]OT445[I^O!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?-7_!8;_E&?\7O^Q:7_P!*8:^E:^:O^"PW_*,_
MXO?]BTO_ *4PUG6_A2]&<&:?\BRO_@E_Z2S^:RBBBOES^?@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *_H)_P"#>C_E&?X?_P"QEU?_ -*37\^U?T$_
M\&]'_*,_P_\ ]C+J_P#Z4FN_+?\ >'Z?Y'V7 O\ R.9?X'^<3[?HHHKW3]>"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^:O\ @L-_
MRC/^+W_8M+_Z4PU]*UYK^V'^SQ_PUC^S/XO_ &=?^$O_ + _X2O3!:?VQ_9_
MVK[+B5'W>5YD>_[F,;UZ]:BHG*FTNQR8^E.M@:M."NY1DEZM-(_EAHK]=/\
MB%=_ZOM_\QA_]\Z/^(5W_J^W_P QA_\ ?.O!^HXK^7\5_F?CW^J/$/\ SY_\
MFA_\D?D717ZZ?\0KO_5]O_F,/_OG1_Q"N_\ 5]O_ )C#_P"^='U'%?R_BO\
M,/\ 5'B'_GS_ .30_P#DC\BZ*_73_B%=_P"K[?\ S&'_ -\Z/^(5W_J^W_S&
M'_WSH^HXK^7\5_F'^J/$/_/G_P FA_\ )'Y%T5^NG_$*[_U?;_YC#_[YT?\
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MKJM[[>74^N:***U.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\3OAPMM>#6/#B/'8^(=)N%!BO8XW),;+N02#@ R*  0P'F/PT_:#_P""B_\
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M?^"K?[#'_!3O]NNR^&_@WPY!X<ET#P[X3L[GQ/:2^(4M8KWQ(Z$7<IC48:-
M L9_A#RXQNJH2FHRFX-RTTMIY?<:8:MBH4*V*J864JSY;1<+123]U1ZOEW;T
M?:Q2_8-T_P"(W_!2S_@J!=_\%2+OP'=^&/AMX*TR?1? IODVS:N_D3VPSCAM
MJW-Q)(RDJCM'$"^UF'Z>7MO]LLY;3S&3S8F3>O5<C&17PG^P_P" ?^"T'PY^
M+/@WP7\?K?X:Z=\)-(@EM=1TGPO;6<3V]NEK*MND*Q("H$WDYQVSGO7M_P"R
MUI/_  4 L?VB?BM>?M2>)]'O?AW/K,I^%5K81V@FMK+[7.464PQ+(3Y!@'[Q
MF.0><Y)WP_NPLT[MZW77_(];)I.AAU&=.ISU)-R<HV]YI-NU](]%Z'YM_P#!
M2+_@GO\  ']@7X@?LR:%\((-2OM5U_XCSS>)?$^NWGG7NJ2)<Z84WD!415,D
MA"JH^^22Q)8_HW_P5J\!:;\1O^";_P 7]#U2!72T\'SZI%N7.V6R*W:$>AW0
MBO-_^"L?[#OQY_:_^)GP(\4_!G3],GM/A_XNN-0\1'4-26!D@>:P<&,$'><6
M\G ]!ZUV7_!9GXJZ=\)O^";/Q/U&\G59];T9="L82?FFEO94@*KZD1O(_P!$
M-1[-4E5TLK?H<D<'3P$<P7)RTG%6TLFE3UMWUW\RU_P1Z^)NL_%S_@FK\)O%
MWB"X>6[AT"72WDD.69+&[GLHR3W.RW7GO7R;_P %P? .C?%;_@H7^RU\+O$:
M;M/\2:I)I=\NW.8;B_M8GX[_ "N:^UO^":GP-U;]G#]A#X8?"#Q!9M;:EI_A
MF.YU2UD&&M[NZ=[N>)O=))W4^ZUY'^W]^Q%\=OVB/VZ_V=OC]\-M/TR7P[\-
MO$,5YXGEO-16*5(EOK:8^6A&9#LB;@=\"G4A*6%C&VON_I<WQN%Q%?AVE1<7
M*5J5UZ./-^MS\U4^/WC/4_\ @F!I_P#P2Z%UM\;O^T"?#!TLL2?L/G"X QU_
MY"3@8_V?6OK7_@A?X*T7X;?MY_M;?#KPW#Y>G:!XN_LVPCQC;#!J>I1(/^^5
M%:VG?\$=?BM:?\%FY/VQ)-/T;_A6'_"6R>)T<:@OVLW[6IFQY.,C&H,6SG[H
MSU.*]?\ ^"=G[$/QV_9K_;1_:0^.'Q/T_3(M!^)WB^;4?"TEEJ*S2R0-J-].
M#(@&8SLGCX/?([5STJ-55HN2V=ODD>)EF69A2S*C4K0?[N3@G;[$822?HW(^
MSJ***]0_00HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH0J]Q*%W%(P%.YL<X)'UK9_X:Y^.'_1C/CO_ ,"8*F_:P_Y+9\#_ /L>Y?\
MTF:O=* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&
MN?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\
M"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C
M/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@
M#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\
M1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AK
MGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P#
MF"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&
MN?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\
M"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C
M/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@
M#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\
M1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AK
MGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P#
MF"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&
MN?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\
M"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C
M/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@
M#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\
M1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AK
MGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P#
MF"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8*]ZHH \%_P"&
MN?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@#P7_ (:Y^.'_ $8SX[_\
M"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\ 1C/CO_P)@H_X:Y^.'_1C
M/CO_ ,"8*]ZHH \%_P"&N?CA_P!&,^.__ F"C_AKGXX?]&,^._\ P)@KWJB@
M#P7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P# F"O>J* /!?\ AKGXX?\
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M110!FWO@[PEJ/B>Q\;:AX7TZ?6=,MI[?3=6FLD:YM(9BAFCCE(W(K^7'N52
MVQ<YP*TJ** "BBB@ HHHH **** "N"_:4_9Y\(?M3?"BZ^"WQ"UW6K/0-2O+
M:36;?0[M('U&WBE64V<KLC,()2@60(4=ERH=03GO:* (--TW3M&TZWT?2+&&
MUM+2!(;6VMXPD<,:@*J*HX50   . !4]%% !1110 4444 %%%% $&GZ7IFD0
M&VTK3H+6-I&=H[>%44L3DM@ <D]34]%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45S/QETCXFZ]\*]?T
MGX,>+K;0O%DVF2?\([JM[9I<0078&8_-C<$-&6 5N,A6)'(%?$O_  2#_P""
MGGQF_:+^)_CG]D/]M6*TT[XI^%KZ:6RCCL4M/M,$+"*YMC&GRF6&0;\K]])"
M1Q&20#] **_.+P[_ ,%&OVL/VS?^"IUW^S%^QGXHTS3OA3X+D"^,_$LFBPW;
M7$5O(1=2QRR A3+*?L\.W((7S<%=V.&_:Y^/7_!?W]DWX9>*?V@O'GBGX>0>
M#- O(]TEK8V4]PL,]Y';0?)LRQW31@^@R>U ['ZK45^6?['_ ,<?^"^W[4W@
M;P=\??#7B?X>3^!?$%\))7GLK*"Y:TBNV@G^39E6_=2 <^AJ+]JW_@H!_P %
M/=4_X*L^*OV"OV./%?A>)+9+5]!LM;T>VPJ_V-;WT^^>123RTI&?84!8_5&B
MOR;^)7_!1O\ X+/?\$ZO$.A^./V\O@UX8\2> =6U%;.YO-%BMU96P6,<4]J^
M(9MBLRB:,JX5@.A*_J-\+OB5X/\ C)\-]!^+/P_U07NB>)-)M]2TJZ P9()H
MPZ$C^%L-@J>000>10(WJ*^//^"OO_!23Q?\ L"?#SPKX?^#G@VTUSQ_\0-2F
ML_#D&HQO);VR1>4))FC1E:1]\\*(FY02Y))"%6^9/'W_  47_P""M_\ P3>^
M(7@GQ'_P41\.^#O$7@3QE>&*Z70((!<Z<%V&5$>W"@31JX8*XD20!E5\_,H.
MQ^KU%?#O_!5[_@I5\8/V:/''P^_93_9"\+Z;K'Q1^)<L3:=/J<?F0V5O-/\
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MT4MC) ]*GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2W^$HU\2"?\ LR_,?F=?(.IW9A_#RMF/;%?*GC?_ ()<?\%>OV^?$&C>%?\
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M2\K @CBOHG]B7X=?\%S/#W[16BZG^VM\=O"FM_#F.WNQK.F:59Z6DTDAMY!
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M*5&0FYK'_!+?^RA_P;]_% S;/+_X1SQO]MST_P"/&7.?^ ;?PKZ#_8D^"O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_BSXC^!7AOQQ:W?BWPC;VL_B30XU?S;".XC62%G)4*0Z,K#!/7G% '6T444
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MUM%%8_Q \?>#_A9X(U7XD?$#78M+T/0["6]U;49PQ2VMXU+/(VT$X !/ )H
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M/V=O"/QZ^%EY_P %)OVCO#ECXM^)?Q1\0ZA>0:KK5LMP-(LH+J2UCM[5) 1
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MIW@?X :C\*=7\5LS76EVFC>'+=;E6A!E,D;>2"I0+NR"",9%>:_LP:C8:/\
M\%IOVM=6U6\CM[6U\)>$IKFXF<*D4:Z5;LS,3P  "2?:OK'P=^SE^SU\.]>B
M\5?#_P" _@S0M4A5EAU+1O"]I:W$:L"K!9(XU8 @D'!Y!Q7Q#X=\%:]\2?\
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MC\5OC/XL_P"":_[&'@[0=>CUWXS>,X9[#PIX<6VM?LMSK]_)N2 SMF7R%"(
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MGWX]^(H^+WAO5M,\4> ]0L?#D5EJL4S:O<7=I)###$BL6<EI!N &44,6 "G
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M[H$%%%% !1110!^$_P#P<\_\G[^$?^R06'_ITU6OSCK]'/\ @YY_Y/W\(_\
M9(+#_P!.FJU^<=!HM@K]'/\ @V&_Y/W\7?\ 9(+_ /\ 3II5?G'7Z.?\&PW_
M "?OXN_[)!?_ /ITTJ@3V/W8KY4_X+=_\HM?BU_V#=/_ /3I:5]5U\J?\%N_
M^46OQ:_[!NG_ /ITM*"5N>8?L[?M@?\ !&/1?V?O NC^./&GP>36[3P;ID.L
M)>^'+=IENEM(EE$C& DOO#9.3DYKTG]L'XY?LP?"'_@F5XL_:1^#OP/^'_C[
MP',+"\B\-/HT":/K9DU.UM?,DC\DJY1MK LA.Z!/0$=;^RK^R7^RMK'[+_PW
MU?5_V9_A]=7=UX"T>:ZNKGP98O)-(UE"S.S-$2S$DDD\DFO._P#@MMX6\,>"
M?^"1'Q-\+>#?#EAI&F6<.C)9Z=IEFEO! IURQ)"1H JC))P!U)H!;E[]KC_@
MH[XF_9-\2_ CP'X'_9W/BR3XMZ7?1V&AZ/?+;S07<-M:?8[6'<OEK&\UU&CR
M-@11J7P<8K _X>#?ML?L^_'SX??#S]NK]ESPIH/A;XH>(8M"\/\ B3P5XG>\
M.F:A*56&"Z608<EF4%EV+C<REMA6N5_:FCCE_;M_8#61 P%GKY ([C2[ @_F
M*Z7_ (+5@;/V:3CG_AISPUS_ -_Z T/1OVG/VS?CWX<_:+T[]D+]D']GNU\8
M^,[CPZ=<UO6_$VJ/8:+HMGYGEKYDBHS32,Q7Y$((#H?FRVWF_@3^W=^U%H?[
M8>B_L3_MQ? +PWX=U_Q?H5UJ?@SQ+X'UR2ZT^_%LCR30LDP\R-@D<AR2#E0-
MN'#5PGQQ^.'[1O[2W_!2_P 3_L'>#?VJC\%/"W@OPG9ZF;S2]/MGU;Q3//%#
M*P@EN/\ 5QQB8J?+Y!B8D-G,?BOA;PY\*_AQ_P %T_@1\/\ P9^UAXU^+6L:
M?HGB#_A*-<\9>+5U;[#<R:3?[+.)HU6.#"KN:)1D>8F[DT ?1&I_\%)?VJOB
M'^U-\4/V/?V7OV4](\0^(_ 6JP1C7];\1-::7:V+0JQFNCMWF5I&"1PQY)"N
MY("$5V_[$/[=?Q<^-'QR\<_LB_M3_!.Q\$?$SP)8V^HSQ:)JAN]/U2PFV[;B
M%CRH'F1<%F_U@SM964<%_P $X8X_^'E?[:DNP;O^$I\+C=CG'V6^XJKX*TZ?
M5?\ @NY\7=+L[DP2W7[.]I%'.O6-FNK10WX9!_"@#1T#_@H)^VG^UEXH\4:E
M_P $]?V:/".L> O">M3:5_PFGQ \22VJ^(;J''FK8Q0KE4Y&V1R5(8$[3E5Y
MSXX_\%-/"WCK_@FIXY^.WQ7_ &0=)U+7/ OC&W\-^.?A3X\BCN[*+4DO88F(
M9XF69%+AT;9PZ$?P[C/_ ,$*OBQ\./AU^Q5/^S=\0O%&E>'/&WPR\4ZQ8^,]
M"U>^CMKBU<WDLHF99""8]K[/,^[F)AGBO.?^"H/[9_A/]M+_ ()7?&OQ+\./
M"-]!X:\+?$73M"TKQ--.CVOB#R=1M]]S:XP3%RN">#NX/!P!U/HK]M'_ (**
M^./V5/CI\+?@5\/OV>G\<:A\2](O3I.FV&IBVG^W1B-;>$,Z^7'"6D!DE;B.
M-&;!QBN<T+_@H#^V7\$_VF/ 'P/_ &[OV9?"V@:-\4]4;2_"?B?P1XCDO([6
M_P#E"6URD@RQ9GC7<-@^?*[PK!<C]J...7_@L7^QVLB!@/#7BP@$=QI$I!_,
M5<_X*[ ?\+S_ &1#CG_AHS2.?^VL= '9_M'_ +=OQPC_ &GV_8H_8?\ @EI/
MC3QWI>BQZMXQUCQ1JSVFC^'+>4*84F,8\R65PZ-L4@A74@/\^SFOA%_P4D_:
M0NOVY_"/[!'[1_[+FG^$O$NKZ3J%_J>LZ;K[7=C=6T5O)-;W-B=@+)(T,L;J
M^&1D/).0O)_ SX@^"OV2/^"Q/[0'A;]H/Q18^'4^+VE:#K?@+7==N5MK:_BM
M8)(9K9)I"%$@>1E"$Y/V<X[9R?&O[2/P:^/'_!>CX,>'?@_XOTWQ"OA+P+KU
MMK.KZ/<I/;BYEL[F3[,LJ$J[1J%+;20IEVGY@P !^B5?G5_P3'^'7A#]O?\
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M#O\ JZ[_ ,L7_P"[J/\ AP=_U==_Y8O_ -W5^B5%?(?\0UX)_P"@7_R>I_\
M)GR_^H'"7_0-_P"3U/\ Y,^#_A!_P1,_X53\6O"_Q1_X:9^W_P#"->(K+5?L
M/_"&>5]I^SSI-Y>_[8VS=LQNVG&<X/2OO"BBOH<FX>RCA^E.GE]+D4G=^]*5
MWM]IL]S*LDRO)*<J>"I\BD[O63U_[>;"O._C]^R3^S1^U+I]OIO[0?P3\/\
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M-W  Z"O6O!O@OP?\.O"]EX(\ >%M/T31M-@$.GZ5I5FEO;VT8YVI&@"J,DG
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MN@9%./\ 9%=-10!XU\<_^">O[%/[2OC!?B!\;_V;_#>O:X%59-6FMFBN)PH
M42O$R&8   !]V ,#CBNK\0_LR?L]^*O@U%^SQKOP;\/3>!H$B2'PFNF1I8QB
M.02(%B0!1AP&X'7GK7=44 <OK?P5^$_B3XB>'?BWKW@'3;OQ+X2@N(?#6MS6
MX-QIT<\9BF6)OX0Z$J?4&G?$#X-?"OXK:IX?UKXC^!-.UF[\*:Q'JOARXOX
M[:=>QD%+B(_PN"!@^U=-10!\4_MR>(?B1I?Q\N- _:8_X)\S?'CX&WNFP3^%
M+GP5X+CUG6_#^IA42X26%Y ^QRI;S$"?*RKN?#*.4_8T_9]\5_%W]NK0OVK?
M#_['=]\"OA3\-_ ]UHG@CPMKVCPZ;J>J7UV[^?=2V41/D+LD8$N26*H0S[GV
M?H#10 5PWQT_9G_9_P#VFO#T/A;X_?"'0?%EE;.SVB:S8+*]LQP&:*3[\1(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145750752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386,373,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146516160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 643.7<span></span>
</td>
<td class="nump">$ 642.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Short-term marketable securities</a></td>
<td class="nump">2,596.6<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">785.7<span></span>
</td>
<td class="nump">713.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">498.6<span></span>
</td>
<td class="nump">306.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">173.8<span></span>
</td>
<td class="nump">192.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,698.4<span></span>
</td>
<td class="nump">3,668.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">1,078.9<span></span>
</td>
<td class="nump">1,055.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">25.3<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">144.5<span></span>
</td>
<td class="nump">173.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">501.3<span></span>
</td>
<td class="nump">341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">47.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,596.2<span></span>
</td>
<td class="nump">5,391.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,373.1<span></span>
</td>
<td class="nump">901.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">151.3<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion of long-term senior convertible notes</a></td>
<td class="nump">124.2<span></span>
</td>
<td class="nump">772.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,678.6<span></span>
</td>
<td class="nump">1,839.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long-term senior convertible notes</a></td>
<td class="nump">2,432.4<span></span>
</td>
<td class="nump">1,197.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">83.4<span></span>
</td>
<td class="nump">94.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">133.9<span></span>
</td>
<td class="nump">128.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,328.3<span></span>
</td>
<td class="nump">3,259.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at September&#160;30, 2023 and December&#160;31, 2022</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value, 800.0 million shares authorized; 405.5 million and 386.4 million shares issued and outstanding, respectively, at September&#160;30, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December&#160;31, 2022</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">3,618.0<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(35.6)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">765.1<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost; 19.1 million shares at September&#160;30, 2023 and 6.9 million shares at December&#160;31, 2022</a></td>
<td class="num">(2,080.0)<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,267.9<span></span>
</td>
<td class="nump">2,131.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,596.2<span></span>
</td>
<td class="nump">$ 5,391.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-Sale and Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145654960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">405,500,000<span></span>
</td>
<td class="nump">393,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">386,400,000<span></span>
</td>
<td class="nump">386,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">19,100,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146490624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 975.0<span></span>
</td>
<td class="nump">$ 769.6<span></span>
</td>
<td class="nump">$ 2,587.8<span></span>
</td>
<td class="nump">$ 2,094.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">351.7<span></span>
</td>
<td class="nump">275.4<span></span>
</td>
<td class="nump">955.5<span></span>
</td>
<td class="nump">752.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">623.3<span></span>
</td>
<td class="nump">494.2<span></span>
</td>
<td class="nump">1,632.3<span></span>
</td>
<td class="nump">1,341.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">131.4<span></span>
</td>
<td class="nump">110.3<span></span>
</td>
<td class="nump">369.7<span></span>
</td>
<td class="nump">367.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">284.7<span></span>
</td>
<td class="nump">234.6<span></span>
</td>
<td class="nump">876.6<span></span>
</td>
<td class="nump">702.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">417.8<span></span>
</td>
<td class="nump">346.7<span></span>
</td>
<td class="nump">1,251.5<span></span>
</td>
<td class="nump">1,076.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">205.5<span></span>
</td>
<td class="nump">147.5<span></span>
</td>
<td class="nump">380.8<span></span>
</td>
<td class="nump">265.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Income from equity investments</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">33.9<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="nump">82.4<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">240.4<span></span>
</td>
<td class="nump">146.2<span></span>
</td>
<td class="nump">464.2<span></span>
</td>
<td class="nump">257.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">119.7<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">179.0<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 120.7<span></span>
</td>
<td class="nump">$ 101.2<span></span>
</td>
<td class="nump">$ 285.2<span></span>
</td>
<td class="nump">$ 249.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in USD per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income per share (in shares)</a></td>
<td class="nump">386.6<span></span>
</td>
<td class="nump">389.8<span></span>
</td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">390.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in USD per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income per share (in shares)</a></td>
<td class="nump">426.8<span></span>
</td>
<td class="nump">425.8<span></span>
</td>
<td class="nump">428.3<span></span>
</td>
<td class="nump">428.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145641040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 120.7<span></span>
</td>
<td class="nump">$ 101.2<span></span>
</td>
<td class="nump">$ 285.2<span></span>
</td>
<td class="nump">$ 249.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Translation adjustments and other</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
<td class="num">(25.8)<span></span>
</td>
<td class="num">(34.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(18.1)<span></span>
</td>
<td class="num">(24.0)<span></span>
</td>
<td class="num">(41.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 114.4<span></span>
</td>
<td class="nump">$ 83.1<span></span>
</td>
<td class="nump">$ 261.2<span></span>
</td>
<td class="nump">$ 207.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332140682800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 2,042.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2,108.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 138.7<span></span>
</td>
<td class="num">$ (206.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(557.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">92.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">249.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(41.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">1,824.5<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,072.1<span></span>
</td>
<td class="num">(41.1)<span></span>
</td>
<td class="nump">388.1<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 2,042.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,108.7<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">138.7<span></span>
</td>
<td class="num">(206.2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2022</a></td>
<td class="nump">386.3<span></span>
</td>
<td class="nump">386.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2022</a></td>
<td class="nump">$ 2,131.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2022</a></td>
<td class="nump">2,255.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,028.9<span></span>
</td>
<td class="num">(23.0)<span></span>
</td>
<td class="nump">286.9<span></span>
</td>
<td class="num">(37.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(557.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">30.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">101.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(18.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">$ 1,824.5<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,072.1<span></span>
</td>
<td class="num">(41.1)<span></span>
</td>
<td class="nump">388.1<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="nump">386.3<span></span>
</td>
<td class="nump">386.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 2,131.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment', window );">Purchases of treasury stock, including excise tax</a></td>
<td class="num">(188.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(188.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,296.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax', window );">Purchase of capped call transactions, net of tax</a></td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">113.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">285.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (24.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2023</a></td>
<td class="nump">386.4<span></span>
</td>
<td class="nump">386.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2023</a></td>
<td class="nump">$ 2,267.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">3,618.0<span></span>
</td>
<td class="num">(35.6)<span></span>
</td>
<td class="nump">765.1<span></span>
</td>
<td class="num">(2,080.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2023</a></td>
<td class="nump">2,100.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,269.0<span></span>
</td>
<td class="num">(29.3)<span></span>
</td>
<td class="nump">644.4<span></span>
</td>
<td class="num">(784.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment', window );">Purchases of treasury stock, including excise tax</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,296.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">39.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">120.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2023</a></td>
<td class="nump">386.4<span></span>
</td>
<td class="nump">386.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2023</a></td>
<td class="nump">$ 2,267.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 3,618.0<span></span>
</td>
<td class="num">$ (35.6)<span></span>
</td>
<td class="nump">$ 765.1<span></span>
</td>
<td class="num">$ (2,080.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromBenefitOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Benefit Of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromBenefitOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromBenefitOfNoteHedgeValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Benefit Of Note Hedge, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromBenefitOfNoteHedgeValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Including Excise Tax Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332141245744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 285.2<span></span>
</td>
<td class="nump">$ 249.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">133.5<span></span>
</td>
<td class="nump">119.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">113.9<span></span>
</td>
<td class="nump">92.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Realized (gain) loss on equity investment</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(136.5)<span></span>
</td>
<td class="num">(53.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash income and expenses</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="nump">31.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(72.9)<span></span>
</td>
<td class="num">(51.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(193.6)<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="nump">13.2<span></span>
</td>
<td class="num">(81.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">496.5<span></span>
</td>
<td class="nump">171.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and related expenses</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred revenue and other liabilities</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">614.9<span></span>
</td>
<td class="nump">537.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(2,947.9)<span></span>
</td>
<td class="num">(1,397.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">2,228.4<span></span>
</td>
<td class="nump">1,387.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(184.1)<span></span>
</td>
<td class="num">(301.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(18.5)<span></span>
</td>
<td class="num">(12.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(922.1)<span></span>
</td>
<td class="num">(327.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(188.7)<span></span>
</td>
<td class="num">(557.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of senior convertible notes, net of issuance costs</a></td>
<td class="nump">1,230.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="num">(101.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments for conversions of senior convertible notes</a></td>
<td class="num">(650.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(16.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">313.3<span></span>
</td>
<td class="num">(551.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(12.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(354.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">643.3<span></span>
</td>
<td class="nump">1,053.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">644.8<span></span>
</td>
<td class="nump">699.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">643.7<span></span>
</td>
<td class="nump">698.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">644.8<span></span>
</td>
<td class="nump">699.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Shares issued for conversions of 2023 Notes</a></td>
<td class="nump">1,316.4<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge', window );">Shares received under note hedge upon conversion of 2023 Notes</a></td>
<td class="num">(1,296.1)<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">47.0<span></span>
</td>
<td class="nump">60.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 15.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Benefit Received From Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332149842176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1. Organization and Significant Accounting Policies</span></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Seasonality</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Significant Accounting Policies</span></td></tr></table>There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the nine months ended September&#160;30, 2023<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of September&#160;30, 2023 included unbilled accounts receivable of $8.8 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.3 million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151086480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Development and Other Agreements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2. Development and Other Agreements</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7,363,772 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued 2,945,508 shares of our common stock in connection with our achievement of the related milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) 5,154,640 shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">life of 64 months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148349456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3. Fair Value Measurements</span></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of September&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transfers into or out of Level 3 securities during the three and nine months ended September&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 5 &#8220;Debt&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $89.0 million and $62.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$38.5&#160;million as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant impairment losses during the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148239648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Balance Sheet Details and Other Financial Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4. Balance Sheet Details and Other Financial Information</span></div></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.60&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $1.81&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst </span></div>reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at September&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.<div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Inventory</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Prepaid and Other Current Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Property and Equipment</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accrued Payroll and Related Expenses</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Long-Term Liabilities</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Income (Expense), Net</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividend income</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332150933088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5. Debt</span></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Senior Convertible Notes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Not applicable as no notes were outstanding at this date.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.75% Senior Convertible Notes due 2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#8220;2023 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$41.07&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#8220;2023 Note Hedge&#8221;) and </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants (the &#8220;2023 Warrants&#8221;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2022, holders of $17.5&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued 425,552 shares to settle the converted 2023 Notes. We received 287,492 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2023, we settled $650.5&#160;million in aggregate principal amount of the 2023 Notes through a combination of $650.5&#160;million in cash for the principal amount and 10,599,907 shares of common stock for the amount in excess of the principal amount. We received 10,585,850 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining outstanding principal of $124.3&#160;million as of September&#160;30, 2023 and any amount in excess of the principal amount will settle on or before the maturity date of December&#160;1, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes had the ability to convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022, March&#160;31, 2023, and June&#160;30, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through August 31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. See above for a description of conversion activity related to the 2023 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom was permitted to redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price was equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the &#8220;2023 Counterparties&#8221;) entitling us to purchase up to&#160;20.7 million&#160;shares of our common stock at an initial price of&#160;$41.07&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;20.7 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $49.60 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Senior Convertible Notes due 2025</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the &#8220;2025 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $150.11 per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom was not permitted to redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.375% Senior Convertible Notes due 2028</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we completed an offering of $1.25&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.375% and a maturity date of May&#160;15, 2028 (the &#8220;2028 Notes&#8221;). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and estimated costs directly related to the offering, were approximately $1.23&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $162.41 per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at the Option of the Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on such trading day;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">upon the occurrence of specified corporate transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights at Our Option</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Capped Call Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#8220;2028 Capped Calls&#8221;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $212.62 per share, subject to adjustments, which represents a premium of 80% over the closing price of our common stock of $118.12 per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of $101.3 million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders (the &#8220;Credit Facility&#8221;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#8220;ABR&#8221;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between 0.375% to 1.000%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) for a one month interest period plus 1%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between 1.375% to 2.000%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#8220;RFR&#8221;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between 0.0326% to 0.100% depending on the loan denomination. We will also pay a commitment fee of between 0.175% and 0.250%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $5.3&#160;million term deposit that is included in non-current &#8220;Other assets&#8221; on our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148773520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6. Contingencies</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:23.15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between June 2021 through the nine months ended September 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities have served complaints against each other in multiple jurisdictions, including in the United States (United States District Court ("U.S.D.C.&#8221;), District of Delaware), the United Kingdom (Business and Property Courts of England and Wales), France (United Patent Court (&#8220;UPC&#8221;) in Paris), Spain (Commercial Courts of Barcelona) and Germany (National Courts (&#8220;N.C.&#8221;) of Munich, Mannheim, Dusseldorf and Hamburg and the UPC in Munich), primarily involving claims of patent infringement, invalidity and other patent related actions. In June and July of 2021, we initiated patent infringement litigation against Abbott in the United States (U.S.D.C., Western District of Texas) and Germany (N.C. in Mannheim) and filed additional patent infringement actions in May 2023 in Germany (N.C. in Munich) over certain of Abbott's continuous glucose monitoring products. In July and August 2023, we initiated patent infringement litigation in France and Germany in the UPC and in Spain (Commercial Courts of Barcelona).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between July 2021 through the nine months ended September 30, 2023, Abbott initiated patent infringement litigation against Dexcom in multiple jurisdictions, including the United States (U.S.D.C., Delaware), the United Kingdom (Business and Property Courts of England and Wales), and in Germany (N.C. in Mannheim, Dusseldorf and Hamburg) over certain of Dexcom's continuous glucose monitoring products. In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in that jurisdiction. Three trials on liability have already been conducted in the United Kingdom. On October 18, judgment was handed down in favor of Dexcom in one of these trials. The parties are awaiting rulings on the remaining two. Dexcom and Abbott seek injunctive relief and monetary damages as a result of their respective claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract lawsuit against Dexcom in the U.S.D.C., District of Delaware alleging that Dexcom breached the parties' Settlement and License Agreement dated July 2, 2014 (&#8220;SLA&#8221;). The U.S.D.C., District of Delaware consolidated Abbott&#8217;s breach of contract lawsuit with Dexcom&#8217;s patent infringement lawsuit which had been transferred from the U.S.D.C., Western District of Texas. Dexcom asserted counterclaims that Abbott also breached the SLA. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury verdict determined that Abbott was not licensed to thirteen claims of certain Dexcom patents and that Abbott was licensed to five claims. Dexcom&#8217;s patent infringement claims in Delaware are stayed until November 10, 2023, at which point the U.S. Patent and Trademark Office will have issued </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its final written decisions on certain patents involved in the lawsuit. We will continue to enforce the remaining claims of the patents asserted in Delaware.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s patent infringement action against Dexcom is currently scheduled for trial in the U.S.D.C., District of Delaware on March 11, 2024. In the lead up to trial, the U.S.D.C., District of Delaware invalidated one of Abbott&#8217;s patents and Abbott dropped four other patents from the litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in December 2023, Abbott has several patent infringement hearings against Dexcom in the National Court in Hamburg and Munich wherein Abbott is seeking damages and injunctive relief.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March and April of 2024, Dexcom has several patent infringement hearings in Munich against Abbott, wherein Dexcom is seeking damages and injunctive relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding patent litigation procedures initiated by Dexcom and Abbott throughout multiple jurisdictions, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#8217;s claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151707712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our annual effective tax rate to be 24.7% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, increases to unrecognized tax benefits, and impact of foreign operations, partially offset by federal tax credits generated. Our actual effective tax rate of</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.6% for the nine months ended September&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, increased by discrete foreign taxes related to an intra-entity transfer of certain intellectual property, and decrease in the state tax rate applied to beginning of year deferred tax assets, partially offset by tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, we completed an intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries to align our structure with the expansion of international business operations. We recorded a $186.6&#160;million deferred tax asset, which represents the difference between the basis of the intellectual property for financial statement and tax purposes, applying the appropriate enacted statutory tax rate. Based on available evidence, management believes it is not more-likely-than-not that the additional foreign deferred tax asset will be realizable, and is therefore, fully offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer resulted in $65.2&#160;million of net tax expense, which increased our actual effective tax rate for the nine months ended September&#160;30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145740560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8. Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $238.4 million and are expected to be recognized through 2027.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest date fair value of RSUs and PSUs that vested during the nine months ended September&#160;30, 2023 was $138.5 million and $9.9 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#8220;2022 Share Repurchase Program&#8221;). Shares of common stock repurchased under the 2022 Share Repurchase Program became treasury shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased approximately $557.7 million of our outstanding common stock throughout the duration of the 2022 Share Repurchase Program. The 2022 Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023. There were no share repurchases under the 2022 Share Repurchase Program in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase 1.6 million shares of our common stock for $188.7 million, excluding excise tax due under the Inflation Reduction Act of 2022, for an average per share price of $118.12, via privately negotiated transactions, independent of the 2022 Share Repurchase Program.</span></div>Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332150425616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by geographic region</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by customer sales channel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151783360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10. Subsequent Events</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2023, our Board of Directors authorized and approved a share repurchase program of up to $500.0&#160;million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#8220;2023 Share Repurchase Program&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases of our common stock under the 2023 Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, and other applicable federal and state laws and regulations. The timing of any repurchases will depend on market conditions and will be made at our discretion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Share Repurchase Program does not obligate us to repurchase any dollar amount or number of shares, and the program may be extended, modified, suspended, or discontinued at any time.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148624224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 120.7<span></span>
</td>
<td class="nump">$ 101.2<span></span>
</td>
<td class="nump">$ 285.2<span></span>
</td>
<td class="nump">$ 249.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332140286704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Plans</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2023, none of our directors or officers informed us of the adoption or termination of a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Character of Trading Arrangement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 10b5-1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Rule 10b5-1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Shares to be Sold</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Brown</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/29/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/15/2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Brown</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/29/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to 14,463</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicholas Augustinos</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/15/2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to 7,648</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/15/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)</span></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on 12/15/2022 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), as then in effect, under the Exchange Act.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The number of shares of common stock sold under the Rule 10b5-1 trading arrangement will be net of shares withheld for applicable tax obligations upon the vesting of covered securities and is not yet determinable.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=dxcm_MichaelBrownMember', window );">Michael Brown [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">367 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=dxcm_NicholasAugustinosMember', window );">Nicholas Augustinos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Nicholas Augustinos<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Director<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">9/15/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">366 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">7,648<span></span>
</td>
<td class="nump">7,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023TerminationMember', window );">Michael Brown August 2023 Termination [Member] | Michael Brown [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Michael Brown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Executive Vice President, Chief Legal Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">8/29/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrTerminationDate', window );">Termination Date</a></td>
<td class="text">12/15/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">3,612<span></span>
</td>
<td class="nump">3,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023AdoptionMember', window );">Michael Brown August 2023 Adoption [Member] | Michael Brown [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Michael Brown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Executive Vice President, Chief Legal Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">8/29/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">14,463<span></span>
</td>
<td class="nump">14,463<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrTerminationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrTerminationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=dxcm_MichaelBrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=dxcm_MichaelBrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=dxcm_NicholasAugustinosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=dxcm_NicholasAugustinosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023TerminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023TerminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023AdoptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrAxis=dxcm_MichaelBrownAugust2023AdoptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332142836064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#8220;Additional paid-in capital&#8221; to &#8220;Common stock.&#8221; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Contract Balances</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of September&#160;30, 2023 included unbilled accounts receivable of $8.8 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.3 million</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08,</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. </span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div>We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332149641520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income - diluted</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148204048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Hierarchy for Financial Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of September&#160;30, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332242501088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-Term Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Assets</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock', window );">Schedule of Accrued Payroll and Related Expenses</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Income (Expense), Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividend income</span></div></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid And Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued Payroll and Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145490944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal amount</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Converted Value of Notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total by which the notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> if-converted value exceeds their principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Other Income (Expense), Net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Not applicable as no notes were outstanding at this date.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Availability and Outstanding Borrowings on Credit Agreement</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available principal amount </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148260448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148204048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text">The following table sets forth revenue by major sales channel for the periods shown:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145672480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 10, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split ratio</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Contract payment term (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Contract payment term (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ContractPaymentTermsNumberofDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Payment Terms, Number of Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ContractPaymentTermsNumberofDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332147874240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 120.7<span></span>
</td>
<td class="nump">$ 101.2<span></span>
</td>
<td class="nump">$ 285.2<span></span>
</td>
<td class="nump">$ 249.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Net income - diluted</a></td>
<td class="nump">$ 123.7<span></span>
</td>
<td class="nump">$ 104.0<span></span>
</td>
<td class="nump">$ 294.8<span></span>
</td>
<td class="nump">$ 257.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in USD per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in USD per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">386.6<span></span>
</td>
<td class="nump">389.8<span></span>
</td>
<td class="nump">386.7<span></span>
</td>
<td class="nump">390.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">426.8<span></span>
</td>
<td class="nump">425.8<span></span>
</td>
<td class="nump">428.3<span></span>
</td>
<td class="nump">428.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (in shares)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (in shares)</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (in shares)</a></td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">28.7<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145702496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332142820256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements (Details) - Verily Life Sciences - Collaborative Arrangement - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Amortization period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">64 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember', window );">Initial Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeArrangementUpfrontFee', window );">Initial payment on collaborative agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with acquisition, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,363,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="nump">$ 87.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember', window );">Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,154,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementApprovalMilestoneMember', window );">Approval Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,945,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Future Common Stock Issuable, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialFutureCommonStockIssuableSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementApprovalMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementApprovalMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146581984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 390.8<span></span>
</td>
<td class="nump">$ 420.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">2,596.6<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">3,001.1<span></span>
</td>
<td class="nump">2,244.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,819.0<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">387.3<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">390.3<span></span>
</td>
<td class="nump">163.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">360.9<span></span>
</td>
<td class="nump">375.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">374.6<span></span>
</td>
<td class="nump">386.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">29.9<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">2,596.6<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">2,626.5<span></span>
</td>
<td class="nump">1,858.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,819.0<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">387.3<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">390.3<span></span>
</td>
<td class="nump">163.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332147855376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueAssetsLevel3TransfersAmount', window );">Transfers into or out of Level 3 securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign exchange forward | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative instrument</a></td>
<td class="nump">$ 89,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueAssetsLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueAssetsLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145674384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">$ 2,531.2<span></span>
</td>
<td class="nump">$ 3,451.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">281.3<span></span>
</td>
<td class="nump">2,136.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">1,140.5<span></span>
</td>
<td class="nump">1,314.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes:</a></td>
<td class="nump">$ 1,109.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Fair Value Disclosures [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332140577552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 2,599.2<span></span>
</td>
<td class="nump">$ 1,819.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">2,596.6<span></span>
</td>
<td class="nump">1,813.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,820.5<span></span>
</td>
<td class="nump">1,535.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,819.0<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">387.5<span></span>
</td>
<td class="nump">119.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">387.3<span></span>
</td>
<td class="nump">119.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt securities, available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">391.2<span></span>
</td>
<td class="nump">164.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 390.3<span></span>
</td>
<td class="nump">$ 163.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148648784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale securities current</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 1,810<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148597808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 277.5<span></span>
</td>
<td class="nump">$ 159.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">193.6<span></span>
</td>
<td class="nump">130.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 498.6<span></span>
</td>
<td class="nump">$ 306.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151961024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 55.2<span></span>
</td>
<td class="nump">$ 48.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidInventoryCurrent', window );">Prepaid inventory</a></td>
<td class="nump">61.5<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredCompensationPlanAssetsCurrent', window );">Deferred compensation plan assets</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivables</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 173.8<span></span>
</td>
<td class="nump">$ 192.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredCompensationPlanAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Plan Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredCompensationPlanAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Inventory, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332147798400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total cost</a></td>
<td class="nump">$ 1,545.2<span></span>
</td>
<td class="nump">$ 1,418.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(466.3)<span></span>
</td>
<td class="num">(363.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment, net</a></td>
<td class="nump">1,078.9<span></span>
</td>
<td class="nump">1,055.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and land improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">31.8<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">54.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">632.5<span></span>
</td>
<td class="nump">449.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">276.6<span></span>
</td>
<td class="nump">264.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 343.1<span></span>
</td>
<td class="nump">$ 542.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145669488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Other Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 38.5<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LongTermDeposits', window );">Long-term deposits</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherLongTermAssets', window );">Other assets</a></td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">$ 74.4<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long -Term Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Long -Term Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151906544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable trade</a></td>
<td class="nump">$ 242.4<span></span>
</td>
<td class="nump">$ 237.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedTaxAuditAndLegalFees', window );">Accrued tax, audit, and legal fees</a></td>
<td class="nump">218.8<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PharmacyRebates', window );">Accrued rebates</a></td>
<td class="nump">837.4<span></span>
</td>
<td class="nump">556.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued warranty</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred compensation plan liabilities</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">47.5<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,373.1<span></span>
</td>
<td class="nump">$ 901.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedTaxAuditAndLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedTaxAuditAndLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PharmacyRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PharmacyRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483070/710-10-25-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483043/710-10-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332148632720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract', window );"><strong>Employee-related Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedWagesBonusesAndTaxesCurrent', window );">Accrued wages, bonus and taxes</a></td>
<td class="nump">$ 129.1<span></span>
</td>
<td class="nump">$ 96.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Other accrued employee benefits</a></td>
<td class="nump">22.2<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Total accrued payroll and related expenses</a></td>
<td class="nump">$ 151.3<span></span>
</td>
<td class="nump">$ 134.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedWagesBonusesAndTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Wages, Bonuses and Taxes, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedWagesBonusesAndTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145738784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">$ 57.9<span></span>
</td>
<td class="nump">$ 59.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherTaxLiabilitiesNoncurrent', window );">Other tax liabilities</a></td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 133.9<span></span>
</td>
<td class="nump">$ 128.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Tax Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146504528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income</a></td>
<td class="nump">$ 41.5<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 101.2<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(15.4)<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense, net</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">$ 33.9<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="nump">$ 82.4<span></span>
</td>
<td class="num">$ (8.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332147763952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Senior Convertible Notes (Details) - Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 2,581,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,982,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(25,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Carrying amount of senior convertible notes</a></td>
<td class="nump">2,556,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,970,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">124,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332140550960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Value of Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 158.1<span></span>
</td>
<td class="nump">$ 1,395.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">158.1<span></span>
</td>
<td class="nump">1,361.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145978672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CashInterestExpenseAbstract', window );"><strong>Cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as percent)</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as percent)</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Interest Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NonCashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Interest Expense [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NonCashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332135779168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 02, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>purchaser </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>d </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,230,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions', window );">Number of Initial purchasers | purchaser</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Shares received from Note Hedge | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,581,800,000<span></span>
</td>
<td class="nump">$ 2,581,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,982,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of revolving credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount', window );">Option to increase revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Federal Reserve Bank Of New York Rate (NYFRB)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Minimum | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Minimum | Simple Risk Free Rate (RFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0326%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Maximum | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Maximum | Simple Risk Free Rate (RFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,300,000<span></span>
</td>
<td class="nump">$ 124,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled', window );">Debt instrument, convertible principal amount settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,500,000<span></span>
</td>
<td class="nump">650,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash', window );">Debt instrument, convertible principal amount settled through cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,500,000<span></span>
</td>
<td class="nump">$ 650,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled', window );">Debt instrument convertible principal amount exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Shares received from Note Hedge | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,585,850<span></span>
</td>
<td class="nump">10,585,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash', window );">Debt instrument, convertible, principal amount settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock counterparties to acquire with warrants purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants or rights (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0243476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares', window );">Stock issued upon conversion of senior notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of 2025 Notes issuance, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,599,907<span></span>
</td>
<td class="nump">10,599,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,207,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.006662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0061571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare', window );">Capped call, cap price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 212.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage', window );">Sale of stock premium (as percent)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 118.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes | Term one | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes | Term one | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes | Term two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes | Term two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Cap Call Transaction, Cap Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCapCallTransactionCapPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Exercised And Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Exercised, Not Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Expected To Settle Through Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Settled Through Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Repurchase Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCovenantRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Initial Purchasers For Convertible Note Hedge Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromBenefitOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Benefit Of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromBenefitOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dxcm_FederalReserveBankOfNewYorkRateNYFRBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dxcm_FederalReserveBankOfNewYorkRateNYFRBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dxcm_SimpleRiskFreeRateRFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dxcm_SimpleRiskFreeRateRFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332147628816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Total available balance</a></td>
<td class="nump">$ 192,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Available principal amount and letters of credit sub-facility</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Available principal amount and letters of credit sub-facility</a></td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit</a></td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332151906096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>claim </div>
<div>patent</div>
</th>
<th class="th">
<div>Oct. 18, 2023 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 14, 2023 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LossContingencyPendingClaimsRemainingNumber', window );">Number of pending claims remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dxcm_AbbottMember', window );">Abbott</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of pending claims or trials</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber', window );">Number of claims not licensed to</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber', window );">Number of invalidated patents | patent</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber', window );">Number of additional patent infringements dropped | patent</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Additional Patents Found Not Infringed, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims Counterparty Not Licensed To, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LossContingencyPendingClaimsRemainingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims Remaining, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LossContingencyPendingClaimsRemainingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity was found not to have infringed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsFoundNotInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_AbbottMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_AbbottMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146513248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent', window );">Estimated annual effective tax rate (as percent)</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (as percent)</a></td>
<td class="nump">38.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other adjustments, effective tax rate</a></td>
<td class="nump">$ 65.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Annual Effective Income Tax Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332146478960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 39.0<span></span>
</td>
<td class="nump">$ 30.8<span></span>
</td>
<td class="nump">$ 113.9<span></span>
</td>
<td class="nump">$ 92.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 23.7<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 68.5<span></span>
</td>
<td class="nump">$ 52.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dxcm_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332141180832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 26, 2022</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized estimated compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,700,000<span></span>
</td>
<td class="nump">188,700,000<span></span>
</td>
<td class="nump">$ 557,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">$ 557,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total vest date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total vest date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332150606464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332141211712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Schedule of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 975.0<span></span>
</td>
<td class="nump">$ 769.6<span></span>
</td>
<td class="nump">$ 2,587.8<span></span>
</td>
<td class="nump">$ 2,094.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 839.7<span></span>
</td>
<td class="nump">$ 656.2<span></span>
</td>
<td class="nump">$ 2,197.4<span></span>
</td>
<td class="nump">$ 1,768.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as percent)</a></td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 135.3<span></span>
</td>
<td class="nump">$ 113.4<span></span>
</td>
<td class="nump">$ 390.4<span></span>
</td>
<td class="nump">$ 326.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as percent)</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 713.6<span></span>
</td>
<td class="nump">$ 573.4<span></span>
</td>
<td class="nump">$ 1,856.2<span></span>
</td>
<td class="nump">$ 1,535.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as percent)</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 261.4<span></span>
</td>
<td class="nump">$ 196.2<span></span>
</td>
<td class="nump">$ 731.6<span></span>
</td>
<td class="nump">$ 559.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as percent)</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140332145524016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 500.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>dxcm-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:dxcm="http://www.dexcom.com/20230930"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dxcm-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-10-19</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-06-10</startDate>
            <endDate>2022-06-10</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-06-10</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementApprovalMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:SimpleRiskFreeRateRFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:FederalReserveBankOfNewYorkRateNYFRBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-18</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:AbbottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dxcm:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023TerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023TerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023AdoptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:TradingArrAxis">dxcm:MichaelBrownAugust2023AdoptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:NicholasAugustinosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:NicholasAugustinosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">dxcm:MichaelBrownMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="purchaser">
        <measure>dxcm:purchaser</measure>
    </unit>
    <unit id="claim">
        <measure>dxcm:claim</measure>
    </unit>
    <unit id="patent">
        <measure>dxcm:patent</measure>
    </unit>
    <unit id="segment">
        <measure>dxcm:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-28">0001093557</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-162" decimals="7" id="f-847" unitRef="number">0.0243476</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-182" decimals="7" id="f-848" unitRef="number">0.0061571</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-176" decimals="7" id="f-849" unitRef="number">0.006662</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-202"
      decimals="INF"
      id="f-850"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ecd:TrdArrDuration contextRef="c-250" id="f-964">P367D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-248" id="f-965">P366D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-51222</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">200-0200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">386373935</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">643700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">642300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-3" decimals="-5" id="f-32" unitRef="usd">2596600000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-4" decimals="-5" id="f-33" unitRef="usd">1813900000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">785700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">713300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">498600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">306700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">173800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">192600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-40" unitRef="usd">4698400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-41" unitRef="usd">3668800000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">1078900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">1055600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-44" unitRef="usd">73400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-45" unitRef="usd">80000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">25300000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">25700000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-5" id="f-48" unitRef="usd">144500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-49" unitRef="usd">173300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">501300000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">341200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-52" unitRef="usd">74400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-53" unitRef="usd">47100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">6596200000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">5391700000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-56" unitRef="usd">1373100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">901800000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">151300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">134300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-3" decimals="-5" id="f-60" unitRef="usd">124200000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-4" decimals="-5" id="f-61" unitRef="usd">772600000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">21000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">20500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-5" id="f-64" unitRef="usd">9000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-65" unitRef="usd">10100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">1678600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">1839300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-3" decimals="-5" id="f-68" unitRef="usd">2432400000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">1197700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-70" unitRef="usd">83400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-71" unitRef="usd">94600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-72" unitRef="usd">133900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-73" unitRef="usd">128300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-74" unitRef="usd">4328300000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">3259900000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-76" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-77" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-78"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-79"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-80" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-81" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-82" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-83" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-84" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-85" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-3" decimals="-5" id="f-86" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-4" decimals="-5" id="f-87" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-88"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="-5" id="f-90" unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-5" id="f-91" unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-92" unitRef="shares">405500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-93" unitRef="shares">386400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-94" unitRef="shares">393200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-95" unitRef="shares">386300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-3" decimals="-5" id="f-96" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-4" decimals="-5" id="f-97" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-5" id="f-98" unitRef="usd">3618000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-5" id="f-99" unitRef="usd">2258100000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-100" unitRef="usd">-35600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-101" unitRef="usd">-11600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-102" unitRef="usd">765100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-103" unitRef="usd">479900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="-5" id="f-104" unitRef="shares">19100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-105" unitRef="shares">6900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-5" id="f-106" unitRef="usd">2080000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-5" id="f-107" unitRef="usd">595000000.0</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-108" unitRef="usd">2267900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-109" unitRef="usd">2131800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-110" unitRef="usd">6596200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-111" unitRef="usd">5391700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-112" unitRef="usd">975000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-113" unitRef="usd">769600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-114" unitRef="usd">2587800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-115" unitRef="usd">2094600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-116" unitRef="usd">351700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-117" unitRef="usd">275400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-118" unitRef="usd">955500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-119" unitRef="usd">752800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-120" unitRef="usd">623300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-6" decimals="-5" id="f-121" unitRef="usd">494200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-122" unitRef="usd">1632300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-7" decimals="-5" id="f-123" unitRef="usd">1341800000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-124" unitRef="usd">131400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-5" id="f-125" unitRef="usd">110300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-126" unitRef="usd">369700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-5" id="f-127" unitRef="usd">367900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-128" unitRef="usd">1700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-5" id="f-129" unitRef="usd">1800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-130" unitRef="usd">5200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-5" id="f-131" unitRef="usd">5700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-132" unitRef="usd">284700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-5" id="f-133" unitRef="usd">234600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-134" unitRef="usd">876600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-5" id="f-135" unitRef="usd">702400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-5" id="f-136" unitRef="usd">417800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-5" id="f-137" unitRef="usd">346700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-5" id="f-138" unitRef="usd">1251500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-5" id="f-139" unitRef="usd">1076000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-140" unitRef="usd">205500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-141" unitRef="usd">147500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-142" unitRef="usd">380800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-143" unitRef="usd">265800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-5" decimals="-5" id="f-144" unitRef="usd">1000000.0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-6" decimals="-5" id="f-145" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-1" decimals="-5" id="f-146" unitRef="usd">1000000.0</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss contextRef="c-7" decimals="-5" id="f-147" unitRef="usd">200000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-148" unitRef="usd">33900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-149" unitRef="usd">-1300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-150" unitRef="usd">82400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-151" unitRef="usd">-8400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-152" unitRef="usd">240400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-153" unitRef="usd">146200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-154" unitRef="usd">464200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-155" unitRef="usd">257600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-156" unitRef="usd">119700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-157" unitRef="usd">45000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-158" unitRef="usd">179000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-159" unitRef="usd">8200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-160" unitRef="usd">120700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-161" unitRef="usd">101200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-162" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-163" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-164"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-165"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-166"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-167"
      unitRef="usdPerShare">0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-168" unitRef="shares">386600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-169" unitRef="shares">389800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-170" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-171" unitRef="shares">390400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-172"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-173"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-176" unitRef="shares">426800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-177" unitRef="shares">425800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-178" unitRef="shares">428300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-179" unitRef="shares">428000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-180" unitRef="usd">120700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-181" unitRef="usd">101200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-182" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-183" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-184" unitRef="usd">-7000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-185" unitRef="usd">-19600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-186" unitRef="usd">-25800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-187" unitRef="usd">-34900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-5" id="f-188" unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-5" id="f-189" unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-5" id="f-190" unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-5" id="f-191" unitRef="usd">-6700000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-192" unitRef="usd">-6300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-193" unitRef="usd">-18100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-194" unitRef="usd">-24000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-195" unitRef="usd">-41600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-196" unitRef="usd">114400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-5" id="f-197" unitRef="usd">83100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-198" unitRef="usd">261200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-199" unitRef="usd">207800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-5" id="f-200" unitRef="shares">386100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-5" id="f-201" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-202" unitRef="usd">2269000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-5" id="f-203" unitRef="usd">-29300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-5" id="f-204" unitRef="usd">644400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-5" id="f-205" unitRef="usd">-784100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-5" id="f-206" unitRef="usd">2100400000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-14" decimals="-5" id="f-207" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-14" decimals="-5" id="f-208" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-15" decimals="-5" id="f-209" unitRef="usd">14300000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-5" decimals="-5" id="f-210" unitRef="usd">14300000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment contextRef="c-16" decimals="-5" id="f-211" unitRef="usd">200000</dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment>
    <dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment contextRef="c-5" decimals="-5" id="f-212" unitRef="usd">200000</dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-14" decimals="-5" id="f-213" unitRef="shares">10600000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-15" decimals="-5" id="f-214" unitRef="usd">-400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-5" decimals="-5" id="f-215" unitRef="usd">-400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge contextRef="c-14" decimals="-5" id="f-216" unitRef="shares">10500000</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-15" decimals="-5" id="f-217" unitRef="usd">1296100000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-16" decimals="-5" id="f-218" unitRef="usd">-1296100000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-5" decimals="-5" id="f-219" unitRef="usd">0</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-15" decimals="-5" id="f-220" unitRef="usd">39000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-221" unitRef="usd">39000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-17" decimals="-5" id="f-222" unitRef="usd">120700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-223" unitRef="usd">120700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-18" decimals="-5" id="f-224" unitRef="usd">-6300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-225" unitRef="usd">-6300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-19" decimals="-5" id="f-226" unitRef="shares">386400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-227" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-228" unitRef="usd">3618000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-229" unitRef="usd">-35600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-230" unitRef="usd">765100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-231" unitRef="usd">-2080000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-232" unitRef="usd">2267900000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-24" decimals="-5" id="f-233" unitRef="shares">392600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-5" id="f-234" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-5" id="f-235" unitRef="usd">2028900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-5" id="f-236" unitRef="usd">-23000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-5" id="f-237" unitRef="usd">286900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-5" id="f-238" unitRef="usd">-37300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-239" unitRef="usd">2255900000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-30" decimals="-5" id="f-240" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-31" decimals="-5" id="f-241" unitRef="usd">12400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-6" decimals="-5" id="f-242" unitRef="usd">12400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-30" decimals="-5" id="f-243" unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-32" decimals="-5" id="f-244" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-6" decimals="-5" id="f-245" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-31" decimals="-5" id="f-246" unitRef="usd">30800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-5" id="f-247" unitRef="usd">30800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-5" id="f-248" unitRef="usd">101200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-249" unitRef="usd">101200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-34" decimals="-5" id="f-250" unitRef="usd">-18100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-251" unitRef="usd">-18100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-35" decimals="-5" id="f-252" unitRef="shares">386200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-253" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-254" unitRef="usd">2072100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-5" id="f-255" unitRef="usd">-41100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-5" id="f-256" unitRef="usd">388100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-5" id="f-257" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-5" id="f-258" unitRef="usd">1824500000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-41" decimals="-5" id="f-259" unitRef="shares">386300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-5" id="f-260" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-5" id="f-261" unitRef="usd">2258100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-5" id="f-262" unitRef="usd">-11600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-5" id="f-263" unitRef="usd">479900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-264" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-265" unitRef="usd">2131800000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-46" decimals="-5" id="f-266" unitRef="shares">1300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-46" decimals="-5" id="f-267" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-47" decimals="-5" id="f-268" unitRef="usd">26600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-5" id="f-269" unitRef="usd">26600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-46" decimals="-5" id="f-270" unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment contextRef="c-48" decimals="-5" id="f-271" unitRef="usd">-188900000</dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment>
    <dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">-188900000</dxcm:TreasuryStockValueAcquiredIncludingExciseTaxAdjustment>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-46" decimals="-5" id="f-273" unitRef="shares">10600000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-47" decimals="-5" id="f-274" unitRef="usd">-400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-1" decimals="-5" id="f-275" unitRef="usd">-400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge contextRef="c-46" decimals="-5" id="f-276" unitRef="shares">10500000</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-47" decimals="-5" id="f-277" unitRef="usd">1296100000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-48" decimals="-5" id="f-278" unitRef="usd">-1296100000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-1" decimals="-5" id="f-279" unitRef="usd">0</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-47" decimals="-5" id="f-280" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-1" decimals="-5" id="f-281" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-5" id="f-282" unitRef="usd">113900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-283" unitRef="usd">113900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-49" decimals="-5" id="f-284" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-285" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-50" decimals="-5" id="f-286" unitRef="usd">-24000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-287" unitRef="usd">-24000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-19" decimals="-5" id="f-288" unitRef="shares">386400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-289" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-290" unitRef="usd">3618000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-291" unitRef="usd">-35600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-292" unitRef="usd">765100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-293" unitRef="usd">-2080000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-294" unitRef="usd">2267900000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-51" decimals="-5" id="f-295" unitRef="shares">388000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-5" id="f-296" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-5" id="f-297" unitRef="usd">2108700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-5" id="f-298" unitRef="usd">500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-5" id="f-299" unitRef="usd">138700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-5" id="f-300" unitRef="usd">-206200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-5" id="f-301" unitRef="usd">2042100000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-57" decimals="-5" id="f-302" unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-57" decimals="-5" id="f-303" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-58" decimals="-5" id="f-304" unitRef="usd">22500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-7" decimals="-5" id="f-305" unitRef="usd">22500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-57" decimals="-5" id="f-306" unitRef="shares">2900000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-58" decimals="-5" id="f-307" unitRef="usd">-189300000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-59" decimals="-5" id="f-308" unitRef="usd">189200000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone contextRef="c-7" decimals="-5" id="f-309" unitRef="usd">-100000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestone>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-57" decimals="-5" id="f-310" unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-59" decimals="-5" id="f-311" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-7" decimals="-5" id="f-312" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-57" decimals="-5" id="f-313" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-58" decimals="-5" id="f-314" unitRef="usd">4200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-59" decimals="-5" id="f-315" unitRef="usd">13200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-7" decimals="-5" id="f-316" unitRef="usd">17400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge contextRef="c-57" decimals="-5" id="f-317" unitRef="shares">300000</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-58" decimals="-5" id="f-318" unitRef="usd">33500000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-59" decimals="-5" id="f-319" unitRef="usd">-33500000</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <dxcm:SharesReceivedFromBenefitOfNoteHedgeValue contextRef="c-7" decimals="-5" id="f-320" unitRef="usd">0</dxcm:SharesReceivedFromBenefitOfNoteHedgeValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-58" decimals="-5" id="f-321" unitRef="usd">92500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-5" id="f-322" unitRef="usd">92500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-60" decimals="-5" id="f-323" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-324" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-61" decimals="-5" id="f-325" unitRef="usd">-41600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-326" unitRef="usd">-41600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-35" decimals="-5" id="f-327" unitRef="shares">386200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-328" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-329" unitRef="usd">2072100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-5" id="f-330" unitRef="usd">-41100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-5" id="f-331" unitRef="usd">388100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-5" id="f-332" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-5" id="f-333" unitRef="usd">1824500000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-334" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-335" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-336" unitRef="usd">133500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-5" id="f-337" unitRef="usd">119600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-338" unitRef="usd">113900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-5" id="f-339" unitRef="usd">92500000</us-gaap:ShareBasedCompensation>
    <us-gaap:PaidInKindInterest contextRef="c-1" decimals="-5" id="f-340" unitRef="usd">5800000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest contextRef="c-7" decimals="-5" id="f-341" unitRef="usd">4700000</us-gaap:PaidInKindInterest>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-5" id="f-342" unitRef="usd">1000000.0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-7" decimals="-5" id="f-343" unitRef="usd">200000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-344" unitRef="usd">-136500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-345" unitRef="usd">-53600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-346" unitRef="usd">47300000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-5" id="f-347" unitRef="usd">-31900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-348" unitRef="usd">72900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-5" id="f-349" unitRef="usd">51600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-350" unitRef="usd">193600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-5" id="f-351" unitRef="usd">-43600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-352" unitRef="usd">-13200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-5" id="f-353" unitRef="usd">81200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-1" decimals="-5" id="f-354" unitRef="usd">4400000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-7" decimals="-5" id="f-355" unitRef="usd">6100000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-356" unitRef="usd">496500000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-5" id="f-357" unitRef="usd">171300000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-5" id="f-358" unitRef="usd">16600000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-5" id="f-359" unitRef="usd">-14000000.0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-1" decimals="-5" id="f-360" unitRef="usd">5900000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-7" decimals="-5" id="f-361" unitRef="usd">30700000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-362" unitRef="usd">614900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-5" id="f-363" unitRef="usd">537000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-5" id="f-364" unitRef="usd">2947900000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-5" id="f-365" unitRef="usd">1397700000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-5" id="f-366" unitRef="usd">2228400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-7" decimals="-5" id="f-367" unitRef="usd">1387800000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-368" unitRef="usd">184100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-369" unitRef="usd">301300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-7" decimals="-5" id="f-371" unitRef="usd">3900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-372" unitRef="usd">18500000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-5" id="f-373" unitRef="usd">12300000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-374" unitRef="usd">-922100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-5" id="f-375" unitRef="usd">-327400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-5" id="f-376" unitRef="usd">26600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-5" id="f-377" unitRef="usd">22500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-378" unitRef="usd">188700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-5" id="f-379" unitRef="usd">557700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-5" id="f-380" unitRef="usd">1230600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-7" decimals="-5" id="f-381" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-1" decimals="-5" id="f-382" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-7" decimals="-5" id="f-383" unitRef="usd">0</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-1" decimals="-5" id="f-384" unitRef="usd">650500000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-7" decimals="-5" id="f-385" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-5" id="f-386" unitRef="usd">-3400000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-7" decimals="-5" id="f-387" unitRef="usd">-16300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-388" unitRef="usd">313300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-5" id="f-389" unitRef="usd">-551500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-390" unitRef="usd">-4600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-391" unitRef="usd">-12600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-392" unitRef="usd">1500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-5" id="f-393" unitRef="usd">-354500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-394" unitRef="usd">643300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-56" decimals="-5" id="f-395" unitRef="usd">1053600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-396" unitRef="usd">644800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-40" decimals="-5" id="f-397" unitRef="usd">699100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-398" unitRef="usd">643700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-40" decimals="-5" id="f-399" unitRef="usd">698100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-3" decimals="-5" id="f-400" unitRef="usd">1100000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-40" decimals="-5" id="f-401" unitRef="usd">1000000.0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-402" unitRef="usd">644800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-40" decimals="-5" id="f-403" unitRef="usd">699100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-1" decimals="-5" id="f-404" unitRef="usd">1316400000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-7" decimals="-5" id="f-405" unitRef="usd">35900000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-1" decimals="-5" id="f-406" unitRef="usd">-1296100000</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-7" decimals="-5" id="f-407" unitRef="usd">-33500000</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-1" decimals="-5" id="f-408" unitRef="usd">47000000.0</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-7" decimals="-5" id="f-409" unitRef="usd">60300000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet contextRef="c-1" decimals="-5" id="f-410" unitRef="usd">6000000.0</dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet>
    <dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet contextRef="c-7" decimals="-5" id="f-411" unitRef="usd">-700000</dxcm:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-5" id="f-412" unitRef="usd">1800000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-7" decimals="-5" id="f-413" unitRef="usd">15800000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-414">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Organization and Business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DexCom, Inc. is a medical device company that develops and markets continuous glucose monitoring, or CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;Dexcom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Seasonality&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;There were no material changes to our significant accounting policies as described in Note 1 to the financial statements in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 during the nine months ended September&#160;30, 2023&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of September&#160;30, 2023 included unbilled accounts receivable of $8.8 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.3 million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08,&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-415">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-416">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December&#160;31, 2022 included in the Annual Report on Form 10-K that we filed with the SEC on February&#160;9, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company effected a four-for-one forward stock split of its common stock to shareholders of record as of May 19, 2022. The par value of the common stock remains $0.001 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from &#x201c;Additional paid-in capital&#x201d; to &#x201c;Common stock.&#x201d; All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-62"
      decimals="INF"
      id="f-417"
      unitRef="number">4</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-63"
      decimals="INF"
      id="f-418"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-419">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-420">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-421">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of September&#160;30, 2023 included unbilled accounts receivable of $8.8 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months was $21.3 million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized in the period from performance obligations satisfied in previous periods was not material for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-64" id="f-422">P30D</dxcm:ContractPaymentTermsNumberofDays>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-65" id="f-423">P90D</dxcm:ContractPaymentTermsNumberofDays>
    <us-gaap:UnbilledContractsReceivable contextRef="c-3" decimals="-5" id="f-424" unitRef="usd">8800000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-425" unitRef="usd">21300000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-426" unitRef="usd">19000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-427">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from restricted stock units, or RSUs, performance stock units, or PSUs, warrants, and our senior convertible notes. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-428">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-429" unitRef="usd">120700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-430" unitRef="usd">101200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-431" unitRef="usd">285200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-432" unitRef="usd">249400000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-5" decimals="-5" id="f-433" unitRef="usd">3000000.0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-6" decimals="-5" id="f-434" unitRef="usd">2800000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-1" decimals="-5" id="f-435" unitRef="usd">9600000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-7" decimals="-5" id="f-436" unitRef="usd">8300000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-5" decimals="-5" id="f-437" unitRef="usd">123700000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-6" decimals="-5" id="f-438" unitRef="usd">104000000.0</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-1" decimals="-5" id="f-439" unitRef="usd">294800000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-7" decimals="-5" id="f-440" unitRef="usd">257700000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-441"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-442"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-443"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-444"
      unitRef="usdPerShare">0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-445"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-446"
      unitRef="usdPerShare">0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-447"
      unitRef="usdPerShare">0.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-448"
      unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-449" unitRef="shares">386600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-450" unitRef="shares">389800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-451" unitRef="shares">386700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-452" unitRef="shares">390400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-66" decimals="-5" id="f-453" unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-67" decimals="-5" id="f-454" unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-68" decimals="-5" id="f-455" unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-69" decimals="-5" id="f-456" unitRef="shares">900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-70" decimals="-5" id="f-457" unitRef="shares">11600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-71" decimals="-5" id="f-458" unitRef="shares">8600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-72" decimals="-5" id="f-459" unitRef="shares">11800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-73" decimals="-5" id="f-460" unitRef="shares">9800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-74" decimals="-5" id="f-461" unitRef="shares">27600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-75" decimals="-5" id="f-462" unitRef="shares">26900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-76" decimals="-5" id="f-463" unitRef="shares">28700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-77" decimals="-5" id="f-464" unitRef="shares">26900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-465" unitRef="shares">426800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-466" unitRef="shares">425800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-467" unitRef="shares">428300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-468" unitRef="shares">428000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-469">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the diluted net income per share attributable to common stockholders calculations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-78" decimals="-5" id="f-470" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-79" decimals="-5" id="f-471" unitRef="shares">1300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-80" decimals="-5" id="f-472" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-81" decimals="-5" id="f-473" unitRef="shares">500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-474">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08,&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. &lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This guidance is intended improve the accounting for acquired revenue contracts with customers in a business combination. The new guidance requires that the acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. ASU 2021-08 is effective for public business entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The amendments should be applied prospectively to business combinations occurring on or after the adoption date. We adopted ASU 2021-08 in the first quarter of 2023 and there was no impact to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;We do not expect any recently issued accounting pronouncements will have a material effect on our consolidated financial statements</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-475">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;2. Development and Other Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Collaboration with Verily Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#x201c;Verily&#x201d;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#x2019;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of Dexcom and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of Verily&#x2019;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and will make potential payments for contingent sales-based milestones upon the achievement of certain revenue targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Upfront and Incentive payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7,363,772 shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent milestones&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with IPR&amp;amp;D obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we received regulatory approval and issued 2,945,508 shares of our common stock in connection with our achievement of the related milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2022, we received FDA approval and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) 5,154,640 shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;life of 64 months through March 2028. The related amortization expense is recognized in Cost of Sales in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All milestones may be paid in cash or shares of our common stock, at our election. If we elect to make these milestone payments in cash, any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment multiplied by the value of our stock on the date the relevant milestone is achieved, and adjusted to give effect to any stock splits, dividends, or similar events. We intend to pay the sales-based contingent milestones in shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement will continue until December 31, 2028, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party. Upon achievement of the first sales-based milestone event and payment of the corresponding milestone fee by us, the term of the Restated Collaboration Agreement will be extended until December 31, 2033, unless terminated by either party upon uncured material breach of the Restated Collaboration Agreement by the other party.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:SharePrice
      contextRef="c-82"
      decimals="INF"
      id="f-476"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeArrangementUpfrontFee contextRef="c-83" decimals="-5" id="f-477" unitRef="usd">250000000.0</dxcm:CollaborativeArrangementUpfrontFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-84"
      decimals="INF"
      id="f-478"
      unitRef="shares">7363772</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-85" decimals="-5" id="f-479" unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SharePrice
      contextRef="c-82"
      decimals="INF"
      id="f-480"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-86" decimals="-5" id="f-481" unitRef="usd">3200000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-87" decimals="-5" id="f-482" unitRef="usd">87100000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="c-88"
      decimals="INF"
      id="f-483"
      unitRef="shares">2945508</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-89" decimals="-5" id="f-484" unitRef="usd">152400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues
      contextRef="c-90"
      decimals="INF"
      id="f-485"
      unitRef="shares">5154640</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="c-82"
      decimals="INF"
      id="f-486"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-91" id="f-487">P64M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="c-1" id="f-488">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of September&#160;30, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; transfers into or out of Level 3 securities during the three and nine months ended September&#160;30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,531.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on the carrying values of our senior convertible notes, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Convertible Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in Note 5 &#x201c;Debt&#x201d; to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency and Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023 and December&#160;31, 2022, the notional amounts of outstanding foreign currency forward contracts were $89.0 million and $62.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency exposures vary but are primarily concentrated in the Australian Dollar, the British Pound, the Canadian Dollar, the Euro, and the Malaysian Ringgit. We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment.&#160;In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$38.5&#160;million as of September&#160;30, 2023 and $19.0 million as of December&#160;31, 2022. We include them in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no significant impairment losses during the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-489">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of September&#160;30, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2022, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-92" decimals="-5" id="f-490" unitRef="usd">360900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-93" decimals="-5" id="f-491" unitRef="usd">29900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-94" decimals="-5" id="f-492" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-493" unitRef="usd">390800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-5" id="f-494" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-5" id="f-495" unitRef="usd">1819000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-5" id="f-496" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-5" id="f-497" unitRef="usd">1819000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-5" id="f-498" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-5" id="f-499" unitRef="usd">387300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-5" id="f-500" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-5" id="f-501" unitRef="usd">387300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-5" id="f-502" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-5" id="f-503" unitRef="usd">390300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-5" id="f-504" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-505" unitRef="usd">390300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-5" id="f-506" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-5" id="f-507" unitRef="usd">2596600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-5" id="f-508" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-509" unitRef="usd">2596600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-92" decimals="-5" id="f-510" unitRef="usd">13700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-93" decimals="-5" id="f-511" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-94" decimals="-5" id="f-512" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-3" decimals="-5" id="f-513" unitRef="usd">13700000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-92" decimals="-5" id="f-514" unitRef="usd">374600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-93" decimals="-5" id="f-515" unitRef="usd">2626500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-94" decimals="-5" id="f-516" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-5" id="f-517" unitRef="usd">3001100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-107" decimals="-5" id="f-518" unitRef="usd">375900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-108" decimals="-5" id="f-519" unitRef="usd">44800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-109" decimals="-5" id="f-520" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-521" unitRef="usd">420700000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-5" id="f-522" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-523" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-5" id="f-524" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-525" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-5" id="f-526" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-527" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-5" id="f-528" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-5" id="f-529" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-5" id="f-530" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-5" id="f-531" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-120" decimals="-5" id="f-532" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-5" id="f-533" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-5" id="f-534" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" decimals="-5" id="f-535" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-5" id="f-536" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-537" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-538" unitRef="usd">10200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-108" decimals="-5" id="f-539" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-109" decimals="-5" id="f-540" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-4" decimals="-5" id="f-541" unitRef="usd">10200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-542" unitRef="usd">386100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-108" decimals="-5" id="f-543" unitRef="usd">1858700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-109" decimals="-5" id="f-544" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-5" id="f-545" unitRef="usd">2244800000</us-gaap:AssetsFairValueDisclosure>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-6" decimals="0" id="f-546" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-1" decimals="0" id="f-547" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-7" decimals="0" id="f-548" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-5" decimals="0" id="f-549" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="c-1" id="f-550">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,531.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="12" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-122" decimals="-5" id="f-551" unitRef="usd">281300000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-123" decimals="-5" id="f-552" unitRef="usd">2136200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-124" decimals="-5" id="f-553" unitRef="usd">1140500000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-125" decimals="-5" id="f-554" unitRef="usd">1314900000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-126" decimals="-5" id="f-555" unitRef="usd">1109400000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-127" decimals="-5" id="f-556" unitRef="usd">0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-128" decimals="-5" id="f-557" unitRef="usd">2531200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-129" decimals="-5" id="f-558" unitRef="usd">3451100000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeNotionalAmount contextRef="c-130" decimals="-5" id="f-559" unitRef="usd">89000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-131" decimals="-5" id="f-560" unitRef="usd">62000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermInvestments contextRef="c-132" decimals="-5" id="f-561" unitRef="usd">38500000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-133" decimals="-5" id="f-562" unitRef="usd">19000000</us-gaap:LongTermInvestments>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-5" decimals="0" id="f-563" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-7" decimals="0" id="f-564" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-6" decimals="0" id="f-565" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="0" id="f-566" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="c-1" id="f-567">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;4. Balance Sheet Details and Other Financial Information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.60&#160;billion. As of December&#160;31, 2022, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $1.81&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022 were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst &lt;/span&gt;&lt;/div&gt;reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at September&#160;30, 2023 were primarily due to increases in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(466.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Accrued Payroll and Related Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Income (Expense), Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and dividend income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-568">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-98" decimals="-5" id="f-569" unitRef="usd">1820500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-98" decimals="-5" id="f-570" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-98" decimals="-5" id="f-571" unitRef="usd">2000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-5" id="f-572" unitRef="usd">1819000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-102" decimals="-5" id="f-573" unitRef="usd">387500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-102" decimals="-5" id="f-574" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-102" decimals="-5" id="f-575" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-5" id="f-576" unitRef="usd">387300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-106" decimals="-5" id="f-577" unitRef="usd">391200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-106" decimals="-5" id="f-578" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-106" decimals="-5" id="f-579" unitRef="usd">900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-580" unitRef="usd">390300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-581" unitRef="usd">2599200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-5" id="f-582" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-5" id="f-583" unitRef="usd">3100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-584" unitRef="usd">2596600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-113" decimals="-5" id="f-585" unitRef="usd">1535100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-113" decimals="-5" id="f-586" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-113" decimals="-5" id="f-587" unitRef="usd">4600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-588" unitRef="usd">1530700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-117" decimals="-5" id="f-589" unitRef="usd">119600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-117" decimals="-5" id="f-590" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-117" decimals="-5" id="f-591" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-5" id="f-592" unitRef="usd">119400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-121" decimals="-5" id="f-593" unitRef="usd">164300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-121" decimals="-5" id="f-594" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-121" decimals="-5" id="f-595" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-5" id="f-596" unitRef="usd">163800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-5" id="f-597" unitRef="usd">1819000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-5" id="f-598" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-5" id="f-599" unitRef="usd">5300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-600" unitRef="usd">1813900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-7" id="f-601" unitRef="usd">2600000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-7" id="f-602" unitRef="usd">1810000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-603">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-3" decimals="-5" id="f-604" unitRef="usd">277500000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-4" decimals="-5" id="f-605" unitRef="usd">159000000.0</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-3" decimals="-5" id="f-606" unitRef="usd">27500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-607" unitRef="usd">17200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-3" decimals="-5" id="f-608" unitRef="usd">193600000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-609" unitRef="usd">130500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-610" unitRef="usd">498600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-611" unitRef="usd">306700000</us-gaap:InventoryNet>
    <dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-612">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-3" decimals="-5" id="f-613" unitRef="usd">55200000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-5" id="f-614" unitRef="usd">48900000</us-gaap:PrepaidExpenseCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-3" decimals="-5" id="f-615" unitRef="usd">61500000</dxcm:PrepaidInventoryCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-4" decimals="-5" id="f-616" unitRef="usd">67800000</dxcm:PrepaidInventoryCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-3" decimals="-5" id="f-617" unitRef="usd">13700000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-4" decimals="-5" id="f-618" unitRef="usd">10200000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-3" decimals="-5" id="f-619" unitRef="usd">2800000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-4" decimals="-5" id="f-620" unitRef="usd">38900000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-621" unitRef="usd">40600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-622" unitRef="usd">26800000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-623" unitRef="usd">173800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-624" unitRef="usd">192600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-625">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(466.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-134" decimals="-5" id="f-626" unitRef="usd">31800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-135" decimals="-5" id="f-627" unitRef="usd">26900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-136" decimals="-5" id="f-628" unitRef="usd">163200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-137" decimals="-5" id="f-629" unitRef="usd">54300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-138" decimals="-5" id="f-630" unitRef="usd">35900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-139" decimals="-5" id="f-631" unitRef="usd">32600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-140" decimals="-5" id="f-632" unitRef="usd">62100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-141" decimals="-5" id="f-633" unitRef="usd">48800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-142" decimals="-5" id="f-634" unitRef="usd">632500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-143" decimals="-5" id="f-635" unitRef="usd">449200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-144" decimals="-5" id="f-636" unitRef="usd">276600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-145" decimals="-5" id="f-637" unitRef="usd">264400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-146" decimals="-5" id="f-638" unitRef="usd">343100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-147" decimals="-5" id="f-639" unitRef="usd">542600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-640" unitRef="usd">1545200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-641" unitRef="usd">1418800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-642" unitRef="usd">466300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-643" unitRef="usd">363200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-3" decimals="-5" id="f-644" unitRef="usd">1078900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-5" id="f-645" unitRef="usd">1055600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="c-1" id="f-646">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:LongTermInvestments contextRef="c-3" decimals="-5" id="f-647" unitRef="usd">38500000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-4" decimals="-5" id="f-648" unitRef="usd">19000000.0</us-gaap:LongTermInvestments>
    <dxcm:LongTermDeposits contextRef="c-3" decimals="-5" id="f-649" unitRef="usd">13600000</dxcm:LongTermDeposits>
    <dxcm:LongTermDeposits contextRef="c-4" decimals="-5" id="f-650" unitRef="usd">16200000</dxcm:LongTermDeposits>
    <dxcm:OtherLongTermAssets contextRef="c-3" decimals="-5" id="f-651" unitRef="usd">22300000</dxcm:OtherLongTermAssets>
    <dxcm:OtherLongTermAssets contextRef="c-4" decimals="-5" id="f-652" unitRef="usd">11900000</dxcm:OtherLongTermAssets>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-653" unitRef="usd">74400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-654" unitRef="usd">47100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-655">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-3" decimals="-5" id="f-656" unitRef="usd">242400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-4" decimals="-5" id="f-657" unitRef="usd">237900000</us-gaap:AccountsPayableTradeCurrent>
    <dxcm:AccruedTaxAuditAndLegalFees contextRef="c-3" decimals="-5" id="f-658" unitRef="usd">218800000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:AccruedTaxAuditAndLegalFees contextRef="c-4" decimals="-5" id="f-659" unitRef="usd">44800000</dxcm:AccruedTaxAuditAndLegalFees>
    <dxcm:PharmacyRebates contextRef="c-3" decimals="-5" id="f-660" unitRef="usd">837400000</dxcm:PharmacyRebates>
    <dxcm:PharmacyRebates contextRef="c-4" decimals="-5" id="f-661" unitRef="usd">556400000</dxcm:PharmacyRebates>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-3" decimals="-5" id="f-662" unitRef="usd">13300000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-4" decimals="-5" id="f-663" unitRef="usd">12800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-3" decimals="-5" id="f-664" unitRef="usd">13700000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-4" decimals="-5" id="f-665" unitRef="usd">10200000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-666" unitRef="usd">47500000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-667" unitRef="usd">39700000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-668" unitRef="usd">1373100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-669" unitRef="usd">901800000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock contextRef="c-1" id="f-670">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-3" decimals="-5" id="f-671" unitRef="usd">129100000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-4" decimals="-5" id="f-672" unitRef="usd">96800000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-3" decimals="-5" id="f-673" unitRef="usd">22200000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-5" id="f-674" unitRef="usd">37500000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-675" unitRef="usd">151300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-676" unitRef="usd">134300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="c-1" id="f-677">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-678" unitRef="usd">57900000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-679" unitRef="usd">59600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-680" unitRef="usd">21300000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-681" unitRef="usd">19000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-5" id="f-682" unitRef="usd">4600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-5" id="f-683" unitRef="usd">4900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-684" unitRef="usd">37000000.0</dxcm:OtherTaxLiabilitiesNoncurrent>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-685" unitRef="usd">32700000</dxcm:OtherTaxLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-686" unitRef="usd">13100000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-687" unitRef="usd">12100000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-688" unitRef="usd">133900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-689" unitRef="usd">128300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-690">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and dividend income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-5" decimals="-5" id="f-691" unitRef="usd">41500000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-6" decimals="-5" id="f-692" unitRef="usd">5700000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-1" decimals="-5" id="f-693" unitRef="usd">101200000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-7" decimals="-5" id="f-694" unitRef="usd">10400000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-5" id="f-695" unitRef="usd">4900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-5" id="f-696" unitRef="usd">4600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-697" unitRef="usd">15400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-7" decimals="-5" id="f-698" unitRef="usd">13900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-5" decimals="-5" id="f-699" unitRef="usd">2700000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-6" decimals="-5" id="f-700" unitRef="usd">2400000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-1" decimals="-5" id="f-701" unitRef="usd">3400000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-7" decimals="-5" id="f-702" unitRef="usd">4900000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-703" unitRef="usd">33900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-704" unitRef="usd">-1300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-705" unitRef="usd">82400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-706" unitRef="usd">-8400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-707">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;5. Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="12" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.75% Senior Convertible Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we completed an offering of&#160;$850.0 million&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;0.75%&#160;and a maturity date of&#160;December&#160;1, 2023&#160;(the &#x201c;2023 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and costs directly related to the offering, were approximately&#160;$836.6 million. The initial conversion rate of the 2023 Notes is&#160;24.3476&#160;shares per&#160;$1,000 principal amount of notes, which is equivalent to a conversion price of approximately&#160;$41.07&#160;per share, subject to adjustments. We entered into transactions for a convertible note hedge (the &#x201c;2023 Note Hedge&#x201d;) and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;warrants (the &#x201c;2023 Warrants&#x201d;) concurrently with the issuance of the 2023 Notes. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the twelve months ended December&#160;31, 2022, holders of $17.5&#160;million in aggregate principal amount of the 2023 Notes elected conversion at their option. We settled these conversions using treasury stock. We issued 425,552 shares to settle the converted 2023 Notes. We received 287,492 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2023, we settled $650.5&#160;million in aggregate principal amount of the 2023 Notes through a combination of $650.5&#160;million in cash for the principal amount and 10,599,907 shares of common stock for the amount in excess of the principal amount. We received 10,585,850 shares of common stock from the exercise of a portion of the 2023 Note Hedge that we purchased concurrently with the issuance of the 2023 Notes, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining outstanding principal of $124.3&#160;million as of September&#160;30, 2023 and any amount in excess of the principal amount will settle on or before the maturity date of December&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes had the ability to convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after March&#160;31, 2019 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the 2023 Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Circumstance (1) listed above occurred during the quarters ended December&#160;31, 2022, March&#160;31, 2023, and June&#160;30, 2023. As a result, the 2023 Notes were convertible at the option of the holder from January&#160;1, 2023 through August 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after September&#160;1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances. See above for a description of conversion activity related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom did not have a right to redeem the 2023 Notes prior to December&#160;1, 2021. On or after December&#160;1, 2021 and prior to September&#160;1, 2023, Dexcom was permitted to redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price was equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Note Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the &#x201c;2023 Counterparties&#x201d;) entitling us to purchase up to&#160;20.7 million&#160;shares of our common stock at an initial price of&#160;$41.07&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;$218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on December&#160;1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share. See above for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising a portion of the 2023 Note Hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;20.7 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March&#160;1, 2024. We received&#160;$183.8 million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $49.60 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.25% Senior Convertible Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we completed an offering of $1.21 billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.25% and a maturity date of November&#160;15, 2025 (the &#x201c;2025 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and estimated costs directly related to the offering, were approximately $1.19 billion. The initial conversion rate of the 2025 Notes is 6.6620 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $150.11 per share, subject to adjustments. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2025 Notes includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2025 Notes), holders of the 2025 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2025 Notes, plus any accrued and unpaid interest. Holders of the 2025 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025, holders of the 2025 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after September&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;On or after August&#160;15, 2025, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2025 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom was not permitted to redeem the 2025 Notes prior to May&#160;20, 2023. On or after May&#160;20, 2023 and prior to August&#160;15, 2025, Dexcom may redeem for cash all or part of the 2025 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.375% Senior Convertible Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, we completed an offering of $1.25&#160;billion aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.375% and a maturity date of May&#160;15, 2028 (the &#x201c;2028 Notes&#x201d;). The net proceeds from the offering, after deducting initial purchasers&#x2019; discounts and estimated costs directly related to the offering, were approximately $1.23&#160;billion. The initial conversion rate of the 2028 Notes is 6.1571 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $162.41 per share, subject to adjustments. The 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. We use the if-converted method for assumed conversion of the 2028 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No principal payments are due on the 2028 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2028 Notes includes customary terms and covenants, including certain events of default after which the 2028 Notes may be due and payable immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at the Option of the Holders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a fundamental change (as defined in the indenture related to the 2028 Notes), holders of the 2028 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2028 Notes, plus any accrued and unpaid interest. Holders of the 2028 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by Dexcom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2028, holders of the 2028 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during any calendar quarter commencing after September&#160;30, 2023 (and only during such calendar quarter), if the last reported sale price of Dexcom&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom&#x2019;s common stock and the applicable conversion rate of the Notes on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt"&gt;upon the occurrence of specified corporate transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after February&#160;15, 2028, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2028 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Conversion Rights at Our Option&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dexcom may not redeem the 2028 Notes prior to May&#160;20, 2026. On or after May&#160;20, 2026 and prior to February&#160;15, 2028, Dexcom may redeem for cash all or part of the 2028 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2028 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Capped Call Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions (the &#x201c;2028 Capped Calls&#x201d;) with certain financial institutions. The 2028 Capped Calls will cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock that will initially underlie the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $212.62 per share, subject to adjustments, which represents a premium of 80% over the closing price of our common stock of $118.12 per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of $101.3 million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terms of the Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders (the &#x201c;Credit Facility&#x201d;). The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The first base rate is the Alternate Base Rate (&#x201c;ABR&#x201d;) and loans comprising each ABR borrowing shall bear interest at the ABR plus the applicable rate between 0.375% to 1.000%. The ABR is the highest of (a) the prime rate last quoted by The Wall Street Journal, (b) the Federal Reserve Bank of New York rate plus one half of 1%, and (c) the Adjusted Term Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;) for a one month interest period plus 1%. The second base rate is the Term Benchmark rate and loans comprising each Term Benchmark borrowing shall bear interest at the Adjusted Term &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFR, the Adjusted Euro Interbank Offered Rate, the Adjusted Stockholm Interbank Offered Rate, the Adjusted Canadian Dollar Offered Rate, Adjusted Australian Dollar Rate, the Adjusted Bank Bill Benchmark Rate or the Adjusted Tokyo Interbank Offered Rate, as applicable based on the currency denomination borrowed, plus the applicable rate between 1.375% to 2.000%. The third base rate is the Adjusted Daily Simple RepoFunds Rate (&#x201c;RFR&#x201d;) and loans comprising each Daily Simple RFR Loan shall bear interest at a rate per annum equal to the applicable Daily Simple RFR for Sterling or Dollars (as applicable) plus the applicable rate between 0.0326% to 0.100% depending on the loan denomination. We will also pay a commitment fee of between 0.175% and 0.250%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023, we also have a guarantee facility related to our international operations which is collateralized by a $5.3&#160;million term deposit that is included in non-current &#x201c;Other assets&#x201d; on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-122" decimals="-5" id="f-708" unitRef="usd">124300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-123" decimals="-5" id="f-709" unitRef="usd">774800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-124" decimals="-5" id="f-710" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-125" decimals="-5" id="f-711" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-126" decimals="-5" id="f-712" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="-5" id="f-713" unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-128" decimals="-5" id="f-714" unitRef="usd">2581800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-129" decimals="-5" id="f-715" unitRef="usd">1982300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-128" decimals="-5" id="f-716" unitRef="usd">25200000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-129" decimals="-5" id="f-717" unitRef="usd">12000000.0</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleNotesPayable contextRef="c-128" decimals="-5" id="f-718" unitRef="usd">2556600000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="c-129" decimals="-5" id="f-719" unitRef="usd">1970300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c-1" id="f-720">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total by which the notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-148" decimals="-5" id="f-721" unitRef="usd">158100000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-149" decimals="-5" id="f-722" unitRef="usd">1361500000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-150" decimals="-5" id="f-723" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-151" decimals="-5" id="f-724" unitRef="usd">33600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-152" decimals="-5" id="f-725" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-153" decimals="-5" id="f-726" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-154" decimals="-5" id="f-727" unitRef="usd">158100000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-155" decimals="-5" id="f-728" unitRef="usd">1395100000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock contextRef="c-1" id="f-729">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual coupon interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on the 2028 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;* Not applicable as no notes were outstanding at this date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-5" decimals="-5" id="f-730" unitRef="usd">1800000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-6" decimals="-5" id="f-731" unitRef="usd">2300000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-1" decimals="-5" id="f-732" unitRef="usd">7000000.0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-7" decimals="-5" id="f-733" unitRef="usd">6700000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-5" id="f-734" unitRef="usd">2000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-5" id="f-735" unitRef="usd">1400000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-736" unitRef="usd">5500000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-7" decimals="-5" id="f-737" unitRef="usd">4300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt contextRef="c-5" decimals="-5" id="f-738" unitRef="usd">3800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-6" decimals="-5" id="f-739" unitRef="usd">3700000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-5" id="f-740" unitRef="usd">12500000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-7" decimals="-5" id="f-741" unitRef="usd">11000000.0</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-156" decimals="3" id="f-742" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-157" decimals="3" id="f-743" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-156" decimals="3" id="f-744" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-157" decimals="3" id="f-745" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-158" decimals="3" id="f-746" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-159" decimals="3" id="f-747" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-158" decimals="3" id="f-748" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-159" decimals="3" id="f-749" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-160" decimals="3" id="f-750" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-160" decimals="3" id="f-751" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-161"
      decimals="INF"
      id="f-752"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-161" decimals="INF" id="f-753" unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-161"
      decimals="INF"
      id="f-754"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-162" decimals="-5" id="f-755" unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-161"
      decimals="2"
      id="f-756"
      unitRef="usdPerShare">41.07</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled contextRef="c-149" decimals="-5" id="f-757" unitRef="usd">17500000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-163"
      decimals="INF"
      id="f-758"
      unitRef="shares">425552</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge
      contextRef="c-149"
      decimals="INF"
      id="f-759"
      unitRef="shares">287492</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled contextRef="c-164" decimals="-5" id="f-760" unitRef="usd">650500000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled contextRef="c-148" decimals="-5" id="f-761" unitRef="usd">650500000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash contextRef="c-164" decimals="-5" id="f-762" unitRef="usd">650500000</dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash contextRef="c-148" decimals="-5" id="f-763" unitRef="usd">650500000</dxcm:DebtInstrumentConvertiblePrincipalAmountSettledThroughCash>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-165"
      decimals="INF"
      id="f-764"
      unitRef="shares">10599907</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-166"
      decimals="INF"
      id="f-765"
      unitRef="shares">10599907</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge
      contextRef="c-148"
      decimals="INF"
      id="f-766"
      unitRef="shares">10585850</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge
      contextRef="c-164"
      decimals="INF"
      id="f-767"
      unitRef="shares">10585850</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash contextRef="c-167" decimals="-5" id="f-768" unitRef="usd">124300000</dxcm:DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-122"
      decimals="INF"
      id="f-769"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-168" decimals="INF" id="f-770" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-169" decimals="INF" id="f-771" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-168" decimals="2" id="f-772" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-170" decimals="INF" id="f-773" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-171" decimals="INF" id="f-774" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-171" decimals="INF" id="f-775" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-171"
      decimals="INF"
      id="f-776"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-148" decimals="2" id="f-777" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-168" decimals="INF" id="f-778" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-169" decimals="INF" id="f-779" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-148"
      decimals="INF"
      id="f-780"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions
      contextRef="c-172"
      decimals="INF"
      id="f-781"
      unitRef="purchaser">2</dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions>
    <dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares
      contextRef="c-173"
      decimals="-5"
      id="f-782"
      unitRef="shares">20700000</dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-161"
      decimals="2"
      id="f-783"
      unitRef="usdPerShare">41.07</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c-174" decimals="-5" id="f-784" unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="c-174" decimals="-5" id="f-785" unitRef="usd">218900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-162"
      decimals="-5"
      id="f-786"
      unitRef="shares">20700000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-162" decimals="INF" id="f-787" unitRef="d">60</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-162" decimals="-5" id="f-788" unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-161"
      decimals="2"
      id="f-789"
      unitRef="usdPerShare">49.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-175"
      decimals="INF"
      id="f-790"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-175" decimals="-7" id="f-791" unitRef="usd">1210000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-175"
      decimals="INF"
      id="f-792"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-176" decimals="-7" id="f-793" unitRef="usd">1190000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-175"
      decimals="2"
      id="f-794"
      unitRef="usdPerShare">150.11</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-177"
      decimals="INF"
      id="f-795"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-178" decimals="INF" id="f-796" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-179" decimals="INF" id="f-797" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-178" decimals="2" id="f-798" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-180" decimals="INF" id="f-799" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-181" decimals="INF" id="f-800" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-181" decimals="INF" id="f-801" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-181"
      decimals="INF"
      id="f-802"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-150" decimals="2" id="f-803" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-178" decimals="INF" id="f-804" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-179" decimals="INF" id="f-805" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-152"
      decimals="INF"
      id="f-806"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-177"
      decimals="INF"
      id="f-807"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-177" decimals="-7" id="f-808" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-177"
      decimals="INF"
      id="f-809"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-182" decimals="-7" id="f-810" unitRef="usd">1230000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-177"
      decimals="2"
      id="f-811"
      unitRef="usdPerShare">162.41</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-177"
      decimals="INF"
      id="f-812"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-183" decimals="INF" id="f-813" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-184" decimals="INF" id="f-814" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="c-183" decimals="2" id="f-815" unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-185" decimals="INF" id="f-816" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-186" decimals="INF" id="f-817" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-186" decimals="INF" id="f-818" unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-186"
      decimals="INF"
      id="f-819"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock contextRef="c-152" decimals="2" id="f-820" unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-183" decimals="INF" id="f-821" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-184" decimals="INF" id="f-822" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-152"
      decimals="INF"
      id="f-823"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <dxcm:DebtInstrumentCapCallTransactionCapPricePerShare
      contextRef="c-187"
      decimals="INF"
      id="f-824"
      unitRef="usdPerShare">212.62</dxcm:DebtInstrumentCapCallTransactionCapPricePerShare>
    <dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage
      contextRef="c-187"
      decimals="INF"
      id="f-825"
      unitRef="number">0.80</dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage>
    <us-gaap:SharePrice
      contextRef="c-188"
      decimals="INF"
      id="f-826"
      unitRef="usdPerShare">118.12</us-gaap:SharePrice>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-182" decimals="-5" id="f-827" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <us-gaap:DebtInstrumentTerm contextRef="c-189" id="f-828">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-190" decimals="INF" id="f-829" unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount contextRef="c-190" decimals="INF" id="f-830" unitRef="usd">500000000</dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="c-1" id="f-831">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-191" decimals="-5" id="f-832" unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-192" decimals="-5" id="f-833" unitRef="usd">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-191" decimals="-5" id="f-834" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-192" decimals="-5" id="f-835" unitRef="usd">7300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-3" decimals="-5" id="f-836" unitRef="usd">192700000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-193"
      decimals="INF"
      id="f-837"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-194"
      decimals="INF"
      id="f-838"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-195"
      decimals="INF"
      id="f-839"
      unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-196"
      decimals="INF"
      id="f-840"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-197"
      decimals="INF"
      id="f-841"
      unitRef="number">0.02000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-198" decimals="6" id="f-842" unitRef="number">0.000326</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-199" decimals="5" id="f-843" unitRef="number">0.00100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-200" decimals="5" id="f-844" unitRef="number">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c-201" decimals="5" id="f-845" unitRef="number">0.00250</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DepositAssets contextRef="c-3" decimals="-5" id="f-846" unitRef="usd">5300000</us-gaap:DepositAssets>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-851">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;6. Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"&gt;Litigation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:23.15pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between June 2021 through the nine months ended September 30, 2023, we and certain Abbott Diabetes Care, Inc. (&#x201c;Abbott&#x201d;) entities have served complaints against each other in multiple jurisdictions, including in the United States (United States District Court ("U.S.D.C.&#x201d;), District of Delaware), the United Kingdom (Business and Property Courts of England and Wales), France (United Patent Court (&#x201c;UPC&#x201d;) in Paris), Spain (Commercial Courts of Barcelona) and Germany (National Courts (&#x201c;N.C.&#x201d;) of Munich, Mannheim, Dusseldorf and Hamburg and the UPC in Munich), primarily involving claims of patent infringement, invalidity and other patent related actions. In June and July of 2021, we initiated patent infringement litigation against Abbott in the United States (U.S.D.C., Western District of Texas) and Germany (N.C. in Mannheim) and filed additional patent infringement actions in May 2023 in Germany (N.C. in Munich) over certain of Abbott's continuous glucose monitoring products. In July and August 2023, we initiated patent infringement litigation in France and Germany in the UPC and in Spain (Commercial Courts of Barcelona).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between July 2021 through the nine months ended September 30, 2023, Abbott initiated patent infringement litigation against Dexcom in multiple jurisdictions, including the United States (U.S.D.C., Delaware), the United Kingdom (Business and Property Courts of England and Wales), and in Germany (N.C. in Mannheim, Dusseldorf and Hamburg) over certain of Dexcom's continuous glucose monitoring products. In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in that jurisdiction. Three trials on liability have already been conducted in the United Kingdom. On October 18, judgment was handed down in favor of Dexcom in one of these trials. The parties are awaiting rulings on the remaining two. Dexcom and Abbott seek injunctive relief and monetary damages as a result of their respective claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, Abbott filed a breach of contract lawsuit against Dexcom in the U.S.D.C., District of Delaware alleging that Dexcom breached the parties' Settlement and License Agreement dated July 2, 2014 (&#x201c;SLA&#x201d;). The U.S.D.C., District of Delaware consolidated Abbott&#x2019;s breach of contract lawsuit with Dexcom&#x2019;s patent infringement lawsuit which had been transferred from the U.S.D.C., Western District of Texas. Dexcom asserted counterclaims that Abbott also breached the SLA. A jury trial on Abbott&#x2019;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury verdict determined that Abbott was not licensed to thirteen claims of certain Dexcom patents and that Abbott was licensed to five claims. Dexcom&#x2019;s patent infringement claims in Delaware are stayed until November 10, 2023, at which point the U.S. Patent and Trademark Office will have issued &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;its final written decisions on certain patents involved in the lawsuit. We will continue to enforce the remaining claims of the patents asserted in Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Abbott&#x2019;s patent infringement action against Dexcom is currently scheduled for trial in the U.S.D.C., District of Delaware on March 11, 2024. In the lead up to trial, the U.S.D.C., District of Delaware invalidated one of Abbott&#x2019;s patents and Abbott dropped four other patents from the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing in December 2023, Abbott has several patent infringement hearings against Dexcom in the National Court in Hamburg and Munich wherein Abbott is seeking damages and injunctive relief.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March and April of 2024, Dexcom has several patent infringement hearings in Munich against Abbott, wherein Dexcom is seeking damages and injunctive relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to uncertainty surrounding patent litigation procedures initiated by Dexcom and Abbott throughout multiple jurisdictions, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to protect our intellectual property and defend against Abbott&#x2019;s claims vigorously in all of these actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber contextRef="c-203" decimals="0" id="f-852" unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <dxcm:LossContingencyPendingClaimsRemainingNumber contextRef="c-204" decimals="0" id="f-853" unitRef="claim">2</dxcm:LossContingencyPendingClaimsRemainingNumber>
    <dxcm:LossContingencyPendingClaimsCounterpartyNotLicensedToNumber contextRef="c-205" decimals="0" id="f-854" unitRef="claim">13</dxcm:LossContingencyPendingClaimsCounterpartyNotLicensedToNumber>
    <us-gaap:LossContingencyPendingClaimsNumber contextRef="c-205" decimals="0" id="f-855" unitRef="claim">5</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPatentsFoundNotInfringedNumber contextRef="c-206" decimals="0" id="f-856" unitRef="patent">1</us-gaap:LossContingencyPatentsFoundNotInfringedNumber>
    <dxcm:LossContingencyAdditionalPatentsFoundNotInfringedNumber contextRef="c-206" decimals="0" id="f-857" unitRef="patent">4</dxcm:LossContingencyAdditionalPatentsFoundNotInfringedNumber>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-858">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;7. Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate our annual effective tax rate to be 24.7% for the full year 2023, which differs from the U.S. federal statutory rate due to state and foreign income taxes, nondeductible executive compensation, increases to unrecognized tax benefits, and impact of foreign operations, partially offset by federal tax credits generated. Our actual effective tax rate of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.6% for the nine months ended September&#160;30, 2023 was primarily due to income tax expense from normal, recurring operations, increased by discrete foreign taxes related to an intra-entity transfer of certain intellectual property, and decrease in the state tax rate applied to beginning of year deferred tax assets, partially offset by tax benefits recognized for share-based compensation for employees, net of disallowed executive compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2023, we completed an intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries to align our structure with the expansion of international business operations. We recorded a $186.6&#160;million deferred tax asset, which represents the difference between the basis of the intellectual property for financial statement and tax purposes, applying the appropriate enacted statutory tax rate. Based on available evidence, management believes it is not more-likely-than-not that the additional foreign deferred tax asset will be realizable, and is therefore, fully offset by a valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transfer resulted in $65.2&#160;million of net tax expense, which increased our actual effective tax rate for the nine months ended September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent contextRef="c-1" decimals="3" id="f-859" unitRef="number">0.247</dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-860" unitRef="number">0.386</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-207" decimals="-5" id="f-861" unitRef="usd">186600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-5" id="f-862" unitRef="usd">65200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-863">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;8. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2023, unrecognized estimated compensation costs related to RSUs, PSUs and ESPP totaled $238.4 million and are expected to be recognized through 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Award Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vest date fair value of RSUs and PSUs that vested during the nine months ended September&#160;30, 2023 was $138.5 million and $9.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program and Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 26, 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#x201c;2022 Share Repurchase Program&#x201d;). Shares of common stock repurchased under the 2022 Share Repurchase Program became treasury shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We repurchased approximately $557.7 million of our outstanding common stock throughout the duration of the 2022 Share Repurchase Program. The 2022 Share Repurchase Program and the remaining authorization of approximately $142.3&#160;million expired on June 30, 2023. There were no share repurchases under the 2022 Share Repurchase Program in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, we used a portion of the proceeds of the 2028 Notes to repurchase 1.6 million shares of our common stock for $188.7 million, excluding excise tax due under the Inflation Reduction Act of 2022, for an average per share price of $118.12, via privately negotiated transactions, independent of the 2022 Share Repurchase Program.&lt;/span&gt;&lt;/div&gt;Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. We have not yet determined the ultimate disposition of repurchased shares and consequently we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-864">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-208" decimals="-5" id="f-865" unitRef="usd">3900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-209" decimals="-5" id="f-866" unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-210" decimals="-5" id="f-867" unitRef="usd">11100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-211" decimals="-5" id="f-868" unitRef="usd">8100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-212" decimals="-5" id="f-869" unitRef="usd">11400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-213" decimals="-5" id="f-870" unitRef="usd">10800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-214" decimals="-5" id="f-871" unitRef="usd">34300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-215" decimals="-5" id="f-872" unitRef="usd">32000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-216" decimals="-5" id="f-873" unitRef="usd">23700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-217" decimals="-5" id="f-874" unitRef="usd">17000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-218" decimals="-5" id="f-875" unitRef="usd">68500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-219" decimals="-5" id="f-876" unitRef="usd">52400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-877" unitRef="usd">39000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-5" id="f-878" unitRef="usd">30800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-879" unitRef="usd">113900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-5" id="f-880" unitRef="usd">92500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-3" decimals="-5" id="f-881" unitRef="usd">238400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-220" decimals="-5" id="f-882" unitRef="usd">138500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-221" decimals="-5" id="f-883" unitRef="usd">9900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-222" decimals="INF" id="f-884" unitRef="usd">700000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-223" decimals="-5" id="f-885" unitRef="usd">557700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-224" decimals="-5" id="f-886" unitRef="usd">142300000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-225" decimals="0" id="f-887" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-226"
      decimals="-5"
      id="f-888"
      unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-226" decimals="-5" id="f-889" unitRef="usd">188700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-226"
      decimals="2"
      id="f-890"
      unitRef="usdPerShare">118.12</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-891">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;9. Business Segment and Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. None of the components of our business meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue by geographic region and by major sales channel. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by geographic region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2023 and September&#160;30, 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,856.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by customer sales channel&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-892"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-893">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,856.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-5" id="f-894" unitRef="usd">713600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-227" decimals="2" id="f-895" unitRef="number">0.73</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-228" decimals="-5" id="f-896" unitRef="usd">573400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-228" decimals="2" id="f-897" unitRef="number">0.75</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-229" decimals="-5" id="f-898" unitRef="usd">261400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-229" decimals="2" id="f-899" unitRef="number">0.27</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-230" decimals="-5" id="f-900" unitRef="usd">196200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-230" decimals="2" id="f-901" unitRef="number">0.25</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-902" unitRef="usd">975000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-5" decimals="2" id="f-903" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-904" unitRef="usd">769600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-6" decimals="2" id="f-905" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-231" decimals="-5" id="f-906" unitRef="usd">1856200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-231" decimals="2" id="f-907" unitRef="number">0.72</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-232" decimals="-5" id="f-908" unitRef="usd">1535600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-232" decimals="2" id="f-909" unitRef="number">0.73</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-233" decimals="-5" id="f-910" unitRef="usd">731600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-233" decimals="2" id="f-911" unitRef="number">0.28</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-234" decimals="-5" id="f-912" unitRef="usd">559000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-234" decimals="2" id="f-913" unitRef="number">0.27</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-914" unitRef="usd">2587800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-915" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-916" unitRef="usd">2094600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-917" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-918">The following table sets forth revenue by major sales channel for the periods shown:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-235" decimals="-5" id="f-919" unitRef="usd">839700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-235" decimals="2" id="f-920" unitRef="number">0.86</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-236" decimals="-5" id="f-921" unitRef="usd">656200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-236" decimals="2" id="f-922" unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-237" decimals="-5" id="f-923" unitRef="usd">135300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-237" decimals="2" id="f-924" unitRef="number">0.14</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-238" decimals="-5" id="f-925" unitRef="usd">113400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-238" decimals="2" id="f-926" unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-927" unitRef="usd">975000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-5" decimals="2" id="f-928" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-929" unitRef="usd">769600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-6" decimals="2" id="f-930" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-239" decimals="-5" id="f-931" unitRef="usd">2197400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-239" decimals="2" id="f-932" unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-240" decimals="-5" id="f-933" unitRef="usd">1768400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-240" decimals="2" id="f-934" unitRef="number">0.84</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-241" decimals="-5" id="f-935" unitRef="usd">390400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-241" decimals="2" id="f-936" unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-242" decimals="-5" id="f-937" unitRef="usd">326200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-242" decimals="2" id="f-938" unitRef="number">0.16</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-939" unitRef="usd">2587800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-940" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-941" unitRef="usd">2094600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-942" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-943">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"&gt;10. Subsequent Events&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 24, 2023, our Board of Directors authorized and approved a share repurchase program of up to $500.0&#160;million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#x201c;2023 Share Repurchase Program&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repurchases of our common stock under the 2023 Share Repurchase Program may be made from time to time, on the open market, in privately negotiated transactions or by other methods, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, and other applicable federal and state laws and regulations. The timing of any repurchases will depend on market conditions and will be made at our discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Share Repurchase Program does not obligate us to repurchase any dollar amount or number of shares, and the program may be extended, modified, suspended, or discontinued at any time.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-243" decimals="-5" id="f-944" unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-1" id="f-945">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trading Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2023, none of our directors or officers informed us of the adoption or termination of a &#x201c;Rule 10b5-1 trading arrangement&#x201d; or &#x201c;non-Rule 10b5-1 trading arrangement,&#x201d; as those terms are defined in Regulation S-K, Item 408, except as described in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Character of Trading Arrangement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Title&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Action&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Action Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rule 10b5-1*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Rule 10b5-1**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Shares to be Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Michael Brown&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executive Vice President, Chief Legal Officer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/29/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,612&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/15/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Michael Brown&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executive Vice President, Chief Legal Officer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/29/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Up to 14,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/30/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nicholas Augustinos&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Director&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;X&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Up to 7,648&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/15/2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;* Intended to satisfy the affirmative defense of Rule 10b5-1(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on 12/15/2022 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), as then in effect, under the Exchange Act.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The number of shares of common stock sold under the Rule 10b5-1 trading arrangement will be net of shares withheld for applicable tax obligations upon the vesting of covered securities and is not yet determinable.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-946">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-947">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:TrdArrIndName contextRef="c-244" id="f-948">Michael Brown</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-244" id="f-949">Executive Vice President, Chief Legal Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-244" id="f-950">true</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-244" id="f-951">8/29/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-245"
      decimals="INF"
      id="f-952"
      unitRef="shares">3612</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrTerminationDate contextRef="c-244" id="f-953">12/15/2023</ecd:TrdArrTerminationDate>
    <ecd:TrdArrIndName contextRef="c-246" id="f-954">Michael Brown</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-246" id="f-955">Executive Vice President, Chief Legal Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-246" id="f-956">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-246" id="f-957">8/29/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-247"
      decimals="INF"
      id="f-958"
      unitRef="shares">14463</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrIndName contextRef="c-248" id="f-959">Nicholas Augustinos</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-248" id="f-960">Director</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-248" id="f-961">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-248" id="f-962">9/15/2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-249"
      decimals="INF"
      id="f-963"
      unitRef="shares">7648</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -&)6E<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #1B5I7%TV!Z.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*$Y&!R;-I:.G#@8K;.QF;+4UBV-C:R1]^SE>FS*V!]C1TN]/
MGT"M\D*Y@,_!>0QD,-Y-MA^B4'[-3D1> $1U0BMCF1)#:AY<L)+2,QS!2_4A
MCPAU5:W (DDM2<(,+/Q"9%VKE5 !);EPP6NUX/UGZ#-,*\ >+0X4@9<<6#=/
M].>I;^$&F&&$P<;O NJ%F*M_8G,'V"4Y1;.DQG$LQR;GT@X<WIYV+WG=P@R1
MY* P_8I&T-GCFETGOS:;Q_V6=755-P6OBGJUK[G@]X(_O,^N/_QNPM9I<S#_
MV/@JV+7PZRZZ+U!+ P04    " #1B5I7F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M -&)6E>.NE"6R04  +H>   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9EK<^(V&(7_BH9V.NU,B"T9$K(ES!"3;#/=)&Q(M[OM](.P!7C6MEA)#LF_
M[RL;["25A<NLOP"^G(,>ZW9D#3=<?)4KQA1Z2N)4GG=62JW?.8X,5BRA\IBO
M60I7%EPD5,&A6#IR+1@-<U$2.\1U3YR$1FEG-,S/3<5HR#,51RF;"B2S)*'B
M^8+%?'/>P9W=B?MHN5+ZA#,:KNF2S9CZ8ST5<.24+F&4L%1&/$6"+<X[8_S.
M]X@6Y'=\BMA&OOB--,J<\Z_ZX#H\[[BZ1"QF@=(6%+X>F<_B6#M!.;YM33OE
M?VKAR]\[]ZL<'F#F5#*?QW]&H5J==P8=%+(%S6)USS>_L2U07_L%/);Y)]H4
M]_9Z'11D4O%D*X82)%%:?-.G[8-X*< U K(5D#<"7/</WE;@Y:!%R7*L"55T
M-!1\@X2^&]STC_S9Y&J@B5)=C3,EX&H$.C7R^2,3J(ODB@HFAXX"3WW%";;Z
MBT)/:O1GZ(:G:B7191JR\+7>@;*4!2*[ ET0J^&,K8^1YQXAXA+/4![?+K\+
MU#'"9R;YJ^)XY?/Q<C_/^GS^'L^E$M#D_C$]H<*A9W;0_?"=7-. G7>@HTDF
M'EEG]-,/^,3]U83WG<Q>P?9*V)[-?33A009=5*&'YS4SD=KEV.U^-"%950<B
M]4ND?C.DCQD5BHGX&=VS-1?*A&>W4B(S/13?JCH0[Z3$.VF&-V4BXJ'NA0C&
M 6/EV9W*?E?;\:SZ SE/2\[3ABU34)A"\AF@OA[M7@L:2V-%6F4' @Y*P(&U
M4)>IBM0SNHIBAFZS9,Z$"<SNX;INMX\)(28XJ_1 N+,2[JP)W#U;1GH8A6J\
MI8FQC=I])I>?_;N;(W1]ZQ^;&*WJ QFQ6\VD;A/*ZS3@ EHFU8WT",T4=$?$
M!?)YEBKQ#-^A$7V/^^321&P7'8K\(CS@)L@/] E=A] ]HT44Y-R6-KS'TO.Z
M[J!_VN_UC+Q6\:&\I.(E37C'80CN\FCW WV ^]!=:JY7N^6)UW/1C'W+6!HP
M-!$0:HW@5I=#P:L4A*VYXS_@OCZ"1OW -ZD1VFXWHRF:1&S)C:AM1"!<92!L
M3S%O4<L./!7\,8)*,O+:/?VQ$;2-8(2K9(3M>>8MZ)1+16/T5[2N'Z/LCF<$
M$VPD;2,CX2HD87NVR5OK&%:Y]6!V@T%_8,1J(Q+A*A-A>Y#YP .HK^F*I[;,
ML,<$UOM=%SZ,?&TD(EQ%(FS/,P^1@C3$%PB3G^>_P" 99 )JT@AI=_)YDL"D
M-%,\^'J$?G2/71>C*17H$XTSIL,SFND%L/$AM)&<<!6=L#WS0. -HW2)9L_)
MG,=&]CVAZ;-_8^1J(RV1*BT1>Y[9U2:Z? I6-%VRVDRXQ^AV/)N,C>M.N_!0
MPBH<D4;AR,^$T"N78KF25R7,*)GQ7<L>QR_&-S2^774H9Q6*2*-0=)W"\KIX
M*Z>7H'0';N2T.]9QMI&!2)6!2*,,I)=HD.8A%"RY, Y&>WP^4 &M?1P$#(S
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M:"Q*G3$.,TE4F>=4/EU#)M83QW>>-V[9,M5FPXW&!5W"'/1=,9.X<AN7A.7
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MLP1@F,@6I;>5!N?V<98_T#XQZ8B34>)=O4TK^082)N826D;C6P P[/@Z; G
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M@/Q^PY@XW:@!VA]/YO\!4$L#!!0    ( -&)6E?M&GM7M@,  (<-   8
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M>,_T%W'\C53Y] S?2C!5_$?'"NL[:+576N15,*P@I[S\Q2^5#HT X+$'A%5
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MOR_D*G;WY4KB/Q7EYY;C[G]02P,$%     @ T8E:5ZQU&S?*"   T2@  !@
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6RM6MMRVS@2_166=FHKJ8HN!$!=
MO+:J'&=2FX?,N.S)[#-,0A8V%*$!(%_FZ[<!,@0I@+"\<1YB71JMTT!WGP.
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M^:J#IU _BB1<:6:2L GU9]C/Q[ENO'/T)M2>,%8JV4?9B0)%8)&(*\=X["5
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M$4;=A3T4J$K2K_[^@4S.FPSR27AM W1I66*[-0J6B\JB@F6>:]I!<>[W^+%
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M.UJ ]TMK0_N%%'0_AE[\%U!+ P04    " #1B5I7Q9%JKMX*  "?'P  &0
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M9<\4_+1;VFAH12F#RI$F(2CG1^)W9'^>:W)ZN,?3C<+0K9@[=H4#%]9A+<R
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MMIUTG<5:F<*BN-Z3FP[>F'X)TX9:/11&]VERN'-YH Y@3@VBFP!^T U17I/
MP)_$P>?)AZ4:YP#Q=,JHG["$<>!0>5&OF#AD</@<<ZG5Y*Q/XKTW0M_7X1PU
M>L6^X^35[TY]E\1=/T&':,Z8=!;IRVW7G2S!6*^0) ?:P:62CHO%?M'=;>?I
M;;\OCSTBN*F<ZHYFVG-%(;?:JL%MQ;T"PPA'T!D$=/1EZK)/VCK^;/_;EO5>
MSSULW>L(\TSWKB.Y\3KF!BJ_!]6@B-R;)7=Z'1Z:&>A7C7*XV[$\++FIVZ0#
M^*$F<!.UH39R7K(?4$YOZ6DKH-\X_828<#2?'V -RS#9J'E+>=?SKSW_DP/
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M<6[IO@5R-UKD]G.:L=!:I/9RQFC,I!F OYM_D%S=F G*+[*&_P-02P,$%
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M@"?3CR;P\=K2D%*-*4P(R >LEE8+;;UJ1WXU$:^9&]/D%<JI^K7%*?.18B@
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MT&$U):S8MRYB-]RE-9F05*E<L?5@0HC#\4H0)]O>#2(P*G.$$@"AX<5=8$[
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M:#J _84"])8@!=WC>_8W4$L#!!0    ( -&)6E=>6=OEK <  % 6   9
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M#%[AFHFZ$#GNBA.8WL #"]!V0P@VOJH1-F4);^E#=E'!/O$7+]B_E-2ZNWZ
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M\RE4_4>)=+OXDT *0U>V@OD/?!AL?1B\TH==CS?N N?PB/W*]W9'/]#\=:U
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MCB=.T@^=?CBD!6XBW:EW)V/ZZ[M[$@)L&6@G[1?T<OOR[.ZS>R=.YTK_,#,
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MNUOL=>OXNLY>=UM\'X2)4V4*#>SW\[&Q&KGP1U.PI:U>LRWJCQ.3\QC.6M@
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MU,CV,.R!D:YM(A2ID;2=#/OQ)2E%D3*%C@<!S4-,2O>>>\\A+T5RMN?B7FX
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MW #.0!@#_7[%N7KJF #U1=#B&U!+ P04    " #1B5I7[8*;8Y,%   W'0
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MA128$L:K04DTEC*)C=6M?*IIPQF_(UV)F#7='<\[PO4QX3CHR-;'S,>^V_Q
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M:X#Z?L-46*H;/4%]5KK\%U!+ P04    " #1B5I7^L *I0@#  #["0  &0
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MYPS]U56K44VL*OQ;>J<LOLQ^N,3N#+13P/6Y4G8S<0::?B_]"5!+ P04
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M2RYR _7Y79K*QXO\V;?]LXZS_P%02P,$%     @ T8E:5Q1;U[(C!   QQ8
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MW3&1!<#U>\[5TTGV/:OZ?KG\'U!+ P04    " #1B5I78@U,EV@"  !N!0
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MQB?0^5QK][SQ,[>Y8HO?4$L#!!0    ( -&)6E=:6  AP@(  "T'   9
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MK\PR-RQRU4+RM("!'XRD_D_M GK"?#@93>HPC9I?4_,'J=UA+CLXBO(DCY'
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M80!Z?\6Y>IL8!VWSF_T+4$L#!!0    ( -&)6E?:"VA2_@,  "X;   9
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MK&:X4%\5P/4"]7[&F%Q/=-]:?J<$_P!02P,$%     @ T8E:5P?B?'%6 P
M 0\  !D   !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULK9=;;YLP%(#_BL6D
M:9.V<LNU2R(U8=,ZM5W5:MO#M <'3A*KQF:V23II/WZVH32T!#43+PD8G\\^
M'P9\)CLN[N0&0*'[E#(Y=39*9:>N*^,-I%B>\ R8OK+B(L5*GXJU*S,!.+%!
M*74#SQNX*2;,F4ULV[6837BN*&%P+9#,TQ2+/W.@?#=U?.>AX8:L-\HTN+-)
MAM=P"^I;=BWTF5M1$I("DX0S)& U=<[\T\BW ;;'=P([N7>,3"I+SN_,R7DR
M=3PS(Z 0*X/ ^F\+"Z#4D/0\?I=0IQK3!.X?/] _V>1U,DLL8<'I#Y*HS=09
M.2B!%<ZINN&[SU FU#>\F%-I?]&NZ-L?.RC.I>)I&:QGD!)6_./[4L1>0# \
M$!"4 <'3 .] 0%@&A"\-Z)4!/6NF2,5ZB+#"LXG@.R1,;TTS!U:FC=;I$V;N
M^ZT2^BK1<6JVX$P1M@86$Y#H/;K"0F!S*]";"!0F5+Z=N$H/9+J[<0F=%]#@
M '2,+C5V(]%'ED!2CW?U!*M9!@^SG >MP%O(3E#HO4.!%X0HIIBD*,,*F&J8
MW**=]356)\@?[;,:(%$[Y$M.-:1W&%)+,ZQN1FBIO4-IYDL)OW.=%H)M<W+S
M5H)Y2YS*#,<P=?1K0(+8@C-[_<H?>!^:3'4)BSJ"U<SU*G,]2P\/F+O@4J+Z
M6OYYH?N@<P6I_-4DLM>ER"YA44>PFLA^);+?N@2O\G0) O$5TE^61-LL%K?4
M[WCS%=$-32Y;F<>Z+&!]"S.?K>TLF+C;?4$=#5<3-*@$#5H%G2V77#4^F:UQ
MQTKH$A9U!*OY&E:^AET_F<,N178)BSJ"U42.*I&C_WLRN4!*$$QED\O1LX<I
MK#],B]91CQ7T?+A^-5PMZW&5]?B%69?9,JX0);'>>4*"%&_*N95X[/KI$A:-
MG^GQPV8_OO>X@?->:(BP+:8DT?NBI-P=2?3W\#YI7H)KTWFR.-K'/C;]KFAU
M4WM;7?^%IG"2$%-V8%KJT>Y6PKRA4FLM$3S+M,56>_XS>[VG]EKG<[2]CFB%
M/7>O9DA!K&WM)5',<Z:*\J%JK>J[,UO5N(_=B^+P$HLU81)16.E0[V2HG8BB
MWBI.%,]L!6*^G#RUAQM=HX(P'?3U%>?JX<0,4%6]LW]02P,$%     @ T8E:
M5_]3<Z'' @  0P@  !D   !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULK99=
M;]HP%(;_RE%63:W4D9! :#N(1&'3>E&M*NMV,>W")"?$JV-GM@/=OY^=0 I=
MFJG5;HB_WM?G.?YBO!'R7F6(&AYRQM7$R;0N+EQ7Q1GF1/5$@=STI$+F1)NJ
M7+FJD$B22I0SU_>\T,T)Y4XTKMIN9#06I6:4XXT$5>8YD;\OD8G-Q.D[NX9;
MNLJT;7"C<4%6N$!]5]Q(4W,;EX3FR!45'"2F$V?:OYB-[/AJP%>*&[57!DNR
M%.+>5JZ2B>/9@)!AK*T#,9\USI Q:V3"^+7U=)HIK7"_O'/_6+$;EB51.!/L
M&TUT-G'.'$@P)273MV+S";<\0^L7"Z:J7]C48P?G#L2ETB+?BDT$.>7UESQL
M\[ G,#[M G\K\)\*!L\(@JT@J$#KR"JL.=$D&DNQ 6E'&S=;J')3J0T-Y785
M%UJ:7FIT.KKBL<@1OI '5' \1TTH4R?P#NX6<S@^.H$CH!RN*6,FZ6KL:C.G
M5;KQUO^R]O>?\3^':\%UIN #3S YU+LFUB9@?Q?PI=]IN,"B!X%W"K[G!RWQ
MS+KETW)EY/TV^4$X09._H/(+_ID_F%,5,Z%*B?!]NE1:FBWZHRUCM>.@W=$>
MVPM5D!@GCCF7"N4:G>CMFW[HO6_#_4]F!_"#!G[0Y1Y]4)J:DX0)$,Y+P@#3
M%*MS"=HD1)HN."8*"I0Q<GW2EHQZAGZ]/^V=LXZ\GC\8C=WU/F9G(*_$'#:8
MPV[,EU,-VZB"L_ )5>>\KZ0*&ZJPDVJ.*4IIULY"$:50MX%T>KQTK]9FX5Y2
M^F=A[S$I!QRCAF/4R?%99RB!)#_-96F>%ZU.6[9A&]KHKVC"8<]_LD*=<[]T
MA=R]>SI'N:J>+P6Q*+FNK^RFM7DAI]7#X#X.KY_7:R)7E"M@F!JIUQN9K23K
M)ZNN:%%4M_Y2:/.&5,7,O/(H[0#3GPJA=Q4[0?._(?H#4$L#!!0    ( -&)
M6E? MDE>" 0  "85   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;,68
M;6_;-A#'OPJA%5L+I'KT8V8;B"T5*]  0;QN+X:]8*RS)40259*VDWWZDI2L
M2+(B)"N+O(DIZNY'WOW/%Y.S(Z'W+ +@Z"%-,C8W(L[S2\MBFPA2S$R20R;>
M; E-,1>/=&>QG (.E5.:6*YMCZP4QYFQF*FY&[J8D3U/X@QN*&+[-,7T<0D)
M.<X-QSA-W,:[B,L):S'+\0[6P+_F-U0\614EC%/(6$PR1&$[-ZZ<R\#QI(.R
M^"N&(ZN-D0SECI![^? YG!NVW!$DL.$2@<7' 5:0))(D]O&MA!K5FM*Q/C[1
M/ZG@13!WF,&*)'_'(8_FQL1 (6SQ/N&WY/@'E $-)6]#$J;^HF-I:QMHLV><
MI*6SV$$:9\4G?B@347,0G&X'MW1PVPZ#9QR\TL%[Z0J#TF'PTA6&I8,*W2IB
M5XGS,<>+&25'1*6UH,F!RK[R%OF*,UDH:T[%VUCX\<6:D\U]1)(0*/L-!=_V
M,7]$']$ZPA0^+H4"(5J15)0EPTK8X$&. ;WW@>,X81^$\=>UC]Z_^X#>H3A#
MUW&2"$,VL[C8GES$VI1;619;<9_9BH>N2<8CAH(LA+##W^_WG_;X6R(M56[<
M4VZ6;B]P#;F)//L"N;;K=>QG]7)WMRN<'UL]^-^K-Y+A587B*9[W'$]5Q)VJ
MB!O\*'H%1U>4XFP'<GQQJHP0X4S4#,YCCI/X/P@OT%5*]L+ZGR\"B3YS2-F_
M7=51K#_H7E\VS$N6XPW,#=$1&= #&(M??W%&]N]=TNB$^3IA@2980\1!)>*@
MC[[XDPA1$*M)N:E_N:&0L$N<@CM57/G/Y[#PIC/K4$]Y83*JF]CFI&GDGQLY
MCF>V4,&YU=0UAY51(_9A%?NP-_8581R1+6(X@<[NU.O^VOK3"?-UP@)-L(8&
MHTJ#T1LWD9%.$77"?)VP0!.L(>*X$G'\DYI(P1W7.T3[J[\J;(9UFU8+.:<X
MCNFT.LBYT:1FTXA[4L4]Z8W[5F02TTVD:C.$@_B1G<NJ[8JTE_3:,M0)\W7"
M DVPAAS32H[I&_>2J4X1=<)\G;! $ZPAHF,_G3_LG]1-2G"K$0Q:_:3+ZOQG
M28>5-S!;G2<HK1K-R>UN*D[M .;T)F M#LEQMKM .\B BES(<L6A..O%C%,L
MS]&=T?=27UN=6FF^5EJ@B];4QWW2QWWC/E-N0)>4.FF^5EJ@B]:4\ND(Z_0>
MKGZDUWAG)Q+7,\?M7N.=G9*<<;O3G)-&D]K9IDS4N=70K?6V(@%6[=XG!;I3
M%VY,!"6JKCC95[/5I=Z5NLIJS2^=RY73,>_+2T!US_2$+VX0KS'=Q1E#"6S%
M4K8Y%DV1%I=RQ0,GN;IUNB.<DU0-(\ A4&D@WF\)X:<'N4!U-;KX#E!+ P04
M    " #1B5I7B_&F%B@%  !/(P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6S%FFUOJS84Q[^*Q:ZV5NH-#WGNDDAM -T[K5/4K-N+:2]<<!)4P+FV
M26[NIY\-E$!+W&8Z4OLB <?G9_O\;7,X]61/V1/?$"+0]R1.^=38"+&]-DT>
M;$B">8=N22I_65&68"%OV=KD6T9PF!LEL>E8UL!,<)0:LTE>MF"S"<U$'*5D
MP1#/D@2SPRV)Z7YJV,9SP7VTW@A58,XF6[PF2R(>M@LF[\R*$D8)27E$4\3(
M:FK<V->^/5(&>8V_(K+GM6NDAO)(Z9.Z^1I.#4OUB,0D$ J!Y=>.S$D<*Y+L
MQ[<2:E1M*L/Z]3/=SP<O!_.(.9G3^.\H%)NI,3)02%8XB\4]W7\AY8#ZBA?0
MF.>?:%_6M0P49%S0I#26/4BBM/C&WTM'U SLW@D#IS1P7AKT3QAT2X/N>PUZ
MI4'OO5WJEP;]]QH,2H-![OO"6;FG72SP;,+H'C%56]+412Y7;BT='*5J9BT%
MD[]&TD[,EH(&3QL:AX3Q7Y#W+8O$ 7U&?V#&L-(<7;A$X"CFE[+T8>FBBT^7
MZ!,R$=]@1CB*4O201H)?U0KNHCB6LX9/3"%[J-HQ@[(W\Z(WSHG>V.B.IF+#
MD9>&)&RQ=_7V8XV]*3U3N<=Y=L^MHP7^EL4=Y RND&,Y3MMX].9W^("Z=F[=
M;1N-WGI)MAW4M4Z:>^\W;^N[_];0TU.M-US9K69:-^=U3W5'S8_/:A<(T9PF
M<FOD.-]<;N142]=$;E<"/1Y0O=X"'_+BFSUF(?KG=XE$7P5)^+\MX[DMVN^U
MMZ^VZ&N^Q0&9&G(/YH3MB#'[^2=[8/W:)BPDS(6$>9 P'PC6F!&]:D;T=/39
M0\I(0-=I]$-*3;B(Y(-"7@7UR1%0+MHVDELM^ERQ(6%N 1OG,/5@W\V<[JAG
MJ;^)N:LK"=FL#P1K*-FOE.QKE5QD+-C(%<L172$A(QR>L0/BZMG2IIT6=JYV
M_5?NMD>C88N[W:)F_^V:WFMFOS]LJ^D##:7A]4'E]8'6Z\OBB<O(MG1_B"[D
MX[=X$%^V.5[+.]?Q!6Q8=V=G\,+ED UZD# ?"-80;E@)-]0*=[,C3(;M:,NB
M0'X25FB6JZ=BK*JD540M^UP1"YAMU56T1QW;>2$D9*,>),P'@C6$'%5"CMY>
M@>B^6H!HP>B:X:1--BWI7-D@82XDS(.$^4"PAK;C2MOQ!\>K8\@9 0ES(6$>
M),P'@C5FA&T=7Y8M_7I7$4WM@2MW\'R]7R&<B0UE>22+$YJEHDWPDEZ/*XJ@
MXE5<,==WY%P]06D>*,V'HC4EK>4_;,C0M:2](S2<ZQL^6T+[5?3Z,FH%;="'
MHC5U<8ZZ./]SJ3&B,J91NM:M-"W\W+T5E.:"TCQ0FE_2&F]3/:?;G-Y-18_Y
M'UN;3)C=RU=\&?"J5_Q\>:%,)0X13D,5\.9)\E2&P[7?6I4%S?* TEQ0F@=*
M\Z%H3?&/J1Z[]\'1E V:$0*EN: T#Y3F0]&:$^.8.;+UJ:,_J< QVLF] 858
M$+3"$4,['&>D5630U!$HS;5;\DO=4;\MOP3:L ]%:RIXS$+9^C34XHS-&S0!
M!4IS06D>*,V'HC45/J:K[.%';]Z@22U0F@M*\T!I/A2M.3&.Z2];G_\Z<_,&
M38&!TMR25@]\Q^/6K1LTP05%*_0S:^< $L+6^8D-C@+UEE3\S[LJK4Z%W.1G
M(5Z4N_:U5YSM.&**HR9WF*VCE*.8K"32Z@SELX<5IS>*&T&W^6F#1RH$3?++
M#<$A8:J"_'U%J7B^40U49VAF_P%02P,$%     @ T8E:5YX80@TW @  P 0
M !D   !X;"]W;W)K<VAE971S+W-H965T-3,N>&UL?53;CM,P$/T5RT@()*C3
MM%N@))':72[[L*NJ%?" >'"226*M8P?;:9>_QY<T%*GM2^(9SSES9C*3Y"#5
MDVX #'INN= I;HSIEH3HHH&6ZHGL0-B;2JJ6&FNJFNA. 2T]J.4DCJ(%:2D3
M.$N\;Z.R1/:&,P$;A73?ME3]60.7AQ1/\=&Q975CG(-D24=KV('YUFV4M<C(
M4K(6A&92( 55BE?3Y7KNXGW =P8'?7)&KI)<RB=GW)<ICIP@X% 8QT#M:P^W
MP+DCLC)^#YQX3.F I^<C^V=?NZTEIQIN)?_!2M.D^#U&)52TYV8K#U]AJ.?&
M\162:_]$AQ"[6&!4]-K(=@!;!2T3X4V?ASZ< .+X B > +'7'1)YE7?4T"Q1
M\H"4B[9L[N!+]6@KC@GW479&V5MF<29;]]IZM$8[J&VO#:*B1%] UHIV#2O0
MO0@?WG7P+7JD2E'71O3J#@QE7+].B+$R'!DIAI3KD#*^D/(#>I#"-!I]$B64
M_^.)E3_6$!]K6,=7"7?03= L>H/B*)XA'0JYPCL;>S/SO+.+O*$E6^BD,DS4
MZ.<JUT;92?IUKNS -C_/YK9KJ3M:0(KM^FA0>\#9RQ?31?3QBM;YJ'5^C3U[
M[-L<%)*5W12GEN8<CJW0Y\0&NAM/YS9WGTT3LC]50$ZFJ@55^]W1J)"],&'
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M7W!"LS$8V/'],L2_# D&(2V'G<IA9]!AL>HXC5[VG%"99X/&URXME62^2K)
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M971S+W-H965T-34N>&ULM53?;],P$/Y73F9"FS0M:9H-*&DDUH*8Q,2T:O"
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M)X")7.(B^QJ5A%?OE_$PS46[;4+7!'0.DE'GD?"1.R&<324#5DHRQM<FW(/
M+.>Y=)3>KSII )'RMX$#TX.M7.MD3.2RRFTRF-]I??H>L.F!0<9Y8[#GFL!X
M6!"EJ!0WNE.=7 6?0$[=OE\7VN%<DG70NW);0G702::Y3*AL+Q_N)C0><IJ"
M'<GF"SBJO/  5"K/="-A9)X+4GG8,.J&EIU1SN_@.O<CW=%>I5NK5]6M:)K:
M4-TT,J8#^MMJ1GM;MO\B7:=@C[GZO-3#$54?-BJ]E31EJZJ_2AL#F'J JY.B
MX.M/G,U%1LW@CTXX'I(-SUGDDOW6V:!49CI I>L\4JG8;#OR2Y+BGJ[4IIQ6
M*>ZYUT'/_W:>YU102?BV:5W[;WF67^PX[+^6Y>JJLF_8ZK%^=GGK)J^Z8#+J
M@LE.U.2@"R;C#ICLO]I5\SDF@RZ8['7!9-@%DV_SCN/53[Y;C]<[#]=-U(&7
MF)'['5Z,>)O4F2X95TS4O05+$BJ>/&-K>46FG.[JZ_,3FI(E5_<-.'+;]C>:
ML&46-V?=PD349[7MKS"\(&K>H'0N)A*ZHLFD[LKYM&HZNJ&SUA\@[",WU<>.
M8!R#V1' L#R8 XQC6%B>_VD\ W0\!L.\#:S( .4,4(YAV9!)]<7RV#FQ_MA'
M&L=A&$78C$XF5@<3;-ZB"/[L:I@W8&!Y(-/SYAI?;;Q"#M<!MJ:'*@0;*5Z)
MV$CQN0;$/F_ B&/[:F-Y@(&M E8[D-^>!VK*S@E#6%7,&[:#<22.,01JT5ZC
M483,3@1?^_I@NR0,X]B. &9W$(88 KL11S 'X %#PK"Z#^[=C[S-?<IK_VT_
M_@-02P,$%     @ T8E:5Y>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2
MN6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>
M:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEF
MM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;
M&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ
M8K3^-8+)#^Q^ %!+ P04    " #1B5I7KX)%$W4$  # )   #P   'AL+W=O
M<FMB;V]K+GAM;,6:6U/;.!2 _XK&+\L^L(EOX3)-9X#0;F9V@=E07AG%5F(-
MMN1*<FCY]2O;A!X7.-.74S\EEFSE\U%\/EW\X5&;A[76#^Q;52H[#PKGZM/)
MQ&:%J+C]2]="^9J--A5W_M!L)[8V@N>V$,)5Y22:3F>3BDL5?/RP;^O&3."!
M=B)S4BM?V!;<2?%H?]2WAVPGK5S+4KKO\Z#[7HJ 55+)2CZ)?!Y, V8+_?BW
M-O))*\?+569T6<Z#L*^X$\;)[%7QJH6\Y6O;E3B^_H][D'DPF_H&-])8UYW1
MM<\]XT[XD_NCQNE/LG3"++@3GXUN:JFV;3/^+B;@-KHX[#_[()Z:7PFCWFQD
M)A8Z:RJA7!]'(\H64-E"UC9@BE=B'ESHG3#M_?@?6.;]O3D/!2)E3J6O,,N\
MPZ-$45:7,O>_GK-S7G*5"=:%T+*#+PI 1@AD-"+D?00@8P0R_HV0JQ:BO< R
MO6'7]:"[$P0R&0WR0E<U@$P1R'0TR)73&8"<(9"S\2+);0$@CQ#((UK(:[/E
M2CYU%8PK#RJW2OJ+N7+L#$;R&($\IH5<B)TH==V>U3%>NT(8=K8UH@LI@#Q!
M($]H(3]Q:=@=+QO!_A7<-J;O;IC$IU@6G]+B#9(B6PC'96E_1!-BHK(AMLU"
MK&%_AIA30GJI.#\ $"J38M"/F$-"8HDL5:8KP6[YMR$3IHR0V!EMSGTH=)D+
M8_]@EU\;/Z:#;)@I0F)5G#=6*F$M6XGM2P+Y+/36\+J0,,&%F"M"8EFLFK45
M7YL6\'+W<][ _! 2"^*&?V<[RVZ$Z2YO4\A"VJS4;8:#D)@?0F)!+)65_L_'
M;@W/_1/+SHSA_L%]E8 Q/83$?D!-.QBB1I@G(F)/X)@QQ,0\$1%[XAW;L@,_
MF2L'F3%"IR7$"D&M.^QT3"H1L51:Z^Y#]R>$PJP2C6"5-R$QO41CZF78P9A>
M(F*]X$]U C$QV41CSD;N4XB)Z28BU@V..8.8F'$B8N.@TZ;AH@AFG)C8..^E
M\D/6U4!,S#CQ2,8Y9%?<#S<@)F:<F-@X[V->6B<KB(DNA1$;!Q<C'&;$F(-B
M8@?AF#!OQIB%8FH+H9@P;\:8A6)B"^&8,&_&F(5B8@OAF$<0$[-03&PA'/,8
M8F(6BHDMA&.>P%5OS$+)B.MC]]W*W0LF9J&$V$(X9@@Q,0LE(\Y[[D,X]$@P
M"R6_8]YSZ,?N2FK#+K3:M7N*GH%=:3>812;HE@RQA9XQ>S[;#CI[P7=[,FH'
M,3$+)<06>L&L:JWV6QU+Y801UK%+B(E9*"&VT#-F-VIKMW_9P?/_$TXJ$TQ
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M<F]P<R]A<' N>&UL4$L! A0#%     @ T8E:5Q=-@>CN    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ T8E:
M5YE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " #1B5I7CKI0ELD%  "Z'@  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ T8E:
M5P8&! H,!P  *QX  !@              ("!# X  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( -&)6E=^(#(X&@,  -\*   8
M      " @4X5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" #1B5I77YBSL-$%  !(&0  &               @(&>&   >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ T8E:5^T:>U>V P  APT  !@
M             ("!I1X  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( -&)6E=YL&F'H0T  ,.+   8              " @9$B  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #1B5I7K'4;-\H(  #1
M*   &               @(%H,   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ T8E:5\)RPW[U#P  %2L  !@              ("!:#D
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -&)6E>,CWO+
M30H  !@=   8              " @9-)  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " #1B5I7Q9%JKMX*  "?'P  &0
M@($65   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -&)
M6E<&^R3!A @  +,5   9              " @2M?  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ T8E:5Q#:YJ;:%@  "F,  !D
M         ("!YF<  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " #1B5I7'?:@1-4(  !4&   &0              @('W?@  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( -&)6E?PU2H]O00  .0*
M   9              " @0.(  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ T8E:5[41R"Y@!0  H@P  !D              ("!]XP
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #1B5I7=]\8
M>@ &   =#P  &0              @(&.D@  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( -&)6E>W=68OS@,  %4(   9
M  " @<68  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
MT8E:5X-!<SAY @  MP<  !D              ("!RIP  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " #1B5I7Q,A'QG,'  "=)0  &0
M            @(%ZGP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( -&)6E?,_L&2MPT  -TP   9              " @22G  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ T8E:5PEJZLP\!
M;PH  !D              ("!$K4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " #1B5I7$%:YAF8%  "(#P  &0              @(&%
MN0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( -&)6E=>
M6=OEK <  % 6   9              " @2*_  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ T8E:5]_HOQWT!0  \1$  !D
M     ("!!<<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -&)6E?ZP JE" ,  /L)   9              "
M@6W>  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ T8E:
M5YM'4?KW!0  !S,  !D              ("!K.$  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " #1B5I7*-*Z@.8&  #W.   &0
M        @(':YP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( -&)6E<46]>R(P0  ,<6   9              " @??N  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ T8E:5_%^L/0L P  L@T
M !D              ("!4?,  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " #1B5I7QS*OVED$  #+%   &0              @(&T]@
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( -&)6E=B#4R7
M: (  &X%   9              " @43[  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ T8E:5UI8 "'" @  +0<  !D
M ("!X_T  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #1
MB5I75%.8#1,#  "T"   &0              @('<  $ >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( -&)6E>J&%?NE 0  /08   9
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M970T,BYX;6Q02P$"% ,4    " #1B5I7,V"J;U<#   ("P  &0
M    @(%G%0$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M -&)6E?:"VA2_@,  "X;   9              " @?48 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ T8E:5QN',4%3 P  NPX  !D
M             ("!*AT! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " #1B5I7QV#6S%4$  "&&   &0              @(&T( $ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( -&)6E?B;UM%>!L
M ,#) 0 9              " @4 E 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ T8E:5PP'E1(5 P  LPP  !D              ("!
M[T ! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #1B5I7
M!^)\<58#   !#P  &0              @($[1 $ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( -&)6E?_4W.AQP(  $,(   9
M      " @<A' 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ T8E:5\"V25X(!   )A4  !D              ("!QDH! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " #1B5I7B_&F%B@%  !/(P
M&0              @($%3P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( -&)6E>>&$(--P(  , $   9              " @614 0!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ T8E:5W*B=8S;
M!   /!T  !D              ("!TE8! 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " #1B5I74O6EXBL"  #A!   &0
M@('D6P$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( -&)
M6E<T&F.R:@,  ,,7   -              "  49> 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ T8E:5Y>*NQS     $P(   L              ( !VV$!
M %]R96QS+RYR96QS4$L! A0#%     @ T8E:5Z^"11-U!   P"0   \
M         ( !Q&(! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -&)6E>\
M =;!X $  .P@   :              "  69G 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( -&)6E<4U''DT $  *T@   3
M      "  7YI 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     _ #\ ,!$
' ']K 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>250</ContextCount>
  <ElementCount>299</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Development and Other Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreements</Role>
      <ShortName>Development and Other Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Balance Sheet Details and Other Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation</Role>
      <ShortName>Balance Sheet Details and Other Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Business Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</Role>
      <ShortName>Business Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables</Role>
      <ShortName>Balance Sheet Details and Other Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/Debt</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/StockholdersEquity</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Business Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</Role>
      <ShortName>Business Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Development and Other Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails</Role>
      <ShortName>Development and Other Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/DevelopmentandOtherAgreements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Balance Sheet Details and Other Financial Information - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Balance Sheet Details and Other Financial Information - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Balance Sheet Details and Other Financial Information - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Debt - Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Value of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails</Role>
      <ShortName>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ContingenciesNarrativeDetails</Role>
      <ShortName>Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/IncomeTaxes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Business Segment and Geographic Information - Schedule of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails</Role>
      <ShortName>Business Segment and Geographic Information - Schedule of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="dxcm-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/SubsequentEvents</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="dxcm-20230930.htm">dxcm-20230930.htm</File>
    <File>dxcm-20230930.xsd</File>
    <File>dxcm-20230930_cal.xml</File>
    <File>dxcm-20230930_def.xml</File>
    <File>dxcm-20230930_lab.xml</File>
    <File>dxcm-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dxcm-20230930_g1.jpg</File>
    <File>dxcm-20230930_g2.jpg</File>
    <File>dxcm-20230930_g3.jpg</File>
    <File>dxcm-20230930_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="804">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="21">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dxcm-20230930.htm": {
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "dxcm-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "dxcm-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dxcm-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 257,
   "keyCustom": 42,
   "axisStandard": 23,
   "axisCustom": 2,
   "memberStandard": 39,
   "memberCustom": 19,
   "hidden": {
    "total": 11,
    "http://xbrl.sec.gov/ecd/2023": 2,
    "http://xbrl.sec.gov/dei/2023": 5,
    "http://fasb.org/us-gaap/2023": 4
   },
   "contextCount": 250,
   "entityCount": 1,
   "segmentCount": 59,
   "elementCount": 549,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 804,
    "http://xbrl.sec.gov/ecd/2023": 21,
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.dexcom.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited",
     "longName": "0000002 - Statement - Consolidated Balance Sheets (Unaudited)",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
     "longName": "0000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
     "longName": "0000004 - Statement - Consolidated Statements of Operations (Unaudited)",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)",
     "shortName": "Consolidated Statements of Comprehensive Income (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
     "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-57",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies",
     "longName": "0000008 - Disclosure - Organization and Significant Accounting Policies",
     "shortName": "Organization and Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreements",
     "longName": "0000009 - Disclosure - Development and Other Agreements",
     "shortName": "Development and Other Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.dexcom.com/role/FairValueMeasurements",
     "longName": "0000010 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation",
     "longName": "0000011 - Disclosure - Balance Sheet Details and Other Financial Information",
     "shortName": "Balance Sheet Details and Other Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.dexcom.com/role/Debt",
     "longName": "0000012 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.dexcom.com/role/Contingencies",
     "longName": "0000013 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.dexcom.com/role/IncomeTaxes",
     "longName": "0000014 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.dexcom.com/role/StockholdersEquity",
     "longName": "0000015 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation",
     "longName": "0000016 - Disclosure - Business Segment and Geographic Information",
     "shortName": "Business Segment and Geographic Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.dexcom.com/role/SubsequentEvents",
     "longName": "0000017 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R19": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsTables",
     "longName": "9954473 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables",
     "longName": "9954474 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)",
     "shortName": "Balance Sheet Details and Other Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.dexcom.com/role/DebtTables",
     "longName": "9954475 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.dexcom.com/role/StockholdersEquityTables",
     "longName": "9954476 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables",
     "longName": "9954477 - Disclosure - Business Segment and Geographic Information (Tables)",
     "shortName": "Business Segment and Geographic Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9954478 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-62",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-62",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
     "longName": "9954479 - Disclosure - Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)",
     "shortName": "Organization and Significant Accounting Policies - Earnings Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InterestOnConvertibleDebtNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
     "longName": "9954480 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)",
     "shortName": "Organization and Significant Accounting Policies - Anti-dilutive Securities Excluded from Calculation of Net Income (Loss) per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
     "longName": "9954481 - Disclosure - Development and Other Agreements (Details)",
     "shortName": "Development and Other Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails",
     "longName": "9954482 - Disclosure - Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details)",
     "shortName": "Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9954483 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails",
     "longName": "9954484 - Disclosure - Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details)",
     "shortName": "Fair Value Measurements - Estimated Fair Values of Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
     "longName": "9954485 - Disclosure - Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Short-Term Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
     "longName": "9954486 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-7",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-7",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails",
     "longName": "9954487 - Disclosure - Balance Sheet Details and Other Financial Information - Inventory (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails",
     "longName": "9954488 - Disclosure - Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails",
     "longName": "9954489 - Disclosure - Balance Sheet Details and Other Financial Information - Property and Equipment (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails",
     "longName": "9954490 - Disclosure - Balance Sheet Details and Other Financial Information - Other Assets (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "dxcm:LongTermDeposits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails",
     "longName": "9954491 - Disclosure - Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Accounts Payable and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails",
     "longName": "9954492 - Disclosure - Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Accrued Payroll and Related Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails",
     "longName": "9954493 - Disclosure - Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Other Long-Term Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails",
     "longName": "9954494 - Disclosure - Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Other Income (Expense), Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
     "longName": "9954495 - Disclosure - Debt - Senior Convertible Notes (Details)",
     "shortName": "Debt - Senior Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
     "longName": "9954496 - Disclosure - Debt - Conversion Value of Convertible Notes (Details)",
     "shortName": "Debt - Conversion Value of Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
     "longName": "9954497 - Disclosure - Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "shortName": "Debt - Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.dexcom.com/role/DebtNarrativeDetails",
     "longName": "9954498 - Disclosure - Debt - Narrative (Details)",
     "shortName": "Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-172",
      "name": "dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
      "unitRef": "purchaser",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
     "longName": "9954499 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "shortName": "Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
     "longName": "9954500 - Disclosure - Contingencies - Narrative (Details)",
     "shortName": "Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-204",
      "name": "dxcm:LossContingencyPendingClaimsRemainingNumber",
      "unitRef": "claim",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-204",
      "name": "dxcm:LossContingencyPendingClaimsRemainingNumber",
      "unitRef": "claim",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.dexcom.com/role/IncomeTaxesDetails",
     "longName": "9954501 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:EstimatedAnnualEffectiveIncomeTaxRatePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails",
     "longName": "9954502 - Disclosure - Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "shortName": "Stockholders' Equity - Share-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
     "longName": "9954503 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails",
     "longName": "9954504 - Disclosure - Business Segment and Geographic Information - Narrative (Details)",
     "shortName": "Business Segment and Geographic Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails",
     "longName": "9954505 - Disclosure - Business Segment and Geographic Information - Schedule of Revenue (Details)",
     "shortName": "Business Segment and Geographic Information - Schedule of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:RevenuePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.dexcom.com/role/SubsequentEventsDetails",
     "longName": "9954506 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-243",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-243",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20230930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as hedging instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "TreasuryStockValueBenefitReceivedFromNoteHedge",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares received under note hedge upon conversion of 2023 Notes",
        "label": "Treasury Stock, Value, Benefit Received From Note Hedge",
        "documentation": "Treasury Stock, Value, Benefit Received From Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AccruedTaxAuditAndLegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "AccruedTaxAuditAndLegalFees",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued tax, audit, and legal fees",
        "label": "Accrued Tax Audit And Legal Fees",
        "documentation": "Carrying value as of the balance sheet date of accrued current tax, audit and legal fees."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "dxcm_CollaborativeArrangementInitialPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CollaborativeArrangementInitialPaymentMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Payment",
        "label": "Collaborative Arrangement, Initial Payment [Member]",
        "documentation": "Collaborative Arrangement, Initial Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "dxcm_ContractPaymentTermsNumberofDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ContractPaymentTermsNumberofDays",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract payment term (in days)",
        "label": "Contract Payment Terms, Number of Days",
        "documentation": "Contract Payment Terms, Number of Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r255"
     ]
    },
    "dxcm_SharesReceivedFromBenefitOfNoteHedgeValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "SharesReceivedFromBenefitOfNoteHedgeValue",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit of note hedge upon conversions of 2023 Notes",
        "label": "Shares Received From Benefit Of Note Hedge, Value",
        "documentation": "Shares Received From Benefit Of Note Hedge, Value"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_NicholasAugustinosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "NicholasAugustinosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nicholas Augustinos [Member]",
        "documentation": "Nicholas Augustinos"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of conversion price (as percent)",
        "label": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "documentation": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r187",
      "r223",
      "r231",
      "r236",
      "r239",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r449",
      "r639",
      "r813"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in USD per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_SellingGeneralAndAdministrativeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "SellingGeneralAndAdministrativeMember",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling General And Administrative [Member]",
        "documentation": "The allocation of expenses to selling, general and administrative"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConversionTermAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Axis]",
        "documentation": "Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_OtherTaxLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "OtherTaxLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other tax liabilities",
        "label": "Other Tax Liabilities, Noncurrent",
        "documentation": "Other Tax Liabilities, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r98",
      "r138",
      "r223",
      "r231",
      "r236",
      "r239",
      "r508",
      "r517",
      "r639"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_NonCashInterestExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "NonCashInterestExpenseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense:",
        "label": "Non-Cash Interest Expense [Abstract]",
        "documentation": "Non-Cash Interest Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DeferredCompensationPlanAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DeferredCompensationPlanAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan assets",
        "label": "Deferred Compensation Plan Assets, Current",
        "documentation": "Deferred Compensation Plan Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "documentation": "Share Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "StockIssuedDuringPeriodSharesAchievementOfMilestone",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, Achievement Of Milestone",
        "documentation": "Stock Issued During Period, Shares, Achievement Of Milestone"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "dxcm_RestrictedAndPerformanceStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "RestrictedAndPerformanceStockUnitsMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units and performance stock units",
        "label": "Restricted And Performance Stock Units [Member]",
        "documentation": "Restricted And Performance Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PrepaidInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PrepaidInventoryCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid inventory",
        "label": "Prepaid Inventory, Current",
        "documentation": "Prepaid Inventory, Current"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AccruedWagesBonusesAndTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "AccruedWagesBonusesAndTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages, bonus and taxes",
        "label": "Accrued Wages, Bonuses and Taxes, Current",
        "documentation": "Accrued Wages, Bonuses and Taxes, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "dxcm_PotentialFutureCommonStockIssuableSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PotentialFutureCommonStockIssuableSharesNewIssues",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential future common stock issuable (in shares)",
        "label": "Potential Future Common Stock Issuable, Shares, New Issues",
        "documentation": "Potential Future Common Stock Issuable, Shares, New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CollaborativeArrangementApprovalMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CollaborativeArrangementApprovalMilestoneMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approval Milestone",
        "label": "Collaborative Arrangement, Approval Milestone [Member]",
        "documentation": "Collaborative Arrangement, Approval Milestone"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock premium (as percent)",
        "label": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage",
        "documentation": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Accrued Liabilities [Abstract]",
        "label": "Accounts Payable and Accrued Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConversionTermTwoMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term two",
        "label": "Debt Instrument Conversion Term Two [Member]",
        "documentation": "Debt Instrument Conversion Term Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net",
        "label": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "documentation": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87",
      "r88",
      "r126"
     ]
    },
    "dxcm_LossContingencyAdditionalPatentsFoundNotInfringedNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "LossContingencyAdditionalPatentsFoundNotInfringedNumber",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional patent infringements dropped",
        "label": "Loss Contingency, Additional Patents Found Not Infringed, Number",
        "documentation": "Loss Contingency, Additional Patents Found Not Infringed, Number"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PrepaidAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Prepaid And Other Current Assets [Table Text Block]",
        "documentation": "Prepaid And Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountSettledThroughCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertiblePrincipalAmountSettledThroughCash",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, convertible principal amount settled through cash",
        "label": "Debt Instrument, Convertible, Principal Amount Settled Through Cash",
        "documentation": "Debt Instrument, Convertible, Principal Amount Settled Through Cash"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term marketable securities",
        "label": "Debt Securities, Available-for-Sale and Equity Securities",
        "documentation": "Debt Securities, Available-for-Sale and Equity Securities"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_FairValueAssetsLevel3TransfersAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "FairValueAssetsLevel3TransfersAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers into or out of Level 3 securities",
        "label": "Fair Value, Assets, Level 3 Transfers, Amount",
        "documentation": "Fair Value, Assets, Level 3 Transfers, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dxcm_ConvertibleNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ConvertibleNotesDue2028Member",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2028",
        "label": "Convertible Notes Due 2028 [Member]",
        "documentation": "Convertible Notes Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r472",
      "r473",
      "r474",
      "r644",
      "r645",
      "r656",
      "r657",
      "r658"
     ]
    },
    "dxcm_RevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "RevenuePercentage",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of revenue (as percent)",
        "label": "Revenue, Percentage",
        "documentation": "Revenue, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversions of 2023 Notes",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r29",
      "r126"
     ]
    },
    "dxcm_PaymentsUnderCollaborationAgreementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PaymentsUnderCollaborationAgreementsAxis",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Axis]",
        "documentation": "Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "dxcm_OtherLongTermAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "OtherLongTermAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Long -Term Assets",
        "documentation": "Other Long -Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r293",
      "r294",
      "r629"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable trade",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r18"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued employee benefits",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dxcm_DebtInstrumentConversionTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConversionTermDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term [Domain]",
        "label": "Debt Instrument Conversion Term [Domain]",
        "documentation": "[Domain] for Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r775",
      "r835",
      "r838"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r688",
      "r699",
      "r709",
      "r734"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notional amount of derivative instrument",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r733"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used to compute diluted net income per share (in shares)",
        "totalLabel": "Diluted weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r215"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dxcm_ConvertibleNotesDue2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ConvertibleNotesDue2023Member",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2023",
        "label": "Convertible Notes Due 2023 [Member]",
        "documentation": "Convertible Notes Due 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used to compute basic net income per share (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r215"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangibles, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "dxcm_MichaelBrownAugust2023TerminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "MichaelBrownAugust2023TerminationMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael Brown August 2023 Termination [Member]",
        "documentation": "Michael Brown August 2023 Termination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income",
        "label": "Investment Income, Interest and Dividend",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r692",
      "r702",
      "r727"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r295",
      "r504",
      "r642",
      "r662",
      "r803",
      "r804"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales-based milestones",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r503"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r690",
      "r698",
      "r708",
      "r725",
      "r733",
      "r737",
      "r745"
     ]
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesChannelThroughIntermediaryMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributor",
        "label": "Sales Channel, Through Intermediary [Member]",
        "documentation": "Contract with customer in which good or service is transferred through intermediary."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r690",
      "r698",
      "r708",
      "r725",
      "r733",
      "r737",
      "r745"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r680",
      "r691",
      "r701",
      "r726"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other investing activities",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r753",
      "r772"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r72",
      "r543",
      "r545",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r581",
      "r582",
      "r583",
      "r584",
      "r587",
      "r588",
      "r589",
      "r590",
      "r603",
      "r604",
      "r607",
      "r608",
      "r635",
      "r664",
      "r666"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r682",
      "r693",
      "r703",
      "r728"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r680",
      "r691",
      "r701",
      "r726"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r686",
      "r697",
      "r707",
      "r732"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r694",
      "r704",
      "r729"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r694",
      "r704",
      "r729"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r695",
      "r705",
      "r730"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r338",
      "r344",
      "r438",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r519",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r797",
      "r798",
      "r799",
      "r800"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r685",
      "r696",
      "r706",
      "r731"
     ]
    },
    "dxcm_MichaelBrownAugust2023AdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "MichaelBrownAugust2023AdoptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael Brown August 2023 Adoption [Member]",
        "documentation": "Michael Brown August 2023 Adoption"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r218",
      "r501",
      "r533",
      "r539",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r593",
      "r667"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r733"
     ]
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Other Income (Expense), Net",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of debt instrument",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, remaining amount",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance stock units",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r554"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r88",
      "r554",
      "r572",
      "r843",
      "r844"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrual",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued warranty",
        "label": "Standard Product Warranty Accrual",
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r812"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of warrants or rights (in USD per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r49",
      "r51"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r218",
      "r501",
      "r533",
      "r539",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r593",
      "r667"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r335",
      "r459",
      "r774"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive potential common stock outstanding (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r215",
      "r372"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per common share",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "dxcm_CollaborativeArrangementMilestonePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CollaborativeArrangementMilestonePaymentsMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone Payments",
        "label": "Collaborative Arrangement, Milestone Payments [Member]",
        "documentation": "Collaborative Arrangement, Milestone Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale and maturity of marketable securities",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r785"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Outstanding Anti-dilutive Securities Excluded from Diluted Net Income per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesAntidilutiveSecuritiesExcludedfromCalculationofNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r126",
      "r514",
      "r528",
      "r530",
      "r535",
      "r555",
      "r662"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of senior convertible notes, net of issuance costs",
        "verboseLabel": "Proceeds from Convertible Debt",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44"
     ]
    },
    "dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Initial purchasers",
        "label": "Number Of Initial Purchasers For Convertible Note Hedge Transactions",
        "documentation": "Number Of Initial Purchasers For Convertible Note Hedge Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, nonrecurring",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r448"
     ]
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r540",
      "r541",
      "r542",
      "r597",
      "r599",
      "r602",
      "r610",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r626",
      "r650",
      "r666",
      "r816",
      "r839"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unamortized debt issuance costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Financial Statements [Table]",
        "label": "Condensed Financial Statements [Table]"
       }
      }
     },
     "auth_ref": [
      "r191",
      "r751"
     ]
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period (in months)",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r540",
      "r541",
      "r542",
      "r597",
      "r599",
      "r602",
      "r610",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r626",
      "r650",
      "r666",
      "r816",
      "r839"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r157",
      "r187",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r428",
      "r429",
      "r430",
      "r449",
      "r662",
      "r813",
      "r826",
      "r827"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity component of 2025 Notes issuance, net of issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total by which the notes\u2019 if-converted value exceeds their principal amount",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]",
        "label": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r191",
      "r751"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price of convertible notes (in USD per share)",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r316"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on marketable debt securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r280"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r662"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r577"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r577"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r143",
      "r145",
      "r147",
      "r148"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r467"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development and Other Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r144",
      "r152"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r373",
      "r401",
      "r402",
      "r403",
      "r660"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r545",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r581",
      "r582",
      "r583",
      "r584",
      "r587",
      "r588",
      "r589",
      "r590",
      "r603",
      "r604",
      "r607",
      "r608",
      "r664",
      "r666"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under equity incentive plans (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Guidance",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r679",
      "r749"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r359"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue, long-term",
        "terseLabel": "Deferred revenue, long-term",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r359"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r679",
      "r749"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r679",
      "r749"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r289",
      "r509"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common\u00a0Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665",
      "r666",
      "r668",
      "r669",
      "r670",
      "r671",
      "r779",
      "r780",
      "r824",
      "r841",
      "r843"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate (as percent)",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r75",
      "r340",
      "r460"
     ]
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables",
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Estimated Fair Values of Debt Instruments",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate on convertible notes (as percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r315"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r146"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposit assets",
        "label": "Deposit Assets",
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement."
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r820"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r191",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r460",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r776"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r317",
      "r343",
      "r465",
      "r634",
      "r635"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of applicable conversion price (as percent)",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax receivables",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r767"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost; 19.1 million shares at September\u00a030, 2023 and 6.9 million shares at December\u00a031, 2022",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r58",
      "r59"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and related expenses",
        "totalLabel": "Total accrued payroll and related expenses",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Carrying amount of senior convertible notes",
        "label": "Convertible Notes Payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r136",
      "r837"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r230",
      "r234",
      "r235",
      "r241",
      "r243",
      "r245",
      "r357",
      "r358",
      "r501"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of long-term senior convertible notes",
        "label": "Convertible Notes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments, effective tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r360",
      "r367",
      "r396",
      "r397",
      "r398",
      "r475",
      "r499",
      "r524",
      "r544",
      "r545",
      "r596",
      "r598",
      "r600",
      "r601",
      "r609",
      "r623",
      "r624",
      "r640",
      "r648",
      "r659",
      "r663",
      "r666",
      "r808",
      "r815",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r187",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r428",
      "r429",
      "r430",
      "r449",
      "r552",
      "r638",
      "r674",
      "r813",
      "r826",
      "r827"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r367",
      "r499",
      "r524",
      "r544",
      "r545",
      "r596",
      "r598",
      "r600",
      "r601",
      "r609",
      "r623",
      "r624",
      "r640",
      "r648",
      "r659",
      "r663",
      "r815",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833"
     ]
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyPendingClaimsNumber",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of pending claims or trials",
        "label": "Loss Contingency, Pending Claims, Number",
        "documentation": "Number of pending claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r810"
     ]
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term senior convertible notes",
        "label": "Convertible Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r360",
      "r367",
      "r396",
      "r397",
      "r398",
      "r475",
      "r499",
      "r524",
      "r544",
      "r545",
      "r596",
      "r598",
      "r600",
      "r601",
      "r609",
      "r623",
      "r624",
      "r640",
      "r648",
      "r659",
      "r663",
      "r666",
      "r808",
      "r815",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r79",
      "r512",
      "r553"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r367",
      "r499",
      "r524",
      "r544",
      "r545",
      "r596",
      "r598",
      "r600",
      "r601",
      "r609",
      "r623",
      "r624",
      "r640",
      "r648",
      "r659",
      "r663",
      "r815",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "us-gaap_CollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement",
        "label": "Collaborative Arrangement [Member]",
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r137",
      "r515",
      "r662",
      "r777",
      "r802",
      "r825"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of outstanding senior convertible notes:",
        "label": "Convertible Debt, Fair Value Disclosures",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Details and Other Financial Information",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective tax rate (as percent)",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt securities, available-for-sale",
        "terseLabel": "Estimated Market Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r289",
      "r505",
      "r784"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Segment and Geographic Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r229",
      "r233",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r245"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion ratio",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r56",
      "r124",
      "r125",
      "r316"
     ]
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan liabilities",
        "label": "Deferred Compensation Liability, Current",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r127"
     ]
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Paid-in-Kind Interest",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued upon conversion of senior notes (in shares)",
        "label": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares",
        "documentation": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding letters of credit",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r564",
      "r569",
      "r583",
      "r589",
      "r605",
      "r606",
      "r607",
      "r666"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r628",
      "r662"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r128",
      "r149",
      "r421",
      "r422",
      "r778"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment losses",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r52",
      "r118"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r113",
      "r139",
      "r155",
      "r171",
      "r174",
      "r178",
      "r187",
      "r195",
      "r197",
      "r198",
      "r199",
      "r200",
      "r203",
      "r204",
      "r212",
      "r223",
      "r231",
      "r236",
      "r239",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r441",
      "r449",
      "r518",
      "r574",
      "r591",
      "r592",
      "r639",
      "r672",
      "r813"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r631"
     ]
    },
    "us-gaap_UnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled accounts receivable",
        "label": "Unbilled Contracts Receivable",
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerSalesChannelAxis",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Sales Channel [Axis]",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "documentation": "Information by sales channel for delivery of good or service in contract with customer."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r816"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r630"
     ]
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerSalesChannelDomain",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Sales Channel [Domain]",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r816"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r632"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total interest expense recognized on senior notes",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r333",
      "r341",
      "r646",
      "r647"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r342"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r182",
      "r248"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r554"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Legal Matters and Contingencies [Text Block]",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r554",
      "r572",
      "r843",
      "r844"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r468"
     ]
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes",
        "label": "Senior Notes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r411"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dxcm_DebtInstrumentCapCallTransactionCapPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentCapCallTransactionCapPricePerShare",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capped call, cap price (in USD per share)",
        "label": "Debt Instrument, Cap Call Transaction, Cap Price Per Share",
        "documentation": "Debt Instrument, Cap Call Transaction, Cap Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r97",
      "r164",
      "r513",
      "r529",
      "r530"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in USD per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r342"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r173",
      "r175",
      "r180",
      "r506",
      "r520"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r431"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r168",
      "r187",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r427",
      "r429",
      "r449",
      "r662",
      "r813",
      "r814",
      "r826"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r370"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Sundry Liabilities, Noncurrent",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r135"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r227"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisitions, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer software and hardware",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Converted Value of Notes",
        "label": "Convertible Debt [Table Text Block]",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r113"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r361",
      "r366",
      "r443",
      "r473",
      "r644",
      "r645",
      "r656",
      "r657",
      "r658"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract Balances",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r625"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r538",
      "r779",
      "r780",
      "r781",
      "r824",
      "r843"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r725",
      "r733"
     ]
    },
    "us-gaap_CommonStockValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValueOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value, 800.0 million shares authorized; 405.5 million and 386.4 million shares issued and outstanding, respectively, at September\u00a030, 2023; and 393.2 million and 386.3 million shares issued and outstanding, respectively, at December\u00a031, 2022",
        "label": "Common Stock, Value, Outstanding",
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r554"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government agencies",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-Term Marketable Securities",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r361",
      "r366",
      "r443",
      "r472",
      "r656",
      "r657",
      "r658"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r733"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r733"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financing activities",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r754",
      "r773"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r29",
      "r153",
      "r176",
      "r177",
      "r178",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r204",
      "r218",
      "r282",
      "r283",
      "r346",
      "r404",
      "r405",
      "r406",
      "r417",
      "r418",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r464",
      "r525",
      "r526",
      "r527",
      "r538",
      "r593"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r443",
      "r474",
      "r644",
      "r645",
      "r656",
      "r657",
      "r658"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r204",
      "r282",
      "r283",
      "r404",
      "r405",
      "r406",
      "r417",
      "r418",
      "r432",
      "r434",
      "r435",
      "r437",
      "r439",
      "r525",
      "r527",
      "r538",
      "r843"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r411",
      "r511"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r687",
      "r698",
      "r708",
      "r733"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_OtherNonoperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other expense, net",
        "label": "Other Nonoperating Expense",
        "documentation": "Amount of expense related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total vest date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValueOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at September\u00a030, 2023 and December\u00a031, 2022",
        "label": "Preferred Stock, Value, Outstanding",
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r554"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of non-cash investing and financing transactions:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r153",
      "r176",
      "r177",
      "r178",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r204",
      "r218",
      "r282",
      "r283",
      "r346",
      "r404",
      "r405",
      "r406",
      "r417",
      "r418",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r464",
      "r525",
      "r526",
      "r527",
      "r538",
      "r593"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r9",
      "r32",
      "r433",
      "r436",
      "r464",
      "r525",
      "r526",
      "r769",
      "r770",
      "r771",
      "r779",
      "r780",
      "r781"
     ]
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income from equity investments",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r102"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease obligations",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r150",
      "r203",
      "r204",
      "r228",
      "r412",
      "r420",
      "r523"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (as a percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r58",
      "r126"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized estimated compensation costs",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing stock price (in USD per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r838"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r158",
      "r627"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r338",
      "r344",
      "r438",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r519",
      "r641",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r797",
      "r798",
      "r799",
      "r800"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r443",
      "r472",
      "r473",
      "r474",
      "r644",
      "r645",
      "r656",
      "r657",
      "r658"
     ]
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term investments",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Availability and Outstanding Borrowings on Credit Agreement",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive loss, net of tax",
        "terseLabel": "Other comprehensive loss, net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r8",
      "r130",
      "r172",
      "r175"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income - diluted",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Translation adjustments and other",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r8",
      "r130"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r445",
      "r448"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r303",
      "r809",
      "r810"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets measured at fair value on a recurring basis",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dxcm_FairValueDisclosuresLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "FairValueDisclosuresLineItems",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Line Items]",
        "label": "Fair Value Disclosures [Line Items]",
        "documentation": "[Line Items] for Fair Value Disclosures [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebtExcludingAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual coupon interest",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r334",
      "r646",
      "r647"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "totalLabel": "Total other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted net income per share (in USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r207",
      "r213",
      "r214",
      "r215",
      "r217",
      "r440",
      "r441",
      "r507",
      "r521",
      "r637"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r303",
      "r809",
      "r810"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r160",
      "r516"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r53"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r94",
      "r95",
      "r96"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r132"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities, available-for-sale:",
        "label": "Debt Securities, Available-for-Sale [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r636"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price (as percent)",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dxcm_LossContingencyPendingClaimsCounterpartyNotLicensedToNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "LossContingencyPendingClaimsCounterpartyNotLicensedToNumber",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of claims not licensed to",
        "label": "Loss Contingency, Pending Claims Counterparty Not Licensed To, Number",
        "documentation": "Loss Contingency, Pending Claims Counterparty Not Licensed To, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with acquisition, shares (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87",
      "r88",
      "r126",
      "r534",
      "r593",
      "r611"
     ]
    },
    "dxcm_CashInterestExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CashInterestExpenseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash interest expense:",
        "label": "Cash Interest Expense [Abstract]",
        "documentation": "Cash Interest Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_FairValueDisclosuresSeniorConvertibleNotesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "FairValueDisclosuresSeniorConvertibleNotesTable",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Table]",
        "label": "Fair Value Disclosures, Senior Convertible Notes [Table]",
        "documentation": "Fair Value Disclosures, Senior Convertible Notes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConversionTermOneMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term one",
        "label": "Debt Instrument Conversion Term One [Member]",
        "documentation": "Debt Instrument Conversion Term One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ]
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, convertible principal amount settled",
        "label": "Debt Instrument, Convertible, Principal Amount Exercised And Settled",
        "documentation": "Debt Instrument, Convertible, Principal Amount Exercised And Settled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r371",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ]
    },
    "dxcm_PaymentsForPurchasesOfCappedCallTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PaymentsForPurchasesOfCappedCallTransactions",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of capped call transactions",
        "terseLabel": "Purchases of capped call transactions",
        "label": "Payments For Purchases Of Capped Call Transactions",
        "documentation": "Payments For Purchases Of Capped Call Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of capped call transactions, net of tax",
        "label": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax",
        "documentation": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r231",
      "r236",
      "r239",
      "r639"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r371",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ]
    },
    "dxcm_StockIssuedDuringPeriodValueAchievementOfMilestone": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "StockIssuedDuringPeriodValueAchievementOfMilestone",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs",
        "label": "Stock Issued During Period, Value, Achievement Of Milestone",
        "documentation": "Stock Issued During Period, Value, Achievement Of Milestone"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AbbottMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "AbbottMember",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Abbott",
        "label": "Abbott [Member]",
        "documentation": "Abbott"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dxcm_PaymentsUnderCollaborationAgreementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PaymentsUnderCollaborationAgreementsDomain",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments Under Collaboration Agreements [Domain]",
        "label": "Payments Under Collaboration Agreements [Domain]",
        "documentation": "Payments Under Collaboration Agreements [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PharmacyRebates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "PharmacyRebates",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rebates",
        "label": "Pharmacy Rebates",
        "documentation": "Pharmacy Rebates"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_VerilyLifeSciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "VerilyLifeSciencesMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Verily Life Sciences",
        "label": "Verily Life Sciences [Member]",
        "documentation": "Verily Life Sciences [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87",
      "r88",
      "r126"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r409",
      "r414",
      "r415",
      "r416",
      "r419",
      "r423",
      "r424",
      "r425",
      "r536"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average price per share (in USD per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertiblePrincipalAmountExercisedNotSettled",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument convertible principal amount exercised",
        "label": "Debt Instrument, Convertible, Principal Amount Exercised, Not Settled",
        "documentation": "Debt Instrument, Convertible, Principal Amount Exercised, Not Settled"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to increase revolving line of credit",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount",
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversions of 2023 Notes (in shares)",
        "terseLabel": "Repurchase and conversions of notes (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r28",
      "r56",
      "r126",
      "r330"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r668",
      "r669",
      "r670",
      "r671"
     ]
    },
    "dxcm_SharesReceivedFromBenefitOfNoteHedge": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "SharesReceivedFromBenefitOfNoteHedge",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit of note hedge upon conversions of 2023 Notes (in shares)",
        "verboseLabel": "Shares received from Note Hedge",
        "label": "Shares Received From Benefit Of Note Hedge",
        "documentation": "Shares Received From Benefit Of Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_MichaelBrownMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "MichaelBrownMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael Brown [Member]",
        "documentation": "Michael Brown"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock, including excise tax (in shares)",
        "terseLabel": "Shares repurchased (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r88",
      "r126"
     ]
    },
    "dxcm_ConvertibleNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ConvertibleNotesDue2025Member",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2025",
        "label": "Convertible Notes Due 2025 [Member]",
        "documentation": "Convertible Notes Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_FederalReserveBankOfNewYorkRateNYFRBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "FederalReserveBankOfNewYorkRateNYFRBMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal Reserve Bank Of New York Rate (NYFRB)",
        "label": "Federal Reserve Bank Of New York Rate (NYFRB) [Member]",
        "documentation": "Federal Reserve Bank Of New York Rate (NYFRB)"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Payroll and Related Expenses",
        "label": "Schedule of Accrued Payroll and Related Expenses [Table Text Block]",
        "documentation": "Schedule of Accrued Payroll and Related Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EstimatedAnnualEffectiveIncomeTaxRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "EstimatedAnnualEffectiveIncomeTaxRatePercent",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated annual effective tax rate (as percent)",
        "label": "Estimated Annual Effective Income Tax Rate, Percent",
        "documentation": "Estimated Annual Effective Income Tax Rate, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Significant Accounting Policies",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r129",
      "r531",
      "r532"
     ]
    },
    "dxcm_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net",
        "documentation": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CollaborativeArrangementUpfrontFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CollaborativeArrangementUpfrontFee",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial payment on collaborative agreement",
        "label": "Collaborative Arrangement, Upfront Fee",
        "documentation": "Collaborative Arrangement, Upfront Fee"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_LossContingencyPendingClaimsRemainingNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "LossContingencyPendingClaimsRemainingNumber",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of pending claims remaining",
        "label": "Loss Contingency, Pending Claims Remaining, Number",
        "documentation": "Loss Contingency, Pending Claims Remaining, Number"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentConvertiblePrincipalAmountExpectedToSettleThroughCash",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, convertible, principal amount settled",
        "label": "Debt Instrument, Convertible, Principal Amount Expected To Settle Through Cash",
        "documentation": "Debt Instrument, Convertible, Principal Amount Expected To Settle Through Cash"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_SimpleRiskFreeRateRFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "SimpleRiskFreeRateRFRMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simple Risk Free Rate (RFR)",
        "label": "Simple Risk Free Rate (RFR) [Member]",
        "documentation": "Simple Risk Free Rate (RFR)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r140",
      "r179",
      "r226",
      "r458",
      "r578",
      "r672",
      "r842"
     ]
    },
    "dxcm_DebtInstrumentCovenantRepurchasePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "DebtInstrumentCovenantRepurchasePricePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holder's repurchase price percentage in event of fundamental change (as percent)",
        "label": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "documentation": "Debt Instrument, Covenant Repurchase Price, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Realized (gain) loss on equity investment",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r801"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income (Expense), Net",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r111"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r163",
      "r187",
      "r223",
      "r232",
      "r237",
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r427",
      "r429",
      "r449",
      "r510",
      "r566",
      "r662",
      "r674",
      "r813",
      "r814",
      "r826"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic net income per share (in USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r205",
      "r207",
      "r213",
      "r214",
      "r215",
      "r217",
      "r440",
      "r441",
      "r507",
      "r521",
      "r637"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r111",
      "r185"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r752",
      "r766",
      "r806"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less accumulated depreciation and amortization",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r755",
      "r756",
      "r807"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r805"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Income per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r658",
      "r840"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r68",
      "r153",
      "r154",
      "r177",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r282",
      "r283",
      "r346",
      "r404",
      "r405",
      "r406",
      "r417",
      "r418",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r451",
      "r452",
      "r456",
      "r464",
      "r526",
      "r527",
      "r537",
      "r556",
      "r572",
      "r594",
      "r595",
      "r612",
      "r673",
      "r777",
      "r802",
      "r825",
      "r843"
     ]
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for conversions of senior convertible notes",
        "label": "Repayments of Convertible Debt",
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dexcom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r501"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale securities current",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r289"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r186",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r329",
      "r336",
      "r337",
      "r339"
     ]
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesChannelDirectlyToConsumerMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "documentation": "Contract with customer in which good or service is transferred directly to consumer."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r661"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r776"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total available balance",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue and other liabilities",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationAccruedPayrollandRelatedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee-related Liabilities, Current [Abstract]",
        "label": "Employee-related Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r467"
     ]
    },
    "dxcm_TreasuryStockValueAcquiredIncludingExciseTaxAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "TreasuryStockValueAcquiredIncludingExciseTaxAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of treasury stock, including excise tax",
        "label": "Treasury Stock, Value, Acquired, Including Excise Tax Adjustment",
        "documentation": "Treasury Stock, Value, Acquired, Including Excise Tax Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding borrowings",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r136",
      "r837"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r467"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r467"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r689",
      "r700",
      "r710",
      "r735"
     ]
    },
    "dxcm_LongTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "LongTermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term deposits",
        "label": "Long -Term Deposits",
        "documentation": "Long -Term Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
      "http://www.dexcom.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r467"
     ]
    },
    "dxcm_CollaborativeResearchAndDevelopmentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "CollaborativeResearchAndDevelopmentFee",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative research and development fee",
        "label": "Collaborative Research And Development Fee",
        "documentation": "Collaborative Research and Development Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Senior convertible notes",
        "label": "Convertible Debt Securities [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r447"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r688",
      "r699",
      "r709",
      "r734"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r77",
      "r314",
      "r460",
      "r644",
      "r645"
     ]
    },
    "us-gaap_LossContingencyPatentsFoundNotInfringedNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyPatentsFoundNotInfringedNumber",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of invalidated patents",
        "label": "Loss Contingency, Patents Found Not Infringed, Number",
        "documentation": "Number of another entity's patents that the entity was found not to have infringed."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r810"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Long-Term Liabilities",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-cash income and expenses",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused capacity fee (as a percent)",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandAndLandImprovementsMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and land improvements",
        "label": "Land and Land Improvements [Member]",
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r338",
      "r460",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r776"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r84",
      "r85",
      "r134",
      "r136",
      "r191",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r460",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r776"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and related expenses",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.dexcom.com/role/DebtComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionValueofConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails",
      "http://www.dexcom.com/role/DebtSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r56",
      "r57",
      "r74",
      "r75",
      "r77",
      "r80",
      "r123",
      "r125",
      "r191",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r338",
      "r460",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r776"
     ]
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails": {
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes",
        "label": "Interest on Convertible Debt, Net of Tax",
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r211",
      "r215"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for conversions of 2023 Notes",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r42"
     ]
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r91",
      "r92",
      "r114",
      "r556",
      "r572",
      "r594",
      "r595",
      "r662",
      "r674",
      "r777",
      "r802",
      "r825",
      "r843"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r408",
      "r834"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock counterparties to acquire with warrants purchased (in shares)",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r42"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued liabilities",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Assets",
        "label": "Schedule of Other Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesEarningsPerShareBasicandDilutedDetails",
      "http://www.dexcom.com/role/StockholdersEquityNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units and performance stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.dexcom.com/role/ContingenciesNarrativeDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r317",
      "r343",
      "r465",
      "r633",
      "r635"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsFairValueHierarchyforFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r447"
     ]
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20230930",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Maximum borrowing capacity of revolving credit agreement",
        "terseLabel": "Available principal amount and letters of credit sub-facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-22"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//820/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//808/tableOfContent"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001093557-23-000220-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-23-000220-xbrl.zip
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M9).[ $09D7<D6[/)7:2BA%+S6(S'76BCA+@[%M]Q%PO9TT'V[-]-?/[K/T*
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MPOC)&@&!WH(%\N".B)/UI,@&Z3#;QS%O5U3LTQT],_2F1OD+K3][E/RLDT%
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MI+U'?S#J0+\F-:P1L?U?:W6])CED1/'.^@LAXPNDAKYCXG^NIZ30#ZZ(YWT
M$/Z.1@NP .P7GFK56!1@4-?D6J_5U!KMS^?S:^E%)P%W 7G"0CE 7Z2*$&1?
M!;)O[H?L%21[M:%Q1/8%V1V<:ZW'H>L%=;#Y1]*(C>>((@@S#9=6&"5J/DBD
M<G09&6"%W#??C='%%_H<3.L_^TE-TU?7PT9^P!=1&[_I+34IRH#_6K/>@PLG
M'-5-EZ6C\/TI;*+6>NJ9WFTU6KLRRAIBW9=^R&IFGBIEK1"MAZ$LK=93SCJ*
MUNAR1%FGX3CT#0/V$&"MFT%!90)>SR2'!EN)WJS&5!D99(/)G<#Q80+&6QK$
M/G8*Q3=KO79'KZ*E??*$LL%(S4DH.-P=!*.P30^-\AL'3YZXWH<P0O-)P@G@
M@*Y3"+I5ZS6['6%#5I P-DB^#831KO4TN;6[2A0F8$X4WWMT3"QSY@2%,9<;
M$*9@/@$8P_/Z?4P=']TCUI@P2JZM5O0=\(':6J/#D:(7%N%!Y.)V]-(%>NFJ
MN^M13@U#58\*]OD3ET]N0.PB1&2\^Y49Z=FD=*7X89,K/4_YN4))31G,R[,6
M&)C-@NR(S.@ID?5Y>B2WR2G?A>04,%S/6JW.[KK[4"17A1*F5;:L.X9%?#!C
M%LL@QB/63D9$-+<P8R-0WMO$">(@/X,F_/R5M5^BW_!T] -^_F[P TP7Y*(^
MGL?K&T8XPA/%U/Q"QQY\A1UP@B?[(Q=@]"?[-2^CJ9@FD-N=W=,$PDCFCAHW
M&LF\42-+6LFZ7D43G$/)?@?H!SPY+Q+KR2 Q8-3=09UUI-K9"J\D3VV0\!.0
MIG%."L5CTDHKS+ NJ>U<24+9('SS$@J.<9 ;,D>$4EV+]W?7-=\LVQ;F;3[A
ME\ MA7Q;M9ZJ<Y5R%4;F0>3<&IIH,YK@J5ZCNJ;>C1,0Y\5ZMK'SUK:>>Y75
M]<8,? *_**YU2X/K][C?V1H2QPQ4L]G0.5+;PKX[4&9^*X+I1BG+G16EL/,R
MH/L+MI##!KT!>1>)^:WD8@+"&\=P1_2)O$^H?9FX=;G6TV5%6($5)),-TC 7
MF6#RIZDT5([(I+J&X5W<.5P$^[8(]DV+2FY=QUA55Z*KM5Z[*8)\%22034&^
MC 2BU7K-=D/AB$"*+-/DO>XH7?CMWO6B<@>?,VZY[$R=J98J9VI3;]9Z+7;2
MLRBS)ALR..\1()BHJDR4J3HL+Q/IX$">:5VEL*#Q?IFH"EY#>ENK;Q9YMNSI
M5*3'P#5^#ET;@,D&-2GM2RDZP;Q+$Z09[&B  M,-L9?![KVOLEJU>UAB=8-I
M2?,K>TH:VW7 *K SV=[><1KG-2<'V<?D(YJM@X,[#,,+J3F+YUT<E&KH]K2-
ME5V#9SR=?Q_1QN2,340>,PIBNQ)PO86U@%I;X\HM+DC#" :I H-D[$J0G4&6
M>*!=ZW5EI;!#$+P%AKC6?$S)@>+S7-N.!QVQ<F<V,]?QM^RD5>4<T :%<3T:
MV^X'I0\1'#,Q -9/Z")C6$5JV2 ]MZ$6+)[0FEQ1RVDX"HGOA_/_XF&*MNN\
M1&T(?>I8+INVS1:*?H3C!J(38>X.M%, WB+\8KMB)3NT9& 'M;E[P)D_^_GD
M2653U]:\I*+4>NUV 9T/A*&9$^DS[5K=A=-8:P(L)V\\Y#J%E=@.'ZOI'_NP
M*KN?KA%F)G>4DNL85@9*T8!2Y-T+NH6)N6VMKD=?J1-283WFMAX#?,T_K&!X
M%?JP$^IE(/=FK=?EZM2AL" /94%N0RXZN!PR5Q'[4RID,Y93L+M8CJ?7TFB#
M#-TYJ=5B2:U6NX!>K7EQ5"([]/3H;H,PWIWNVFP:@-8M+#;*7S\M#FNGT@GC
MFXB,[B\RBL!] MC.AKWR,DL'A[(T-56<V*@@*66/G!9!2IB1.E.Z[2JVX.9:
MM(I@ZKZ#J>L.-+7E6J]30%LK$4_ECEBVBZ>N)1:EUNLV1<N_ Q[WG2;G=Y6+
M5385LIS^G7'-UM(X]EG5^!K&)BS*PYT!SDHFV !5[52Q_4LI J@B<+KWP&E.
M#ZK=Q.$#6A$\(2*F%2*X[!'3O 2GX^@!5>\6UA%=A$JWKRMU1R,KP);DT3%3
MI %8,76,=1(ZW['-U3A).#*?''SWK0O'LG^M!1Y.1E\,+TTVA%/59[<S(< 6
MXG6!\G@XWUHHH)H% *J]$E#5C7"E';2F[*"U.&Q;E'PSK=<#SPJ,2YM\1.Z9
M]!_K&.F>>H]#XM&U%MC-[=>4B6C15Q@%W1/OSGL,\&3%WXD=TNE;8WTH3[BL
MLYZQ5ZVGN:_U=&L]N2'+RS4F2W^0QL237O%U9]+*+?CX&3__>+F9Q;.5^OTP
M&+H>X-W,:7%TY#403E_>YFF)!2Y/J?7TE!*P97 #1]BX^&C-$IE\\3(O^/,1
M<[3!&]\/%S<WL-ZI6?^3>F[*OM3=P)YQ67=AX =@NX @RK$V+??:\O';EB!K
M'F19VX$,[';'W4RE&>@XIE^+02<:X3I=D40"Z9&. SIZIE[D$&CRF:3*JL9N
M_4*-V4L*NZ1.=#/3+2)TMHT<8XIA.]H DYH92^HE1X$U$7\]2"B@,")J\TA$
MA_9T#FP;HQN(%L4.AO$F#11](J<5VMG2*MYD06RWF(.8Q!MKL"8KW]'@[.:W
MAS<6]12V-@7',*7-8<IC#B>"(H6/*%7;:K-P/I+6?/+0(KP8\DJS73>C#VS^
MIJRG'-^:8 MMN#TO?:7ZV;Q^\ NT3BNEL&:1VM*-US,)KHTI//)*[8^S-;;L
MY3: R,N&V^$0G!"MJZ4<:]\%AWF7O@,.]0B'R_FLK7%8N,]1Y0*F[-RZ;"LN
MX;*%FE>4N56/2K++@PQ4TN:-2JJ;,>S# A&XQ 93US+KEB,99&P%9+MACE7V
MFS?U=YQ \AX >>-<16"<H?R\BJ^#F?66TA'GB2M(39N:(19.35T\I:/JG2J>
M-N8U'#,S]5UR626QX8[&'AU2QP=S5+)=WS\AL_/33N+6AU7#3REM0Q,8L]+1
MJUD(1_.SO@&8;VEP-W@B[\N< 6L#0:NG%-3_(BS2$A/0DH3='P$IM9ZB\$)
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M[=22AX9>LNXQ>:'U9X^2GW4R@)U>$/N-?/BU\WF( 7 6,+0M<-/AIJG$5'+
MK;,I^0=@BY &$L+UV+'8"V!IZN%=L 9RW 5(0P\%X5\V8PV,CR=D>.GS.2G7
MLMU!Z98L7:&6<@*?K3R%Y_(1.I/44T'%M - P29CGUXD/UPFYTXMAVV+/70Y
M_W9DN 7-P'8<78YYL=MM='0-V3%.Y,<?CCFUP3AU0=G%3W8:77GU9;FA_.><
M"LI3*!"CN\!"@;CL(;N,53-5"GRA[U?NZ$RZ<8S&G&E0W2T#M3,CA034E!X#
M^ ]K-X#5[+,&&*MV:E]*D2%6'=BP]UQ@'P7+R "M3S\<$IH6P.J791@L666'
MYGY88T..F#@O^ZM:0U/T3.R?[YJN91,J>1;;:2C*=F\5:UV_UE:W+#2@*(V6
MTBW)8LM$!.V&KI:&".1&2VX58;1LT?AC8_%?GEN[2_>FJ,78$=UCE&>CH1TU
M#H&_2-_AMJ$O78.5;2[756II)L*"HZ\V(PMY'F2>^[98.\E#A>E*0V%%K/K&
MD>#M-C@B_E*(..-V5U++E%CRA)MXI*2HCC.*Q3UFG2B69<_KF#(%Y&6'X[0W
MV.=G[[R'#<+J-P[[.6X3EI,&!9!3@&P8X2BTF:<4'06>.PT@X4$  >:=P?Q
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M:Z?-^! Y3;XH2G"[P(W C<!-E7"S6T[S@$I2X4E)5C:OR?SP^C/@"#<V&E/
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MA*H>'0SE#M-]PX M %H]:E#K%0_:L*$=0OWE4W\@R3Q*?/J%1O^]<1+(/DP
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M1[)Y;A*)]>W'^C(JY$%H/T55<7*\JBA]-L47_KF^,.LENC,+./NF!93%9=@
M1CKK,GH:Y#VX=L0H8G[%F(%9*<>/(965.L66V%<W,.PC<DU.F^#5##E069.Y
M&D_9>=W1P[Y6DSNZ91F5DLBNF<C.[(X>]@<UN://G!EZE#OZ-'.LZW9'O^XN
M+U8)^A*NUS;#FDC0A4S+G]NN'WK4LPS0_X;THM1, -"*DM*[=(>=PWS1-<88
M3K;&Q=KX7Y8&:+C4>0XTW)R&'UI?&R@?-EI\'&!W7(3@S3M7RV5K038X=IFX
MC_%!M)_ 0CR0IB'RB[L5 "A0*R9?#?M#&AZKCBYQ/K&DB_;314%3EO)TD45]
M')^AYTR"D\Z=4PDWC\V9]03B#8[ /.I7I2R9^<B4<(UEJ/%%'BCO9%RJ/:4D
M1;6QU,ONJVAD3JV4*13U"W/8 E?EF(1=1!!'_A.QJ++P&U%WV>GHPF8Q2_JX
M /HH*K4ZB#ZR)# &(3AHRFS(BS7N4H.E*6%,S/XF"YY%@[_!LL<2-S[YSYC/
M47'QE;7Q8J!#!!^%#SVT#FW+F%EV;IL=J?,VD_;K[ ;D.N@(^NA],KQ _)%"
ML/?8?O#.]UG@1V.0<]7?2>=V.&Y4;%.:?9($RIE]-9$ YC#U:VN,)2W ?2E,
M^.\;=W$3^B#+Z&H4=Q88\"#)N[@W$7H^43H:Y.*VJ1_%(?).ZKJM(?9][>\)
M;SXN_O 9T?-'@3(/3M0& 'M'1NCR&V++;P)97CZPG,X 0[4/1'^\V)-6GZ2$
MU[+ZZJ<)M7/;E_.HFB0">5R7'2$ I;;;=@$8IZF6H'?>D)-M4GL>J5-7I[K*
MJ*75)^G@C!,8ZJ2# ="!WBA"(,'W8X#>OELQO@7^LY5,-M1Z8VP1OG:YJ?O6
M8S;(^2?VT[-E!LL(Z*D?\I>\[2<_,6:^:X?![I^L#._1<F[$+T?P.O$))FF-
M-LEFSN &/?Z)Y9CPUUN<^4NT60.2J?TB+--P]].ML3>I_R[C?+RU\<AN9AXS
MOMT8"]CT6\-^-E[\SH^;AX=S;@'[4#CE@V"@&:9: 023HM0Q@ "'/Q"/ZU$E
M\UN*L.)3L ?C=3>@+#TD[[]9TX6A#TQU-#=-8]A?]*>#P9B-%X/%6-/A;_8_
MX\[M5W)V__RCT:YMNXO6;5FY1]Y+Q<ZP\QSRR2(ZHO6TB>3_A3&*F*S@C5BU
MF#<*2_+2DL!4^[N9*1X,)6@QA@V&'<F!)0>6'+A6#ER!C6#- 5UES+LHSQ[@
M8AMKG[V-_O&3:?EKVWAY:SET4/K13YOO0Q+<TEWI??SKA#I[?4ZAPGTCWBR^
M[M%76QHU_VXZZ4W[N[_N]]1_'.P>$AA0HWM(.+O*\UVM5/+_._;]WEUUE0=G
MWMNP/R[WR)3>IP0N4@*5XQA8WBF&BQBV\B6 #U:9CBRM!@BM\]8*X!WS$B#Z
MX0_'"$T+X/(F"X.LM5A2.(\[!_"8V)C_$*[@>/.L%VO37O_H/1J.]6_BD<D%
MPQ]WCOG)8SZ6N>"?'Q?QC2<7_BZN?OD*K_C%=N??$N-]R#T'EA,R\RX0G^$&
M&!CZ:]A"X(5,,L -Y!?'%P=*%<#5'T(^$;=0>TH:I2@EZ@OLQ5K OIQ N>,Y
M4ZC_?X*CS;>]Y9LDLX'*U4EHV(])"%82V,CW%6,I8F0.GFJ5==CSXO%TVANJ
M^B%HK)9'8[GLZ9;-91&JWMG"H!0K,.&?('E/("BK*N '"\H,:_@E].$A?Q\/
M.$S+?CW3/*TB*I:O&,J*F7@1BLF>K#E3A M$"99&@)\QVUWS]AEPD&\8<13\
MR U]Y=$.YZ[/E)7K6('KP85W%==3[O_Y>U?Q7WP0Q'SR>+"$9PP';'=*4W47
MBFD9,X:JV^Q%60/$46!CVPZ//5I8PM'E7?7@ ,"%X;R*01*)5GIV/=OL*7\X
M-MP-?2+4",5CE*OE*RX. WVV?-:E[\&8@9W@U&2M_],SZ]*_U)^B3T)_^Q,W
M].*/< 'QL0!._!4<37P#<(4OH\_!A&,>:J4;X,8360! /YSY%@#  _'2V[+:
MMB1!)7DR*"%/M%QY,JBJF/UB^);_<9'(2Q*7+_R_.>J6GE&L*KUN0_?;^9)1
MYB521LIEI8RL4T82X2,#3YM?Q-D^ ?N?6VN;T=<;%'M!\O-/IBR-)Z:L/;8&
M8<4%TD;@((RL;61JB4MB$;LD_-A"C<HT/),R=9ZM8*G\T?O24QZ9PSS#ME_P
M:[;&WQN):;*.(4W2]I]W=Y^Z)&8M]-I9J]2[+(<7M$671*_ +5M4W\I[/:"@
M>@^/*6K_YO_08W>(>, +U3[>Y1<V#SU*':(OHU@YW/%J9?E8;4G[^/+K?5?Y
MS!Y#F[_OR\W_[9%%Y2&6VR\DBE^ "#"V$I6J*'!*? ??T^9FD_85?B39:6PT
M'ECT-U@!% *6"]P>"%U:UEV#$L'+9A(=I$LO-LQ_A7ZPXLK'\]*:+^-]N0Y
MW\']V%AU&GH>-<Q(?D#7:P&%PZ8<-@=5Q/!>:%N&LC L#U$DII NQYH98TY<
MI-/;&5UJ.A'$J8'84BVT@T3)"Y8>XY5&#OP*]<)@Z6.7:P#2%T3DU8QY/$%B
MT._R"ET@(\*("(BP2X 1*J4828N0(WH3Z:4KXP5@J;#O:T;MW*+7OS##P[?A
MUM[!<JFWJ?QM[07ZUR6@4PF>XB_=T#81/!XS*"T0?O.OT.'),S$#*,^D>.L\
MFQYPN+L5E&L&3&,;[/! +M2UC<(T_,6= ZJI#=QB[7H!#A".^,__QR_X&6G:
M9BF&!=R%GF,S+P1"X^M/K^52(ZX421LJ[ /*R-@78+@ (W-1=+C/F!:Z86PH
M=\#T_)3#BR1&9/+-#!OE$+_Q=#.@%/-BMK6"#08LPJQ$RK?W%B*A#GS>-D"@
M+2PD#-"^#!30*U%&Z8&!#$8O0-8CM.4@0(#G7AG0!X ')1K^DZQ4$")H_J8%
M0WN!]M%1_BMT4$?@-,XM[7N!2XSF*J+>HNS,WW-"Y!3;*7PC+9W#]_#A_;8Q
M2*7*@.(@>GUL_Q:\8!"(/OVRMJU4-X_/".+-CC9PVCD6]C^#5@*7$.?U]1,S
M<MRY7<"M9O+Z;F"9&]>A[.IGPT/+ %ZI^/A.I$6+=((5R#SQ#5R[CVTKQ%[Q
M&0]#O@ 4^N-WD&(J9V%:3P%6H(!*J3QA$78D]3;6\]@*$-)7_KXO(_(3\ZA7
M1@:L@P*PWM.K"(R?#.^C1X$4DTK"DS6ST)I@XG^_G^U_@$,M^/FWM$ CHBDL
M7 ::$=21.;LEYG>:?!5?J  HVQ>>NZ)GTE?P;/B;%$Q/"?_,'9A:N"UXW]JP
MS!N:2KQ&LR=V\[C1L_<IH/>BKXESXCZ(.\9GVU!:E[ #XI(@'3T7X?#$4(<G
MI1%M!1<]0S801F;SI#?"*_@D$#_B$6W6$H&KF@P];Z@)XGD70@G!+KW$"C&^
M@K>-/)0DD6.([]-2"U5^Y+WLF9K4P4+,>;(\UR%?XC/J(@HS0'6/?_2")M**
M:Y+<E J$5$.-T0'P8KEG#Y6.?>\%.>KOVC5>/6[%=N<;7W11=2'9B0H3/W:^
M0 =D(%O/1,<2< ?T-3^*^[]AM%=A9_'M$X;PF@\\2:J@@U?V \\#VR;O5P0<
MOC#]#<!D3LBZP"'\( 47'S6$/UFB;(ACP.%O(@4P;0"1 K "3%W";U%5AQ^Z
M*TX@W+(-5R'_&?ECMYX&T\Z/]$%&?%P!YAQU.$"<V-"+A'8"9,=8P#<JN.DC
M<44""BR9PRC2J@PIE',X ^S4X[\":)BN)TP+O%B@&#>MY:20E<X!#SH[,)IW
M9*#71@K$AHZUL1=4'VA! ;@?Q#6\Z8(Q%$3:Q0844BB$0.*&&#R0XT?>B$WF
M_'VPGWE4PL\\R/4S#Z5/5BXK?;(U^V2_@):$/ @XZ&5Y6KE_A_-E[@,BP84B
M-A+K*570L!-M8NVY9C@/D-V#4K6PX=]A_#1HG6"]47Q._).D2?"RQIL%G0'?
M"QH 29L$METN.VSW&94_>IN07@O+\X-X6=@"25SRBA#?][CN1TKM"N.ML!4;
ME10V9^2K0GL#EHYW\W5I^?&KQ;O61H":BG#%D'U)^H/!72D@ D./!*3)\.@6
M\DU4(H6$#YU%2!X:T#^_TY?^6GC*(H="G;'(Z>'I83LD2G[&EBYEA%Q6RHAB
M&7%,EMLF%VB=)-G#5/1<IC(BQZR'@H9B$PK8]PSWH7#;BI@OBIFT*S4=H!-0
M13^/R?RY9\VX)8&.*D6-9,&ND""V)%(>'KK* WRH3"*9ML=G'CGB%Q8Z:$KX
MX\W0BXSITH&:+"KL]DW(^JB]]5%J'?51NB;KHV1]E*R/.J8^:K=D&.5*AG'5
MS+4_?/9Q\:L?6"A"_,1M/I6Y:NW6(MNU[%7JO$![J#O%U'=!SA$*%E(*6C)V
MODRVF8A(HZ^=G!F42A5G38>DV*Z,;RQV7K,(>#S(X/OA:BV2QLA;3F%>GI8@
MXN3;P?%R"2:X0CK?:V68+'*O9.OR>\H=A@;%SO'CM":>[#F*9'ALAG]W,3J"
M.>/8(1+52LP=PVE(#B:OLV0G&(>, 1L]@*%+;)]LV#RL@L&71_X4EQ2/40@H
M6D:$.87^3FGK0)I,"8SOZ*%ZLOPHU8U[MP"O_RT:SE"./&:1D^\(GN>AGQXH
M]/[:@FU',3.'-@#7!J<&9+9P'OU\'I)O;//RL&F8QWU*U XZN4L\6!!2HAM/
MLL+\*M-:8!([><SP9?%B)4(-A[J-=+U$:&&<*YDG!^24HS7 ">BSY7^[!U!;
M ?XK%M-:7XKI=@N^=BU[E6)Z@Q I=YP(44%*O""1_3Z5E!W-%O)%TO':)49.
MP0<_G/T+96H8I9 EP*'PQIQ#QP/H\!1D/TBE.^ #N1.0NY@8Z@4WF) A2KDX
M;XJ3N[O1A(!(CN, "'R&HB.8]Q=P0?!]S6<*XO92F\%*+MN@28(D]W$#/!4
MQPV*XZ+282@+]@Q[^)?K;:2J@X )0A[-5J*4/!"V*=$&F/X8@@1%Z.(.'PW*
M*@)911E?"\H93O('TF\64M;RT)D7I;.G(OZH0/ P#299D>XC\NQA;[S\[3N
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M5C6(<2E>9CJ;!%L&;'*$6X7)H2YPKBN9X7:/H4LL'@5E-^-FK',@3>[\EH8
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M\)\]-\F8-M:&1[P[;S@;$&;>*W?Z14\+ARIR;Z-HNQ^)/?/[?/4VEG9<^-'
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M6FOSO):?<I&TU^  )7;IVF9,3I$_Y(GY@5 KEP"01!>-Z*^XP2NW*',<X('
M^?@=#>E<<5I(&Z?MT+&C_OW\YZSH#2DHX/@-.-)7YJT>$FRI[ A1L9/KSES9
MV)-3Z >K>+*"7/HZ3J:!0;+?/46'RG?@D04;21Z@R57B#Q7,/\\!.C-LDM/^
MDC$48 _$"H$QTKOGI!VC= C)(&6B?G[+ZYS+!7*9"&5$BAC/ GT*Q([X;^%'
M0KQS;PC8_\Q^X6V$N)@$>Y@\(DE8#E:,9XEFG!CI!^D],X9^X=1/N)L+SL0W
MA?]+\L/\5^@'NP)^V9-:B[1D0MYO+2QL5?7$ >&E'?9SRYN'*_2H8FD][6MI
M@%ID;+C2(G][QL'?7MF4M#92CN\'$Y'=0RS"/RZ0!']#;8=KX/\)B//>]?[P
MBQM4)CUA1H,Z^NB<;'?#.CHCG6QW>AW=D4ZVNU%=W7XV"#6E0XJ8U''==BHX
MPH\)>D\FG:HLA$_&J-2*Y<XT+1[TB"/+#PE33E)HLNU61N-LNY71.*?=RGE[
M@$RGO:&J']("1)WTIOT3=-60RU9:-C=#6M7W)!\*OU'=,P1%YE9Y(:N5:HXP
M["F_")7N"ZITH"R"(6AS1P,?,)A.\HAI,6>&WV96UU8^5U47^50M2+$1U)U#
M\UIE[Y_D"7+9.GG"1G:E2MF5 5HBQ_*&.KS46G4O-:]96[I><(,6J_*[X7UC
MG&:2.<39IBJ;"9Z5](#-$<?;HY!W=%P;3=K<6XW#-T#XKA+X)DT9NU%36]05
MP:J,;=(;X,DW/H"%MT=._T)V5=OX;CCIJ:-I_9P#OAP,V])536[VE)LMAUW'
M]JO3U#8UK"MH7B:[T[6]P=K="D07QL%^GGD_WMZ[?B"[TY4&WC\]U_<)<'\X
M'H-=1'#\)^8N2T >#\C?R,TF(5D:DG'78P(?U_;IGY2!4H5YM[A'Q[MM93JK
M<+\M@U-'M:DZ: YMV<X/<I.-WN2YVXREC+Z-@3:@UVIG-(:)^'8-Z:DSGV'4
M*YRMT]\W6Z?LG*24A[1BXZ2+*B"_J"KP:=$$TRV/U98_*]*7456FY,W*F1]3
M&FRJ760+.$DBDD3NYO-P%5+1*.GUB4J/9M$O5-;ZU?B>0QKC?N=6DH4DBS.>
MZ(<FT 5:N7OI IM:Y^0*9AQ4DB0D231:4B34L$D;596HL49*5&X&;>N[GC:\
M)=^]NUHQCY)*UL::>;+A:6:Z>D%F?'43(TL  \R,'Q^O+,GVIA>'/V7U[](-
M4'%>8?,:H$ITJTFM/1F^%>JU.MI[V0:7Y?5:B4[MYUZ[=<(LPHRXU*MKNH_L
MPUQ>Z?/6V!2 9ZK)62(9I"_H<5^'RC<&Y)_6UQ"X0<X B3]'XD_]*M^D-I5/
MHEL35;X3X5NARC=%E2\[JJ;-KLR+1*>38E,%E6_21ZG7/U[E.Y^?KWES9]OR
M9)T.5$WG#=::ITOSF2:9BH]LDMJ!XQ/E\(,3P*3M/+J@I<FILUXF*LTSF4[K
MGA7:]'DF]<SME20M2;IFDCXX2V>BU9*E(\E8DO'%DG$E8_Q$=%QDBD\PA)PS
MEJAR]$62L"3ARR/A$U)P75E0DR%7JD>]T65(XYS>$[*?P657W<O-RGX&YRN/
MC=JI*E$G5=G.X*+*GV4[ ]G.H,& E.T,9#L#V<Y ;K)EFY3M#&0[@^:RQ^NN
MP%/5UX[LZEB*IP_TVB;<-RBU2]*(I)%C0J6C_ (721>2+DYTHFIIP*<BC,+8
MXQC;UV>C%FU. Y8TT52:."E)U!;,FW ]JM\;-TA>R)8&LJB3J&)\\OJV"39&
M4Z>UQ;(;E%LB\>=(_*F]OFW:ERT-VH5N%17;$^%;D6*+LX]D2X,6H--)L:E"
M?=M4XU)OV" V)%L:R*+.&U533Z[R30> _*-AHXH[95%P,_"G?I6OOBY6$MT:
MJ/*="M\*53X]OQZJS;[,BT2GDV)3%95OA%)OT)LTB W)E@:RI8%L:=#P>(NL
MNMK@T</737R9CFOK0=V,ZBM92"E)NM4D?7">SG122YZ.)&-)QA=+QI6,\1/1
M<:$I/NW<ZCG>1-G20)*P).%32N*:LJ!&_3Y7J@<Y/4);*8VKM#08;+8T&$04
M93DF<X*WFM:KK?I%[TT*:TZT?34G:MFBDSJKG_?LM'.K/#AS.S29S_T0[@SV
M9.#>?<7R_9"9RNQ%V2KGN?'7\#W($U.ABL>U9_FP@.MM/QC7_?2VBFDXCGX(
M5[#G>:5V%2>[VV)N0/"Z@W,NE"]L'5!)/*>N09_JX@==)5@RA47EE\J*2B^5
M)RR[Q)^YH:?X2S"A;P!JJVW/C_)L!4MB*$B[H6'#[X/HNW"M!*ZB:LH*OE_"
MLX:O_/WP;BOC0UG3?>AY /IR'&J:<"@:QC;:9?//>+5]3^'@C1H.".B*K@--
MAN[P=:&+Z1"]R:Y2HABZI!@JD5ZH/&*%NF(XIF)3B;4"AT1WHU\"FK!!NHY@
MZ3%&:SA *Q'\&-"GN8M*Z.G\[S3EF7E,<5QX%_!&:P%\T@FVN$>+N,6?3%G#
M+UT3^;W] J!_LM@SP78-H%V U'01V-O0!60T&<(=86HM &(OBN4\ >X36[6
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MYS7;\WQACN5Z*,AI=T@P']Q@JX]E3E>>'4VV]/Z->HC]\'K6PM<E4^:&Y[W
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M?UH"U/M(@ TIZVRZQ*@Q4KPG?-L4&/UOZ>EJ*U&KDJ@E49<@ZOR,J7T)4Q7
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M;H?_^AU,2\MG)ES.%\ZO*ILT.!M[O#.-1I@UR 7W&^=;>,)L4,DWV1DY[W#
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M_"M#&G %\N)G@-!X.8!5+]F/*AEO+J^#*@W^C'W*@EG2;W_'B[V- $,CXW\
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MK',=(+ND?A7Q< R"%3O]-. [[A&H[G@ZD2!;(2NZ@T\F0!^,JB(!\1W 9%O
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M0<FS?V(2/EW\G8DCN\DJN7-L'/-HH>P+EA3,5";0;Z ,X^H1&2[)*.U$#)+
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M/1Q#=PP_D:1]J.W0/46RY?/J&/ZX 00MZK2HJ^QPC&Y;#\?0HNY$HNZA?2'
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M,M<8^[2(!@Z2:R]U;X;#<*'3.DIOAG[KXHWNS:![,^C>#'K,<-4<H'K9?;S
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M1W>0900\Y  $YME&[$V0)FP !O].7X8+3@J)P2P+=),H;!Z,*T^,ZM<^@!_
M3H"J+<+G3H$1&#>VX0^V$R 1N&SL!W23<[A^?%L(R!7"[0J$( PCO).XCYFX
MMN$K6N!V0ZY)5QZ&?#YV :<!E;*+AU; %@WX'H@,* ?^/6%6Y =+PP<E<\89
M/!(O%GY HSV1U.;,B_&9.*!/Q-A/WPN;QOO57R9G@N<=("F'AXWD.+A/*PXX
M3L^AK5@ L<!W&RMOX![<&>?XYP92#)(FGD=@?P.WQX,[)X0]2'!YH.+@JDA7
M0! 2;$"5\$H'<  N$('. @#'!-?%SI$>GS@1;(_"7Y=H@-A$S-P+Z7P-=8BE
M:KY"KUZX<"AZ[R(.K!G]+,3]6!P@<@4@E1PJ?ZAT2Q)&""SZ-,&(IG$#!P(E
M7KR=S?$._J*]X#,6F  ,?@,4 YO!-15>.&"? ,S&B%7X!L <?\MKZLH$OL#5
M,@ Y =\&2>'Z"[SUVO*#3X EP89#*9P+,R@,]!(ZXB8S-$*_3)9)?I9A&HB-
M2&N.%_MQ:$Q!6/I )7/?<X!\<8F(6S,/SCH% K%@HR@FC8AX4 -6FL:P%A*Z
M6KV +I&ZIP&;9PA>DHF2U!/@0"N+-XU-EYH>)$_&65XX7[C^DO,5JDUYX $D
MC[N(8&'0,O&XZ@UJ,Z1&*/("J(9@##H3.%!VPPCQA=!="/+Y(V?V-X[M*<?#
M)(^ K9H_CKQ<9SZ.@Y!X'.P^BNUE]O;P&63!(>)6YH[R;T[$!CX.U^9;CH!D
MP #JF2/NAY99)F-,.!?W"[P?0)(PQ(;@\20FPK6U$CRI+4NZ6N'1*2<F 1S5
M5U=!),A)('GQ:Z1(^,ZL/V.'E."$D=!M SQ R>"HFQ/^ 5E$XAN?QI DOUL#
M7&U1XA8.3)J+,&!<06[V'$@QC +R6M4:*<+=Y]LANS:P9:&=;N#,Q%R0F_+O
MW(KQ)?![QP/! X=J",4&!4_PC4>T.\>#7\S%;U>0<F6S8#594I\5LW$*F;KB
M=+"IN1.B[IE]GUR7O+0AO?_F*ZCGD^@>I9?0V*1:VD@-N0:2Q(33:@#(A(GB
M.?TX"AUXG\NG\!6:;P!X25,V1\..M&@0),A:&P8JV],<I<*'8%'24ZBT6ODO
ME0(>QBX=(&'_=:6[/8=UUHWDMA_+<$(BD\!!@@':"CB ZR_X\Q1,A3#O.\'O
M8=MKJ^R\\FI<\#Z#J^IVNUO.I#AFEHD*#8,':-&3,H51*DX\@59 )00U3A;.
M&O1/NNP[N'LOX:\@TB]AB;ED7N1X#H&G!F2M&VCX3WS7\1O(BC@J<_!=P#UK
MB9HBL&-BEA*_<$G7#Y&?R" 8(AN?3#@J_+#=M364ITXP4*4CT(F4AK%BN83<
M<WPR8(B]XGX]/]K&J734:&O4R-P<-<*#.?:_+G:[TMO]SH6.->E8DXXU/4*L
M2>82"5ZM6!4500,47+8(^2OUA]>V$RY<MGSE>'0L^M'K_.H%^1=T8O%U2HO-
MEJ!'F;<@WRR_;M)7*ZE=\KM!L]_N;/RZU6P?]%V[V6T-#_SEYLT.ALW>8+37
MLCLJ0Q3D/9]XPCX_6<T7*M:]1@F?>_//<?#3*BH=-7/I 0DH:Y+NV KC)I*5
M*3P!Y\8'>&X6&N\H$';+%Q&?CWD@TA$[K89AMLP.D&4:LMNH1-3D-*:Q.=MH
M11]J]QX])7%WZQA:Q(!_=O9NV+ %5:6&M8*L<\>V7?YTYDNK*%J_)WP!-(,]
MH2P2OU(PRZ.5I&RXJRUY91M5KA,IJU\S20%@Y(!F"0;"/<L:178 *KUGC)?)
M [:,L-Z!ZC[G*AZ'[-D/I;WCA>B0SM@L,CZ"EG/@WT<S]:M[/W#M>_3$6'$(
M+ _,-?1.B4 !&M8S9Q+A(K\,T-\"H*0$ W\R"<&&@TW-G>_R(1$,<2R>];Y3
MQ@$93;A;Y4<F*V[&/$_Z?)*(+SJM^'2YV?;9<%M%@J,J=_QV]6(R#F)U]ZF3
M@RT &-^=N<BP&+5^H*1-RL-4#^//O_!8+/EO%MCDA=NU5+MH*73'4:(G\>.Y
MX,=\FW1I&@\YSW!PO/-TCG$><TLVZXI\.85X69$,Y;.N2^RQ6%C9(WMH]\L4
M43U8/MIC_.]!S8SJ*1OSB3%_9_/%:^.7P ]#<I [FP?3/P3HYR@N\X!$OC'-
M@#$C(#/B4\A V&$B7QTO)T#/2MB@0@&6?7+0''R$S97)^5?Y?]',">QL_A_9
M$:NI?T5/F1NU%?S%:HX/W4(^$IJJ#0VE!@B_J=(/4,' /T_77*+/CU=O89R:
M5Q_+CMF>&:(-G%+\:!<XM_'L%^U.LP_T[[K(/BC/+XV87ZHPBL@\G*-D\'QT
M!R:_G\$^@%%AYB;E!Y\5H_\]M>GPK&/N.@!=D6H^\<&8HZR33"35VYSTA.JV
MA0$R2J828:E)',7PL;06130=H!\YE%2@ DA*@(A@V\)ER,;)=A0B(_L6X/\>
MOQ>YW N;[B[)G:/8G4RJ$F>@/7%,KG+3'#_X;!R'  N0:1MLQ4<6"O65!B48
MT_%D0I$/^11/ZFT<X*6OEZ#>(Q&MOC([$QWI8(C_*25-"4!OE>8=LVD>49IO
M*:+FW!R8W:,#XIAUVWN^$D#]+,[YHFWF53V1%[@I*9?T"Z;R_QQ/I%J2EN&R
M^S!V5G6]&G'CY[D-K:I5356KIU:P3Q9E;;2 )Q7[6R#9V"[G>\VAB+%D^/GA
M>9T-602Y-9N3*B-S'M[DA?(=Z*;,"8]L&GSVA^)-Z>_1R@QS!:4KOF1R=,)5
M"G\J6MSPBC%S,04^7'.BADRT)75\*EU\^A!4Q=CB/E1W$J]F_L5GR1QELGW$
MOA]J&3U?;HBU.6%$P6=;M2P0B>!H_R!(TVX.'I;FN%A9BGGA^:KR)#ICBV?-
M8;/W S('L]L<_ !,5!2LEHK)KS/A; @HC'!CR$15MCKLEH>-'!.;<)ML.SP(
M?&ICP9)J46$79WYDV2"\,O;@N#[P5"S/P&5RA4\K/!,T05C-OX='DXJGG$%(
M#!UKO>'_\##\,N)BWUDN+II9@1%Z"42'51^4PC\1T2E54+ZY2"\+)>+-!*GD
M+JFN2+QHS,$<]^@F)Z(OALWA-8$\JJSIVYQM5T,'LQ2H*PP#<1JIW#X@U6(E
M5,BB*'#&L1#JD5_TLIW4M%%TZI9;AQ5/=(Y3/-'7Q1.Z>$(73SQ2\<0Z'P&T
M<^93(PRL?UW8WZWY):H)L(_6?Z>=YA^+Z87!W.A?%]V+%;;8,5N+[X>44_1:
M\$,DY0-K%%<V7YM:D,Z@:;:Z1Z_:&#;[H][1*TQ:S<Y0[U7O];GO==#:;S\G
M[&K[M(Z C_!)^5JB?7^U6H![0*'8FI/!;!_N>SEF!_6=*L(N^!H I&-X749U
M@@>ATF4>-Q[F93OUV(G13LHJ[@G]\L938<RP 7:L!?>>3J'"A%AL5/GC/J,\
M]AU+7M4+/\H9CU*$=_JBS]- D0I<9&'=,8/R/>R4OO/]FSK<F\WAC@;W>Q?P
M/MW]5XA03$THFE".5^E>:W)X85Q3J4>E2:(JP/JA"%CG.]YS0X7YKH-MO.+5
M6SZK\6;[G[J* ZC,1F\X4%DD)SMZC6:C/0R)JW*M\,_J7>GC'?^'?:3:L0<X
M:O971_;7&G6;_>K1BF9_FOUI]J?9WVF/VQUUFF;U*$4SOP?)M ,'BI\C[RMM
MHT_H/S6PT8L'695!^H*C5AJO1[U>L^R<[N+K/"D_6GGE0?RH;E?3&3S)O51=
MHWJ.J##HF:7=29I*'X=*R]JYFDK/%17,EME\&IZMKV;7U3PO67JD*!H==U!)
M37VO_I,/L4[K@]OM1K]C-CM'MD_/SMU0GPOM=YKMBMUFU=4-C4!YCM#IMH\>
M?]8<X>DX0E=S!(U #]%_1ZW2;KYGQP_J=:,5##'5QMRI34#BDV@5D)D ^^JD
M[AB]AEZCJFN<OU-C4[?QAS@X:B/0.OU1:>_IEANN@2)2FZMI'YC\4%-U0J/"
M-BH=-$>:2JMX->T#'3Z:2L\/%0YU_FD:/>W%_/UO0[-MOGY6A%J13MWZR:=Z
M\DCNF0H;;E<K@^)6I\0]CUS27NFT=YW]4F&I4^\4&(T/VPA5IZE5\F(TH6I\
MR+7C:C5[:\VV-)$^\:6,'OM**FJYG4'$98_A<,\B^#(<] \MV-<NHQ-[W'7P
M1:."+ -KF<VGP09]-9I*-97N&7P9= _M_Z"I]+178QZ8 UM3*CVFX[W=J:0"
M_]6/0&OWU](D'^)P/X-\[W;#[+4/;>Q0C8SO([H6SN!"NP>6_S_;^@^-/GE^
MT (+OVS_-LT/*GNAO;+U8)H?:/3)VB@'MWW2W*""UWE@$YJSXP;GVSX^K003
M@V:?>=.+SK"E"]S/YSK;52M.KKHZH]$GY]?K]S0W.)_K;%>MF9'F!K5"GW:O
MM*OCV7&#6MUH]]@,H<8\X7R;7=R086-, G]N\#]C)UJ"K7/'PV@N!LT_@Q**
M]J$^VIKZ7FIS,3HS6^-#%E(M7>M4S8O1A*KQ(4^H9]0X_V%J7E6NY!__>"X^
M^VC& ^FO-U[*U*0?&X;'GT=+IZ%.5Z[HS1QH3Y^Y?'R.F/!RV.SN7\^FR;/"
M2JPFTG/%A]'!P>XJ4NK#=+NJW,E#M=BZN67'?.('7&FS$?O^[)/LN_WRA3XZ
MB:ZRUUFZ?^*Y)M%I]#FLMFQ0NH1><X/*7F>[:IQ=<X,ZH8_9*M]00W.#RE[G
ML&JE4[7)/JF-L_XF,6Q4$?&S\-&W!Z-#D^6JZ%LXIZMYFFD85=<SGB,F#'5#
MD6I>C';4:WS(2U/MJ:_<I3P;3_U''FVH#CVAB5:1L[\XT9&KB-#F\.!6^]JY
M4+WK;.M>'D=%'\WLSHK9=4>ELP@ULZLNLZN:X-+,3C.[RJ!(IWP? \WKJLOK
MJB:WGCAJI%ZMGNP2<CR!TR(#X Y T?9C'-66@_ Q?")ZBWJ+SW&+Y^MA^YF%
MCH7U6RH/=L&!J\U84-KC=K;:5^5UK%9S<*!<KJ(F=98EH8]D&VD:?#H:[&L:
MK-B=:!I\;C38ULV&*DF)A[9SKK=WX QS2M\Z;AQQ^V$&P[XY,!4Y\_Z,LNA@
M5<164%9&.J>G6G=RH+*R TB:!BM,@V>4I:YI4--@'6FP=49R\*S2CI_E7,N5
M<.)H2S2Q!$?6C];^T6*#LK_VH[+"PW;NU!+T$\>SN0<HVFGVZ.5'H(=><]C;
M@R)>+_S0B1P?*)2[+'+N^&N,SEUVFFW\^>H!6,AQA8LW+]L_&HJ4CK#;T5[$
M^W7&C3">&_[$B&;800;@Z-@Q<]$8M@"";,I#8\Z6AN='V/D;OL$'(YKM:L?X
M)X/8%UQ:,^$$L$K][WL_"/[C'\9' ,V<,P_.,8G=34#X*6)CEZO/,_N?LV#J
M>)?B:*_Z\%;Y":)-/P\3O!(>R/.]^><X^.E-_GV/L*X\?M=L#A"AU]']WK&C
MF01/]H=R)ZWT)VP<^NB&V?B3\F=XG44'TSP>.NP6AZ:8-K^" )E_XL$<^U\7
MSFC">AV[W;=LFW5;D]:HTQGPP:0S&9@]^#O_;[L_NE"_F@4IL4SYY3C@[-LE
MF\!97S'WGBW#BY_R, /PK-S1H> MAES'9':[!.2&*X ;% !.7)O-+1]'J0%J
M $OA@>",_V1/NP%C%O#)OR[^MOO:!L!1D<J!D;-Z;=N?U&[+QC6\2(R?8&^*
MB&Y?1!]NX(7$L%/F18DV !>7+4+^2OWAM>V$"Y<M7SD>'91^]#K_O@*Y3^\3
M7TOJ'(U O^@@@4IQ*5\L:;=)M+MB/<CO!LU^=_/7K6;[H._:3;/?/?"7FW<S
M&#;[H_Y>R^X(/BC >SXQB7U^<EI%=T\=9N[8MLL+=)@"4?Q <ER366OT*(H3
MX1/C SPV"XUW0(RV<<L7$9^/>2",UTZK89@MLP,D-U^P !X M6^C@E"/PYB;
MM=759-C>HYNON].,:1&C90SVSNW;@J92==J$J$>]/%KGE0/V@V/M<9U?^!WW
MXLT-7QX"7J1. $<"7WFHDO0,EY0G9OE[L?Q&+>I$^B=:=(& &<8U05D,N7'/
M0F,1.""5X#6&'8"6[AGCY19SDW-S8':/OKMC6KA[OE(! 00-<\&8O0.+8\[1
MXO7CP$ AXH="T',O](-06;5HYEJPN@.0M(UIX-]',_6K>S]P;1!8\$0<@@CG
M@8&&O,$\FWX7SIQ)A(O\,F@8P# C. 4 WI],0AX!X(VY\UT^A#^!J['@QV'H
M6P[#H/2] ^_"A3CN%I4D]69KQCR/N_)GOAU;@+T1*%)\NFQNY,@;,'*'H?>D
M>/QV]6+HR#Z-;5#X;8$T"AR\6K8 8'P'!(\XP'DX^H$\&N2D4 _CS[_P6"SY
M;Q;8]R#(=B[5;A<L-8'=X.UX*&KF0M3P;7*S:3SH./WC':=[A..86QP]*Z+S
M\27G-J]CB<T5"V![C/\M$T1\L,S?]LJS%/C7?A@AC@IN_7<V7[PV?@G\$"68
M/W$VCV?1FD">@^8!B?QBF@&CD<K%C&8@1!_L,%$='"\G-\]*QJ"N9//TH#GX
M"!,^XP?')\@(LC)&$++#3>H5,54V]P%'_F)*B!-L(^9-'63<(/-Y1@=H*)G>
MH,^4L$=M ?\\Y:%FO9KUGM#6"CD+K!DAGPW:@>LO<,#KSJZ;FO7F&<LN0&YC
MOB_,?G,().^ZR#& YR"[@1\1![FD( M'>(91",H:L'C/1Y]C\OL9[ .4RAEG
MMN7'7O0LC#R$\QV T8_#!+8A0B.-:+HXLC@$7'$F@#=P%PZHMF&Q>?:BW5>-
M3=1% .MV_7N.FK(3V/2KI6#2OA?&+IB)4V/">580J+N";83^)"(%/8L,J'=[
M_%[Q?"&CLSOD'C!]B].,9?KR1;O=[&5Q0VQ)($/V=3RZC!>&@ I0E9 ^XC'U
MUNM?/M H9]K+68GUWU/#'8$QYJX#4(>+8PASL-@!2)GIU0C'8!/!XIU9@4.L
M!A=#&WP21S%\+%T" @> 1",'HY^&"F[BLJ@  #)\X]'"92C>R4$@? O9MP!R
MX97@M_'"IEO,(P4/[D ]",49:$_PLR#=DH7S7\9Q"+  #6:#0^"1E04#_MG1
M.L/>.D-1/.,43^IM'! QJI<B=\M!0GC3AC'E'D<V@4R$V7/'<X@W()_2.ETY
MJ5("IEO5NT&G.<JK%@_7\1K&BVZGV<II!GP*>U0;*E1*&&@Q&$"'QR<!'(T4
M#<-E]V'L2 OT1:?5'&27939=4HCJ#CX@I!O^3>QVU8D]=?TQ9I-)5[7+8L^:
M:3-6BZ0:R@*]#;T-O8T:;:.>RMLAH^FULI97UK; L+%5.\-QOEE]QT$TX:'P
MT9,KB7NV6AC=0FA\LW#6H'^20^6.N>A6:&3T(QGWM6+T)*"/R ^B"4#;;QI?
M9SP7;$E>*-^!L86<SI9S865^*-Z4_AY= +B)T+@'S17_O1+6H>@$W*((;: [
M!%X!RAJZG,)<D(-2&IBHD'=\6P9"=!BX'DI</;E@B9E?FOFMAS6=-? !%['P
MS';Y]!7#R;JU610%SC@63 V=S1%P&F)V.(4:P)$;1 T\U\>UP?JCB"?_#FR0
MC.6LS=O(>^UC#S<+?.XO9$!PAC'8W!-',54'6)-%7E/U1A\X$RVTP:$_X3;9
M[+@6O,>&I:0=#TR/F'# R:\*6@9\'\G-9SFOJ(\"2_\2B,9!YS_%;N$#+YR
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M]7E4*P9Z':T8[,$UL2G:I6B*%G!G/HZ#D*O65CD=(?5[B\;96E8=#G5*/0$
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MEO[=2-L$_TP5KKP^+[7VWJ57LU=:FZ-ZF^V*>C+*+47%?7[T%Z0.NVKQH[<
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MW\\??3Y0CF>_@W;$(?SB\8>6ZG0Q'L([\R'.%3;+7Q QE0\1J)#&^,'21[N
M'Y!,*IP02FZB^N8_=#Q9TU^M[MP(;.GOX7]0]J O  (:5U1^$+T^-'3K5,G^
M"@]_TI6?=OP!UZ=AUFL:9GW;0MLL8+]:P,9-/K3[9V)E45OWVPGV*V90\A$5
M%PGW^3%D1U9B3H&-+&N1MB(TZ9"H(@]2%Y]0MB.O7&!;2N26"1]ROH#"MD7#
MM>[2U8=; X]F8?C5PG!1>?-)2'!X>1.;S3%]T>S)$("@A#POA@82.&,CY!Y'
M'?%Q#?RY<)>DO[)4",3+XW*:M-L<4$OFZUNEU7D'SVNW9=ODQ1FX6Y*Q*>&1
MQ&(-WR933;DF_C<VV4;3YL6NK EPQ=0NJRW!50/+TK)7Q)S>!;F*DI _'6-2
MAHH9":N18N8K+91CI3KR^_R*Z\*[\/LEQR3\68!<X]>F'\MA4BU>NPU>D\ .
M&%7@BOF<W=DY>P/,9><"Z,F?!>^F[A-U>^4X9NCSM^ '<@2_@)2&7H6.^7FZ
MGO .RL532\ !J>=$8U7ERT9=U'@:%%[-#BX=NZC!F<4G/I4,ZN:.&"\EER4$
M.'$*%AM7BUD'@9&91I&J<!99917RUUB7O308S%)W9U+WPNH,W7'F.I*80G@[
MA?T]7ZW<'J(U;\I=.OA,N%\?*/7"='RK?,_'0?M;J.^9:D^EJZ7XU,"=SZ/A
M\&82$6KPVWM*<V,(F?>^Z L\O>"XJ.A8BQG8M,U5OXUE#=!I*3^;3=>$;VSS
M=C<;ASN4B.>)*(2:8\D U4_$V!=EUQYX-)$P@?K?J,@@7S&H2$V(V:#*I?VK
M*C[PTM76(.I,X\=9!NXR*F-[KQ2$T8G#,2^U'MP<^L[OR8I=2<'Q!Z..NI?W
MOB\/%1EF\3A%440)ZH@/>.F=^G+'W)],IU W]9FA[Q/A0];!A^4'<K(5ZYO
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MF?SJ.,SD:O!!_#^'O0]8_+[2*I 9"QYO+1PL])"VH\<Z/H9T!0 #MFI^,>L
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M[DW&[/_;4R*P6'Q'70^,,>C=!M&.=HD;ZX&GY>Z%^%S4C$7'F8O1* HQN)&
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M(R0W_YA'WMW5R#O:NN^^@$A]]_>P87[?=WL&$'N]T#*@EY,Z<"!<W0$YL*C
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ML#7",8:)8PF,MI!%YJJE?XB;*JSTKZ+DJI:M<)H\.4+$B@;.!8Z 08#ST1I
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MR^<7O-.<=/XXR<*85O%*8F*#'YP%XX,I^A/H'._'\T3F=;32;-TM/F+0]\5
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M$W%RRE=KR+79,P- ZKZ[H5B-Q*B."VM[2N?GJV/B+DVS:BW8*H.L,G5'@UV
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M,CB1;8Z\H\U*@6F9S5S$V-.(UTX9K.(8E\!S3I](KP::?),1=V'2$XI-I7?
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MJ(R,9GA'I^L=JY[G7CB5P>V&]\KXF103&^&R-?4!@ 929N/R*PK'%K&*A28
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M%Q%/2],T!H[0:(//%]]5S1(7A)^A+BF^N&)Q(I4&8=CFG6GY-F-3N>%":!7
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MD:87VM/!QH7?(54NNC?!?R#OTYN9( &IVRT^"O0T.(K>]!)Z_%H31?;$;7T
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M49QK<@GY\V3>VV1V ]/XL8J]*Z^!1,X7F;1PX&H;%AE/?,3SC-V[P)%E6V)
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M:&5%A>MR\90;0JE]JCCF%*(<2<U?(FW(#4;4'*)_9V!FD/96ZM8=5>H<+/Q
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M-3=[S=6"JV$-;HQN$F#E/\,7";C7!K C $8J=?P#L7"OB<#C:Y%0+@,S,_!
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MX(=FB5:RG4^AV)U;6M-@3!I[J+[L?_2FW!R'F5ADOE:&(6!N49I$HD,MC"C
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M4^Y(M?;R<=6289AY3%;7QNETX_G$Q?9"DN> (_<?T/K^\4SK>YI$N:=UV0^
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M__S7P\\>?/%0"C'*$_R"XE*J _''GS[@SWG(J#E+0M7Y,5,/31IAOV+XW8M
MC-#:$'L'1YA79?S___WPTS]<?OXIG;+L'S"PMB.V)7S^Q\\N'WR6/C[=)?CR
M+1;= CUG<>EPG7VYSY2J4] P+>&/ 6&;Z!X ZWG6M+XW.1EG%\JZW.Z[GDGG
MB66O27V>Z6]S.Z8=P9VKUD5S\HL434HUB9SRLW#4O4TL8AF.T^.D_"N:RSX0
MN'."83S/P;W-@41^F3Q\MG.HBUC]'6$\.4_'O4V'^H!D@1S*Q;6.Q7$:NK[=
MGR?AWB:!D.R45^%<&2BR%JI)QXJ?<!/&-!@F2%9,6;R$B70L8B8>;3S#XOVN
M&:%"[?GL5;)M/$_TO4UT1B@-E]$U0;4)+)CLHD[^>5+N;5*,#=<BK<:[9OGF
M3/4C]*9$#Z(^'U#W.3O:8SY#!WP>]7L;==]XOCH/]OT.MF\1.]03?![^^[,P
MG,X2X:[X(.L0[<R(1HMD#:+/]?CY/Y\]N7CXN7WM U/V79:K5U=M/ _7%_(,
M&_S/%^][TCA1JQ(:[5S[>OQ&X72^Z\VV8BGGQ3]>$0LCIR2?=6T9MD72K2!6
MD#>(7I"2XTK:K9)VA.AK=L6HU5EH[/:6.N8OK9I66&T+M^,!?W'EUE*([.[*
MEAE0"5I2=;OWO7%^\W].-T/[[1:58L @6FKT48R YE_7H5NUU3*LXR1V@=DL
MD+6K.FW/H K5XBE_7]LSNB =)UEG$2H+R&2(BQ^OI$X,\27ZAJLX+@0"=G7M
MVV8[4&>?6RJ<'@:HM]GTH8;>YF*HE4=&Z!ZA*((>0Z?=FC);+L.8D7PGE!*'
M^<J8MVR;<JVOP!4I_H*-&H$$%&.\S61<WER#83=Z*XW'.86M>]+377,O4@YY
MM2V)'H1;A&B?,T,H%H.;T"4J-;VQ]XS)0WD9N$8Y 3#0 #JL@Y)UN"E0A'G5
MNI(76CK?](C'"HE, #A#[_1&4FN1]V0ZO[/FY#O"TO]PAJ6?8>EG6/HO"Y;^
MWF D+T=$\MQY)+GCG#Z@:5.U)7UM7&-AS!^(XM_F" =O2_0X?$::(!CDD1,M
M289<(+Y:/M3I?"<9M-,]V,&E^W8C[X.1)8311Z=D%^H*>F(U(%AD!NI&6+^4
MEF)5M:MAQYCX&0$!N?N!&=+\I'^2X88^^7WQ\/>_*S[[W8.C5Y"N7R#2H8H0
M?_G/.&Z$&QY:>HI>/<WO0L<LP(\)P+A4QH-'6J0H[G$=AA7-4T&+[+J\Z=YU
M32[>"LKA4.5R8Z'AD>Y@7TEC@6]?ZI07)["'4(U3DRTD2T=T!5AH3'?@9 ][
MIK&8:QKI2%Y09"L<A"$W!@0T\6R;X,2K5L'F>AVGRTO8$(=$UQ3Y,L@O/Z;J
MS['R8*2LUZ,2%2.Y";4L(\+#"@$,GGE:#U8,0;2?B6"<:L_Q]X$H"HE8(]%=
MWP#)3PT(1"%AS?S<Y0WO0!;%R5K-[X79@A4::=\ C TMW$KHHM((2,^%UC Q
M[\SYQ01PHAC#@T=L?U7M.2VLC$8]]Q4SC6<*/]S(.];ZS(GF[VR>&%VNAH:)
M+#%E=,OTT+K/)K-F70O$S94,+4A*4A'7>H['K2G';AHWIZ>6S^SH1\GDZY_>
M=.S<73?(@U$Q[/"Q4)"] P,9R$[R8XW#3%SN8U9)KI$;X(MZ#5%E;#0F=DE$
MY+BYS=N= MH.<+IVX5&,C2_Z:.-!^^\D+/"NUX JQ149?0%NJ*F)VV-;WN$D
M*>_$?N*0*!>[T%X1XVC/?(H-FH2X_/\:CDA/:4T[1 H^OI9HRB$*244;]FVY
M/HH,/5V+]-*Z]1+[E"U!VA;D/_2!Y5T]AQ,T*?9,'^U$??.K0(U&I^<KR?X]
M=E?Y6PG956OCZN+\$9B0F(2VY9XG"^GM1 R%M!U0H9X+*2/VX*XLU*W)(\A4
MHYS\\QD\>G^%B;A^_MR4+8B$GE31\FFRE!F%2#7:S0N[6K>D&2RNE=G=FU9)
MJ=C&<7<=(\@7MXW*75MAO*7G.A<*[W=JLR-6' 1X-HZ)3N:&YX,58&!?-]">
MXS9$-J5K6Q_$#(>CDE21MT;/[$[N<L)AY7L9O5$^+X'[0^K9!MR%T$N'["1\
MU8FDMA2>Q^GD36T$!_>/KTF"L:R/?8_^_OBZ"IO%EZ]C)(9%]YS.<CKSZ<-O
MHPFIN+>6881_"^5Z\:Q./;=ZM?-:>7_F0I59>SAI*V5LOHO+@JI 1%X4A^T\
M(^_[;*XZB:B@9]DP%2C7Q,#:0;NYJ9U>9_R!VFA8<_#M?73=W%%T6[!PES"*
M+ARC:#0)<;9 .F@,>J#D*YEX[Y!)H>_Q8Z.+FG1" YXN^JA2_Q7^0I*&W0XI
M%F.A,/ [$_UB.F[T0OH:_ 3;_<<?&)[E?:_ .Z/^HC9W9":B1:BD%9_\..5%
MIW\KI$1SK#-KEZ O'-C=<!.?4L4C0B"O8@E;0Y0U-VQOLK55YMZH+,$3[@A5
M+LY/C(K3U;E),91Y#5A&6?0$)K2I4SYE"L\H'L?6)KZU;5GM.BO:4S,FT3("
MQ1'CN8&E@Q-5*=_5-NKHF51V&X((8ZE*^(ZH> %I8JV<9#L>(#$K],I:6.<\
MO&C,JC0?A#(<TXDQH^J[KBO)/^FK;F946<AN% :?&:)[TU&"C(IJ9.1V52\O
M"6K+95#^5#)*MUCD U,F4OV?9?M813=&I<0I >Y=43%=.-EBCKP%ES6H2,1H
M&%%B*!=/Y86>XF;?:ES.PBC1<K*8 .3HFYO^\ ^DUS( X* _T_D;;@#<>4QC
M90NMEX2!1?Z2PY8Z ,$)79H 2INE] /'"+!25BF?U[E<?']-G<1<7Y#]7#?@
MG&DELUGV4VI1F438>7X/GU37)[8[C=ZGS3099*$<&J;N6AG^90NLF=\ZZ2=
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MDK3Z+L$^?)G@:B_'-)KF\*6>KS$ 6:)#98J?>\%94 ,Q.&I<I.IF9\W,.A^
MWQ]N[YVZF4:\?"/"U':"2'8C^;&ON,\@"=@0DX_U1= 3NJ 9$<?Q[E'H'?RM
M@%=Y%Y*?Z]9/ <M)BJ0TO$4U?Q*<<X*6^1!<_%5HYZO$1:'7)4C)) Y\S,S
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M$4HRZ0P*MP]AP?IA&NP2A)FVZ70G.1C(G%;!XVN,,S(+R9H%U3$-L=@ T#>
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M=KN06_?^X*C>;!6(>?<9J!G<(,W##VI53_5A=S,:F+Y)_C G:J_AP8!$"3(
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M]J9G)KUK)\%8_D\_'T0?_S]02P,$%     @ T8E:5U*-#1(O$0  #+0  !$
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M(NHNU)"\+V<1%D?E1/#^0+U7.AWV#X_ZQT<%4C/E<?_PI'\"E$A*3D:QQ+>
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MG99,9PRNLK\K8ZU.%37*(*_']'O[M _$G;  B4$\!HLDE!GRK-7ENY!@:75
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M_G)!WF!!Q4P= 9%M>1O05(TR$.%=R)9KZFVCJU<'KW<;JF-X U48L>D$5E5
M[38$]\&["H"O<"K)I.'H!JM )9$,#+$N2L*XAAPUC=2ZAS:2?1_ZY'G0J91K
MEU7=A_-5R:'!],)/Y]_?3^;OAA%M+DA?)BO<T6?CG'<D1U_:<]I,+.1,C G&
M4:VRS>W9\0"(Y\^6FEKHI'/Y;>A^OIP7?3E.B/;M.$_+3](*K+  2O)(@ <T
MO5E LRF@$6ZB#SEK%Z.M/H1W'X!/GD[=JZ5B=G,;]T]26DC<CQ[ '(SU$".:
MW+R8] B_I/D2B=%S:="+RS8<LOLT!?#DJ=*;]"LVT]LIBF5 #RA-B@I/LN9
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M:)3T1DA3NR[CF"1Z:,;V(^'0/EKI(D=Z ]&7L^GD\O3L;9FT<0YIZ*??UUV
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MP;\QU/]X\0^6R[']33K4^C5FH&O]_WWN]]J!WP. ^#'&-G'_?<XR#0!J0P&
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MOT@M/F!.Q!W3[%6Y_QI1Q]LS4F7W*?#8?!7*W-#UTX9!GE>F\/LXD?KF<F-
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M3-U;7.L)&D DHO?XY1L:L!:^1&W.&H,$T(!I?1.*T0=R[^X4#6@16"'+L[^
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MHHOD/SH7<O];455!R,OD?DT(@84&"-<H,?>8W$G6!2L<5G#[N@DA/!#BAOT
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MP0L5/FT?$QY+B"%#LHCD:K5<L98Q15SJ%)NW!6KF\288TNJ-^KG\]+TYP6I
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M0.1KCN24"BE.O&^W-ZY7=UMKLBPW1S=_1,?;?7@V30NN6<N7.EC,#P"M(N,
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M:<U &6EEVJ_??^[5[[]A5V'U7K/+&O>UTIKXN!$7V1'K.,0E^=*(@\Q'OQX
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MQYQR&P;50[ G=3^]SQ56S?^FB96+X%_<D%^]29R*,IQFK>F%MT?3*V7YB?O
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M-<C]Q<I_2)M[/1.)'=27J'T8-!'Z1;5#0; &<-261@H0WG-,X\+Y<T-U!J3
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MFQI+#]\'*P]EY]BPT]]C"3XYG^U?_-6.HKT%W)($JH\^ >4FS6*R+DKD);M
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MQ*B(9*IX$0WS9Q,W!J2L: !)8APA:QWXQDL4="X=PJVAXUT_=ZV#(;HS$LP
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M,'B>M;-0.@OMG!\%%.GG)Z1S7A#L//>"# "7!":% $<FY1N<[%45KM15224
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MZ.#3[G"[_9<1SVB .D&J&@W F-G(M\7X\T21-IH8HIK[@&1+ P2@-UB7%VF
MS14X\3"Z%?BGVVD..,#%T6N<5#5*,ICJWT,# .)(#&11Q$GX'Z(_3Q31"=$
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M$D7]]JI#QES5%;6\7$(#"@W-8X,[];*..\2>@Y1#4"N%$KW'_XFP)+IRBG;
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M.T-TQ7D1W*PHE%$:,-J()-5++'KY3&_E4W_$;!@&K^FL1(*;H.!JPPE0:V)
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M0#T9D@R39BKZSTM\O7HEX^TOYQ7.&TO"0A&RK<]E#W_/U.>.,4Q5_:ZNQQ1
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MM>H6D:*3O&PCTY\E/.]QF.\5PF?@]J?+WQ6O?EHT^ 5_ J]F 6O5)&]*%RC
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MH04,"QAGU#AZM6Y@[Q-0]V+6X>?L3:'I>6C2!1A59;<7/<4"%L!ZS8^([H!
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M9:':B[-=-1IT_DKD9Z_C$]B@X6F[CNF\%/6E2'@BG/=-;%?2H<$*89SH:Q:
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MWK* [SLL8%8'A:.C5L=06WLL8$.:.DQ-\1!A :?A?X[8,4W_V(%3$K _E5B
M8AD+^ 0MNNR\'$*']3(K+5B !H:Y4,R$+K( IV(6D#?! FY]90%"JG&HGZK_
MRL #WK43_AN\8_9E%K $^:JBNMWX[U@@9!90;L\"^G^Q@"9_%I"<TP'[+?:O
M/!P,U(+&'A\+^*R"VN+YF2/V9^;?<_PW*G59$]![_/]@86-B27D,3O!..; _
M'+^M_T<F@!&/W+)C<*'^3@=8 )QJPXQ#;5FCZ;%[1\R0=UG OYF\P(3M!,+^
M1*-V!:%DX28E9ASV[]P8%(9^!#0C[%_,R! NPAJA_NNI)!8 W:N'TMNQM =9
M_\;DL FF, MXB:9GE[* @\@4>_@+[+^=C<IBN&4QX7 &SH)^[CUHF)>8?TR&
M@L;@0WVQ8UHYL("'L'-O,4/X?S/[W^S;86?0)E^<_S$9\L]]_M^SSR]'-6!U
MX3/19_NGEC]FWQBZNP$LGMH;V]E5?O,^J\I6-US4WDP3!"M3KO\O$D*)+L;!
M/'^6"&$@IE$K=SY$SOV[4X@V*] I-K29'\!='9%:6F8!6X>[41/-(/2KT9W
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M<\#?;R8RWK.  (UI5=R\.K68S!RVK"4A4X(;AAUKJTZH#DMJP,C5=RQ)5AS
M0ZT+MZJ>7XWKOBY*NHT;+S5X,U'WAE I=G=COA][MS5-L%O_O+FAI.O%<KX+
MZV&CH4[6ZW._/1F0]S\Q,>&8&1B3'TISU4A%*B,_,86^_$9S(=R(ENN$L>#B
MW.U+QPJO9BW/2E]+="FZ(?#!.4S>#K,":]Q,I6O0!.'(4:AT.R106B(EO!^]
MMKA ZY=:6QS3D'R9:AFUT&3:@1/9#MY:NNCRMK\SM- N;3G;(4._Q\'AB71"
M,32E>Z?Q^N-H$7F9U*TV.YU*_0[S2PY/W-*+Y6;A[O>/[D'MOL(+I3'KKU@
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M!SS:'K@1VH'!51J&+IR#@32R45V6"@>)C@)%##]>\AHM%QD0V7KH=.^7A:;
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M@$T81FWV).Z\U=VA;@R0/GRXM*27,A"[M-N$\ Y[-!VHUGEI[X;W29V=>W\
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M(4<_92V;1B!'Q2DHUF;HL= 5$$<[>\0,#"0NW<4SGVRL"O<K>XBOA7("/7W
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MQF &RD!X=;]L=NQ[$[DK0O\MBW+:5+%A%*M8NI)\+-(%"%OGG(MDR#*1#^H
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M+3@<MMHE1N0_4"V-L0J![ZV0H=]CW(.JJ%_%/K"WE V;.S_BLXO.R_0=^;"
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M<1]1 7D5JH*93%$R#4F1Q.]@PUP1D0B^,K5TU-U5?TU*5<8%$^TYF(ILGWA
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M;WC=RL9DU0BL^9=JE/<]$J :6R]E!*?=&A?(OZ1+W7Q?!U&/*";.-S/4W9(
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M4H^;/92Z;[)(_0'$DO!GO:N(61%6 PRB#R>_G>P9%">9QU:GM)V6V+OZ?,9
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MXBET8QACCEK,VS,Z#Y/EA-8V1\"3L8> =>J&S?AU^;S^9O3\6GFFK/[\R9+
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MA0>7 \L2DVX6;@5138@F7WA8?UE\&Z6$JEL)]QY5;-1CXW9.KOL8M[,M!P:
M%@Y?"2/90I,]1'&@;]*H5TDYL00![B&57!_"!,_7R+O/AHFL,7I%WC&JDQ\T
MXY0_VTMGPZJ>7A57]S-6SB44\@_U1LD6S\_Z4S+FG;OBB,=+KKXN.1GS$,:]
M%TOGX3N0I'K0VG#>[:@8%)OV/433LPYWWPK]@%PLJ]DEFRNI1G\'+7$6N8[I
MJ6M7%78.ED>I0@W+X@,"@,+V(Y1G=COI%_4,Z=P7HW"[(91\G9'@D-X%UIXC
M\Y??];W=.W&=0_;O#2(S,,*R<1(X'Q2@@A[ S!X,["+E<@>7A!LW/<;GEJUQ
MF1?/I;OK5@<*64D97&>MOS1\YCG7<0[1?29SI@<"#W'X9V#R7L D@RO/Z(87
M.8)B3WOU)U!6G.B6:_@CC)"R^_:7UFKM@;Y5GL(EXSI-=DZ\[WB' N7O8!.,
MZ@Y&W7"W[D.QXV["DG$"U=%*1*U3EW4>;Z^E^]VXT^G4;ND3_RT=KJGJP_GS
MJ<U.(!^\YNE5DX8=%0H3B'\:.0VK"Z:*N/]]F$,XVIRTF]JA@?)ZP-Z"'45I
MNI2MM%SE\GX^7W]T(6B WT?QI58FHJ: D$L56J;DD-!4L1P&A$*;"NXX&LT3
M6G4KUZ9?K.(P;C:D;"1 SE.7;?393PSF4=;H!=JAXH>M1!3)1H"#/H(YA/*V
M%D.(4^K)U;@$JF1E+U_3Z&-MZ6!*V,0EC$^A*RN[<Y^W[S?8/=( [AC*"P4H
MHZDB5M$GWB!X*,=!H0L!=7AL5$VUIO&K=WBTT.C=]Q?*"^IGC\!NMNLV^F3X
M7N%>/7,TX ]V>:T+F[#4.-B]>1\/[]_D79>3(\OFSO[A"7M2DJK79IEJMI%T
MI*0RW)N#HPQYUX@J;5\!V((S\Q5 "^Q0@N3$^-]\X* Q?B^+,)"Q=J7 !Z%3
M/7ZV14%9I[<)@N8$)9&D&HZ9@G9D0P-)>!W(K:Q;^0)QC5AA9Z=;=RWK#?J?
M&S\U) T//U33-FUX E%ZBZV*/O'WS@&MK!$+:*5B2%=-*K=Y43WL<_U3G^/#
MG/GH'XXY:^;N>C@L[%7I[] 6'U1^Q>&?@^%Q$?80/%\YR6.?1:!7OP9B^^:H
M(?W5"(SC-2LY1<6J0WW/SXHMOTUMT+_><.B-^(\WS&MKJ,V(?V.&/([J=HEF
M.;B-T#OHY<$O\07(R;1.>KZ;4DS_79;V<<CP?9RYTR9'D)OWOF,#JOL&S@N6
M@FMQW,CEZ(;%Y!J;N@Q[:#=,YC4-3<= E57+'?8R9+:&4QZA/0+6WZCR%.F"
M7'X!',N8V0C*49) %RS)SLFJ!A%P(7/)YH$>H>QAN]M%^9F--TZ!(9/\H1ZC
MYB*<0"^=AX>D3VFA8:,U\.A9!;Q ;) ""95$M6(;[-N6 ,/1U5P.<T/DM:V.
MNI6#56U_N?KCR);'+#N'3+#SN12F,9R?#J!2R(!LN))NS_G!9UTNQWGPNF:>
M._3!<ZQ1]WV7<.(UW0;\$V^=F/,"XXU7.58<P;WF.@Q0*]]\0,3.;N.QFZXD
M'7,2]"&2Z31?]>AC3[)H]63;2*/RU)G2.R,*D6E\SW5C'R8[?T4?UOCS)5E5
MMB=9]<7I?WIT\%_P+_@_ 1L/E\$'MRA9^FP9=_JE.4@&6B),:' --<M@0&!&
M.$!L$M4C4(H:'=FFLS7=MCD%1C\I]@=T9P=<(QX%6E#E]RVHU$6PR;@Z]/\+
M\U^8_\+\%^:_,/^%^7\CYM3+5S\^^SL4CW]=\>&]XG-W$!/JH/J".?G_0U"Y
M/M><_<(_0FJUO<)UUMFY:\+]Z]=+=?V\M_0^;?2Q7652+(*(>G:&@6-\!0 ?
M7-2B)9O:E%-A+:U%3CY-K9.;@4QZEWUE/OYZR*&HS5)+7Y?"CX1D#=5_G'E]
MMG BM;2X;=9C4,PGI8A#I_)Q:N3S(RNY]S5F6O X0 V]D;*,3HG <#6.)C77
M=GB<\9^;FM5UOJ5O]<0S^3R$W18R%,CK%*CE,4]D0"01U@0&)#&HPWT9+33S
M0\H],[A]TD"Z+$$BX8[>\"E)18A))F05IX[R&15 =BTU!B<W"8"CK*@*NEML
M!PCH_>PW83#LT-!9'BR3%&5+F/J<]#PF M_YK8NW)'@!V@1.R$H5R$D8;[0X
MJ> B,'6_Q&]1Q,?(QL.IX$-88(:BC6DFET)?<@R\(,#[XQ7V$T -E'A%?N1N
M%/#:KMSE%C59Z-MT7J65U??,W:S $Q9EHUD?]#>V]3[^]%3@#O/&OG^I$3 \
M55I6?W'QRH^W>X6X7NMY5\HUH)L83W+LQ:9+*9=47NB_7KOC(JER8^ZP.C8_
M)"ON0Y?RN_,X/1S^-;@ZX7RQ<7)J0#!IFN).\FG.(K,UL?W:C(8I\* UG[K>
MS%U5')ZX7H)YMNEI?8&F,V&[?]+XJ\$)^RT'$7'^6.[11V_1MU??U4 _A<J$
MFXC&# S(_);140_\9>;]]=WFM9+ !U%RS5;YRW7/AJ\(BTOLC(5TO$0Z#A<T
MMRT:3O\^@4M&R9@)1@O6-TXBM:AGQZDP-FJU[//\PO>IE]:9KK?^?&BQYB3'
M1:O%^6PGR:DUDJP?TD\@[MM/8;_FC%HW= IH]E]KY38A7,.\P*:B\/5F)TEI
MVYLZ) QA$*VIH_-;5AFZ>3+B\L1I_87Y!??2N^>>^="6+6Y]Q.D]@9^0'+F'
MJ6W^^Z;- !DUV*ZA$[_$U#3*3#T]/N=\S\G4HG*Q[MG>)9GS4NOG? 4;,M-?
M+"N%IJ*ERL67U4/._9K3*Y$X$X+N7"W7*/TVY+T<%IX9Z%YT"<"(FATI@E^X
M5L+Y47=WX6G9O>>MMY\'5UH9UHQ6=^K2)^$-VQL,B,&[\@%H\OZ5Q- P:%ZP
M;XA:Y%?]-*)JK]E"C)&7)$>1!IR &0B.ATN::B\> UR7-_7=)A0\&]S]=P_W
M:;)?>(^+,AS@_P+!QZ8'[!PLAV%[K!\MD>S0P@@&A+)*PE#6XCHL2AKI(F_?
M-AX$MAVJ5?3!2RJ>KSCF>N&YKL, YXUI!J1;I>.P/U$'#1.C:U/5QU3&.\5N
MC7^X4?PC:ZCQ_2I*SU3>\YJ%8,B'Y4_<7-T]W62D5Q)1Y_7'YR?<K7HS3MQW
M>JWQ)O/ -//'>M7,#42)+-QTOR!.<^WXW5>TTFOVD]\F<MQ/VA>8Y3,@"?NT
M5-CW%>K?A[R4:K $WTU!$FPY;.H;NL<Z6<KBL?+$LI6.UX1V7(*HYYF<P5.6
ML.SHO(-@Y'LHR1HZJX_G+R<?I3(E!WK<%#.3J<_M-ZZ9W?;FJZT]<%1-KE;@
MUSN4&F,>Y4@5VJ&<;*'E=7*:$[>%YHR!]@'#SU]_\AQ6V+ASO5'LY7U1?F?@
M$T7A27'[44F<R.ACKUS/E^;]%D5!!04A5];5=A2Q*O73YQ;SX>5L>621AO?X
MD*.EX^AC"S)+ZE$61"L/:Y]9PP>&PV_*\AY"O#.C')]\12ZAZLHP*0(Q-2@_
M+%_U_L@WW0/GHQIK$OJ/OO'?W^Z_!V_2B>T()/-0[I);8LQDW)XUC=CU1CCL
M!RD)YBGZO?_5*\2<*WDI$_(UTQSI[(\\3DNYAYIQM05.$JWC,S&I/UY?%IA/
MS[]$Q+L7IK><Z.FK)? Z?WM*+3=Y@VA(UFWE5Q:I4 ^Y(H0QL% L)4YO$8*;
MM\-0;]TN]CEU% A*W7LJ=.?IWAN/\9"65ND'+?=_[D+K#HWP#:N%!.M]D$F6
M.B'XR,%6CU/A=8T7<7M@-![%U&'$D6JF@_@T?69".SCG$T][TUVLB4+;BYG2
ME:H@%%ZY%3:#ZEHT!0(.5!#2W5!A99UJ)[\W+:H37+RJG[9%3![)[X4<"R%9
M[AU7=(Q#==]%K8 9S8#X"$TP();!/Z='&JJNL,2OY0T4OJJH^/5QWS"W;=.W
M;(-RTG3(L.\Z$.X<=\/_M=K=H1)_/\H<Q:P8L""W$*P',?R7B=MQ9H:-T_=^
M!@PT%JT/'^72>]-Z1H*EL":QG.RH1128#Z#8DUK0JX KENH_7MUQFFU_9N25
MWD=W;8EXP<Q#J2N/IJNCX\%4?T%^#FN8[F- DG',';ZOCSD81LG(J33Z7S&<
MMQ!JQ[7Z:6O-,""M/^#*3G,!=!V@A" PI]+GTS^8CE3_^MXF_:Y7:WWVLZBT
MW=LX$C>0&OP8L2]I*/;.V":L7$T](Z+QA/*+_25'U;G-K>ATG73=QKM5!GYV
MZ*;GI:\*-^6<5<U:ICZX;-!ZBY,U_I3\[OJO_S#Q_WK JM(:4'X8$>00C%4;
MJ8L((.12E31\'O"ZQ)=3DIK%:JU:D9^=+ Y?AP[9OH7^U,](A3J^#I,UL9[:
M4!EO"I (J@[R]*L)K#DB(/.ZE[>J_/#3F-,<,7QWE_T]-0CJ=B_M9D=>E6BH
M?-PW.0E].9I2[M$L=J?$S*IQ4T/%=VSV.TW@/6I.8W"I#C?(@TW"B-VCF4U;
M3AD(\ '(Y>ZVH *6TXI1E4'BY&-^;]"I4+WS$L=YRS7U_P2G,R"WH1)T,#)(
MU@*),-)3EZ;!OI.AO1DN?LU13Q3GXU*A9F&F&'65.!'37!^.M+ZHW-Y10,5B
M8X]TL$QO(1>-=GE <S[^XCG[XCM?<:P8.E1L6P\QI*_MEJW V<Z=ZO@JVHY6
MV,D1'=31B -:2#A+,NL7P<9PVUOA/6>YZ]ABUEY92NX[KNXY<I'EA(HTA*6>
M_O"\I7;Z^*N2:@L5FSGZSI7/$U\=K.M(SL%\OC.W$,_//%>;?OW<+MD_P.;#
MR-S^[)S4_3?3&\@H>@]4G &YL9VP>*2 DD^K0/DE3INIWIJP,IL?%5B/X"G-
M?:\2-2^:Z=D19-<DLGEEA;9,UJ"T Z*D@@&Z*!"Y'"SBYKI>=.PH6L!<K.!8
M2LCJQSIEYVMQ0\;H HE1@P(&A)?G0 (UUHRP ^>'2F=HH\5&RP-RRS*\5^O6
M:*\47TX2OM"!SV$7GC';Q*R%B3:^IQL_5]N^Z7OWJS"$-WHQQSXG1(?_F]#+
M*\=\M/U<<PRDL^XV65V[FU-='=EXX6M5.K5%9_279O583)F:A^$WNZ#+0TM/
MYZ.:FSJ3HIQE!C>%#WRB!0&V U<@H LC9<8Y-R\]9)#32_39$(3-+/MD(,]^
M._:02U_ZQL"8\G+WVAH#DH[4(UEOG@7%=0)<7R-'C)]+??C\J=#H<=,[Q9OB
MZ8L_UI[E<?"+,0LC[UR,^W1*=!?3'QR#XD*>\+,BX%(P HTCR$^2//.#KUW9
M_612Q=( OP\R0J5"Q]_ .7"^T$<8B-:6%IV?>G2\43@<TE;TB?GF,_[D7ZW:
M76&09J::U-'$AJI1L>]3U0*5QG45I+GB;PTK#HT>E<O(/^T%-R7E I]YNJMG
MW_@386M@)GW-K3GZS=Q)QS[:SP@S/B",&!Q;) E.R:71U][16G -(HW3_H0
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M.(KJO@BR^XP2PN"QR1ULU0CI_G[GZF-I"%ZW;/=5@]L:FH].!U:E/#FN4O9
M\LUZ?E#B*[>?+B._'9K#[YCN1NB_%SV<)M)@HHM7A61:G]+XM409H96;B4;?
MH.&0$M%7 *8W!4!CP(CZW)IK\KBE[598YXYIW:IZ0[R5J)5"X<H]YL['M'=(
M540O)0UH*$.!V<MRZZ9)M5/9=)_[37['RQ/3 <^<T/;J&WI&0<FF=')\^#<W
M+UN)2VX:UYR2QE^_O'+5ZKZCP99B3NZ[K2\YCM_#OBW8V1Z_?>W6B&.AVNO3
M_4J;;KEM58WOML,;ZW%G/S,@WG! %18+NPU-HJN1H#'1?)$^/H3OI@?N'NLD
MHWFB?N0MHM;#P8R$;L548F<<=A0%**G$'H,G0ING!Z&)1=+.[(4OOKK_^/*_
ML?>> 5$MZ;IP*RH""H)DD#:0HPB(Q%8120*"! &A542RB&1HNL5 #@(""D(+
M"*B$!DD2FXR(Y!P$FD8RTDU<T.E;[#GWGMFSYYP[L\_<^>;.S(_UHZJZ5JU5
M];[/\[Q5M:KWVX]/<RN(G=9OK1C-%*E!/C/'UE=$VR;/.-4JZ_3/)GOKR'CK
M.SX8W/P9H"H6TWK?0CD_TG$OW\Q2)U\2T4ZZ"F*502T_@@-(A=6C( C%H6K4
M= "'B&D189?Z\UM01>P;B6+EZ)OBQVJ8]A\^L;W\G&2'.$LIJN8+F(;MMYQP
MW-Z]ML!<FN%T"K%T]:'N>9,7\V-6S@\?11X^8#Z')A^?G)Y;N: NAM BLBS/
M$<RO$5&19 WQ"2?E;*SOZ?+"<KD.P8\Z<5)=\A@!^E>P_KD#^\V760#A[=:8
M8"CGI@RO XKPUM,0@M#J]=I?*U?:FV<FAVBQH-/Y'+5C@6AV&"[KK7OBX[Y&
MEFOV"_9X;?S![%.4<D&&R??S"9D!HJ:C-W1L=*HL1IS+NT"J9[,MOM7P9M%4
ME^-6[]/LWFTW.]X473/SN >#WI8K&X;-\!-C9"D /FT8-I3L\;T9U[%_W22Q
M5Y&Q3ZJ:1>QBZTFVXSPKR3NK6VH@SF7X,FU]!C[1( R2ZKR3 ')YX8:-Y;B-
MD^RWXA*7E(Q])L?&+%+40YV'8<[8'?G5,!IDRV 32SF9C)7 WF= X2X!Q5/V
M*S#6-9=-%LY%7NGB<X1<MC;^1W(!KV2@ K7FI=[N]JRSKZ51SW*NZEQWU,WX
MA%PMB>2K,C>;G>\L$.HJYL]1:;S\,BZCUXLCJ;&+NSS VBHE'91A*YE@I"Q&
M4%QV)=)= SQRR6JU0ZMN&T'O=5U6>UG=^+2);U5>SL3SH=\*E*Y ]ZM+C) ]
M !AN-:(2&2.-I@^5GZD*_^JH47TJ;$</LD_5W_Q'ZTJZ"%F>JV5RE 6O E71
M)P@J>T=E7_AA^\KI_.#C#QMW./ !JQN8'B@@TD5^#6]$D3CO4%WU@C_'R'=\
MSN4(^2!(6#SG.9#8\WYA8JNJ*N)[Q$GP\;O"9.6==#?8[TWEE47NR 18?V_>
M5(L.%\7T=%7_6^G\3R^>6ME"(G,N[H2Y'B&Z4K[&<LX@34KNQMF\)[VXS#O\
M8R<LK)P37/,.7Z@_A#U;?8ETDSI@LP\HG7([@@3#!OK-KF- ?+VZZ("TR]>;
MDO:6X=,=;V^>86W^\26(>N?TH8/\D79^%,,"GV8L8_51/)H3\&@5$.X9Q=\@
MI(X/*1^MJX@]6/VIZ:ZW>!['VK/(LR>]^(?:W:4UHCHYE'"RTB_?#@P2XHPC
M2R/ZDE7+(W;4!-!*Z)GAZIX;B;Q5.:*EV43GY'.#,GHM0[^4<2._(CF [R1F
M9.,$#!CX2#Y7%=-<*S; .==8RUS>-Q.GIP^$<\9Q''PA%COCT'E8NY^-H6ZG
M;\L:*"?*3/DTNUKANYK=AKM:8*S5SN^M>?*].@ST4E!%Q8';-SO>5+S88(DM
MO3K U(F"BV)XL?OU*<87;MWZT'JDIA_'4W!_S,/)TD-E(:>JMS7!ZNE]:CZ_
MNEB#/%?EFS,R?F7CHXE)/GWZRC=W<IO@Y6Y-@3);YPQ'DV$CF.ME [!2RU%\
M Y=//,_)Y_>\'$>HG7E<3JMMD1 6F\TY&H1PG>4Y[!CL 70XH [+IP[U/:^C
ML.2LXNI7#;L_Z\@[NC@LW]-<=TX9+?683I*UD*$.9DSV K2Q_+7\-@C9*F)!
M?OKP8F214_%\!V^'AX-OXIA'KHL%>X+0PX>!#/29A,D03_AA7^_&!B1?H9Z^
MBMZG\-Z&0=658.[NTR>[+C"^17(L3J])(AT-"IA.6'0^6[@J-2I6&?:]0[!D
M1$5-YM/X1I&2NISL\VO"YW(3>&Y$NCEDSZ:.]^KIQY<-C4"3H7Q(480+"(1I
MWQ'*%#19AB '[W[7\^!9FNS )M]]SJUU=NV9%*&+4:R(EGVU]Z79C\2D+,#'
M2-,QK;#'9@+LH,B6F'H0A4<]Q]TM)SY(\$@O728*&GR^$?<EE/BPH*?07"-^
M711VH^=F-TY54YG[M2&/2&A^FW^XK-EUL_"9 ?F!'6PRY<A[PH"O$49L^MV2
MZ8\: Y.\]'?FTAUN'>0AV 6P1R6:H.7E*X%3J% !.DK: W4H60+P[QX7]%AP
M=&1?TU(<9<RX^C%R3?O,Y0^I[U/"VO;7P*=19#:6RT (,: )RY6'<N@Z-E]N
M(S10(%,@M4$ZN%_F_.79L],7+2ZI4226P\7N %!13R%^_ZWUESOCM4==O\9=
M=VK3NE+0K/%TK?6J40MU]U&27%)]?H7I2\M/>E=*86>Q=]##/BUPPIB-:(PU
M42;<,Q<:4BNN:*:<M^L2FQ.:.&9TDM[[Y+DO[_E?6*W:)Y/D<.8K1L0SK31(
M:4X$S#[5;<IU-B$=0/9.6T$YO_3YF:_P%V9\# X5^29DVXC^'$C\*6\V(L.H
M<;*Q)9JY.'S.(RUL/2?@TO<J(:^/ V,W;N4$X^.ZHR2ES#DZ?TC)?"LM\7K0
MYOAQ2&/=OLXRIPD+",FLJ."+IZ%/+"?#5%GQ#(KSHVD1#+>-[.+TO%B>I/?K
M$JM=3(N#>;B_+\()UUB>P3@5W")1;%@75+C X4K"-QOEJA02EU9-5)Q9M'/\
MPY^FCUTC0@=N!F%G3]KRD(S#Y]J!<VET?+K(">/,JS=2E;WU$F_4K$K-)'Q/
M3*S-?S7E:\PM::T4<'_!^&46H[?-4L+JZH/>JD]DBSKJ0!G7*&:Y@BARK4\R
MJZ*B@L!<Q%%3S9KD9YV7S1B>F7A7&\*LH[!#=",I :O-6(*VAYO(XTU?\B4<
M.O2<4V*E[<*G_/%8%:&JYY$%T^<[JJ<\8]1R-SG#5[HN6+&DW;6V+';:R-$=
MQ#;US6Y&Z+SSLN=7T;C0I)P@/+#P-36?W*'N9C+8^F/[,=9^,C19A,SF,WVU
M)M=7QC*IB2I+]'HY^U5?W:PZ<8)IS,O,X>NJB-]G!#Z]JR:P@T3OJ)P=0A)
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MRK+:*N#F#F/%CW<>9-%PGM=5XO%P2U2]#@UR1^8)ZI-BG<S!1>J^XJH4>.5
M8JOEP$^W>W=\-8N+/X<6::\MO6!_>*%MR;IK69.D1-:CI*+N26EMO05L"8MP
M=H0!L?EQ&>%Y?F%4DO:G^ N?'\U(&TR>C?8(C:>3L4(1KKL]@?&3K6F0 P
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ME:4*>Q&G,ML#U3XM6GY+T4WM5E:ZN?8:,A7B0>98KPG<)I9/<6!;]*^.;<D
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M&C7A>X^F;T6V8W2G>U_S]%R'$O)$G#7;?(S(N6]%K\O.W<PSJ<B1:6SSULL
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M_?2>E;6(K(7^#LKX)UG_^S\I@=_Z+3[JS\V%??0%1;R0IN'NI@Q%G'Z>"MI
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M_?<Y_R?.I/__X__! =V?^P]02P,$%     @ T8E:5Q$?LQ5Q. $ N>P! !0
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M<& XA17#=%R>^-,:K_L6<UEN(B?J>H'&W6Q=8<6&7L#YSJ';EWGCV^)5N!Y
MSRR M&@1%U<76'0/LP?CLZD 9)\;>Y(:T:9]H)GON.5C;VZ[E-"<MP^I+RX^
M,&MAQV%(%1@N!.DIFF><Y4Z[:VI_?EQ7EI+<JZ0T47ZNK<'_[#[LL4:5''S!
MH0DH0IG[530N&>,3/+/ & ,&:#A'&HZU-Y$C&$["\:$,QO5L*PO<Z3=>JS25
M^G;;:1-SN32N\JDG1-AU& JGD?^&(-[03!MU+3UZFIU8N7D)<=@K-#211=\N
MTRK_I=\!N@S.^8#>UT;ORL.QU.D^+95D#6)#7=WQV1.!!AK&9YR.PW_[<9]H
MQ'.=@D@?>5[YFZ401"LX#3B3L1E*1]BYG1B?I\#S/W^&S[]U[S!(<WW]T2PZ
M,_UER-/HMB-M03UP;?L/2-HYD-MP> $<&!C10 Z&NK!G.J ^VI/8*U=;R,=N
M&%2(PL[4N3\K=A&SJ>Q]IA 28KE?CMG!$<8PY:(#J3"6! Z)$$7)>GN_0!EU
M8*16G(H\TLY42G8@X^KCS*)]BFZ\&QR0RQO6Y4_^@A#G&+/,@$ :U(7]K-G.
MX4JTKQ6MJ7VGK<6KN/ARW*<NS]#\B'>.<W6*:P-X4@F"YH@4PA L.F4IB!0E
M;L 6!P1;TSA5TJ7:S0/E7G="1@I5K%C/$:N?>]T16].A\WA-,VT0\"VSTQ&D
M!,X>=JF,YU=*-4X2#EVMO_/XP8I1<$%D%M2AZTH12BDS%7I-8QO$>&?F41 *
M53C=:&[ ]87_@N]$[>WZ:N"1:\@N9$8&TY4#9[_H44%8F7,%*@W2(\<H6KN0
M;JR$"VI_1T,K_?H?OF]HV3?CSWQ:DQW\KKAW5EY.,7]8?O/P26@BLF@74F?
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MAQ&:U=B"Q-+F7R62 BPV>/4!#.$XQF\34*MMIL,=@.T8\LL*ND?M(Z6"78@
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M08>F-+NG@UUNG[.8A[!Q==5C"Z#EY/OIG+SW:VY_?K/$D1RA-:83<BH:R?C
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M7IN9:'4ZF!!,:B06FH1RNR_3VH%/T!@,#/HXL&<@0J)W0YHA&"J[==2%+*S
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MGA_#%4T/6MQ(F#F)]=^_M^,AB70]LK8V39UG*Y$C6 $:I(I=A;^. ]0M,T%
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M5O!2SR=O8P0]:BK?9J=5NMN>2W?J$CLA*WS3KS-_!A-B3;'8L^</CO&<774
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M/F#P9OK!4E)#^R[D'>A,EH+X+D2]G=[*3OH5S#Y)0%Y$"0)PVBPC"+ L1\$
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M["8OW:U48+"NVWO([M")EC6"[Q6-;Z]3$.!;%]V81UA:R,3 HE,(OT,F4K>
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MLWN8"VX\]Q8/YD ZL&M ]]@^I4W$;;C(-FD\IGX.6<-T20,PYY\7G=G@?,W
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M34!>R@MS@B@N?%XE.S@E>DN8HBACQ'HKR&LR&^9B\E0Z?7,KY/8..*3=3]E
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M)65_1>>VWP1C<!^.@W/X *U7".4AO')!Z]4?/7!^]/[_CJ7ZU?!7P[^Q8;[
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M[]Y5K..<9Y?OJQMQ,HB8C_CX'N/R^,"M*CU3GH1PQ4-/^TJ3MO;QKU@;UP"
MF\1L9U&I$43U7M!1\'WA6U22JTM02;X-UMT !Q,QL^>+0)IW/CA]=OF,PGQK
M.B4# UV(A44RD.@D;UCS.QG9GX'(HFNY+ ==V;.HLEH5Z,$%$C8*G@&U.__F
MSI>\B1W1B4"B0%HMEF$1N[#3CL(HZZ;,;XW][6AIVG'PB#7N?2R\VQ3A0[6
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MFI&!8NY&+@73+2Y25ODO#.<^^K2EI>T,[^$YX3ESAU-16])&M01')?NVLHM
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M,A+Y_1ZB#[1"C%2ZF(Y76:6J^-EA+PNE#LO@L6NGM.G^_S5[W';P*E69+)J
MNT NFWR2+ZH8=BW1]+S@Q(\V%=-''U/ W=@M?,2.!ZBI1RC:%F8S3_@.'U%3
M")-FU5T)K7]C57(A:>1RX(._)&?\$NJZW@].;KR#@21E[?/;11HJ&Y#.[/_K
M7<C%SY*\&"<'I;/BZ/7CQO'+  F_6H>< L;O>Y'.?RWT'<+ILME_\[?MW\P;
MPL_Y,.D/8W.V"6K;=\GCT">=XE1X!K(063_:;HM'P72,?)&=R4OA(P(BT(V
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MNX %0SRWQK -VI,+K;'F(Y;"6#/W$!_1,@B3LR_CJ-* .31^7F0A[A;0]A;
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MZ=NFDF5-3G<>$WM=:R$CWB-2()" 8CKCUW)UN[%;:&M#ZT(@<?!<'ICSNG^
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M_&Y* 6I Y+F2H\3)YQ6RY:4WEK\/_IY-TBX[ 1;^%V8L_J]KFS<XPM[,TZP
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M4'Y$IB9'F8OHO^'*O-X< !UFZN'/@&B6S/34W+)767D^%R%(3+5 %OUXJY,
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M691N]T'%3+*U7IOG'$(_NL=ZW_E+L9H%_EMVZ?CZ[$>(%P]_1\<!U$(2Z Q
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MSW$;?UDJ@4MFUQ:O?R[[6B!B6CO!2)TUH)AX*^]-._."[_*EF(.N>FHMJH?
MQ$XC/G^,%(NGO//%_/7OMUS>GBA"7,S9]U/[<D8DXNJ9N/=;:^?_M83T.V$/
M_BITF&D)&6)ODY0(ZGX<N;X=5U.?!YJ5"AO?M4O=&ZKV2'E7;+<RKY7*6=DU
MH V ]$@LZ;AI;"H5"@?7&,_[?(8,YR1=W0(BY'*OC1\_(:N6N2)8%.$5\^1<
MMCK/H^'^_X&EUS#_8J#O_A@H^G\8:.X? PW\8Z"-_]Y >^:2R )O\MN*_<Z/
M,!"7<Q'1LFMF+$M;CE &%V$;32.Q!-YR$=.F8RSQ/YG,A&Y43<&+E_-$7H+%
M#U6UMWTF)8.UYZX4/E(*/':Q3 ^;BN./F=8JN,^S=,;%&(R<UFI'D@5H7?GT
M2"HE>;EV56R!$\D(+O,K5R-^>$B[Q]."S;:;B%(Y,^SX'Y?2R6Z:P_8W!@^=
MPQG#5)8LA])Z$Y#5V*X*R&9=CXM(W'[]Z40Z2^UZT"RSGC2XR]]LPLUN6H?O
MJ-]%DF%(ICU4RD'^2<]WYR**7L)8KW0$QGI% 1_ 9MUE#9908N9/)BKL"+X!
MWU.? #_%HDMA!J?^K^/5899#IU )R)H<>#Q[$SV)1+G<IT__,5S!QQK2P-1Y
M,_*8S9R019'_)=*^D+N"/,_2AW2URT.GACM)B<@M!-4 S'9+ ZB<<A1<25>T
M+'DYH2>__&WFW.#=F +W;SB5>:F^/HPQT#X#4!\BUR,GE6!G<Z."8^S>G4C"
M]HZL=@);:GO)ONT4E?6\BBTXK).#6&A'1B<JP__:\I975T1O5#E^XHU7VXBC
M(%3;K0\_78A0G'P8].J'BYYIV;B0:<W'1_9*S[T]B2</OYC_-T7-WRU-6%<A
M)^9!UJ%W4!F]HJNN617\=2O#-O*EA]Z#*7_U<U\ED[ISO%7,OPJX6.]3*&R(
M-]QY]?V"@GRDP%W_P7_5M:B-90&F,^$+4$5,W$EW69:@QUF#94\_[ATM?QK*
M7"QL&-\9S^NP;Z]QI9N"PF.)PX6-2HPH>&7S":V46I=DZ19@"Q?AQT8Z#WT7
M6"([3I0-$4-#;V;N2ONIG7L)H7Y+]*K0O-ZDW[_.>:99F!4!V3.M<>IX6TAG
M.ADC.9\:9?I\\,JW-H7"H"JM+R^OE:3=YQGJL_9B6=$WXCC;<6IGH0PZKWNR
MP]=U<R%L>)#-U4Z#LNE3O6I!?%0$&I&+&"EL]H&5Z/V?*D34_&JC&1<1LX%A
M^;P#$ 0*C%J]G48)'MI0#U4B_:!-"2V=ORL35W0N5J?C^O77&@X)*7O>"SP^
MI,T[\OS5J@!4WUZ  K-SIDD" 7V4'XJ3^?R<K&C!G88&SU(O)UF_%Q!-*;[,
M^]GOZ__>4\D4@-9KL,X/6!SB(KRWPX!M9[2X1(8^<D1RN C-A[15IG8=\?=A
M */5C?II-XUJX2),\,/R<,2S)PFVCX7T#TG:A:2[O;.\?<!EY*8Y*I["< I#
MLXT22)&+8!SC,!=QKQJ"[<M;[A@7T0\%;A!(CQL5N8@,'SU6"/P)>JQ1%_Z+
MH,4*_+F'LQ/ZT$[KC3'MO7WPU5^,M]O3PY^/%S[:GB:8Z\P+GL:( *T**%^L
M(.LZ=![6%7Y-=E'C :\IRAU !G_TN<?AEXO.'Z^:)&L;%M>F37Y3Y[/BN0FZ
M\-E6\@@WH,(A9NMOWP[4ED4/Q-##^((WQ>,_-KPMP22_W'W=S?+#K0!H1R)[
MM1*K@)NK,,M^"-02DV"/R8_;H)6_B]Y^ATVZ5I=-YN2%A&I\BMQ>??Q(3W;V
M$6GS%&_!+\I:2]T+;/$YC@@_4Q%_@ XL]4PAR?=HQ,1EO!'=EA9T#Y?77F#\
MM6QHB&Y-7'V:9)O"J_L@^\B3ZMJVC-:+HX ,0"VWU(1LF3J<7B3R,;2;8] ,
MM60S<K/3GYWP:I#KFHBT#FC8.;IBGWIX7M!BO01625<@F!A_C?#E[?#2'28*
M*F_O!F2:=<E$L7D/6;!V)K+:6G9X92X7T,X0WM1H6]F1?3&DUCWG RK82 R'
M8O#!Y%D,\IT*?BK4SU&&&&THJ07=IX6IT[%&->,W4Y;.BWS8:ARO,L\[@@_Y
M1VE0/7#Y\]%VHB07$;PZ>J/UMUD[:EL Z#],7HVU.&WZBW+K^Z,I-4+5#OO[
MR@FXJT4"?)7' #MV%2JX0I:U'2JAH4:QC&#H"$FR61\B?W%@FUD33VV/..B1
MKW!Q>./>W8CN-\JZ*=OWO!X7_\IQ@$=L@J;!TF[@M>-<"SJ18-1O@9Y:32)W
MI9;@Y([UF0J6SPVJ<_KJ&M:\SHW<4WV?M$F,#+MMO"8*$9?/@_N0 D#K>0M>
MSW_\A$YJ^RS72>1;#D-*X(^ OK=='(P#LJ]I9W>YO7#*\KKZ[L,C[]FX1X\D
M)4J:D9P)4DUW&T!6:@.J<U@R(E14HH615L>!XCK0++51HMP^ZJD[Y;' DK3Z
M!_4$Y_$GY\!/'Q!=YZ,JTI#@J5YRP3"CE[ZZ9,#4)7PX&)EJX4;+4]G+13B2
M!DW[ OVR3Y_O/C2X8?V!?V2M5<:O7.2AT/NQVL:\J8VE7J8^9,1X 1F >5.H
MY5],:_QY>M9J6I I1@CGC??R?-7YM#=PUP>C"JGITU@$3_4NUO?M1XJ$.Z[7
M+[7R&<#+U<-^MN*Z^S*:%W(_2W^_M6LP UI&9B'"4=M(P1@RQ9YN&X/R24]
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MZ?_DLI#V\"TH++ZT050Z,^-47#]RKSZ1[5 7#$^9)9G!_FQ]UC0+/N98<VW
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MOZ!HH9;C,S+A98M3'UHWT;RHDVYDT+X(!@0@'Z?6DQN[XU%BO'0TK11=(?*
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M:^4)A5UR$W^[%_'^O%U!6/&"2>VW['\^3(SG]>JVZBI&^5C#/C<:5,$/6:H
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MFB#)FFN'<D>Y48X"Z'N'X2-G#;;@(AETX>PK84RCWS,)RC\OOHTOH45>M8O
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MR&.D$?08"I<1>@/W\R^18![!?C%>K7BYO?]YRNOY=\_5W/0,1O_UNSH0?OV
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M[QG'^YERJ:B.0UY=EF3M0\L$@^33;",>F>#.BF0O]E!#IN#\CLBI;0W27%/
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MWPG9?E\X).$X#5WH>VD $4T9C%V6PC!%21@F;DJIT0[K1#]SF^923',K]!B
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M7]HKUY2'S/-I)!.:(NEQ%,#8H112L4_DA#B,<:/,TQ=),[=-4:L,V,@,-NH
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MO4QVEFZL>/=DW?SEH77F4EZ6HCW\73G:5^*;]>_:_9ZZRU]$<<Q2[L30"9P
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M/-]S?)>%, PQ@2@2AFF2L!CZ3NI1@KS "7PCIC[;Y=QX6.(L=HYK,:\ 7JL
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MFY0;*,$-(RXUP-<^L+4(Z?AGLY>B::^FZ0% 8]<UW78XC]JF!P!HUS<]?'.
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M 3AE%NTW+0^551K,Y_5:NC$?MK6ZI9(R5JR)OY>"_FK^:;W(,A3A F( !80
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M,9 Y-[(ZTCJH.[6;4%IV4#P07+<]O0'\&D=C[D'US%#'>.XT;@J ]G0./OG
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M-.BQM%]P/5.Q5+[MC[=37U4T_$59$)35K\$!]H,57L(K[4%TQ*@6"DQ*F_8
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M;9ZZ_/].9]?5 <[-@]Z'Q@^ZGK\2(]4 ]LKWJ@%X+P$P@)C?U/]S@N>0\C\
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M[+HD9MH,K1%C3U*MQIZW; :Z)>LF:F?S477S^[)/FDPPC4*!&6!9ELI-2R8
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M4,)#(%(624K)PBPSJL*K(7-N_/%E53V +W*+RZ0G43TT^:G-O9C<GDEU#2]
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M@OC.L&!OF6J7=; M:(PSXZ%KYE"/K"::&<^,9C$17DZ9'*+JB ROT612QG0
MV6M:=3&D'?=^?'Q:KEXX_\Z7>,/9EQ(3=7(N=U5=D.2^Z4P2(Y9&>0H*AF(
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M)=G*7TW#3!<MC/4\?.?(>2:%1M^@4_@FZ%0.^CI[Z&EFA)*K-!4MF=.FI9C
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M[V#ER&'O>LK 3?^2KQYE$2,A ?(B*XL%QM3U",80AWX,44@#B!T<0.9'ODP
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M?*(R1IW,-+6=O^",-1^XT&&M.J$W&^'.K\J%&W*'NRB E&$'HM0E,&$\@"3
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MA%P863Z%),(II!'',<9A%,5(1]]?2,\\K8&FGW>;*[ 4#%V!57WT6^*?>M;
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MY0F\2J8 %SQQ5LAGLS5XV7(&L$8]6"OKJGAW/-%JC7VE+-AH)03*3@([3J[
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M$\]-W%>4@J(B%>0K\-H0"]:"VJK*)M:LLZF]%"9W]W8 GOJ>O@;[^P[L+>%
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M$QY6?5QO?G"ONU:4I-QG0LR'/*+" 8X1)(1CR-S B9+ IS[R= J"CKE6$Q0
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M!G1/?]V/?M<4<_<PS8M++)'CU4ADG<I4V'N>FW"(:.Q!0EU/+ DC3H(P":-
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M091R%\;$1Y CQ_/<T!-?DE;CK8YYYB8WCBUO\RXZ7<"JF1X6X)K8#1RG><X
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M8A&, ^3(W,3(]5*7.IZS6/%'+*37@[J!VC^KTM>>U%_[R=SC??DMHB^O #N
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M1"I/=1",8AFI@+$,:@\32/PTHHG+<.1H]2(WIF1NF[LF6III%=4@Y<)2PP7
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M/_WGOVU_(_Z+X(+_Y[_]?U!+ P04    " #1B5I7WI[/_0&+  !89@8 %0
M &1X8VTM,C R,S Y,S!?<')E+GAM;.R]V9:;.9(F>-]/$9-S.Y:!?:E357T4
M6C)U.B*DD12=/7/#@\4@<9(B521=(=73MX'T?1,7_/PAU51E1+B[7(0M'PQF
M!H/9O_[W+Q]G/WW&Y6JZF/_;7_A?V5]^PGE:Y.G\_;_]Y8]W+\#]Y;__^W_[
M;__Z?P#\KU_>_/K3LT4Z^XCS]4]/EQC6F'_Z<[K^\-/Z _[TC\7RG]//X:?7
ML[ NB^5'@'_?_+6GBT]?E]/W']8_"2;DQ:]=_.GR7ZPKHK BP!MA0"%S$)V*
M8)3PIA3ZH?7_U_M_X1F34*C!Q.Q!118@>,6!!^NSR3IS(S<?.IO.__DO]5\Q
MK/ G8F^^VGS[;W_YL%Y_^I>??_[SSS__^B4N9W]=+-__+!B3/U_\]E_.?_W+
MG=__4VY^FWOO?][\Z>6OKJ;W_2)]+/_Y?_WVZ]OT 3\&F,Y7ZS!/=8'5]%]6
MFQ_^NDAAO9'Z-^GZZ<'?J-_!Q:]!_1%P 9+_]<LJ_^7?_]M//VW%L5S,\ V6
MG^I__WCS\L:2&;^DQ<>_TC\_US_^^>F"X$"$;O[B^NLG_+>_K*8?/\WPXF<?
MEEC^[2_Y2_H(5:/,2U:7^S^W?_'GJU4_+7%%4-EP^2O]X/SOUU7VI0"_K'&>
M<<O3Q>?/%NG&+\VJ1!>7?W,6(LXV/YUDG$XVG_HDKM;+D-83EAQ#&RT8IB0H
M*Q "1@=,YJ"LLC::?)/A2O"**-XH8(7IK^\7GW^F#_ZY"J%^L9'&1A)WEMM*
MY3"Z+W;<._K="1<R("L2@G.T"W0I$%-PD -CR@=G31)'D7U]M9M47]?FDV7Z
M:;',N"23<;%<6*8[FKT)UO/?^/E36-('0?HPG5W*N"P7'UOH:KUH(+FM6HC<
MO_Q$7!=<+C'_NM7*@\QM.%N3(<7-;[;0^/]]%I;TB;.O;_#38KF>2&\=HO:@
M68J@E"$63+ 0@TQ<.J.-U4V4?VOAG7 @^L?!,?+L!!*O<3E=Y.?S_(P.WPG+
MO&0,9/-]L:""+> P6PC"HE*"BUA2$T#<6'8G.,C^X7"X+#L!P[MEF*^F5?#G
M@!:180PN@0LY$P\N@B]. '>1_"HIC1.AS>EP:^6=(*'ZA\11$AT9%<_GZ^GZ
MZXOI#'\_^QAQ.?'6E*P(PCZ0=ZTD"<.;I"%K)4R4OJ3$CD+#[15W0H'N%P5'
M2; +[;_!]],JA/GZ]_ 1)]+8E+TN@$(EBIE(&MZ1(+(G4,> )8G8  $W5]T)
M!:9W%!PAR2Z0\)*"^"69L(W@WY+\\>GB;+Y>?GVZR,1.L(9YAU!4)&"'DB!F
M36>?UDDR@Q:E:0",1XG8"2>V=YRTDW,7L'D7OKS,)+YIF6ZS$^>6D*Q@9B(I
MT-(H<I6] L<+!^$L<>6]+<$V ,P#R^\$%=<[5%K(M@N0/,F95+ Z_\^OTSGR
MB;2$9^L"227X&DLQ\"*2D)C-$5T)T90& +EGZ9W X7L'Q[$R[0D83^G+5\MW
MBS_G$^6RD2(E$"9H4$4*<)DX2H9\**<R!=K8#A97"^^6NF+?"2H.%&A/F-@<
MC:^6KY>+S]-YPHD627O!#&AE$)3G))=0,L3"I<9(4A&^'3!NK;X;.CK.;#83
M;4\0>;U8K</L_YU^VKA."H,MCKPFQBCH5H@*HG4*@DHE,*Z\8RT\COO6W@T>
M'2<\&XEU9'!4J_=DB6%#=Y;!,.XYL,SH0&3"$\F:@XFA:)^+"%H=!8?KJ^T&
M@(Y3G >+;F25USO1V>L/B_E%!L:Z9+RGD!M5(@&40DCEC X^H:56*6IACLMP
MWUYQ-]5WG,H\2H0CJ_\MIK,E09>+^&ZZGN%$,.>T)Y=7<D/6*B-!EV)G^LH&
MI0HZXX]+8=Y><3?U=YS#/$J$(ZO_W3+4NI.W7S_&Q6S"*/CAP2:PEI$$A$<*
MBYT 3=&/C4IR+8X+'6XLMYOB.TY;'BZ\3C;]\R_I0YB_QTV^U2>D*)>3T7)<
M@$K50Y%TA!5.QU<ICDMYW'%_WZJ[8:#CE.31HNPB''AZMJSBVM[ 54B3#LY6
M$V:#T3(@&%OKQ*P0X",:H&B&RQPE<_FXZH?'5M\-&MVG(!N(M@N(O)S3IY$X
MII_Q65B'<[8F@CMG8[+@M":HUWK"P!)"]CPSX33RU"*I</_JNT&D^T1D ]%V
M 9%ZC;M\&M;X?K'\.HDLU(29(ESG LHS^DJK L4H'RSZ$GBKN_#+17<KF^H^
M!WFX(+O P=N/83;[Y6PUG>-J-?&1PAZ3-9189*TB9A"%89 P!\R<O*70XN+S
MQJ*[X:#[;./A@NP"!\\_XO(]'7E_6R[^7']XNOCX*<R_3@SYR4&C R\CQ40I
M2'"&#!S3!D.VWF?1PJFX=_'=<-%]FO%XP7:!C[<?<#:[H)ZKF(R( @PB!\4-
M\5%00.9>4MP<BCFRL/+NFKNAH>.<XY%B[ ($1/C'6L:Q2/]\^X'DMGIUMJXO
M-VID/;$ILU@4 Q-" %5"(6X\@9LS&;-@TC'> !2/T; ;2#K.3C86\\B@>?(1
MY[G6C;Z8A?<3H1 M:@LYVTPR*>0:92%!DX_LC,Q*2'D4/FXLMQL4.LY4'BZ\
M3LJO7TQ7*<S^'PS+%_23U20IEG..$2SYP* "TW3XT;D7LT2FF"\E'F<?'EAX
M-R1TG+IL(="N,+%]6;!E@IO$K:%8*>OLR)PI RY:!3:RD@S%SO+(4LL'E]X-
M%QVG,]L(M0_'@MA8AMG+><8O_P._3I@0GG''0%A.8323EL)H6R!)S4RQKGAL
MDLR\N>QNB.@_BWF$,,>N:=BFTZXLW<7S(_0F9Z(3G,^6?)V<(:3(P9/3K)SS
MPAUYX?'0RKMAHN.T91.1-H/%O_Y\1XZ_T@\.?8H]7RUFTUP?VO\29O4%.<57
MN%[],0]G>4H_O4G_KN^TO_FI31YQ[T?[D2^\SU;P/H1/DTTQ7#TT7I47TSFM
M.J638[%]TW4)->36%BDUQ&@15#:)0@QC0)MLD.O F'_,4RMA%3<P.%]TN^-P
MMEY=_.1JZ^U#UZ&&Y6*-)ZL5R?>22UYB<=EQ,-;0AE+UQ;- "58HXXQ%'^5C
M;\4/X?(F!>.\'Q\,"1=&IX&X1SR%;E)_;CPOF4@,R5!P"Y8G.DH=_<MI#%"8
M9T84[;5^K.CB<,S<(F1<Z!RCV7M!<HR8.\#*T[#Z\&2>ZW^>_\?9]'.8$3.K
M)^NG8;G\.IV__Y]A=H:3X)AVADM@C/-Z)1#!V^0!;9*<!U:P/';[>@AV=B*L
M!RP=!8#%T-H8TRDF]V3R#./ZO'9EBJLGG\.4?F.&+Q;+M\0<\5KY7'^]^I4)
M&E9H(WK@LK['3+0YH^ >&!?HK=;,W2X'ONL'';;T.,TPVJ/I!(+OP'(]2:D^
MQUR]P82T4XBWWW%]4=.0>':6>0LQ6T>'/VT1%R4G7AQ/6MN@'WT@?]!A]P@]
MX_35&,Y.-9-]!SAZ.?],5"^67XF%B4<5*5BE2#)904)!04XC1:I)&]2ID&O@
M'XO5#\'-]?7':;8Q'$X.EFT'N'B]Q$]AFI]_^83S5368K]8?<'E#1A.6I0U<
M"C"RRD8+A*B\AYR<S;D(KZ-K#)<=R!JG6<=P*&JMB0[ =9-X9$YJHQ"$UH&(
MIT/7)R[ 2F]4EE%[\=@+ZZ-#LW'Z>@QX/!TLW<.AL5B'62.[L_B$R_77U[-
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MY6G"O$ *7LE/U)HD)#!!U I!,V99X+0[6.NBUP>)V0E0S:?_G0Q0;930_W3
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MGE'<+WEA*I4B6_?).([B\5OIC1T2#Z':+JI5'G.*O\VNB5:R$&G[^JQJP\H
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MG7N<@336IT5[$:;+33[MMTV"[7!+=O\'-;!@.U#8R')=KG2EZJN3M(8;IK@
MC+,(*C$'+FH!TC)A_::>H?5CAL?H.=8NW2?5E_-/9_>?W*@HJ'.J0(CF,LH3
M#KQSF9,$?/N[Z+T('-<V-</-;5,TG)+Z-$:_A%D-]M]^0%P_PW68SE873LNE
MBWDM"7&(F=IWB08&["BNNHJ.<_9:\.R!AXR@+!U\+@<+VFL3HG-HFS_HZB(Z
M?I+S)ID?9O<I[+Z]Z ++4FI#'D<=XN)SA) = ZL*Q3HE).Y:N[5[$_DCQ+?[
M(/*V=1U6JWU:V$U;@X/BU(MV",>&H[?7;V3@Z@??$P@HP^C4BQI4J"\2#>?@
MO=1T^I:@-).)(H$!RD':QY$W/_5:!,*$,#I*"*KV!T9CP#-KZ5],1.NY=J9U
MGNT!4L8U)PWT?U\UR[$B[],*W B?#S$'-S^@@5UXA*)1TE+2NA0+1?*.10<J
MB@B.>P\N"%9DUCXU'\YSTK34K_@^S'X+ZPJSVZM=(;V4$(QV$K13FW)8 ;'V
MSI7)8,B2A!%;3\G:B;#O*16U#Y)N6Z#V6NK3'KV<TY?X+GPYS!I=_^L-;-&#
MU#2R1)>??P]:;++2!^&!%=*@TKZ>5T*#U1X3*I&=M8UWW"/D-!C'=_NCKV#+
MBF(J1 /H<P;RH M$9R5@]-D6)JU2K:]:'Z-G].'U33!QSYR]-AKHTW!LRD$_
M+&:DG%5]3;'^>HC]N.=3&IB1;]'6*O"Y5.RFU6D=O[TA]7R8Y]/%:KUZ^X%
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M'_'9XF.8SB>2J2R33B 3(W-DA:VUZ0IX=#P9:S'8UH^YOT73N!#N!CP[@?I
M37: S#=(!^(TD=>Y20'^,9]2$/WVC_-;/)6CBEQ:R$K6%[*Z3BY5'*P4R13G
M*8!IW<WF48)ZQ.2ANK]31MU*$1V@ZA^U)G.^/B?>VL298!R8H:A711G 4;0+
MRA5T/ K)0VL4W2!@W,+G05%SN* [0,FMU_E7PCEG1U@;)&,!,-<12HEDXFL9
MMTDI6"PB23Y JNLQDL9]GCXHDEHJHX_WZ-]R?1_R?*_R@L7(%+WSY".H>MO%
M$%PM9O)&6)%\UC$V;YUY--4C/_/H(O0XL>X[L*6_XWF+B5\7J]5$,9:4DQGH
M1*BS;XVIS9;)S64N)N&4"LU/W!L$C!S^GEC[=X8''ZJ*#G!TT9[DU?S6@4!<
MO2KOPI>)8SF5ZGOR'&I)9[W#"'0:6*M<0FE1^M:G\C>)&MGFC8NWMBKK (,W
M-M"3-85%D0+]^J1O\7JCD/-[DDF562Z1@?2,HB)R<"#R%"#9X)2,Q<GF5_"[
MTC:NI]B3!6REP,.!N5B'61-@WLXR7;UA+2)J\KPA^$02<W7,/&8+%(W)$"36
M/F.-@?@0+>,V,!H9>$T4U($%O/>">,*=M"YI![S4.=>R)/#)"<A:V.@TB8:U
M?CYZ+R'C>G=M=/P-X.PO\ Y1<V%EM7 2(V9 SVA'11L@!B:K"\HDA5D>9>O1
M80^0,JZ?=A+D'"+T#K#S#YR^_T!T/R$',KS';='F>1"_>G6V7M7>-^=C>U-]
M(R2,MQ8<,0G*%P]..@>2,YECS@5+:\=K+P+'G8$S\B$XG"J[R.N19[D=JQYF
MY[7K&\9NNIEWY7LM[S31O)A84C7D)E81*_">UZTJZ,<8/!.M^^X>3_6X@W%&
MCW%/JO1^#?+Y\7)G,T^\]"HRH\&7>D.8!(.04@%GO$@F*"US:TSO2>*X8W/Z
M-,I-U-DL,AZM6/CQ:H^JS*=AELYFFP];E!OYA4\7CM=I*HI;DGKBLN/!I-Q5
M;7)AV=5_ !67H*SCX"47P(W!%%.(++4NI>JL-OG(VJGM]9LT1BI-$DPB!K)X
M(I)?J J$K$+24J586J>TVG+P(U0I[X/E1P8)GAH/';A/0]8/6I^4E8R#]8*<
M >WH6'9T-ENN,3IR+,MNO4'^_U+E<5%ZPGKE?2#3[>ZY5FG$G..J>J:6)P>*
M'& (0A1 '@+GQ@<N6E?&_->M5]X+//O6*^^CR;'?]E_5R-93%)>;_MOSA%<5
ML^?%:CX*)ITC?@0%:<I8!YXY 25KE3SR7(K^5E"PUXH]@N]0)2^&EGBW!F[G
M[7J5$R I:JM)J&CJ#*F(!B)&!LRD$GCBM#E;MS)I17LOA8+?^\%_&!B^_TWP
MY&/-+TRLX<&IF('7NP.%G$XGS3Q(S"1W5N=I=/9P;TMXCR9[:,RU!?X! .BS
MO?HS_(RSQ:?S"1_;>=#OE[@-QH_(*^[TN4T&T.Y+?Z.,7;V+F:ZW.8OYI@L+
MX0/G-=EXSQBS*+3(WI!G4/NP$&(2Q*(-6&T8!F=]=*W?O.]%X+'V="/X:RMN
M3R9![''M%6A3+UBE31!8D1!S<(''P"(OC;F^EY!Q[=UP2+EMU([7PMAASL6\
MJC]HAQ(G,_KSQ7*KJ<M=O0D,A8E&!0S ZD1ZE<GSJ5.B0,K:H=D+IVZ_F7\@
MS-EUQ9%SJL=K=C&TF+\'[%R\%C-683:R]O*CN,W5!EE6T[>1/&9K6:0-V P]
M8^9H!M3VOG@Z0/1C(^H:)Y_QVGWY2XK^IV%VSO5%&L **34WX'*H,^QJ35WV
MVW(+%93C*<B=,+7/JIVCZA"=+TZA@%Z1]=MTAJOU8HX7TCWG+7H4'$T"BXHL
M?2@1@M8"BJUENE&R=+ML:T]P/;#PB(UAQ\17"S7T"K$GGSXM%Y_#[)+'<]ZR
M%2DYI@&MC36:)N-O:],^KF6RS+' Q%$0>V#A$7O%C@FQ%FH8>6S$TYH#P24)
M>OVU9MPW/D0,)OM",N+."J+?X:;/(QBFB0.CC>4[%>-]8WK$?6N/F]5MYZ(W
MD>W8PX/PT]DR?0@KO-Q*MUDZWUE6B*046BA.,U")T\Y"<CII'V0;,V:==KI/
M_=9HH5T)&F\&S?$Z7PRM@+$/M?^)R^GLZZ_3@F_3%.?ILD>'E#):*R48'\GY
M<UJ#XQ9K%B5++0R3CNUT>CVTPHBCB8;1Y**U6#NXUGE'O_>J7#]EZQ9RPE+@
MJ@)DA1R4KH%!JN7O2C'!>7*Z>8>Y>PD9]V%TN_.IG;0[@,SUAQ)/YOGWQ3Q<
M_>0=?;4*J:KH,@20@7S][$%+VED45Q)[=<Y3Y$D)'EU.J?5+U#U)'#=3V0 4
MMZ_J!M10!P!\, 8];VR6@J#80H!&3C;=U,9FR2.Y R(QH0)9^M8O6!^G:.3+
MXR'!<*<O6#/-=("SV_;_ZAZ]N&1R4!Q*$;5$BAR(6%!0J&N4C]8SYYH_&WB(
MF'%[.+0_(]M(O0/X;,H>7B^G"2?!&I.S"2"X(*<P*:Q9, =8#"91C).R=>'7
MU>I]W<,=J,[[>K;M+]NQ@[&'[.,?GTAP\_4+Q FWV>N(&E@0=.XG1E(A#D R
M7@)F7I]@'Y54O%JKK^S/<< 80KP]V)!:.OMRM3K#_.QL69_G4=RY.'\"^CO^
MN?DCDEC0-I-40&B=0/F4P$=G00AF1$3ZL]#Z/>]NE/45P#6R/>UU,FJOA+M;
MYPVIB8CY0.[BM6JQNGT*]T+2/H%(7)'<7 0O8Z+=Q'@H&(.[W55H%^OTX'I]
M^3:M+50;,8]]IKU>K(GJ:9B].%N?+?':B,BZ$:H[>'MG6!9R]$F03VC(!F<R
MOX%V"B2> BI?3+B=$'BHEF3?I<=M]3( GH85?@<'X(OI?+K&7VFWY)>U8/5]
M[5?Y9+7"]>IOR]HRU66+HG@#0B4)J@A#X6KPX(QRDF(-Q4+KQV7?HFG<YBO#
M''I-]=!%:Z!'.'J#]7* 3O8G'Q?+]?G#[.TISR?$)NH2:WO>6BJ3L5XO!0V(
M+GEMM!/8ND3W0%+'[:%R<APVTUJ?[PY>A.ER,VGY-PRU_GDCU,L?_GV*R^I+
M?"V+Y663@*U<CGB3</2:#=XKM.6[T5N&R_6OZM&O&C$PS(8KQH#3R0H* ^$;
M">D"0RHI<F6;#\)YC)ZC#>7%9V_%2M[JQ<C2S<"'C5+RJ_F;^B:HAD/;)//R
MXMO:.>X\+>AYP2Q% (8123 Q@HL9R?<(P3"NLV@>IC8C?MPL6C.\W;&GHRBW
M!\?R@O%?OMXU)K_6<&QS#1>"2-:5#)+5:[A2$@13)#AA4_21%9GU4)!]E+).
M\'A:V#P$WG8Z[ F9CQ]XYQ4L"3T%;2;7V3JJ.C81 B<SH%5R%B43@@UVV.Q"
M8"<X;8B0AT#87%U]A$D7G+R<?SHC+[[*C%]4WI*G;H7E8&BG@HK1@-/%@];2
M9'0A$]%#8>\N.9T@K3T,'@+<D1KIR=1=8T6<LX+)%J=-HCV9:O[<>'"HW6:0
MF(M"Z,!;EPT]0LZX=V7C@NL0C70*+GGQ\LE'*8T2@"S1/E'!0*PE5IF%K)SE
M*K3/&CY,SKBW9.."ZQ"-] "NBUS#RSE%86>797M*:>N=$)#KI&"5;!4/V6/G
M91$\65^X: VL^TGIQ&*-&R TT%('8-M4Z='*58QO<?EYFDA$UYJ!7G&WJL6D
MJ_O_Z'P#FQP<3Y%#RKX^CR@<O+*!]IT.T7%K)6L]DJTE_2-[>2T =;LH?"SM
M=H#L/][^;4'1RGS[1&/YZ?PQ817%D_..'W>&RUJIA:7CH':EVP1KQ*+@&9)A
M13 3LF@^Z?< ,D>N*1\-4XO3*K@##-<[+ERFS>OZ3[@\9T([QYDD[UAJ:T!Q
MJ8'.*P&^CI;(/)CV)5GW$C*N&] -#H]74A=(VVZ@^X=N.Q,H.$,.UA9)'C2O
M1=<QU3F>+@=)LLNM8YI'"1HWJND(>:V4U@$"6[CU5X4 %# 2]]'7YL2\-@/,
M$!+Y]U:$8E+)Q=G!4CPM&.@D;N_C#N;DB/A!ML/E-:Z43A>T$J++9&0861HG
MM >F?2[2DJ'0@UTU-J"_D_3[Z6$XP(8X"!,=[(>G8?7A^7^<33^'V>:YX?II
M6"Z_$E<;@4P*(W)C2&!#I,-.T($:-O<41H@@&:/#KGE/ST<I^OXQ>QA2;KLH
M[=36 0B?? [363W77BR6;XFC*Y_KI@<V(;]-B/JFNF"=Y(JY>O]:@\R5*VZC
M+:U?<>Y*V_>?O&T"S$%4V<6U^K;O\D:\]]1V33A1K5*Q8'Q6%)B* C&:!-KD
M)#"E'%7K@5J/4_3]N[I- -E0;3U8R@<9":Z$3$X0T!=D\FMSTV@S!UYT1BR*
M16M:F\:CH#?8([!NH-=&67V._[SW"OKWVJ>BOI-K7<!^YX.'JE)_G(-3E*)'
MAR0,P2';;2\T"Q3!*- 2O8\&76A_'?U=E*)G7ZS$F,$91@Z#40ZB"A3A16Y"
M=((YUOJ _:]0BKX/WH8K1=]'N1T<P\]P2:%7M1-7F><WT]4_-S?+6CE15"$.
MA'2@BD?R; M"2HYCP, 9:YT5>HR>3K!W6H@L!M)75]BK8S;J'JZW(>?7'L)@
MR(X\"61U7)!/%/@GK4#632ZC326T#I ?HV=<[+73^H-P.E(%'<")XG2<OI\_
M_Y(^U.8K].V?89DOZT>C#H$"(VU-K-DC\E@1:0N&D*)RC&O6.JAXC)Y>X'2L
MUF\?HZU4T &<_H[Y/=GM9[@BCK:JJ;LM,U>RHC [N,Q (<,:4&E0UCCGC.=9
MM;[IOI^2[S]-=_QIV$!'72+M?"LBUXDI2_;<)N)#> .^. ,J6)F$-=ZHUG<6
M#]$RKL%JH>=O0N< H7< G@L&,#]9G?-TY2.<6][ZDJS4^G9OC*^7*!I<';TB
MD;9>UKI$U3H2WX&LWB!UB/[ON%-ME=$!OJZ]8KR67GJQQ/\XPWGZNIU$93FJ
M5 ?@H261>7(^G>,"F#!%9YD8BM:^^@YD??_7!L<?D*VUUQ,@[V/H? ^KR(-,
MIH!/FEQ-3MYL<.1T&NF8S2J49 <K9WF8K$[R%ZV@L,-;Y&/TTBG45M=WZ;E)
M-Y[BI7KKD76B@T(8 \2/@<)M<H)K;UWSX'(WTCJ!7"M([/+\_4C]] 2[)O5D
M&(M5269(,0I0KF@()&8PC@?EC&#&#O;<]&2%KEU?P38\QD^.B+$[?-[B?/ML
M]ZJ^?CO8/06FA:+#R@H62+3DO,<L"[A@!#H?DKL=)S_0U'.7U3HQJ:='PF)(
MM71@=J^RHK\OJCK#[)R/H'T4DA?06&K;4I4A1*9J^40,@7/K1>NG @_1\OTG
M_8X#7U-==5&,]^MB_OX=+C^^G'_&U;9;Y0116*6%!\[IE%!2>O*.HH-$YP5B
M"#(TK\:_AXSO/WYN@[5C-=2!:7OY\1.)LY+^JE1V-CU,MX+].\[RB\7RCQ5.
M=!$BBEIKK1VYXDPJ"%X(P*"$=9'YXEM/"MF)L._? VP#Q/9:_(ZZS3Y?K:<?
M:V;U\D]7BU(KL:^_F&Q<K+?/FD/5\1W,]RE*_))B1AD>0)1:^I[JQ&5)T#-)
MY:"DMH2^[Z#$[Z9+>^V#W^)\NE@^79#E7ZYKMV?R-O \GM,V!&MB >\"@BK9
M0! H0*ML)0N1H]MMR/N>"W<2?QP+A_O#B0%DW\'Q6XTU?=K'NFUKI<6V;(=Y
M9XU-$*/CU85P$*RNSYM\4,I$;V7KYIGWT3$.G(;7^CU.W%$JZ!!&%PT"A$N9
MD1R*K!E4C?7"4ANP2%\R8H&%UCUI[J=D7,MTO(:_ 9D#Q-T!:+8;:K.+SK/A
M##W989. 1Z^  I::B/09<G':<U$".8^-\7*'B+Z@<HAF;P_F.DK,'>#DIDNY
MV3S<:"NYL) V!7NL6*#X@4[WG+QF.0HE6]\<W*5BG(S7R<^G(\7?'8"NS;G7
M4:H8 J,85_C:P(:L,6,>K!=&!*\YZM:WHP_1,G;9[7$Z?A0R!PI\[/N=VSOI
MV1E6;5Y<W&:7=%9T:.M:*Z5]@&AX;7+HT4N3F(BW$J$/COQ[9)F>4'&H&A>#
MR+1/=.B+2CKML2A11RK5286:D;TE6PO&U)]+JXMC1Z!#]]#$[E3H.$2F?:+#
MG7,B0W#%"7*XS&;TEJG%P=X#%JF8\JC(O!Z!#M=#H[E3H>,0F8Z-CON\MZL\
MO&>.L]HEEPEE0+GZ@MW(S:Q<0<8Q*FMW&W7]Z#+CH.-DSFMC.7?@Q%Z33=U;
M]_$V"<8*'R.CS53O_HSD4%L@0'$E)BV-;-\Y< >R.LOC'8B ._TKVZJCS_NN
M7\(LS!.^_8"X/K_*"?.\:?=RK2]H62P_;A9Z^V&Q7-<+Z=_"\I_TZ_%F;Z*#
MK\"&(*/!K=C@TFET4?9J^3[,SR=_$FY7B]DT;_??/+^^QONU9J]OZ2?;6[[+
M*Y0<6931*N!.UIJIS"%J+2 [+-$*PG-H?2O0A/!##>]JN9Z\31\PG\WP5:'E
M,\Y7F.]9:7M,A:"LI],(;&"TVW460'O?@).,^Q*D-6FGY"6M>TTV]-V57/8D
M:=SH\?2HN[#10VJN T_@H6D+ 34+J4@H1M=##&OXK 0$)YCU.7/%FU]Y'S%D
MI3GP!E7[CB-4]M%!!U!JV@X<BY!9J0C.>@F*,0$4@04PG#EK)'+;?.[=CS]"
M92] #3E"91_M=H#L0R9L&)8XKS&FQ.JOAZ@@8HI@-6.AB$ A0>OKQ__:(U3V
MPE2#$2K[*+@##-\_G4,8Y-(;#3K6NV 9B(FB2&BZ4+!I,<80F@?Y/_8(E6-P
M>+R2ND#:H],X=)&<<0Z,Y0Q*I0"NC@56QC/%Z'Q"T]JQ_*\R0N4XY+52VH@(
MK$[[8Z[ZT_!I8]:OLG8F9&DU;2B--6O'T4!,44*2,B7$X-#L=&G_C3A[+Z+&
ML86G"'B&U4\'IN_A9NJ7.0BCN#2RRBW7_M7!D@]>LB<&'8L^%,\B:VS_ODW5
M>#'V@'#8N=']0;KI$&TW3?>3CXOE>OJ?F)\N5NO-\YP)LNR%3 R"E[61%"*0
MDZJ!DPP#"G(RL'76=5\:QPU(6F/D&Q!LJK!F;<<' V1*9Q_/9O61S]^6B]7J
MC_D2PZPR_#?R7G[!LECBN_!E8GS0RC@+>E.Y@SZ!I_\#*;T2SLFH=>M"[R:$
MCQO#C O= 53;OX%]D.E?Z;MK3$M?F.8*#'.UVY!QX%428(O@//JL2FH]IK0)
MX>-&1IWB^7#5[H]GO\7S'-]70MZ=?GH3R3>55#FK;\"5+9&VJU'@LO;9,*."
M:IW#;#J]:;#'TB<&9Q,%_1!%(2T&EAR[Y.F+/4XRY*3-%;M#D:TW# RWF2(T
M"LZ<31:8E,B4C(PUGX8R:F''OEOVZ=FR&ACRA+Q2BDFP6)NN2N$@).X@:EN"
M3I9E/99I/2?Q1RCXV >-AQKA0S3Z0]CBVBAF3KOBZ^EL\9TE3V^+'^>Z*UNL
MDHD2R3'(OO:#1%=?!3L$<DVB"88I=OOAR(]ABR]5]";\^1M]^))66?V.ZU?E
M#5&P_%RK:56V-@@%T2/61NJ<#$,I8+0K7#@EHFM=W/QMJGX$B[L/YNXT_FFK
MMPX2")<<_6.Q_.?+^>OE(N'J%DN>!2:-\L"4J4^1HH=H P=?&[IQ5W)*S=M1
M?9NL<9-9'6&QD>9Z B/);+KZ@/EOBT6^Q9+FR9@<-*3@"SE,.H-CR@%C15&@
M2=R5,A08'R9KW$Q41V!LI+F>P$A<3&3R6#R2AQY5!%5K6[R1#)S!S(HK2IO6
MQ9[7UQ\WE]01O/;519^3;O=TZ$G&GP*)_/Q7SL.Y;;_!TT4VNU!Q^F!G;]ET
M%?]8C124\YH=U>0L9ALA_N_VOJPWKAU)\WU^Q6#>V<U] 08#R%NU 9=MV+ZW
MT$\"5SFGI$Q7+BY[?OT$<]&2RN7D.4R14M5#72\J\P0C/@9C8T00&A$O! W.
M4>U?9"QJ+;6WOW[DRHI-?((Z;TE.NR41+.):<*29%H@9K;#2- A9FAL["7D)
M7LXIR-K6ML.E4_O)^7H'M]?&9@^:"J^H-R@:[A'/SZJM,P3AR)C'7G(JNS6J
MV/.!E^"3]$%.,:;7!LZ;]3=?3VXR^%=7#%Q(JPMELR/NC;<)ML!=9A'-254-
MCCZ3 O9"=>#;<\/WP*C3YUZ";]$;5.4%TH1K >9.3L_'V9?HX^CGLEX5="A1
M+$9$!:%@UV*/-&6@8)63TBB!4_&Z\YV$O 1G8\CU-UPZ#4!L:0T_/"0$B.86
M3@51*@># OC?S!JD&%<<G":9<.DPWF,J.H%+O%QP#91+ \AZ:!U>K!VOAUN"
MBYUY:0+"'KQS#A8C,A1SY"DA7BOM67&H=2"K$_;DR\5>:<F]D.#*Y$><SG_#
M_^?M/Q:C'YG=3QE4V?_U&L&4CKQH*HAB-566,X6"B.!?R(CA2%B"'&&!",.2
M":6']#011+E["[616S:,YQ?WA+=Z"$554)S@A *7"G%B::X!C<@93))CCD=6
M.J[2E;:7$&HY!7^/NE6?0X9-& E[=O/J]VU+>&PHTX9Y9 /.?*,):4P%\CRD
M8(TC7)?V=SJ051>1Y\'#(SN@K'!:QMN]KO(F::]MM CGD9_<&8VLP7!L,7AO
M'OXC0_GP\E&RZN*M.!2Z0JVG7!J V@>PCO+L,?CE_<V/Z>3GZCJX;>H<L9$Q
M(NL903P&.)=2>D3!5*=.,J=2::5VD*!&X=57_-N308K)H@%@O5H +^]F96M#
M*4\8C GLP-VS&B.3$D/*4B.,8=:+TC[T0PKJ)C/.#9T!W&X *^\6T_%HOIAF
M+_[=Z%?^W2WJ&7<ASUQEP<D\^XO"GGQ 6C.3NU%C14H72.VGIF[NXMP8*B2%
M!O"4TRL+6.Z60YO&/CA%R1E#*1B3>P9KI*UEB%*#,><I5_ 4!M,>4NIF)<Z-
MI!+\;P!&V^1;QRRG1"#P@\%+,6 _.IGK3ZF2'+MHI"[=O*L/;,Z6;S@W;(;P
MNP&X?(AV%K]/KG<9;\REQ"FUB.0W45QQ@70B$47,74R2BX!+0^< .753!V<W
MHPO)H0%(Y3#>?+KPJX=0P+@KD-5F+X8%:IT'7X FGF<^@VM@M4%42V,L#Q+[
M\IW=]M/3"53JN8*JF"0:0-5>7GVX;?PD?%+@8FHD+98Y<6:1QHHB';V* 0<C
M9.GGLL>IJNO"U0UF]A--RV!;-OJXE(28Q)A$"=0OXM@S!"<43A(.7FOE;*+D
MJ8"VI*C1$%-/^7>%U^G":!E:2P<VI[CBTA;X,KKZ/O^4_IC%977 JIW,O98S
M;R+LP(\VN;)U7[#E'R^-8-(P#_YNR(?9&X%<Y-D0C8XZ(C'\U5/AL]RV&@V&
MG1GDE6#Q?$]*1V8$KGW4H">2X1AQ)CA<>"HA0FDTC#JGBY=ZGG5#C8;YJIZ.
M,T"AG09=?7F2X(1V9(R+V@0E$_(2= 67D2$C24+,,G [,$O FD;.2/==-1K%
MK'M0S@2*%U&>>*]$\^FJ$G=\].F+$8_MO*D:1)42,R11%(D#ZU\;\&!9,(AZ
M;!3ES!O\(A]R?IB,K_*,O_SH:S9?+GW)L% \#X-(L&O$702;3SJ/L 8SCS,5
M#"O='7<'&2^ALO 45#V*Z0Z43.V7>!OZX3:8S$9 /,GS2PD.B(687>V06^PP
M()XK(1.7/.ET3 _N7/E%/-KL@93A;*Z-D>45L=G!ZJH  T:#29TPLE2#A>#R
M4\ D S+*I&"YHM2Q3C#9L?B+>(G9%RE#F=V 4W_/I/@X&?OUDY<4C4O)&#!T
M)7"$IPB_$QHQYITA5@3*2SOC.PEY$>\N!]Q8PZ7S(BQ^\(0F"^#I9_L[)T=R
MA:/WTP7L9&3=Z/J)ATN?0LW3^PB]>=64\R!,U(':/"Z&V#P]S2--8IZ!:15.
MFFKN2U?L->$\;$GO8I?T-@U]QN%.)]PR#JZ9R!QF2,K<44P(@9R+!BFL C,R
M4M!&A1DWE.:7X):<@M='/8N?4N8-F!Q;^_TVM>&VHX[!CF(M)1(L5T(X[I%Q
MBB#'<=2625N^^],!<BK/-7I27!P&96\AU?:'UBS[9G]=+,(H,^I#O++7[V*<
M709G)8Z,HZ0=S_M0L(5LGAEAA/<R.$$Z^44'/E)YOE -"!7E>VW\?/YNP;#R
MO[]$!TH?W#L@TCFE$5%$@:)/'%D-BAZL_.B#)$90UPDS6PM7GMM3#2=#^-O
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M:4EM;>'N*"DA% 9=CKQ0X->!CX>LY1H)H7'"+#(B[3%C\_AG7L+3A3YX*BR
M!G39<C-?%^,P_;UG/]@ -[Q""O@"^U$!@;IFB!!/:%2><5<\8'^$II<P4VJ(
M-BLJLU8PN'LGQE)GO8=-8!ERM0@PS$2'F,]UYXEH@TM'=?93\Q+F20W&W7 Y
MO9P8S\J<6"=?/\8GG"-U\/.5HCN=N-%4:(<X):.D'%&+->+:,>0D#@B;%#"/
M1&I>?$)B"Z&=NQX!*YF]'X,RA[\!&MZ,?HX"2.C2!&>B8: CE-'Y7;B%.T1:
M)!CV+BJEI"W-FPYDO800SRFH>SRKM*SD&KC]-UM8*XY+R3$18*8@ZZQ!W+N
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M0.4C]BE]M==QMFEPP1*7#'PZG@)'W+N4)\IB1%R>P^-U2KAT<NP1$4T"IX^
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M=C3]TUXO0&&RD)M6*61PC(@[#5Q*5H,1P'Q^R96$.HO?]N0[;3PB<=Y3^ S
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MU*U&IVV-,W)"#B-0<0&X3,X5PCSI%;>KJ]4@J028J" N2.WFV[E3)XWJ'TT
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M/TS.2DS.^2:8G%?3 U/B>,1^'4#_&TC0>]#N0_.?-P[U?_SX/U!+ P04
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M+O5P!W*WA4%9KC,DBG&=)PR5CIP"KIM?BQ0-)4&^8$5DE(A$@DG%YP025F;
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MRF]4%FCFYO?J@H4'@+3<;F;9]!N*C3]X*?[ZG]\<N9_]_!=02P,$%     @
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M9-<=8.>5<O.L+[A=>['^"U!+ P04    " #1B5I7*^UD!AX$  "F#@  &@
M &1X8VTY,S R,#(S97AH:6)I=#,R,#(N:'1MW5=;;]LV%'[?KSASL#0!?)'D
M6RPY 0S'QERT299+BST-M$A%1&E2I:C$WJ_?(24E:=V@[D.S;'X0+)W;=[YS
M>$B.4[,2)^.4$7KRR_C75@M.55RLF#00:T8,HU#D7-["1\KR3]!J55I3E6TT
MOTT-!%[0A8]*?^)WI)0;;@0[J?V,.^7[N.."C)>*;D[&E-\!I\<-'B][+!D,
M64!]VNN2/B$D]@?>T8 EH^$RH'_Y#31%]=(F-QO!CALK+ELIL_'#7M >]C,3
MW7-JTM#WO-\:3O5DG"AI,)Y&^_)OZ6;+F6%KTR*"W\K0I=0H36MQK(32X9[G
M?I&5M!*RXF(3OIEH3L2;9DYDWLJ9YDDISOG?#)$@*/=Z7P(=HK7@DM7 _<!"
MG:U3ON0&ND';"[X$^C1?HF\Q9:.R<(1NGR".D6*F?Q+DWC<A3V>7UXOY8CJY
M7IR?P?D<IK\O9G.8+\XF9]/%Y!U^0NGL\MEL_EWX%S>75S>3LVNX/G^E"/TC
MN&E?M:=MN)I-'<E^M^_MV!POBO0Z95!(RG2.5#':A+=,LQ6#]PA](^X(ETV8
MK5E<&'['X ./&5QHEG-J!PR1%*8I9PG,N20R1C1PGB2HI$$E<,K64[5JPD+&
M;3@P&&E_[R@(O B_9D1NW)L?'38A*W1>$/1H%#QRM[_G#X:19:X)*<):;@ ]
M&YYPEH-)B=G?ZQ]%N[#:KY<<EQ9X&/3<R'E1I@_X(5@./A=$8S^*#5RR3&D#
M2L)<Z17X7NL/2)1V6AD&4108XJ5PQ3+#5DNF+2->U$4^W-!&CJUN1><7%)>^
M:X8A*00&C%%16/+NN4F=J6:?"VX++DUNW5VQV' ERSA^]X < @+R^P?TL(Z&
M*H7FQKJ9K>.4R%L&D]A8L3_J]K FH\AVQG^G+E5AN$3R5\3FCTQ)@[V/W'/I
MA%6M$L)MY3)< I:RIA43(0#-F(6"A.89<H@2:Y4\+ MT2+ES;1<-:A6B9%QA
MI5W,_*MRMK<(?'9#W$GV,FR>VA.'6Y=P'AOUT+/!H.S9709VO8<;LA2LEB^5
MQBG50O2"9#D+ZS\1Y7DFR";DTJ%Q1E'58TMEC%JY-KNSDR,FHHKAPI7BZN#1
M&[0'W:$]>QCDT- Z<'4L:;MC2<?0;=GHJ#WRGA=[;?]!UG&^=:U04U?V/!IB
M5CD6_[C1;=0Z&:$4SV^A![[3>NKG>S9!MK963X\;@B5;9)0\O-2J<U3M[_6&
M4>Z>\'9V.7L_<UO.G^\^3!9G#TVR0ZI57]AI@IE"K@2G8%%'KY^$K;WV1Q)_
MU>GY?7<R_O%SP_^& 5?@@PO-,;T,\WO,U&8_B6-52&/O957BA]N9=]PLVW'(
M?S52ZDM5IG*W[82:"6)KL77->EQ(;E9ZCR9DB:NI,-LFW[F95<_RGMAQ]]-_
M %!+ 0(4 Q0    ( -&)6E<804G0.7D"  4!'  1              "  0
M  !D>&-M+3(P,C,P.3,P+FAT;5!+ 0(4 Q0    ( -&)6E=2C0T2+Q$   RT
M   1              "  6AY @!D>&-M+3(P,C,P.3,P+GAS9%!+ 0(4 Q0
M   ( -&)6E>SH.L; "(  #5+ 0 5              "  <:* @!D>&-M+3(P
M,C,P.3,P7V-A;"YX;6Q02P$"% ,4    " #1B5I7\=ALD&1*  !,+ , %0
M            @ 'YK ( 9'AC;2TR,#(S,#DS,%]D968N>&UL4$L! A0#%
M  @ T8E:5X?VU_;3'@$ A+$! !0              ( !D/<" &1X8VTM,C R
M,S Y,S!?9S$N:G!G4$L! A0#%     @ T8E:5^W0G62@EP  X]<  !0
M         ( !E18$ &1X8VTM,C R,S Y,S!?9S(N:G!G4$L! A0#%     @
MT8E:5PY:,<88G0  +M\  !0              ( !9ZX$ &1X8VTM,C R,S Y
M,S!?9S,N:G!G4$L! A0#%     @ T8E:5Q$?LQ5Q. $ N>P! !0
M     ( !L4L% &1X8VTM,C R,S Y,S!?9S0N:G!G4$L! A0#%     @ T8E:
M5T0K\=W.\@  1Q * !4              ( !5(0& &1X8VTM,C R,S Y,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( -&)6E?>GL_] 8L  %AF!@ 5
M  "  55W!P!D>&-M+3(P,C,P.3,P7W!R92YX;6Q02P$"% ,4    " #1B5I7
M($G(\7<+  #X8P  '@              @ &) @@ 9'AC;3DS,#(P,C-E>#$P
M,#$M8GER86UH96$N:'1M4$L! A0#%     @ T8E:5WV5!9@-#0  >&\  !X
M             ( !/ X( &1X8VTY,S R,#(S97@Q,# R+65D9V5P87)K+FAT
M;5!+ 0(4 Q0    ( -&)6E<LP^7'T0<  $@E   :              "  84;
M" !D>&-M.3,P,C R,V5X:&EB:70S,3 Q+FAT;5!+ 0(4 Q0    ( -&)6E?R
MG4P*SP<  /TC   :              "  8XC" !D>&-M.3,P,C R,V5X:&EB
M:70S,3 R+FAT;5!+ 0(4 Q0    ( -&)6E?%V3V)&@0  %\/   :
M      "  94K" !D>&-M.3,P,C R,V5X:&EB:70S,C Q+FAT;5!+ 0(4 Q0
M   ( -&)6E<K[60&'@0  *8.   :              "  ><O" !D>&-M.3,P
I,C R,V5X:&EB:70S,C R+FAT;5!+!08     $  0 $H$   ]- @    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
